|
a |
|
b/R-scripts/data/clinical/breast |
|
|
1 |
sampleID AJCC_Stage_nature2012 Age_at_Initial_Pathologic_Diagnosis_nature2012 CN_Clusters_nature2012 Converted_Stage_nature2012 Days_to_Date_of_Last_Contact_nature2012 Days_to_date_of_Death_nature2012 ER_Status_nature2012 Gender_nature2012 HER2_Final_Status_nature2012 Integrated_Clusters_no_exp__nature2012 Integrated_Clusters_unsup_exp__nature2012 Integrated_Clusters_with_PAM50__nature2012 Metastasis_Coded_nature2012 Metastasis_nature2012 Node_Coded_nature2012 Node_nature2012 OS_Time_nature2012 OS_event_nature2012 PAM50Call_RNAseq PAM50_mRNA_nature2012 PR_Status_nature2012 RPPA_Clusters_nature2012 SigClust_Intrinsic_mRNA_nature2012 SigClust_Unsupervised_mRNA_nature2012 Survival_Data_Form_nature2012 Tumor_T1_Coded_nature2012 Tumor_nature2012 Vital_Status_nature2012 _EVENT _INTEGRATION _OS _OS_IND _OS_UNIT _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_BRCA _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_BRCA _PANCAN_mutation_PANCAN _PATIENT _RFS _RFS_IND _RFS_UNIT _TIME_TO_EVENT _TIME_TO_EVENT_UNIT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision axillary_lymph_node_stage_method_type axillary_lymph_node_stage_other_method_descriptive_text bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode breast_cancer_surgery_margin_status breast_carcinoma_estrogen_receptor_status breast_carcinoma_immunohistochemistry_er_pos_finding_scale breast_carcinoma_immunohistochemistry_pos_cell_score breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl breast_carcinoma_primary_surgical_procedure_name breast_carcinoma_progesterone_receptor_status breast_carcinoma_surgical_procedure_name breast_neoplasm_other_surgical_procedure_descriptive_text cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_last_known_alive days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment disease_code distant_metastasis_present_ind2 er_detection_method_text er_level_cell_percentage_category fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng followup_case_report_form_submission_reason form_completion_date gender her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt her2_erbb_method_calculation_method_text her2_erbb_pos_finding_cell_percent_category her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt her2_immunohistochemistry_level_result her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt her2_neu_breast_carcinoma_copy_analysis_input_total_number her2_neu_chromosone_17_signal_ratio_value her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr histological_type histological_type_other history_of_neoadjuvant_treatment hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr icd_10 icd_o_3_histology icd_o_3_site immunohistochemistry_positive_cell_score informed_consent_verified init_pathology_dx_method_other initial_pathologic_diagnosis_method initial_weight is_ffpe lab_proc_her2_neu_immunohistochemistry_receptor_status lab_procedure_her2_neu_in_situ_hybrid_outcome_type lost_follow_up lymph_node_examined_count margin_status menopause_status metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt metastatic_breast_carcinoma_estrogen_receptor_status metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt metastatic_breast_carcinoma_progesterone_receptor_status metastatic_site_at_diagnosis metastatic_site_at_diagnosis_other methylation_Clusters_nature2012 miRNA_Clusters_nature2012 mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment number_of_lymphnodes_positive_by_he number_of_lymphnodes_positive_by_ihc oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status pgr_detection_method_text pos_finding_her2_erbb2_other_measurement_scale_text pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt pos_finding_progesterone_receptor_other_measurement_scale_text positive_finding_estrogen_receptor_other_measurement_scale_text postoperative_rx_tx primary_lymph_node_presentation_assessment progesterone_receptor_level_cell_percent_category project_code radiation_therapy sample_type sample_type_id surgical_procedure_purpose_other_text system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_BRCA_RPPA_RBN _GENOMIC_ID_TCGA_BRCA_mutation _GENOMIC_ID_TCGA_BRCA_PDMRNAseq _GENOMIC_ID_TCGA_BRCA_hMethyl450 _GENOMIC_ID_TCGA_BRCA_RPPA _GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV _GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene _GENOMIC_ID_TCGA_BRCA_hMethyl27 _GENOMIC_ID_TCGA_BRCA_PDMarrayCNV _GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq _GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene _GENOMIC_ID_TCGA_BRCA_miRNA_GA _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile _GENOMIC_ID_data/public/TCGA/BRCA/miRNA_GA_gene _GENOMIC_ID_TCGA_BRCA_gistic2thd _GENOMIC_ID_data/public/TCGA/BRCA/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_BRCA_G4502A_07_3 _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2 _GENOMIC_ID_TCGA_BRCA_gistic2 _GENOMIC_ID_TCGA_BRCA_PDMarray |
|
|
2 |
TCGA-3C-AAAU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-3C-AAAU-01 4047 0 days NA NA NA NA NA NA NA NA NA TCGA-3C-AAAU 4047 0 days 4047 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-3C-AAAU-F68069 TCGA-3C-AAAU TCGA-3C-AAAU-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -20211 3599 NA 0 4047 NA NA 1808 NA NA NA 50-59% NA NA 2015-3-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 60 NO Negative NA NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis NA NA NO 4 NA true No MX NX TX Stage X TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf AAAU WITH TUMOR NA NA NA NA NA NO YES 50-59% NA NO Primary Tumor 01 NA 6th NA NO YES 3C Breast A LIVING 2004 6ef883fc-81f3-4089-95e0-86904ffc0d38 6ef883fc-81f3-4089-95e0-86904ffc0d38 NA NA TCGA-3C-AAAU-01 TCGA-3C-AAAU-01A-11D-A41Q-05 NA TCGA-3C-AAAU-01 NA NA NA TCGA-3C-AAAU-01 NA NA 6ef883fc-81f3-4089-95e0-86904ffc0d38 NA TCGA-3C-AAAU-01A-11D-A41E-01 TCGA-3C-AAAU-01 NA 6ef883fc-81f3-4089-95e0-86904ffc0d38 TCGA-3C-AAAU-01A-11D-A41E-01 |
|
|
3 |
TCGA-3C-AALI-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-3C-AALI-01 4005 0 days NA NA NA NA NA NA NA NA NA TCGA-3C-AALI 4005 0 days 4005 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-3C-AALI-F68057 TCGA-3C-AALI TCGA-3C-AALI-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -18538 3772 NA 0 4005 NA NA NA NA NA NA <10% NA NA 2014-11-13 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Positive NA NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf AALI TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES 3C Breast A LIVING 2003 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 NA NA TCGA-3C-AALI-01 TCGA-3C-AALI-01A-11D-A41Q-05 1B37DE89-DEB6-4049-A2D4-450A4A1DE5D3 TCGA-3C-AALI-01 NA NA NA TCGA-3C-AALI-01 NA NA dd8d3665-ec9d-45be-b7b9-a85dac3585e2 NA TCGA-3C-AALI-01A-11D-A41E-01 TCGA-3C-AALI-01 NA dd8d3665-ec9d-45be-b7b9-a85dac3585e2 TCGA-3C-AALI-01A-11D-A41E-01 |
|
|
4 |
TCGA-3C-AALJ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-3C-AALJ-01 1474 0 days NA NA NA NA NA NA NA NA NA TCGA-3C-AALJ 1474 0 days 1474 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right NA NA TCGA-3C-AALJ-F71675 TCGA-3C-AALJ NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -22848 NA NA 0 1474 NA NA NA NA NA NA 90-99% NA NA 2015-3-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Indeterminate NA NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No M0 N1a T2 Stage IIB NA AALJ TUMOR FREE NA NA NA NA NA NO YES 30-39% NA NO Primary Tumor 01 NA 7th NA NO YES 3C Breast NA LIVING 2011 c924c2a8-ab41-4499-bb30-79705cc17d45 c924c2a8-ab41-4499-bb30-79705cc17d45 NA NA TCGA-3C-AALJ-01 TCGA-3C-AALJ-01A-31D-A41Q-05 NA TCGA-3C-AALJ-01 NA NA NA TCGA-3C-AALJ-01 NA NA c924c2a8-ab41-4499-bb30-79705cc17d45 NA TCGA-3C-AALJ-01A-31D-A41E-01 TCGA-3C-AALJ-01 NA c924c2a8-ab41-4499-bb30-79705cc17d45 TCGA-3C-AALJ-01A-31D-A41E-01 |
|
|
5 |
TCGA-3C-AALK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-3C-AALK-01 1448 0 days NA NA NA NA NA NA NA NA NA TCGA-3C-AALK 1448 0 days 1448 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Sentinel node biopsy alone NA TCGA-3C-AALK-F71676 TCGA-3C-AALK TCGA-3C-AALK-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19074 1022 NA 0 1448 NA NA NA NA NA NA 70-79% NA NA 2015-3-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Positive NA NO 2 Close NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T1c Stage IA TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf AALK TUMOR FREE NA NA NA NA NA NO YES 80-89% NA NO Primary Tumor 01 NA 7th NA NO YES 3C Breast A LIVING 2011 1a19e068-d213-41ef-aebb-104017a883cc 1a19e068-d213-41ef-aebb-104017a883cc NA NA TCGA-3C-AALK-01 TCGA-3C-AALK-01A-11D-A41Q-05 4B79D851-B233-49F8-95B1-B4AA057D7FD2 TCGA-3C-AALK-01 NA NA NA TCGA-3C-AALK-01 NA NA 1a19e068-d213-41ef-aebb-104017a883cc NA TCGA-3C-AALK-01A-11D-A41E-01 TCGA-3C-AALK-01 NA 1a19e068-d213-41ef-aebb-104017a883cc TCGA-3C-AALK-01A-11D-A41E-01 |
|
|
6 |
TCGA-4H-AAAK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-4H-AAAK-01 348 0 days NA NA NA NA NA NA NA NA NA TCGA-4H-AAAK 348 0 days 348 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-4H-AAAK-F67414 TCGA-4H-AAAK TCGA-4H-AAAK-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -18371 35 NA 0 348 NA NA NA NA NA NA 60-69% NA NA 2014-11-13 FEMALE NA NA 10-19% NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 770 NO Equivocal NA NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 4 NA true No M0 N2a T2 Stage IIIA TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf AAAK TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 NA 7th NA YES NO 4H Breast A LIVING 2013 2ea9e472-a408-4ae0-975d-50a566f22b2a 2ea9e472-a408-4ae0-975d-50a566f22b2a NA NA TCGA-4H-AAAK-01 TCGA-4H-AAAK-01A-12D-A41Q-05 C1C10723-C328-4CAB-9959-E98025E4CD71 TCGA-4H-AAAK-01 NA NA NA TCGA-4H-AAAK-01 NA NA 2ea9e472-a408-4ae0-975d-50a566f22b2a NA TCGA-4H-AAAK-01A-12D-A41E-01 TCGA-4H-AAAK-01 NA 2ea9e472-a408-4ae0-975d-50a566f22b2a TCGA-4H-AAAK-01A-12D-A41E-01 |
|
|
7 |
TCGA-5L-AAT0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-5L-AAT0-01 1477 0 days NA NA NA NA NA NA NA NA NA TCGA-5L-AAT0 1477 0 days 1477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right|Right Lower Outer Quadrant Axillary lymph node dissection alone NA NA TCGA-5L-AAT0 TCGA-5L-AAT0-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15393 1320 NA 0 1477 NA NA NA NA NA NA 70-79% NA NA 2014-8-15 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Incisional Biopsy 80 NO Negative NA NA 8 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf AAT0 TUMOR FREE NA NA NA NA NA YES YES 50-59% NA YES Primary Tumor 01 NA 7th NA NO YES 5L Breast A LIVING 2010 32e61645-eb89-49f7-9876-85b1497c7e42 32e61645-eb89-49f7-9876-85b1497c7e42 NA NA TCGA-5L-AAT0-01 TCGA-5L-AAT0-01A-12D-A41Q-05 NA TCGA-5L-AAT0-01 NA NA NA TCGA-5L-AAT0-01 NA NA 32e61645-eb89-49f7-9876-85b1497c7e42 NA TCGA-5L-AAT0-01A-12D-A41E-01 TCGA-5L-AAT0-01 NA 32e61645-eb89-49f7-9876-85b1497c7e42 TCGA-5L-AAT0-01A-12D-A41E-01 |
|
|
8 |
TCGA-5L-AAT1-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-5L-AAT1-01 1471 0 days NA NA NA NA NA NA NA NA NA TCGA-5L-AAT1 1471 0 days 1471 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Other (specify) Level 1 clearance NA TCGA-5L-AAT1 TCGA-5L-AAT1-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23225 1259 NA 0 1471 NA NA NA NA NA NA 80-89% NA NA 2014-8-15 FEMALE NA CISH NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 130 NO Equivocal NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA NA NA NA NA NA NA NA NA NA NO 0 NA false Yes M1 N0 T2 Stage IV TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf AAT1 WITH TUMOR NA CISH NA NA NA YES YES 10-19% NA NO Primary Tumor 01 NA 7th NA NO YES 5L Breast A LIVING 2010 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 NA NA TCGA-5L-AAT1-01 TCGA-5L-AAT1-01A-12D-A41Q-05 047431B7-6180-49AB-9DD0-D23D794F2953 TCGA-5L-AAT1-01 NA NA NA NA NA NA 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 NA TCGA-5L-AAT1-01A-12D-A41E-01 NA NA 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 TCGA-5L-AAT1-01A-12D-A41E-01 |
|
|
9 |
TCGA-5T-A9QA-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-5T-A9QA-01 303 0 days NA NA NA NA NA NA NA NA NA TCGA-5T-A9QA 303 0 days 303 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left No axillary staging NA TCGA-5T-A9QA-F66889 TCGA-5T-A9QA TCGA-5T-A9QA-01A NA Positive 3 Point Scale NA NA NA Negative NA NA NO NA NA -19031 31 NA 0 303 NA NA NA NA NA NA 70-79% NA NA 2014-10-25 FEMALE NA NA 10-19% NA 2+ NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 2+ YES NA Excisional Biopsy 650 NO Equivocal Negative NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX NX T2 Stage IIA TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf A9QA NA NA NA NA NA NA YES NO NA NA YES Primary Tumor 01 NA 7th NA YES NO 5T Breast A LIVING 2013 41ab76d7-fae0-490c-9545-be576b64b827 41ab76d7-fae0-490c-9545-be576b64b827 NA NA TCGA-5T-A9QA-01 TCGA-5T-A9QA-01A-11D-A41Q-05 9E71A150-8FD7-466C-96AF-AAB29520BCDC TCGA-5T-A9QA-01 NA NA NA TCGA-5T-A9QA-01 NA NA 41ab76d7-fae0-490c-9545-be576b64b827 NA TCGA-5T-A9QA-01A-11D-A41E-01 TCGA-5T-A9QA-01 NA 41ab76d7-fae0-490c-9545-be576b64b827 TCGA-5T-A9QA-01A-11D-A41E-01 |
|
|
10 |
TCGA-A1-A0SB-01 Stage I 70 1 Stage I 259 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 259 0 Normal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-A1-A0SB-01 259 0 days Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 NA BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A1-A0SB NA NA days 259 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Sentinel node biopsy alone NA NA TCGA-A1-A0SB NA NA Positive NA NA NA NA Negative Lumpectomy NA NA NA NA -25833 NA NA 0 259 NA NA NA NA NO NA 70-79% NA NA 2011-6-30 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8200/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 T1c Stage I NA A0SB TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast NA LIVING 2008 a2405d64-34eb-4915-abf7-8530151d5cb0 a2405d64-34eb-4915-abf7-8530151d5cb0 NA TCGA-A1-A0SB-01A-11D-A142-09 TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A145-05 NA TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A142-09 NA NA TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A142-09 NA a2405d64-34eb-4915-abf7-8530151d5cb0 NA TCGA-A1-A0SB-01A-11D-A141-01 TCGA-A1-A0SB-01 NA a2405d64-34eb-4915-abf7-8530151d5cb0 TCGA-A1-A0SB-01A-11D-A141-01 |
|
|
11 |
TCGA-A1-A0SD-01 Stage IIA 59 2 Stage IIA 437 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 437 0 LumA Luminal A Positive NA -9 -3 enrollment T_Other T2 LIVING 0 TCGA-A1-A0SD-01 437 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-A1-A0SD NA NA days 437 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SD TCGA-A1-A0SD-01A Negative Positive NA NA NA Lumpectomy Positive Lumpectomy NA NA NA NA -21793 1697 NA 0 437 NA NA NA NA NA NA 90-99% NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 50 NO Negative NA NA 3 Positive NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 T2 Stage IIA TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf A0SD NA NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2005 15bad71d-3031-413b-9e8d-6426ae5dfbea 15bad71d-3031-413b-9e8d-6426ae5dfbea NA TCGA-A1-A0SD-01A-11D-A10Y-09 TCGA-A1-A0SD-01 NA NA TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11D-A10Y-09 TCGA-A1-A0SD-01A-11D-A112-05 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11D-A10Y-09 NA 15bad71d-3031-413b-9e8d-6426ae5dfbea NA TCGA-A1-A0SD-01A-11D-A111-01 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11R-A115-07 15bad71d-3031-413b-9e8d-6426ae5dfbea TCGA-A1-A0SD-01A-11D-A111-01 TCGA-A1-A0SD-01 |
|
|
12 |
TCGA-A1-A0SE-01 Stage I 56 2 Stage I 1320 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1320 0 LumA Luminal A Positive NA -5 -7 enrollment T1 T1 LIVING 0 TCGA-A1-A0SE-01 1321 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A1-A0SE NA NA days 1321 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SE NA NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NA NA NA -20717 NA NA 0 1321 NA NA NA NA NA NA 80-89% 2 NA 2010-12-6 FEMALE NA NA NA NA 1+ NA 2 1 NA Mixed Histology (please specify) invasive ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative Negative NA 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 (i-) T1c Stage I NA A0SE TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast NA LIVING 2005 a998e0ce-9248-460f-aabc-2dad452a1ff9 a998e0ce-9248-460f-aabc-2dad452a1ff9 NA TCGA-A1-A0SE-01A-11D-A099-09 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A10P-05 NA TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A099-09 NA TCGA-A1-A0SE-01 NA TCGA-A1-A0SE-01A-11D-A099-09 TCGA-A1-A0SE-01 a998e0ce-9248-460f-aabc-2dad452a1ff9 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A087-01 NA TCGA-A1-A0SE-01A-11R-A084-07 a998e0ce-9248-460f-aabc-2dad452a1ff9 TCGA-A1-A0SE-01A-11D-A087-01 TCGA-A1-A0SE-01 |
|
|
13 |
TCGA-A1-A0SF-01 Stage IIA 54 3 Stage IIA 1463 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1463 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A1-A0SF-01 1463 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-A1-A0SF NA NA days 1463 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SF TCGA-A1-A0SF-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19731 1648 NA 0 1463 NA NA NA NA NO NA 90-99% NA NA 2011-5-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 190 NO Negative NA NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf A0SF TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2006 28089e15-5e2c-4e83-ba6c-62b3cb40e431 28089e15-5e2c-4e83-ba6c-62b3cb40e431 TCGA-A1-A0SF-01A-21-A17I-20 TCGA-A1-A0SF-01A-11D-A142-09 TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A145-05 f0b3d871-c0aa-4ef8-ab74-c3e812393ed5 TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A142-09 NA NA TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A142-09 NA 28089e15-5e2c-4e83-ba6c-62b3cb40e431 NA TCGA-A1-A0SF-01A-11D-A141-01 TCGA-A1-A0SF-01 NA 28089e15-5e2c-4e83-ba6c-62b3cb40e431 TCGA-A1-A0SF-01A-11D-A141-01 |
|
|
14 |
TCGA-A1-A0SG-01 Stage IIB 61 4 Stage IIB 433 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 433 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A1-A0SG-01 434 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation c1uster 9 TCGA-A1-A0SG NA NA days 434 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SG TCGA-A1-A0SG-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -22380 1581 NA 0 434 NA NA NA NA NA NA 90-99% NA NA 2011-5-31 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8507/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf A0SG NA NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2006 0df6b948-367d-4951-9d98-d3bebabff63e 0df6b948-367d-4951-9d98-d3bebabff63e NA TCGA-A1-A0SG-01A-11D-A142-09 TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A145-05 NA TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A142-09 NA NA TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A142-09 NA 0df6b948-367d-4951-9d98-d3bebabff63e NA TCGA-A1-A0SG-01A-11D-A141-01 TCGA-A1-A0SG-01 NA 0df6b948-367d-4951-9d98-d3bebabff63e TCGA-A1-A0SG-01A-11D-A141-01 |
|
|
15 |
TCGA-A1-A0SH-01 Stage IIA 39 5 Stage IIA 1437 NA Negative FEMALE Negative 1 1 1 Negative M0 Negative N0 1437 0 LumA Luminal A Positive Her2 -5 -7 enrollment T_Other T2 LIVING 0 TCGA-A1-A0SH-01 1437 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation c1uster 10 TCGA-A1-A0SH NA NA days 1437 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Upper Inner Quadrant Sentinel node biopsy alone NA NA TCGA-A1-A0SH TCGA-A1-A0SH-01A NA Negative NA NA NA NA Positive Lumpectomy NA NA NA NA -14595 1305 NA 0 1437 NA NA NA NA NA NA NA 1.8 NA 2010-12-6 FEMALE NA NA NA NA 2+ NA 2.5 1.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 240 NO Equivocal Negative NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf A0SH TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2006 dce3de3e-f851-4859-a208-72e65d36ab3d dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01A-21-A13A-20 TCGA-A1-A0SH-01A-11D-A099-09 TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A10P-05 4760c029-9150-4384-b036-263684155c89 TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A099-09 NA TCGA-A1-A0SH-01 NA TCGA-A1-A0SH-01A-11D-A099-09 TCGA-A1-A0SH-01 dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A087-01 NA TCGA-A1-A0SH-01A-11R-A084-07 dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01A-11D-A087-01 TCGA-A1-A0SH-01 |
|
|
16 |
TCGA-A1-A0SI-01 Stage IIB 52 3 Stage IIB 634 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 634 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A1-A0SI-01 635 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 3 TCGA-A1-A0SI NA NA days 635 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SI TCGA-A1-A0SI-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -19250 1267 NA 0 635 NA NA NA NA NO NA 50-59% NA NA 2011-6-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 40 NO Negative NA NA 23 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 7 NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf A0SI TUMOR FREE NA NA NA NA NA NA YES 10-19% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2007 44d93b9f-95d6-4382-9590-f6e7bdda65c5 44d93b9f-95d6-4382-9590-f6e7bdda65c5 NA TCGA-A1-A0SI-01A-11D-A142-09 TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A145-05 NA TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A142-09 NA NA TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A142-09 NA 44d93b9f-95d6-4382-9590-f6e7bdda65c5 NA TCGA-A1-A0SI-01A-11D-A141-01 TCGA-A1-A0SI-01 NA 44d93b9f-95d6-4382-9590-f6e7bdda65c5 TCGA-A1-A0SI-01A-11D-A141-01 |
|
|
17 |
TCGA-A1-A0SJ-01 Stage IIIA 39 3 Stage IIIA 426 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 426 0 LumA Luminal A Positive ReacI -3 -3 enrollment T_Other T3 LIVING 0 TCGA-A1-A0SJ-01 416 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SJ NA NA days 416 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SJ TCGA-A1-A0SJ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14383 1399 NA 0 416 NA NA NA NA NA NA 70-79% 4 NA 2010-12-6 FEMALE NA NA NA NA 2+ NA 5 1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Equivocal Negative NA 19 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 3 NA true No M0 N1a T3 Stage IIIA TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf A0SJ TUMOR FREE NA NA NA NA NA NA NA 10-19% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2006 61017170-a36a-4ce9-9b8e-324755b88dd7 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01A-21-A13A-20 TCGA-A1-A0SJ-01A-11D-A099-09 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A10P-05 33773418-77f8-4219-9b75-04d5ba09bb97 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A099-09 NA TCGA-A1-A0SJ-01 NA TCGA-A1-A0SJ-01A-11D-A099-09 TCGA-A1-A0SJ-01 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A087-01 NA TCGA-A1-A0SJ-01A-11R-A084-07 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01A-11D-A087-01 TCGA-A1-A0SJ-01 |
|
|
18 |
TCGA-A1-A0SK-01 Stage IIA 54 1 Stage IIA 594 967 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 967 1 Basal Basal-like Negative Basal -13 -6 followup T_Other T2 DECEASED 1 TCGA-A1-A0SK-01 967 1 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 GBM-like c6 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-A1-A0SK NA NA days 967 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A1-A0SK-F15926 TCGA-A1-A0SK TCGA-A1-A0SK-01A Negative Negative NA NA NA Other Negative Lumpectomy surgical resection NA NA NA -20048 1164 967 0 NA NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-9-7 FEMALE NA NA NA NA 0 NA NA NA NA Other, specify NA No NA C50.9 8013/3 C50.9 NA YES NA Excisional Biopsy 160 NO Negative NA NA 4 Positive Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf A0SK WITH TUMOR NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A DECEASED 2007 a63583ca-0ef2-4417-b435-5f3a6951d0c2 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01A-21-A13A-20 TCGA-A1-A0SK-01A-12D-A099-09 TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A10P-05 8d8099ba-c207-473b-8ffc-e9610494386c TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A099-09 NA TCGA-A1-A0SK-01 NA TCGA-A1-A0SK-01A-12D-A099-09 TCGA-A1-A0SK-01 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A087-01 NA TCGA-A1-A0SK-01A-12R-A084-07 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01A-12D-A087-01 TCGA-A1-A0SK-01 |
|
|
19 |
TCGA-A1-A0SM-01 Stage IIA 77 2 Stage IIA 242 NA Positive MALE Positive NA NA NA Negative M0 Negative N0 242 0 LumA Luminal B Negative NA -1 -3 enrollment T_Other T2 LIVING 0 TCGA-A1-A0SM-01 242 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SM NA NA days 242 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SM NA NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -28198 NA NA 0 242 NA NA NA NA NA NA 20-29% 2 NA 2010-12-6 MALE NA NA NA NA 3+ NA 21 11 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive Positive NA 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A0SM TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast NA LIVING 2007 e637db43-508a-4a37-92e4-eea96b35b65b e637db43-508a-4a37-92e4-eea96b35b65b NA TCGA-A1-A0SM-01A-11D-A099-09 TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A10P-05 NA TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A099-09 NA TCGA-A1-A0SM-01 NA TCGA-A1-A0SM-01A-11D-A099-09 TCGA-A1-A0SM-01 e637db43-508a-4a37-92e4-eea96b35b65b TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A087-01 NA TCGA-A1-A0SM-01A-11R-A084-07 e637db43-508a-4a37-92e4-eea96b35b65b TCGA-A1-A0SM-01A-11D-A087-01 TCGA-A1-A0SM-01 |
|
|
20 |
TCGA-A1-A0SN-01 Stage IIIA 50 5 Stage IIA 1196 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 1196 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-A1-A0SN-01 1196 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SN NA NA days 1196 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SN TCGA-A1-A0SN-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -18401 1091 NA 0 1196 NA NA NA NA NA NA 90-99% NA NA 2011-5-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Positive NA NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 4 NA true No MX N1 T1c Stage IIA TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf A0SN TUMOR FREE NA NA NA NA NA NA YES 60-69% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2007 7fdf1ebf-149a-43d5-bae7-6e01beb647dd 7fdf1ebf-149a-43d5-bae7-6e01beb647dd NA TCGA-A1-A0SN-01A-11D-A142-09 TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A145-05 NA TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A142-09 NA NA TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A142-09 NA 7fdf1ebf-149a-43d5-bae7-6e01beb647dd NA TCGA-A1-A0SN-01A-11D-A141-01 TCGA-A1-A0SN-01 NA 7fdf1ebf-149a-43d5-bae7-6e01beb647dd TCGA-A1-A0SN-01A-11D-A141-01 |
|
|
21 |
TCGA-A1-A0SO-01 Stage IIB 67 1 Stage IIB 852 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 852 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-A1-A0SO-01 852 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-A1-A0SO NA NA days 852 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SO TCGA-A1-A0SO-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -24826 1057 NA 0 852 NA NA NA NA NA NA NA 3.2 NA 2010-12-6 FEMALE NA NA NA NA NA NA 5 1.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Equivocal Negative NA 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf A0SO TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2007 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01A-11-A13A-20 TCGA-A1-A0SO-01A-22D-A099-09 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01A-22D-A10P-05 3c86150e-49f3-4303-bd6e-3d4bcc4aad50 TCGA-A1-A0SO-01 NA NA TCGA-A1-A0SO-01 NA TCGA-A1-A0SO-01A-22D-A099-09 TCGA-A1-A0SO-01 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01A-22D-A087-01 NA TCGA-A1-A0SO-01A-22R-A084-07 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01A-22D-A087-01 TCGA-A1-A0SO-01 |
|
|
22 |
TCGA-A1-A0SP-01 Stage IIA 40 NA Stage IIA 583 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 583 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A1-A0SP-01 584 0 days High C4-BRCA/Basal NA BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 NA mutation cluster 5 TCGA-A1-A0SP NA NA days 584 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Axillary lymph node dissection alone NA NA TCGA-A1-A0SP NA NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -14954 NA NA 0 584 NA NA NA NA NA NA NA NA NA 2010-12-6 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA NA NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA NA Yes M0 N0 (i-) T2 Stage IIA NA A0SP TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast NA LIVING 2007 f091d050-4847-4d4d-b94c-1efacecdef6b f091d050-4847-4d4d-b94c-1efacecdef6b NA TCGA-A1-A0SP-01A-11D-A099-09 TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A10P-05 NA TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A099-09 NA TCGA-A1-A0SP-01 NA TCGA-A1-A0SP-01A-11D-A099-09 TCGA-A1-A0SP-01 f091d050-4847-4d4d-b94c-1efacecdef6b TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A087-01 NA TCGA-A1-A0SP-01A-11R-A084-07 f091d050-4847-4d4d-b94c-1efacecdef6b TCGA-A1-A0SP-01A-11D-A087-01 TCGA-A1-A0SP-01 |
|
|
23 |
TCGA-A1-A0SQ-01 Stage IIB 45 3 Stage IIB 553 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 553 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A1-A0SQ-01 554 0 days Iq C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-A1-A0SQ NA NA days 554 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-A1-A0SQ TCGA-A1-A0SQ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16458 967 NA 0 554 NA NA NA NA NO NA 90-99% NA NA 2011-6-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NA 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 1 NA true No MX N1 T2 Stage IIB TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf A0SQ TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 6th NA NO YES A1 Breast A LIVING 2007 9efdba02-2752-4c89-bb53-e8018f5aa7bf 9efdba02-2752-4c89-bb53-e8018f5aa7bf TCGA-A1-A0SQ-01A-11-A17I-20 TCGA-A1-A0SQ-01A-21D-A142-09 TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A145-05 5f624f7e-a0d0-454e-ba7a-6ca212ec4fda TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A142-09 NA NA TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A142-09 NA 9efdba02-2752-4c89-bb53-e8018f5aa7bf NA TCGA-A1-A0SQ-01A-21D-A141-01 TCGA-A1-A0SQ-01 NA 9efdba02-2752-4c89-bb53-e8018f5aa7bf TCGA-A1-A0SQ-01A-21D-A141-01 |
|
|
24 |
TCGA-A2-A04N-01 Stage IA 66 4 Stage I 3188 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3188 0 LumA Luminal A Positive LumA -5 -3 followup T1 T1 LIVING 0 TCGA-A2-A04N-01 4354 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A04N 4354 0 days 4354 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Other (specify) Sentinel lymph node biopsy plus non-sentinel lymph node biopsy TCGA-A2-A04N-F59311 TCGA-A2-A04N TCGA-A2-A04N-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -24155 2850 NA 0 4354 NA NA NA NA NA NA NA NA NA 2014-5-8 FEMALE NA NA NA NA NA NA NA 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 130 NO NA Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf A04N TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA 5th YES NO YES A2 Breast A LIVING 2002 71b60d53-513c-4da5-b095-39f913bd4f11 71b60d53-513c-4da5-b095-39f913bd4f11 TCGA-A2-A04N-01A-21-A13A-20 TCGA-A2-A04N-01A-11D-A10Y-09 TCGA-A2-A04N-01 NA 2ef34d44-4aa3-4b06-8029-f92c4b3a49a7 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11D-A10Y-09 TCGA-A2-A04N-01A-11D-A112-05 TCGA-A2-A04N-01 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11D-A10Y-09 NA 71b60d53-513c-4da5-b095-39f913bd4f11 NA TCGA-A2-A04N-01A-11D-A111-01 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11R-A115-07 71b60d53-513c-4da5-b095-39f913bd4f11 TCGA-A2-A04N-01A-11D-A111-01 TCGA-A2-A04N-01 |
|
|
25 |
TCGA-A2-A04P-01 Stage IIIC 36 1 No_Conversion 547 547 Negative FEMALE Negative 2 2 2 Negative M0 Positive N3 547 1 Basal Basal-like Negative Basal -13 0 followup T_Other T2 DECEASED 1 TCGA-A2-A04P-01 548 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-A2-A04P 179 1 days 548 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NO 36 Left Axillary lymph node dissection alone NA TCGA-A2-A04P-F71021 TCGA-A2-A04P TCGA-A2-A04P-01A Positive Negative NA NA NA Mastectomy NOS Negative Lumpectomy NA NO NA NA -13238 2623 548 0 NA NA 179 179 NA NA NA <10% NA NA 2015-3-13 FEMALE NA NA NA NA NA NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 250 NO NA Negative NO 20 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA Negative NA NA NA 1.0 NA NA NA Negative NA NA NA Negative NA NA 5 5 NA NA NA Other, specify Locoregional Recurrence Axilla YES YES 18 0 true No M0 N3c T2 Stage IIIC TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf A04P WITH TUMOR NA NA NA NA NA YES NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2003 357ba9f6-716c-4ef0-8ac8-41977397dbf5 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01A-41-A13A-20 TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01 NA 15a1aee0-d9cf-4122-9290-0d4bfaee159a TCGA-A2-A04P-01 TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01A-31D-A032-05 TCGA-A2-A04P-01 NA TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01 TCGA-A2-A04P-01A-31D-A036-01 NA TCGA-A2-A04P-01A-31R-A034-07 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01A-31D-A036-01 TCGA-A2-A04P-01 |
|
|
26 |
TCGA-A2-A04Q-01 Stage IA 48 3 Stage I 1275 NA Negative FEMALE Negative 1 2 3 Negative M0 Negative N0 1275 0 Basal Basal-like Negative ReacII -13 -12 followup T1 T1 LIVING 0 TCGA-A2-A04Q-01 2385 0 days High C4-BRCA/Basal cluster 1 BRCA CIMP c7 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A04Q NA NA days 2385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant|Right Other (specify) SLN AND NON-SLN BX TCGA-A2-A04Q-F59314 TCGA-A2-A04Q TCGA-A2-A04Q-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -17660 2260 NA 0 2385 NA NA NA NA NA NA <10% NA NA 2014-5-8 FEMALE NA NA NA NA 2+ NA NA 1.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES SKIN BIOPSY Other method, specify: 230 NO Equivocal Negative YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf A04Q TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2004 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01A-11-A13A-20 TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01 NA 9e43165b-f93c-4a25-a1c8-7bdad54cee95 TCGA-A2-A04Q-01 TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01A-21D-A032-05 TCGA-A2-A04Q-01 NA TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01 TCGA-A2-A04Q-01A-21D-A036-01 NA TCGA-A2-A04Q-01A-21R-A034-07 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01A-21D-A036-01 TCGA-A2-A04Q-01 |
|
|
27 |
TCGA-A2-A04R-01 Stage IA 36 5 Stage I 2499 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2499 0 LumB Luminal B Positive NA -10 -3 followup T1 T1 LIVING 0 TCGA-A2-A04R-01 3709 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 10 TCGA-A2-A04R 3709 0 days 3709 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A04R-F59315 TCGA-A2-A04R TCGA-A2-A04R-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -13483 2233 NA 0 3709 NA NA NA NA NA NA 60-69% NA NA 2014-5-8 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 160 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf A04R TUMOR FREE NA NA NA NA NA YES NA 80-89% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2004 8801f107-f5d5-4ad5-877d-a5acb12596b3 8801f107-f5d5-4ad5-877d-a5acb12596b3 NA TCGA-A2-A04R-01A-41D-A117-09 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A10A-05 NA TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A117-09 NA TCGA-A2-A04R-01 NA TCGA-A2-A04R-01A-41D-A117-09 TCGA-A2-A04R-01 8801f107-f5d5-4ad5-877d-a5acb12596b3 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A107-01 NA TCGA-A2-A04R-01A-41R-A109-07 8801f107-f5d5-4ad5-877d-a5acb12596b3 TCGA-A2-A04R-01A-41D-A107-01 TCGA-A2-A04R-01 |
|
|
28 |
TCGA-A2-A04T-01 Stage IIA 62 1 Stage IIA 2246 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 2246 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-A2-A04T-01 2246 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 5 NA TCGA-A2-A04T NA NA days 2246 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A04T-F9343 TCGA-A2-A04T TCGA-A2-A04T-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -22707 1979 NA 0 2246 NA NA NA NA NA NA <10% NA NA 2011-3-17 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Equivocal Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf A04T TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2004 79d7a589-60bd-4b4a-89c1-d557fe24c733 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01A-31-A13A-20 NA TCGA-A2-A04T-01 NA 2724de89-78e5-4da5-b2d9-350a986a8abb TCGA-A2-A04T-01 TCGA-A2-A04T-01A-21W-A050-09 TCGA-A2-A04T-01A-21D-A032-05 TCGA-A2-A04T-01 NA NA TCGA-A2-A04T-01 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01 TCGA-A2-A04T-01A-21D-A036-01 NA TCGA-A2-A04T-01A-21R-A034-07 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01A-21D-A036-01 TCGA-A2-A04T-01 |
|
|
29 |
TCGA-A2-A04U-01 Stage IIA 47 NA Stage IIA 670 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 670 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-A2-A04U-01 2654 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A2-A04U NA NA days 2654 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Sentinel node biopsy alone NA TCGA-A2-A04U-F59317 TCGA-A2-A04U TCGA-A2-A04U-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -17474 1924 NA 0 2654 NA NA NA NA NA NA <10% NA NA 2014-5-8 FEMALE NA NA NA NA 1+ NA NA 2.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Negative Positive YES 3 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf A04U TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2004 4d12d021-3673-4e14-9fd9-033f811f87da 4d12d021-3673-4e14-9fd9-033f811f87da TCGA-A2-A04U-01A-21-A13A-20 TCGA-A2-A04U-01A-11D-A10Y-09 TCGA-A2-A04U-01 NA 485e1504-dfe0-43a4-83a1-f4376e8e687b TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11D-A10Y-09 TCGA-A2-A04U-01A-11D-A112-05 TCGA-A2-A04U-01 TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11D-A10Y-09 NA 4d12d021-3673-4e14-9fd9-033f811f87da NA TCGA-A2-A04U-01A-11D-A111-01 TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11R-A115-07 4d12d021-3673-4e14-9fd9-033f811f87da TCGA-A2-A04U-01A-11D-A111-01 TCGA-A2-A04U-01 |
|
|
30 |
TCGA-A2-A04V-01 Stage IIA 39 2 Stage IIA 1920 1920 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1920 1 LumA Luminal A Positive LumA/B 0 -3 enrollment T_Other T2 DECEASED 1 TCGA-A2-A04V-01 1920 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A04V NA NA days 1920 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NO 39 Right Lower Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-A2-A04V-F10273 TCGA-A2-A04V TCGA-A2-A04V-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -14250 1812 1920 0 NA NA NA 1470 NA NA NA 90-99% NA NA 2011-3-18 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Equivocal Negative NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf A04V WITH TUMOR NA NA NA MODERATE STRONG NA NA 10-19% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2005 72d79574-45e1-453a-bc95-a2dca1d3e251 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01A-11-A13A-20 TCGA-A2-A04V-01A-21W-A050-09 TCGA-A2-A04V-01 NA 676bd916-c1a1-4b1f-b406-0c3bae66640e TCGA-A2-A04V-01 TCGA-A2-A04V-01A-21W-A050-09 TCGA-A2-A04V-01A-21D-A032-05 TCGA-A2-A04V-01 NA TCGA-A2-A04V-01A-21W-A050-09,TCGA-A2-A04V-01A-21D-A045-09 TCGA-A2-A04V-01 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01 TCGA-A2-A04V-01A-21D-A036-01 NA TCGA-A2-A04V-01A-21R-A034-07 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01A-21D-A036-01 TCGA-A2-A04V-01 |
|
|
31 |
TCGA-A2-A04W-01 Stage IIB 50 3 No_Conversion 1948 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 1948 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING 0 TCGA-A2-A04W-01 3102 0 days Squamous C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation cluster 3 TCGA-A2-A04W 3102 0 days 3102 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A04W-F59320 TCGA-A2-A04W TCGA-A2-A04W-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18345 1630 NA 0 3102 NA NA NA NA NA NA <10% NA NA 2014-5-8 FEMALE NA NA NA NA NA NA NA 3.2 NA Other, specify NA No NA C50.9 8401/3 C50.9 NA YES NA Core needle biopsy 420 NO Positive Positive NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T2 Stage IIB TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf A04W TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2005 ddb62dc3-293b-4021-905a-83ae10aa0f8e ddb62dc3-293b-4021-905a-83ae10aa0f8e TCGA-A2-A04W-01A-21-A13A-20 TCGA-A2-A04W-01A-31D-A10Y-09 TCGA-A2-A04W-01 NA 469913c6-08bb-4c19-8a68-2735f5c4f981 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31D-A10Y-09 TCGA-A2-A04W-01A-31D-A112-05 TCGA-A2-A04W-01 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31D-A10Y-09 NA ddb62dc3-293b-4021-905a-83ae10aa0f8e NA TCGA-A2-A04W-01A-31D-A111-01 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31R-A115-07 ddb62dc3-293b-4021-905a-83ae10aa0f8e TCGA-A2-A04W-01A-31D-A111-01 TCGA-A2-A04W-01 |
|
|
32 |
TCGA-A2-A04X-01 Stage IIA 34 3 Stage IIA 1686 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1686 0 Her2 HER2-enriched Positive NA -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A04X-01 1686 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A04X NA NA days 1686 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Left Sentinel node biopsy alone NA TCGA-A2-A04X-F9335 TCGA-A2-A04X TCGA-A2-A04X-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -12642 1390 NA 0 1686 NA NA NA NA NA NA 80-89% NA NA 2011-3-18 FEMALE NA NA NA NA 3+ NA NA 3.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 180 NO Positive Positive NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf A04X TUMOR FREE NA NA NA MODERATE STRONG NA NA 50-59% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2006 08c54c9c-195c-4754-83af-a97544d0eb12 08c54c9c-195c-4754-83af-a97544d0eb12 NA TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01 NA NA TCGA-A2-A04X-01 TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01A-21D-A032-05 TCGA-A2-A04X-01 NA TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01 08c54c9c-195c-4754-83af-a97544d0eb12 TCGA-A2-A04X-01 TCGA-A2-A04X-01A-21D-A036-01 NA TCGA-A2-A04X-01A-21R-A034-07 08c54c9c-195c-4754-83af-a97544d0eb12 TCGA-A2-A04X-01A-21D-A036-01 TCGA-A2-A04X-01 |
|
|
33 |
TCGA-A2-A04Y-01 Stage IIB 53 5 No_Conversion 1099 NA Positive FEMALE Negative 2 3 3 Negative M0 Positive N1 1099 0 LumB Luminal A Positive LumA -2 -3 followup T_Other T2 LIVING 0 TCGA-A2-A04Y-01 1099 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A2-A04Y NA NA days 1099 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A04Y-F9330 TCGA-A2-A04Y TCGA-A2-A04Y-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19533 756 NA 0 1099 NA NA NA NA NA NA 90-99% NA NA 2011-3-18 FEMALE NA NA NA NA 1+ NA NA 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative Negative NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 5 NA NA NA NA NA NA NA NA 1 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf A04Y TUMOR FREE NA NA NA NA Strong NA NA 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 7002615e-435b-4631-bb5b-e4b7532a143a 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01A-11-A13A-20 TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01 NA b850ebdc-d177-4c59-8c71-9cf8dd589307 TCGA-A2-A04Y-01 TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01A-21D-A032-05 TCGA-A2-A04Y-01 NA TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01 TCGA-A2-A04Y-01A-21D-A036-01 NA TCGA-A2-A04Y-01A-21R-A034-07 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01A-21D-A036-01 TCGA-A2-A04Y-01 |
|
|
34 |
TCGA-A2-A0CK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A0CK-01 4159 0 days Iq NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 14 NA NA TCGA-A2-A0CK 1364 1 days 4159 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 60 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0CK-F42396 TCGA-A2-A0CK TCGA-A2-A0CK-01A Negative Positive 3 Point Scale 3+ 3 Point Scale Modified radical mastectomy Positive Lumpectomy NA NO NA NA -22094 3080 NA 0 4159 NA 1409 1364 NA NO NA 40-49% NA NA 2013-4-18 FEMALE NA NA NA NA NA NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Excisional Biopsy 230 NO Negative Negative NO 20 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Positive 50-59% NA NA 1.2 3 Point Scale 2+ 1+ Negative NA 10-19% NA Positive NA NA NA NA NA NA 3 Point Scale Other, specify New Primary Tumor LEFT BREAST YES YES 4 NA true No M0 N2a T3 Stage IIIA TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf A0CK TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 5th NA NO YES A2 Breast A LIVING 2001 fe5e8cb8-45e2-4321-ad32-a776f79bfcac fe5e8cb8-45e2-4321-ad32-a776f79bfcac TCGA-A2-A0CK-01A-21-A24A-20 NA TCGA-A2-A0CK-01 TCGA-A2-A0CK-01A-11D-A22B-05 9c5f525e-a62e-4bfd-aed9-96603a95f72b TCGA-A2-A0CK-01 TCGA-A2-A0CK-01A-11D-A228-09 NA NA TCGA-A2-A0CK-01 NA NA fe5e8cb8-45e2-4321-ad32-a776f79bfcac NA TCGA-A2-A0CK-01A-11D-A227-01 TCGA-A2-A0CK-01 NA fe5e8cb8-45e2-4321-ad32-a776f79bfcac TCGA-A2-A0CK-01A-11D-A227-01 |
|
|
35 |
TCGA-A2-A0CL-01 Stage IIIA 37 3 No_Conversion 1963 NA Positive FEMALE Negative 1 1 1 Negative M0 Positive N2 1963 0 Normal HER2-enriched Positive Basal -2 -5 followup T_Other T3 LIVING 0 TCGA-A2-A0CL-01 3015 0 days High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A0CL 3015 0 days 3015 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0CL-F59313 TCGA-A2-A0CL NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -13556 NA NA 0 3015 NA NA NA NA NA NA 20-29% NA Scheduled Follow-up Submission 2014-5-8 FEMALE NA NA NA NA 1+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Negative NO 14 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 9 0 NA No M0 N2a T3 Stage IIIA NA A0CL TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast NA LIVING 2006 ee92fcd7-4be2-47c2-9725-1ec425d212cf ee92fcd7-4be2-47c2-9725-1ec425d212cf TCGA-A2-A0CL-01A-21-A13C-20 TCGA-A2-A0CL-01A-11D-A10Y-09 TCGA-A2-A0CL-01 NA f660575f-37ae-427d-acf6-767799017d6d TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11D-A10Y-09 TCGA-A2-A0CL-01A-11D-A112-05 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11D-A10Y-09 NA ee92fcd7-4be2-47c2-9725-1ec425d212cf NA TCGA-A2-A0CL-01A-11D-A111-01 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11R-A115-07 ee92fcd7-4be2-47c2-9725-1ec425d212cf TCGA-A2-A0CL-01A-11D-A111-01 TCGA-A2-A0CL-01 |
|
|
36 |
TCGA-A2-A0CM-01 Stage IIA 40 4 Stage IIA 754 754 Negative FEMALE Negative 1 1 2 Negative M0 Negative N0 754 1 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 DECEASED 1 TCGA-A2-A0CM-01 754 1 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0CM NA NA days 754 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 40 Left Sentinel node biopsy alone NA TCGA-A2-A0CM-F2013 TCGA-A2-A0CM TCGA-A2-A0CM-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -14969 2546 754 0 NA NA NA 382 NA NA NA <10% NA NA 2010-9-6 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Excisional Biopsy 300 NO Negative NA NA 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf A0CM WITH TUMOR NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2003 62dd11c2-2271-45e7-b753-d0f0d79fdf23 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01A-21-A13C-20 TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01 NA bd38e599-aa6d-4349-b7de-630514cc1220 TCGA-A2-A0CM-01 TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01A-31D-A032-05 TCGA-A2-A0CM-01 NA TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01 TCGA-A2-A0CM-01A-31D-A036-01 NA TCGA-A2-A0CM-01A-31R-A034-07 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01A-31D-A036-01 TCGA-A2-A0CM-01 |
|
|
37 |
TCGA-A2-A0CO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-A2-A0CO-01 3492 1 days Iq NA NA BRCA non-CIMP c9 NA NA miRNA cluster 3 NA NA TCGA-A2-A0CO 3492 0 days 3492 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 85 Right Axillary lymph node dissection alone NA TCGA-A2-A0CO-F42395 TCGA-A2-A0CO NA NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -31404 NA 3492 0 3409 NA NA NA NA NO NA 40-49% NA NA 2013-4-18 FEMALE NA NA NA NA NA NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy NA NA Negative Negative NO 11 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T3 Stage IIB NA A0CO TUMOR FREE NA NA NA NA NA YES YES 20-29% NA YES Primary Tumor 01 NA 7th NA NO YES A2 Breast NA DECEASED 2002 cb2d5668-d44b-49dc-8941-79615d2fb6c2 cb2d5668-d44b-49dc-8941-79615d2fb6c2 NA NA TCGA-A2-A0CO-01 TCGA-A2-A0CO-01A-13D-A22B-05 NA TCGA-A2-A0CO-01 TCGA-A2-A0CO-01A-13D-A228-09 NA NA TCGA-A2-A0CO-01 NA NA cb2d5668-d44b-49dc-8941-79615d2fb6c2 NA TCGA-A2-A0CO-01A-13D-A227-01 TCGA-A2-A0CO-01 NA cb2d5668-d44b-49dc-8941-79615d2fb6c2 TCGA-A2-A0CO-01A-13D-A227-01 |
|
|
38 |
TCGA-A2-A0CP-01 Stage IA 60 4 Stage I 2813 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 2813 0 LumA Luminal A Positive X -5 -7 followup T1 T1 LIVING 0 TCGA-A2-A0CP-01 2813 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0CP 2813 0 days 2813 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Sentinel node biopsy alone NA TCGA-A2-A0CP-F13741 TCGA-A2-A0CP TCGA-A2-A0CP-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -22133 2445 NA 0 2813 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 160 NO NA Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf A0CP TUMOR FREE NA NA NA NA NA NA NA 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01A-21-A13B-20 TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01 NA 901a41bd-d57b-46b6-afec-bfc93e5d2c93 TCGA-A2-A0CP-01 TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01A-11D-A032-05 TCGA-A2-A0CP-01 NA TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01 TCGA-A2-A0CP-01A-11D-A036-01 NA TCGA-A2-A0CP-01A-11R-A034-07 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01A-11D-A036-01 TCGA-A2-A0CP-01 |
|
|
39 |
TCGA-A2-A0CQ-01 Stage IA 62 2 Stage I 2694 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 2694 0 LumA Luminal A Positive LumA/B -12 -3 followup T1 T1 LIVING 0 TCGA-A2-A0CQ-01 2695 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0CQ 2695 0 days 2695 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Sentinel node biopsy alone NA TCGA-A2-A0CQ-F13723 TCGA-A2-A0CQ TCGA-A2-A0CQ-01A Negative Positive NA NA NA Lumpectomy Positive Lumpectomy NA YES NA NA -22810 2310 NA 0 2695 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 2+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Equivocal Negative NA 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf A0CQ TUMOR FREE NA NA NA NA NA NA NA 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 31ff1045-fdc1-4b02-ae0e-880f652adb31 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01A-11-A13B-20 TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01 NA deba1bb0-c1bf-4018-8c35-1376661c7d01 TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01A-21D-A032-05 TCGA-A2-A0CQ-01 NA TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01A-21D-A036-01 NA TCGA-A2-A0CQ-01A-21R-A034-07 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01A-21D-A036-01 TCGA-A2-A0CQ-01 |
|
|
40 |
TCGA-A2-A0CR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A0CR-01 3283 0 days Quiet NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 13 NA NA TCGA-A2-A0CR 3283 0 days 3283 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0CR-F42400 TCGA-A2-A0CR TCGA-A2-A0CR-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -20075 2191 NA 0 3283 NA NA NA NA NO NA 60-69% NA NA 2013-4-18 FEMALE NA NA NA NA NA NA NA 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 1+ YES NA Core needle biopsy 280 NO Negative Negative NO 16 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T3 Stage IIB TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf A0CR TUMOR FREE NA NA NA NA NA YES YES 80-89% NA NO Primary Tumor 01 NA 7th NA NO YES A2 Breast A LIVING 2004 00e597fa-72b4-4e92-9428-7ec686e4cc0b 00e597fa-72b4-4e92-9428-7ec686e4cc0b TCGA-A2-A0CR-01A-22-A24A-20 NA TCGA-A2-A0CR-01 TCGA-A2-A0CR-01A-11D-A22B-05 3ed7fa0f-b208-4493-aac0-71cb01860ac9 TCGA-A2-A0CR-01 TCGA-A2-A0CR-01A-11D-A228-09 NA NA TCGA-A2-A0CR-01 NA NA 00e597fa-72b4-4e92-9428-7ec686e4cc0b NA TCGA-A2-A0CR-01A-11D-A227-01 TCGA-A2-A0CR-01 NA 00e597fa-72b4-4e92-9428-7ec686e4cc0b TCGA-A2-A0CR-01A-11D-A227-01 |
|
|
41 |
TCGA-A2-A0CS-01 Stage IV 73 2 No_Conversion 2298 NA Positive FEMALE Negative 3 3 3 Positive M1 Positive N3 2298 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T4 LIVING 1 TCGA-A2-A0CS-01 2348 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0CS 2348 0 days 2348 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Axillary lymph node dissection alone NA TCGA-A2-A0CS-F59316 TCGA-A2-A0CS TCGA-A2-A0CS-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -26817 2030 2348 0 2298 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2014-5-8 FEMALE NA NA NA NA 2+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Skin biopsy Other method, specify: 220 NO Equivocal Negative NO 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Positive NA NA NA 1.09 NA NA NA Negative NA NA NA Positive Other, specify Ovary 2 4 NA NA NA NA NA NA NA NO 12 0 true No M1 N3a T4b Stage IV TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D.pdf A0CS TUMOR FREE NA NA NA NA NA YES NA 80-89% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A DECEASED 2004 560ab6aa-cbfe-42ac-9446-9d3df720bc81 560ab6aa-cbfe-42ac-9446-9d3df720bc81 TCGA-A2-A0CS-01A-21-A13B-20 TCGA-A2-A0CS-01A-11D-A10Y-09 TCGA-A2-A0CS-01 NA b49a2c08-435f-4790-818a-267a2ce6499c TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11D-A10Y-09 TCGA-A2-A0CS-01A-11D-A112-05 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11D-A10Y-09 NA 560ab6aa-cbfe-42ac-9446-9d3df720bc81 NA TCGA-A2-A0CS-01A-11D-A111-01 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11R-A115-07 560ab6aa-cbfe-42ac-9446-9d3df720bc81 TCGA-A2-A0CS-01A-11D-A111-01 TCGA-A2-A0CS-01 |
|
|
42 |
TCGA-A2-A0CT-01 Stage IIA 71 5 Stage IIA 2288 NA Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 2288 0 LumA Luminal B Negative LumA/B -10 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0CT-01 2289 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CT 2289 0 days 2289 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0CT-F13730 TCGA-A2-A0CT NA NA Positive NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -25959 NA NA 0 2289 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-9 FEMALE NA NA NA NA 2+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T2 Stage IIA NA A0CT TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast NA LIVING 2005 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01A-11-A13B-20 TCGA-A2-A0CT-01A-31W-A071-09 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31D-A10P-05 cfc7cb7e-3c46-41d6-9b19-ee2652b2c3e9 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31W-A071-09 NA TCGA-A2-A0CT-01 NA TCGA-A2-A0CT-01A-31W-A071-09 TCGA-A2-A0CT-01 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31D-A059-01 NA TCGA-A2-A0CT-01A-31R-A056-07 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01A-31D-A059-01 TCGA-A2-A0CT-01 |
|
|
43 |
TCGA-A2-A0CU-01 Stage IIA 73 5 Stage IIA 139 157 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 157 1 LumA Luminal A Positive LumA/B 0 -3 followup T_Other T2 DECEASED 1 TCGA-A2-A0CU-01 158 1 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CU 158 0 days 158 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0CU-F13735 TCGA-A2-A0CU TCGA-A2-A0CU-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -26823 1911 158 0 NA NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 2+ NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Equivocal Negative NA 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D.pdf A0CU TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2005 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01A-21-A13B-20 TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01 NA 74d7ee07-2eba-4552-a888-c29010bbc5ea TCGA-A2-A0CU-01 TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01A-12D-A032-05 TCGA-A2-A0CU-01 NA TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01 TCGA-A2-A0CU-01A-12D-A036-01 NA TCGA-A2-A0CU-01A-12R-A034-07 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01A-12D-A036-01 TCGA-A2-A0CU-01 |
|
|
44 |
TCGA-A2-A0CV-01 Stage IIB 41 2 No_Conversion 1929 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1929 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0CV-01 3011 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation c1uster 9 TCGA-A2-A0CV 3011 0 days 3011 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0CV-F59321 TCGA-A2-A0CV NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15289 NA NA 0 3011 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2014-5-8 FEMALE NA NA NA NA 1+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Negative NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 4 0 NA No M0 N1a T2 Stage IIB NA A0CV TUMOR FREE NA NA NA NA NA YES NA 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast NA LIVING 2005 a8154f60-e391-44b5-b378-c944c5e8621d a8154f60-e391-44b5-b378-c944c5e8621d TCGA-A2-A0CV-01A-21-A13B-20 TCGA-A2-A0CV-01A-31D-A10Y-09 TCGA-A2-A0CV-01 NA b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31D-A10Y-09 TCGA-A2-A0CV-01A-31D-A112-05 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31D-A10Y-09 NA a8154f60-e391-44b5-b378-c944c5e8621d NA TCGA-A2-A0CV-01A-31D-A111-01 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31R-A115-07 a8154f60-e391-44b5-b378-c944c5e8621d TCGA-A2-A0CV-01A-31D-A111-01 TCGA-A2-A0CV-01 |
|
|
45 |
TCGA-A2-A0CW-01 Stage IIB 67 1 No_Conversion 1947 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1947 0 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0CW-01 3283 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 3 TCGA-A2-A0CW 3283 0 days 3283 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0CW-F70690 TCGA-A2-A0CW TCGA-A2-A0CW-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -24541 1533 NA 0 3283 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2015-3-2 FEMALE NA NA NA NA 2+ NA NA 0.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 290 NO Equivocal Negative NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf A0CW TUMOR FREE NA NA NA NA NA YES NA 10-19% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2006 1c1560f6-62bf-4185-912f-25c234ebd71f 1c1560f6-62bf-4185-912f-25c234ebd71f TCGA-A2-A0CW-01A-11-A13B-20 TCGA-A2-A0CW-01A-21D-A10Y-09 TCGA-A2-A0CW-01 NA 6d65d556-9be9-4491-bd22-85cee7a0ee7c TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21D-A10Y-09 TCGA-A2-A0CW-01A-21D-A112-05 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21D-A10Y-09 NA 1c1560f6-62bf-4185-912f-25c234ebd71f NA TCGA-A2-A0CW-01A-21D-A111-01 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21R-A115-07 1c1560f6-62bf-4185-912f-25c234ebd71f TCGA-A2-A0CW-01A-21D-A111-01 TCGA-A2-A0CW-01 |
|
|
46 |
TCGA-A2-A0CX-01 Stage IIA 52 3 Stage IIA 1728 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1728 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0CX-01 1728 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 NA NA mutation cluster 5 TCGA-A2-A0CX 1728 0 days 1728 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Sentinel node biopsy alone NA TCGA-A2-A0CX-F13721 TCGA-A2-A0CX TCGA-A2-A0CX-01A NA Positive NA NA NA NA Negative Lumpectomy NA YES NA NA -19152 1316 NA 0 1728 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 560 NO Positive NA NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf A0CX TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2006 b1ecc303-eb55-436f-9629-cdac63bde297 b1ecc303-eb55-436f-9629-cdac63bde297 TCGA-A2-A0CX-01A-11-A13B-20 TCGA-A2-A0CX-01A-21W-A019-09 TCGA-A2-A0CX-01 NA 1f7a4605-1972-4f36-b0e7-543ce95a3d0f TCGA-A2-A0CX-01 TCGA-A2-A0CX-01A-21W-A019-09 TCGA-A2-A0CX-01A-21D-A00Y-05 TCGA-A2-A0CX-01 NA TCGA-A2-A0CX-01A-21W-A019-09 NA b1ecc303-eb55-436f-9629-cdac63bde297 NA TCGA-A2-A0CX-01A-21D-A011-01 NA TCGA-A2-A0CX-01A-21R-A00Z-07 b1ecc303-eb55-436f-9629-cdac63bde297 TCGA-A2-A0CX-01A-21D-A011-01 TCGA-A2-A0CX-01 |
|
|
47 |
TCGA-A2-A0CY-01 Stage IIB 63 1 No_Conversion 1673 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1673 0 NA HER2-enriched Positive LumA/B 0 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0CY-01 1673 0 days Kirc+ NA cluster 5 Cluster 5 BRCA nonbasal-like c8 NA miRNA c1uster 10 cluster 7 NA TCGA-A2-A0CY 1673 0 days 1673 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0CY-F13731 TCGA-A2-A0CY TCGA-A2-A0CY-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -23229 1274 NA 0 1673 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-9 FEMALE NA NA NA NA 1+ NA NA 0.89 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative Negative NA 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 7 NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf A0CY TUMOR FREE NA NA NA NA NA NA NA 10-19% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2006 c7d2b685-5f11-4879-82d5-e983b5dbb07d c7d2b685-5f11-4879-82d5-e983b5dbb07d TCGA-A2-A0CY-01A-21-A13C-20 NA TCGA-A2-A0CY-01 NA 3dc93dcc-2b14-4725-b40e-23be7cdbbb9d NA NA TCGA-A2-A0CY-01A-12D-A032-05 NA NA NA TCGA-A2-A0CY-01 c7d2b685-5f11-4879-82d5-e983b5dbb07d TCGA-A2-A0CY-01 NA NA TCGA-A2-A0CY-01A-12R-A034-07 c7d2b685-5f11-4879-82d5-e983b5dbb07d NA TCGA-A2-A0CY-01 |
|
|
48 |
TCGA-A2-A0CZ-01 Stage IIA 46 4 Stage IIA 1615 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1615 0 Normal Luminal A Positive ReacII -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0CZ-01 1616 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CZ 1616 0 days 1616 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0CZ-F13728 TCGA-A2-A0CZ TCGA-A2-A0CZ-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -17026 1204 NA 0 1616 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 1+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO Negative Negative NA 2 Positive Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860.pdf A0CZ TUMOR FREE NA NA NA NA NA NA NA 20-29% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2007 229ebbe9-4dc8-434f-998c-fc0660cd2b00 229ebbe9-4dc8-434f-998c-fc0660cd2b00 TCGA-A2-A0CZ-01A-21-A13C-20 TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01 NA af5345d8-db03-4d37-b327-5a62c1fe1285 NA TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01A-11D-A032-05 NA NA TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01 229ebbe9-4dc8-434f-998c-fc0660cd2b00 TCGA-A2-A0CZ-01 NA NA TCGA-A2-A0CZ-01A-11R-A034-07 229ebbe9-4dc8-434f-998c-fc0660cd2b00 NA TCGA-A2-A0CZ-01 |
|
|
49 |
TCGA-A2-A0D0-01 Stage IIA 60 1 Stage IIA 643 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 643 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-A2-A0D0-01 2048 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 5 mutation cluster 5 TCGA-A2-A0D0 2048 0 days 2048 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0D0-F59399 TCGA-A2-A0D0 TCGA-A2-A0D0-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA NO NA NA -22115 720 NA 0 2048 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA NA NA 0 NA NA 1.17 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 500 NO Negative Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf A0D0 TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01A-21-A13C-20 TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01 NA 980c774a-c662-489e-82a3-212d0a45f759 TCGA-A2-A0D0-01 TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01A-11D-A00Y-05 TCGA-A2-A0D0-01 NA TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01 TCGA-A2-A0D0-01A-11D-A011-01 NA TCGA-A2-A0D0-01A-11R-A00Z-07 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01A-11D-A011-01 TCGA-A2-A0D0-01 |
|
|
50 |
TCGA-A2-A0D1-01 Stage IIA 76 1 Stage IIA 1051 NA Negative FEMALE Positive 2 2 1 Negative M0 Negative N0 1051 0 Her2 HER2-enriched Negative Basal -2 -6 followup T_Other T2 LIVING 0 TCGA-A2-A0D1-01 1051 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-A2-A0D1 1051 0 days 1051 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0D1-F13733 TCGA-A2-A0D1 TCGA-A2-A0D1-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -28084 637 NA 0 1051 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-6-9 FEMALE NA NA NA NA 3+ NA NA 5.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 340 NO Positive Positive NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3.pdf A0D1 TUMOR FREE NA NA NA Intensity=Weak Intensity=Weak NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 01370d42-f75c-4532-9b9c-24ff7302b033 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01A-21-A13C-20 TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01 NA aa90ba5a-1a36-46e9-a3f5-21ba48c5f29a TCGA-A2-A0D1-01 TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01A-11D-A032-05 TCGA-A2-A0D1-01 NA TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01 TCGA-A2-A0D1-01A-11D-A036-01 NA TCGA-A2-A0D1-01A-11R-A034-07 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01A-11D-A036-01 TCGA-A2-A0D1-01 |
|
|
51 |
TCGA-A2-A0D2-01 Stage IIB 45 3 Stage IIA 1027 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1027 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-A2-A0D2-01 1027 0 days High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-A2-A0D2 1027 0 days 1027 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0D2-F14458 TCGA-A2-A0D2 TCGA-A2-A0D2-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -16623 614 NA 0 1027 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-6-9 FEMALE NA NA NA NA 0 NA NA 1.05 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 330 NO Negative Negative NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 4 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf A0D2 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 2ad8d416-08a4-4e6f-947e-d74269d02ab1 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01A-11-A13C-20 TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01 NA 74c3c43d-b3f1-4846-be03-3b65098774c7 TCGA-A2-A0D2-01 TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01A-21D-A032-05 TCGA-A2-A0D2-01 NA TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01 TCGA-A2-A0D2-01A-21D-A036-01 NA TCGA-A2-A0D2-01A-21R-A034-07 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01A-21D-A036-01 TCGA-A2-A0D2-01 |
|
|
52 |
TCGA-A2-A0D3-01 Stage IA 42 2 Stage I 875 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 875 0 LumA Luminal A Positive LumA -5 -3 followup T1 T1 LIVING 0 TCGA-A2-A0D3-01 1873 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-A2-A0D3 1873 0 days 1873 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0D3-F59451 TCGA-A2-A0D3 TCGA-A2-A0D3-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -15524 545 NA 0 1873 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2014-5-13 FEMALE NA NA NA NA 1+ NA NA 1.41 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf A0D3 TUMOR FREE NA NA NA NA NA YES NA 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 eefe67c9-48a1-4381-a3ef-81b51e46c6df eefe67c9-48a1-4381-a3ef-81b51e46c6df TCGA-A2-A0D3-01A-21-A13A-20 TCGA-A2-A0D3-01A-11D-A10Y-09 TCGA-A2-A0D3-01 NA 068b3d7e-b3b4-4fd1-89c5-2019253806b2 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11D-A10Y-09 TCGA-A2-A0D3-01A-11D-A112-05 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11D-A10Y-09 NA eefe67c9-48a1-4381-a3ef-81b51e46c6df NA TCGA-A2-A0D3-01A-11D-A111-01 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11R-A115-07 eefe67c9-48a1-4381-a3ef-81b51e46c6df TCGA-A2-A0D3-01A-11D-A111-01 TCGA-A2-A0D3-01 |
|
|
53 |
TCGA-A2-A0D4-01 Stage IIB 37 5 No_Conversion 767 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 767 0 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0D4-01 767 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A2-A0D4 767 0 days 767 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Left Axillary lymph node dissection alone NA TCGA-A2-A0D4-F13726 TCGA-A2-A0D4 TCGA-A2-A0D4-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -13805 384 NA 0 767 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 1+ NA NA 1.14 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative Negative NA 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf A0D4 TUMOR FREE NA NA NA Intensity=weak Intensity=moderate NA NA 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 2522bd3d-f6b3-45df-b68f-577ffbf3a819 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01A-21-A13C-20 TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01 NA 33556a57-3d4b-4d1d-ac6f-bf0974c4ca36 TCGA-A2-A0D4-01 TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01A-11D-A00Y-05 TCGA-A2-A0D4-01 NA TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01 TCGA-A2-A0D4-01A-11D-A011-01 NA TCGA-A2-A0D4-01A-11R-A00Z-07 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01A-11D-A011-01 TCGA-A2-A0D4-01 |
|
|
54 |
TCGA-A2-A0EM-01 Stage IA 73 2 Stage I 3093 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 3093 0 LumA Luminal A Positive NA -12 -3 followup T1 T1 LIVING 0 TCGA-A2-A0EM-01 3094 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EM 3094 0 days 3094 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0EM-F13714 TCGA-A2-A0EM TCGA-A2-A0EM-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -26845 2696 NA 0 3094 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-9 FEMALE NA NA NA NA NA NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 20 NO NA Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf A0EM TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 5th YES NO YES A2 Breast A LIVING 2002 8d30a0ab-a41f-40ef-bd59-f738f4b39941 8d30a0ab-a41f-40ef-bd59-f738f4b39941 NA TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01 NA NA TCGA-A2-A0EM-01 TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01A-11D-A032-05 TCGA-A2-A0EM-01 NA TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01 8d30a0ab-a41f-40ef-bd59-f738f4b39941 TCGA-A2-A0EM-01 TCGA-A2-A0EM-01A-11D-A036-01 NA TCGA-A2-A0EM-01A-11R-A034-07 8d30a0ab-a41f-40ef-bd59-f738f4b39941 TCGA-A2-A0EM-01A-11D-A036-01 TCGA-A2-A0EM-01 |
|
|
55 |
TCGA-A2-A0EN-01 Stage IIA 70 2 Stage IIA 2717 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2717 0 LumA Luminal A Positive NA -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0EN-01 2718 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EN 2718 0 days 2718 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Sentinel node biopsy alone NA TCGA-A2-A0EN-F13725 TCGA-A2-A0EN TCGA-A2-A0EN-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -25771 2348 NA 0 2718 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 2+ NA NA 1.4 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Excisional Biopsy 110 NO Equivocal Negative NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 2 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf A0EN TUMOR FREE NA NA NA NA NA NA NA 50-59% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed NA TCGA-A2-A0EN-01A-13D-A099-09 TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A10P-05 NA TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A099-09 NA TCGA-A2-A0EN-01 NA TCGA-A2-A0EN-01A-13D-A099-09 TCGA-A2-A0EN-01 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A087-01 NA TCGA-A2-A0EN-01A-13R-A084-07 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed TCGA-A2-A0EN-01A-13D-A087-01 TCGA-A2-A0EN-01 |
|
|
56 |
TCGA-A2-A0EO-01 Stage IA 54 2 Stage I 2441 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 2441 0 LumA Luminal A Positive LumA -5 -7 followup T1 T1 LIVING 0 TCGA-A2-A0EO-01 2442 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EO 2442 0 days 2442 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Sentinel node biopsy alone NA TCGA-A2-A0EO-F13732 TCGA-A2-A0EO TCGA-A2-A0EO-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -19880 2331 NA 0 2442 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-13 FEMALE NA NA NA NA 1+ NA NA 1.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative Negative NA 3 Close Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610.pdf A0EO TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 cdeceaf0-beb6-4374-8aea-83bd35318892 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01A-21-A13B-20 TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01 NA 368ae06c-f56e-4ba9-af38-0cc01e900f70 TCGA-A2-A0EO-01 TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01A-11D-A032-05 TCGA-A2-A0EO-01 NA TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01 TCGA-A2-A0EO-01A-11D-A036-01 NA TCGA-A2-A0EO-01A-11R-A034-07 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01A-11D-A036-01 TCGA-A2-A0EO-01 |
|
|
57 |
TCGA-A2-A0EP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A0EP-01 3603 0 days NA NA NA NA BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-A2-A0EP 3603 0 days 3603 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0EP-F58499 TCGA-A2-A0EP NA NA Positive 3 Point Scale NA NA NA Negative Simple Mastectomy NA YES NA NA -20585 NA NA 0 3603 NA NA NA NA NA NA 80-89% NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.3 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 NA No M0 N0 (i+) T1 Stage I NA A0EP TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES A2 Breast NA LIVING 2004 b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c TCGA-A2-A0EP-01A-61-A24A-20 NA TCGA-A2-A0EP-01 TCGA-A2-A0EP-01A-52D-A230-05 be62a150-20f9-449e-8992-796d4640879a TCGA-A2-A0EP-01 TCGA-A2-A0EP-01A-52D-A22X-09 NA NA TCGA-A2-A0EP-01 NA NA b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c NA TCGA-A2-A0EP-01A-52D-A22W-01 TCGA-A2-A0EP-01 NA b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c TCGA-A2-A0EP-01A-52D-A22W-01 |
|
|
58 |
TCGA-A2-A0EQ-01 Stage IIA 64 4 Stage IIA 2426 NA Negative FEMALE Positive 1 1 4 Negative M0 Negative N0 2426 0 Her2 HER2-enriched Negative Basal -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0EQ-01 2426 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 8 TCGA-A2-A0EQ 2426 0 days 2426 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Other (specify) Sentinel lymph node and non-sentinel lymph node biopsy TCGA-A2-A0EQ-F13720 TCGA-A2-A0EQ NA Negative Negative NA 0 NA Lumpectomy Negative Lumpectomy NA YES NA NA -23543 NA NA 0 2426 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-6-13 FEMALE NA NA NA NA 3+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy NA NA Positive Negative NA 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T2 Stage IIA NA A0EQ TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast NA LIVING 2004 a083b072-7c1e-4ed6-90cf-1e49d21df4cb a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01A-21-A13C-20 TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01 NA cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01A-11D-A032-05 TCGA-A2-A0EQ-01 NA TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01 a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01A-11D-A036-01 NA TCGA-A2-A0EQ-01A-11R-A034-07 a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01A-11D-A036-01 TCGA-A2-A0EQ-01 |
|
|
59 |
TCGA-A2-A0ER-01 Stage IB 63 5 No_Conversion 2262 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2262 0 LumA Luminal B Positive ReacII -10 -3 followup T1 T1 LIVING 0 TCGA-A2-A0ER-01 2263 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0ER 2263 0 days 2263 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0ER-F13719 TCGA-A2-A0ER TCGA-A2-A0ER-01A Negative Positive NA NA NA Lumpectomy Positive Lumpectomy NA YES NA NA -23021 1862 NA 0 2263 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-13 FEMALE NA NA NA NA 2+ NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Equivocal Negative NA 14 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 1 0 true No M0 N1mi T1c Stage IB TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf A0ER TUMOR FREE NA NA NA NA NA NA NA 80-89% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2005 9c8e0865-894b-4a0b-83e4-c3e7a40e871b 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01A-11-A13C-20 TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01 NA 7b71576b-d077-4e99-ae77-0c061517a5f9 TCGA-A2-A0ER-01 TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01A-21D-A032-05 TCGA-A2-A0ER-01 NA TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01 TCGA-A2-A0ER-01A-21D-A036-01 NA TCGA-A2-A0ER-01A-21R-A034-07 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01A-21D-A036-01 TCGA-A2-A0ER-01 |
|
|
60 |
TCGA-A2-A0ES-01 Stage IIA 52 4 Stage IIA 1127 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1127 0 LumA Luminal A Positive ReacII -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0ES-01 2190 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A2-A0ES 2190 0 days 2190 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0ES-F59395 TCGA-A2-A0ES TCGA-A2-A0ES-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19160 756 NA 0 2190 NA NA NA NA NA NA 60-69% NA Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA NA NA 1+ NA NA 1.32 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 460 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf A0ES TUMOR FREE NA NA NA NA NA YES NA 10-19% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 698c9928-1aa8-4b48-9048-5675e5943c22 698c9928-1aa8-4b48-9048-5675e5943c22 TCGA-A2-A0ES-01A-21-A13B-20 TCGA-A2-A0ES-01A-11D-A10Y-09 TCGA-A2-A0ES-01 NA 8d841c4a-d6b2-4d89-8d26-b415bce6c25d TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11D-A10Y-09 TCGA-A2-A0ES-01A-11D-A112-05 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11D-A10Y-09 NA 698c9928-1aa8-4b48-9048-5675e5943c22 NA TCGA-A2-A0ES-01A-11D-A111-01 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11R-A115-07 698c9928-1aa8-4b48-9048-5675e5943c22 TCGA-A2-A0ES-01A-11D-A111-01 TCGA-A2-A0ES-01 |
|
|
61 |
TCGA-A2-A0ET-01 Stage IIIA 58 3 No_Conversion 1066 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1066 0 LumA Luminal A Positive NA -10 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0ET-01 1066 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A2-A0ET 1066 0 days 1066 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0ET-F13713 TCGA-A2-A0ET TCGA-A2-A0ET-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21464 674 NA 0 1066 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 2+ NA NA 1.09 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 890 NO Equivocal Negative NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 5 0 true No M0 N2a T2 Stage IIIA TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf A0ET TUMOR FREE NA NA NA Intensity=Strong Intensity=Strong NA NA 70-79% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 4eb0c00d-595c-47ee-bcad-818c7723656d 4eb0c00d-595c-47ee-bcad-818c7723656d NA TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01 NA NA TCGA-A2-A0ET-01 TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01A-31D-A032-05 TCGA-A2-A0ET-01 NA TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01 4eb0c00d-595c-47ee-bcad-818c7723656d TCGA-A2-A0ET-01 TCGA-A2-A0ET-01A-31D-A036-01 NA TCGA-A2-A0ET-01A-31R-A034-07 4eb0c00d-595c-47ee-bcad-818c7723656d TCGA-A2-A0ET-01A-31D-A036-01 TCGA-A2-A0ET-01 |
|
|
62 |
TCGA-A2-A0EU-01 Stage IA 79 4 Stage I 1043 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1043 0 LumA Luminal A Positive ReacI -10 -3 followup T1 T1 LIVING 0 TCGA-A2-A0EU-01 1043 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0EU 1043 0 days 1043 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0EU-F13717 TCGA-A2-A0EU TCGA-A2-A0EU-01A Negative Positive NA NA NA Lumpectomy Positive Lumpectomy NA YES NA NA -29144 644 NA 0 1043 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 0 NA NA 0.97 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 610 NO Negative Negative NA 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf A0EU TUMOR FREE NA NA NA Intensity=Strong Intensity=Strong NA NA 90-99% NA YES Primary Tumor 01 NA 6th NO NO YES A2 Breast A LIVING 2008 70633069-e9df-4fce-84df-6849f4b2693c 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01A-11-A13B-20 TCGA-A2-A0EU-01A-22W-A071-09 TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22D-A10P-05 616af0e6-b37f-48aa-aa61-2e5b5a72b749 TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22W-A071-09 NA TCGA-A2-A0EU-01 NA TCGA-A2-A0EU-01A-22W-A071-09 TCGA-A2-A0EU-01 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22D-A059-01 NA TCGA-A2-A0EU-01A-22R-A056-07 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01A-22D-A059-01 TCGA-A2-A0EU-01 |
|
|
63 |
TCGA-A2-A0EV-01 Stage IA 80 3 Stage I 968 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 968 0 LumA Luminal A Positive ReacI 0 -4 followup T1 T1 LIVING 0 TCGA-A2-A0EV-01 968 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0EV 968 0 days 968 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Sentinel node biopsy alone NA TCGA-A2-A0EV-F13712 TCGA-A2-A0EV TCGA-A2-A0EV-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -29285 590 NA 0 968 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA <10% NA 0 NA NA 1.40 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 960 NO Negative Negative NA 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf A0EV TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NO Primary Tumor 01 NA 6th NO NO YES A2 Breast A LIVING 2008 75cd6423-52b8-4d29-97de-1fe2583dbac1 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01A-21-A13C-20 TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01 NA 19683ba7-695c-484a-95ba-39a8dd02a6a3 TCGA-A2-A0EV-01 TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01A-11D-A032-05 TCGA-A2-A0EV-01 NA TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01 TCGA-A2-A0EV-01A-11D-A036-01 NA TCGA-A2-A0EV-01A-11R-A034-07 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01A-11D-A036-01 TCGA-A2-A0EV-01 |
|
|
64 |
TCGA-A2-A0EW-01 Stage IIIC 53 2 No_Conversion 904 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N3 904 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING 1 TCGA-A2-A0EW-01 1884 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0EW 1353 1 days 1884 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 53 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0EW-F59511 TCGA-A2-A0EW TCGA-A2-A0EW-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19413 542 1884 0 905 NA NA 1353 NA NA NA 90-99% NA Scheduled Follow-up Submission 2014-5-14 FEMALE NA NA NA NA 0 NA NA 1.33 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1710 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA Bone Distant Metastasis NA NO YES 26 0 true No M0 N3a T1b Stage IIIC TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A.pdf A0EW WITH TUMOR NA NA NA NA NA YES NA 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2008 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 TCGA-A2-A0EW-01A-31-A13B-20 TCGA-A2-A0EW-01A-21D-A10Y-09 TCGA-A2-A0EW-01 NA e365a292-15b3-4e28-bf58-3ecdde392c22 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21D-A10Y-09 TCGA-A2-A0EW-01A-21D-A112-05 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21D-A10Y-09 NA 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 NA TCGA-A2-A0EW-01A-21D-A111-01 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21R-A115-07 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 TCGA-A2-A0EW-01A-21D-A111-01 TCGA-A2-A0EW-01 |
|
|
65 |
TCGA-A2-A0EX-01 Stage IIB 46 4 Stage IIB 549 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 549 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 LIVING 0 TCGA-A2-A0EX-01 752 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0EX 752 0 days 752 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 46 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0EX-F13742 TCGA-A2-A0EX TCGA-A2-A0EX-01A Negative Positive NA NA NA Mastectomy NOS Positive Lumpectomy NA YES NA NA -16858 468 NA 0 752 NA NA NA NA NA NA 60-69% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 1+ NA NA 1.22 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 650 NO Negative Negative NA 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf A0EX TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 6fc8b7da-3de6-4111-b685-bb03c032466a 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01A-11-A13C-20 TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01 NA 83a37012-5a0c-4263-a361-3aaff03b0429 TCGA-A2-A0EX-01 TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01A-21D-A032-05 TCGA-A2-A0EX-01 NA TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01 TCGA-A2-A0EX-01A-21D-A036-01 NA TCGA-A2-A0EX-01A-21R-A034-07 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01A-21D-A036-01 TCGA-A2-A0EX-01 |
|
|
66 |
TCGA-A2-A0EY-01 Stage IIB 62 3 No_Conversion 735 NA Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 735 0 LumB Luminal B Negative Her2 -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0EY-01 1925 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-A2-A0EY 1925 0 days 1925 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0EY-F13716 TCGA-A2-A0EY TCGA-A2-A0EY-01A NA Positive NA NA NA NA Negative Lumpectomy NA YES NA NA -22872 358 NA 0 1925 NA NA NA NA NA NA 60-69% NA Scheduled Follow-up Submission 2011-6-10 FEMALE NA NA NA NA 3+ NA NA 7.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 580 NO Positive Positive NA 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf A0EY TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01A-21-A13C-20 TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01 NA b4fefb35-16bd-4db4-aa7a-805703f36514 TCGA-A2-A0EY-01 TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01A-11D-A032-05 TCGA-A2-A0EY-01 NA TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01 TCGA-A2-A0EY-01A-11D-A036-01 NA TCGA-A2-A0EY-01A-11R-A034-07 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01A-11D-A036-01 TCGA-A2-A0EY-01 |
|
|
67 |
TCGA-A2-A0ST-01 Stage IIA 62 1 No_Conversion 1643 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1643 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING 0 TCGA-A2-A0ST-01 3017 0 days Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A2-A0ST NA NA days 3017 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0ST-F14035 TCGA-A2-A0ST TCGA-A2-A0ST-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -22922 2597 NA 0 3017 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-7-14 FEMALE NA NA NA NA NA NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 210 NO NA Negative NA 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA YES 3 0 true No M0 N1a T1c Stage IIA TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf A0ST WITH TUMOR NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 920e47c0-1b19-46e6-b1db-b5fd95e44df0 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01A-21-A13A-20 TCGA-A2-A0ST-01A-12D-A099-09 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A10P-05 d662c746-aeee-4b37-b811-a236222583b8 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A099-09 NA TCGA-A2-A0ST-01 NA TCGA-A2-A0ST-01A-12D-A099-09 TCGA-A2-A0ST-01 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A087-01 NA TCGA-A2-A0ST-01A-12R-A084-07 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01A-12D-A087-01 TCGA-A2-A0ST-01 |
|
|
68 |
TCGA-A2-A0SU-01 Stage IIA 66 2 Stage IIA 1661 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1661 0 LumA Luminal A Positive LumA/B 0 0 followup T_Other T2 LIVING 0 TCGA-A2-A0SU-01 1662 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0SU 1662 0 days 1662 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Sentinel node biopsy alone NA TCGA-A2-A0SU-F13954 TCGA-A2-A0SU TCGA-A2-A0SU-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -24219 1317 NA 0 1662 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 380 NO Negative NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf A0SU TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2006 05aa0960-505b-4b04-be9f-7b54940f5b27 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01A-21-A13C-20 TCGA-A2-A0SU-01A-11D-A099-09 TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A10P-05 4fbcc317-6f56-4227-a6ef-304afa8880eb TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A099-09 NA TCGA-A2-A0SU-01 NA TCGA-A2-A0SU-01A-11D-A099-09 TCGA-A2-A0SU-01 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A087-01 NA TCGA-A2-A0SU-01A-11R-A084-07 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01A-11D-A087-01 TCGA-A2-A0SU-01 |
|
|
69 |
TCGA-A2-A0SV-01 Stage IV 63 5 No_Conversion 825 825 Positive FEMALE Negative 3 3 4 Positive M1 Positive N2 825 1 LumB Luminal B Positive Basal -2 -3 followup T_Other T2 DECEASED 1 TCGA-A2-A0SV-01 825 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-A2-A0SV NA NA days 825 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NO 63 Right Axillary lymph node dissection alone NA TCGA-A2-A0SV-F3755 TCGA-A2-A0SV TCGA-A2-A0SV-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23126 1513 825 0 NA NA NA NA NA NA NA 90-99% NA NA 2010-11-22 FEMALE NA NA NA NA 2+ NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 600 NO Equivocal Negative NA 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA 2 6 NA NA NA NA NA NA NA NA 8 NA true No M1 N2a T2 Stage IV TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633.pdf A0SV WITH TUMOR NA NA NA NA NA NA NA 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2006 783d861d-ba0c-4b0d-9922-06ac23d3fc85 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01A-21-A13A-20 TCGA-A2-A0SV-01A-11D-A099-09 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A10P-05 fc3b7efa-17e1-4f22-82f6-46b9eb25ab83 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A099-09 NA TCGA-A2-A0SV-01 NA TCGA-A2-A0SV-01A-11D-A099-09 TCGA-A2-A0SV-01 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A087-01 NA TCGA-A2-A0SV-01A-11R-A084-07 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01A-11D-A087-01 TCGA-A2-A0SV-01 |
|
|
70 |
TCGA-A2-A0SW-01 Stage IV 82 4 No_Conversion 1364 1364 Positive FEMALE Negative 1 1 4 Positive M1 Positive N2 1364 1 LumB Luminal B Negative Basal -2 -5 followup T_Other T2 DECEASED 1 TCGA-A2-A0SW-01 1365 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A2-A0SW NA NA days 1365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 82 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0SW-F3701 TCGA-A2-A0SW NA NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -30085 NA 1365 0 NA NA NA 653 NA NA NA 40-49% NA NA 2010-11-8 FEMALE NA NA NA Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified NA 60 NA 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Liver NA 4 3 NA NA NA NA NA NA NA NA 4 NA NA No M1 N2 T2 Stage IV NA A0SW WITH TUMOR NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast NA DECEASED 2006 d17676ea-d64e-49d0-9737-3b852879ce52 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01A-21-A13A-20 TCGA-A2-A0SW-01A-11D-A099-09 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A10P-05 dc3609ce-4a40-4456-b26f-f366770af706 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A099-09 NA TCGA-A2-A0SW-01 NA TCGA-A2-A0SW-01A-11D-A099-09 TCGA-A2-A0SW-01 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A087-01 NA TCGA-A2-A0SW-01A-11R-A084-07 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01A-11D-A087-01 TCGA-A2-A0SW-01 |
|
|
71 |
TCGA-A2-A0SX-01 Stage IA 48 1 Stage I 1288 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1288 0 Basal Basal-like Negative Basal -13 -12 followup T1 T1 LIVING 0 TCGA-A2-A0SX-01 1534 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0SX 1534 0 days 1534 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 48 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0SX-F14037 TCGA-A2-A0SX TCGA-A2-A0SX-01A Negative Negative NA NA NA Lumpectomy Negative Lumpectomy NA YES 1239 NA -17774 1177 NA 0 1534 NA NA 1239 NA NA NA NA NA Scheduled Follow-up Submission 2011-7-14 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 910 NO Negative NA NA 1 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf A0SX WITH TUMOR NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2007 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01A-21-A13A-20 TCGA-A2-A0SX-01A-12D-A099-09 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A10P-05 13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A099-09 NA TCGA-A2-A0SX-01 NA TCGA-A2-A0SX-01A-12D-A099-09 TCGA-A2-A0SX-01 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A087-01 NA TCGA-A2-A0SX-01A-12R-A084-07 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01A-12D-A087-01 TCGA-A2-A0SX-01 |
|
|
72 |
TCGA-A2-A0SY-01 Stage IIIA 62 2 No_Conversion 1347 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 1347 0 LumA Luminal A Positive NA -5 -7 followup T_Other T3 LIVING 0 TCGA-A2-A0SY-01 1347 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0SY 1347 0 days 1347 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0SY-F13943 TCGA-A2-A0SY TCGA-A2-A0SY-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -22928 1083 NA 0 1347 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified NA 60 NA 4.8 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 510 NO NA Positive NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T3 Stage IIIA TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf A0SY TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2007 30fad3cd-09a5-4867-9d18-a940041a2b60 30fad3cd-09a5-4867-9d18-a940041a2b60 NA TCGA-A2-A0SY-01A-31D-A099-09 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A10P-05 NA TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A099-09 NA TCGA-A2-A0SY-01 NA TCGA-A2-A0SY-01A-31D-A099-09 TCGA-A2-A0SY-01 30fad3cd-09a5-4867-9d18-a940041a2b60 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A087-01 NA TCGA-A2-A0SY-01A-31R-A084-07 30fad3cd-09a5-4867-9d18-a940041a2b60 TCGA-A2-A0SY-01A-31D-A087-01 TCGA-A2-A0SY-01 |
|
|
73 |
TCGA-A2-A0T0-01 Stage IIB 59 1 No_Conversion 533 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 533 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-A2-A0T0-01 533 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 12 TCGA-A2-A0T0 533 0 days 533 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0T0-F13944 TCGA-A2-A0T0 TCGA-A2-A0T0-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -21575 268 NA 0 533 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Negative NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf A0T0 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 7e073ecd-452a-4cba-9dfd-8601f3245721 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01A-11-A13D-20 TCGA-A2-A0T0-01A-22D-A099-09 TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A10P-05 87565b35-30bd-4e31-bb26-404baf053cdc TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A099-09 NA TCGA-A2-A0T0-01 NA TCGA-A2-A0T0-01A-22D-A099-09 TCGA-A2-A0T0-01 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A087-01 NA TCGA-A2-A0T0-01A-22R-A084-07 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01A-22D-A087-01 TCGA-A2-A0T0-01 |
|
|
74 |
TCGA-A2-A0T1-01 Stage IIIC 55 4 No_Conversion 520 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N3 520 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T3 LIVING 0 TCGA-A2-A0T1-01 521 0 days High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0T1 521 0 days 521 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0T1-F13946 TCGA-A2-A0T1 TCGA-A2-A0T1-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -20227 233 NA 0 521 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 230 NO Positive NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 10 NA true No M0 N3 T3 Stage IIIC TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf A0T1 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 8a19b992-4173-400d-8aec-d156525eedd6 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01A-11-A13D-20 TCGA-A2-A0T1-01A-21D-A099-09 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A10P-05 84b6d9cc-201e-421d-b7af-77156e50c627 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A099-09 NA TCGA-A2-A0T1-01 NA TCGA-A2-A0T1-01A-21D-A099-09 TCGA-A2-A0T1-01 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A087-01 NA TCGA-A2-A0T1-01A-21R-A084-07 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01A-21D-A087-01 TCGA-A2-A0T1-01 |
|
|
75 |
TCGA-A2-A0T2-01 Stage IV 66 3 No_Conversion 240 240 Negative FEMALE Negative 2 2 2 Positive M1 Positive N3 240 1 Basal Basal-like Negative Basal -13 0 followup T_Other T3 DECEASED 1 TCGA-A2-A0T2-01 255 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A2-A0T2 NA NA days 255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NO 66 Right Axillary lymph node dissection alone NA TCGA-A2-A0T2-F3706 TCGA-A2-A0T2 TCGA-A2-A0T2-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -24235 261 255 0 NA NA NA NA NA NA NA <10% NA NA 2010-11-12 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 270 NO Negative NA NA 14 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Liver Abdomen 5 3 NA NA NA NA NA NA NA NA 10 NA true No M1 N3 T3 Stage IV TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf A0T2 WITH TUMOR NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA NO NO YES A2 Breast A DECEASED 2009 491c6c41-d1c5-4be7-bb7c-9df7275aa388 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01A-21-A13D-20 TCGA-A2-A0T2-01A-11W-A097-09 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11D-A10P-05 73634c23-d25e-4268-a1bb-f8270a5d1d00 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11W-A097-09 NA TCGA-A2-A0T2-01 NA TCGA-A2-A0T2-01A-11W-A097-09 TCGA-A2-A0T2-01 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11D-A087-01 NA TCGA-A2-A0T2-01A-11R-A084-07 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01A-11D-A087-01 TCGA-A2-A0T2-01 |
|
|
76 |
TCGA-A2-A0T3-01 Stage IA 37 3 Stage IIA 569 NA Positive FEMALE Negative 4 5 4 Negative M0 Positive N1 569 0 LumB Luminal B Positive ReacII 0 -3 followup T1 T1 LIVING 0 TCGA-A2-A0T3-01 1516 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 5 TCGA-A2-A0T3 1516 0 days 1516 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0T3-F59384 TCGA-A2-A0T3 NA Negative Positive 3 Point Scale 3+ 3 Point Scale Other Positive Lumpectomy Margin resection YES NA NA -13680 NA NA 0 1516 NA NA NA NA NO NA 90-99% 2.3 Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA NA NA 2+ 556 3.2 1.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Equivocal Negative NO 13 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 2 0 NA No M0 N1mi T1c Stage IB NA A0T3 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES A2 Breast NA LIVING 2009 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 TCGA-A2-A0T3-01A-11-A13D-20 TCGA-A2-A0T3-01A-21D-A10Y-09 TCGA-A2-A0T3-01 NA c6a1647b-f6fb-4d3d-a67e-07719db0a308 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21D-A10Y-09 TCGA-A2-A0T3-01A-21D-A112-05 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21D-A10Y-09 NA d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 NA TCGA-A2-A0T3-01A-21D-A111-01 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21R-A115-07 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 TCGA-A2-A0T3-01A-21D-A111-01 TCGA-A2-A0T3-01 |
|
|
77 |
TCGA-A2-A0T4-01 Stage IIA 62 2 Stage IIA 624 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 624 0 LumA Luminal B Positive ReacI -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0T4-01 624 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0T4 624 0 days 624 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Inner Quadrant Other (specify) SLN and non-SLN biopsy TCGA-A2-A0T4-F13948 TCGA-A2-A0T4 TCGA-A2-A0T4-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA YES NA NA -22849 303 NA 0 624 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 1500 NO Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf A0T4 TUMOR FREE NA NA NA NA NA NA NA 60-69% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 09787ddc-336f-4a53-a687-339d90457085 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01A-21-A13D-20 TCGA-A2-A0T4-01A-31D-A099-09 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A10P-05 a5869d20-d1ff-42f3-979d-797d1ed7a9e2 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A099-09 NA TCGA-A2-A0T4-01 NA TCGA-A2-A0T4-01A-31D-A099-09 TCGA-A2-A0T4-01 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A087-01 NA TCGA-A2-A0T4-01A-31R-A084-07 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01A-31D-A087-01 TCGA-A2-A0T4-01 |
|
|
78 |
TCGA-A2-A0T5-01 Stage IIB 39 2 Stage IIA 531 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 531 0 LumA Luminal A Positive LumA -5 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0T5-01 531 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 NA TCGA-A2-A0T5 531 0 days 531 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Sentinel node biopsy alone NA TCGA-A2-A0T5-F13949 TCGA-A2-A0T5 TCGA-A2-A0T5-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -14503 263 NA 0 531 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA 1+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1740 NO Negative Negative NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf A0T5 TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 4c15b588-6017-4f0c-9b66-4f18122acc83 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01A-11-A13D-20 NA TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A10P-05 c7933393-6f03-4495-9e54-53e3e72d81e7 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A099-09 NA TCGA-A2-A0T5-01 NA NA TCGA-A2-A0T5-01 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A087-01 NA TCGA-A2-A0T5-01A-21R-A084-07 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01A-21D-A087-01 TCGA-A2-A0T5-01 |
|
|
79 |
TCGA-A2-A0T6-01 Stage IIB 50 2 Stage IIB 575 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 575 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING 0 TCGA-A2-A0T6-01 575 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0T6 575 0 days 575 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Sentinel node biopsy alone NA TCGA-A2-A0T6-F13950 TCGA-A2-A0T6 NA NA Positive NA 3+ NA NA Positive Simple Mastectomy NA YES NA NA -18334 NA NA 0 575 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T3 Stage IIB NA A0T6 TUMOR FREE NA NA NA NA NA NA NA 90-99% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast NA LIVING 2009 e3639f71-cfe7-46c7-8390-73f8043ac6b0 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01A-21-A13C-20 TCGA-A2-A0T6-01A-11D-A099-09 TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A10P-05 dcf310c3-9f6b-492b-b733-ece45d60089a TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A099-09 NA TCGA-A2-A0T6-01 NA TCGA-A2-A0T6-01A-11D-A099-09 TCGA-A2-A0T6-01 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A087-01 NA TCGA-A2-A0T6-01A-11R-A084-07 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01A-11D-A087-01 TCGA-A2-A0T6-01 |
|
|
80 |
TCGA-A2-A0T7-01 Stage IIA 51 2 Stage IIA 631 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 631 0 LumA Luminal A Positive ReacI -3 0 followup T_Other T2 LIVING 0 TCGA-A2-A0T7-01 631 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0T7 631 0 days 631 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-A2-A0T7-F13953 TCGA-A2-A0T7 TCGA-A2-A0T7-01A Negative Positive NA 2+ NA Other Positive Modified Radical Mastectomy Skin excision YES NA NA -18756 280 NA 0 631 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 990 NO Negative NA NA 2 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf A0T7 TUMOR FREE NA NA NA NA NA NA NA 70-79% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 b5de3654-8983-45ab-a83a-d15284740d39 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01A-11-A13A-20 TCGA-A2-A0T7-01A-21D-A099-09 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A10P-05 7a10bda1-1af5-4641-91bd-9a5174a68ff9 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A099-09 NA TCGA-A2-A0T7-01 NA TCGA-A2-A0T7-01A-21D-A099-09 TCGA-A2-A0T7-01 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A087-01 NA TCGA-A2-A0T7-01A-21R-A084-07 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01A-21D-A087-01 TCGA-A2-A0T7-01 |
|
|
81 |
TCGA-A2-A0YC-01 Stage IIB 59 2 No_Conversion 989 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 989 0 LumA Luminal A Positive ReacII -12 -3 followup T_Other T2 LIVING 0 TCGA-A2-A0YC-01 990 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0YC 798 1 days 990 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 59 Right Upper Inner Quadrant Other (specify) Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy TCGA-A2-A0YC-F15846 TCGA-A2-A0YC TCGA-A2-A0YC-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA 798 -21685 673 NA 0 990 NA NA 798 NA NA NA 90-99% NA Additional New Tumor Event 2011-8-30 FEMALE NA NA NA Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified NA 60 NA 1.18 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1170 NO NA Negative NA 3 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Equivocal NA NA Positive NA NA NA NA NA NA NA NA NA NA NA Positive NA NA 4 4 NA NA NA Bone Distant Metastasis NA NA YES 1 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1.pdf A0YC WITH TUMOR NA NA NA NA NA NA NA 90-99% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2008 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01A-21-A13D-20 TCGA-A2-A0YC-01A-11D-A117-09 TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A10A-05 ca761204-8a14-4297-afa7-f200bc37d53a TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A117-09 NA TCGA-A2-A0YC-01 NA TCGA-A2-A0YC-01A-11D-A117-09 TCGA-A2-A0YC-01 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A107-01 NA TCGA-A2-A0YC-01A-11R-A109-07 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01A-11D-A107-01 TCGA-A2-A0YC-01 |
|
|
82 |
TCGA-A2-A0YD-01 Stage IIB 63 2 Stage IIB 769 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 769 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T3 LIVING 0 TCGA-A2-A0YD-01 769 0 days Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A0YD 769 0 days 769 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0YD-F15770 TCGA-A2-A0YD NA NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -23021 NA NA 0 769 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-30 FEMALE NA NA NA Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified NA 60 NA 1.04 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 1 NA No M0 N0 (i+) T3 Stage IIB NA A0YD TUMOR FREE NA NA NA NA NA NA NA 80-89% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast NA LIVING 2009 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01A-21-A13D-20 TCGA-A2-A0YD-01A-11D-A10G-09 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A10A-05 b3a0423a-0d47-45f2-aa7c-1ae650ab5dd0 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A10G-09 NA TCGA-A2-A0YD-01 NA TCGA-A2-A0YD-01A-11D-A10G-09 TCGA-A2-A0YD-01 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A107-01 NA TCGA-A2-A0YD-01A-11R-A109-07 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01A-11D-A107-01 TCGA-A2-A0YD-01 |
|
|
83 |
TCGA-A2-A0YE-01 Stage IIB 48 3 No_Conversion 553 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 553 0 Basal Basal-like Negative X -13 -12 followup T_Other T2 LIVING 0 TCGA-A2-A0YE-01 554 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA NA TCGA-A2-A0YE 554 0 days 554 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0YE-F15771 TCGA-A2-A0YE TCGA-A2-A0YE-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -17727 238 NA 0 554 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-8-30 FEMALE NA No membrane staining or incomplete membrane staining in <10% of tumor cells is negative <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO Negative NA NA 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf A0YE TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2010 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b TCGA-A2-A0YE-01A-21-A13D-20 NA TCGA-A2-A0YE-01 TCGA-A2-A0YE-01A-11D-A10A-05 510563aa-4a19-4dd1-82c8-ac67f8a77a55 TCGA-A2-A0YE-01 TCGA-A2-A0YE-01A-11D-A10G-09 NA TCGA-A2-A0YE-01 NA NA NA 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b NA TCGA-A2-A0YE-01A-11D-A107-01 NA TCGA-A2-A0YE-01A-11R-A109-07 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b TCGA-A2-A0YE-01A-11D-A107-01 TCGA-A2-A0YE-01 |
|
|
84 |
TCGA-A2-A0YF-01 Stage IA 67 2 Stage I 469 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 469 0 LumA Luminal A Negative ReacII -12 -3 followup T1 T1 LIVING 0 TCGA-A2-A0YF-01 1535 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A2-A0YF 1535 0 days 1535 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Sentinel node biopsy alone NA TCGA-A2-A0YF-F59385 TCGA-A2-A0YF TCGA-A2-A0YF-01A NA Positive NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -24660 343 NA 0 1535 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 600 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T1b Stage I TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf A0YF TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 b3ac6331-6c8f-4165-add7-482aadf7fa68 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01A-11-A13D-20 TCGA-A2-A0YF-01A-21D-A10G-09 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A10A-05 85fd3e18-e927-47b3-9e06-b73de5edd740 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A10G-09 NA TCGA-A2-A0YF-01 NA TCGA-A2-A0YF-01A-21D-A10G-09 TCGA-A2-A0YF-01 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A107-01 NA TCGA-A2-A0YF-01A-21R-A109-07 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01A-21D-A107-01 TCGA-A2-A0YF-01 |
|
|
85 |
TCGA-A2-A0YG-01 Stage IIIC 63 5 No_Conversion 665 NA Positive FEMALE Positive 1 1 4 Negative M0 Positive N3 665 0 LumB Luminal B Positive Her2 -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0YG-01 666 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-A2-A0YG 666 0 days 666 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0YG-F16753 TCGA-A2-A0YG TCGA-A2-A0YG-01A NA Positive NA 2+ NA NA Positive Lumpectomy NA NO NA NA -23058 329 NA 0 666 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-9-16 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 1530 NO Positive NA NA 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 14 NA true No M0 N3a T2 Stage IIIC TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf A0YG TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 c539f561-93db-41f3-8d9f-71cd77a096a7 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01A-31-A13D-20 TCGA-A2-A0YG-01A-21D-A10G-09 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A10A-05 2d2789e0-0933-496a-a29b-63c0b05cfa19 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A10G-09 NA TCGA-A2-A0YG-01 NA TCGA-A2-A0YG-01A-21D-A10G-09 TCGA-A2-A0YG-01 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A107-01 NA TCGA-A2-A0YG-01A-21R-A109-07 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01A-21D-A107-01 TCGA-A2-A0YG-01 |
|
|
86 |
TCGA-A2-A0YH-01 Stage IIIA 53 4 No_Conversion 658 NA Positive FEMALE Negative 3 3 4 Negative M0 Positive N2 658 0 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 LIVING 0 TCGA-A2-A0YH-01 659 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A2-A0YH 659 0 days 659 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0YH-F16752 TCGA-A2-A0YH TCGA-A2-A0YH-01A NA Positive NA 3+ NA NA Positive Lumpectomy NA NO NA NA -19596 321 NA 0 659 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2011-9-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 480 NO Negative NA NA 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T2 Stage IIIA TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf A0YH TUMOR FREE NA NA NA NA NA NA NA 70-79% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 5275bc42-18a3-43d1-9dee-dfb80c39ba20 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01A-21-A13D-20 TCGA-A2-A0YH-01A-11D-A10G-09 TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A10A-05 1682b578-8f05-4a4c-b98c-4ffe7ef3346e TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A10G-09 NA TCGA-A2-A0YH-01 NA TCGA-A2-A0YH-01A-11D-A10G-09 TCGA-A2-A0YH-01 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A107-01 NA TCGA-A2-A0YH-01A-11R-A109-07 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01A-11D-A107-01 TCGA-A2-A0YH-01 |
|
|
87 |
TCGA-A2-A0YI-01 Stage IA 62 3 Stage I 441 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 441 0 LumA Luminal A Positive ReacI -12 -4 followup T1 T1 LIVING 0 TCGA-A2-A0YI-01 1505 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0YI 1505 0 days 1505 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Other (specify) Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy TCGA-A2-A0YI-F59386 TCGA-A2-A0YI TCGA-A2-A0YI-01A NA Positive NA 2+ NA NA Positive Lumpectomy NA YES NA NA -22961 303 NA 0 1505 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8522/3 C50.9 3+ YES NA Core needle biopsy 340 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T1c Stage I TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf A0YI TUMOR FREE NA NA NA NA NA YES NA 60-69% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2009 4de3ad78-68e4-4ab9-b1f6-eb0666140761 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01A-21-A13D-20 TCGA-A2-A0YI-01A-31D-A10M-09 TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10N-05 0dca7119-3230-47a7-89e3-93c4bd405f4d TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10M-09 NA TCGA-A2-A0YI-01 NA TCGA-A2-A0YI-01A-31D-A10M-09 TCGA-A2-A0YI-01 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10L-01 NA TCGA-A2-A0YI-01A-31R-A10J-07 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01A-31D-A10L-01 TCGA-A2-A0YI-01 |
|
|
88 |
TCGA-A2-A0YJ-01 Stage IIIA 39 3 No_Conversion 565 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 565 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T3 LIVING 0 TCGA-A2-A0YJ-01 566 0 days COAD-READ C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation cluster 5 TCGA-A2-A0YJ 559 1 days 566 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES NA 39 Left Axillary lymph node dissection alone NA TCGA-A2-A0YJ-F16756 TCGA-A2-A0YJ TCGA-A2-A0YJ-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA 559 -14448 264 NA 0 566 NA NA 559 NA NA NA <10% NA Scheduled Follow-up Submission 2011-9-16 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 1080 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 1+ NA Negative NA NA <10% NA NA NA NA NA NA NA NA Negative NA NA 5 NA NA NA NA Other, specify Distant Metastasis Left Cervical Lymph Node NA YES 5 NA true No M0 N2a T3 Stage IIIA TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514.pdf A0YJ WITH TUMOR NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2010 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 TCGA-A2-A0YJ-01A-21-A13D-20 TCGA-A2-A0YJ-01A-11D-A10G-09 TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01A-11D-A10A-05 d6e27bfa-0efe-457b-8628-38958d21268b TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01A-11D-A10G-09 NA TCGA-A2-A0YJ-01 NA TCGA-A2-A0YJ-01A-11D-A10G-09 NA 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 NA TCGA-A2-A0YJ-01A-11D-A107-01 NA TCGA-A2-A0YJ-01A-11R-A109-07 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 TCGA-A2-A0YJ-01A-11D-A107-01 TCGA-A2-A0YJ-01 |
|
|
89 |
TCGA-A2-A0YK-01 Stage IIA 61 5 Stage IIA 587 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 587 0 Normal Normal-like Negative ReacII -5 -7 followup T_Other T2 LIVING 0 TCGA-A2-A0YK-01 588 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A0YK 588 0 days 588 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A0YK-F16750 TCGA-A2-A0YK TCGA-A2-A0YK-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -22625 280 NA 0 588 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-9-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 620 NO Negative NA NA 3 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf A0YK TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2009 ae614f7b-b310-4c60-bd50-9e02be984943 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01A-31-A13D-20 TCGA-A2-A0YK-01A-22D-A117-09 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A10A-05 07e19b85-cee6-4ea4-8588-5df93bf33053 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A117-09 NA TCGA-A2-A0YK-01 NA TCGA-A2-A0YK-01A-22D-A117-09 TCGA-A2-A0YK-01 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A107-01 NA TCGA-A2-A0YK-01A-22R-A109-07 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01A-22D-A107-01 TCGA-A2-A0YK-01 |
|
|
90 |
TCGA-A2-A0YL-01 Stage IIIA 48 2 No_Conversion 445 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 445 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING 0 TCGA-A2-A0YL-01 1474 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0YL 1474 0 days 1474 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A0YL-F59387 TCGA-A2-A0YL TCGA-A2-A0YL-01A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA YES NA NA -17702 205 NA 0 1474 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2014-5-12 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 730 NO Negative NA NO 29 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 4 0 true No M0 N2a T3 Stage IIIA TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf A0YL TUMOR FREE NA NA NA NA NA YES NA 90-99% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A LIVING 2010 32cfb4f4-1de9-4937-8cfa-dc6c37081583 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01A-11-A13D-20 TCGA-A2-A0YL-01A-21D-A10G-09 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A10A-05 2f4ab3d7-e280-4c21-9b13-e1c240627337 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A10G-09 NA TCGA-A2-A0YL-01 NA TCGA-A2-A0YL-01A-21D-A10G-09 TCGA-A2-A0YL-01 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A107-01 NA TCGA-A2-A0YL-01A-21R-A109-07 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01A-21D-A107-01 TCGA-A2-A0YL-01 |
|
|
91 |
TCGA-A2-A0YM-01 Stage IIA 67 3 Stage IIA 964 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 964 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-A2-A0YM-01 965 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 OV-like c4 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-A2-A0YM 965 0 days 965 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left Upper Outer Quadrant Other (specify) Sentinel lymph node biopsy and non-sentinel lymph node biopsy TCGA-A2-A0YM-F15767 TCGA-A2-A0YM TCGA-A2-A0YM-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -24831 691 NA 0 965 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-8-30 FEMALE NA NA NA Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified NA 60 NA 1.08 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO NA Negative NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf A0YM TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA NO NO YES A2 Breast A LIVING 2008 1e59ea3f-36fa-4860-8c28-87b4b09075ec 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01A-21-A13D-20 TCGA-A2-A0YM-01A-11D-A10G-09 TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A10A-05 a55195f2-8c4d-40ab-a452-8424a0403d03 TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A10G-09 NA TCGA-A2-A0YM-01 NA TCGA-A2-A0YM-01A-11D-A10G-09 TCGA-A2-A0YM-01 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A107-01 NA TCGA-A2-A0YM-01A-11R-A109-07 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01A-11D-A107-01 TCGA-A2-A0YM-01 |
|
|
92 |
TCGA-A2-A0YT-01 Stage IIIB 56 NA No_Conversion 669 723 Positive FEMALE Negative NA NA NA Negative M0 Positive N2 723 1 LumB NA Negative NA NA NA followup T_Other T4 DECEASED 1 TCGA-A2-A0YT-01 723 1 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation cluster 3 TCGA-A2-A0YT 723 0 days 723 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A0YT-F15768 TCGA-A2-A0YT TCGA-A2-A0YT-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -20482 884 723 0 NA NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-30 FEMALE NA NA NA Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified NA 60 NA 1.3 NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 950 NO NA Negative NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T4b Stage IIIB TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf A0YT TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES A2 Breast A DECEASED 2008 451099b0-f348-4aec-bf9f-2982601f013c 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01A-21-A13D-20 TCGA-A2-A0YT-01A-11D-A10G-09 TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A10A-05 cea5a1de-f9e8-406b-a6ac-08e3d9869c5b TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A10G-09 NA TCGA-A2-A0YT-01 NA TCGA-A2-A0YT-01A-11D-A10G-09 TCGA-A2-A0YT-01 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A107-01 NA TCGA-A2-A0YT-01A-11R-A109-07 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01A-11D-A107-01 TCGA-A2-A0YT-01 |
|
|
93 |
TCGA-A2-A1FV-01 Stage IIB 74 4 Stage IIB 460 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 460 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-A2-A1FV-01 714 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-A2-A1FV 714 0 days 714 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Sentinel node biopsy alone NA TCGA-A2-A1FV-F20238 TCGA-A2-A1FV TCGA-A2-A1FV-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -27287 372 NA 0 714 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 1+ NA NA 0.92 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf A1FV TUMOR FREE NA NA NA Strong Strong NA YES <10% NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 ee12f85b-64f8-4052-9477-392c4bd99257 ee12f85b-64f8-4052-9477-392c4bd99257 TCGA-A2-A1FV-01A-21-A17I-20 TCGA-A2-A1FV-01A-11D-A13L-09 TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13K-05 5d85b493-8ea7-46e2-a2f1-f21b8ccc46c8 TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13L-09 NA NA TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13L-09 NA ee12f85b-64f8-4052-9477-392c4bd99257 NA TCGA-A2-A1FV-01A-11D-A13J-01 TCGA-A2-A1FV-01 NA ee12f85b-64f8-4052-9477-392c4bd99257 TCGA-A2-A1FV-01A-11D-A13J-01 |
|
|
94 |
TCGA-A2-A1FW-01 Stage IIIA 62 3 Stage IIIA 221 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 221 0 LumB NA Negative NA NA NA enrollment T_Other T3 LIVING 0 TCGA-A2-A1FW-01 528 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-A2-A1FW 528 0 days 528 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A1FW-F20810 TCGA-A2-A1FW TCGA-A2-A1FW-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22779 198 NA 0 528 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 640 NO Negative NA NA 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T3 Stage IIIA TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf A1FW TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c TCGA-A2-A1FW-01A-21-A17I-20 TCGA-A2-A1FW-01A-11D-A13L-09 TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13K-05 fdc673b1-add6-4078-8f96-0ed4f6985240 TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13L-09 NA NA TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13L-09 NA 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c NA TCGA-A2-A1FW-01A-11D-A13J-01 TCGA-A2-A1FW-01 NA 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c TCGA-A2-A1FW-01A-11D-A13J-01 |
|
|
95 |
TCGA-A2-A1FX-01 Stage IIIA 61 4 Stage IIIA 935 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 935 0 LumB NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-A2-A1FX-01 1847 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A1FX 1847 0 days 1847 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A1FX-F59654 TCGA-A2-A1FX TCGA-A2-A1FX-01A Negative Positive NA NA NA Mastectomy NOS Positive Lumpectomy NA NO NA NA -22344 937 NA 0 1847 NA NA NA NA NO NA 70-79% 160 Scheduled Follow-up Submission 2014-5-19 FEMALE NA NA NA NA NA 60 185 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO NA Negative NO 24 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 6 NA true No M0 N2a T3 Stage IIIA TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf A1FX TUMOR FREE NA NA NA NA NA YES YES 60-69% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2008 60f078d7-d594-48a2-9011-f0f926243a42 60f078d7-d594-48a2-9011-f0f926243a42 TCGA-A2-A1FX-01A-21-A17I-20 TCGA-A2-A1FX-01A-11D-A13L-09 TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13K-05 0b991416-2ca1-4582-b119-e95e4e8ca5e8 TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13L-09 NA NA TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13L-09 NA 60f078d7-d594-48a2-9011-f0f926243a42 NA TCGA-A2-A1FX-01A-11D-A13J-01 TCGA-A2-A1FX-01 NA 60f078d7-d594-48a2-9011-f0f926243a42 TCGA-A2-A1FX-01A-11D-A13J-01 |
|
|
96 |
TCGA-A2-A1FZ-01 Stage IIA 63 3 Stage IIA 409 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 409 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A1FZ-01 683 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-A2-A1FZ 683 0 days 683 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel node biopsy alone NA TCGA-A2-A1FZ-F20803 TCGA-A2-A1FZ TCGA-A2-A1FZ-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -23055 335 NA 0 683 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 740 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf A1FZ TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 TCGA-A2-A1FZ-01A-11-A17I-20 TCGA-A2-A1FZ-01A-51D-A17G-09 TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A14H-05 5157205e-da8c-4890-9df3-02f40831c268 TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A17G-09 NA NA TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A17G-09 NA 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 NA TCGA-A2-A1FZ-01A-51D-A14F-01 TCGA-A2-A1FZ-01 NA 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 TCGA-A2-A1FZ-01A-51D-A14F-01 |
|
|
97 |
TCGA-A2-A1G0-01 Stage IIB 49 3 Stage IIB 380 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 380 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A1G0-01 616 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A1G0 616 0 days 616 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A1G0-F20802 TCGA-A2-A1G0 TCGA-A2-A1G0-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -18002 315 NA 0 616 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 2+ NA NA 1.2 NA Other, specify NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 730 NO Equivocal Negative NA 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf A1G0 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 753e77c2-6175-49d8-afd4-3a87d1dc2404 753e77c2-6175-49d8-afd4-3a87d1dc2404 TCGA-A2-A1G0-01A-21-A17I-20 TCGA-A2-A1G0-01A-11D-A13L-09 TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13K-05 5875ba8b-aa27-4573-b1c7-30878613288e TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13L-09 NA NA TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13L-09 NA 753e77c2-6175-49d8-afd4-3a87d1dc2404 NA TCGA-A2-A1G0-01A-11D-A13J-01 TCGA-A2-A1G0-01 NA 753e77c2-6175-49d8-afd4-3a87d1dc2404 TCGA-A2-A1G0-01A-11D-A13J-01 |
|
|
98 |
TCGA-A2-A1G1-01 Stage IIB 85 4 Stage IIB 371 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 371 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A1G1-01 584 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 14 cluster 6 mutation cluster 5 TCGA-A2-A1G1 584 0 days 584 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 85 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A1G1-F20808 TCGA-A2-A1G1 TCGA-A2-A1G1-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -31223 338 NA 0 584 NA NA NA NA NO NA NA 51 Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA 2+ 30 816 16.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Equivocal Positive NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf A1G1 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th NO YES NO A2 Breast A LIVING 2010 122a1ed2-9757-4cac-9656-149da6d872f4 122a1ed2-9757-4cac-9656-149da6d872f4 TCGA-A2-A1G1-01A-11-A17I-20 TCGA-A2-A1G1-01A-21D-A13L-09 TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13K-05 cd315ed6-e7af-4f4e-9990-348e464d5738 TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13L-09 NA NA TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13L-09 NA 122a1ed2-9757-4cac-9656-149da6d872f4 NA TCGA-A2-A1G1-01A-21D-A13J-01 TCGA-A2-A1G1-01 NA 122a1ed2-9757-4cac-9656-149da6d872f4 TCGA-A2-A1G1-01A-21D-A13J-01 |
|
|
99 |
TCGA-A2-A1G4-01 Stage IIIA 71 4 Stage IIIA 372 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 372 0 LumB NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-A2-A1G4-01 595 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-A2-A1G4 595 0 days 595 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A1G4-F20805 TCGA-A2-A1G4 TCGA-A2-A1G4-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -25966 310 NA 0 595 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 710 NO Negative NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 2 NA true Yes M0 N1a T3 Stage IIIA TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf A1G4 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 TCGA-A2-A1G4-01A-21-A17I-20 TCGA-A2-A1G4-01A-11D-A13L-09 TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13K-05 d573b843-5656-47aa-958a-c295311876f0 TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13L-09 NA NA TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13L-09 NA 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 NA TCGA-A2-A1G4-01A-11D-A13J-01 TCGA-A2-A1G4-01 NA 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 TCGA-A2-A1G4-01A-11D-A13J-01 |
|
|
100 |
TCGA-A2-A1G6-01 Stage IIIA 50 1 Stage IIIA 132 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N2 132 0 Normal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A1G6-01 501 0 days Quiet C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A2-A1G6 501 0 days 501 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Axillary lymph node dissection alone NA TCGA-A2-A1G6-F20947 TCGA-A2-A1G6 TCGA-A2-A1G6-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18514 229 NA 0 501 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 770 NO Negative NA NA 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 4 NA true No M0 N2a T2 Stage IIIA TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf A1G6 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 8b216b0f-1881-45de-a4ae-78dfd87764fe 8b216b0f-1881-45de-a4ae-78dfd87764fe TCGA-A2-A1G6-01A-21-A17I-20 TCGA-A2-A1G6-01A-11D-A13L-09 TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13K-05 02e55cff-87a6-4719-b988-4b8f46f079a5 TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13L-09 NA NA TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13L-09 NA 8b216b0f-1881-45de-a4ae-78dfd87764fe NA TCGA-A2-A1G6-01A-11D-A13J-01 TCGA-A2-A1G6-01 NA 8b216b0f-1881-45de-a4ae-78dfd87764fe TCGA-A2-A1G6-01A-11D-A13J-01 |
|
|
101 |
TCGA-A2-A259-01 Stage IA 70 4 Stage I 1285 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1285 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-A2-A259-01 1596 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation c1uster 9 TCGA-A2-A259 1596 0 days 1596 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Sentinel node biopsy alone NA TCGA-A2-A259-F31034 TCGA-A2-A259 TCGA-A2-A259-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA YES NA NA -25666 1238 NA 0 1596 NA NA NA NA NO NA 90-99% 125 Scheduled Follow-up Submission 2012-4-23 FEMALE NA NA NA NA NA 60 132 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative Negative NA 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf A259 TUMOR FREE NA NA NA Strong using Weak, Moderate and Strong Strong using Weak, Moderate and Strong NA YES 80-89% NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2007 7157ccb4-b4f6-41ba-9f9c-da862b749a57 7157ccb4-b4f6-41ba-9f9c-da862b749a57 TCGA-A2-A259-01A-21-A17I-20 TCGA-A2-A259-01A-11D-A16D-09 TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16G-05 f49215ab-aaf7-4a3a-bf77-196395a8cae7 TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16D-09 NA NA TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16D-09 NA 7157ccb4-b4f6-41ba-9f9c-da862b749a57 NA TCGA-A2-A259-01A-11D-A16C-01 TCGA-A2-A259-01 NA 7157ccb4-b4f6-41ba-9f9c-da862b749a57 TCGA-A2-A259-01A-11D-A16C-01 |
|
|
102 |
TCGA-A2-A25A-01 Stage IIA 44 2 Stage IIA 2968 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2968 0 Normal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25A-01 3276 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation cluster 4 TCGA-A2-A25A 3276 0 days 3276 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-A2-A25A-F30927 TCGA-A2-A25A TCGA-A2-A25A-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -16084 2927 NA 0 3276 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2012-4-19 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 160 NO Equivocal Negative NA 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 0 true Yes M0 N0 (i-) T2 Stage IIA TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf A25A TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2003 50c720f4-dbcb-4b8b-9808-d130f5197d27 50c720f4-dbcb-4b8b-9808-d130f5197d27 TCGA-A2-A25A-01A-21-A17I-20 TCGA-A2-A25A-01A-12D-A16D-09 TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16G-05 bf3c63c7-643e-43b2-b5ea-3c2185ba9238 TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16D-09 NA NA TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16D-09 NA 50c720f4-dbcb-4b8b-9808-d130f5197d27 NA TCGA-A2-A25A-01A-12D-A16C-01 TCGA-A2-A25A-01 NA 50c720f4-dbcb-4b8b-9808-d130f5197d27 TCGA-A2-A25A-01A-12D-A16C-01 |
|
|
103 |
TCGA-A2-A25B-01 Stage IIB 39 5 Stage IIB 258 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 258 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25B-01 1291 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-A2-A25B 1290 1 days 1291 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A25B-F70679 TCGA-A2-A25B TCGA-A2-A25B-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -14454 183 NA 0 1291 NA NA 1290 NA NO NA 90-99% NA Scheduled Follow-up Submission 2015-3-2 FEMALE NA NA NA NA 2+ NA NA 0.93 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 840 NO Equivocal Negative NO 8 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA Positive NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA Bone Distant Metastasis NA NO YES 2 NA true No M0 N1 T2 Stage IIB TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf A25B WITH TUMOR NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b TCGA-A2-A25B-01A-21-A17I-20 TCGA-A2-A25B-01A-11D-A167-09 TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A16A-05 b5b0794f-7149-4056-8687-98a9a1401d2c TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A167-09 NA NA TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A167-09 NA 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b NA TCGA-A2-A25B-01A-11D-A166-01 TCGA-A2-A25B-01 NA 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b TCGA-A2-A25B-01A-11D-A166-01 |
|
|
104 |
TCGA-A2-A25C-01 Stage IIB 50 3 Stage IIB 285 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 285 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25C-01 523 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 4 TCGA-A2-A25C 523 0 days 523 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A25C-F31282 TCGA-A2-A25C NA NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -18508 NA NA 0 523 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-4-17 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NA 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T2 Stage IIB NA A25C TUMOR FREE NA NA NA NA NA NA YES 20-29% NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast NA LIVING 2010 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 TCGA-A2-A25C-01A-21-A17I-20 TCGA-A2-A25C-01A-11D-A167-09 TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A16A-05 dbc23df1-b14d-4f24-81ef-fc12e2cdda21 TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A167-09 NA NA TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A167-09 NA f5b16ba5-0fd1-4ca4-865f-fdff0af65901 NA TCGA-A2-A25C-01A-11D-A166-01 TCGA-A2-A25C-01 NA f5b16ba5-0fd1-4ca4-865f-fdff0af65901 TCGA-A2-A25C-01A-11D-A166-01 |
|
|
105 |
TCGA-A2-A25D-01 Stage IIIC 90 4 Stage IIIC 243 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 243 0 LumA NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25D-01 552 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 4 TCGA-A2-A25D 552 0 days 552 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A25D-F30931 TCGA-A2-A25D TCGA-A2-A25D-01A NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -32872 224 NA 0 552 NA NA NA NA NO NA 70-79% 118 Scheduled Follow-up Submission 2012-4-19 FEMALE NA NA NA NA 1+ 60 145 1.22 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 430 NO Negative Negative NA 24 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 22 NA true No M0 N3a T2 Stage IIIC TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf A25D TUMOR FREE NA NA NA NA Moderate using the scale of Weak, Moderate, Strong NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2010 d6b5cec3-edeb-46c5-839b-e62a1e850e0e d6b5cec3-edeb-46c5-839b-e62a1e850e0e TCGA-A2-A25D-01A-21-A17I-20 TCGA-A2-A25D-01A-12D-A16D-09 TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16G-05 6ff66f90-93c3-4c1e-84c6-9db89ca701c2 TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16D-09 NA NA TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16D-09 NA d6b5cec3-edeb-46c5-839b-e62a1e850e0e NA TCGA-A2-A25D-01A-12D-A16C-01 TCGA-A2-A25D-01 NA d6b5cec3-edeb-46c5-839b-e62a1e850e0e TCGA-A2-A25D-01A-12D-A16C-01 |
|
|
106 |
TCGA-A2-A25E-01 Stage IIIA 34 5 Stage IIIA 2511 NA Positive FEMALE Equivocal NA NA NA Negative M0 Positive N2 2511 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25E-01 3204 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-A2-A25E 2989 1 days 3204 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 34 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A25E-F44982 TCGA-A2-A25E TCGA-A2-A25E-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -12601 2441 NA 0 3204 NA 3024 2989 NA NO NA 80-89% NA Scheduled Follow-up Submission 2013-7-2 FEMALE NA NA NA NA 2+ NA NA 2.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 200 NO Equivocal Equivocal NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 1+ NA Positive 90-99% NA NA NA 3 Point Scale 3+ 2+ NA NA <10% NA Positive NA NA 4 5 NA NA 3 Point Scale Other, specify Locoregional Recurrence Left Chest Wall YES YES 6 NA true No M0 N2a T2 Stage IIIA TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf A25E TUMOR FREE NA NA NA Strong, using scale of Weak, Moderate and Strong Moderate using scale of Weak, Moderate, Strong YES YES 60-69% NA YES Primary Tumor 01 NA 6th YES NO YES A2 Breast A LIVING 2004 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 TCGA-A2-A25E-01A-21-A17I-20 TCGA-A2-A25E-01A-11D-A167-09 TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A16A-05 6a6f4c33-d59e-462a-9fa7-aed32a35ff44 TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A167-09 NA NA TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A167-09 NA 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 NA TCGA-A2-A25E-01A-11D-A166-01 TCGA-A2-A25E-01 NA 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 TCGA-A2-A25E-01A-11D-A166-01 |
|
|
107 |
TCGA-A2-A25F-01 Stage IIA 66 1 Stage IIA 113 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 113 0 Basal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A2-A25F-01 322 0 days Kirc+ C4-BRCA/Basal cluster 1 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation c1uster 9 TCGA-A2-A25F 322 0 days 322 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A25F-F31197 TCGA-A2-A25F TCGA-A2-A25F-01A NA Negative NA NA NA NA Positive Lumpectomy NA YES NA NA -24319 86 NA 0 322 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-4-23 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 390 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf A25F TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 7th YES YES NO A2 Breast A LIVING 2011 acd59617-770c-4653-891f-71ea87d67c41 acd59617-770c-4653-891f-71ea87d67c41 TCGA-A2-A25F-01A-21-A17I-20 TCGA-A2-A25F-01A-11D-A167-09 TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A16A-05 04f35825-e128-4a77-b58e-7b98019dad24 TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A167-09 NA NA TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A167-09 NA acd59617-770c-4653-891f-71ea87d67c41 NA TCGA-A2-A25F-01A-11D-A166-01 TCGA-A2-A25F-01 NA acd59617-770c-4653-891f-71ea87d67c41 TCGA-A2-A25F-01A-11D-A166-01 |
|
|
108 |
TCGA-A2-A3KC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3KC-01 1102 0 days Iq C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-A2-A3KC 1102 0 days 1102 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A3KC-F59210 TCGA-A2-A3KC TCGA-A2-A3KC-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -20401 299 NA 0 1102 NA NA NA NA NO NA 90-99% 1.9 NA 2014-5-5 FEMALE NA NA NA NA 2+ 20 1.8 1.0 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 780 NO Equivocal Negative NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf A3KC TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2011 7bbe4637-394e-42c0-af7d-6184c3f48916 7bbe4637-394e-42c0-af7d-6184c3f48916 TCGA-A2-A3KC-01A-21-A24A-20 NA TCGA-A2-A3KC-01 TCGA-A2-A3KC-01A-11D-A212-05 aa78b6ce-fccf-478e-b4b0-9cebaeeb99fb TCGA-A2-A3KC-01 TCGA-A2-A3KC-01A-11D-A20S-09 NA NA TCGA-A2-A3KC-01 NA NA 7bbe4637-394e-42c0-af7d-6184c3f48916 NA TCGA-A2-A3KC-01A-11D-A20R-01 TCGA-A2-A3KC-01 NA 7bbe4637-394e-42c0-af7d-6184c3f48916 TCGA-A2-A3KC-01A-11D-A20R-01 |
|
|
109 |
TCGA-A2-A3KD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3KD-01 1206 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-A2-A3KD 1206 0 days 1206 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A3KD-F37343 TCGA-A2-A3KD TCGA-A2-A3KD-01A Close Positive 3 Point Scale NA 3 Point Scale Mastectomy NOS Positive Lumpectomy NA YES NA NA -17372 700 NA 0 1206 NA NA NA NA NO NA 90-99% NA NA 2012-12-3 FEMALE NA NA NA NA 1+ NA NA 1.2 NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy 770 NO Negative Negative NO 19 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 true No M0 N1mi T3 Stage IIIA TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf A3KD TUMOR FREE NA NA NA Strong Strong YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2010 8a224dc6-632b-418b-bd5e-bcefc8ad049e 8a224dc6-632b-418b-bd5e-bcefc8ad049e TCGA-A2-A3KD-01A-21-A24A-20 NA TCGA-A2-A3KD-01 TCGA-A2-A3KD-01A-12D-A212-05 981593f7-f9eb-44af-a697-624af03e6bbf TCGA-A2-A3KD-01 TCGA-A2-A3KD-01A-12D-A20S-09 NA NA TCGA-A2-A3KD-01 NA NA 8a224dc6-632b-418b-bd5e-bcefc8ad049e NA TCGA-A2-A3KD-01A-12D-A20R-01 TCGA-A2-A3KD-01 NA 8a224dc6-632b-418b-bd5e-bcefc8ad049e TCGA-A2-A3KD-01A-12D-A20R-01 |
|
|
110 |
TCGA-A2-A3XS-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-A2-A3XS-01 1032 1 days NA NA NA NA NA NA miRNA cluster 4 NA NA TCGA-A2-A3XS 682 1 days 1032 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A3XS-F34446 TCGA-A2-A3XS TCGA-A2-A3XS-01A Negative Negative NA NA NA Mastectomy NOS Negative Lumpectomy NA YES NA NA -23000 3355 1032 0 NA NA NA 682 NA YES NA NA NA Additional New Tumor Event 2012-8-15 FEMALE NA NA NA NA NA NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 40 NO NA Negative NA 19 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis NA NA YES 9 0 true No M0 N2a T1 Stage IIIA TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf A3XS WITH TUMOR NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES A2 Breast A DECEASED 2003 799df122-75f1-46bf-8b5e-ca557cd38d53 799df122-75f1-46bf-8b5e-ca557cd38d53 NA NA TCGA-A2-A3XS-01 TCGA-A2-A3XS-01A-11D-A230-05 NA TCGA-A2-A3XS-01 TCGA-A2-A3XS-01A-11D-A22X-09 NA NA TCGA-A2-A3XS-01 NA NA 799df122-75f1-46bf-8b5e-ca557cd38d53 NA TCGA-A2-A3XS-01A-11D-A22W-01 TCGA-A2-A3XS-01 NA 799df122-75f1-46bf-8b5e-ca557cd38d53 TCGA-A2-A3XS-01A-11D-A22W-01 |
|
|
111 |
TCGA-A2-A3XT-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3XT-01 2770 0 days NA NA NA NA BRCA basal-like c6 NA miRNA cluster 4 NA NA TCGA-A2-A3XT 2770 0 days 2770 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Other (specify) F plus axillary lymph node dissection TCGA-A2-A3XT-F55841 TCGA-A2-A3XT TCGA-A2-A3XT-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -16649 2164 NA 0 2770 NA NA NA NA NA NA NA NA NA 2014-1-16 FEMALE NA NA NA NA NA NA NA 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 340 NO Negative Negative NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf A3XT TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES A2 Breast A LIVING 2006 e0a10445-6266-4f41-a747-fb19d7182652 e0a10445-6266-4f41-a747-fb19d7182652 TCGA-A2-A3XT-01A-21-A24A-20 NA TCGA-A2-A3XT-01 TCGA-A2-A3XT-01A-11D-A230-05 904a9035-e5e9-4a07-99dd-3a74f66c9145 TCGA-A2-A3XT-01 TCGA-A2-A3XT-01A-11D-A22X-09 NA NA TCGA-A2-A3XT-01 NA NA e0a10445-6266-4f41-a747-fb19d7182652 NA TCGA-A2-A3XT-01A-11D-A22W-01 TCGA-A2-A3XT-01 NA e0a10445-6266-4f41-a747-fb19d7182652 TCGA-A2-A3XT-01A-11D-A22W-01 |
|
|
112 |
TCGA-A2-A3XU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-A2-A3XU-01 912 1 days NA NA NA NA BRCA basal-like c6 NA miRNA cluster 4 NA NA TCGA-A2-A3XU 596 1 days 912 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 35 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A3XU-F34704 TCGA-A2-A3XU TCGA-A2-A3XU-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -13046 2089 912 0 NA NA NA 596 NA NA NA NA 1.5 NA 2012-8-30 FEMALE NA NA NA NA NA 60 1.66 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 350 NO NA Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Positive NA NA NA NA NA NA NA NA NA NA NA Positive NA NA NA NA NA NA NA Other, specify Locoregional Recurrence Breast NO YES 3 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf A3XU WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES A2 Breast A DECEASED 2006 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 TCGA-A2-A3XU-01A-21-A24A-20 NA TCGA-A2-A3XU-01 TCGA-A2-A3XU-01A-12D-A230-05 2233e116-6f58-4bf5-bcb7-528fc4ff8d30 TCGA-A2-A3XU-01 TCGA-A2-A3XU-01A-12D-A22X-09 NA NA TCGA-A2-A3XU-01 NA NA 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 NA TCGA-A2-A3XU-01A-12D-A22W-01 TCGA-A2-A3XU-01 NA 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 TCGA-A2-A3XU-01A-12D-A22W-01 |
|
|
113 |
TCGA-A2-A3XV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3XV-01 996 0 days NA NA NA NA BRCA basal-like c6 NA NA NA NA TCGA-A2-A3XV 996 0 days 996 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Sentinel node biopsy alone NA TCGA-A2-A3XV-F59117 TCGA-A2-A3XV NA NA Positive 3 Point Scale NA NA NA Negative Lumpectomy NA YES NA NA -16971 NA NA 0 996 NA NA NA NA NA NA <10% 1.7 NA 2014-5-1 FEMALE NA NA NA NA 2+ 60 4.5 2.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy NA NA Equivocal Positive NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T2 Stage IIA NA A3XV TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast NA LIVING 2011 fc2aa9aa-3df5-4723-9892-95edcc92bb6f fc2aa9aa-3df5-4723-9892-95edcc92bb6f TCGA-A2-A3XV-01A-41-A24A-20 NA TCGA-A2-A3XV-01 TCGA-A2-A3XV-01A-21D-A23D-05 bcfc3c93-8457-45c3-bace-45fb134af40e TCGA-A2-A3XV-01 TCGA-A2-A3XV-01A-21D-A23C-09 NA NA TCGA-A2-A3XV-01 NA NA fc2aa9aa-3df5-4723-9892-95edcc92bb6f NA TCGA-A2-A3XV-01A-21D-A238-01 TCGA-A2-A3XV-01 NA fc2aa9aa-3df5-4723-9892-95edcc92bb6f TCGA-A2-A3XV-01A-21D-A238-01 |
|
|
114 |
TCGA-A2-A3XW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3XW-01 1712 0 days NA NA NA NA BRCA nonbasal-like c8 NA NA NA NA TCGA-A2-A3XW 1712 0 days 1712 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A2-A3XW-F55843 TCGA-A2-A3XW NA NA Positive 3 Point Scale NA NA NA Negative Simple Mastectomy NA YES NA NA -15670 NA NA 0 1712 NA NA NA NA NO NA 90-99% NA NA 2014-1-16 FEMALE NA NA <10% NA NA NA NA 1.31 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy NA NA Negative Negative NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 NA No M0 N1a T2 Stage IIB NA A3XW TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast NA LIVING 2009 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 TCGA-A2-A3XW-01A-21-A24A-20 NA TCGA-A2-A3XW-01 TCGA-A2-A3XW-01A-11D-A23D-05 d9ca1e39-2191-444f-b17f-f5f57f73aa0c TCGA-A2-A3XW-01 TCGA-A2-A3XW-01A-11D-A23C-09 NA NA TCGA-A2-A3XW-01 NA NA f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 NA TCGA-A2-A3XW-01A-11D-A238-01 TCGA-A2-A3XW-01 NA f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 TCGA-A2-A3XW-01A-11D-A238-01 |
|
|
115 |
TCGA-A2-A3XX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-A2-A3XX-01 1439 1 days NA NA NA NA KIRC-like c1 NA NA NA NA TCGA-A2-A3XX 1439 0 days 1439 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A3XX-F43310 TCGA-A2-A3XX TCGA-A2-A3XX-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -17981 1143 1439 0 1168 NA NA NA NA NO NA NA NA NA 2013-5-16 FEMALE NA NA NA NA 1+ NA NA 1.25 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 780 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf A3XX TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO A2 Breast A DECEASED 2009 043d5dcd-1524-402b-939c-984a1dc916a0 043d5dcd-1524-402b-939c-984a1dc916a0 TCGA-A2-A3XX-01A-41-A24A-20 NA TCGA-A2-A3XX-01 TCGA-A2-A3XX-01A-21D-A23D-05 c4757b28-bb38-49bb-bb06-70fa40ad8298 TCGA-A2-A3XX-01 TCGA-A2-A3XX-01A-21D-A23C-09 NA NA TCGA-A2-A3XX-01 NA NA 043d5dcd-1524-402b-939c-984a1dc916a0 NA TCGA-A2-A3XX-01A-21D-A238-01 TCGA-A2-A3XX-01 NA 043d5dcd-1524-402b-939c-984a1dc916a0 TCGA-A2-A3XX-01A-21D-A238-01 |
|
|
116 |
TCGA-A2-A3XY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-A2-A3XY-01 1093 1 days NA NA NA NA NA NA NA NA NA TCGA-A2-A3XY 1072 1 days 1093 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 49 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A3XY-F55836 TCGA-A2-A3XY TCGA-A2-A3XY-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18059 703 1093 0 786 NA NA 1072 NA NO NA NA NA NA 2014-1-16 FEMALE NA NA NA NA NA NA NA 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 950 NO Negative Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Brain Distant Metastasis NA NO YES 3 NA true No M0 N1a T2 Stage IIB TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf A3XY WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A DECEASED 2010 42c88ed3-de96-487d-8b03-e1d4269d0505 42c88ed3-de96-487d-8b03-e1d4269d0505 NA NA TCGA-A2-A3XY-01 TCGA-A2-A3XY-01A-11D-A23D-05 NA TCGA-A2-A3XY-01 TCGA-A2-A3XY-01A-11D-A23C-09 NA NA TCGA-A2-A3XY-01 NA NA 42c88ed3-de96-487d-8b03-e1d4269d0505 NA TCGA-A2-A3XY-01A-11D-A238-01 TCGA-A2-A3XY-01 NA 42c88ed3-de96-487d-8b03-e1d4269d0505 TCGA-A2-A3XY-01A-11D-A238-01 |
|
|
117 |
TCGA-A2-A3XZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3XZ-01 1532 0 days NA NA NA NA BRCA basal-like c6 NA NA NA NA TCGA-A2-A3XZ 1532 0 days 1532 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A3XZ-F58924 TCGA-A2-A3XZ TCGA-A2-A3XZ-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -16978 909 NA 0 1532 NA NA NA NA NA NA NA NA NA 2014-4-28 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1100 NO Positive NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T1c Stage I TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf A3XZ TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES A2 Breast A LIVING 2009 176b2422-3599-41c5-be62-ae6e28d60b90 176b2422-3599-41c5-be62-ae6e28d60b90 TCGA-A2-A3XZ-01A-51-A24A-20 NA TCGA-A2-A3XZ-01 TCGA-A2-A3XZ-01A-42D-A23D-05 78747541-53ed-4037-af62-694fc6f00433 TCGA-A2-A3XZ-01 TCGA-A2-A3XZ-01A-42D-A23C-09 NA NA TCGA-A2-A3XZ-01 NA NA 176b2422-3599-41c5-be62-ae6e28d60b90 NA TCGA-A2-A3XZ-01A-42D-A238-01 TCGA-A2-A3XZ-01 NA 176b2422-3599-41c5-be62-ae6e28d60b90 TCGA-A2-A3XZ-01A-42D-A238-01 |
|
|
118 |
TCGA-A2-A3Y0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A3Y0-01 1546 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A3Y0 1546 0 days 1546 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A3Y0-F59118 TCGA-A2-A3Y0 TCGA-A2-A3Y0-01A NA Positive 3 Point Scale NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21024 845 NA 0 1546 NA NA NA NA NA NA 90-99% NA NA 2014-5-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 850 NO Negative NA NO 39 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf A3Y0 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA NO YES A2 Breast A LIVING 2010 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 NA NA TCGA-A2-A3Y0-01 TCGA-A2-A3Y0-01A-11D-A23D-05 NA TCGA-A2-A3Y0-01 TCGA-A2-A3Y0-01A-11D-A23C-09 NA NA TCGA-A2-A3Y0-01 NA NA 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 NA TCGA-A2-A3Y0-01A-11D-A238-01 TCGA-A2-A3Y0-01 NA 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 TCGA-A2-A3Y0-01A-11D-A238-01 |
|
|
119 |
TCGA-A2-A4RW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4RW-01 222 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4RW 222 0 days 222 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right|Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A4RW-F59123 TCGA-A2-A4RW NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -18060 NA NA 0 222 NA NA NA NA NA NA 80-89% NA NA 2014-5-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA YES 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 27 0 NA No M0 N3a T2 Stage IIIC NA A4RW TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 7th NA YES NO A2 Breast NA LIVING 2011 f8bfd67a-1d78-44b0-9715-712dee01b008 f8bfd67a-1d78-44b0-9715-712dee01b008 NA NA TCGA-A2-A4RW-01 TCGA-A2-A4RW-01A-21D-A268-05 cee2c148-efa3-45e2-8b28-f65e56a5d2b9 TCGA-A2-A4RW-01 TCGA-A2-A4RW-01A-21D-A25Q-09 NA NA TCGA-A2-A4RW-01 NA NA f8bfd67a-1d78-44b0-9715-712dee01b008 NA TCGA-A2-A4RW-01A-21D-A25N-01 TCGA-A2-A4RW-01 NA f8bfd67a-1d78-44b0-9715-712dee01b008 TCGA-A2-A4RW-01A-21D-A25N-01 |
|
|
120 |
TCGA-A2-A4RX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4RX-01 742 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4RX 742 0 days 742 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A4RX-F58491 TCGA-A2-A4RX NA NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -24779 NA NA 0 742 NA NA NA NA NA NA <10% NA NA 2014-4-11 FEMALE NA NA NA NA 1+ NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 1+ YES NA Core needle biopsy NA NA Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T2 Stage IIA NA A4RX TUMOR FREE NA NA NA NA NA NA YES <10% NA NA Primary Tumor 01 NA 7th NA YES NO A2 Breast NA LIVING 2012 cbef9672-38ba-4873-b232-9a656b7428ce cbef9672-38ba-4873-b232-9a656b7428ce NA NA TCGA-A2-A4RX-01 TCGA-A2-A4RX-01A-11D-A268-05 d980ca91-4ae1-4fc2-a4d1-052051aa7d41 TCGA-A2-A4RX-01 TCGA-A2-A4RX-01A-11D-A25Q-09 NA NA TCGA-A2-A4RX-01 NA NA cbef9672-38ba-4873-b232-9a656b7428ce NA TCGA-A2-A4RX-01A-11D-A25N-01 TCGA-A2-A4RX-01 NA cbef9672-38ba-4873-b232-9a656b7428ce TCGA-A2-A4RX-01A-11D-A25N-01 |
|
|
121 |
TCGA-A2-A4RY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4RY-01 648 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4RY 648 0 days 648 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Axillary lymph node dissection alone NA TCGA-A2-A4RY-F59208 TCGA-A2-A4RY TCGA-A2-A4RY-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -17157 149 NA 0 648 NA NA NA NA NA NA 90-99% NA NA 2014-5-5 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 1180 NO Negative NA NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 18 0 true No M0 N3a T3 Stage IIIC TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf A4RY TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2012 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 NA NA TCGA-A2-A4RY-01 TCGA-A2-A4RY-01A-31D-A268-05 e40037c5-5570-43d6-ad24-cd4ceea41828 TCGA-A2-A4RY-01 TCGA-A2-A4RY-01A-31D-A25Q-09 NA NA TCGA-A2-A4RY-01 NA NA 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 NA TCGA-A2-A4RY-01A-31D-A25N-01 TCGA-A2-A4RY-01 NA 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 TCGA-A2-A4RY-01A-31D-A25N-01 |
|
|
122 |
TCGA-A2-A4S0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4S0-01 706 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4S0 706 0 days 706 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A4S0-F59120 TCGA-A2-A4S0 TCGA-A2-A4S0-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -28416 159 NA 0 706 NA NA NA NA NA NA 90-99% NA NA 2014-5-1 FEMALE NA NA NA NA 1+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 3+ YES NA Core needle biopsy 960 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf A4S0 TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2012 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 NA NA TCGA-A2-A4S0-01 TCGA-A2-A4S0-01A-21D-A268-05 b37a030f-c2f7-4690-8503-78a2af066cdf TCGA-A2-A4S0-01 TCGA-A2-A4S0-01A-21D-A25Q-09 NA NA TCGA-A2-A4S0-01 NA NA 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 NA TCGA-A2-A4S0-01A-21D-A25N-01 TCGA-A2-A4S0-01 NA 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 TCGA-A2-A4S0-01A-21D-A25N-01 |
|
|
123 |
TCGA-A2-A4S1-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4S1-01 820 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4S1 820 0 days 820 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A2-A4S1-F58925 TCGA-A2-A4S1 TCGA-A2-A4S1-01A NA Positive 3 Point Scale NA NA NA Negative Lumpectomy NA YES NA NA -24353 282 NA 0 820 NA NA NA NA NA NA <10% NA NA 2014-4-28 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 1+ YES NA Core needle biopsy 350 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf A4S1 TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2012 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 NA NA TCGA-A2-A4S1-01 TCGA-A2-A4S1-01A-21D-A268-05 ae7e510a-5cda-4520-b879-ec7685609a2e TCGA-A2-A4S1-01 TCGA-A2-A4S1-01A-21D-A25Q-09 NA NA TCGA-A2-A4S1-01 NA NA 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 NA TCGA-A2-A4S1-01A-21D-A25N-01 TCGA-A2-A4S1-01 NA 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 TCGA-A2-A4S1-01A-21D-A25N-01 |
|
|
124 |
TCGA-A2-A4S2-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4S2-01 643 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4S2 643 0 days 643 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Axillary lymph node dissection alone NA TCGA-A2-A4S2-F59085 TCGA-A2-A4S2 TCGA-A2-A4S2-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -22936 112 NA 0 643 NA NA NA NA NA NA 90-99% NA NA 2014-4-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8524/3 C50.9 2+ YES NA Core needle biopsy 1390 NO Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 0 true No M0 N2 T3 Stage IIIA TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf A4S2 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2012 2c6af71f-b876-4475-a94a-61e99075123f 2c6af71f-b876-4475-a94a-61e99075123f NA NA TCGA-A2-A4S2-01 TCGA-A2-A4S2-01A-12D-A268-05 e2a6282d-a3b4-42be-b034-d1203d078044 TCGA-A2-A4S2-01 TCGA-A2-A4S2-01A-12D-A25Q-09 NA NA TCGA-A2-A4S2-01 NA NA 2c6af71f-b876-4475-a94a-61e99075123f NA TCGA-A2-A4S2-01A-12D-A25N-01 TCGA-A2-A4S2-01 NA 2c6af71f-b876-4475-a94a-61e99075123f TCGA-A2-A4S2-01A-12D-A25N-01 |
|
|
125 |
TCGA-A2-A4S3-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A2-A4S3-01 666 0 days NA NA NA NA NA NA NA NA NA TCGA-A2-A4S3 666 0 days 666 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-A2-A4S3-F59128 TCGA-A2-A4S3 TCGA-A2-A4S3-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -21762 147 NA 0 666 NA NA NA NA NA NA 90-99% NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1500 NO Negative NA NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf A4S3 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 7th NA YES NO A2 Breast A LIVING 2012 a26b4751-91a2-420c-9ff3-7df7361939fd a26b4751-91a2-420c-9ff3-7df7361939fd NA NA TCGA-A2-A4S3-01 TCGA-A2-A4S3-01A-21D-A268-05 18c0493c-af12-4d29-9e41-e4debdf3e0b1 TCGA-A2-A4S3-01 TCGA-A2-A4S3-01A-21D-A25Q-09 NA NA TCGA-A2-A4S3-01 NA NA a26b4751-91a2-420c-9ff3-7df7361939fd NA TCGA-A2-A4S3-01A-21D-A25N-01 TCGA-A2-A4S3-01 NA a26b4751-91a2-420c-9ff3-7df7361939fd TCGA-A2-A4S3-01A-21D-A25N-01 |
|
|
126 |
TCGA-A7-A0CD-01 Stage IA 66 3 Stage I 372 NA Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 372 0 LumA Luminal A Positive LumA -10 -3 followup T1 T1 LIVING 0 TCGA-A7-A0CD-01 1165 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A7-A0CD 1165 0 days 1165 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Sentinel node biopsy alone NA TCGA-A7-A0CD-F39827 TCGA-A7-A0CD TCGA-A7-A0CD-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -24242 157 NA 0 1165 NA NA NA NA NA NA 90-99% 4.0 NA 2013-2-4 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 279 4.6 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO Equivocal Negative NO 2 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO 0 NA false Yes M0 N0 T1 Stage I TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf A0CD TUMOR FREE NA NA NA NA NA YES NA 70-79% NA YES Primary Tumor 01 NA 6th YES YES NO A7 Breast A LIVING 2009 1edf44b5-61ba-47cd-81ed-b586ae81cb32 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01A-21-A13A-20 TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01 NA 0466e496-e1c2-4cd0-ab1d-34babdbfc80f TCGA-A7-A0CD-01 TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01A-11D-A00Y-05 TCGA-A7-A0CD-01 NA TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01 TCGA-A7-A0CD-01A-11D-A011-01 NA TCGA-A7-A0CD-01A-11R-A00Z-07 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01A-11D-A011-01 TCGA-A7-A0CD-01 |
|
|
127 |
TCGA-A7-A0CE-01 Stage IIA 57 1 Stage IIA 309 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 309 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-A7-A0CE-01 1074 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A7-A0CE 1074 0 days 1074 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0CE-F39153 TCGA-A7-A0CE TCGA-A7-A0CE-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -20863 129 NA 0 1074 NA NA NA NA NA NA <10% 2.9 NA 2013-1-14 FEMALE Vysis AutoVysion System NA NA PathVysion 2+ 389 3.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 330 NO Equivocal Negative NO 1 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf A0CE TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01A-21-A13A-20 TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01 NA 7a0dcaa3-a8ab-4437-b642-11872fbf6456 TCGA-A7-A0CE-01 TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01A-11D-A00Y-05 TCGA-A7-A0CE-01 NA TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01 TCGA-A7-A0CE-01A-11D-A011-01 NA TCGA-A7-A0CE-01A-11R-A00Z-07 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01A-11D-A011-01 TCGA-A7-A0CE-01 |
|
|
128 |
TCGA-A7-A0CE-11 NA 57 NA NA 309 NA NA FEMALE NA NA NA NA NA NA NA NA 309 0 NA NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A0CE-11 1074 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-A7-A0CE 1074 0 days 1074 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0CE-F39153 TCGA-A7-A0CE TCGA-A7-A0CE-11A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -20863 129 NA 0 1074 NA NA NA NA NA NA <10% 2.9 NA 2013-1-14 FEMALE Vysis AutoVysion System NA NA PathVysion 2+ 389 3.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 290 NO Equivocal Negative NO 1 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA NA A0CE TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2009 2d5351f1-e9d7-44a3-ae43-f595a0151516 2d5351f1-e9d7-44a3-ae43-f595a0151516 NA NA NA TCGA-A7-A0CE-11A-21D-A10Q-05 NA NA NA NA NA NA NA TCGA-A7-A0CE-11 2d5351f1-e9d7-44a3-ae43-f595a0151516 TCGA-A7-A0CE-11 NA NA TCGA-A7-A0CE-11A-21R-A089-07 2d5351f1-e9d7-44a3-ae43-f595a0151516 NA |
|
|
129 |
TCGA-A7-A0CG-01 Stage IIA 78 2 Stage IIA 230 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 230 0 LumA Luminal A Negative ReacI -5 -7 followup T_Other T2 LIVING 0 TCGA-A7-A0CG-01 1043 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 4 TCGA-A7-A0CG 1043 0 days 1043 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0CG-F39202 TCGA-A7-A0CG TCGA-A7-A0CG-01A NA Positive NA NA NA NA Negative Lumpectomy NA YES NA NA -28596 93 NA 0 1043 NA NA NA NA NA NA 90-99% NA NA 2013-1-15 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) Mixed infiltrating lobular and grade 1 ductal carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 5 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE.pdf A0CG TUMOR FREE NA NA NA NA NA NO NA <10% NA YES Primary Tumor 01 NA NA NO YES NO A7 Breast A LIVING 2010 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01A-21-A13A-20 TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01 NA 0b26254d-1199-487f-8cc1-e99d2dc58737 TCGA-A7-A0CG-01 TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01A-11D-A00Y-05 TCGA-A7-A0CG-01 NA TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01 TCGA-A7-A0CG-01A-11D-A011-01 NA TCGA-A7-A0CG-01A-12R-A056-07 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01A-11D-A011-01 TCGA-A7-A0CG-01 |
|
|
130 |
TCGA-A7-A0CH-01 Stage IIA 79 2 Stage IIA 232 NA NA FEMALE Negative 3 3 3 Negative M0 Negative N0 232 0 LumA Luminal A NA LumA -12 -3 followup T_Other T2 LIVING 0 TCGA-A7-A0CH-01 1079 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A7-A0CH 1079 0 days 1079 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-A7-A0CH-F39148 TCGA-A7-A0CH TCGA-A7-A0CH-01A NA NA NA NA NA NA NA Simple Mastectomy NA YES NA NA -29104 121 NA 0 1079 NA NA NA NA NA NA NA NA NA 2013-1-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf A0CH TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 0b225e38-d4c8-4cb5-a668-316894ab858f 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01A-11-A13A-20 TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01 NA d44c8f0f-090f-417f-b80e-ff5da42138d0 TCGA-A7-A0CH-01 TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01A-21D-A00Y-05 TCGA-A7-A0CH-01 NA TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01 TCGA-A7-A0CH-01A-21D-A011-01 NA TCGA-A7-A0CH-01A-21R-A00Z-07 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01A-21D-A011-01 TCGA-A7-A0CH-01 |
|
|
131 |
TCGA-A7-A0CH-11 NA 79 NA NA 232 NA NA FEMALE NA NA NA NA NA NA NA NA 232 0 NA NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A0CH-11 1079 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-A7-A0CH 1079 0 days 1079 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-A7-A0CH-F39148 TCGA-A7-A0CH TCGA-A7-A0CH-11A NA NA NA NA NA NA NA Simple Mastectomy NA YES NA NA -29104 121 NA 0 1079 NA NA NA NA NA NA NA NA NA 2013-1-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 390 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA NA A0CH TUMOR FREE NA NA NA NA NA YES NA NA NA NO Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2009 a4b19504-8f04-48db-b88b-d76b8b3c3881 a4b19504-8f04-48db-b88b-d76b8b3c3881 NA NA NA TCGA-A7-A0CH-11A-32D-A10Q-05 NA NA NA NA NA NA NA NA a4b19504-8f04-48db-b88b-d76b8b3c3881 NA NA NA TCGA-A7-A0CH-11A-32R-A089-07 a4b19504-8f04-48db-b88b-d76b8b3c3881 NA |
|
|
132 |
TCGA-A7-A0CJ-01 Stage IIA 57 1 Stage IIA 409 NA Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 409 0 LumB Luminal B Positive LumA/B -6 -3 followup T_Other T2 LIVING 0 TCGA-A7-A0CJ-01 931 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-A7-A0CJ 931 0 days 931 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0CJ-F39740 TCGA-A7-A0CJ TCGA-A7-A0CJ-01A NA Positive NA NA NA Other Positive Lumpectomy Re-excision of the inferior margin YES NA NA -21014 36 NA 0 931 NA NA NA NA NA NA 90-99% NA NA 2013-1-31 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 310 NO Negative NA NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782.pdf A0CJ TUMOR FREE NA NA NA NA NA YES NA 70-79% NA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2010 62de6863-5d60-473c-8e13-e300b0640ed7 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01A-11-A13A-20 TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01 NA d9f09beb-2d34-4507-a3bf-039786bba9a9 TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01A-21D-A00Y-05 TCGA-A7-A0CJ-01 NA TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01A-21D-A011-01 NA TCGA-A7-A0CJ-01A-21R-A00Z-07 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01A-21D-A011-01 TCGA-A7-A0CJ-01 |
|
|
133 |
TCGA-A7-A0D9-01 Stage IIA 37 4 Stage IIA 272 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 272 0 LumA Luminal A Negative ReacII -3 -3 followup T_Other T2 LIVING 0 TCGA-A7-A0D9-01 1139 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-A7-A0D9 1139 0 days 1139 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-A7-A0D9-F39771 TCGA-A7-A0D9 TCGA-A7-A0D9-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -13836 173 NA 0 1139 NA NA NA NA NA NA 90-99% NA NA 2013-2-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1760 NO Negative NA NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf A0D9 TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 755912f4-6725-4b7b-84b1-518c7529a176 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01A-21-A13C-20 TCGA-A7-A0D9-01A-31W-A071-09 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31D-A10P-05 8cbc03f3-4f0a-4a76-99cd-3a8479558cb1 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31W-A071-09 NA TCGA-A7-A0D9-01 NA TCGA-A7-A0D9-01A-31W-A071-09 TCGA-A7-A0D9-01 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31D-A059-01 NA TCGA-A7-A0D9-01A-31R-A056-07 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01A-31D-A059-01 TCGA-A7-A0D9-01 |
|
|
134 |
TCGA-A7-A0D9-11 NA 37 NA NA 272 NA NA FEMALE NA NA NA NA NA NA NA NA 272 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A0D9-11 1139 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-A7-A0D9 1139 0 days 1139 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-A7-A0D9-F39771 TCGA-A7-A0D9 TCGA-A7-A0D9-11A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -13836 173 NA 0 1139 NA NA NA NA NA NA 90-99% NA NA 2013-2-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1830 NO Negative NA NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA NA A0D9 TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2009 fc5bb351-c5f7-4d8c-850c-13e69e13e04d fc5bb351-c5f7-4d8c-850c-13e69e13e04d NA NA NA TCGA-A7-A0D9-11A-53D-A10Q-05 NA NA NA NA NA NA NA NA fc5bb351-c5f7-4d8c-850c-13e69e13e04d NA NA NA TCGA-A7-A0D9-11A-53R-A089-07 fc5bb351-c5f7-4d8c-850c-13e69e13e04d NA |
|
|
135 |
TCGA-A7-A0DA-01 Stage IIA 62 1 Stage IIA 373 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 373 0 Basal Basal-like Negative X -13 0 followup T_Other T2 LIVING 0 TCGA-A7-A0DA-01 1085 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 4 mutation cluster 13 TCGA-A7-A0DA 1085 0 days 1085 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0DA-F38487 TCGA-A7-A0DA TCGA-A7-A0DA-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -22708 177 NA 0 1085 NA NA NA NA NA NA NA NA NA 2012-12-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 350 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf A0DA TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 9d04c180-7c23-490e-92cf-c018629b8b7f 9d04c180-7c23-490e-92cf-c018629b8b7f TCGA-A7-A0DA-01A-11-A13C-20 TCGA-A7-A0DA-01A-31D-A10Y-09 TCGA-A7-A0DA-01 NA 190fcd17-0d7a-4d28-9958-492d56360678 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31D-A10Y-09 TCGA-A7-A0DA-01A-31D-A112-05 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31D-A10Y-09 NA 9d04c180-7c23-490e-92cf-c018629b8b7f NA TCGA-A7-A0DA-01A-31D-A111-01 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31R-A115-07 9d04c180-7c23-490e-92cf-c018629b8b7f TCGA-A7-A0DA-01A-31D-A111-01 TCGA-A7-A0DA-01 |
|
|
136 |
TCGA-A7-A0DB-01 Stage IIA 56 2 Stage IIA 266 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 266 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING 0 TCGA-A7-A0DB-01 1007 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-A7-A0DB 1007 0 days 1007 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0DB-F38479 TCGA-A7-A0DB TCGA-A7-A0DB-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -20570 167 NA 0 1007 NA NA NA FPPP NA NA 90-99% NA NA 2012-12-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative NA NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3.pdf A0DB TUMOR FREE NA NA NA NA NA YES NA 60-69% TCGA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01A-21-A13C-20 TCGA-A7-A0DB-01A-11W-A019-09 TCGA-A7-A0DB-01 NA 74072dd9-7503-4152-9734-65dcb4bca217 TCGA-A7-A0DB-01 TCGA-A7-A0DB-01A-11W-A019-09,TCGA-A7-A0DB-01A-11D-A272-09 TCGA-A7-A0DB-01A-11D-A00Y-05 TCGA-A7-A0DB-01 NA TCGA-A7-A0DB-01A-11W-A019-09 TCGA-A7-A0DB-01 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01 TCGA-A7-A0DB-01A-11D-A011-01 NA TCGA-A7-A0DB-01A-11R-A00Z-07 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01A-11D-A011-01 TCGA-A7-A0DB-01 |
|
|
137 |
TCGA-A7-A0DB-11 NA 56 NA NA 266 NA NA FEMALE NA NA NA NA NA NA NA NA 266 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A0DB-11 1007 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-A7-A0DB 1007 0 days 1007 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0DB-F38479 TCGA-A7-A0DB TCGA-A7-A0DB-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -20570 167 NA 0 1007 NA NA NA FPPP NA NA 90-99% NA NA 2012-12-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 400 NO Negative NA NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA NA A0DB TUMOR FREE NA NA NA NA NA YES NA 60-69% TCGA YES Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2009 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 NA NA NA TCGA-A7-A0DB-11A-33D-A093-05 NA NA NA NA NA NA NA NA 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 NA NA NA TCGA-A7-A0DB-11A-33R-A089-07 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 NA |
|
|
138 |
TCGA-A7-A0DC-01 Stage IA 63 NA Stage I 386 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 386 0 LumA NA Negative NA NA NA followup T1 T1 LIVING 0 TCGA-A7-A0DC-01 906 0 days NA NA NA NA BRCA nonbasal-like c8 NA NA NA NA TCGA-A7-A0DC 906 0 days 906 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0DC-F40607 TCGA-A7-A0DC TCGA-A7-A0DC-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -23294 238 NA 0 906 NA NA NA NA NA NA 90-99% NA NA 2013-2-25 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 200 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T1c Stage IA TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2.pdf A0DC TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2009 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 TCGA-A7-A0DC-01A-21-A13C-20 NA NA TCGA-A7-A0DC-01B-04D-A22R-05 31b94bd4-e63e-4e52-b366-3bafe08524e7 NA TCGA-A7-A0DC-01B-04D-A22N-09 TCGA-A7-A0DC-01A-11D-A00Y-05 NA NA NA NA 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 NA TCGA-A7-A0DC-01A-11D-A011-01 NA TCGA-A7-A0DC-01A-11R-A00Z-07 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 TCGA-A7-A0DC-01A-11D-A011-01 |
|
|
139 |
TCGA-A7-A0DC-11 NA 63 NA NA 386 NA NA FEMALE NA NA NA NA NA NA NA NA 386 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A0DC-11 906 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A0DC 906 0 days 906 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A0DC-F40607 TCGA-A7-A0DC TCGA-A7-A0DC-11A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -23294 238 NA 0 906 NA NA NA NA NA NA 90-99% NA NA 2013-2-25 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 470 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T1c Stage IA NA A0DC TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2009 cb3f974e-6bce-4757-a350-aef8e7925086 cb3f974e-6bce-4757-a350-aef8e7925086 NA NA NA TCGA-A7-A0DC-11A-41D-A10Q-05 NA NA NA NA NA NA NA NA cb3f974e-6bce-4757-a350-aef8e7925086 NA NA NA TCGA-A7-A0DC-11A-41R-A089-07 cb3f974e-6bce-4757-a350-aef8e7925086 NA |
|
|
140 |
TCGA-A7-A13D-01 Stage IIA 46 3 Stage IIA 267 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 267 0 Basal Basal-like Positive ReacII -13 0 followup T_Other T2 LIVING 0 TCGA-A7-A13D-01 965 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 2 TCGA-A7-A13D 965 0 days 965 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A13D-F39794 TCGA-A7-A13D TCGA-A7-A13D-01A Negative Negative NA NA NA Lumpectomy Positive Lumpectomy NA NO NA NA -17070 240 NA 0 965 NA NA NA FPPP NA NA <10% 1.8 NA 2013-2-1 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 197 1.9 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO Equivocal Negative NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf A13D TUMOR FREE NA NA NA NA NA YES NA <10% TCGA YES Primary Tumor 01 NA NA YES YES NO A7 Breast A LIVING 2010 3af60b03-66c3-48a1-a42b-1e05fdb529c4 3af60b03-66c3-48a1-a42b-1e05fdb529c4 TCGA-A7-A13D-01A-21-A13E-20 TCGA-A7-A13D-01A-13D-A12Q-09 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12R-05 bf4b9dc3-df06-4735-b9b6-4cc8240c93b7 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09 NA TCGA-A7-A13D-01 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12Q-09 NA 3af60b03-66c3-48a1-a42b-1e05fdb529c4 NA TCGA-A7-A13D-01A-13D-A12N-01 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13R-A12P-07 3af60b03-66c3-48a1-a42b-1e05fdb529c4 TCGA-A7-A13D-01A-13D-A12N-01 TCGA-A7-A13D-01 |
|
|
141 |
TCGA-A7-A13E-01 Stage IIB 62 1 No_Conversion 326 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 326 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 1 TCGA-A7-A13E-01 614 1 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 NA TCGA-A7-A13E 556 1 days 614 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A13E-F30405 TCGA-A7-A13E TCGA-A7-A13E-01A NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -22690 220 614 0 326 NA NA 556 FPPP NA NA 20-29% 3.0 Additional New Tumor Event 2012-4-9 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 561 3.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 730 NO Equivocal Negative NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 4 5 NA NA NA Other, specify Distant Metastasis Lung, Bone, Liver, Brain and Skin Nodules NA YES 2 NA false No MX N1 T2 Stage IIB TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf A13E WITH TUMOR NA NA NA NA NA NA NA <10% TCGA NO Primary Tumor 01 NA NA YES YES NO A7 Breast A DECEASED 2010 b7f491a9-eddf-43b1-9baf-862db2d50383 b7f491a9-eddf-43b1-9baf-862db2d50383 TCGA-A7-A13E-01A-21-A13E-20 NA TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11D-A12R-05 724b7cef-9bb6-4c6b-8c78-b632f910fe85 TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09 NA TCGA-A7-A13E-01 TCGA-A7-A13E-01 NA NA b7f491a9-eddf-43b1-9baf-862db2d50383 NA TCGA-A7-A13E-01A-11D-A12N-01 TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11R-A12P-07 b7f491a9-eddf-43b1-9baf-862db2d50383 TCGA-A7-A13E-01A-11D-A12N-01 TCGA-A7-A13E-01 |
|
|
142 |
TCGA-A7-A13E-11 NA 62 NA NA 326 NA NA FEMALE NA NA NA NA NA NA NA NA 326 0 Normal NA NA NA NA NA followup NA NA LIVING 1 TCGA-A7-A13E-11 614 1 days NA C4-BRCA/Basal NA NA NA NA NA NA NA TCGA-A7-A13E 556 1 days 614 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A13E-F30405 TCGA-A7-A13E TCGA-A7-A13E-11A NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -22690 220 614 0 326 NA NA 556 FPPP NA NA 20-29% 3.0 Additional New Tumor Event 2012-4-9 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 561 3.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 770 NO Equivocal Negative NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA NA NA NA NA NA Other, specify Distant Metastasis Lung, Bone, Liver, Brain and Skin Nodules NA YES 2 NA false No MX N1 T2 Stage IIB NA A13E WITH TUMOR NA NA NA NA NA NA NA <10% TCGA NO Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A DECEASED 2010 80efdbaa-067b-4018-89b2-b8869bfb9163 80efdbaa-067b-4018-89b2-b8869bfb9163 NA NA NA TCGA-A7-A13E-11A-61D-A12R-05 E408026E-6C07-4F2E-A609-29F21E997938 NA NA NA NA TCGA-A7-A13E-11 NA NA 80efdbaa-067b-4018-89b2-b8869bfb9163 NA NA TCGA-A7-A13E-11 TCGA-A7-A13E-11A-61R-A12P-07 80efdbaa-067b-4018-89b2-b8869bfb9163 NA |
|
|
143 |
TCGA-A7-A13F-01 Stage IIIA 44 3 No_Conversion 387 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 387 0 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T3 LIVING 0 TCGA-A7-A13F-01 765 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A7-A13F 765 0 days 765 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A13F-F39779 TCGA-A7-A13F NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -16363 NA NA 0 765 NA NA NA NA NA NA NA 2.8 Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 403 3.0 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T3 Stage IIIA NA A13F TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA NA YES YES NO A7 Breast NA LIVING 2010 fc4f35dd-9924-4e5d-ba71-0d7a79752b6a fc4f35dd-9924-4e5d-ba71-0d7a79752b6a TCGA-A7-A13F-01A-21-A13E-20 TCGA-A7-A13F-01A-11D-A12Q-09 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12R-05 ad57bf3d-f283-4c26-95ad-86a116794296 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12Q-09 NA TCGA-A7-A13F-01 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12Q-09 NA fc4f35dd-9924-4e5d-ba71-0d7a79752b6a NA TCGA-A7-A13F-01A-11D-A12N-01 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11R-A12P-07 fc4f35dd-9924-4e5d-ba71-0d7a79752b6a TCGA-A7-A13F-01A-11D-A12N-01 TCGA-A7-A13F-01 |
|
|
144 |
TCGA-A7-A13F-11 NA 44 NA NA 387 NA NA FEMALE NA NA NA NA NA NA NA NA 387 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A13F-11 765 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-A7-A13F 765 0 days 765 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A13F-F39779 TCGA-A7-A13F TCGA-A7-A13F-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -16363 121 NA 0 765 NA NA NA NA NA NA NA 2.8 Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 403 3.0 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 960 NO Equivocal Negative NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA false No M0 N1a T3 Stage IIIA NA A13F TUMOR FREE NA NA NA NA NA YES NA NA NA YES Solid Tissue Normal 11 NA NA YES YES NO A7 Breast A LIVING 2010 82f3157c-09cc-40d7-872e-59f82f5f31f4 82f3157c-09cc-40d7-872e-59f82f5f31f4 NA NA NA TCGA-A7-A13F-11A-42D-A12R-05 2F10F1D9-54A0-42EB-B9B7-C9733D431824 NA NA NA NA TCGA-A7-A13F-11 NA NA 82f3157c-09cc-40d7-872e-59f82f5f31f4 NA NA TCGA-A7-A13F-11 TCGA-A7-A13F-11A-42R-A12P-07 82f3157c-09cc-40d7-872e-59f82f5f31f4 NA |
|
|
145 |
TCGA-A7-A13G-01 Stage IIA 79 2 Stage IIA 348 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 348 0 LumA NA Positive NA NA NA followup T_Other T2 LIVING 0 TCGA-A7-A13G-01 718 0 days Iq NA cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 3 mutation cluster 4 TCGA-A7-A13G 586 1 days 718 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 79 Left Sentinel node biopsy alone NA TCGA-A7-A13G-F35039 TCGA-A7-A13G NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -28969 NA NA 0 718 NA 586 586 NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-9-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA Other, specify New Primary Tumor Skin, right leg YES YES 0 NA NA Yes MX N0 T2 Stage IIA NA A13G TUMOR FREE NA NA NA NA NA YES YES 50-59% NA NO Primary Tumor 01 NA 7th YES YES NO A7 Breast NA LIVING 2010 ac567288-88cc-4a65-937e-086655c038df ac567288-88cc-4a65-937e-086655c038df NA TCGA-A7-A13G-01A-11D-A13L-09 TCGA-A7-A13G-01 TCGA-A7-A13G-01B-04D-A22R-05,TCGA-A7-A13G-01A-11D-A13K-05 NA TCGA-A7-A13G-01 TCGA-A7-A13G-01A-11D-A13L-09 NA NA TCGA-A7-A13G-01 TCGA-A7-A13G-01A-11D-A13L-09 NA ac567288-88cc-4a65-937e-086655c038df NA TCGA-A7-A13G-01A-11D-A13J-01 TCGA-A7-A13G-01 NA ac567288-88cc-4a65-937e-086655c038df TCGA-A7-A13G-01A-11D-A13J-01 |
|
|
146 |
TCGA-A7-A13G-11 NA 79 NA NA 348 NA NA FEMALE NA NA NA NA NA NA NA NA 348 0 LumA NA NA NA NA NA followup NA NA LIVING 0 TCGA-A7-A13G-11 718 0 days NA NA NA NA NA NA NA NA mutation cluster 4 TCGA-A7-A13G 586 1 days 718 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 79 Left Sentinel node biopsy alone NA TCGA-A7-A13G-F35039 TCGA-A7-A13G TCGA-A7-A13G-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -28969 69 NA 0 718 NA 586 586 NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-9-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 880 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify New Primary Tumor Skin, right leg YES YES 0 NA false Yes MX N0 T2 Stage IIA NA A13G TUMOR FREE NA NA NA NA NA YES YES 50-59% NA NO Solid Tissue Normal 11 NA 7th YES YES NO A7 Breast A LIVING 2010 76f30f56-7b80-4938-b514-1e1c2d24ff66 76f30f56-7b80-4938-b514-1e1c2d24ff66 NA NA NA TCGA-A7-A13G-11A-51D-A13T-05 NA NA NA NA NA NA NA NA 76f30f56-7b80-4938-b514-1e1c2d24ff66 NA NA NA NA 76f30f56-7b80-4938-b514-1e1c2d24ff66 NA |
|
|
147 |
TCGA-A7-A13H-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A13H-01 899 0 days Iq NA NA BRCA non-CIMP c9 NA NA miRNA cluster 4 NA NA TCGA-A7-A13H 795 1 days 899 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 61 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A13H-F41651 TCGA-A7-A13H TCGA-A7-A13H-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -22643 62 NA 0 899 NA 840 795 NA NO NA 80-89% 2.7 NA 2013-3-25 FEMALE NA NA NA Pathvysion HER2 D Probe Kit 2+ 371 3.2 2.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 140 NO Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify New Primary Tumor Skin lesion-Basal Cell Left Lower Lateral Back YES YES 2 2 false No MX N1a T2 Stage IIB TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf A13H TUMOR FREE NA NA NA NA NA NO YES 30-39% NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2010 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 NA NA TCGA-A7-A13H-01 TCGA-A7-A13H-01A-11D-A22B-05 NA TCGA-A7-A13H-01 TCGA-A7-A13H-01A-11D-A228-09 NA NA TCGA-A7-A13H-01 NA NA 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 NA TCGA-A7-A13H-01A-11D-A227-01 TCGA-A7-A13H-01 NA 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 TCGA-A7-A13H-01A-11D-A227-01 |
|
|
148 |
TCGA-A7-A26E-01 Stage IIIA 71 2 Stage IIIA 421 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 421 0 LumA NA Positive NA NA NA followup T_Other T3 LIVING 0 TCGA-A7-A26E-01 954 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-A7-A26E 954 0 days 954 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A26E-F39792 TCGA-A7-A26E TCGA-A7-A26E-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -26274 372 NA 0 954 NA NA NA FPPP NO NA 90-99% NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 230 NO Negative NA NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 0 NA false Yes MX N1a T3 Stage IIIA TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf A26E TUMOR FREE NA NA NA NA NA YES YES 20-29% TCGA YES Primary Tumor 01 NA 7th YES YES NO A7 Breast A LIVING 2010 6130b450-8b88-4a9a-b462-a34ec94183c9 6130b450-8b88-4a9a-b462-a34ec94183c9 TCGA-A7-A26E-01A-21-A17I-20 TCGA-A7-A26E-01A-11D-A167-09 TCGA-A7-A26E-01 TCGA-A7-A26E-01A-11D-A27B-05,TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05 1c700207-2bd3-421f-8c10-5365a680df72 TCGA-A7-A26E-01 TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09 NA NA TCGA-A7-A26E-01 TCGA-A7-A26E-01A-11D-A167-09 NA 6130b450-8b88-4a9a-b462-a34ec94183c9 NA TCGA-A7-A26E-01A-11D-A275-01 TCGA-A7-A26E-01 NA 6130b450-8b88-4a9a-b462-a34ec94183c9 TCGA-A7-A26E-01A-11D-A275-01 |
|
|
149 |
TCGA-A7-A26F-01 Stage IA 55 3 Stage I 257 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 257 0 Basal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-A7-A26F-01 738 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 3 TCGA-A7-A26F 738 0 days 738 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Sentinel node biopsy alone NA TCGA-A7-A26F-F38499 TCGA-A7-A26F TCGA-A7-A26F-01A Negative Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -20210 173 NA 0 738 NA NA NA NA NO NA NA 1.8 Scheduled Follow-up Submission 2012-12-14 FEMALE NA NA NA PathVysion HER-2 D probe kit. 2+ 330 1.9 1.1 NA Other, specify NA No NA C50.9 8575/3 C50.9 NA YES NA Fine needle aspiration biopsy 190 NO Equivocal Negative NO 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 0 NA false Yes M0 N0 T1 Stage IA TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf A26F TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO A7 Breast A LIVING 2010 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b TCGA-A7-A26F-01A-11-A17I-20 TCGA-A7-A26F-01A-21D-A167-09 TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05 6bda0261-6c33-4c86-8cf9-c9dce2bcadec TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09 NA NA TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A167-09 NA 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b NA TCGA-A7-A26F-01A-21D-A166-01 TCGA-A7-A26F-01 NA 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b TCGA-A7-A26F-01A-21D-A166-01 |
|
|
150 |
TCGA-A7-A26G-01 Stage IIA 50 3 Stage IIA 209 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 209 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A7-A26G-01 722 0 days COAD-READ C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A7-A26G 722 0 days 722 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A26G-F39047 TCGA-A7-A26G TCGA-A7-A26G-01A NA Negative NA NA NA NA Negative Other NA NO NA NA -18362 161 NA 0 722 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-9 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 410 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 (i+) T2 Stage IIA TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf A26G TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total Mastectomy 7th YES YES NO A7 Breast A LIVING 2010 8cf1853a-55b2-4fb9-9a65-a46243304d54 8cf1853a-55b2-4fb9-9a65-a46243304d54 TCGA-A7-A26G-01A-11-A17I-20 TCGA-A7-A26G-01A-21D-A167-09 TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A16A-05 1c0d3d0a-579d-4cfc-bea5-cd7ecb74dd88 TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A167-09 NA NA TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A167-09 NA 8cf1853a-55b2-4fb9-9a65-a46243304d54 NA TCGA-A7-A26G-01A-21D-A166-01 TCGA-A7-A26G-01 NA 8cf1853a-55b2-4fb9-9a65-a46243304d54 TCGA-A7-A26G-01A-21D-A166-01 |
|
|
151 |
TCGA-A7-A26H-01 Stage IIA 72 3 Stage IIA 64 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 64 0 LumA NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-A7-A26H-01 724 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-A7-A26H 311 1 days 724 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 72 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A26H-F39890 TCGA-A7-A26H TCGA-A7-A26H-01A NA Positive NA NA NA NA Negative Other NA NO NA NA -26423 79 NA 0 724 NA NA 311 NA NO NA 90-99% 2.2 Scheduled Follow-up Submission 2013-2-5 FEMALE NA NA NA PathVysion Her-2 D 2+ 20 5.8 2.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Equivocal Positive NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Positive 10-19% NA NA NA NA NA NA NA NA NA NA Negative NA NA 4 NA NA NA NA Liver Distant Metastasis NA NA YES 0 1 false Yes M0 N1a T1 Stage IIA TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf A26H WITH TUMOR NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Bilateral Mastectomy 7th YES YES NO A7 Breast A LIVING 2011 d1810175-47a5-4409-b1b8-f5ba78ed1c30 d1810175-47a5-4409-b1b8-f5ba78ed1c30 TCGA-A7-A26H-01A-21-A17I-20 TCGA-A7-A26H-01A-11D-A167-09 TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A16A-05 24bf1453-2154-4eb2-a417-274489d22753 TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A167-09 NA NA TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A167-09 NA d1810175-47a5-4409-b1b8-f5ba78ed1c30 NA TCGA-A7-A26H-01A-11D-A166-01 TCGA-A7-A26H-01 NA d1810175-47a5-4409-b1b8-f5ba78ed1c30 TCGA-A7-A26H-01A-11D-A166-01 |
|
|
152 |
TCGA-A7-A26I-01 Stage IIA 65 1 Stage IIA 122 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 122 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A7-A26I-01 661 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 NA mutation cluster 5 TCGA-A7-A26I 661 0 days 661 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Axillary lymph node dissection alone NA TCGA-A7-A26I-F39791 TCGA-A7-A26I TCGA-A7-A26I-01A Negative Negative NA NA NA Other Negative Lumpectomy Re-Excision of Superior Margin NO NA NA -23948 40 NA 0 661 NA NA NA NA NO NA NA 2.0 Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA Path Vysion HER-2 D probe kit 2+ 229 2.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 120 NO Equivocal Negative NO 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA false Yes M0 N0 T2 Stage IIA TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf A26I TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO A7 Breast A LIVING 2011 5610fa97-eac4-4306-aead-983ee6570baf 5610fa97-eac4-4306-aead-983ee6570baf TCGA-A7-A26I-01A-21-A17I-20 TCGA-A7-A26I-01A-11D-A167-09 TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A16A-05 c74b933c-9dd5-42a6-a906-4951a21e8bc2 TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09 NA NA TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A167-09 NA 5610fa97-eac4-4306-aead-983ee6570baf NA TCGA-A7-A26I-01A-11D-A166-01 TCGA-A7-A26I-01 NA 5610fa97-eac4-4306-aead-983ee6570baf TCGA-A7-A26I-01A-11D-A166-01 |
|
|
153 |
TCGA-A7-A26J-01 Stage IIA 49 3 Stage IIA 67 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 67 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-A7-A26J-01 627 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A7-A26J 627 0 days 627 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A26J-F39793 TCGA-A7-A26J NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -17930 NA NA 0 627 NA NA NA FPPP NO NA 90-99% NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A26J TUMOR FREE NA NA NA NA NA YES YES 70-79% TCGA NO Primary Tumor 01 NA 7th YES YES NO A7 Breast NA LIVING 2011 ed40061b-ad15-4f91-94ae-ae276394f42d ed40061b-ad15-4f91-94ae-ae276394f42d NA TCGA-A7-A26J-01A-11D-A167-09 TCGA-A7-A26J-01 TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05 NA TCGA-A7-A26J-01 TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09 NA NA TCGA-A7-A26J-01 TCGA-A7-A26J-01A-11D-A167-09 NA ed40061b-ad15-4f91-94ae-ae276394f42d NA TCGA-A7-A26J-01A-11D-A275-01 TCGA-A7-A26J-01 NA ed40061b-ad15-4f91-94ae-ae276394f42d TCGA-A7-A26J-01A-11D-A275-01 |
|
|
154 |
TCGA-A7-A2KD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A2KD-01 679 0 days Squamous C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-A7-A2KD 679 0 days 679 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right No axillary staging NA TCGA-A7-A2KD-F39783 TCGA-A7-A2KD TCGA-A7-A2KD-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -19563 141 NA 0 679 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 260 NO Positive NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 8 0 false Yes MX N2a T2 Stage IIIA TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf A2KD TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th YES YES NO A7 Breast A LIVING 2011 5e04619f-0fa5-45fa-a30b-31b062600047 5e04619f-0fa5-45fa-a30b-31b062600047 TCGA-A7-A2KD-01A-41-A24A-20 NA TCGA-A7-A2KD-01 TCGA-A7-A2KD-01A-31D-A21R-05 58fcf58b-b94c-4605-a0fc-7ddc5e269879 TCGA-A7-A2KD-01 TCGA-A7-A2KD-01A-31D-A21Q-09 NA NA TCGA-A7-A2KD-01 NA NA 5e04619f-0fa5-45fa-a30b-31b062600047 NA TCGA-A7-A2KD-01A-31D-A21P-01 TCGA-A7-A2KD-01 NA 5e04619f-0fa5-45fa-a30b-31b062600047 TCGA-A7-A2KD-01A-31D-A21P-01 |
|
|
155 |
TCGA-A7-A3IY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A3IY-01 345 0 days Kirc+ NA NA BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-A7-A3IY 345 0 days 345 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A3IY-F33856 TCGA-A7-A3IY NA Negative Positive NA NA NA Lumpectomy Positive Lumpectomy NA NO NA NA -26042 NA NA 0 345 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-7-20 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A3IY TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES YES NO A7 Breast NA LIVING 2011 c4149cf6-980f-4da1-b749-c24aae86f351 c4149cf6-980f-4da1-b749-c24aae86f351 NA NA TCGA-A7-A3IY-01 TCGA-A7-A3IY-01A-21D-A21R-05 NA TCGA-A7-A3IY-01 TCGA-A7-A3IY-01A-21D-A21Q-09 NA NA TCGA-A7-A3IY-01 NA NA c4149cf6-980f-4da1-b749-c24aae86f351 NA TCGA-A7-A3IY-01A-21D-A21P-01 TCGA-A7-A3IY-01 NA c4149cf6-980f-4da1-b749-c24aae86f351 TCGA-A7-A3IY-01A-21D-A21P-01 |
|
|
156 |
TCGA-A7-A3IZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A3IZ-01 322 0 days Kirc+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA NA TCGA-A7-A3IZ 322 0 days 322 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A3IZ-F34491 TCGA-A7-A3IZ TCGA-A7-A3IZ-01A Negative Positive NA NA NA Other Negative Lumpectomy Reexcision YES NA NA -22997 86 NA 0 322 NA NA NA NA NO NA 90-99% 3.0 NA 2012-8-16 FEMALE NA NA NA PathVysion HER-2 D probe kit. 2+ 569 3.0 1.0 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 290 NO Equivocal Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 1 false No M0 N0 (i+) T2 Stage IIA TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf A3IZ TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2011 e4400dbf-b871-48ab-b571-4f883bb3c24e e4400dbf-b871-48ab-b571-4f883bb3c24e TCGA-A7-A3IZ-01A-21-A24A-20 NA TCGA-A7-A3IZ-01 TCGA-A7-A3IZ-01A-11D-A212-05 0d5491ae-73ff-44ad-9aba-cde4b61fbf78 TCGA-A7-A3IZ-01 TCGA-A7-A3IZ-01A-11D-A20S-09 NA NA TCGA-A7-A3IZ-01 NA NA e4400dbf-b871-48ab-b571-4f883bb3c24e NA TCGA-A7-A3IZ-01A-11D-A20R-01 TCGA-A7-A3IZ-01 NA e4400dbf-b871-48ab-b571-4f883bb3c24e TCGA-A7-A3IZ-01A-11D-A20R-01 |
|
|
157 |
TCGA-A7-A3J0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A3J0-01 313 0 days BRCA-LUAD+ C3-BRCA/Luminal NA Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA NA TCGA-A7-A3J0 313 0 days 313 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Sentinel node biopsy alone NA TCGA-A7-A3J0-F35965 TCGA-A7-A3J0 TCGA-A7-A3J0-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22672 78 NA 0 313 NA NA NA NA NO NA 90-99% NA NA 2012-10-12 FEMALE NA NA NA NA 1+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf A3J0 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2011 1fbf8004-0091-4eb0-9042-d2f1a5174abe 1fbf8004-0091-4eb0-9042-d2f1a5174abe TCGA-A7-A3J0-01A-21-A24A-20 NA TCGA-A7-A3J0-01 TCGA-A7-A3J0-01A-11D-A212-05 d601836e-e95a-41eb-ad27-e72deada49b6 TCGA-A7-A3J0-01 TCGA-A7-A3J0-01A-11D-A20S-09 NA NA TCGA-A7-A3J0-01 NA NA 1fbf8004-0091-4eb0-9042-d2f1a5174abe NA TCGA-A7-A3J0-01A-11D-A20R-01 TCGA-A7-A3J0-01 NA 1fbf8004-0091-4eb0-9042-d2f1a5174abe TCGA-A7-A3J0-01A-11D-A20R-01 |
|
|
158 |
TCGA-A7-A3J1-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A3J1-01 343 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-A7-A3J1 343 0 days 343 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A3J1-F36693 TCGA-A7-A3J1 TCGA-A7-A3J1-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -23209 49 NA 0 343 NA NA NA NA NO NA 90-99% NA NA 2012-11-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 100 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false Yes MX N0 T1c Stage IA TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf A3J1 TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2011 3b042185-867f-492b-a448-7c51e05f9b42 3b042185-867f-492b-a448-7c51e05f9b42 TCGA-A7-A3J1-01A-21-A24A-20 NA TCGA-A7-A3J1-01 TCGA-A7-A3J1-01A-11D-A212-05 88ae23a8-e617-43a4-85be-d4b1f25847ec TCGA-A7-A3J1-01 TCGA-A7-A3J1-01A-11D-A20S-09 NA NA TCGA-A7-A3J1-01 NA NA 3b042185-867f-492b-a448-7c51e05f9b42 NA TCGA-A7-A3J1-01A-11D-A20R-01 TCGA-A7-A3J1-01 NA 3b042185-867f-492b-a448-7c51e05f9b42 TCGA-A7-A3J1-01A-11D-A20R-01 |
|
|
159 |
TCGA-A7-A3RF-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A3RF-01 408 0 days Quiet NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA c1uster 10 NA NA TCGA-A7-A3RF 174 1 days 408 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 79 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A3RF-F40413 TCGA-A7-A3RF TCGA-A7-A3RF-01A Negative Positive NA NA NA Other Positive Lumpectomy Left breast reexcision NO NA NA -29184 61 NA 0 408 NA NA 174 NA NA NA 90-99% NA NA 2013-2-19 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy 190 NO Negative NA NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 0 NA false No M0 N0 T2 Stage IIA TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf A3RF WITH TUMOR NA NA NA NA NA YES YES 30-39% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 de0a584e-117e-4cf6-8c4a-6fb040270eda de0a584e-117e-4cf6-8c4a-6fb040270eda TCGA-A7-A3RF-01A-21-A24A-20 NA TCGA-A7-A3RF-01 TCGA-A7-A3RF-01A-11D-A22B-05 1ecde81b-56db-4c3f-981d-6f1c4baa4a32 TCGA-A7-A3RF-01 TCGA-A7-A3RF-01A-11D-A228-09 NA NA TCGA-A7-A3RF-01 NA NA de0a584e-117e-4cf6-8c4a-6fb040270eda NA TCGA-A7-A3RF-01A-11D-A227-01 TCGA-A7-A3RF-01 NA de0a584e-117e-4cf6-8c4a-6fb040270eda TCGA-A7-A3RF-01A-11D-A227-01 |
|
|
160 |
TCGA-A7-A425-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A425-01 447 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A425 419 1 days 447 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A425-F41648 TCGA-A7-A425 TCGA-A7-A425-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -25678 198 NA 0 447 NA 419 419 NA NA NA 90-99% 2.5 NA 2013-3-25 FEMALE NA NA 30-39% Pathvysion HER-2 D Probe Kit 3+ 228 2.8 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 400 NO Indeterminate Negative NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Positive 90-99% NA NA NA 3 Point Scale NA NA NA NA <10% NA Negative NA NA NA NA NA NA 3 Point Scale Other, specify Locoregional Recurrence Left Breast YES YES 12 NA false No MX N3a T3 Stage IIIC TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf A425 WITH TUMOR NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 0a423f86-ffa5-4c16-97ab-2d262c34fd41 0a423f86-ffa5-4c16-97ab-2d262c34fd41 NA NA TCGA-A7-A425-01 TCGA-A7-A425-01A-11D-A244-05 45d1596a-0b23-41ad-87c5-b1acc92619d2 TCGA-A7-A425-01 TCGA-A7-A425-01A-11D-A243-09 NA NA TCGA-A7-A425-01 NA NA 0a423f86-ffa5-4c16-97ab-2d262c34fd41 NA TCGA-A7-A425-01A-11D-A242-01 TCGA-A7-A425-01 NA 0a423f86-ffa5-4c16-97ab-2d262c34fd41 TCGA-A7-A425-01A-11D-A242-01 |
|
|
161 |
TCGA-A7-A426-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A426-01 364 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A426 364 0 days 364 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A426-F41743 TCGA-A7-A426 TCGA-A7-A426-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -18296 132 NA 0 364 NA NA NA NA NA NA 70-79% NA NA 2013-3-26 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 180 NO Negative NA NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 13 NA false Yes MX N3a T3 Stage IIIC TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf A426 TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 185d3410-2daa-4d28-ab60-a7c13ae9d4fb 185d3410-2daa-4d28-ab60-a7c13ae9d4fb NA NA TCGA-A7-A426-01 TCGA-A7-A426-01A-22D-A244-05 NA TCGA-A7-A426-01 TCGA-A7-A426-01A-22D-A243-09 NA NA TCGA-A7-A426-01 NA NA 185d3410-2daa-4d28-ab60-a7c13ae9d4fb NA TCGA-A7-A426-01A-22D-A242-01 TCGA-A7-A426-01 NA 185d3410-2daa-4d28-ab60-a7c13ae9d4fb TCGA-A7-A426-01A-22D-A242-01 |
|
|
162 |
TCGA-A7-A4SA-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SA-01 454 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SA 454 0 days 454 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A4SA-F49560 TCGA-A7-A4SA TCGA-A7-A4SA-01A NA Positive 3 Point Scale NA NA NA Negative Simple Mastectomy NA YES NA NA -14906 127 NA 0 454 NA NA NA NA NA NA 80-89% NA NA 2013-10-3 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 false No M0 N1a T2 Stage IIB TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf A4SA TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 781945fb-6d9e-4b45-8082-57675f21dc4a 781945fb-6d9e-4b45-8082-57675f21dc4a NA NA TCGA-A7-A4SA-01 TCGA-A7-A4SA-01A-11D-A268-05 95bdb84b-c36a-4c64-8059-445ebf7adbb4 TCGA-A7-A4SA-01 TCGA-A7-A4SA-01A-11D-A25Q-09 NA NA TCGA-A7-A4SA-01 NA NA 781945fb-6d9e-4b45-8082-57675f21dc4a NA TCGA-A7-A4SA-01A-11D-A25N-01 TCGA-A7-A4SA-01 NA 781945fb-6d9e-4b45-8082-57675f21dc4a TCGA-A7-A4SA-01A-11D-A25N-01 |
|
|
163 |
TCGA-A7-A4SA-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SA-11 454 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SA 454 0 days 454 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A4SA-F49560 TCGA-A7-A4SA TCGA-A7-A4SA-11A NA Positive 3 Point Scale NA NA NA Negative Simple Mastectomy NA YES NA NA -14906 127 NA 0 454 NA NA NA NA NA NA 80-89% NA NA 2013-10-3 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1430 NO Negative NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 false No M0 N1a T2 Stage IIB NA A4SA TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th NA YES NO A7 Breast A LIVING 2012 NA NA NA NA NA NA BF5A86FA-5213-494A-852B-C0782A9A0A56 NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
164 |
TCGA-A7-A4SB-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SB-01 418 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SB 418 0 days 418 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A4SB-F49625 TCGA-A7-A4SB TCGA-A7-A4SB-01A Negative Positive 3 Point Scale NA 3 Point Scale Other Positive Lumpectomy Right Breast reexcision YES NA NA -20539 75 NA 0 418 NA NA NA NA NA NA 70-79% NA NA 2013-10-4 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 false No M0 N1mi T3 Stage IIIA TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf A4SB TUMOR FREE NA NA NA NA NA YES YES 50-59% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 352dc94a-fc74-4292-890c-4ed9c22dcfbc 352dc94a-fc74-4292-890c-4ed9c22dcfbc NA NA TCGA-A7-A4SB-01 TCGA-A7-A4SB-01A-21D-A268-05 NA TCGA-A7-A4SB-01 TCGA-A7-A4SB-01A-21D-A25Q-09 NA NA TCGA-A7-A4SB-01 NA NA 352dc94a-fc74-4292-890c-4ed9c22dcfbc NA TCGA-A7-A4SB-01A-21D-A25N-01 TCGA-A7-A4SB-01 NA 352dc94a-fc74-4292-890c-4ed9c22dcfbc TCGA-A7-A4SB-01A-21D-A25N-01 |
|
|
165 |
TCGA-A7-A4SC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SC-01 446 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SC 446 0 days 446 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant NA NA TCGA-A7-A4SC-F49714 TCGA-A7-A4SC TCGA-A7-A4SC-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -23008 110 NA 0 446 NA NA NA NA NA NA 90-99% 2.2 NA 2013-10-8 FEMALE NA NA NA PathVysion HER-2 D Probe kit 3+ 303 2.4 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 360 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T3 Stage IIB TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf A4SC TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 84633979-56dd-4244-90bc-fa4652718880 84633979-56dd-4244-90bc-fa4652718880 NA NA TCGA-A7-A4SC-01 TCGA-A7-A4SC-01A-12D-A268-05 3d087331-9673-4816-97ac-741f364cccae NA TCGA-A7-A4SC-01A-12D-A25Q-09 NA NA TCGA-A7-A4SC-01 NA NA 84633979-56dd-4244-90bc-fa4652718880 NA NA TCGA-A7-A4SC-01 NA 84633979-56dd-4244-90bc-fa4652718880 NA |
|
|
166 |
TCGA-A7-A4SC-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SC-11 446 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SC 446 0 days 446 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant NA NA TCGA-A7-A4SC-F49714 TCGA-A7-A4SC TCGA-A7-A4SC-11A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -23008 110 NA 0 446 NA NA NA NA NA NA 90-99% 2.2 NA 2013-10-8 FEMALE NA NA NA PathVysion HER-2 D Probe kit 3+ 303 2.4 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 610 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T3 Stage IIB NA A4SC TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th NA YES NO A7 Breast A LIVING 2012 NA NA NA NA NA NA 325798E1-709A-4A61-AF20-E1E85844CF20 NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
167 |
TCGA-A7-A4SD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SD-01 441 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SD 441 0 days 441 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Sentinel node biopsy alone NA TCGA-A7-A4SD-F52732 TCGA-A7-A4SD TCGA-A7-A4SD-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -19131 63 NA 0 441 NA NA NA NA NA NA NA 5 NA 2013-12-5 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 20 6.4 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 230 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf A4SD TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 cb0d669b-658a-4a41-9904-f838ddb12db2 cb0d669b-658a-4a41-9904-f838ddb12db2 NA NA TCGA-A7-A4SD-01 TCGA-A7-A4SD-01A-11D-A268-05 148f42bd-6aee-4dc7-bf8b-d5e8580c1b4d TCGA-A7-A4SD-01 TCGA-A7-A4SD-01A-11D-A25Q-09 NA NA TCGA-A7-A4SD-01 NA NA cb0d669b-658a-4a41-9904-f838ddb12db2 NA TCGA-A7-A4SD-01A-11D-A25N-01 TCGA-A7-A4SD-01 NA cb0d669b-658a-4a41-9904-f838ddb12db2 TCGA-A7-A4SD-01A-11D-A25N-01 |
|
|
168 |
TCGA-A7-A4SD-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SD-11 441 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SD 441 0 days 441 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Sentinel node biopsy alone NA TCGA-A7-A4SD-F52732 TCGA-A7-A4SD TCGA-A7-A4SD-11A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -19131 63 NA 0 441 NA NA NA NA NA NA NA 5 NA 2013-12-5 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 20 6.4 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 980 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA NA A4SD TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th NA YES NO A7 Breast A LIVING 2012 NA NA NA NA NA NA 3EB15608-D3BE-4E35-89F9-BEF3DFEB60EC NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
169 |
TCGA-A7-A4SE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SE-01 644 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SE 644 0 days 644 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Sentinel node biopsy alone NA TCGA-A7-A4SE-F50162 TCGA-A7-A4SE TCGA-A7-A4SE-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -20080 306 NA 0 644 NA NA NA NA NA NA NA NA NA 2013-10-16 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 160 NO Negative NA YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf A4SE TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2011 6bb217e7-3fd4-477f-87bf-b55e50a33e45 6bb217e7-3fd4-477f-87bf-b55e50a33e45 NA NA TCGA-A7-A4SE-01 TCGA-A7-A4SE-01A-11D-A268-05 7309fdea-a4df-4081-adac-88e2966c8642 TCGA-A7-A4SE-01 TCGA-A7-A4SE-01A-11D-A25Q-09 NA NA TCGA-A7-A4SE-01 NA NA 6bb217e7-3fd4-477f-87bf-b55e50a33e45 NA TCGA-A7-A4SE-01A-11D-A25N-01 TCGA-A7-A4SE-01 NA 6bb217e7-3fd4-477f-87bf-b55e50a33e45 TCGA-A7-A4SE-01A-11D-A25N-01 |
|
|
170 |
TCGA-A7-A4SE-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SE-11 644 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SE 644 0 days 644 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Sentinel node biopsy alone NA TCGA-A7-A4SE-F50162 TCGA-A7-A4SE TCGA-A7-A4SE-11A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -20080 306 NA 0 644 NA NA NA NA NA NA NA NA NA 2013-10-16 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 650 NO Negative NA YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA NA A4SE TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th NA YES NO A7 Breast A LIVING 2011 NA NA NA NA NA NA 715C8450-EEA3-4C5C-8B9B-D30D994FB08D NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
171 |
TCGA-A7-A4SF-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A4SF-01 545 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A4SF 545 0 days 545 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Sentinel node biopsy alone NA TCGA-A7-A4SF-F49721 TCGA-A7-A4SF NA Positive Positive 3 Point Scale NA NA Other Negative Lumpectomy Right Breast Reexcision YES NA NA -19985 NA NA 0 545 NA NA NA NA NA NA 90-99% NA NA 2013-10-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive NA NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T2 Stage IIA NA A4SF TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast NA LIVING 2012 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 NA NA TCGA-A7-A4SF-01 TCGA-A7-A4SF-01A-11D-A268-05 e04e9fb6-be99-430f-8f5b-fd4aaba872dc TCGA-A7-A4SF-01 TCGA-A7-A4SF-01A-11D-A25Q-09 NA NA TCGA-A7-A4SF-01 NA NA f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 NA TCGA-A7-A4SF-01A-11D-A25N-01 TCGA-A7-A4SF-01 NA f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 TCGA-A7-A4SF-01A-11D-A25N-01 |
|
|
172 |
TCGA-A7-A56D-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A56D-01 448 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A56D 448 0 days 448 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A56D-F50426 TCGA-A7-A56D TCGA-A7-A56D-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -30783 140 NA 0 448 NA NA NA NA NA NA 90-99% NA NA 2013-10-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 80 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf A56D TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 NA NA TCGA-A7-A56D-01 TCGA-A7-A56D-01A-11D-A27Y-05 NA TCGA-A7-A56D-01 TCGA-A7-A56D-01A-11D-A27P-09 NA NA TCGA-A7-A56D-01 NA NA 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 NA TCGA-A7-A56D-01A-11D-A27O-01 TCGA-A7-A56D-01 NA 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 TCGA-A7-A56D-01A-11D-A27O-01 |
|
|
173 |
TCGA-A7-A5ZV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A5ZV-01 368 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A5ZV 368 0 days 368 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Sentinel node biopsy alone NA TCGA-A7-A5ZV-F51143 TCGA-A7-A5ZV NA NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -22966 NA NA 0 368 NA NA NA NA NA NA NA 2.5 NA 2013-11-8 FEMALE NA NA NA PathVysion HER-2 D Probe Kit 2+ 40 3.8 1.5 NA Infiltrating Carcinoma NOS NA No NA C50.9 8010/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A5ZV TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast NA LIVING 2012 e121ae32-63c2-4b13-b135-d1837fc10999 e121ae32-63c2-4b13-b135-d1837fc10999 NA NA TCGA-A7-A5ZV-01 TCGA-A7-A5ZV-01A-11D-A28C-05 cc46932d-0799-42ae-8a92-5bf65e381969 TCGA-A7-A5ZV-01 TCGA-A7-A5ZV-01A-11D-A28B-09 NA NA TCGA-A7-A5ZV-01 NA NA e121ae32-63c2-4b13-b135-d1837fc10999 NA TCGA-A7-A5ZV-01A-11D-A28A-01 TCGA-A7-A5ZV-01 NA e121ae32-63c2-4b13-b135-d1837fc10999 TCGA-A7-A5ZV-01A-11D-A28A-01 |
|
|
174 |
TCGA-A7-A5ZW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A5ZW-01 326 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A5ZW 326 0 days 326 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A5ZW-F51509 TCGA-A7-A5ZW TCGA-A7-A5ZW-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -17529 77 NA 0 326 NA NA NA NA NA NA 90-99% NA NA 2013-11-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 60 NO Negative NA NO 1 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf A5ZW TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2012 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f NA NA TCGA-A7-A5ZW-01 TCGA-A7-A5ZW-01A-12D-A29O-05 NA TCGA-A7-A5ZW-01 TCGA-A7-A5ZW-01A-12D-A29N-09 NA NA TCGA-A7-A5ZW-01 NA NA 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f NA TCGA-A7-A5ZW-01A-12D-A29M-01 TCGA-A7-A5ZW-01 NA 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f TCGA-A7-A5ZW-01A-12D-A29M-01 |
|
|
175 |
TCGA-A7-A5ZX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A5ZX-01 336 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A5ZX 336 0 days 336 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A5ZX-F52721 TCGA-A7-A5ZX NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Other NA YES NA NA -17683 NA NA 0 336 NA NA NA NA NA NA NA NA NA 2013-12-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 24 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 21 NA NA Yes M0 N3a T2 Stage IIIC NA A5ZX TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders. 7th NA YES NO A7 Breast NA LIVING 2012 e3c70f4d-4a23-486b-b221-3058b13a1c69 e3c70f4d-4a23-486b-b221-3058b13a1c69 NA NA TCGA-A7-A5ZX-01 TCGA-A7-A5ZX-01A-12D-A29O-05 NA TCGA-A7-A5ZX-01 TCGA-A7-A5ZX-01A-12D-A29N-09 NA NA TCGA-A7-A5ZX-01 NA NA e3c70f4d-4a23-486b-b221-3058b13a1c69 NA TCGA-A7-A5ZX-01A-12D-A29M-01 TCGA-A7-A5ZX-01 NA e3c70f4d-4a23-486b-b221-3058b13a1c69 TCGA-A7-A5ZX-01A-12D-A29M-01 |
|
|
176 |
TCGA-A7-A6VV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A6VV-01 313 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A6VV 313 0 days 313 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A6VV-F57249 TCGA-A7-A6VV TCGA-A7-A6VV-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18695 85 NA 0 313 NA NA NA NA NA NA NA NA NA 2014-3-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1100 NO Negative NA NO 5 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf A6VV TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2013 c02ec36d-9e79-4e2f-a46c-f898838766df c02ec36d-9e79-4e2f-a46c-f898838766df NA NA TCGA-A7-A6VV-01 TCGA-A7-A6VV-01A-22D-A33F-05 66E3766B-46AB-4A9B-8B6E-1EECA04D9B62 TCGA-A7-A6VV-01 NA NA NA TCGA-A7-A6VV-01 NA NA c02ec36d-9e79-4e2f-a46c-f898838766df NA TCGA-A7-A6VV-01A-22D-A33D-01 TCGA-A7-A6VV-01 NA c02ec36d-9e79-4e2f-a46c-f898838766df TCGA-A7-A6VV-01A-22D-A33D-01 |
|
|
177 |
TCGA-A7-A6VW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A6VW-01 285 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A6VW 285 0 days 285 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Sentinel node biopsy alone NA TCGA-A7-A6VW-F57227 TCGA-A7-A6VW NA NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -17539 NA NA 0 285 NA NA NA NA NA NA NA NA NA 2014-3-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A6VW TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast NA LIVING 2013 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 NA NA TCGA-A7-A6VW-01 TCGA-A7-A6VW-01A-21D-A33F-05 NA TCGA-A7-A6VW-01 NA NA NA TCGA-A7-A6VW-01 NA NA f572c953-e1aa-4dd2-a8f8-e292ab7bd139 NA TCGA-A7-A6VW-01A-21D-A33D-01 TCGA-A7-A6VW-01 NA f572c953-e1aa-4dd2-a8f8-e292ab7bd139 TCGA-A7-A6VW-01A-21D-A33D-01 |
|
|
178 |
TCGA-A7-A6VX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A6VX-01 317 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A6VX 317 0 days 317 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-A7-A6VX-F57518 TCGA-A7-A6VX TCGA-A7-A6VX-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -25066 73 NA 0 317 NA NA NA NA NA Immune Stain by GenPath 90-99% NA NA 2014-3-13 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf A6VX TUMOR FREE Immune stain by GenPath NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2013 aed86155-1d12-4447-bdf6-3aaba9938a71 aed86155-1d12-4447-bdf6-3aaba9938a71 NA NA TCGA-A7-A6VX-01 TCGA-A7-A6VX-01A-12D-A33F-05 8C0E2DD9-D3B3-4AF6-A450-4B7F1DBA5CE7 TCGA-A7-A6VX-01 NA NA NA TCGA-A7-A6VX-01 NA NA aed86155-1d12-4447-bdf6-3aaba9938a71 NA TCGA-A7-A6VX-01A-12D-A33D-01 TCGA-A7-A6VX-01 NA aed86155-1d12-4447-bdf6-3aaba9938a71 TCGA-A7-A6VX-01A-12D-A33D-01 |
|
|
179 |
TCGA-A7-A6VY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-A7-A6VY-01 266 0 days NA NA NA NA NA NA NA NA NA TCGA-A7-A6VY 266 0 days 266 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-A7-A6VY-F57257 TCGA-A7-A6VY TCGA-A7-A6VY-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -17640 29 NA 0 266 NA NA NA NA NA NA NA NA NA 2014-3-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Negative NA NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No M0 N1 T2 Stage IIB TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf A6VY TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO A7 Breast A LIVING 2013 2fb506f2-4b76-4c20-ae45-8939f2e14753 2fb506f2-4b76-4c20-ae45-8939f2e14753 NA NA TCGA-A7-A6VY-01 TCGA-A7-A6VY-01A-12D-A33F-05 NA TCGA-A7-A6VY-01 NA NA NA TCGA-A7-A6VY-01 NA NA 2fb506f2-4b76-4c20-ae45-8939f2e14753 NA TCGA-A7-A6VY-01A-12D-A33D-01 TCGA-A7-A6VY-01 NA 2fb506f2-4b76-4c20-ae45-8939f2e14753 TCGA-A7-A6VY-01A-12D-A33D-01 |
|
|
180 |
TCGA-A8-A06N-01 Stage IIIB 66 3 Stage IIIB 0 NA Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 0 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T4 LIVING NA TCGA-A8-A06N-01 NA NA days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A06N NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left NA NA NA TCGA-A8-A06N TCGA-A8-A06N-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -24288 241 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 510 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T4b Stage IIIB TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf A06N TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 a14dc21a-6a46-4be8-9247-76cbc70dfe8b a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01A-21-A13B-20 TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01 NA 99692232-7d23-4ea5-847e-17064bac010d TCGA-A8-A06N-01 TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01A-11D-A00Y-05 TCGA-A8-A06N-01 NA TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01 a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01 TCGA-A8-A06N-01A-11D-A011-01 NA TCGA-A8-A06N-01A-12R-A056-07 a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01A-11D-A011-01 TCGA-A8-A06N-01 |
|
|
181 |
TCGA-A8-A06O-01 Stage I 60 5 Stage I 396 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 396 0 LumB Luminal B Positive NA -2 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A06O-01 396 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A06O 396 0 days 396 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left NA NA TCGA-A8-A06O-F40806 TCGA-A8-A06O TCGA-A8-A06O-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -22157 272 NA 0 396 NA NA NA NA NA NA NA NA NA 2013-3-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T1c Stage I TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf A06O TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 7dbd8795-b264-4f68-bdea-4cfe39884864 7dbd8795-b264-4f68-bdea-4cfe39884864 NA TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01 NA NA TCGA-A8-A06O-01 TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01A-11D-A00Y-05 TCGA-A8-A06O-01 NA TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01 7dbd8795-b264-4f68-bdea-4cfe39884864 TCGA-A8-A06O-01 TCGA-A8-A06O-01A-11D-A011-01 NA TCGA-A8-A06O-01A-11R-A00Z-07 7dbd8795-b264-4f68-bdea-4cfe39884864 TCGA-A8-A06O-01A-11D-A011-01 TCGA-A8-A06O-01 |
|
|
182 |
TCGA-A8-A06P-01 Stage IIIA 63 4 Stage IIIA 396 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 396 0 LumA Luminal A Positive ReacI -5 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A06P-01 396 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06P NA NA days 396 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right NA NA TCGA-A8-A06P-F40814 TCGA-A8-A06P TCGA-A8-A06P-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23011 241 NA 0 396 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 210 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA NA NA false No M0 N2a T1c Stage IIIA TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf A06P TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 9d8f2b85-f203-47ac-8217-987640f89b26 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01A-21-A13B-20 TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01 NA 9d804a48-aeb9-4785-af7c-2b8a4763c148 TCGA-A8-A06P-01 TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01A-11D-A00Y-05 TCGA-A8-A06P-01 NA TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01 TCGA-A8-A06P-01A-11D-A011-01 NA TCGA-A8-A06P-01A-11R-A00Z-07 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01A-11D-A011-01 TCGA-A8-A06P-01 |
|
|
183 |
TCGA-A8-A06Q-01 Stage IIIA 63 3 No_Conversion 31 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 31 0 LumB Luminal B Positive NA -2 -3 enrollment T_Other T3 LIVING 0 TCGA-A8-A06Q-01 31 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 3 TCGA-A8-A06Q NA NA days 31 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant NA NA NA TCGA-A8-A06Q TCGA-A8-A06Q-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23164 1184 NA 0 31 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 50 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NA NA NA false No M0 N2 T3 Stage IIIA TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf A06Q TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2007 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae NA TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01 NA NA TCGA-A8-A06Q-01 TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01A-11D-A032-05 TCGA-A8-A06Q-01 NA TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae TCGA-A8-A06Q-01 TCGA-A8-A06Q-01A-11D-A036-01 NA TCGA-A8-A06Q-01A-11R-A034-07 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae TCGA-A8-A06Q-01A-11D-A036-01 TCGA-A8-A06Q-01 |
|
|
184 |
TCGA-A8-A06R-01 Stage IIB 69 NA No_Conversion 546 NA Positive FEMALE Equivocal NA NA NA Negative M0 Positive N1 546 0 LumB Luminal B Negative ReacI -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A06R-01 547 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06R 547 0 days 547 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant NA NA TCGA-A8-A06R-F40815 TCGA-A8-A06R TCGA-A8-A06R-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -25477 1184 NA 0 547 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 220 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf A06R TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2007 e2d7656c-0d06-427c-998c-c26ba4a1def4 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01A-21-A13A-20 TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01 NA 7bcd06e7-a4de-4c5b-9337-4d7d3b8014b9 TCGA-A8-A06R-01 TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01A-11D-A00Y-05 TCGA-A8-A06R-01 NA TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01 TCGA-A8-A06R-01A-11D-A011-01 NA TCGA-A8-A06R-01A-11R-A00Z-07 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01A-11D-A011-01 TCGA-A8-A06R-01 |
|
|
185 |
TCGA-A8-A06T-01 Stage IIIA 75 4 Stage IIIA 1249 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1249 0 LumA Luminal A Positive NA -10 -3 enrollment T_Other T3 LIVING 0 TCGA-A8-A06T-01 1614 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 14 TCGA-A8-A06T NA NA days 1614 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Upper Outer Quadrant NA NA TCGA-A8-A06T-F40816 TCGA-A8-A06T NA NA Positive NA NA NA NA Positive Other NA NA NA NA -27393 NA NA 0 1614 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA NA NA NA Yes M0 N1a T3 Stage IIIA NA A06T TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2007 de1cdf25-62e6-41c0-b1c8-257175519041 de1cdf25-62e6-41c0-b1c8-257175519041 NA TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01 NA NA TCGA-A8-A06T-01 TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01A-11D-A00Y-05 TCGA-A8-A06T-01 NA TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01 de1cdf25-62e6-41c0-b1c8-257175519041 TCGA-A8-A06T-01 TCGA-A8-A06T-01A-11D-A011-01 NA TCGA-A8-A06T-01A-11R-A00Z-07 de1cdf25-62e6-41c0-b1c8-257175519041 TCGA-A8-A06T-01A-11D-A011-01 TCGA-A8-A06T-01 |
|
|
186 |
TCGA-A8-A06U-01 Stage IIB 80 NA Stage IIB 882 882 Positive FEMALE Equivocal NA NA NA Negative M0 Positive N1 882 1 LumA Luminal A Positive LumA/B -2 -5 enrollment T_Other T2 DECEASED 1 TCGA-A8-A06U-01 883 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06U NA NA days 883 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Upper Outer Quadrant NA NA TCGA-A8-A06U-F40817 TCGA-A8-A06U TCGA-A8-A06U-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -29525 759 883 0 NA NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 250 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false Yes M0 N1a T2 Stage IIB TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf A06U TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2008 89f9e509-5f4c-439b-b610-860f209332d2 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01A-21-A13A-20 TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01 NA f47ef5b8-45ae-4cd2-915a-ba5f790465bd TCGA-A8-A06U-01 TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01A-11D-A00Y-05 TCGA-A8-A06U-01 NA TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01 TCGA-A8-A06U-01A-11D-A011-01 NA TCGA-A8-A06U-01A-11R-A00Z-07 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01A-11D-A011-01 TCGA-A8-A06U-01 |
|
|
187 |
TCGA-A8-A06X-01 Stage IIB 77 1 Stage IIB 943 943 Positive FEMALE Positive NA NA NA Negative M0 Negative N0 943 1 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T3 DECEASED 1 TCGA-A8-A06X-01 943 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation c1uster 10 TCGA-A8-A06X NA NA days 943 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant NA NA TCGA-A8-A06X-F40818 TCGA-A8-A06X TCGA-A8-A06X-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -28338 1276 943 0 NA NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 760 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NA NA NA false No M0 N0 T3 Stage IIB TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf A06X TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2006 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 TCGA-A8-A06X-01A-11-A13A-20 TCGA-A8-A06X-01A-21W-A019-09 TCGA-A8-A06X-01 NA 1896a8eb-415e-4b05-aad1-dec8b4a5c473 TCGA-A8-A06X-01 TCGA-A8-A06X-01A-21W-A019-09 TCGA-A8-A06X-01A-21D-A00Y-05 TCGA-A8-A06X-01 NA TCGA-A8-A06X-01A-21W-A019-09 NA 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 NA TCGA-A8-A06X-01A-21D-A011-01 NA TCGA-A8-A06X-01A-21R-A00Z-07 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 TCGA-A8-A06X-01A-21D-A011-01 TCGA-A8-A06X-01 |
|
|
188 |
TCGA-A8-A06Y-01 Stage IIA 66 4 Stage IIA 791 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 791 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A06Y-01 791 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A06Y 791 1 days 791 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Outer Quadrant NA NA TCGA-A8-A06Y-F40819 TCGA-A8-A06Y TCGA-A8-A06Y-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24442 667 NA 0 791 NA NA 791 NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 130 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA YES NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf A06Y TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 14f20743-35f3-4e68-a2e5-e03edfe31a97 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01A-11-A13A-20 TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01 NA 71251016-7304-4492-8278-a1718ecdb97a TCGA-A8-A06Y-01 TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01A-21D-A00Y-05 TCGA-A8-A06Y-01 NA TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01 TCGA-A8-A06Y-01A-21D-A011-01 NA TCGA-A8-A06Y-01A-21R-A00Z-07 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01A-21D-A011-01 TCGA-A8-A06Y-01 |
|
|
189 |
TCGA-A8-A06Z-01 Stage IIB 84 5 Stage IIB 31 NA Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 31 0 LumB Luminal B Positive Her2 -10 -3 enrollment T_Other T3 LIVING 0 TCGA-A8-A06Z-01 31 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A8-A06Z NA NA days 31 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right Upper Outer Quadrant NA NA NA TCGA-A8-A06Z TCGA-A8-A06Z-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -30984 1003 NA 0 31 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 330 NO Negative Negative NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 1 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T3 Stage IIB TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584.pdf A06Z NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2007 42b99ee7-a1ae-4383-b343-adf468cb8b51 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01A-21-A13A-20 TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01 NA afd9a962-46e2-4b42-bc6e-eb091d7f9b5b TCGA-A8-A06Z-01 TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01A-11D-A00Y-05 TCGA-A8-A06Z-01 NA TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01 TCGA-A8-A06Z-01A-11D-A011-01 NA TCGA-A8-A06Z-01A-11R-A00Z-07 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01A-11D-A011-01 TCGA-A8-A06Z-01 |
|
|
190 |
TCGA-A8-A075-01 Stage IIB 42 2 Stage IIB 517 NA Positive FEMALE Negative 5 2 1 Negative M0 Positive N1 517 0 LumB HER2-enriched Positive X -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A075-01 518 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-A8-A075 518 0 days 518 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Upper Outer Quadrant NA NA TCGA-A8-A075-F40820 TCGA-A8-A075 TCGA-A8-A075-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -15369 394 NA 0 518 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 120 NO Positive Positive NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 1 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf A075 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 1ccf908a-7620-4af8-b83f-0e287f3655c5 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01A-21-A13A-20 TCGA-A8-A075-01A-11D-A099-09 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A10P-05 a84864ab-5eba-4a64-aa65-883deca0c967 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A099-09 NA TCGA-A8-A075-01 NA TCGA-A8-A075-01A-11D-A099-09 TCGA-A8-A075-01 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A087-01 NA TCGA-A8-A075-01A-11R-A084-07 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01A-11D-A087-01 TCGA-A8-A075-01 |
|
|
191 |
TCGA-A8-A076-01 Stage IIA 66 4 Stage IIA 1641 NA Positive FEMALE Positive 1 1 1 Negative M0 Negative N0 1641 0 LumB HER2-enriched Positive Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A076-01 1642 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation c1uster 9 TCGA-A8-A076 1642 0 days 1642 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Outer Quadrant NA NA TCGA-A8-A076-F40821 TCGA-A8-A076 TCGA-A8-A076-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24230 1518 NA 0 1642 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 210 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf A076 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2006 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01A-11-A13A-20 TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01 NA 9d5a9ed1-b633-4e0d-8006-826e20c62538 TCGA-A8-A076-01 TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01A-21D-A00Y-05 TCGA-A8-A076-01 NA TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01 TCGA-A8-A076-01A-21D-A011-01 NA TCGA-A8-A076-01A-21R-A00Z-07 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01A-21D-A011-01 TCGA-A8-A076-01 |
|
|
192 |
TCGA-A8-A079-01 Stage IIIB 69 5 Stage IIIC 274 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N3 274 0 LumB Luminal B Positive LumA/B -6 -3 enrollment T_Other T4 LIVING 0 TCGA-A8-A079-01 274 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A8-A079 NA NA days 274 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Outer Quadrant NA NA TCGA-A8-A079-F40822 TCGA-A8-A079 TCGA-A8-A079-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25294 1033 NA 0 274 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 380 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NA NA NA false No M0 N3 T4b Stage IIIB TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf A079 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2007 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01A-11-A13A-20 TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01 NA b22ff43f-3646-49dd-ba2e-3cc1a82eb7bd TCGA-A8-A079-01 TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01A-21D-A00Y-05 TCGA-A8-A079-01 NA TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01 TCGA-A8-A079-01A-21D-A011-01 NA TCGA-A8-A079-01A-21R-A00Z-07 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01A-21D-A011-01 TCGA-A8-A079-01 |
|
|
193 |
TCGA-A8-A07B-01 Stage IIA 69 5 Stage IIA 1004 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1004 0 LumA HER2-enriched Positive NA -1 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A07B-01 1308 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 2 TCGA-A8-A07B NA NA days 1308 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Lower Outer Quadrant NA NA TCGA-A8-A07B-F40823 TCGA-A8-A07B TCGA-A8-A07B-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25475 880 NA 0 1308 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 90 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf A07B TUMOR FREE NA NA NA NA NA NO NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2007 0c9fe532-3920-4a59-b348-65b184c0eff4 0c9fe532-3920-4a59-b348-65b184c0eff4 NA TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01 NA NA TCGA-A8-A07B-01 TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01A-11D-A00Y-05 TCGA-A8-A07B-01 NA TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01 0c9fe532-3920-4a59-b348-65b184c0eff4 TCGA-A8-A07B-01 TCGA-A8-A07B-01A-11D-A011-01 NA TCGA-A8-A07B-01A-11R-A00Z-07 0c9fe532-3920-4a59-b348-65b184c0eff4 TCGA-A8-A07B-01A-11D-A011-01 TCGA-A8-A07B-01 |
|
|
194 |
TCGA-A8-A07C-01 Stage IIA 57 2 Stage IIA 580 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 580 0 Basal Basal-like Negative NA -13 -12 enrollment T_Other T2 LIVING 0 TCGA-A8-A07C-01 1034 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 14 TCGA-A8-A07C 1034 0 days 1034 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Outer Quadrant NA NA TCGA-A8-A07C-F40824 TCGA-A8-A07C TCGA-A8-A07C-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -20820 637 NA 0 1034 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 80 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf A07C TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 19d713e8-e754-44a4-9b23-0ef70f5d6b44 19d713e8-e754-44a4-9b23-0ef70f5d6b44 NA TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01 NA NA NA TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01A-11D-A032-05 NA NA TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01 19d713e8-e754-44a4-9b23-0ef70f5d6b44 TCGA-A8-A07C-01 NA NA TCGA-A8-A07C-01A-11R-A034-07 19d713e8-e754-44a4-9b23-0ef70f5d6b44 NA TCGA-A8-A07C-01 |
|
|
195 |
TCGA-A8-A07E-01 Stage X 81 2 Stage IIIC 608 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N3 608 0 LumA Luminal A Positive ReacII -4 -3 enrollment T_Other T4 LIVING 0 TCGA-A8-A07E-01 608 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A07E 608 0 days 608 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Left Upper Outer Quadrant NA NA TCGA-A8-A07E-F40825 TCGA-A8-A07E TCGA-A8-A07E-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -29800 545 NA 0 608 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 260 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO NA NA false Yes MX N3a T4b Stage X TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf A07E TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 3510559d-33b7-423a-88c9-d8c42270d546 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01A-21-A13B-20 TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01 NA 857d3ad8-e3a8-4366-8f34-2b89be3dd24c TCGA-A8-A07E-01 TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01A-11D-A032-05 TCGA-A8-A07E-01 NA TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01 TCGA-A8-A07E-01A-11D-A036-01 NA TCGA-A8-A07E-01A-11R-A034-07 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01A-11D-A036-01 TCGA-A8-A07E-01 |
|
|
196 |
TCGA-A8-A07F-01 Stage IIB 65 2 Stage IIB 576 NA Positive FEMALE Negative 1 4 3 Negative M0 Positive N1 576 0 LumA Luminal A Positive ReacI -1 -1 enrollment T_Other T2 LIVING 0 TCGA-A8-A07F-01 577 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-A8-A07F 577 0 days 577 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Outer Quadrant NA NA TCGA-A8-A07F-F40826 TCGA-A8-A07F TCGA-A8-A07F-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23742 453 NA 0 577 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 150 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf A07F TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 f6fd41e3-c597-4c5d-8f47-a315be0330f8 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01A-21-A13B-20 TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01 NA 4d97ec15-8bf1-4bc7-9bc9-4ef5c58f1fbc TCGA-A8-A07F-01 TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01A-11D-A00Y-05 TCGA-A8-A07F-01 NA TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01 TCGA-A8-A07F-01A-11D-A011-01 NA TCGA-A8-A07F-01A-11R-A00Z-07 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01A-11D-A011-01 TCGA-A8-A07F-01 |
|
|
197 |
TCGA-A8-A07G-01 Stage IIA 65 3 Stage IIA 576 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 576 0 LumA Luminal A Positive NA -5 -7 enrollment T1 T1 LIVING 0 TCGA-A8-A07G-01 577 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A07G 577 0 days 577 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Upper Outer Quadrant NA NA TCGA-A8-A07G-F40827 TCGA-A8-A07G NA NA Positive NA NA NA NA Positive Other NA NA NA NA -23926 NA NA 0 577 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO NA NA NA No M0 N1a T1c Stage IIA NA A07G TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 aad6a297-72fe-4483-8c81-b7bef2522437 aad6a297-72fe-4483-8c81-b7bef2522437 NA TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01 NA NA TCGA-A8-A07G-01 TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01A-11D-A032-05 TCGA-A8-A07G-01 NA TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01 aad6a297-72fe-4483-8c81-b7bef2522437 TCGA-A8-A07G-01 TCGA-A8-A07G-01A-11D-A036-01 NA TCGA-A8-A07G-01A-11R-A034-07 aad6a297-72fe-4483-8c81-b7bef2522437 TCGA-A8-A07G-01A-11D-A036-01 TCGA-A8-A07G-01 |
|
|
198 |
TCGA-A8-A07I-01 Stage IIIA 69 3 Stage IIIA 426 NA Positive FEMALE Positive 1 1 1 Negative M0 Positive N2 426 0 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A07I-01 426 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A07I 426 0 days 426 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Outer Quadrant NA NA TCGA-A8-A07I-F40828 TCGA-A8-A07I TCGA-A8-A07I-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -25263 302 NA 0 426 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 130 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO NA NA false No M0 N2a T2 Stage IIIA TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf A07I TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 670eab31-e873-4404-bbff-1b427e7b80c1 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01A-21-A13B-20 TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01 NA f8e3aadc-06b2-43d4-9cdb-a3c285bedaee TCGA-A8-A07I-01 TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01A-11D-A00Y-05 TCGA-A8-A07I-01 NA TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01 TCGA-A8-A07I-01A-11D-A011-01 NA TCGA-A8-A07I-01A-11R-A00Z-07 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01A-11D-A011-01 TCGA-A8-A07I-01 |
|
|
199 |
TCGA-A8-A07J-01 Stage IIB 35 2 Stage IIB 365 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 365 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-A8-A07J-01 365 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A07J 365 0 days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Outer Quadrant NA NA TCGA-A8-A07J-F40829 TCGA-A8-A07J NA NA Positive NA NA NA NA Positive Other NA NA NA NA -12965 NA NA 0 365 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO NA NA NA No M0 N1a T2 Stage IIB NA A07J TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 NA TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01 NA NA TCGA-A8-A07J-01 TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01A-11D-A00Y-05 TCGA-A8-A07J-01 NA TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 TCGA-A8-A07J-01 TCGA-A8-A07J-01A-11D-A011-01 NA TCGA-A8-A07J-01A-11R-A00Z-07 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 TCGA-A8-A07J-01A-11D-A011-01 TCGA-A8-A07J-01 |
|
|
200 |
TCGA-A8-A07L-01 Stage IIIA 58 4 Stage IIIA 517 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 517 0 LumB Luminal B Positive NA -10 -3 enrollment T_Other T3 LIVING 0 TCGA-A8-A07L-01 975 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 12 TCGA-A8-A07L 975 0 days 975 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant NA NA TCGA-A8-A07L-F40830 TCGA-A8-A07L TCGA-A8-A07L-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21428 394 NA 0 975 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 80 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T3 Stage IIIA TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf A07L TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 76cbecbe-22ef-479a-9306-2f09e1d87757 76cbecbe-22ef-479a-9306-2f09e1d87757 NA TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01 NA NA TCGA-A8-A07L-01 TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01A-11D-A00Y-05 TCGA-A8-A07L-01 NA TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01 76cbecbe-22ef-479a-9306-2f09e1d87757 TCGA-A8-A07L-01 TCGA-A8-A07L-01A-11D-A011-01 NA TCGA-A8-A07L-01A-11R-A040-07 76cbecbe-22ef-479a-9306-2f09e1d87757 TCGA-A8-A07L-01A-11D-A011-01 TCGA-A8-A07L-01 |
|
|
201 |
TCGA-A8-A07O-01 Stage IIA 51 1 Stage IIA 304 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 304 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-A8-A07O-01 304 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07O 304 0 days 304 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Outer Quadrant NA NA TCGA-A8-A07O-F40831 TCGA-A8-A07O TCGA-A8-A07O-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -18870 180 NA 0 304 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 220 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf A07O TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01A-21-A13B-20 TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01 NA d7dd9819-8523-4dff-8ffb-689d37a73368 TCGA-A8-A07O-01 TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01A-11D-A00Y-05 TCGA-A8-A07O-01 NA TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01 TCGA-A8-A07O-01A-11D-A011-01 NA TCGA-A8-A07O-01A-11R-A00Z-07 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01A-11D-A011-01 TCGA-A8-A07O-01 |
|
|
202 |
TCGA-A8-A07P-01 Stage IIB 68 4 Stage IIB 334 NA Positive FEMALE Positive 4 3 3 Negative M0 Positive N1 334 0 LumA Luminal A Positive LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A07P-01 334 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A07P NA NA days 334 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant NA NA TCGA-A8-A07P-F40832 TCGA-A8-A07P TCGA-A8-A07P-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24929 210 NA 0 334 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 120 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NA NA NA false No M0 N1 T2 Stage IIB TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf A07P TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01A-21-A13B-20 TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01 NA 00703e0f-8964-4b44-a5f3-d1246e5358ff TCGA-A8-A07P-01 TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01A-11D-A00Y-05 TCGA-A8-A07P-01 NA TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01 TCGA-A8-A07P-01A-11D-A011-01 NA TCGA-A8-A07P-01A-11R-A00Z-07 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01A-11D-A011-01 TCGA-A8-A07P-01 |
|
|
203 |
TCGA-A8-A07R-01 Stage IIIC 80 3 Stage IIIC 273 NA Negative FEMALE Equivocal 2 2 2 Negative M0 Positive N3 273 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-A8-A07R-01 273 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07R NA NA days 273 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Upper Outer Quadrant NA NA NA TCGA-A8-A07R NA NA Negative NA NA NA NA Negative Other NA NA NA NA -29251 NA NA 0 273 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Positive NA NA NA Positive NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NA NA NA NA No M0 N3a T2 Stage IIIC NA A07R NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01A-12-A13B-20 TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01 NA f547b351-f375-4f31-970f-40e006020b01 TCGA-A8-A07R-01 TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01A-21D-A032-05 TCGA-A8-A07R-01 NA TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01 TCGA-A8-A07R-01A-21D-A036-01 NA TCGA-A8-A07R-01A-21R-A034-07 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01A-21D-A036-01 TCGA-A8-A07R-01 |
|
|
204 |
TCGA-A8-A07S-01 Stage IIA 73 2 Stage IIA 242 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 242 0 LumB Luminal B Negative LumA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A07S-01 243 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 NA TCGA-A8-A07S 243 0 days 243 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Upper Outer Quadrant NA NA TCGA-A8-A07S-F40833 TCGA-A8-A07S TCGA-A8-A07S-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -26998 119 NA 0 243 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) lobular/ductal No NA C50.9 8522/3 C50.9 NA YES NA NA 220 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A.pdf A07S WITH TUMOR NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 15acd388-f958-4f43-bc38-39bab4cb830e 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01A-22-A13B-20 NA TCGA-A8-A07S-01 NA a86ad293-8480-4f2f-b3d2-6f59fa709d03 TCGA-A8-A07S-01 NA TCGA-A8-A07S-01A-11D-A032-05 TCGA-A8-A07S-01 NA NA TCGA-A8-A07S-01 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01 TCGA-A8-A07S-01A-11D-A036-01 NA TCGA-A8-A07S-01A-11R-A034-07 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01A-11D-A036-01 TCGA-A8-A07S-01 |
|
|
205 |
TCGA-A8-A07U-01 Stage IIIA 66 3 Stage IIIA 303 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N2 303 0 Basal Basal-like Positive NA -13 -12 enrollment T_Other T2 LIVING 0 TCGA-A8-A07U-01 760 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-A8-A07U 760 0 days 760 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant NA NA TCGA-A8-A07U-F40834 TCGA-A8-A07U TCGA-A8-A07U-01A NA Negative NA NA NA NA Positive Other NA NA NA NA -24411 210 NA 0 760 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO NA NA false No M0 N2a T2 Stage IIIA TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf A07U TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 77daa4a6-93c2-4455-a173-ead372d92010 77daa4a6-93c2-4455-a173-ead372d92010 NA TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01 NA NA TCGA-A8-A07U-01 TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01A-11D-A032-05 TCGA-A8-A07U-01 NA TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01 77daa4a6-93c2-4455-a173-ead372d92010 TCGA-A8-A07U-01 TCGA-A8-A07U-01A-11D-A036-01 NA TCGA-A8-A07U-01A-11R-A034-07 77daa4a6-93c2-4455-a173-ead372d92010 TCGA-A8-A07U-01A-11D-A036-01 TCGA-A8-A07U-01 |
|
|
206 |
TCGA-A8-A07W-01 Stage IV 76 3 Stage IV 304 NA Positive FEMALE Negative 1 1 4 Positive M1 Negative N0 304 0 LumB Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A07W-01 304 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07W NA NA days 304 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant NA NA TCGA-A8-A07W-F40835 TCGA-A8-A07W TCGA-A8-A07W-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -27942 180 NA 0 304 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 180 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false No M1 NX T2 Stage IV TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C.pdf A07W WITH TUMOR NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 03403807-a06f-4d79-ac2d-2d494d4fabee 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01A-21-A13A-20 TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01 NA e407dd09-754f-4167-b2cf-391893051541 TCGA-A8-A07W-01 TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01A-11D-A00Y-05 TCGA-A8-A07W-01 NA TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01 TCGA-A8-A07W-01A-11D-A011-01 NA TCGA-A8-A07W-01A-11R-A00Z-07 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01A-11D-A011-01 TCGA-A8-A07W-01 |
|
|
207 |
TCGA-A8-A07Z-01 Stage IIA 85 3 Stage IIA 853 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 853 0 NA Luminal B Positive LumA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A07Z-01 1371 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A07Z 1371 0 days 1371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 85 Left NA NA TCGA-A8-A07Z-F40836 TCGA-A8-A07Z NA NA Positive NA NA NA NA Positive Other NA NA NA NA -31351 NA NA 0 1371 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T2 Stage IIA NA A07Z TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2008 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01A-21-A13A-20 TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01 NA a0ca1a15-ed13-4ba7-9565-604073ec88a3 TCGA-A8-A07Z-01 TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01A-11D-A00Y-05 TCGA-A8-A07Z-01 NA TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01 TCGA-A8-A07Z-01A-11D-A011-01 NA TCGA-A8-A07Z-01A-11R-A00Z-07 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01A-11D-A011-01 TCGA-A8-A07Z-01 |
|
|
208 |
TCGA-A8-A081-01 Stage IIA 80 5 Stage IIA 0 NA Positive FEMALE Negative 1 1 1 Negative M0 Negative N0 0 0 LumB HER2-enriched Positive Her2 -2 -5 enrollment T_Other T2 LIVING NA TCGA-A8-A081-01 NA NA days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A8-A081 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right NA NA NA TCGA-A8-A081 TCGA-A8-A081-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -29555 637 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 150 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf A081 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 c88b614b-811e-42f9-86e3-10909ced98e7 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01A-21-A13A-20 TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01 NA 8392c9cd-b36d-4cb2-887b-8fa3c219d843 TCGA-A8-A081-01 TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01A-11D-A00Y-05 TCGA-A8-A081-01 NA TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01 TCGA-A8-A081-01A-11D-A011-01 NA TCGA-A8-A081-01A-11R-A00Z-07 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01A-11D-A011-01 TCGA-A8-A081-01 |
|
|
209 |
TCGA-A8-A082-01 Stage IIB 58 4 Stage IIB 549 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 549 0 LumB Luminal B Positive LumA -9 -3 enrollment T_Other T2 LIVING NA TCGA-A8-A082-01 NA NA days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A8-A082 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right NA NA TCGA-A8-A082-F40837 TCGA-A8-A082 TCGA-A8-A082-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21338 606 NA 0 -31 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 130 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf A082 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 2fd81438-46a2-42f5-910e-728faea3872a 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01A-21-A13A-20 TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01 NA a9d13722-7419-4250-a943-ccb78a486228 TCGA-A8-A082-01 TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01A-11D-A00Y-05 TCGA-A8-A082-01 NA TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01 TCGA-A8-A082-01A-11D-A011-01 NA TCGA-A8-A082-01A-11R-A00Z-07 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01A-11D-A011-01 TCGA-A8-A082-01 |
|
|
210 |
TCGA-A8-A083-01 Stage IIB 67 2 Stage IIB 0 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T3 LIVING NA TCGA-A8-A083-01 NA NA days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A083 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left NA NA NA TCGA-A8-A083 TCGA-A8-A083-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24746 575 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 300 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T3 Stage IIB TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf A083 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 72b7ab0e-81e0-4385-8125-5146243e21ac 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01A-11-A13A-20 TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01 NA 503f0e18-bc85-4950-bba1-b55d4c29760a TCGA-A8-A083-01 TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01A-21D-A00Y-05 TCGA-A8-A083-01 NA TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01 TCGA-A8-A083-01A-21D-A011-01 NA TCGA-A8-A083-01A-21R-A00Z-07 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01A-21D-A011-01 TCGA-A8-A083-01 |
|
|
211 |
TCGA-A8-A084-01 Stage IIB 81 1 No_Conversion 458 NA Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 458 0 LumB Luminal B Negative X -1 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A084-01 458 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A8-A084 NA NA days 458 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Left NA NA TCGA-A8-A084-F40838 TCGA-A8-A084 TCGA-A8-A084-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -29858 1033 NA 0 458 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA NA 270 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 3 NA NA NA NA NA NA NA NA NA NA false Yes M0 N1a T2 Stage IIB TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B.pdf A084 WITH TUMOR NA NA NA NA NA NO NA NA NA YES Primary Tumor 01 Surgical resection 5th NA NO YES A8 Breast A LIVING 2007 2f2fe990-f8f6-4904-b3d5-083e17a7a29d 2f2fe990-f8f6-4904-b3d5-083e17a7a29d TCGA-A8-A084-01A-11-A13A-20 TCGA-A8-A084-01A-21W-A019-09 TCGA-A8-A084-01 NA adfcebcc-edf7-4351-ba59-e1fea8580893 TCGA-A8-A084-01 TCGA-A8-A084-01A-21W-A019-09 TCGA-A8-A084-01A-21D-A00Y-05 TCGA-A8-A084-01 NA TCGA-A8-A084-01A-21W-A019-09 NA 2f2fe990-f8f6-4904-b3d5-083e17a7a29d NA TCGA-A8-A084-01A-21D-A011-01 NA TCGA-A8-A084-01A-21R-A00Z-07 2f2fe990-f8f6-4904-b3d5-083e17a7a29d TCGA-A8-A084-01A-21D-A011-01 TCGA-A8-A084-01 |
|
|
212 |
TCGA-A8-A085-01 Stage IIB 44 5 Stage IIB 1124 NA Positive MALE Negative 1 3 4 Negative M0 Positive N1 1124 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A085-01 1124 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A085 1124 0 days 1124 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left NA NA TCGA-A8-A085-F40839 TCGA-A8-A085 TCGA-A8-A085-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16377 788 NA 0 1124 NA NA NA NA NA NA NA NA NA 2013-3-2 MALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 130 NO Negative Negative NO NA Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf A085 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 4be8001c-c6a2-420c-8761-93469a6a7904 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01A-21-A13B-20 TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01 NA 96e8bae5-7cde-475e-b1ba-ec2ac2efeb6e TCGA-A8-A085-01 TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01A-11D-A00Y-05 TCGA-A8-A085-01 NA TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01 TCGA-A8-A085-01A-11D-A011-01 NA TCGA-A8-A085-01A-11R-A00Z-07 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01A-11D-A011-01 TCGA-A8-A085-01 |
|
|
213 |
TCGA-A8-A086-01 Stage IIA 59 5 Stage IIA 396 NA Positive FEMALE Negative 2 3 3 Negative M0 Positive N1 396 0 LumA Luminal A Positive LumA -9 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A086-01 396 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A8-A086 396 0 days 396 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right NA NA TCGA-A8-A086-F40840 TCGA-A8-A086 TCGA-A8-A086-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21731 272 NA 0 396 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 150 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO NA NA false No M0 N1a T1c Stage IIA TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf A086 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 7347a336-6248-47be-817b-88543164d564 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01A-21-A13B-20 TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01 NA faed055f-e054-4c59-953f-c118dd531f04 TCGA-A8-A086-01 TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01A-11D-A00Y-05 TCGA-A8-A086-01 NA TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01 TCGA-A8-A086-01A-11D-A011-01 NA TCGA-A8-A086-01A-11R-A00Z-07 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01A-11D-A011-01 TCGA-A8-A086-01 |
|
|
214 |
TCGA-A8-A08A-01 Stage I 89 2 Stage I 30 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 30 0 NA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A08A-01 30 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A08A NA NA days 30 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 89 Left Upper Inner Quadrant NA NA NA TCGA-A8-A08A TCGA-A8-A08A-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -32750 1033 NA 0 30 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 160 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T1c Stage I TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6.pdf A08A TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2007 bf92b8cc-9a5c-4e96-917c-c264fe588f8d bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01A-21-A13A-20 TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01 NA 80af2202-8a16-4cb7-8556-5ff94a042038 TCGA-A8-A08A-01 TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01A-11D-A00Y-05 TCGA-A8-A08A-01 NA TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01 bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01 TCGA-A8-A08A-01A-11D-A011-01 NA TCGA-A8-A08A-01A-11R-A00Z-07 bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01A-11D-A011-01 TCGA-A8-A08A-01 |
|
|
215 |
TCGA-A8-A08B-01 Stage IIA 52 3 Stage IIA 702 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 702 0 Her2 HER2-enriched Negative NA -1 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A08B-01 1156 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 7 mutation cluster 4 TCGA-A8-A08B 1156 0 days 1156 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Inner Quadrant NA NA TCGA-A8-A08B-F40841 TCGA-A8-A08B TCGA-A8-A08B-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -19114 759 NA 0 1156 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Positive Positive NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf A08B TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 0307bd0b-b59a-4996-b89d-612e72652890 0307bd0b-b59a-4996-b89d-612e72652890 NA TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01 NA NA TCGA-A8-A08B-01 TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01A-11D-A00Y-05 TCGA-A8-A08B-01 NA TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01 0307bd0b-b59a-4996-b89d-612e72652890 TCGA-A8-A08B-01 TCGA-A8-A08B-01A-11D-A011-01 NA TCGA-A8-A08B-01A-11R-A00Z-07 0307bd0b-b59a-4996-b89d-612e72652890 TCGA-A8-A08B-01A-11D-A011-01 TCGA-A8-A08B-01 |
|
|
216 |
TCGA-A8-A08C-01 Stage IIA 65 2 Stage IIA 607 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 607 0 LumA Luminal A Positive NA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A08C-01 881 0 days BRCA-LUAD+ NA cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 NA NA NA TCGA-A8-A08C 881 0 days 881 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Inner Quadrant NA NA TCGA-A8-A08C-F40842 TCGA-A8-A08C TCGA-A8-A08C-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24017 484 NA 0 881 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 110 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06.pdf A08C TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a NA NA TCGA-A8-A08C-01 NA NA TCGA-A8-A08C-01 TCGA-A8-A08C-01A-11W-A019-09 TCGA-A8-A08C-01A-11D-A00Y-05 TCGA-A8-A08C-01 NA TCGA-A8-A08C-01A-11W-A019-09 NA 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a NA TCGA-A8-A08C-01A-11D-A011-01 NA TCGA-A8-A08C-01A-11R-A00Z-07 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a TCGA-A8-A08C-01A-11D-A011-01 TCGA-A8-A08C-01 |
|
|
217 |
TCGA-A8-A08F-01 Stage IIIC 59 4 Stage IIIC 549 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 549 0 LumB Luminal B Positive NA -2 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A08F-01 1004 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-A8-A08F 1004 0 days 1004 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Inner Quadrant NA NA TCGA-A8-A08F-F40843 TCGA-A8-A08F TCGA-A8-A08F-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21641 637 NA 0 1004 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO NA NA false Yes M0 N3a T2 Stage IIIC TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647.pdf A08F TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 523e45c2-4f98-4010-b48e-bdbda62865cf 523e45c2-4f98-4010-b48e-bdbda62865cf NA TCGA-A8-A08F-01A-11W-A019-09 TCGA-A8-A08F-01 NA NA TCGA-A8-A08F-01 TCGA-A8-A08F-01A-11W-A019-09 TCGA-A8-A08F-01A-11D-A00Y-05 TCGA-A8-A08F-01 NA TCGA-A8-A08F-01A-11W-A019-09 NA 523e45c2-4f98-4010-b48e-bdbda62865cf NA TCGA-A8-A08F-01A-11D-A011-01 NA TCGA-A8-A08F-01A-11R-A00Z-07 523e45c2-4f98-4010-b48e-bdbda62865cf TCGA-A8-A08F-01A-11D-A011-01 TCGA-A8-A08F-01 |
|
|
218 |
TCGA-A8-A08G-01 Stage IIA 41 3 Stage IIA 606 NA Positive FEMALE Positive 3 3 4 Negative M0 Negative N0 606 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A08G-01 607 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A08G 607 0 days 607 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Inner Quadrant NA NA TCGA-A8-A08G-F40844 TCGA-A8-A08G TCGA-A8-A08G-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -14976 422 NA 0 607 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 180 NO Positive Positive NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf A08G TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 0584b467-a0f7-45fd-9948-9a01318d34bd 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01A-21-A13B-20 TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01 NA df81dd47-6e43-495c-ad4a-e3347a9d233e TCGA-A8-A08G-01 TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01A-11D-A00Y-05 TCGA-A8-A08G-01 NA TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01 TCGA-A8-A08G-01A-11D-A011-01 NA TCGA-A8-A08G-01A-11R-A00Z-07 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01A-11D-A011-01 TCGA-A8-A08G-01 |
|
|
219 |
TCGA-A8-A08H-01 Stage IIA 66 1 Stage IIA 0 NA Positive FEMALE Positive 1 4 3 Negative M0 Negative N0 0 0 Normal Basal-like Positive ReacI -5 -8 enrollment T_Other T2 LIVING NA TCGA-A8-A08H-01 NA NA days Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A08H NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Inner Quadrant NA NA NA TCGA-A8-A08H TCGA-A8-A08H-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24137 1184 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 250 NO Positive Positive NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf A08H TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2007 9c5eb452-caec-4a9a-9ced-215be92c91d2 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01A-11-A13B-20 TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01 NA 1ff81e2a-4af2-471e-805a-073a952b5b0e TCGA-A8-A08H-01 TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01A-21D-A00Y-05 TCGA-A8-A08H-01 NA TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01 TCGA-A8-A08H-01A-21D-A011-01 NA TCGA-A8-A08H-01A-21R-A00Z-07 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01A-21D-A011-01 TCGA-A8-A08H-01 |
|
|
220 |
TCGA-A8-A08I-01 Stage IIA 53 4 Stage IIA 365 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 365 0 LumB Luminal B Positive NA -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A08I-01 365 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A08I 365 0 days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Inner Quadrant NA NA TCGA-A8-A08I-F40845 TCGA-A8-A08I TCGA-A8-A08I-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -19389 241 NA 0 365 NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 80 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf A08I TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 3e853cb1-4747-4f98-be64-d5de7fba801e 3e853cb1-4747-4f98-be64-d5de7fba801e NA TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01 NA NA TCGA-A8-A08I-01 TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01A-11D-A00Y-05 TCGA-A8-A08I-01 NA TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01 3e853cb1-4747-4f98-be64-d5de7fba801e TCGA-A8-A08I-01 TCGA-A8-A08I-01A-11D-A011-01 NA TCGA-A8-A08I-01A-11R-A00Z-07 3e853cb1-4747-4f98-be64-d5de7fba801e TCGA-A8-A08I-01A-11D-A011-01 TCGA-A8-A08I-01 |
|
|
221 |
TCGA-A8-A08J-01 Stage IV 52 5 Stage IV 1127 1127 Positive FEMALE Negative 1 1 1 Positive M1 Positive N3 1127 1 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T4 DECEASED 1 TCGA-A8-A08J-01 1127 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-A8-A08J NA NA days 1127 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right NA NA TCGA-A8-A08J-F40846 TCGA-A8-A08J TCGA-A8-A08J-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -19266 1733 1127 0 NA NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8541/3 C50.9 NA YES NA NA 630 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false No M1 N3 T4b Stage IV TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0.pdf A08J WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2005 67e019fc-65c4-4274-a0f7-5a92f0f87bba 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01A-21-A13A-20 TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01 NA c8144900-30dc-4081-882a-4dc863120a39 TCGA-A8-A08J-01 TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01A-11D-A00Y-05 TCGA-A8-A08J-01 NA TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01 TCGA-A8-A08J-01A-11D-A011-01 NA TCGA-A8-A08J-01A-11R-A00Z-07 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01A-11D-A011-01 TCGA-A8-A08J-01 |
|
|
222 |
TCGA-A8-A08L-01 Stage IIIA 89 1 Stage IIIA 304 304 Positive FEMALE Negative 5 2 1 Negative M0 Positive N2 304 1 Her2 HER2-enriched Negative X -2 -6 enrollment T_Other T3 DECEASED 1 TCGA-A8-A08L-01 304 1 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 1 TCGA-A8-A08L NA NA days 304 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 89 Left NA NA TCGA-A8-A08L-F40847 TCGA-A8-A08L TCGA-A8-A08L-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -32842 698 304 0 NA NA NA NA NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 200 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NA NA NA false No M0 N2a T3 Stage IIIA TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf A08L TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2008 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01A-21-A13A-20 TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01 NA 7a837782-6edf-48bb-83db-40548ddd2b69 TCGA-A8-A08L-01 TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01A-11D-A00Y-05 TCGA-A8-A08L-01 NA TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01 TCGA-A8-A08L-01A-11D-A011-01 NA TCGA-A8-A08L-01A-11R-A00Z-07 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01A-11D-A011-01 TCGA-A8-A08L-01 |
|
|
223 |
TCGA-A8-A08O-01 Stage IV 45 2 Stage IV 942 NA Positive FEMALE Negative 3 4 3 Positive M1 Positive N3 942 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING 0 TCGA-A8-A08O-01 943 0 days COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-A8-A08O 762 1 days 943 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right NA NA TCGA-A8-A08O-F40848 TCGA-A8-A08O NA NA Positive NA NA NA NA Positive Other NA NA NA NA -16681 NA NA 0 943 NA NA 762 NA NA NA NA NA NA 2013-3-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA YES NA NA NA No M1 N3a T2 Stage IV NA A08O WITH TUMOR NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2008 f71db767-ac59-49c8-b6a9-50bf20767ddc f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01A-11-A13A-20 TCGA-A8-A08O-01A-21W-A071-09 TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21D-A10P-05 b661ea2e-2f24-44b9-b8ed-30f38223b85c TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21W-A071-09 NA TCGA-A8-A08O-01 NA TCGA-A8-A08O-01A-21W-A071-09 TCGA-A8-A08O-01 f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21D-A059-01 NA TCGA-A8-A08O-01A-21R-A056-07 f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01A-21D-A059-01 TCGA-A8-A08O-01 |
|
|
224 |
TCGA-A8-A08P-01 Stage IIIA 70 3 Stage IIIA 942 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N2 942 0 LumB Luminal B Positive ReacII -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A08P-01 943 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 3 TCGA-A8-A08P 943 0 days 943 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right NA NA TCGA-A8-A08P-F40561 TCGA-A8-A08P TCGA-A8-A08P-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25598 819 NA 0 943 NA NA NA NA NA NA NA NA NA 2013-2-24 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 210 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA false No M0 N2a T2 Stage IIIA TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1.pdf A08P TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 f8dbf3ce-7c30-4e62-a25f-d98843794672 f8dbf3ce-7c30-4e62-a25f-d98843794672 TCGA-A8-A08P-01A-21-A13A-20 TCGA-A8-A08P-01A-11W-A019-09 TCGA-A8-A08P-01 NA 4e6516f3-1962-4f3e-99a4-e086891381c1 TCGA-A8-A08P-01 TCGA-A8-A08P-01A-11W-A019-09 TCGA-A8-A08P-01A-11D-A00Y-05 TCGA-A8-A08P-01 NA TCGA-A8-A08P-01A-11W-A019-09 NA f8dbf3ce-7c30-4e62-a25f-d98843794672 NA TCGA-A8-A08P-01A-11D-A011-01 NA TCGA-A8-A08P-01A-11R-A00Z-07 f8dbf3ce-7c30-4e62-a25f-d98843794672 TCGA-A8-A08P-01A-11D-A011-01 TCGA-A8-A08P-01 |
|
|
225 |
TCGA-A8-A08R-01 Stage IIB 52 4 Stage IIB 30 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 30 0 Basal Basal-like Negative NA -13 -12 enrollment T_Other T2 LIVING 0 TCGA-A8-A08R-01 30 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A8-A08R NA NA days 30 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left NA NA NA TCGA-A8-A08R TCGA-A8-A08R-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -19298 728 NA 0 30 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 90 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NA NA NA false No M0 N1a T2 Stage IIB TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf A08R TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 3a1d8959-f829-4b8a-a65f-70a51845f118 3a1d8959-f829-4b8a-a65f-70a51845f118 NA TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01 NA NA TCGA-A8-A08R-01 TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01A-11D-A032-05 TCGA-A8-A08R-01 NA TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01 3a1d8959-f829-4b8a-a65f-70a51845f118 TCGA-A8-A08R-01 TCGA-A8-A08R-01A-11D-A036-01 NA TCGA-A8-A08R-01A-11R-A034-07 3a1d8959-f829-4b8a-a65f-70a51845f118 TCGA-A8-A08R-01A-11D-A036-01 TCGA-A8-A08R-01 |
|
|
226 |
TCGA-A8-A08S-01 Stage IIA 71 NA Stage IIA 580 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 580 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-A8-A08S-01 1004 0 days Squamous C3-BRCA/Luminal NA BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-A8-A08S 1004 0 days 1004 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left NA NA TCGA-A8-A08S-F40560 TCGA-A8-A08S TCGA-A8-A08S-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25994 637 NA 0 1004 NA NA NA NA NA NA NA NA NA 2013-2-24 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA NA 80 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false Yes M0 N1 T1c Stage IIA TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf A08S TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical resection 6th NA NO YES A8 Breast A LIVING 2008 667c209e-9b4a-474d-8f69-102cfaffddf2 667c209e-9b4a-474d-8f69-102cfaffddf2 NA TCGA-A8-A08S-01A-11W-A050-09 TCGA-A8-A08S-01 NA NA TCGA-A8-A08S-01 TCGA-A8-A08S-01A-11W-A050-09 TCGA-A8-A08S-01A-11D-A032-05 TCGA-A8-A08S-01 NA TCGA-A8-A08S-01A-11W-A050-09 NA 667c209e-9b4a-474d-8f69-102cfaffddf2 NA TCGA-A8-A08S-01A-11D-A036-01 NA TCGA-A8-A08S-01A-11R-A034-07 667c209e-9b4a-474d-8f69-102cfaffddf2 TCGA-A8-A08S-01A-11D-A036-01 TCGA-A8-A08S-01 |
|
|
227 |
TCGA-A8-A08T-01 Stage IV 64 4 Stage IV 2830 NA Positive FEMALE Negative 1 3 3 Positive M1 Positive N1 2830 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T2 LIVING 1 TCGA-A8-A08T-01 3409 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A08T 2557 1 days 3409 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right NA NA TCGA-A8-A08T-F40559 TCGA-A8-A08T TCGA-A8-A08T-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23560 2767 3409 0 2830 NA NA 2557 NA NA NA NA NA NA 2013-2-24 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 190 NO Positive Positive NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA YES NA NA false No M1 N1a T2 Stage IV TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A.pdf A08T WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2002 ed6ebb15-1401-49e0-be9a-e1391e84b374 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01A-11-A13A-20 TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01 NA 68cba786-7b1c-4e7c-863b-19a037b1d07e TCGA-A8-A08T-01 TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01A-21D-A00Y-05 TCGA-A8-A08T-01 NA TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01 TCGA-A8-A08T-01A-21D-A011-01 NA TCGA-A8-A08T-01A-21R-A00Z-07 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01A-21D-A011-01 TCGA-A8-A08T-01 |
|
|
228 |
TCGA-A8-A08X-01 Stage IIIC 43 3 Stage IIIC 1034 NA Negative FEMALE Positive 2 2 1 Negative M0 Positive N3 1034 0 Her2 HER2-enriched Negative Her2 -13 -10 enrollment T_Other T4 LIVING 0 TCGA-A8-A08X-01 1308 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A08X 366 1 days 1308 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left NA NA TCGA-A8-A08X-F40558 TCGA-A8-A08X TCGA-A8-A08X-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -15705 941 NA 0 1308 NA NA 366 NA NA NA NA NA NA 2013-2-24 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 170 NO Positive Positive NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA YES NA NA false No M0 N3a T4d Stage IIIC TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf A08X TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2007 354adce5-6ca4-4d6d-a519-4eabc01c6b36 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01A-11-A13B-20 TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01 NA 3fd8c428-08bb-4598-b3cb-0c4a33fc4eab TCGA-A8-A08X-01 TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01A-21D-A00Y-05 TCGA-A8-A08X-01 NA TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01 TCGA-A8-A08X-01A-21D-A011-01 NA TCGA-A8-A08X-01A-21R-A00Z-07 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01A-21D-A011-01 TCGA-A8-A08X-01 |
|
|
229 |
TCGA-A8-A08Z-01 Stage IIIB 76 2 Stage IIIC 1217 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N3 1217 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T4 LIVING 0 TCGA-A8-A08Z-01 1217 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A08Z NA NA days 1217 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left NA NA NA TCGA-A8-A08Z TCGA-A8-A08Z-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -28003 2036 NA 0 1217 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 350 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA NA NA false No M0 N3a T4b [Discrepancy] TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf A08Z TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2004 1462b0a9-6467-4977-aea7-006ea3f5109e 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01A-11-A13B-20 TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01 NA 8f5042d5-cb01-4d32-a80e-f1e3c161ab78 TCGA-A8-A08Z-01 TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01A-21D-A00Y-05 TCGA-A8-A08Z-01 NA TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01 TCGA-A8-A08Z-01A-21D-A011-01 NA TCGA-A8-A08Z-01A-21R-A00Z-07 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01A-21D-A011-01 TCGA-A8-A08Z-01 |
|
|
230 |
TCGA-A8-A090-01 Stage IIA 74 4 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA Luminal A Positive NA 0 -3 enrollment T_Other T2 LIVING NA TCGA-A8-A090-01 NA NA days COAD-READ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A090 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Right NA NA NA TCGA-A8-A090 TCGA-A8-A090-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -27121 667 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 110 NO Positive Positive NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf A090 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 752efa27-8d87-4007-9dc5-baef53b37a87 752efa27-8d87-4007-9dc5-baef53b37a87 NA TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01 NA NA TCGA-A8-A090-01 TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01A-11D-A00Y-05 TCGA-A8-A090-01 NA TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01 752efa27-8d87-4007-9dc5-baef53b37a87 TCGA-A8-A090-01 TCGA-A8-A090-01A-11D-A011-01 NA TCGA-A8-A090-01A-11R-A00Z-07 752efa27-8d87-4007-9dc5-baef53b37a87 TCGA-A8-A090-01A-11D-A011-01 TCGA-A8-A090-01 |
|
|
231 |
TCGA-A8-A091-01 Stage IIA 61 4 Stage IIA 580 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 580 0 LumA Luminal A Negative LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A091-01 1004 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A091 243 1 days 1004 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right NA NA TCGA-A8-A091-F40557 TCGA-A8-A091 TCGA-A8-A091-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -22554 637 NA 0 1004 NA NA 243 NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 180 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA YES NA NA false Yes M0 N0 T2 Stage IIA TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf A091 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 e43cb8f2-6541-4d55-b11c-8288dcf3b78f e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01A-21-A13B-20 TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01 NA 30426ea5-f884-4216-9435-4ba810f8687e TCGA-A8-A091-01 TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01A-11D-A00Y-05 TCGA-A8-A091-01 NA TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01 e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01 TCGA-A8-A091-01A-11D-A011-01 NA TCGA-A8-A091-01A-11R-A00Z-07 e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01A-11D-A011-01 TCGA-A8-A091-01 |
|
|
232 |
TCGA-A8-A092-01 Stage IIIA 48 2 Stage IIIA 518 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 518 0 LumB HER2-enriched Positive NA -2 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A092-01 942 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A8-A092 942 0 days 942 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left NA NA TCGA-A8-A092-F40556 TCGA-A8-A092 TCGA-A8-A092-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -17807 575 NA 0 942 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA false No M0 N2a T2 Stage IIIA TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf A092 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 98b2b18a-004d-459c-8aba-499d06897910 98b2b18a-004d-459c-8aba-499d06897910 NA TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01 NA NA TCGA-A8-A092-01 TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01A-11D-A00Y-05 TCGA-A8-A092-01 NA TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01 98b2b18a-004d-459c-8aba-499d06897910 TCGA-A8-A092-01 TCGA-A8-A092-01A-11D-A011-01 NA TCGA-A8-A092-01A-11R-A00Z-07 98b2b18a-004d-459c-8aba-499d06897910 TCGA-A8-A092-01A-11D-A011-01 TCGA-A8-A092-01 |
|
|
233 |
TCGA-A8-A093-01 Stage IIA 61 3 Stage IIA 545 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 545 0 LumA Luminal A Positive NA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A093-01 546 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 2 mutation cluster 4 TCGA-A8-A093 546 0 days 546 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right NA NA TCGA-A8-A093-F40555 TCGA-A8-A093 TCGA-A8-A093-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -22373 422 NA 0 546 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO NA NA false Yes M0 N0 T2 Stage IIA TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf A093 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical resection 6th NA NO YES A8 Breast A LIVING 2009 54d372bf-07c8-4525-a081-ff26c28aff39 54d372bf-07c8-4525-a081-ff26c28aff39 NA TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01 NA NA TCGA-A8-A093-01 TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01A-11D-A00Y-05 TCGA-A8-A093-01 NA TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01 54d372bf-07c8-4525-a081-ff26c28aff39 TCGA-A8-A093-01 TCGA-A8-A093-01A-11D-A011-01 NA TCGA-A8-A093-01A-11R-A00Z-07 54d372bf-07c8-4525-a081-ff26c28aff39 TCGA-A8-A093-01A-11D-A011-01 TCGA-A8-A093-01 |
|
|
234 |
TCGA-A8-A094-01 Stage IIA 75 1 Stage IIA 0 NA Positive FEMALE Negative 2 2 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Negative Basal -11 -5 enrollment T_Other T2 LIVING NA TCGA-A8-A094-01 NA NA days Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 6 TCGA-A8-A094 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left NA NA NA TCGA-A8-A094 TCGA-A8-A094-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -27729 363 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 400 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf A094 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 877adc79-0651-4140-bb6a-876162733bf3 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01A-21-A13B-20 TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01 NA c7af042d-07e1-40fd-878d-a91d31397bb6 TCGA-A8-A094-01 TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01A-11D-A00Y-05 TCGA-A8-A094-01 NA TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01 TCGA-A8-A094-01A-11D-A011-01 NA TCGA-A8-A094-01A-11R-A00Z-07 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01A-11D-A011-01 TCGA-A8-A094-01 |
|
|
235 |
TCGA-A8-A095-01 Stage I 45 3 Stage I 1276 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1276 0 LumB Luminal B Positive ReacII -7 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A095-01 1277 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A095 1277 0 days 1277 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left NA NA TCGA-A8-A095-F40554 TCGA-A8-A095 TCGA-A8-A095-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16742 1153 NA 0 1277 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 160 NO Negative Negative NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T1c Stage I TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf A095 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2007 c943873c-e153-42bc-a8de-e1080b252e81 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01A-21-A13B-20 TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01 NA 61dbc912-9edf-4635-926c-e9ae57c40b67 TCGA-A8-A095-01 TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01A-11D-A00Y-05 TCGA-A8-A095-01 NA TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01 TCGA-A8-A095-01A-11D-A011-01 NA TCGA-A8-A095-01A-11R-A00Z-07 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01A-11D-A011-01 TCGA-A8-A095-01 |
|
|
236 |
TCGA-A8-A096-01 Stage IIA 73 2 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB Luminal B Positive NA -12 -4 enrollment T_Other T2 LIVING NA TCGA-A8-A096-01 NA NA days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A096 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right NA NA NA TCGA-A8-A096 TCGA-A8-A096-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26723 394 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 110 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf A096 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 7bf79330-52fa-4111-88fe-b3ea62bcc63a 7bf79330-52fa-4111-88fe-b3ea62bcc63a NA TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01 NA NA TCGA-A8-A096-01 TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01A-11D-A00Y-05 TCGA-A8-A096-01 NA TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01 7bf79330-52fa-4111-88fe-b3ea62bcc63a TCGA-A8-A096-01 TCGA-A8-A096-01A-11D-A011-01 NA TCGA-A8-A096-01A-11R-A00Z-07 7bf79330-52fa-4111-88fe-b3ea62bcc63a TCGA-A8-A096-01A-11D-A011-01 TCGA-A8-A096-01 |
|
|
237 |
TCGA-A8-A097-01 Stage IIB 65 5 Stage IIB 365 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 365 0 LumA Luminal B Positive NA 0 -2 enrollment T_Other T2 LIVING 0 TCGA-A8-A097-01 365 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A097 365 0 days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left NA NA TCGA-A8-A097-F40553 TCGA-A8-A097 TCGA-A8-A097-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23741 241 NA 0 365 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA false No M0 N1 T2 Stage IIB TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf A097 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 1873a785-0f15-40ef-a7c9-1799ab482338 1873a785-0f15-40ef-a7c9-1799ab482338 NA TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01 NA NA TCGA-A8-A097-01 TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01A-11D-A032-05 TCGA-A8-A097-01 NA TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01 1873a785-0f15-40ef-a7c9-1799ab482338 TCGA-A8-A097-01 TCGA-A8-A097-01A-11D-A036-01 NA TCGA-A8-A097-01A-11R-A034-07 1873a785-0f15-40ef-a7c9-1799ab482338 TCGA-A8-A097-01A-11D-A036-01 TCGA-A8-A097-01 |
|
|
238 |
TCGA-A8-A099-01 Stage X 76 2 Stage IIIC 304 NA Positive FEMALE Positive 4 3 3 Negative M0 Positive N3 304 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T4 LIVING 0 TCGA-A8-A099-01 304 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A099 304 0 days 304 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Right NA NA TCGA-A8-A099-F40552 TCGA-A8-A099 TCGA-A8-A099-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -28063 180 NA 0 304 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 210 NO Positive Positive NO NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO NA NA false No MX N3a T4b Stage X TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07.pdf A099 NA NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01A-21-A13B-20 TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01 NA 6e221e0d-416e-420d-a798-9afde72b03fb TCGA-A8-A099-01 TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01A-11D-A00Y-05 TCGA-A8-A099-01 NA TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01 TCGA-A8-A099-01A-11D-A011-01 NA TCGA-A8-A099-01A-11R-A00Z-07 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01A-11D-A011-01 TCGA-A8-A099-01 |
|
|
239 |
TCGA-A8-A09A-01 Stage X 40 4 Stage IIA 304 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 304 0 LumA Luminal A Positive LumA -3 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09A-01 304 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation c1uster 10 TCGA-A8-A09A NA NA days 304 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left NA NA TCGA-A8-A09A-F40551 TCGA-A8-A09A TCGA-A8-A09A-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -14883 180 NA 0 304 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 170 NO Negative Negative NO NA Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false No M0 NX T2 Stage X TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF.pdf A09A WITH TUMOR NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 7b1992b8-781d-49cc-a600-4bee56bcf1b5 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01A-21-A13B-20 TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01 NA 5e5a89f5-a778-4893-9d17-38c946016d53 TCGA-A8-A09A-01 TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01A-11D-A00Y-05 TCGA-A8-A09A-01 NA TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01 TCGA-A8-A09A-01A-11D-A011-01 NA TCGA-A8-A09A-01A-11R-A00Z-07 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01A-11D-A011-01 TCGA-A8-A09A-01 |
|
|
240 |
TCGA-A8-A09B-01 Stage IIIB 58 4 Stage IIIB 365 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 365 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T4 LIVING 0 TCGA-A8-A09B-01 365 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A09B NA NA days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left NA NA TCGA-A8-A09B-F40550 TCGA-A8-A09B NA NA Positive NA NA NA NA Positive Other NA NA NA NA -21520 NA NA 0 365 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA NA No M0 N1a T4b Stage IIIB NA A09B TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 df95b9f5-437f-438d-89b4-7c556e79b616 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01A-21-A13B-20 TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01 NA cc046686-7a84-4a71-8b94-70b2ec82c616 TCGA-A8-A09B-01 TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01A-11D-A00Y-05 TCGA-A8-A09B-01 NA TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01 TCGA-A8-A09B-01A-11D-A011-01 NA TCGA-A8-A09B-01A-11R-A00Z-07 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01A-11D-A011-01 TCGA-A8-A09B-01 |
|
|
241 |
TCGA-A8-A09C-01 Stage X 69 4 Stage IIA 31 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 31 0 LumB Luminal B Positive LumA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09C-01 31 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A09C NA NA days 31 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right NA NA NA TCGA-A8-A09C TCGA-A8-A09C-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25355 180 NA 0 31 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 120 NO Negative Negative NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA NA NA false Yes MX N0 T2 Stage X TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66.pdf A09C NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical resection 6th NA NO YES A8 Breast A LIVING 2009 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01A-21-A13A-20 TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01 NA 9012f763-2482-415b-9d86-fdabde299719 TCGA-A8-A09C-01 TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01A-11D-A00Y-05 TCGA-A8-A09C-01 NA TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01 TCGA-A8-A09C-01A-11D-A011-01 NA TCGA-A8-A09C-01A-11R-A00Z-07 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01A-11D-A011-01 TCGA-A8-A09C-01 |
|
|
242 |
TCGA-A8-A09D-01 Stage IIB 47 5 No_Conversion 396 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 396 0 LumA Luminal B Positive NA -3 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09D-01 1522 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A09D 1522 0 days 1522 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Lower Outer Quadrant NA NA TCGA-A8-A09D-F40549 TCGA-A8-A09D NA NA Positive NA NA NA NA Positive Other NA NA NA NA -17440 NA NA 0 1522 NA NA NA NA NA NA NA NA NA 2013-2-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 1 NA NA NA NA NA NA NA NO NA NA NA No M0 N1 T2 Stage IIB NA A09D TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast NA LIVING 2007 f2563687-e055-41a8-8436-614fbad762d4 f2563687-e055-41a8-8436-614fbad762d4 NA TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01 NA NA TCGA-A8-A09D-01 TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01A-11D-A00Y-05 TCGA-A8-A09D-01 NA TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01 f2563687-e055-41a8-8436-614fbad762d4 TCGA-A8-A09D-01 TCGA-A8-A09D-01A-11D-A011-01 NA TCGA-A8-A09D-01A-11R-A00Z-07 f2563687-e055-41a8-8436-614fbad762d4 TCGA-A8-A09D-01A-11D-A011-01 TCGA-A8-A09D-01 |
|
|
243 |
TCGA-A8-A09E-01 Stage IIIB 73 NA Stage IIIB 942 NA Positive FEMALE Equivocal NA NA NA Negative M0 Positive N1 942 0 NA NA Positive NA NA NA enrollment T_Other T4 LIVING 0 TCGA-A8-A09E-01 1492 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 14 NA mutation c1uster 9 TCGA-A8-A09E 1492 0 days 1492 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Lower Outer Quadrant NA NA TCGA-A8-A09E-F40334 TCGA-A8-A09E TCGA-A8-A09E-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26724 819 NA 0 1492 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA NA 220 NO Positive Positive NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false Yes M0 N1a T4b Stage IIIB TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03.pdf A09E WITH TUMOR NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical resection 6th NA NO YES A8 Breast A LIVING 2008 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd TCGA-A8-A09E-01A-21-A13A-20 TCGA-A8-A09E-01A-11W-A019-09 TCGA-A8-A09E-01 NA f0bc5acd-5e59-47c9-b2a6-8f47508a9ec6 TCGA-A8-A09E-01 TCGA-A8-A09E-01A-11W-A019-09 TCGA-A8-A09E-01A-11D-A00Y-05 TCGA-A8-A09E-01 NA TCGA-A8-A09E-01A-11W-A019-09 NA 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd NA TCGA-A8-A09E-01A-11D-A011-01 NA TCGA-A8-A09E-01A-11R-A00Z-07 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd TCGA-A8-A09E-01A-11D-A011-01 TCGA-A8-A09E-01 |
|
|
244 |
TCGA-A8-A09G-01 Stage IIIC 79 2 Stage IIIC 0 NA Positive FEMALE Positive 3 2 1 Negative M0 Positive N3 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T3 LIVING NA TCGA-A8-A09G-01 NA NA days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A8-A09G NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Lower Outer Quadrant NA NA NA TCGA-A8-A09G TCGA-A8-A09G-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -29006 759 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 270 NO Positive Positive NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NA NA NA false No M0 N3a T3 Stage IIIC TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf A09G TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 31757dda-12d6-4f35-87f1-d00464f2815b 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01A-11-A13A-20 TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01 NA 8390a7e5-0373-43e2-adc0-8f6fbdc665d1 TCGA-A8-A09G-01 TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01A-21D-A00Y-05 TCGA-A8-A09G-01 NA TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01 TCGA-A8-A09G-01A-21D-A011-01 NA TCGA-A8-A09G-01A-21R-A00Z-07 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01A-21D-A011-01 TCGA-A8-A09G-01 |
|
|
245 |
TCGA-A8-A09I-01 Stage IIA 84 5 Stage IIA 1006 NA Positive FEMALE Positive 1 1 4 Negative M0 Negative N0 1006 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A09I-01 1371 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A09I 1371 0 days 1371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right Lower Outer Quadrant NA NA TCGA-A8-A09I-F40333 TCGA-A8-A09I TCGA-A8-A09I-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -30711 698 NA 0 1371 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 430 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO NA NA false Yes M0 N0 T2 Stage IIA TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf A09I TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 433b49ba-949b-4914-985a-be19b3b32502 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01A-11-A13A-20 TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01 NA 93a8128c-9314-44b7-8737-0c5b08c057f4 TCGA-A8-A09I-01 TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01A-22D-A032-05 TCGA-A8-A09I-01 NA TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01 TCGA-A8-A09I-01A-22D-A036-01 NA TCGA-A8-A09I-01A-22R-A034-07 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01A-22D-A036-01 TCGA-A8-A09I-01 |
|
|
246 |
TCGA-A8-A09K-01 Stage IIA 68 NA Stage IIA 911 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 911 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-A8-A09K-01 912 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation c1uster 9 TCGA-A8-A09K 912 0 days 912 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Lower Outer Quadrant NA NA TCGA-A8-A09K-F40332 TCGA-A8-A09K TCGA-A8-A09K-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24960 788 NA 0 912 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA NA 240 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false Yes M0 N1 T1c Stage IIA TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf A09K TUMOR FREE NA NA NA NA NA NO NA NA NA NO Primary Tumor 01 Surgical resection 6th NA NO YES A8 Breast A LIVING 2008 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 TCGA-A8-A09K-01A-21-A13A-20 TCGA-A8-A09K-01A-11W-A019-09 TCGA-A8-A09K-01 NA 795da071-d853-421e-85e3-902a7e1af1eb TCGA-A8-A09K-01 TCGA-A8-A09K-01A-11W-A019-09 TCGA-A8-A09K-01A-11D-A00Y-05 TCGA-A8-A09K-01 NA TCGA-A8-A09K-01A-11W-A019-09 NA 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 NA TCGA-A8-A09K-01A-11D-A011-01 NA TCGA-A8-A09K-01A-11R-A00Z-07 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 TCGA-A8-A09K-01A-11D-A011-01 TCGA-A8-A09K-01 |
|
|
247 |
TCGA-A8-A09M-01 Stage IIIC 75 5 Stage IIIC 457 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N3 457 0 LumB Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A09M-01 1006 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation c1uster 10 TCGA-A8-A09M 1006 0 days 1006 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Lower Outer Quadrant NA NA TCGA-A8-A09M-F40331 TCGA-A8-A09M TCGA-A8-A09M-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -27455 333 NA 0 1006 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 170 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO NA NA false No M0 N3a T2 Stage IIIC TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf A09M TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 3e08280c-f748-43c7-928b-007b322917b2 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01A-21-A13B-20 TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01 NA fcc864a9-3f22-4717-a5e1-2c034b9ae7f5 TCGA-A8-A09M-01 TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01A-11D-A00Y-05 TCGA-A8-A09M-01 NA TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01 TCGA-A8-A09M-01A-11D-A011-01 NA TCGA-A8-A09M-01A-11R-A00Z-07 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01A-11D-A011-01 TCGA-A8-A09M-01 |
|
|
248 |
TCGA-A8-A09N-01 Stage IIIC 57 1 Stage IIIC 31 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N3 31 0 LumB Luminal B Positive NA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09N-01 31 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 5 TCGA-A8-A09N NA NA days 31 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Lower Outer Quadrant NA NA NA TCGA-A8-A09N TCGA-A8-A09N-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21002 1276 NA 0 31 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 70 NO Positive Positive NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NA NA NA false No M0 N3a T2 Stage IIIC TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf A09N TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2006 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 NA TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01 NA NA TCGA-A8-A09N-01 TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01A-11D-A00Y-05 TCGA-A8-A09N-01 NA TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 TCGA-A8-A09N-01 TCGA-A8-A09N-01A-11D-A011-01 NA TCGA-A8-A09N-01A-11R-A00Z-07 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 TCGA-A8-A09N-01A-11D-A011-01 TCGA-A8-A09N-01 |
|
|
249 |
TCGA-A8-A09Q-01 Stage IIIB 83 2 Stage IIIB 761 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 761 0 LumB Luminal B Positive NA -2 -5 enrollment T_Other T4 LIVING 0 TCGA-A8-A09Q-01 761 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A09Q NA NA days 761 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Left Lower Inner Quadrant NA NA TCGA-A8-A09Q-F41022 TCGA-A8-A09Q TCGA-A8-A09Q-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -30528 637 NA 0 761 NA NA NA NA NA NA NA NA NA 2013-3-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA NA NA false No M0 N2a T4b Stage IIIB TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7.pdf A09Q WITH TUMOR NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 9560e482-cb14-4456-b9a6-d2ac12f96a4f 9560e482-cb14-4456-b9a6-d2ac12f96a4f NA TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01 NA NA TCGA-A8-A09Q-01 TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01A-11D-A00Y-05 TCGA-A8-A09Q-01 NA TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01 9560e482-cb14-4456-b9a6-d2ac12f96a4f TCGA-A8-A09Q-01 TCGA-A8-A09Q-01A-11D-A011-01 NA TCGA-A8-A09Q-01A-11R-A00Z-07 9560e482-cb14-4456-b9a6-d2ac12f96a4f TCGA-A8-A09Q-01A-11D-A011-01 TCGA-A8-A09Q-01 |
|
|
250 |
TCGA-A8-A09R-01 Stage IIB 82 5 Stage IIB 273 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 273 0 LumB Luminal B Positive Her2 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09R-01 273 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A09R 273 0 days 273 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 82 Left Lower Inner Quadrant NA NA TCGA-A8-A09R-F40330 TCGA-A8-A09R TCGA-A8-A09R-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -30196 149 NA 0 273 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 180 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA false No M0 N1 T2 Stage IIB TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf A09R TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 f4fcb7e1-20b8-4b66-86a2-1be81b06785e f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01A-21-A13B-20 TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01 NA 7c1073e9-1995-4dfa-a9aa-e260e8999d54 TCGA-A8-A09R-01 TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01A-11D-A00Y-05 TCGA-A8-A09R-01 NA TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01 f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01 TCGA-A8-A09R-01A-11D-A011-01 NA TCGA-A8-A09R-01A-11R-A00Z-07 f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01A-11D-A011-01 TCGA-A8-A09R-01 |
|
|
251 |
TCGA-A8-A09T-01 Stage X 68 4 Stage I 578 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 578 0 LumA Luminal A Positive NA -12 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A09T-01 579 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A09T 579 0 days 579 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left NA NA TCGA-A8-A09T-F40329 TCGA-A8-A09T NA NA Positive NA NA NA NA Positive Other NA NA NA NA -25110 NA NA 0 579 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO NA NA NA No MX N0 T1c Stage X NA A09T TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 NA TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01 NA NA TCGA-A8-A09T-01 TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01A-11D-A00Y-05 TCGA-A8-A09T-01 NA TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 TCGA-A8-A09T-01 TCGA-A8-A09T-01A-11D-A011-01 NA TCGA-A8-A09T-01A-11R-A00Z-07 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 TCGA-A8-A09T-01A-11D-A011-01 TCGA-A8-A09T-01 |
|
|
252 |
TCGA-A8-A09V-01 Stage IIA 51 2 Stage IIA 457 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 457 0 LumA Luminal A Positive NA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A09V-01 457 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-A8-A09V 457 0 days 457 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Inner Quadrant NA NA TCGA-A8-A09V-F40328 TCGA-A8-A09V TCGA-A8-A09V-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -18628 333 NA 0 457 NA NA NA NA NA NA NA NA NA 2013-2-17 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 60 NO Negative Negative NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf A09V TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 416041ff-f179-4c72-a281-f39d32c595c1 416041ff-f179-4c72-a281-f39d32c595c1 NA TCGA-A8-A09V-01A-11D-A045-09 TCGA-A8-A09V-01 NA NA TCGA-A8-A09V-01 TCGA-A8-A09V-01A-11D-A045-09 TCGA-A8-A09V-01A-11D-A032-05 TCGA-A8-A09V-01 NA TCGA-A8-A09V-01A-11D-A045-09 NA 416041ff-f179-4c72-a281-f39d32c595c1 NA TCGA-A8-A09V-01A-11D-A036-01 NA TCGA-A8-A09V-01A-11R-A034-07 416041ff-f179-4c72-a281-f39d32c595c1 TCGA-A8-A09V-01A-11D-A036-01 TCGA-A8-A09V-01 |
|
|
253 |
TCGA-A8-A09W-01 Stage IIIB 70 2 Stage IIIC 30 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 30 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A09W-01 30 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-A8-A09W NA NA days 30 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Inner Quadrant NA NA NA TCGA-A8-A09W TCGA-A8-A09W-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25659 1033 NA 0 30 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 180 NO Negative Negative NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NA NA NA false No M0 N3 T2 Stage IIIB TCGA-A8-A09W.B73AF7B0-EED3-413C-B249-C97F27E4EA1C.pdf A09W NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 5th NA NO YES A8 Breast A LIVING 2007 aaec0cbc-a493-48f4-9cc7-32629880ee24 aaec0cbc-a493-48f4-9cc7-32629880ee24 TCGA-A8-A09W-01A-21-A13A-20 TCGA-A8-A09W-01A-11W-A019-09 TCGA-A8-A09W-01 NA 074231b9-2438-4e1e-9965-6ae7e02ae660 TCGA-A8-A09W-01 TCGA-A8-A09W-01A-11W-A019-09 TCGA-A8-A09W-01A-11D-A00Y-05 TCGA-A8-A09W-01 NA TCGA-A8-A09W-01A-11W-A019-09 NA aaec0cbc-a493-48f4-9cc7-32629880ee24 NA TCGA-A8-A09W-01A-11D-A011-01 NA TCGA-A8-A09W-01A-11R-A00Z-07 aaec0cbc-a493-48f4-9cc7-32629880ee24 TCGA-A8-A09W-01A-11D-A011-01 TCGA-A8-A09W-01 |
|
|
254 |
TCGA-A8-A09X-01 Stage IIIC 62 3 Stage IIIC 426 426 Negative FEMALE Negative 2 1 1 Negative M0 Positive N3 426 1 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 DECEASED 1 TCGA-A8-A09X-01 426 1 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A09X NA NA days 426 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Inner Quadrant NA NA NA TCGA-A8-A09X TCGA-A8-A09X-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -22858 302 426 0 NA NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 150 NO Negative Negative NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NA NA NA false No M0 N3a T2 Stage IIIC TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491.pdf A09X NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A DECEASED 2009 f97f68be-6838-455c-91bf-7549543a82c3 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01A-21-A13A-20 TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01 NA 62752717-e2ef-42c9-b0c2-282f66bc0096 TCGA-A8-A09X-01 TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01A-11D-A00Y-05 TCGA-A8-A09X-01 NA TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01 TCGA-A8-A09X-01A-11D-A011-01 NA TCGA-A8-A09X-01A-11R-A00Z-07 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01A-11D-A011-01 TCGA-A8-A09X-01 |
|
|
255 |
TCGA-A8-A09Z-01 Stage IIB 83 2 Stage IIB 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 NA Luminal B Negative Basal 0 -5 enrollment T_Other T3 LIVING NA TCGA-A8-A09Z-01 NA NA days Iq NA cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 14 cluster 2 NA TCGA-A8-A09Z NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Right NA NA NA TCGA-A8-A09Z TCGA-A8-A09Z-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -30590 728 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 320 NO Negative Negative NA NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T3 Stage IIB TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D.pdf A09Z WITH TUMOR NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2008 2c3ad15f-0d26-441e-8139-85194b3389f2 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01A-21-A13A-20 NA TCGA-A8-A09Z-01 NA c8b43014-8e13-462a-90c5-c38032e02d7a TCGA-A8-A09Z-01 TCGA-A8-A09Z-01A-11W-A019-09 TCGA-A8-A09Z-01A-11D-A00Y-05 TCGA-A8-A09Z-01 NA NA TCGA-A8-A09Z-01 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01 TCGA-A8-A09Z-01A-11D-A011-01 NA TCGA-A8-A09Z-01A-11R-A00Z-07 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01A-11D-A011-01 TCGA-A8-A09Z-01 |
|
|
256 |
TCGA-A8-A0A1-01 Stage IIA 84 2 Stage IIA 365 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 365 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A1-01 365 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-A8-A0A1 NA NA days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right NA NA NA TCGA-A8-A0A1 TCGA-A8-A0A1-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -30742 241 NA 0 365 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 90 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf A0A1 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 8522865b-457c-4199-a870-bf8353f2b0a5 8522865b-457c-4199-a870-bf8353f2b0a5 NA TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01 NA NA TCGA-A8-A0A1-01 TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01A-11D-A00Y-05 TCGA-A8-A0A1-01 NA TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01 8522865b-457c-4199-a870-bf8353f2b0a5 TCGA-A8-A0A1-01 TCGA-A8-A0A1-01A-11D-A011-01 NA TCGA-A8-A0A1-01A-11R-A00Z-07 8522865b-457c-4199-a870-bf8353f2b0a5 TCGA-A8-A0A1-01A-11D-A011-01 TCGA-A8-A0A1-01 |
|
|
257 |
TCGA-A8-A0A2-01 Stage IIA 66 2 Stage IIA 578 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 578 0 LumA Luminal A Positive NA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A2-01 579 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A0A2 NA NA days 579 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Lower Outer Quadrant NA NA NA TCGA-A8-A0A2 TCGA-A8-A0A2-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -24380 394 NA 0 579 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 70 NO Negative Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NA NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf A0A2 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 6330ab59-db9d-4b22-a96b-1024c9b4908d 6330ab59-db9d-4b22-a96b-1024c9b4908d NA TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01 NA NA TCGA-A8-A0A2-01 TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01A-11D-A032-05 TCGA-A8-A0A2-01 NA TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01 6330ab59-db9d-4b22-a96b-1024c9b4908d TCGA-A8-A0A2-01 TCGA-A8-A0A2-01A-11D-A036-01 NA TCGA-A8-A0A2-01A-11R-A034-07 6330ab59-db9d-4b22-a96b-1024c9b4908d TCGA-A8-A0A2-01A-11D-A036-01 TCGA-A8-A0A2-01 |
|
|
258 |
TCGA-A8-A0A4-01 Stage IIA 73 2 Stage IIA 396 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 396 0 LumA Luminal A Positive ReacII -5 -7 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A4-01 396 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A8-A0A4 396 0 days 396 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left NA NA TCGA-A8-A0A4-F40326 TCGA-A8-A0A4 TCGA-A8-A0A4-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26693 272 NA 0 396 NA NA NA NA NA NA NA NA NA 2013-2-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 160 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf A0A4 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01A-21-A13A-20 TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01 NA 9748e726-7d5e-4e3c-ad24-ab078118010c TCGA-A8-A0A4-01 TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01A-11D-A00Y-05 TCGA-A8-A0A4-01 NA TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01 TCGA-A8-A0A4-01A-11D-A011-01 NA TCGA-A8-A0A4-01A-11R-A00Z-07 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01A-11D-A011-01 TCGA-A8-A0A4-01 |
|
|
259 |
TCGA-A8-A0A6-01 Stage IIIC 64 2 Stage IIIC 640 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 640 0 LumA Luminal A Positive NA -5 -4 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A6-01 640 0 days BRCA-LUAD+ NA cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 NA TCGA-A8-A0A6 640 0 days 640 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Upper Outer Quadrant NA NA TCGA-A8-A0A6-F40325 TCGA-A8-A0A6 TCGA-A8-A0A6-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23404 394 NA 0 640 NA NA NA NA NA NA NA NA NA 2013-2-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 90 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO NA NA false No M0 N3a T2 Stage IIIC TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E.pdf A0A6 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 surgical resection 6th NA NO YES A8 Breast A LIVING 2009 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 NA NA TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12D-A10P-05 NA TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12W-A071-09 NA TCGA-A8-A0A6-01 NA NA TCGA-A8-A0A6-01 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12D-A059-01 NA TCGA-A8-A0A6-01A-12R-A056-07 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 TCGA-A8-A0A6-01A-12D-A059-01 TCGA-A8-A0A6-01 |
|
|
260 |
TCGA-A8-A0A7-01 Stage IIB 57 3 Stage IIB 30 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 30 0 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A7-01 30 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A0A7 NA NA days 30 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Outer Quadrant NA NA NA TCGA-A8-A0A7 NA NA Negative NA NA NA NA Negative Other NA NA NA NA -20940 NA NA 0 30 NA NA NA NA NA NA NA NA NA 2011-5-27 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA NA NA Positive Positive NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA NA NA NA No M0 N1a T2 Stage IIB NA A0A7 TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2009 bae23acf-5981-4071-a7e1-6363ab128561 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01A-21-A13A-20 TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01 NA d459629a-8ef9-4556-adfb-a3105e460556 TCGA-A8-A0A7-01 TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01A-11D-A00Y-05 TCGA-A8-A0A7-01 NA TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01 TCGA-A8-A0A7-01A-11D-A011-01 NA TCGA-A8-A0A7-01A-11R-A040-07 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01A-11D-A011-01 TCGA-A8-A0A7-01 |
|
|
261 |
TCGA-A8-A0A9-01 Stage IIA 80 3 Stage IIA 396 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 396 0 LumA Luminal B Positive NA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A0A9-01 822 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A0A9 822 0 days 822 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Upper Outer Quadrant NA NA TCGA-A8-A0A9-F40323 TCGA-A8-A0A9 TCGA-A8-A0A9-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -29370 272 NA 0 822 NA NA NA NA NA NA NA NA NA 2013-2-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 100 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf A0A9 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 1766e42e-f8cf-447d-a694-3999a1fec43a 1766e42e-f8cf-447d-a694-3999a1fec43a NA TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01 NA NA TCGA-A8-A0A9-01 TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01A-11D-A00Y-05 TCGA-A8-A0A9-01 NA TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01 1766e42e-f8cf-447d-a694-3999a1fec43a TCGA-A8-A0A9-01 TCGA-A8-A0A9-01A-11D-A011-01 NA TCGA-A8-A0A9-01A-11R-A00Z-07 1766e42e-f8cf-447d-a694-3999a1fec43a TCGA-A8-A0A9-01A-11D-A011-01 TCGA-A8-A0A9-01 |
|
|
262 |
TCGA-A8-A0AB-01 Stage IIA 54 2 Stage IIA 517 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 517 0 LumA Luminal B Positive NA -1 -3 enrollment T_Other T2 LIVING 0 TCGA-A8-A0AB-01 518 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A0AB 518 0 days 518 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant NA NA TCGA-A8-A0AB-F40322 TCGA-A8-A0AB TCGA-A8-A0AB-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -19814 394 NA 0 518 NA NA NA NA NA NA NA NA NA 2013-2-16 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 70 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655.pdf A0AB TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast A LIVING 2009 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 NA TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01 NA NA TCGA-A8-A0AB-01 TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01A-11D-A032-05 TCGA-A8-A0AB-01 NA TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 TCGA-A8-A0AB-01 TCGA-A8-A0AB-01A-11D-A036-01 NA TCGA-A8-A0AB-01A-11R-A034-07 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 TCGA-A8-A0AB-01A-11D-A036-01 TCGA-A8-A0AB-01 |
|
|
263 |
TCGA-A8-A0AD-01 Stage I 83 2 Stage I 1157 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1157 0 LumA Luminal A Positive NA -12 -3 enrollment T1 T1 LIVING 0 TCGA-A8-A0AD-01 1157 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-A8-A0AD 1157 0 days 1157 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Right Upper Outer Quadrant NA NA TCGA-A8-A0AD-F40321 TCGA-A8-A0AD NA NA Positive NA NA NA NA Positive Other NA NA NA NA -30407 NA NA 0 1157 NA NA NA NA NA NA NA NA NA 2013-2-16 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) lobular/ductal No NA C50.9 8522/3 C50.9 NA YES NA NA NA NA Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T1c Stage I NA A0AD TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Surgical Resection 6th NA NO YES A8 Breast NA LIVING 2007 b62f3825-9634-4252-b841-4c455a007353 b62f3825-9634-4252-b841-4c455a007353 NA TCGA-A8-A0AD-01A-11W-A071-09 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11D-A10P-05 NA TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11W-A071-09 NA TCGA-A8-A0AD-01 NA TCGA-A8-A0AD-01A-11W-A071-09 TCGA-A8-A0AD-01 b62f3825-9634-4252-b841-4c455a007353 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11D-A059-01 NA TCGA-A8-A0AD-01A-11R-A056-07 b62f3825-9634-4252-b841-4c455a007353 TCGA-A8-A0AD-01A-11D-A059-01 TCGA-A8-A0AD-01 |
|
|
264 |
TCGA-AC-A23C-01 NA 62 3 Stage IIB 29 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 29 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AC-A23C-01 585 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 4 TCGA-AC-A23C 585 0 days 585 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left NA NA TCGA-AC-A23C-F43235 TCGA-AC-A23C TCGA-AC-A23C-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -22751 198 NA 0 585 NA NA NA NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 100 NO Positive Positive NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 1 NA false No MX N1 T2 Stage IIB TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf A23C TUMOR FREE NA NA NA NA NA YES YES 50-59% NA NO Primary Tumor 01 NA 7th NA NO YES AC Breast A LIVING 2010 052b565f-1955-4c4e-8b1f-dd48743ba944 052b565f-1955-4c4e-8b1f-dd48743ba944 TCGA-AC-A23C-01A-21-A17I-20 TCGA-AC-A23C-01A-12D-A167-09 TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A16A-05 53968cee-b8a9-43d6-b9cd-d4b9cd39baf0 TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A167-09 NA NA TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A167-09 NA 052b565f-1955-4c4e-8b1f-dd48743ba944 NA TCGA-AC-A23C-01A-12D-A166-01 TCGA-AC-A23C-01 NA 052b565f-1955-4c4e-8b1f-dd48743ba944 TCGA-AC-A23C-01A-12D-A166-01 |
|
|
265 |
TCGA-AC-A23E-01 NA 50 2 Stage IIB 72 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 72 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AC-A23E-01 698 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 4 TCGA-AC-A23E 698 0 days 698 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Sentinel node biopsy alone NA TCGA-AC-A23E-F43240 TCGA-AC-A23E TCGA-AC-A23E-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -18500 158 NA 0 698 NA NA NA NA NO NA 30-39% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO NA NA NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO 1 NA false No MX N1 T2 Stage IIB TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf A23E TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA NA NA AC Breast A LIVING 2010 25be50e7-7705-492d-a44a-0e40180d10c8 25be50e7-7705-492d-a44a-0e40180d10c8 TCGA-AC-A23E-01A-21-A17I-20 TCGA-AC-A23E-01A-11D-A159-09 TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A161-05 f5ca4ea4-d35a-456e-aabb-0aec9f48a7be TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A159-09 NA NA TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A159-09 NA 25be50e7-7705-492d-a44a-0e40180d10c8 NA TCGA-AC-A23E-01A-11D-A160-01 TCGA-AC-A23E-01 NA 25be50e7-7705-492d-a44a-0e40180d10c8 TCGA-AC-A23E-01A-11D-A160-01 |
|
|
266 |
TCGA-AC-A23G-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A23G-01 2248 0 days Iq NA NA BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A23G 2248 0 days 2248 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Right Upper Inner Quadrant NA NA TCGA-AC-A23G-F43241 TCGA-AC-A23G TCGA-AC-A23G-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -27934 1590 NA 0 2248 NA NA NA NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 40 NO Positive Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No MX N1 T1c Stage IIA TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf A23G TUMOR FREE NA NA NA NA NA YES YES 80-89% NA NO Primary Tumor 01 Right Total Mastectomy and Sentinel Node Biopsy 6th NA NO YES AC Breast A LIVING 2006 3cd0b704-99b5-401b-8f52-daead9359692 3cd0b704-99b5-401b-8f52-daead9359692 NA NA TCGA-AC-A23G-01 TCGA-AC-A23G-01A-11D-A212-05 NA TCGA-AC-A23G-01 TCGA-AC-A23G-01A-11D-A20S-09 NA NA TCGA-AC-A23G-01 NA NA 3cd0b704-99b5-401b-8f52-daead9359692 NA TCGA-AC-A23G-01A-11D-A20R-01 TCGA-AC-A23G-01 NA 3cd0b704-99b5-401b-8f52-daead9359692 TCGA-AC-A23G-01A-11D-A20R-01 |
|
|
267 |
TCGA-AC-A23H-01 NA 90 3 Stage IIA 81 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 81 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 1 TCGA-AC-A23H-01 174 1 days High NA cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A23H 174 0 days 174 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Upper Inner Quadrant|Right Lower Inner Quadrant NA NA TCGA-AC-A23H-F45572 TCGA-AC-A23H TCGA-AC-A23H-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -32873 478 174 0 81 NA NA NA NA NO NA 10-19% NA NA 2013-7-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO NA NA false No M0 NX T2 Stage IIA TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf A23H WITH TUMOR NA NA NA NA NA NO NO NA NA NO Primary Tumor 01 NA 7th NA NO YES AC Breast A DECEASED 2009 28199d71-9111-4763-a07f-66734769bb98 28199d71-9111-4763-a07f-66734769bb98 NA NA TCGA-AC-A23H-01 TCGA-AC-A23H-01A-11D-A161-05 NA TCGA-AC-A23H-01 TCGA-AC-A23H-01A-11D-A159-09 NA NA TCGA-AC-A23H-01 NA NA 28199d71-9111-4763-a07f-66734769bb98 NA TCGA-AC-A23H-01A-11D-A160-01 TCGA-AC-A23H-01 NA 28199d71-9111-4763-a07f-66734769bb98 TCGA-AC-A23H-01A-11D-A160-01 |
|
|
268 |
TCGA-AC-A23H-11 NA 90 NA NA 81 NA NA FEMALE NA NA NA NA NA NA NA NA 81 0 Normal NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-AC-A23H-11 174 1 days NA NA NA NA NA NA NA NA NA TCGA-AC-A23H 174 0 days 174 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Upper Inner Quadrant|Right Lower Inner Quadrant NA NA TCGA-AC-A23H-F45572 TCGA-AC-A23H TCGA-AC-A23H-11A NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -32873 478 174 0 81 NA NA NA NA NO NA 10-19% NA NA 2013-7-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Positive Positive NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false No M0 NX T2 Stage IIA NA A23H WITH TUMOR NA NA NA NA NA NO NO NA NA NO Solid Tissue Normal 11 NA 7th NA NO YES AC Breast A DECEASED 2009 93108690-ccc2-4ae4-89e0-042a654a0228 93108690-ccc2-4ae4-89e0-042a654a0228 NA NA NA TCGA-AC-A23H-11A-12D-A161-05 NA NA NA NA NA TCGA-AC-A23H-11 NA NA 93108690-ccc2-4ae4-89e0-042a654a0228 NA NA TCGA-AC-A23H-11 NA 93108690-ccc2-4ae4-89e0-042a654a0228 NA |
|
|
269 |
TCGA-AC-A2B8-01 NA NA 2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2B8-01 677 0 days Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A2B8 654 1 days 677 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 84 Right Axillary lymph node dissection alone NA TCGA-AC-A2B8-F43210 TCGA-AC-A2B8 TCGA-AC-A2B8-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -31003 101 NA 0 677 NA 672 654 NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA Other, specify New Primary Tumor Rectum YES YES 0 0 false No M0 N0 (i-) T3 Stage IIB TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf A2B8 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 TCGA-AC-A2B8-01A-21-A24A-20 NA TCGA-AC-A2B8-01 TCGA-AC-A2B8-01A-11D-A17F-05 7365ebda-a4f6-4d52-bed9-220059dc5e5e TCGA-AC-A2B8-01 TCGA-AC-A2B8-01A-11D-A17D-09 NA NA TCGA-AC-A2B8-01 NA NA ed74a7e1-90de-4943-9ca2-e7f94a5540e4 NA TCGA-AC-A2B8-01A-11D-A17C-01 TCGA-AC-A2B8-01 NA ed74a7e1-90de-4943-9ca2-e7f94a5540e4 TCGA-AC-A2B8-01A-11D-A17C-01 |
|
|
270 |
TCGA-AC-A2BK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2BK-01 2222 0 days High C4-BRCA/Basal NA BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 NA NA TCGA-AC-A2BK 2222 0 days 2222 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A2BK-F43987 TCGA-AC-A2BK TCGA-AC-A2BK-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -28625 1717 NA 0 2222 NA NA NA NA NO NA NA NA NA 2013-6-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative NA NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 6 NA false No MX N2a T2 Stage IIIA TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf A2BK TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2006 08893743-829b-4594-ab67-d5eb5e80a4f3 08893743-829b-4594-ab67-d5eb5e80a4f3 TCGA-AC-A2BK-01A-21-A24A-20 NA TCGA-AC-A2BK-01 TCGA-AC-A2BK-01A-11D-A21R-05 1392fc51-37de-493d-a7e9-01269e73c9c5 TCGA-AC-A2BK-01 TCGA-AC-A2BK-01A-11D-A21Q-09 NA NA TCGA-AC-A2BK-01 NA NA 08893743-829b-4594-ab67-d5eb5e80a4f3 NA TCGA-AC-A2BK-01A-11D-A21P-01 TCGA-AC-A2BK-01 NA 08893743-829b-4594-ab67-d5eb5e80a4f3 TCGA-AC-A2BK-01A-11D-A21P-01 |
|
|
271 |
TCGA-AC-A2BM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2BM-01 3022 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A2BM 3022 0 days 3022 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2BM-F66202 TCGA-AC-A2BM TCGA-AC-A2BM-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -15212 2164 NA 0 3022 NA NA NA NA NO NA 60-69% NA NA 2014-10-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 120 NO NA Negative NO 13 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 false No MX N1a T2 Stage IIB TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf A2BM TUMOR FREE NA NA NA NA NA NO YES 10-19% NA NO Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2005 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 TCGA-AC-A2BM-01A-21-A24A-20 NA TCGA-AC-A2BM-01 TCGA-AC-A2BM-01A-11D-A21R-05 2222f10b-39fd-4aa4-8021-7f320c835f88 TCGA-AC-A2BM-01 TCGA-AC-A2BM-01A-11D-A21Q-09 NA NA TCGA-AC-A2BM-01 NA NA 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 NA TCGA-AC-A2BM-01A-11D-A21P-01 TCGA-AC-A2BM-01 NA 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 TCGA-AC-A2BM-01A-11D-A21P-01 |
|
|
272 |
TCGA-AC-A2FB-01 NA NA 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FB-01 1234 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A2FB 1234 0 days 1234 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A2FB-F45574 TCGA-AC-A2FB TCGA-AC-A2FB-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -23851 576 NA 0 1234 NA NA NA NA NO NA 90-99% NA NA 2013-7-17 FEMALE NA NA 10-19% NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 140 NO Positive NA NO 1 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T2 Stage IIA TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf A2FB TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2009 fce0d59e-78a5-4d7b-8136-b8421f5116b0 fce0d59e-78a5-4d7b-8136-b8421f5116b0 TCGA-AC-A2FB-01A-21-A24A-20 NA TCGA-AC-A2FB-01 TCGA-AC-A2FB-01A-11D-A17F-05 6bde7ec5-1170-4bdf-afa6-bff4642ef9e3 TCGA-AC-A2FB-01 TCGA-AC-A2FB-01A-11D-A17D-09 NA NA TCGA-AC-A2FB-01 NA NA fce0d59e-78a5-4d7b-8136-b8421f5116b0 NA TCGA-AC-A2FB-01A-11D-A17C-01 TCGA-AC-A2FB-01 NA fce0d59e-78a5-4d7b-8136-b8421f5116b0 TCGA-AC-A2FB-01A-11D-A17C-01 |
|
|
273 |
TCGA-AC-A2FB-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FB-11 1234 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA NA TCGA-AC-A2FB 1234 0 days 1234 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A2FB-F45574 TCGA-AC-A2FB NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -23851 NA NA 0 1234 NA NA NA NA NO NA 90-99% NA NA 2013-7-17 FEMALE NA NA 10-19% NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy NA NA Positive NA NO 1 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No MX N0 T2 Stage IIA NA A2FB TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Solid Tissue Normal 11 NA 6th NA NO YES AC Breast NA LIVING 2009 f18b2ff7-eddb-40b5-9bbe-7ef09787ddef f18b2ff7-eddb-40b5-9bbe-7ef09787ddef NA NA NA TCGA-AC-A2FB-11A-13D-A17F-05 NA NA NA NA NA TCGA-AC-A2FB-11 NA NA f18b2ff7-eddb-40b5-9bbe-7ef09787ddef NA NA TCGA-AC-A2FB-11 NA f18b2ff7-eddb-40b5-9bbe-7ef09787ddef NA |
|
|
274 |
TCGA-AC-A2FE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A2FE-01 2636 1 days BRCA-LUAD+ NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 5 NA NA TCGA-AC-A2FE 2496 1 days 2636 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2FE-F47725 TCGA-AC-A2FE TCGA-AC-A2FE-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22746 2228 2636 0 791 NA NA 2496 NA NA NA 60-69% NA NA 2013-8-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 120 NO NA NA NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Liver Distant Metastasis NA NO YES 18 NA false No MX N3a T3 Stage IIIC TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf A2FE WITH TUMOR NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES AC Breast A DECEASED 2005 22e03b77-aa0f-4348-98c1-9b0914e8af8b 22e03b77-aa0f-4348-98c1-9b0914e8af8b TCGA-AC-A2FE-01A-21-A24A-20 NA TCGA-AC-A2FE-01 TCGA-AC-A2FE-01A-11D-A19Z-05 419206c6-a1d6-4541-b154-10aae75b04a2 TCGA-AC-A2FE-01 TCGA-AC-A2FE-01A-11D-A19Y-09 NA NA TCGA-AC-A2FE-01 NA NA 22e03b77-aa0f-4348-98c1-9b0914e8af8b NA TCGA-AC-A2FE-01A-11D-A19X-01 TCGA-AC-A2FE-01 NA 22e03b77-aa0f-4348-98c1-9b0914e8af8b TCGA-AC-A2FE-01A-11D-A19X-01 |
|
|
275 |
TCGA-AC-A2FF-01 NA NA 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FF-01 2759 0 days Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A2FF 2759 0 days 2759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2FF-F58655 TCGA-AC-A2FF TCGA-AC-A2FF-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA NA 1904 NA 0 2759 NA NA NA NA NO NA 30-39% NA NA 2014-4-17 FEMALE NA NA NA NA NA NA NA 1.7 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 130 NO NA Negative NO 7 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 3 0 false No MX N1 T2 Stage IIB TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf A2FF TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2006 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 TCGA-AC-A2FF-01A-21-A24A-20 NA TCGA-AC-A2FF-01 TCGA-AC-A2FF-01A-11D-A17F-05 588f1cc2-09a3-4ffa-b934-a8b7c4c8524c TCGA-AC-A2FF-01 TCGA-AC-A2FF-01A-11D-A17D-09 NA NA TCGA-AC-A2FF-01 NA NA f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 NA TCGA-AC-A2FF-01A-11D-A17C-01 TCGA-AC-A2FF-01 NA f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 TCGA-AC-A2FF-01A-11D-A17C-01 |
|
|
276 |
TCGA-AC-A2FF-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FF-11 2759 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA NA TCGA-AC-A2FF 2759 0 days 2759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2FF-F58655 TCGA-AC-A2FF TCGA-AC-A2FF-11A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA NA 1904 NA 0 2759 NA NA NA NA NO NA 30-39% NA NA 2014-4-17 FEMALE NA NA NA NA NA NA NA 1.7 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 80 NO NA Negative NO 7 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 false No MX N1 T2 Stage IIB NA A2FF TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Solid Tissue Normal 11 NA 6th NA NO YES AC Breast A LIVING 2006 3610639e-d947-446f-8483-86be65c80ed3 3610639e-d947-446f-8483-86be65c80ed3 NA NA NA TCGA-AC-A2FF-11A-13D-A17F-05 NA NA NA NA NA NA NA NA 3610639e-d947-446f-8483-86be65c80ed3 NA NA NA NA 3610639e-d947-446f-8483-86be65c80ed3 NA |
|
|
277 |
TCGA-AC-A2FG-01 NA NA 2 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FG-01 1853 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 NA NA TCGA-AC-A2FG 1853 0 days 1853 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2FG-F43221 TCGA-AC-A2FG TCGA-AC-A2FG-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -29211 1517 NA 0 1853 NA NA NA NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 120 NO NA Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 1 1 false No MX N1a T2 Stage IIB TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf A2FG TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2007 c4cc228f-ab41-4779-b405-175618e5f77c c4cc228f-ab41-4779-b405-175618e5f77c TCGA-AC-A2FG-01A-21-A24A-20 NA TCGA-AC-A2FG-01 TCGA-AC-A2FG-01A-11D-A17F-05 4be4e39c-7061-4ef0-8347-75622194af98 TCGA-AC-A2FG-01 TCGA-AC-A2FG-01A-11D-A17D-09 NA NA TCGA-AC-A2FG-01 NA NA c4cc228f-ab41-4779-b405-175618e5f77c NA TCGA-AC-A2FG-01A-11D-A17C-01 TCGA-AC-A2FG-01 NA c4cc228f-ab41-4779-b405-175618e5f77c TCGA-AC-A2FG-01A-11D-A17C-01 |
|
|
278 |
TCGA-AC-A2FG-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FG-11 1853 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA NA TCGA-AC-A2FG 1853 0 days 1853 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A2FG-F43221 TCGA-AC-A2FG TCGA-AC-A2FG-11A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -29211 1517 NA 0 1853 NA NA NA NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 120 NO NA Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 false No MX N1a T2 Stage IIB NA A2FG TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 6th NA NO YES AC Breast A LIVING 2007 NA NA NA NA NA TCGA-AC-A2FG-11A-22D-A17F-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
279 |
TCGA-AC-A2FK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FK-01 2650 0 days Quiet NA NA Low purity c2 NA BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-AC-A2FK 2650 0 days 2650 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant NA NA TCGA-AC-A2FK-F66196 TCGA-AC-A2FK TCGA-AC-A2FK-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16627 1833 NA 0 2650 NA NA NA NA NO NA 90-99% NA NA 2014-10-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 80 NO NA Negative NO 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA false No M0 N3a T2 Stage IIIC TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf A2FK TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES AC Breast A LIVING 2006 1fff796f-626b-4408-9fd1-4fea54e153a6 1fff796f-626b-4408-9fd1-4fea54e153a6 NA NA TCGA-AC-A2FK-01 TCGA-AC-A2FK-01A-12D-A17Z-05 NA TCGA-AC-A2FK-01 TCGA-AC-A2FK-01A-12D-A17W-09 NA NA TCGA-AC-A2FK-01 NA NA 1fff796f-626b-4408-9fd1-4fea54e153a6 NA TCGA-AC-A2FK-01A-12D-A17U-01 TCGA-AC-A2FK-01 NA 1fff796f-626b-4408-9fd1-4fea54e153a6 TCGA-AC-A2FK-01A-12D-A17U-01 |
|
|
280 |
TCGA-AC-A2FM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A2FM-01 792 1 days High NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 5 NA NA TCGA-AC-A2FM 780 1 days 792 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 87 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A2FM-F43237 TCGA-AC-A2FM TCGA-AC-A2FM-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA YES NA NA -31805 2606 792 0 NA NA NA 780 NA YES NA NA NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 170 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify Distant Metastasis Bone Marrow NO YES 0 0 false No M0 N1mi T2 Stage IIB TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf A2FM WITH TUMOR NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 6th NA NO YES AC Breast A DECEASED 2004 c1280be2-b926-4632-975a-fe52bb04c65d c1280be2-b926-4632-975a-fe52bb04c65d TCGA-AC-A2FM-01A-21-A24A-20 NA TCGA-AC-A2FM-01 TCGA-AC-A2FM-01A-11D-A19Z-05 26f52e65-dac7-4cd4-9d02-7d01c2c6f0b7 TCGA-AC-A2FM-01 TCGA-AC-A2FM-01A-11D-A19Y-09 NA NA TCGA-AC-A2FM-01 NA NA c1280be2-b926-4632-975a-fe52bb04c65d NA TCGA-AC-A2FM-01A-11D-A19X-01 TCGA-AC-A2FM-01 NA c1280be2-b926-4632-975a-fe52bb04c65d TCGA-AC-A2FM-01A-11D-A19X-01 |
|
|
281 |
TCGA-AC-A2FM-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A2FM-11 792 1 days NA NA NA NA NA NA NA NA NA TCGA-AC-A2FM 780 1 days 792 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 87 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A2FM-F43237 TCGA-AC-A2FM TCGA-AC-A2FM-11B NA NA NA NA NA NA NA Modified Radical Mastectomy NA YES NA NA -31805 2733 792 0 NA NA NA 780 NA YES NA NA NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 220 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify Distant Metastasis Bone Marrow NO YES 0 0 false No M0 N1mi T2 Stage IIB NA A2FM WITH TUMOR NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 NA 6th NA NO YES AC Breast B DECEASED 2004 68ec8441-f60a-4c80-8a9f-7609a0f81430 68ec8441-f60a-4c80-8a9f-7609a0f81430 NA NA NA TCGA-AC-A2FM-11B-32D-A19Z-05 NA NA NA NA NA TCGA-AC-A2FM-11 NA NA 68ec8441-f60a-4c80-8a9f-7609a0f81430 NA NA TCGA-AC-A2FM-11 NA 68ec8441-f60a-4c80-8a9f-7609a0f81430 NA |
|
|
282 |
TCGA-AC-A2FO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2FO-01 2255 0 days Iq NA NA BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 NA NA TCGA-AC-A2FO 2255 0 days 2255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Outer Quadrant Other (specify) Sentinel lymph node plus Level I and Level II lymph nodes TCGA-AC-A2FO-F43223 TCGA-AC-A2FO NA NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -23928 NA NA 0 2255 NA NA NA NA NO NA 90-99% NA NA 2013-5-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Indeterminate NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA NA No MX N1 T2 Stage IIB NA A2FO TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES AC Breast NA LIVING 2005 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 NA NA TCGA-AC-A2FO-01 TCGA-AC-A2FO-01A-11D-A17Z-05 NA TCGA-AC-A2FO-01 TCGA-AC-A2FO-01A-11D-A17W-09 NA NA TCGA-AC-A2FO-01 NA NA bd07aa68-708b-4bd3-88b9-78a8b9e298f5 NA TCGA-AC-A2FO-01A-11D-A17U-01 TCGA-AC-A2FO-01 NA bd07aa68-708b-4bd3-88b9-78a8b9e298f5 TCGA-AC-A2FO-01A-11D-A17U-01 |
|
|
283 |
TCGA-AC-A2QH-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2QH-01 1005 0 days Squamous NA NA Cluster 5 NA GBM-like c6 miRNA cluster 13 NA NA TCGA-AC-A2QH 1005 0 days 1005 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A2QH-F64100 TCGA-AC-A2QH NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -21488 NA NA 0 1005 NA NA NA NA NO NA NA NA NA 2014-8-26 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No MX N0 T3 Stage IIB NA A2QH TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2011 d848ad65-9261-4854-a6bd-e76484c6a337 d848ad65-9261-4854-a6bd-e76484c6a337 NA NA TCGA-AC-A2QH-01 TCGA-AC-A2QH-01A-11D-A18O-05,TCGA-AC-A2QH-01B-04D-A22R-05 NA TCGA-AC-A2QH-01 TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09 NA NA TCGA-AC-A2QH-01 NA NA d848ad65-9261-4854-a6bd-e76484c6a337 NA TCGA-AC-A2QH-01A-11D-A18N-01 TCGA-AC-A2QH-01 NA d848ad65-9261-4854-a6bd-e76484c6a337 TCGA-AC-A2QH-01A-11D-A18N-01 |
|
|
284 |
TCGA-AC-A2QI-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A2QI-01 588 0 days BRCA-LUAD+ NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 3 NA NA TCGA-AC-A2QI 588 0 days 588 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Right Sentinel node biopsy alone NA TCGA-AC-A2QI-F57047 TCGA-AC-A2QI TCGA-AC-A2QI-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -27865 91 NA 0 588 NA NA NA NA NO NA 90-99% NA NA 2014-2-28 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No MX N1a T3 Stage IIIA TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf A2QI TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Total Mastectomy 7th NA YES NO AC Breast A LIVING 2011 d620baa1-c329-46c6-a56a-dc08dfa23470 d620baa1-c329-46c6-a56a-dc08dfa23470 TCGA-AC-A2QI-01A-21-A24A-20 NA TCGA-AC-A2QI-01 TCGA-AC-A2QI-01A-12D-A19Z-05 3d65de31-a929-4c60-af58-5c24b7e3d6a5 TCGA-AC-A2QI-01 TCGA-AC-A2QI-01A-12D-A19Y-09 NA NA TCGA-AC-A2QI-01 NA NA d620baa1-c329-46c6-a56a-dc08dfa23470 NA TCGA-AC-A2QI-01A-12D-A19X-01 TCGA-AC-A2QI-01 NA d620baa1-c329-46c6-a56a-dc08dfa23470 TCGA-AC-A2QI-01A-12D-A19X-01 |
|
|
285 |
TCGA-AC-A2QJ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A2QJ-01 446 1 days BRCA-LUAD+ NA NA BRCA non-CIMP c9 KIRC-like c1 NA miRNA cluster 5 NA NA TCGA-AC-A2QJ 237 1 days 446 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 48 Left Upper Outer Quadrant|Left Lower Outer Quadrant Other (specify) Sentinel lymph node and axillary lymph node biopsy TCGA-AC-A2QJ-F44021 TCGA-AC-A2QJ TCGA-AC-A2QJ-01A NA Negative NA NA NA NA Negative Other NA NO NA NA -17569 160 446 0 69 NA NA 237 NA NO NA NA NA NA 2013-6-28 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 0 NA false No M0 N0 T4b Stage IIIB TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf A2QJ WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Mastectomy 7th NA YES NO AC Breast A DECEASED 2011 49a0f1eb-6ece-48fc-970f-3922263fd20b 49a0f1eb-6ece-48fc-970f-3922263fd20b TCGA-AC-A2QJ-01A-21-A24A-20 NA TCGA-AC-A2QJ-01 TCGA-AC-A2QJ-01A-12D-A19Z-05 5755434d-e797-4963-b728-caefc7bd49d5 TCGA-AC-A2QJ-01 TCGA-AC-A2QJ-01A-12D-A19Y-09 NA NA TCGA-AC-A2QJ-01 NA NA 49a0f1eb-6ece-48fc-970f-3922263fd20b NA TCGA-AC-A2QJ-01A-12D-A19X-01 TCGA-AC-A2QJ-01 NA 49a0f1eb-6ece-48fc-970f-3922263fd20b TCGA-AC-A2QJ-01A-12D-A19X-01 |
|
|
286 |
TCGA-AC-A3BB-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3BB-01 987 0 days BRCA-LUAD+ NA NA BRCA non-CIMP c9 NA NA miRNA cluster 5 NA NA TCGA-AC-A3BB 987 0 days 987 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A3BB-F58953 TCGA-AC-A3BB TCGA-AC-A3BB-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16983 106 NA 0 987 NA NA NA NA NO NA 90-99% NA NA 2014-4-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 160 NO Negative NA NO 14 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA false No MX N2a T3 Stage IIIA TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf A3BB TUMOR FREE NA NA NA NA NA YES NA 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa NA NA TCGA-AC-A3BB-01 TCGA-AC-A3BB-01A-21D-A19Z-05 NA TCGA-AC-A3BB-01 TCGA-AC-A3BB-01A-21D-A19Y-09 NA NA TCGA-AC-A3BB-01 NA NA 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa NA TCGA-AC-A3BB-01A-21D-A19X-01 TCGA-AC-A3BB-01 NA 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa TCGA-AC-A3BB-01A-21D-A19X-01 |
|
|
287 |
TCGA-AC-A3EH-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A3EH-01 197 1 days BRCA-LUAD+ NA NA BRCA CIMP c7 NA NA miRNA c1uster 9 NA NA TCGA-AC-A3EH 197 0 days 197 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Axillary lymph node dissection alone NA TCGA-AC-A3EH-F65834 TCGA-AC-A3EH TCGA-AC-A3EH-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -29014 67 197 0 17 NA NA NA NA NA NA NA NA NA 2014-9-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8022/3 C50.9 NA YES NA Excisional Biopsy 150 NO Negative Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 12 NA false No M0 N3 T3 Stage IIIC TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf A3EH TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A DECEASED 2011 616255fe-88b3-4567-ae8d-bd68dd8380a3 616255fe-88b3-4567-ae8d-bd68dd8380a3 NA NA TCGA-AC-A3EH-01 TCGA-AC-A3EH-01A-22D-A22B-05 NA TCGA-AC-A3EH-01 TCGA-AC-A3EH-01A-22D-A228-09 NA NA TCGA-AC-A3EH-01 NA NA 616255fe-88b3-4567-ae8d-bd68dd8380a3 NA TCGA-AC-A3EH-01A-22D-A227-01 TCGA-AC-A3EH-01 NA 616255fe-88b3-4567-ae8d-bd68dd8380a3 TCGA-AC-A3EH-01A-22D-A227-01 |
|
|
288 |
TCGA-AC-A3HN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3HN-01 496 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AC-A3HN 496 0 days 496 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 87 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A3HN-F65835 TCGA-AC-A3HN TCGA-AC-A3HN-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -32061 97 NA 0 496 NA NA NA NA NO NA 90-99% NA NA 2014-9-30 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 160 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 false No MX N1a T2 Stage IIB TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf A3HN TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 79a14838-69d2-4c73-83a7-b57ff6ecdd79 79a14838-69d2-4c73-83a7-b57ff6ecdd79 TCGA-AC-A3HN-01A-21-A24A-20 NA TCGA-AC-A3HN-01 TCGA-AC-A3HN-01A-11D-A212-05 b7044729-14de-486e-932a-ed425ff476f0 TCGA-AC-A3HN-01 TCGA-AC-A3HN-01A-11D-A20S-09 NA NA TCGA-AC-A3HN-01 NA NA 79a14838-69d2-4c73-83a7-b57ff6ecdd79 NA TCGA-AC-A3HN-01A-11D-A20R-01 TCGA-AC-A3HN-01 NA 79a14838-69d2-4c73-83a7-b57ff6ecdd79 TCGA-AC-A3HN-01A-11D-A20R-01 |
|
|
289 |
TCGA-AC-A3OD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3OD-01 451 0 days High NA NA BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 NA NA TCGA-AC-A3OD 451 0 days 451 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A3OD-F45582 TCGA-AC-A3OD TCGA-AC-A3OD-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -25186 63 NA 0 451 NA NA NA NA NO NA 90-99% NA NA 2013-7-17 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 30 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No MX N1mi T2 Stage IIB TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf A3OD TUMOR FREE NA NA NA NA NA NO YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 7c521ef7-4adf-46ef-ade0-088cbe02223d 7c521ef7-4adf-46ef-ade0-088cbe02223d NA NA TCGA-AC-A3OD-01 TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05 NA TCGA-AC-A3OD-01 TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09 NA NA TCGA-AC-A3OD-01 NA NA 7c521ef7-4adf-46ef-ade0-088cbe02223d NA TCGA-AC-A3OD-01A-11D-A21P-01 TCGA-AC-A3OD-01 NA 7c521ef7-4adf-46ef-ade0-088cbe02223d TCGA-AC-A3OD-01A-11D-A21P-01 |
|
|
290 |
TCGA-AC-A3QP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3QP-01 675 0 days NA NA NA NA BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3QP 675 0 days 675 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Sentinel node biopsy alone NA TCGA-AC-A3QP-F56161 TCGA-AC-A3QP TCGA-AC-A3QP-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -29113 184 NA 0 675 NA NA NA NA NO NA 70-79% 2.2 NA 2014-1-29 FEMALE NA NA NA NA 2+ 30 2.6 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 150 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 true No MX N1mi T2 Stage IIB TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf A3QP TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 4545ed8f-a83b-4049-9504-ba673ecd6d1d 4545ed8f-a83b-4049-9504-ba673ecd6d1d TCGA-AC-A3QP-01A-21-A24A-20 NA TCGA-AC-A3QP-01 TCGA-AC-A3QP-01A-11D-A230-05 334363b1-b6e4-4135-a42d-4d49e62ce2c5 TCGA-AC-A3QP-01 TCGA-AC-A3QP-01A-11D-A22X-09 NA NA TCGA-AC-A3QP-01 NA NA 4545ed8f-a83b-4049-9504-ba673ecd6d1d NA TCGA-AC-A3QP-01A-11D-A22W-01 TCGA-AC-A3QP-01 NA 4545ed8f-a83b-4049-9504-ba673ecd6d1d TCGA-AC-A3QP-01A-11D-A22W-01 |
|
|
291 |
TCGA-AC-A3QQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3QQ-01 734 0 days Iq NA NA BRCA non-CIMP c9 NA NA miRNA c1uster 10 NA NA TCGA-AC-A3QQ 734 0 days 734 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Sentinel node biopsy alone NA TCGA-AC-A3QQ-F66024 TCGA-AC-A3QQ NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -19723 NA NA 0 734 NA NA NA NA NA NA 90-99% NA NA 2014-10-1 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Positive NA NO 5 Close Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No MX N0 (i-) T1c Stage IA NA A3QQ TUMOR FREE NA NA NA NA NA NO YES 70-79% NA NO Primary Tumor 01 Nipple Sparing Total Mastectomy 7th NA YES NO AC Breast NA LIVING 2011 bf9ca847-f30f-4dcf-bb91-a483be8db666 bf9ca847-f30f-4dcf-bb91-a483be8db666 NA NA TCGA-AC-A3QQ-01 TCGA-AC-A3QQ-01A-11D-A22B-05 NA TCGA-AC-A3QQ-01 NA NA NA TCGA-AC-A3QQ-01 NA NA bf9ca847-f30f-4dcf-bb91-a483be8db666 NA TCGA-AC-A3QQ-01A-11D-A227-01 TCGA-AC-A3QQ-01 NA bf9ca847-f30f-4dcf-bb91-a483be8db666 TCGA-AC-A3QQ-01A-11D-A227-01 |
|
|
292 |
TCGA-AC-A3TM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3TM-01 762 0 days Iq NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3TM 762 0 days 762 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Sentinel node biopsy alone NA TCGA-AC-A3TM-F60193 TCGA-AC-A3TM TCGA-AC-A3TM-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -18535 136 NA 0 762 NA NA NA NA NO NA 90-99% 1.9 NA 2014-5-31 FEMALE NA NA NA NA 2+ 60 3.3 1.9 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 160 NO Equivocal Equivocal NO 4 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 2 false No M0 N1mi T3 Stage IIIA TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf A3TM TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 902592e6-c7c5-46b8-b70b-5520df79a8a3 902592e6-c7c5-46b8-b70b-5520df79a8a3 TCGA-AC-A3TM-01A-21-A24A-20 NA TCGA-AC-A3TM-01 TCGA-AC-A3TM-01A-11D-A22B-05 c53769a6-b6af-4346-9a88-ffa6ffc19bfe TCGA-AC-A3TM-01 TCGA-AC-A3TM-01A-11D-A228-09 NA NA TCGA-AC-A3TM-01 NA NA 902592e6-c7c5-46b8-b70b-5520df79a8a3 NA TCGA-AC-A3TM-01A-11D-A227-01 TCGA-AC-A3TM-01 NA 902592e6-c7c5-46b8-b70b-5520df79a8a3 TCGA-AC-A3TM-01A-11D-A227-01 |
|
|
293 |
TCGA-AC-A3TN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3TN-01 456 0 days Iq NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3TN 456 0 days 456 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A3TN-F60190 TCGA-AC-A3TN TCGA-AC-A3TN-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -27421 78 NA 0 456 NA NA NA NA NO NA 90-99% NA NA 2014-5-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Other method, specify: 140 NO Positive Indeterminate NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T3 Stage IIB TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf A3TN TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 032db552-7828-4ed4-a1d7-b01b7fa89e29 032db552-7828-4ed4-a1d7-b01b7fa89e29 TCGA-AC-A3TN-01A-21-A24A-20 NA TCGA-AC-A3TN-01 TCGA-AC-A3TN-01A-11D-A22B-05 c619a2c9-fbfd-4c44-b40c-3a12259b24c2 TCGA-AC-A3TN-01 TCGA-AC-A3TN-01A-11D-A228-09 NA NA TCGA-AC-A3TN-01 NA NA 032db552-7828-4ed4-a1d7-b01b7fa89e29 NA TCGA-AC-A3TN-01A-11D-A227-01 TCGA-AC-A3TN-01 NA 032db552-7828-4ed4-a1d7-b01b7fa89e29 TCGA-AC-A3TN-01A-11D-A227-01 |
|
|
294 |
TCGA-AC-A3W5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3W5-01 504 0 days High NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3W5 504 0 days 504 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Sentinel node biopsy alone NA TCGA-AC-A3W5-F56177 TCGA-AC-A3W5 TCGA-AC-A3W5-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -24029 120 NA 0 504 NA NA NA NA NA NA 50-59% NA NA 2014-1-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 130 NO NA Positive NO 3 Close NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes MX N0 T2 Stage IIA TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf A3W5 TUMOR FREE NA NA NA NA NA YES YES 30-39% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 3e775d6c-3845-49a7-80e0-82c5c68a473c 3e775d6c-3845-49a7-80e0-82c5c68a473c TCGA-AC-A3W5-01A-21-A24A-20 NA TCGA-AC-A3W5-01 TCGA-AC-A3W5-01A-11D-A22B-05 795bf55f-c58c-45f4-9443-7f9fd1ef4c3e TCGA-AC-A3W5-01 TCGA-AC-A3W5-01A-11D-A228-09 NA NA TCGA-AC-A3W5-01 NA NA 3e775d6c-3845-49a7-80e0-82c5c68a473c NA TCGA-AC-A3W5-01A-11D-A227-01 TCGA-AC-A3W5-01 NA 3e775d6c-3845-49a7-80e0-82c5c68a473c TCGA-AC-A3W5-01A-11D-A227-01 |
|
|
295 |
TCGA-AC-A3W6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3W6-01 602 0 days Iq NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3W6 602 0 days 602 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Sentinel node biopsy alone NA TCGA-AC-A3W6-F57046 TCGA-AC-A3W6 TCGA-AC-A3W6-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -32872 101 NA 0 602 NA NA NA NA NA NA 90-99% NA NA 2014-2-28 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 1+ YES NA Core needle biopsy 140 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 3 false Yes MX N1 T3 Stage IIIA TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf A3W6 TUMOR FREE NA NA NA NA NA NO YES 20-29% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 bfedc051-75dd-44f8-add4-40ec7eabf0b0 bfedc051-75dd-44f8-add4-40ec7eabf0b0 TCGA-AC-A3W6-01A-21-A24A-20 NA TCGA-AC-A3W6-01 TCGA-AC-A3W6-01A-12D-A22B-05 37b78d3f-d378-49c8-970c-8b83f7372aeb TCGA-AC-A3W6-01 TCGA-AC-A3W6-01A-12D-A228-09 NA NA TCGA-AC-A3W6-01 NA NA bfedc051-75dd-44f8-add4-40ec7eabf0b0 NA TCGA-AC-A3W6-01A-12D-A227-01 TCGA-AC-A3W6-01 NA bfedc051-75dd-44f8-add4-40ec7eabf0b0 TCGA-AC-A3W6-01A-12D-A227-01 |
|
|
296 |
TCGA-AC-A3W7-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3W7-01 471 0 days Iq NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AC-A3W7 471 0 days 471 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-AC-A3W7-F57847 TCGA-AC-A3W7 TCGA-AC-A3W7-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -24327 65 NA 0 471 NA NA NA NA NA NA 90-99% NA NA 2014-3-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No MX N1a T2 Stage IIB TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf A3W7 TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 e5636c48-9d0d-42d5-9ac2-31ad566bd168 e5636c48-9d0d-42d5-9ac2-31ad566bd168 TCGA-AC-A3W7-01A-21-A24A-20 NA TCGA-AC-A3W7-01 TCGA-AC-A3W7-01A-11D-A22B-05 1a6ceae8-c0e6-48fe-8ebc-1897613040c1 TCGA-AC-A3W7-01 TCGA-AC-A3W7-01A-11D-A228-09 NA NA TCGA-AC-A3W7-01 NA NA e5636c48-9d0d-42d5-9ac2-31ad566bd168 NA TCGA-AC-A3W7-01A-11D-A227-01 TCGA-AC-A3W7-01 NA e5636c48-9d0d-42d5-9ac2-31ad566bd168 TCGA-AC-A3W7-01A-11D-A227-01 |
|
|
297 |
TCGA-AC-A3YI-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3YI-01 707 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A3YI 707 0 days 707 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A3YI-F61513 TCGA-AC-A3YI TCGA-AC-A3YI-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27143 87 NA 0 707 NA NA NA NA NA NA 90-99% NA NA 2014-6-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 120 NO Positive NA NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 12 NA false No MX N3a T1c Stage IIIC TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf A3YI TUMOR FREE NA NA NA NA NA YES YES 20-29% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 NA NA TCGA-AC-A3YI-01 TCGA-AC-A3YI-01A-21D-A23D-05 NA TCGA-AC-A3YI-01 TCGA-AC-A3YI-01A-21D-A23C-09 NA NA TCGA-AC-A3YI-01 NA NA 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 NA TCGA-AC-A3YI-01A-21D-A238-01 TCGA-AC-A3YI-01 NA 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 TCGA-AC-A3YI-01A-21D-A238-01 |
|
|
298 |
TCGA-AC-A3YJ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A3YJ-01 754 0 days NA NA NA NA BRCA nonbasal-like c8 NA NA NA NA TCGA-AC-A3YJ 754 0 days 754 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Sentinel node biopsy alone NA TCGA-AC-A3YJ-F60187 TCGA-AC-A3YJ TCGA-AC-A3YJ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -24439 114 NA 0 754 NA NA NA NA NA NA NA NA NA 2014-5-31 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8050/3 C50.9 NA YES NA Core needle biopsy 220 NO NA NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf A3YJ TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 5d5982c0-530f-4b2b-b1fb-d70c8168c793 5d5982c0-530f-4b2b-b1fb-d70c8168c793 TCGA-AC-A3YJ-01A-21-A24A-20 NA TCGA-AC-A3YJ-01 TCGA-AC-A3YJ-01A-11D-A230-05 7de47993-6f31-4dd7-8219-b5734464922f TCGA-AC-A3YJ-01 TCGA-AC-A3YJ-01A-11D-A22X-09 NA NA TCGA-AC-A3YJ-01 NA NA 5d5982c0-530f-4b2b-b1fb-d70c8168c793 NA TCGA-AC-A3YJ-01A-11D-A22W-01 TCGA-AC-A3YJ-01 NA 5d5982c0-530f-4b2b-b1fb-d70c8168c793 TCGA-AC-A3YJ-01A-11D-A22W-01 |
|
|
299 |
TCGA-AC-A4ZE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A4ZE-01 890 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A4ZE 890 0 days 890 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-AC-A4ZE-F72379 TCGA-AC-A4ZE TCGA-AC-A4ZE-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23284 169 NA 0 890 NA NA NA NA NA NA NA NA NA 2015-6-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 180 NO Positive NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T3 Stage IIB TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf A4ZE TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 089da1d2-bdac-4ef2-9d59-2d144f77d5da 089da1d2-bdac-4ef2-9d59-2d144f77d5da NA NA TCGA-AC-A4ZE-01 TCGA-AC-A4ZE-01A-11D-A41Q-05 77F57ED3-C635-4292-9D39-987F74C22793 TCGA-AC-A4ZE-01 NA NA NA TCGA-AC-A4ZE-01 NA NA 089da1d2-bdac-4ef2-9d59-2d144f77d5da NA TCGA-AC-A4ZE-01A-11D-A41E-01 TCGA-AC-A4ZE-01 NA 089da1d2-bdac-4ef2-9d59-2d144f77d5da TCGA-AC-A4ZE-01A-11D-A41E-01 |
|
|
300 |
TCGA-AC-A5EH-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A5EH-01 511 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A5EH 511 0 days 511 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A5EH-F60185 TCGA-AC-A5EH NA NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -27964 NA NA 0 511 NA NA NA NA NA NA 20-29% NA NA 2014-5-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 14 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No MX N1mi T2 Stage IIB NA A5EH TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2012 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 NA NA TCGA-AC-A5EH-01 TCGA-AC-A5EH-01A-11D-A28C-05 NA TCGA-AC-A5EH-01 TCGA-AC-A5EH-01A-11D-A28B-09 NA NA TCGA-AC-A5EH-01 NA NA eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 NA TCGA-AC-A5EH-01A-11D-A28A-01 TCGA-AC-A5EH-01 NA eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 TCGA-AC-A5EH-01A-11D-A28A-01 |
|
|
301 |
TCGA-AC-A5EI-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A5EI-01 442 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A5EI 442 0 days 442 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-AC-A5EI-F60184 TCGA-AC-A5EI NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -32375 NA NA 0 442 NA NA NA NA NA NA 90-99% NA NA 2014-5-31 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 9020/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA Yes MX N1mi T1c Stage IB NA A5EI TUMOR FREE NA NA NA NA NA NO YES 60-69% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2012 NA NA NA NA NA TCGA-AC-A5EI-01A-11D-A27Y-05 d26ea3b4-9e10-4e5e-8922-0d4070605764 NA TCGA-AC-A5EI-01A-11D-A27P-09 NA NA TCGA-AC-A5EI-01 NA NA NA NA TCGA-AC-A5EI-01A-11D-A27O-01 TCGA-AC-A5EI-01 NA NA TCGA-AC-A5EI-01A-11D-A27O-01 |
|
|
302 |
TCGA-AC-A5XS-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A5XS-01 588 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A5XS 588 0 days 588 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A5XS-F64108 TCGA-AC-A5XS TCGA-AC-A5XS-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -27160 127 NA 0 588 NA NA NA NA NA NA NA NA NA 2014-8-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative NA NO 8 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false Yes MX N0 T2 Stage IIA TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf A5XS TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 b713b36d-44c7-41ed-82a5-762322472a56 b713b36d-44c7-41ed-82a5-762322472a56 NA NA TCGA-AC-A5XS-01 TCGA-AC-A5XS-01A-11D-A29O-05 5bb0d7f3-6b33-4d61-95e4-1a9006c4b4c3 TCGA-AC-A5XS-01 TCGA-AC-A5XS-01A-11D-A29N-09 NA NA TCGA-AC-A5XS-01 NA NA b713b36d-44c7-41ed-82a5-762322472a56 NA TCGA-AC-A5XS-01A-11D-A29M-01 TCGA-AC-A5XS-01 NA b713b36d-44c7-41ed-82a5-762322472a56 TCGA-AC-A5XS-01A-11D-A29M-01 |
|
|
303 |
TCGA-AC-A5XU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A5XU-01 455 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A5XU 455 0 days 455 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-AC-A5XU-F60181 TCGA-AC-A5XU NA NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -27191 NA NA 0 455 NA NA NA NA NA NA 90-99% NA NA 2014-5-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No MX N0 (i-) T3 Stage IIB NA A5XU TUMOR FREE NA NA NA NA NA YES YES 60-69% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2013 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 NA NA TCGA-AC-A5XU-01 TCGA-AC-A5XU-01A-11D-A28C-05 e6e4ace7-7888-4b68-9662-0b7caa3c68c5 TCGA-AC-A5XU-01 TCGA-AC-A5XU-01A-11D-A28B-09 NA NA TCGA-AC-A5XU-01 NA NA f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 NA TCGA-AC-A5XU-01A-11D-A28A-01 TCGA-AC-A5XU-01 NA f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 TCGA-AC-A5XU-01A-11D-A28A-01 |
|
|
304 |
TCGA-AC-A62V-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AC-A62V-01 348 1 days NA NA NA NA NA NA NA NA NA TCGA-AC-A62V 348 0 days 348 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A62V-F60177 TCGA-AC-A62V TCGA-AC-A62V-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -21389 38 348 0 2 NA NA NA NA NA NA 90-99% NA NA 2014-5-31 MALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO NA NA NO 17 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA NA NA NA NA NA NA NA NA NA NO 3 NA false No M1 N1a T2 Stage IV TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf A62V WITH TUMOR NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A DECEASED 2013 7a356940-c460-4714-a949-42afe6ea5d86 7a356940-c460-4714-a949-42afe6ea5d86 NA NA TCGA-AC-A62V-01 TCGA-AC-A62V-01A-11D-A31V-05 NA TCGA-AC-A62V-01 NA NA NA TCGA-AC-A62V-01 NA NA 7a356940-c460-4714-a949-42afe6ea5d86 NA TCGA-AC-A62V-01A-11D-A31T-01 TCGA-AC-A62V-01 NA 7a356940-c460-4714-a949-42afe6ea5d86 TCGA-AC-A62V-01A-11D-A31T-01 |
|
|
305 |
TCGA-AC-A62X-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A62X-01 417 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A62X 417 0 days 417 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-AC-A62X-F64105 TCGA-AC-A62X TCGA-AC-A62X-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -26627 70 NA 0 417 NA NA NA NA NA NA <10% NA NA 2014-8-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false Yes MX N0 T2 Stage IIA TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf A62X TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2013 cdc523d2-da82-4a3d-a97e-9745c8a802d1 cdc523d2-da82-4a3d-a97e-9745c8a802d1 NA NA TCGA-AC-A62X-01 TCGA-AC-A62X-01A-11D-A29O-05 4956c5cb-1ab4-46c2-8df0-1d71a2a73f15 TCGA-AC-A62X-01 TCGA-AC-A62X-01A-11D-A29N-09 NA NA TCGA-AC-A62X-01 NA NA cdc523d2-da82-4a3d-a97e-9745c8a802d1 NA TCGA-AC-A62X-01A-11D-A29M-01 TCGA-AC-A62X-01 NA cdc523d2-da82-4a3d-a97e-9745c8a802d1 TCGA-AC-A62X-01A-11D-A29M-01 |
|
|
306 |
TCGA-AC-A62Y-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A62Y-01 530 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A62Y 530 0 days 530 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Sentinel node biopsy alone NA TCGA-AC-A62Y-F65833 TCGA-AC-A62Y TCGA-AC-A62Y-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -28876 112 NA 0 530 NA NA NA NA NA NA 90-99% NA NA 2014-9-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 50 NO Negative NA NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No MX N1 T2 Stage IIB TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf A62Y TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 02d9d59b-de6f-41c7-b529-142116debfd9 02d9d59b-de6f-41c7-b529-142116debfd9 NA NA TCGA-AC-A62Y-01 TCGA-AC-A62Y-01A-11D-A29O-05 NA TCGA-AC-A62Y-01 TCGA-AC-A62Y-01A-11D-A29N-09 NA NA TCGA-AC-A62Y-01 NA NA 02d9d59b-de6f-41c7-b529-142116debfd9 NA TCGA-AC-A62Y-01A-11D-A29M-01 TCGA-AC-A62Y-01 NA 02d9d59b-de6f-41c7-b529-142116debfd9 TCGA-AC-A62Y-01A-11D-A29M-01 |
|
|
307 |
TCGA-AC-A6IV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A6IV-01 568 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A6IV 568 0 days 568 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Sentinel node biopsy alone NA TCGA-AC-A6IV-F66023 TCGA-AC-A6IV TCGA-AC-A6IV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -17521 289 NA 0 568 NA NA NA NA NA NA 90-99% NA NA 2014-10-1 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8524/3 C50.9 NA YES NA Core needle biopsy 110 NO Equivocal NA NO 1 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 false No MX N1 T2 Stage IIB TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf A6IV TUMOR FREE NA NA NA NA NA YES YES 60-69% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2012 253e692f-71db-4a5a-b2f4-9e640ef831a2 253e692f-71db-4a5a-b2f4-9e640ef831a2 NA NA TCGA-AC-A6IV-01 TCGA-AC-A6IV-01A-12D-A33F-05 NA TCGA-AC-A6IV-01 NA NA NA TCGA-AC-A6IV-01 NA NA 253e692f-71db-4a5a-b2f4-9e640ef831a2 NA TCGA-AC-A6IV-01A-12D-A33D-01 TCGA-AC-A6IV-01 NA 253e692f-71db-4a5a-b2f4-9e640ef831a2 TCGA-AC-A6IV-01A-12D-A33D-01 |
|
|
308 |
TCGA-AC-A6IW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A6IW-01 413 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A6IW 413 0 days 413 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-AC-A6IW-F64106 TCGA-AC-A6IW TCGA-AC-A6IW-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -26896 74 NA 0 413 NA NA NA NA NA NA <10% NA NA 2014-8-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf A6IW TUMOR FREE NA NA NA NA NA NO YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2013 fceb1551-4b16-45de-8ba0-7906aa3fe841 fceb1551-4b16-45de-8ba0-7906aa3fe841 NA NA TCGA-AC-A6IW-01 TCGA-AC-A6IW-01A-12D-A33F-05 7FE7ED52-C8B0-4C86-BE4E-BF31EFBEA9BB TCGA-AC-A6IW-01 NA NA NA TCGA-AC-A6IW-01 NA NA fceb1551-4b16-45de-8ba0-7906aa3fe841 NA TCGA-AC-A6IW-01A-12D-A33D-01 TCGA-AC-A6IW-01 NA fceb1551-4b16-45de-8ba0-7906aa3fe841 TCGA-AC-A6IW-01A-12D-A33D-01 |
|
|
309 |
TCGA-AC-A6IX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A6IX-01 373 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A6IX 373 0 days 373 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A6IX-F66025 TCGA-AC-A6IX TCGA-AC-A6IX-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17969 107 NA 0 373 NA NA NA NA NA NA 90-99% NA NA 2014-10-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO NA NA NO 21 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 19 NA false No MX N3a T2 Stage IIIC TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf A6IX TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2013 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 NA NA TCGA-AC-A6IX-01 TCGA-AC-A6IX-01A-12D-A32T-05 A01C3771-F0E8-4514-AE2A-927E852F47D8 TCGA-AC-A6IX-01 NA NA NA TCGA-AC-A6IX-01 NA NA ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 NA TCGA-AC-A6IX-01A-12D-A32H-01 TCGA-AC-A6IX-01 NA ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 TCGA-AC-A6IX-01A-12D-A32H-01 |
|
|
310 |
TCGA-AC-A6IX-06 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A6IX-06 373 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A6IX 373 0 days 373 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AC-A6IX-F66025 TCGA-AC-A6IX TCGA-AC-A6IX-06A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17969 107 NA 0 373 NA NA NA NA NA NA 90-99% NA NA 2014-10-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 40 NO NA NA NO 21 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 19 NA false No MX N3a T2 Stage IIIC TCGA-AC-A6IX.A92859DA-41AD-4CF9-86AF-E4073E6276ED.pdf A6IX TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Metastatic 06 NA 7th NA YES NO AC Breast A LIVING 2013 9d5cd723-da40-47ce-a413-20057593905d 9d5cd723-da40-47ce-a413-20057593905d NA NA NA TCGA-AC-A6IX-06A-11D-A32T-05 NA NA NA NA NA TCGA-AC-A6IX-06 NA NA 9d5cd723-da40-47ce-a413-20057593905d NA NA TCGA-AC-A6IX-06 NA 9d5cd723-da40-47ce-a413-20057593905d NA |
|
|
311 |
TCGA-AC-A6NO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A6NO-01 51 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A6NO 51 0 days 51 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Axillary lymph node dissection alone NA NA TCGA-AC-A6NO TCGA-AC-A6NO-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15996 605 NA 0 51 NA NA NA NA NA NA NA NA NA 2014-4-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 150 NO Negative NA NA 16 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No MX N1a T2 Stage IIB TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf A6NO TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 5055b564-b80d-4003-b1c1-3fe080c99fc1 5055b564-b80d-4003-b1c1-3fe080c99fc1 NA NA TCGA-AC-A6NO-01 TCGA-AC-A6NO-01A-12D-A33F-05 EE1327D4-4700-49EF-84B1-292DE21BB827 TCGA-AC-A6NO-01 NA NA NA TCGA-AC-A6NO-01 NA NA 5055b564-b80d-4003-b1c1-3fe080c99fc1 NA TCGA-AC-A6NO-01A-12D-A33D-01 TCGA-AC-A6NO-01 NA 5055b564-b80d-4003-b1c1-3fe080c99fc1 TCGA-AC-A6NO-01A-12D-A33D-01 |
|
|
312 |
TCGA-AC-A7VB-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A7VB-01 250 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A7VB 250 0 days 250 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AC-A7VB-F66026 TCGA-AC-A7VB NA NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18806 NA NA 0 250 NA NA NA NA NA NA 80-89% NA NA 2014-10-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA NA NO 15 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA NA No MX N1a T1c Stage IIA NA A7VB TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2013 a0059fcb-6adc-47f4-8601-b7eed9e12576 a0059fcb-6adc-47f4-8601-b7eed9e12576 NA NA TCGA-AC-A7VB-01 TCGA-AC-A7VB-01A-11D-A357-05 NA TCGA-AC-A7VB-01 NA NA NA TCGA-AC-A7VB-01 NA NA a0059fcb-6adc-47f4-8601-b7eed9e12576 NA TCGA-AC-A7VB-01A-11D-A350-01 TCGA-AC-A7VB-01 NA a0059fcb-6adc-47f4-8601-b7eed9e12576 TCGA-AC-A7VB-01A-11D-A350-01 |
|
|
313 |
TCGA-AC-A7VC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A7VC-01 1 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A7VC 1 0 days 1 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Sentinel node biopsy alone NA NA TCGA-AC-A7VC NA NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -20479 NA NA 0 1 NA NA NA NA NA NA NA NA NA 2014-3-29 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No MX N0 T3 Stage IIB NA A7VC TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2013 f88a5259-4413-4d0c-9083-600d74caffbc f88a5259-4413-4d0c-9083-600d74caffbc NA NA TCGA-AC-A7VC-01 TCGA-AC-A7VC-01A-11D-A357-05 NA TCGA-AC-A7VC-01 NA NA NA TCGA-AC-A7VC-01 NA NA f88a5259-4413-4d0c-9083-600d74caffbc NA TCGA-AC-A7VC-01A-11D-A350-01 TCGA-AC-A7VC-01 NA f88a5259-4413-4d0c-9083-600d74caffbc TCGA-AC-A7VC-01A-11D-A350-01 |
|
|
314 |
TCGA-AC-A8OP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A8OP-01 614 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A8OP 614 0 days 614 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Right Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-AC-A8OP-F66027 TCGA-AC-A8OP TCGA-AC-A8OP-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -26550 921 NA 0 614 NA NA NA NA NA NA 90-99% NA NA 2014-10-1 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Indeterminate NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf A8OP TUMOR FREE NA NA NA NA NA YES YES 10-19% NA NO Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 NA NA TCGA-AC-A8OP-01 TCGA-AC-A8OP-01A-11D-A36K-05 NA TCGA-AC-A8OP-01 NA NA NA TCGA-AC-A8OP-01 NA NA 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 NA TCGA-AC-A8OP-01A-11D-A36I-01 TCGA-AC-A8OP-01 NA 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 TCGA-AC-A8OP-01A-11D-A36I-01 |
|
|
315 |
TCGA-AC-A8OQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A8OQ-01 34 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A8OQ 34 0 days 34 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Right Upper Outer Quadrant Sentinel node biopsy alone NA NA TCGA-AC-A8OQ TCGA-AC-A8OQ-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -26535 742 NA 0 34 NA NA NA NA NA NA NA NA NA 2014-2-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 100 NO Indeterminate NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No MX N1a T2 Stage IIB TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf A8OQ TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2011 cca6f765-44ff-4540-a961-0a2be4e41f93 cca6f765-44ff-4540-a961-0a2be4e41f93 NA NA TCGA-AC-A8OQ-01 TCGA-AC-A8OQ-01A-11D-A41Q-05 4B47C521-A9C2-4CF0-91BB-27DD99200EC7 TCGA-AC-A8OQ-01 NA NA NA TCGA-AC-A8OQ-01 NA NA cca6f765-44ff-4540-a961-0a2be4e41f93 NA TCGA-AC-A8OQ-01A-11D-A41E-01 TCGA-AC-A8OQ-01 NA cca6f765-44ff-4540-a961-0a2be4e41f93 TCGA-AC-A8OQ-01A-11D-A41E-01 |
|
|
316 |
TCGA-AC-A8OR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A8OR-01 40 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A8OR 40 0 days 40 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Sentinel node biopsy alone NA NA TCGA-AC-A8OR TCGA-AC-A8OR-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -27605 98 NA 0 40 NA NA NA NA NA NA 90-99% NA NA 2014-2-26 FEMALE NA NA <10% NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf A8OR TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NA Primary Tumor 01 NA 7th NA YES NO AC Breast A LIVING 2013 15c73666-b316-4108-97e9-9d0e40540a2c 15c73666-b316-4108-97e9-9d0e40540a2c NA NA TCGA-AC-A8OR-01 TCGA-AC-A8OR-01A-21D-A41Q-05 NA TCGA-AC-A8OR-01 NA NA NA TCGA-AC-A8OR-01 NA NA 15c73666-b316-4108-97e9-9d0e40540a2c NA TCGA-AC-A8OR-01A-21D-A41E-01 TCGA-AC-A8OR-01 NA 15c73666-b316-4108-97e9-9d0e40540a2c TCGA-AC-A8OR-01A-21D-A41E-01 |
|
|
317 |
TCGA-AC-A8OS-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AC-A8OS-01 70 0 days NA NA NA NA NA NA NA NA NA TCGA-AC-A8OS 70 0 days 70 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Upper Outer Quadrant Sentinel node biopsy alone NA NA TCGA-AC-A8OS NA NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -26248 NA NA 0 70 NA NA NA NA NA NA 90-99% NA NA 2014-2-26 FEMALE NA NA 10-19% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Positive NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No MX N0 (i-) T2 Stage IIA NA A8OS TUMOR FREE NA NA NA NA NA NA YES <10% NA NA Primary Tumor 01 NA 7th NA YES NO AC Breast NA LIVING 2013 c119a170-e1ba-4965-a9c6-5c0b41ceefba c119a170-e1ba-4965-a9c6-5c0b41ceefba NA NA TCGA-AC-A8OS-01 TCGA-AC-A8OS-01A-12D-A41Q-05 NA TCGA-AC-A8OS-01 NA NA NA TCGA-AC-A8OS-01 NA NA c119a170-e1ba-4965-a9c6-5c0b41ceefba NA TCGA-AC-A8OS-01A-12D-A41E-01 TCGA-AC-A8OS-01 NA c119a170-e1ba-4965-a9c6-5c0b41ceefba TCGA-AC-A8OS-01A-12D-A41E-01 |
|
|
318 |
TCGA-AN-A03X-01 Stage IIA 74 4 No_Conversion 10 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 10 0 LumA Luminal A Positive NA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A03X-01 10 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A03X NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A03X-F68976 TCGA-AN-A03X NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -27163 NA NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Positive NA YES 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 0 0 NA No M0 N0 T2 Stage IIA NA A03X TUMOR FREE NA NA NA 200 200 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast NA LIVING 2010 ae97b841-ddef-4bed-81ac-0b91627c4ef3 ae97b841-ddef-4bed-81ac-0b91627c4ef3 NA TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01 NA NA TCGA-AN-A03X-01 TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01A-21D-A00Y-05 TCGA-AN-A03X-01 NA TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01 ae97b841-ddef-4bed-81ac-0b91627c4ef3 TCGA-AN-A03X-01 TCGA-AN-A03X-01A-21D-A011-01 NA TCGA-AN-A03X-01A-21R-A00Z-07 ae97b841-ddef-4bed-81ac-0b91627c4ef3 TCGA-AN-A03X-01A-21D-A011-01 TCGA-AN-A03X-01 |
|
|
319 |
TCGA-AN-A03Y-01 Stage IIA 66 3 No_Conversion 10 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 10 0 LumB Luminal B Positive NA -1 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A03Y-01 10 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation cluster 4 TCGA-AN-A03Y NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A03Y-F68977 TCGA-AN-A03Y TCGA-AN-A03Y-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -24232 36 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 160 NO Negative NA YES 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831.pdf A03Y TUMOR FREE NA NA NA 210 210 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 7509b7dc-18cc-4430-ad93-fa598fc97330 7509b7dc-18cc-4430-ad93-fa598fc97330 NA TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01 NA NA TCGA-AN-A03Y-01 TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01A-21D-A00Y-05 TCGA-AN-A03Y-01 NA TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01 7509b7dc-18cc-4430-ad93-fa598fc97330 TCGA-AN-A03Y-01 TCGA-AN-A03Y-01A-21D-A011-01 NA TCGA-AN-A03Y-01A-21R-A00Z-07 7509b7dc-18cc-4430-ad93-fa598fc97330 TCGA-AN-A03Y-01A-21D-A011-01 TCGA-AN-A03Y-01 |
|
|
320 |
TCGA-AN-A041-01 Stage IIB 29 5 Stage IIB 7 NA Positive FEMALE Equivocal 1 3 4 Negative M0 Positive N1 7 0 LumA Luminal B Negative LumA -2 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A041-01 7 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A041 NA NA days 7 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Left Upper Outer Quadrant NA NA TCGA-AN-A041-F68971 TCGA-AN-A041 NA NA Positive NA NA NA NA Negative NA NA NA NA NA -10812 NA NA 0 7 NA NA NA NA NO NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Positive NA YES 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 1 NA NA No M0 N1a T2 Stage IIB NA A041 TUMOR FREE NA NA NA 0 170 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast NA LIVING 2010 dc131436-aa38-4601-a42e-e3ad746d5be3 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01A-31-A13A-20 TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01 NA a64d4ca5-a6f8-4e09-9278-c8f7e2d88e86 TCGA-AN-A041-01 TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01A-11D-A032-05 TCGA-AN-A041-01 NA TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01 TCGA-AN-A041-01A-11D-A036-01 NA TCGA-AN-A041-01A-11R-A034-07 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01A-11D-A036-01 TCGA-AN-A041-01 |
|
|
321 |
TCGA-AN-A046-01 Stage IIA 68 2 No_Conversion 10 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 10 0 LumA Luminal A Positive NA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A046-01 10 0 days Iq NA cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 NA TCGA-AN-A046 NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Lower Inner Quadrant No axillary staging NA TCGA-AN-A046-F68972 TCGA-AN-A046 TCGA-AN-A046-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -25158 27 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 150 NO Negative NA NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6.pdf A046 TUMOR FREE NA 0 NA 108 205 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 20eb1da4-ef70-49dd-956f-18d65725ba27 20eb1da4-ef70-49dd-956f-18d65725ba27 NA NA TCGA-AN-A046-01 NA NA TCGA-AN-A046-01 TCGA-AN-A046-01A-21W-A050-09 TCGA-AN-A046-01A-21D-A032-05 TCGA-AN-A046-01 NA NA TCGA-AN-A046-01 20eb1da4-ef70-49dd-956f-18d65725ba27 TCGA-AN-A046-01 TCGA-AN-A046-01A-21D-A036-01 NA TCGA-AN-A046-01A-21R-A034-07 20eb1da4-ef70-49dd-956f-18d65725ba27 TCGA-AN-A046-01A-21D-A036-01 TCGA-AN-A046-01 |
|
|
322 |
TCGA-AN-A049-01 Stage IIA 62 5 No_Conversion 19 NA Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 19 0 LumA Luminal B Positive ReacI 0 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A049-01 19 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AN-A049 NA NA days 19 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A049-F68978 TCGA-AN-A049 TCGA-AN-A049-01A NA Positive NA 2+ NA Modified radical mastectomy Positive Simple Mastectomy NA NO NA NA -22710 769 NA 0 19 NA NA NA NA NA Allred (Biocare) NA NA NA 2014-12-24 FEMALE NA Dako Hercept test NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 330 NO Negative NA YES 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A049.8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D.pdf A049 TUMOR FREE Allred (Biocare) NA NA 100 80 NA NA NA NA NA Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2008 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01A-31-A13A-20 TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01 NA e292a5df-0dcf-4760-92cf-7bb2c8f69e1e TCGA-AN-A049-01 TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01A-21D-A00Y-05 TCGA-AN-A049-01 NA TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01 TCGA-AN-A049-01A-21D-A011-01 NA TCGA-AN-A049-01A-21R-A00Z-07 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01A-21D-A011-01 TCGA-AN-A049-01 |
|
|
323 |
TCGA-AN-A04A-01 Stage IIIA 36 5 No_Conversion 89 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 89 0 LumA Luminal A Positive LumA/B -5 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A04A-01 90 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A04A NA NA days 90 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Left Lower Inner Quadrant|Left Lower Outer Quadrant No axillary staging NA TCGA-AN-A04A-F68973 TCGA-AN-A04A TCGA-AN-A04A-01A NA Positive NA 1+ NA Modified radical mastectomy Positive Simple Mastectomy NA NO NA NA -13445 743 NA 0 90 NA NA NA NA NA Allred (Biocare) NA NA NA 2014-12-24 FEMALE NA Dako Hercept test NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Tumor resection 370 NO Negative NA YES 7 Positive Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 4 0 true No M0 N2 T2 Stage IIIA TCGA-AN-A04A.6FB7A794-C3E7-4501-A844-CF65B9C3D32C.pdf A04A TUMOR FREE Allred (Biocare) 0 NA 87 112 NA NA NA NA NA Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2008 7e09faf6-137d-4d33-98dd-80c48af7ebab 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01A-11-A13A-20 TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01 NA 08c6c9ec-04e4-4ce9-8b57-b35f8e562e32 TCGA-AN-A04A-01 TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01A-21D-A032-05 TCGA-AN-A04A-01 NA TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01 TCGA-AN-A04A-01A-21D-A036-01 NA TCGA-AN-A04A-01A-21R-A034-07 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01A-21D-A036-01 TCGA-AN-A04A-01 |
|
|
324 |
TCGA-AN-A04C-01 Stage IIB 51 3 No_Conversion 54 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 54 0 Her2 HER2-enriched Negative NA -11 -9 enrollment T_Other T2 LIVING 0 TCGA-AN-A04C-01 54 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 5 mutation cluster 3 TCGA-AN-A04C NA NA days 54 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A04C-F68974 TCGA-AN-A04C NA NA Negative NA 0 NA Modified radical mastectomy Negative Simple Mastectomy NA NO NA NA -18851 NA NA 0 54 NA NA NA NA NA Allred (Biocare) NA NA NA 2014-12-24 FEMALE NA Dako Hecept Test NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Tumor resection NA NA Positive NA YES 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NA 2 0 NA No M0 N1 T2 Stage IIB NA A04C TUMOR FREE Allred (Biocare) NA NA 0 0 NA NA NA NA NA Primary Tumor 01 NA NA NA NO YES AN Breast NA LIVING 2008 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 NA TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01 NA NA TCGA-AN-A04C-01 TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01A-21D-A032-05 TCGA-AN-A04C-01 NA TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 TCGA-AN-A04C-01 TCGA-AN-A04C-01A-21D-A036-01 NA TCGA-AN-A04C-01A-21R-A034-07 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 TCGA-AN-A04C-01A-21D-A036-01 TCGA-AN-A04C-01 |
|
|
325 |
TCGA-AN-A04D-01 Stage IIB 58 1 No_Conversion 52 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 52 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A04D-01 52 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AN-A04D NA NA days 52 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A04D-F68975 TCGA-AN-A04D NA NA Negative NA 0 NA Modified radical mastectomy Negative Simple Mastectomy NA NO NA NA -21426 NA NA 0 52 NA NA NA NA NA Allred (Biocare) NA NA NA 2014-12-24 FEMALE NA Dako Hercept Test NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Tumor resection NA NA Negative NA YES 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 2 0 NA No M0 N1 T2 Stage IIB NA A04D TUMOR FREE Allred (Biocare) NA NA 0 0 NA NA NA NA NA Primary Tumor 01 NA NA NA NO YES AN Breast NA LIVING 2008 a09baab9-3eac-4271-9c12-2684642f8869 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01A-31-A13A-20 TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01 NA e48b250c-b634-4bfb-90e4-c2e1c0069400 TCGA-AN-A04D-01 TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01A-21D-A032-05 TCGA-AN-A04D-01 NA TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01 TCGA-AN-A04D-01A-21D-A036-01 NA TCGA-AN-A04D-01A-21R-A034-07 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01A-21D-A036-01 TCGA-AN-A04D-01 |
|
|
326 |
TCGA-AN-A0AJ-01 Stage IIB 79 5 No_Conversion 243 NA Positive FEMALE Positive 1 1 4 Negative M0 Negative N0 243 0 LumB Luminal B Positive LumA -2 -5 enrollment T_Other T3 LIVING 0 TCGA-AN-A0AJ-01 303 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AN-A0AJ 303 0 days 303 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0AJ-F68941 TCGA-AN-A0AJ TCGA-AN-A0AJ-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -29131 63 NA 0 303 NA NA NA NA NA dextran coated charcoal 80-89% NA NA 2014-12-23 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8522/3 C50.9 3+ YES NA Tumor resection 310 NO Positive NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T3 Stage IIB TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf A0AJ TUMOR FREE dextran coated charcoal NA NA 120 230 NO NA 40-49% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 cc92e983-2367-4353-ac01-88851fd0f71e cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01A-21-A13B-20 TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01 NA 69d158b2-9c07-471c-a594-36551fb6f7f3 TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01A-11D-A00Y-05 TCGA-AN-A0AJ-01 NA TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01 cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01A-11D-A011-01 NA TCGA-AN-A0AJ-01A-11R-A00Z-07 cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01A-11D-A011-01 TCGA-AN-A0AJ-01 |
|
|
327 |
TCGA-AN-A0AK-01 Stage IIA 76 1 No_Conversion 223 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 223 0 LumB Luminal B Negative Basal -10 -5 enrollment T_Other T2 LIVING 0 TCGA-AN-A0AK-01 224 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 NA TCGA-AN-A0AK 224 0 days 224 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0AK-F68942 TCGA-AN-A0AK TCGA-AN-A0AK-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -27977 58 NA 0 224 NA NA NA NA NA dextran coated charcoal 80-89% NA NA 2014-12-23 FEMALE NA NA 70-79% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 290 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf A0AK TUMOR FREE dextran coated charcoal NA NA NA 230 NO NA <10% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01A-11-A13B-20 NA TCGA-AN-A0AK-01 NA d4158db7-366b-400e-af77-9a6db7eec59c TCGA-AN-A0AK-01 TCGA-AN-A0AK-01A-21W-A019-09 TCGA-AN-A0AK-01A-21D-A00Y-05 TCGA-AN-A0AK-01 NA NA TCGA-AN-A0AK-01 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01 TCGA-AN-A0AK-01A-21D-A011-01 NA TCGA-AN-A0AK-01A-21R-A00Z-07 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01A-21D-A011-01 TCGA-AN-A0AK-01 |
|
|
328 |
TCGA-AN-A0AL-01 Stage IIIB 41 1 No_Conversion 197 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 197 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T4 LIVING 0 TCGA-AN-A0AL-01 227 0 days Squamous C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AN-A0AL 227 0 days 227 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0AL-F68944 TCGA-AN-A0AL TCGA-AN-A0AL-01A NA Negative NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -15286 49 NA 0 227 NA NA NA NA NA dextran coated charcoal <10% NA NA 2014-12-23 FEMALE NA dextran coated charcoal <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Tumor resection 300 NO Negative NA NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T4 Stage IIIB TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf A0AL TUMOR FREE dextran coated charcoal NA NA NA NA NO NA <10% NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 467314d6-f946-447f-920a-d33b60f66eb2 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01A-21-A13B-20 TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01 NA b689bc66-7909-4edc-a0e1-701ffcd1a602 TCGA-AN-A0AL-01 TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01A-11D-A00Y-05 TCGA-AN-A0AL-01 NA TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01 TCGA-AN-A0AL-01A-11D-A011-01 NA TCGA-AN-A0AL-01A-11R-A00Z-07 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01A-11D-A011-01 TCGA-AN-A0AL-01 |
|
|
329 |
TCGA-AN-A0AM-01 Stage IIA 56 3 No_Conversion 5 NA Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 5 0 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 LIVING 0 TCGA-AN-A0AM-01 5 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0AM NA NA days 5 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0AM-F68945 TCGA-AN-A0AM TCGA-AN-A0AM-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -20713 47 NA 0 5 NA NA NA NA NA NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 350 NO Negative NA YES 20 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf A0AM TUMOR FREE NA 0 NA 0 205 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 6050d8b9-2d10-4a03-ae57-979cba25bb70 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01A-21-A13B-20 TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01 NA a2edc1b2-9932-44f8-9135-cf6ec465f84d TCGA-AN-A0AM-01 TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01A-11D-A032-05 TCGA-AN-A0AM-01 NA TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01 TCGA-AN-A0AM-01A-11D-A036-01 NA TCGA-AN-A0AM-01A-11R-A034-07 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01A-11D-A036-01 TCGA-AN-A0AM-01 |
|
|
330 |
TCGA-AN-A0AR-01 Stage IIA 55 1 No_Conversion 9 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 9 0 NA Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A0AR-01 10 0 days Squamous C8-BLCA cluster 5 Cluster 5 BRCA basal-like c6 NA miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0AR NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Upper Inner Quadrant No axillary staging NA TCGA-AN-A0AR-F68946 TCGA-AN-A0AR TCGA-AN-A0AR-01A NA Negative NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -20152 34 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-23 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Tumor resection 150 NO Negative NA YES 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf A0AR TUMOR FREE NA NA NA NA NA NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 12c36b7c-f302-4cea-bb4f-5a01211e00e9 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01A-21-A13B-20 TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01 NA a18bbbc7-9c94-4fe9-a927-5c07be69428c TCGA-AN-A0AR-01 TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01A-11D-A00Y-05 TCGA-AN-A0AR-01 NA TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01 TCGA-AN-A0AR-01A-11D-A011-01 NA TCGA-AN-A0AR-01A-11R-A00Z-07 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01A-11D-A011-01 TCGA-AN-A0AR-01 |
|
|
331 |
TCGA-AN-A0AS-01 Stage IIIA 70 3 No_Conversion 9 NA Positive FEMALE Negative 3 3 4 Negative M0 Positive N2 9 0 LumA Luminal B Negative Basal -1 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0AS-01 10 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AN-A0AS NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0AS-F68947 TCGA-AN-A0AS TCGA-AN-A0AS-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -25658 33 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-23 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 290 NO Negative NA YES 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 4 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf A0AS TUMOR FREE NA NA NA 0 190 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 e866475d-4919-4bf6-920e-5390720d15bf e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01A-21-A13B-20 TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01 NA 52341dad-b2bf-4985-bb60-4921675983de TCGA-AN-A0AS-01 TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01A-11D-A00Y-05 TCGA-AN-A0AS-01 NA TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01 e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01 TCGA-AN-A0AS-01A-11D-A011-01 NA TCGA-AN-A0AS-01A-11R-A00Z-07 e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01A-11D-A011-01 TCGA-AN-A0AS-01 |
|
|
332 |
TCGA-AN-A0AT-01 Stage IIA 62 1 No_Conversion 10 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 10 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AN-A0AT-01 10 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation c1uster 9 TCGA-AN-A0AT NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Inner Quadrant No axillary staging NA TCGA-AN-A0AT-F68948 TCGA-AN-A0AT NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22798 NA NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NA 0 0 NA No M0 N0 T2 Stage IIA NA A0AT TUMOR FREE NA 0 NA 0 0 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast NA LIVING 2010 edda9023-a8d9-45dc-af21-5bba663967e4 edda9023-a8d9-45dc-af21-5bba663967e4 TCGA-AN-A0AT-01A-21-A13C-20 TCGA-AN-A0AT-01A-11D-A045-09 TCGA-AN-A0AT-01 NA d29e84ac-dc3b-4139-950c-fd197d9ca11f TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11D-A045-09 TCGA-AN-A0AT-01A-11D-A032-05 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11D-A045-09 NA edda9023-a8d9-45dc-af21-5bba663967e4 NA TCGA-AN-A0AT-01A-11D-A036-01 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11R-A034-07 edda9023-a8d9-45dc-af21-5bba663967e4 TCGA-AN-A0AT-01A-11D-A036-01 TCGA-AN-A0AT-01 |
|
|
333 |
TCGA-AN-A0FD-01 Stage IIA 71 1 No_Conversion 195 NA Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 195 0 LumA Luminal A Positive LumA/B -8 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FD-01 196 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FD NA NA days 196 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FD-F68949 TCGA-AN-A0FD TCGA-AN-A0FD-01A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -26007 84 NA 0 196 NA NA NA NA NA dextran coated charcoal 80-89% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 60-69% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 260 NO Positive Positive YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3.pdf A0FD TUMOR FREE dextran coated charcoal NA NA NA NA NO NA 10-19% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 3264f809-4bbf-48e6-bbfd-77eaca9e602e 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01A-21-A13C-20 TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01 NA aecc7da7-67e1-41cb-b17f-5be1e6c55e34 TCGA-AN-A0FD-01 TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01A-11D-A032-05 TCGA-AN-A0FD-01 NA TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01 TCGA-AN-A0FD-01A-11D-A036-01 NA TCGA-AN-A0FD-01A-11R-A034-07 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01A-11D-A036-01 TCGA-AN-A0FD-01 |
|
|
334 |
TCGA-AN-A0FE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FE-01 NA NA days NA NA NA NA NA NA NA NA NA TCGA-AN-A0FE NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FE-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 330 NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA false NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FE-01A-11D-A00Y-05 NA NA NA NA NA NA NA NA TCGA-AN-A0FE-01A-11R-A00Z-07 NA NA |
|
|
335 |
TCGA-AN-A0FF-01 Stage IA 32 3 No_Conversion 140 NA Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 140 0 LumB Luminal B Positive LumA 0 -3 enrollment T1 T1 LIVING 0 TCGA-AN-A0FF-01 172 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AN-A0FF 172 0 days 172 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 32 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FF-F68943 TCGA-AN-A0FF TCGA-AN-A0FF-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -11929 75 NA 0 172 NA NA NA NA NA dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA dextran coated charcoal <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 300 NO Negative NA NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T1b Stage IA TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf A0FF TUMOR FREE dextran coated charcoal NA NA NA NA NO NA 90-99% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 7a5bc56e-e787-4798-8c4d-ee792f9e3149 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01A-21-A13C-20 TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01 NA 87bf53e1-aab3-44d0-a641-3464095b9a51 TCGA-AN-A0FF-01 TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01A-11D-A032-05 TCGA-AN-A0FF-01 NA TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01 TCGA-AN-A0FF-01A-11D-A036-01 NA TCGA-AN-A0FF-01A-11R-A034-07 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01A-11D-A036-01 TCGA-AN-A0FF-01 |
|
|
336 |
TCGA-AN-A0FG-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FG-01 NA NA days NA NA NA NA NA NA NA NA NA TCGA-AN-A0FG NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FG-01A NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 400 NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA false NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA NA NA NA NA NA NA A NA NA NA NA NA NA NA NA NA NA NA TCGA-AN-A0FG-01A-11D-A00Y-05 NA NA NA NA NA NA NA NA TCGA-AN-A0FG-01A-11R-A00Z-07 NA NA |
|
|
337 |
TCGA-AN-A0FJ-01 Stage IV 59 1 No_Conversion 241 NA Positive FEMALE Negative 2 2 2 Negative M0 Positive N2 241 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FJ-01 242 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0FJ NA NA days 242 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FJ-F68950 TCGA-AN-A0FJ NA NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -21910 NA NA 0 242 NA NA NA NA NA dextran coated charcoal 10-19% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 40-49% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Tumor resection NA NA Positive NA YES 14 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 8 0 NA No M1 N2 T2 Stage IV NA A0FJ TUMOR FREE dextran coated charcoal NA NA NA NA NO NA <10% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast NA LIVING 2010 d6b8993f-e850-47a9-842d-ef6173866780 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01A-21-A13A-20 TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01 NA d2876882-dd7e-43af-b066-d578da1f8f3d TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01A-11D-A00Y-05 TCGA-AN-A0FJ-01 NA TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01A-11D-A011-01 NA TCGA-AN-A0FJ-01A-11R-A00Z-07 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01A-11D-A011-01 TCGA-AN-A0FJ-01 |
|
|
338 |
TCGA-AN-A0FK-01 Stage IIIB 88 2 No_Conversion 212 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 212 0 LumA Luminal B Positive LumA -12 -3 enrollment T_Other T4 LIVING 0 TCGA-AN-A0FK-01 213 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FK NA NA days 213 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FK-F68951 TCGA-AN-A0FK TCGA-AN-A0FK-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -32462 69 NA 0 213 NA NA NA NA NA dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 20-29% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 340 NO Positive NA YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T4 Stage IIIB TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf A0FK TUMOR FREE dextran coated charcoal NA NA 230 230 NO NA 90-99% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 570ee0fd-7003-45ce-9c42-8f6145604186 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01A-21-A13A-20 TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01 NA 2030c965-6cfa-4164-b5c9-222e1d522f58 TCGA-AN-A0FK-01 TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01A-11D-A032-05 TCGA-AN-A0FK-01 NA TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01 TCGA-AN-A0FK-01A-11D-A036-01 NA TCGA-AN-A0FK-01A-11R-A034-07 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01A-11D-A036-01 TCGA-AN-A0FK-01 |
|
|
339 |
TCGA-AN-A0FL-01 Stage IIA 62 1 No_Conversion 230 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 230 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FL-01 231 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0FL NA NA days 231 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FL-F68952 TCGA-AN-A0FL TCGA-AN-A0FL-01A NA Negative NA 1+ NA NA Negative Modified Radical Mastectomy NA NO NA NA -22805 69 NA 0 231 NA NA NA NA NA dextran coated charcoal <10% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 20-29% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Tumor resection 310 NO Positive NA YES 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf A0FL TUMOR FREE dextran coated charcoal NA NA NA NA NO NA <10% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 299add94-3b97-41a6-9fd4-c572f88982d5 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01A-21-A13A-20 TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01 NA ef3ba9e1-e1ca-477a-8700-37e88c048655 TCGA-AN-A0FL-01 TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01A-11D-A032-05 TCGA-AN-A0FL-01 NA TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01 TCGA-AN-A0FL-01A-11D-A036-01 NA TCGA-AN-A0FL-01A-11R-A034-07 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01A-11D-A036-01 TCGA-AN-A0FL-01 |
|
|
340 |
TCGA-AN-A0FN-01 Stage IB 61 1 No_Conversion 218 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 218 0 LumA Luminal A Positive NA -5 -7 enrollment T1 T1 LIVING 0 TCGA-AN-A0FN-01 218 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FN NA NA days 218 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FN-F68953 TCGA-AN-A0FN TCGA-AN-A0FN-01A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -22629 57 NA 0 218 NA NA NA NA NA dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 20-29% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 110 NO Positive NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf A0FN TUMOR FREE dextran coated charcoal NA NA NA 250 NO NA 10-19% NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 4aac7c40-db6b-4648-a82a-7bf397de913a 4aac7c40-db6b-4648-a82a-7bf397de913a NA TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01 NA NA TCGA-AN-A0FN-01 TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01A-11D-A032-05 TCGA-AN-A0FN-01 NA TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01 4aac7c40-db6b-4648-a82a-7bf397de913a TCGA-AN-A0FN-01 TCGA-AN-A0FN-01A-11D-A036-01 NA TCGA-AN-A0FN-01A-11R-A034-07 4aac7c40-db6b-4648-a82a-7bf397de913a TCGA-AN-A0FN-01A-11D-A036-01 TCGA-AN-A0FN-01 |
|
|
341 |
TCGA-AN-A0FS-01 Stage IB 55 2 No_Conversion 191 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 191 0 LumA Luminal A Negative ReacII -5 -7 enrollment T1 T1 LIVING 0 TCGA-AN-A0FS-01 210 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AN-A0FS NA NA days 210 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FS-F68954 TCGA-AN-A0FS TCGA-AN-A0FS-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -20352 44 NA 0 210 NA NA NA NA NA dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA dextran coated charcoal 20-29% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 170 NO Positive NA YES 14 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf A0FS TUMOR FREE dextran coated charcoal NA NA NA 230 NO NA <10% NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 29ac13ea-a350-42e9-a3eb-024c537ead94 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01A-21-A13C-20 TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01 NA 9cc29dc5-b324-4ee3-b94b-42a1f5927ae9 TCGA-AN-A0FS-01 TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01A-11D-A032-05 TCGA-AN-A0FS-01 NA TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01 TCGA-AN-A0FS-01A-11D-A036-01 NA TCGA-AN-A0FS-01A-11R-A034-07 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01A-11D-A036-01 TCGA-AN-A0FS-01 |
|
|
342 |
TCGA-AN-A0FT-01 Stage IIB 63 3 No_Conversion 183 NA Positive FEMALE Positive 4 5 3 Negative M0 Positive N1 183 0 LumA Luminal A Positive Her2 -2 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FT-01 214 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 5 mutation cluster 5 TCGA-AN-A0FT NA NA days 214 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0FT-F68964 TCGA-AN-A0FT TCGA-AN-A0FT-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -23300 44 NA 0 214 NA NA NA NA NA dextran coated charcoal 90-99% NA NA 2014-12-24 FEMALE NA dextran coated charcoal 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Positive NA YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NA 1 0 false No M0 N1 T2 Stage IIB TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf A0FT TUMOR FREE dextran coated charcoal NA NA NA 230 NO NA 90-99% NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 ae592879-5689-4818-8ac3-23a00c5d3934 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01A-21-A13C-20 TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01 NA 3953f300-15f9-4c43-a4a2-cc7d1c056d59 TCGA-AN-A0FT-01 TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01A-11D-A032-05 TCGA-AN-A0FT-01 NA TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01 TCGA-AN-A0FT-01A-11D-A036-01 NA TCGA-AN-A0FT-01A-11R-A034-07 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01A-11D-A036-01 TCGA-AN-A0FT-01 |
|
|
343 |
TCGA-AN-A0FV-01 Stage IIA 58 1 No_Conversion 10 NA Negative FEMALE Positive 1 1 1 Negative M0 Negative N0 10 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FV-01 10 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-AN-A0FV NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant No axillary staging NA TCGA-AN-A0FV-F68965 TCGA-AN-A0FV TCGA-AN-A0FV-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21479 42 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 180 NO Positive NA YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf A0FV TUMOR FREE NA NA NA 0 0 NO NA NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 600db536-d7c5-4cfa-bb80-fcc269b96b8c 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01A-21-A13A-20 TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01 NA db678c4c-245c-4438-9e57-6daad3be0250 TCGA-AN-A0FV-01 TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01A-11D-A00Y-05 TCGA-AN-A0FV-01 NA TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01 TCGA-AN-A0FV-01A-11D-A011-01 NA TCGA-AN-A0FV-01A-11R-A00Z-07 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01A-11D-A011-01 TCGA-AN-A0FV-01 |
|
|
344 |
TCGA-AN-A0FW-01 Stage IIIA 67 3 No_Conversion 11 NA Positive FEMALE Negative 4 3 3 Negative M0 Positive N2 11 0 LumA Luminal A Indeterminate LumA/B -4 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FW-01 11 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AN-A0FW 11 0 days 11 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0FW-F68966 TCGA-AN-A0FW TCGA-AN-A0FW-01A NA Positive NA NA NA NA Indeterminate Modified Radical Mastectomy NA NO NA NA -24692 41 NA 0 11 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 180 NO Negative NA YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 2 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf A0FW TUMOR FREE NA NA NA 10 180 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 34b7764e-748a-415c-84b5-c45d0932e642 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01A-21-A13C-20 TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01 NA 3eec78cf-bead-4279-b0b3-60b9dea9496f TCGA-AN-A0FW-01 TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01A-11D-A032-05 TCGA-AN-A0FW-01 NA TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01 TCGA-AN-A0FW-01A-11D-A036-01 NA TCGA-AN-A0FW-01A-11R-A034-07 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01A-11D-A036-01 TCGA-AN-A0FW-01 |
|
|
345 |
TCGA-AN-A0FX-01 Stage IIA 52 1 No_Conversion 10 NA Negative FEMALE Negative 1 1 2 Negative M0 Negative N0 10 0 Basal Basal-like Negative ReacII -13 -11 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FX-01 10 0 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AN-A0FX NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0FX-F68967 TCGA-AN-A0FX TCGA-AN-A0FX-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -19309 34 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 230 NO Positive NA YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf A0FX TUMOR FREE NA NA NA 0 0 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 c1dc3f35-324b-4a69-b32c-24652ccf9e3a c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01A-21-A13C-20 TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01 NA 14bd231c-c5f5-4e4a-a2e3-4ee4a17248af TCGA-AN-A0FX-01 TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01A-11D-A032-05 TCGA-AN-A0FX-01 NA TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01 c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01 TCGA-AN-A0FX-01A-11D-A036-01 NA TCGA-AN-A0FX-01A-11R-A034-07 c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01A-11D-A036-01 TCGA-AN-A0FX-01 |
|
|
346 |
TCGA-AN-A0FY-01 Stage IB 55 3 No_Conversion 10 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 10 0 LumB Luminal B Positive LumA -2 -3 enrollment T1 T1 LIVING 0 TCGA-AN-A0FY-01 10 0 days High C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-AN-A0FY NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0FY-F68968 TCGA-AN-A0FY TCGA-AN-A0FY-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20347 34 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 170 NO Negative NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf A0FY TUMOR FREE NA NA NA 110 80 NO NA NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01A-21-A13C-20 TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01 NA 22b79545-b004-46b6-a9dc-02285b1e2988 TCGA-AN-A0FY-01 TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01A-11D-A032-05 TCGA-AN-A0FY-01 NA TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01 TCGA-AN-A0FY-01A-11D-A036-01 NA TCGA-AN-A0FY-01A-11R-A034-07 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01A-11D-A036-01 TCGA-AN-A0FY-01 |
|
|
347 |
TCGA-AN-A0FZ-01 Stage IIIA 45 3 No_Conversion 10 NA Positive FEMALE Equivocal 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Negative LumA/B -3 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0FZ-01 10 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-AN-A0FZ NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant No axillary staging NA TCGA-AN-A0FZ-F68969 TCGA-AN-A0FZ TCGA-AN-A0FZ-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -16533 34 NA 0 10 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 230 NO Positive NA YES 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 1 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf A0FZ TUMOR FREE NA NA NA 0 120 NO NA NA NA NO Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 1fc2800f-3427-4134-8a02-fea3ecbd2656 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01A-21-A13C-20 TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01 NA e91f0195-b30d-4641-b90c-5f5b2082c391 TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01A-11D-A032-05 TCGA-AN-A0FZ-01 NA TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01A-11D-A036-01 NA TCGA-AN-A0FZ-01A-11R-A034-07 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01A-11D-A036-01 TCGA-AN-A0FZ-01 |
|
|
348 |
TCGA-AN-A0G0-01 Stage IIA 56 NA No_Conversion 16 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 16 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A0G0-01 16 0 days NA C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AN-A0G0 NA NA days 16 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Inner Quadrant No axillary staging NA TCGA-AN-A0G0-F68970 TCGA-AN-A0G0 TCGA-AN-A0G0-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -20504 34 NA 0 16 NA NA NA NA NA NA NA NA NA 2014-12-24 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Negative NA YES 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NA 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf A0G0 TUMOR FREE NA NA NA 0 0 YES NA NA NA YES Primary Tumor 01 NA NA NA NO YES AN Breast A LIVING 2010 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 TCGA-AN-A0G0-01A-21-A13C-20 TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01 NA 8675dc8b-b185-4aa8-9c1c-60505e502215 NA TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01A-11D-A032-05 NA NA TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 TCGA-AN-A0G0-01 NA NA TCGA-AN-A0G0-01A-11R-A034-07 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 NA TCGA-AN-A0G0-01 |
|
|
349 |
TCGA-AN-A0XL-01 Stage IIA 61 5 Stage IIA 10 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 10 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XL-01 163 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-AN-A0XL NA NA days 163 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Upper Outer Quadrant NA NA TCGA-AN-A0XL-F68955 TCGA-AN-A0XL TCGA-AN-A0XL-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -22341 169 NA 0 163 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Negative NA YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462.pdf A0XL TUMOR FREE NA NA NA 60 130 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 0cde4246-2dcb-478b-ace9-df557f71e4cd 0cde4246-2dcb-478b-ace9-df557f71e4cd NA TCGA-AN-A0XL-01A-11D-A10M-09 TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10N-05 NA TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10M-09 NA TCGA-AN-A0XL-01 NA TCGA-AN-A0XL-01A-11D-A10M-09 TCGA-AN-A0XL-01 0cde4246-2dcb-478b-ace9-df557f71e4cd TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10L-01 NA TCGA-AN-A0XL-01A-11R-A10J-07 0cde4246-2dcb-478b-ace9-df557f71e4cd TCGA-AN-A0XL-01A-11D-A10L-01 TCGA-AN-A0XL-01 |
|
|
350 |
TCGA-AN-A0XN-01 Stage IIIA 68 4 Stage IIIA 10 NA Negative FEMALE Negative 1 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Positive ReacI -5 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XN-01 10 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AN-A0XN NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Upper Inner Quadrant NA NA TCGA-AN-A0XN-F68956 TCGA-AN-A0XN TCGA-AN-A0XN-01A NA Negative NA NA NA NA Positive NA NA NA NA NA -25029 163 NA 0 10 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 180 NO Negative NA YES 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 1 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2.pdf A0XN TUMOR FREE NA 0 NA 170 0 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 5a269a43-59a4-4718-878e-1086a07b13ee 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01A-11-A13D-20 TCGA-AN-A0XN-01A-21D-A10G-09 TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A10A-05 20ec155a-e210-4e70-8de0-236318167eff TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A10G-09 NA TCGA-AN-A0XN-01 NA TCGA-AN-A0XN-01A-21D-A10G-09 TCGA-AN-A0XN-01 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A107-01 NA TCGA-AN-A0XN-01A-21R-A109-07 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01A-21D-A107-01 TCGA-AN-A0XN-01 |
|
|
351 |
TCGA-AN-A0XO-01 Stage IIIA 59 2 Stage IIIA 375 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 375 0 LumA Luminal A Negative LumA/B -7 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XO-01 375 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XO NA NA days 375 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant NA NA TCGA-AN-A0XO-F68957 TCGA-AN-A0XO TCGA-AN-A0XO-01A NA Positive NA NA NA NA Negative NA NA NA NA NA -21640 163 NA 0 375 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Negative NA YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 2 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D.pdf A0XO TUMOR FREE NA NA NA 0 180 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 508f0932-673f-48b4-ac71-845ed9eb7c52 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01A-21-A13D-20 TCGA-AN-A0XO-01A-11D-A10G-09 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A10A-05 591208e6-48b0-4a0a-b925-255e07225396 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A10G-09 NA TCGA-AN-A0XO-01 NA TCGA-AN-A0XO-01A-11D-A10G-09 TCGA-AN-A0XO-01 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A107-01 NA TCGA-AN-A0XO-01A-11R-A109-07 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01A-11D-A107-01 TCGA-AN-A0XO-01 |
|
|
352 |
TCGA-AN-A0XP-01 Stage IIIA 69 2 Stage IIIA 9 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 9 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XP-01 9 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XP NA NA days 9 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Inner Quadrant NA NA TCGA-AN-A0XP-F68958 TCGA-AN-A0XP TCGA-AN-A0XP-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -25305 162 NA 0 9 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 160 NO Positive NA YES 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 1 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC.pdf A0XP TUMOR FREE NA NA NA 140 260 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 14fb9342-c11d-460d-af84-f31f7753beeb 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01A-21-A13D-20 TCGA-AN-A0XP-01A-11D-A117-09 TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A10A-05 a4ce1a58-da4d-4beb-9785-856f1d1a72e5 TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A117-09 NA TCGA-AN-A0XP-01 NA TCGA-AN-A0XP-01A-11D-A117-09 TCGA-AN-A0XP-01 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A107-01 NA TCGA-AN-A0XP-01A-11R-A109-07 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01A-11D-A107-01 TCGA-AN-A0XP-01 |
|
|
353 |
TCGA-AN-A0XR-01 Stage IIIA 55 2 Stage IIIA 10 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 10 0 LumB Luminal B Negative NA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XR-01 10 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XR NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Upper Outer Quadrant NA NA TCGA-AN-A0XR-F56951 TCGA-AN-A0XR TCGA-AN-A0XR-01A NA Positive NA NA NA NA Negative NA NA NA NA NA -20381 155 NA 0 10 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Negative NA YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 7 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6.pdf A0XR TUMOR FREE NA NA NA 0 160 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 2738d02e-ac2a-4d26-beb6-794f3e11cf88 2738d02e-ac2a-4d26-beb6-794f3e11cf88 NA TCGA-AN-A0XR-01A-11D-A10G-09 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A10A-05 NA TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A10G-09 NA TCGA-AN-A0XR-01 NA TCGA-AN-A0XR-01A-11D-A10G-09 TCGA-AN-A0XR-01 2738d02e-ac2a-4d26-beb6-794f3e11cf88 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A107-01 NA TCGA-AN-A0XR-01A-11R-A109-07 2738d02e-ac2a-4d26-beb6-794f3e11cf88 TCGA-AN-A0XR-01A-11D-A107-01 TCGA-AN-A0XR-01 |
|
|
354 |
TCGA-AN-A0XS-01 Stage IIIA 63 4 Stage IIIA 10 NA Negative FEMALE Negative 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Positive LumA -5 -4 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XS-01 10 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-AN-A0XS 10 0 days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant NA NA TCGA-AN-A0XS-F68959 TCGA-AN-A0XS TCGA-AN-A0XS-01A NA Negative NA NA NA NA Positive NA NA NA NA NA -23358 120 NA 0 10 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Negative NA YES 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8.pdf A0XS TUMOR FREE NA NA NA 160 0 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 b77f4222-9000-4485-8728-8864780ebcb8 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01A-11-A13D-20 TCGA-AN-A0XS-01A-22D-A10G-09 TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A10A-05 7ca812ab-5eb8-4ae0-8da0-8a53020c32ef TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A10G-09 NA TCGA-AN-A0XS-01 NA TCGA-AN-A0XS-01A-22D-A10G-09 TCGA-AN-A0XS-01 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A107-01 NA TCGA-AN-A0XS-01A-22R-A109-07 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01A-22D-A107-01 TCGA-AN-A0XS-01 |
|
|
355 |
TCGA-AN-A0XT-01 Stage IIIA 54 2 Stage IIIA 10 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Negative LumA/B 0 -3 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XT-01 10 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 5 TCGA-AN-A0XT NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant NA NA TCGA-AN-A0XT-F68960 TCGA-AN-A0XT TCGA-AN-A0XT-01A NA Positive NA NA NA NA Negative NA NA NA NA NA -19794 114 NA 0 10 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 160 NO Negative NA YES 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 7 NA NA NA NA NA NA NA NA 1 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05.pdf A0XT TUMOR FREE NA NA NA 0 120 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 21f22460-fac7-4dbc-8ab2-75738331cb5c 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01A-21-A13D-20 TCGA-AN-A0XT-01A-11D-A10G-09 TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A10A-05 95d4260a-5886-44ff-824f-6c2c76c9c1bc TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A10G-09 NA TCGA-AN-A0XT-01 NA TCGA-AN-A0XT-01A-11D-A10G-09 TCGA-AN-A0XT-01 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A107-01 NA TCGA-AN-A0XT-01A-11R-A109-07 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01A-11D-A107-01 TCGA-AN-A0XT-01 |
|
|
356 |
TCGA-AN-A0XU-01 Stage IIA 54 1 Stage IIA 10 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 10 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XU-01 10 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AN-A0XU NA NA days 10 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant NA NA TCGA-AN-A0XU-F68961 TCGA-AN-A0XU TCGA-AN-A0XU-01A NA Negative NA NA NA NA Negative NA NA NA NA NA -20052 106 NA 0 10 NA NA NA NA NO NA NA NA NA 2014-12-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 180 NO Negative NA YES 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf A0XU TUMOR FREE NA NA NA 0 0 NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 74cba80b-7677-41d6-ab22-10f1a962ba2f 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01A-21-A13D-20 TCGA-AN-A0XU-01A-11D-A10G-09 TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A10A-05 fa8604b6-7128-4db4-bfaf-6f1000fb4017 TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A10G-09 NA TCGA-AN-A0XU-01 NA TCGA-AN-A0XU-01A-11D-A10G-09 TCGA-AN-A0XU-01 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A107-01 NA TCGA-AN-A0XU-01A-11R-A109-07 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01A-11D-A107-01 TCGA-AN-A0XU-01 |
|
|
357 |
TCGA-AN-A0XV-01 Stage IIIA 67 4 Stage IIIA 162 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 162 0 LumA Luminal A Positive NA 0 0 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XV-01 162 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AN-A0XV 162 0 days 162 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AN-A0XV-F68962 TCGA-AN-A0XV TCGA-AN-A0XV-01A NA Positive NA 1+ 3 Point Scale NA Positive NA NA NO NA NA -24779 121 NA 0 162 NA NA NA NA NO dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA NA 60-69% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 100 NO Positive Negative YES 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 7 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730.pdf A0XV TUMOR FREE dextran coated charcoal NA NA 90 H 270 H NO YES 30-39% NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 7b33b321-fe4b-4296-91bc-53bac35828e5 7b33b321-fe4b-4296-91bc-53bac35828e5 NA TCGA-AN-A0XV-01A-11D-A10G-09 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A10A-05 NA TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A10G-09 NA TCGA-AN-A0XV-01 NA TCGA-AN-A0XV-01A-11D-A10G-09 TCGA-AN-A0XV-01 7b33b321-fe4b-4296-91bc-53bac35828e5 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A107-01 NA TCGA-AN-A0XV-01A-11R-A109-07 7b33b321-fe4b-4296-91bc-53bac35828e5 TCGA-AN-A0XV-01A-11D-A107-01 TCGA-AN-A0XV-01 |
|
|
358 |
TCGA-AN-A0XW-01 Stage IIIA 36 5 Stage IIIA 170 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N2 170 0 LumA Luminal B Positive Her2 -2 -4 enrollment T_Other T2 LIVING 0 TCGA-AN-A0XW-01 170 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0XW 170 0 days 170 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-AN-A0XW-F68963 TCGA-AN-A0XW TCGA-AN-A0XW-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive NA NA NO NA NA -13208 121 NA 0 170 NA NA NA NA NO dextran coated charcoal 90-99% NA NA 2014-12-23 FEMALE NA NA 60-69% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 270 NO Positive Negative YES 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N2 T2 Stage IIIA TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4.pdf A0XW TUMOR FREE dextran coated charcoal NA NA 240 H 240 H NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA NO YES AN Breast A LIVING 2010 52033f64-1e6f-4657-a4fb-7cfeffc61951 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01A-21-A13D-20 TCGA-AN-A0XW-01A-11D-A10G-09 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A10A-05 a8db4abd-7071-4135-96f6-dfcd0f003f02 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A10G-09 NA TCGA-AN-A0XW-01 NA TCGA-AN-A0XW-01A-11D-A10G-09 TCGA-AN-A0XW-01 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A107-01 NA TCGA-AN-A0XW-01A-11R-A109-07 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01A-11D-A107-01 TCGA-AN-A0XW-01 |
|
|
359 |
TCGA-AO-A03L-01 Stage IIIA 34 5 No_Conversion 2442 NA Positive FEMALE Negative 1 3 1 Negative M0 Positive N2 2442 0 LumA HER2-enriched Positive Basal -2 -4 followup T_Other T3 LIVING 0 TCGA-AO-A03L-01 2442 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-AO-A03L 2442 0 days 2442 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03L-F19390 TCGA-AO-A03L TCGA-AO-A03L-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -12443 2456 NA 0 2442 NA NA NA NA NA NA 70-79% 63 Scheduled Follow-up Submission 2011-12-12 FEMALE NA NA 10-19% >= 2.0 Positive 2+ 30 47 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 680 NO Positive Negative NA 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T3 Stage IIIA TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D.pdf A03L TUMOR FREE NA NA NA NA NA NA NA 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2003 34980e1d-956b-4d89-8bf2-dcc008dbaad7 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01A-31-A13A-20 TCGA-AO-A03L-01A-41W-A071-09 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41D-A10P-05 f54048ea-ae8d-4786-b466-a9f4604507e0 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41W-A071-09 NA TCGA-AO-A03L-01 NA TCGA-AO-A03L-01A-41W-A071-09 TCGA-AO-A03L-01 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41D-A059-01 NA TCGA-AO-A03L-01A-41R-A056-07 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01A-41D-A059-01 TCGA-AO-A03L-01 |
|
|
360 |
TCGA-AO-A03M-01 Stage IA 29 1 Stage I 1455 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1455 0 LumA Luminal A Positive ReacII -2 -5 followup T1 T1 LIVING 0 TCGA-AO-A03M-01 1866 0 days High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 NA TCGA-AO-A03M 1866 0 days 1866 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A03M-F30186 TCGA-AO-A03M NA NA Positive NA 3+ NA NA Positive Simple Mastectomy NA YES NA NA -10616 NA NA 0 1866 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2012-4-4 FEMALE NA 3+ Positive 30-39% >= 2.0 Positive 2+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy NA NA Negative Negative NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T1c Stage I NA A03M TUMOR FREE NA NA NA NA NA NA NA 60-69% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast NA LIVING 2006 f65936bc-02d6-4954-9068-0fb7c930d685 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01B-21-A13E-20 NA TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10N-05 dbfbb734-f8c7-46df-b27b-0320a0372428 TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10M-09 NA TCGA-AO-A03M-01 NA NA TCGA-AO-A03M-01 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10L-01 NA TCGA-AO-A03M-01B-11R-A10J-07 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01B-11D-A10L-01 TCGA-AO-A03M-01 |
|
|
361 |
TCGA-AO-A03N-01 Stage IIB 59 3 No_Conversion 1645 NA Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 1645 0 LumB HER2-enriched Positive Her2 -2 -3 followup T_Other T2 LIVING 0 TCGA-AO-A03N-01 2031 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 2 TCGA-AO-A03N 1645 1 days 2031 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 59 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03N-F20915 TCGA-AO-A03N TCGA-AO-A03N-01B NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -21816 1596 NA 0 2031 NA NA 1645 NA NA NA 70-79% NA Scheduled Follow-up Submission 2012-1-24 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 360 NO Negative NA NA 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Negative NA NA NA NA 4 Point Scale NA NA NA NA NA NA Negative NA NA 2 6 NA NA 4 Point Scale NA Locoregional Disease NA NA YES 2 NA true No M0 N1a T2 Stage IIB TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E.pdf A03N WITH TUMOR NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast B LIVING 2006 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01B-21-A13E-20 TCGA-AO-A03N-01B-11D-A10M-09 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10N-05 0a7af48e-5b73-42e8-acf6-a0bca1372cc4 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10M-09 NA TCGA-AO-A03N-01 NA TCGA-AO-A03N-01B-11D-A10M-09 TCGA-AO-A03N-01 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10L-01 NA TCGA-AO-A03N-01B-11R-A10J-07 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01B-11D-A10L-01 TCGA-AO-A03N-01 |
|
|
362 |
TCGA-AO-A03O-01 Stage IIA 69 3 Stage IIA 993 2483 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 2483 1 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 DECEASED 1 TCGA-AO-A03O-01 2483 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-AO-A03O NA NA days 2483 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03O-F3141 TCGA-AO-A03O TCGA-AO-A03O-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -25362 2694 2483 0 NA NA NA NA NA NA >10% STAINING = POSITIVE NA 68 NA 2010-9-19 FEMALE NA 3+ POSITIVE <10% > = 2.0 1+ 29 73 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 690 NO Negative Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E.pdf A03O TUMOR FREE NA NA NA >10% STAINING = POSITIVE NA NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES AO Breast A DECEASED 2002 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01A-31-A13A-20 TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01 NA 191dae29-7228-4645-9efe-8c80596a5e50 TCGA-AO-A03O-01 TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01A-11D-A00Y-05 TCGA-AO-A03O-01 NA TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01 TCGA-AO-A03O-01A-11D-A011-01 NA TCGA-AO-A03O-01A-11R-A00Z-07 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01A-11D-A011-01 TCGA-AO-A03O-01 |
|
|
363 |
TCGA-AO-A03P-01 Stage IIA 54 3 No_Conversion 2576 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2576 0 LumB Luminal B Positive LumA/B -10 -5 enrollment T_Other T2 LIVING 1 TCGA-AO-A03P-01 2911 1 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-AO-A03P 1922 1 days 2911 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 54 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03P-F15452 TCGA-AO-A03P TCGA-AO-A03P-01A NA Positive NA 2+ NA NA Positive Lumpectomy NA YES NA 1922 -19724 2414 2911 0 2576 2576 NA 1922 NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA 4.0 Infiltrating Ductal Carcinoma NA No 40 C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 370 NO Negative NA NA 26 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Equivocal 2+ NA Positive 90-99% 3 Point Scale 20-29% 1.7 4 Point Scale 4+ 2+ Negative NA 80-89% NA Positive NA NA 2 NA 2.4 RATIO >2.2 4 Point Scale Liver Distant Metastasis NA NA YES 0 2 true No M0 N1 T2 Stage IIB TCGA-AO-A03P.0BFAB667-8B40-46AE-A224-535573E268C7.pdf A03P WITH TUMOR NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA 6th NO NO YES AO Breast A DECEASED 2003 9543095d-b05b-43e0-8b8d-74bd916b510b 9543095d-b05b-43e0-8b8d-74bd916b510b TCGA-AO-A03P-01A-31-A13A-20 TCGA-AO-A03P-01A-11W-A019-09 TCGA-AO-A03P-01 NA dafdae39-54bf-4a1a-a15b-3538e36ed42c TCGA-AO-A03P-01 TCGA-AO-A03P-01A-11W-A019-09 TCGA-AO-A03P-01A-11D-A00Y-05 TCGA-AO-A03P-01 NA TCGA-AO-A03P-01A-11W-A019-09 NA 9543095d-b05b-43e0-8b8d-74bd916b510b NA TCGA-AO-A03P-01A-11D-A011-01 NA TCGA-AO-A03P-01A-11R-A00Z-07 9543095d-b05b-43e0-8b8d-74bd916b510b TCGA-AO-A03P-01A-11D-A011-01 TCGA-AO-A03P-01 |
|
|
364 |
TCGA-AO-A03R-01 Stage IIB 57 4 No_Conversion 1707 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1707 0 Normal Normal-like Positive NA 0 0 followup T_Other T2 LIVING 0 TCGA-AO-A03R-01 2091 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation cluster 5 TCGA-AO-A03R 2091 0 days 2091 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03R-F15469 TCGA-AO-A03R TCGA-AO-A03R-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -20930 1608 NA 0 2091 NA NA NA NA NA NA 90-99% 70 Scheduled Follow-up Submission 2011-8-22 FEMALE NA NA <10% Ratio >=2.0 0 28 105 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 140 NO Negative Negative NA 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 3 0 true No M0 N1a T2 Stage IIB TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE.pdf A03R TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2005 6722de75-5d6d-4b1d-a961-856ec5bd12f1 6722de75-5d6d-4b1d-a961-856ec5bd12f1 NA TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01 NA NA TCGA-AO-A03R-01 TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01A-21D-A032-05 TCGA-AO-A03R-01 NA TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01 6722de75-5d6d-4b1d-a961-856ec5bd12f1 TCGA-AO-A03R-01 TCGA-AO-A03R-01A-21D-A036-01 NA TCGA-AO-A03R-01A-21R-A034-07 6722de75-5d6d-4b1d-a961-856ec5bd12f1 TCGA-AO-A03R-01A-21D-A036-01 TCGA-AO-A03R-01 |
|
|
365 |
TCGA-AO-A03T-01 Stage IIB 42 5 No_Conversion 1187 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1187 0 Normal Normal-like Positive NA -2 -3 enrollment T_Other T2 LIVING 0 TCGA-AO-A03T-01 2124 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-AO-A03T 2124 0 days 2124 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A03T-F43476 TCGA-AO-A03T TCGA-AO-A03T-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -15540 1031 NA 0 2124 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2013-5-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 140 NO Negative NA NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971.pdf A03T TUMOR FREE NA NA NA NA NA YES NA 60-69% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2007 0e6447b4-6e63-4420-bfa8-5b1d711d90fc 0e6447b4-6e63-4420-bfa8-5b1d711d90fc NA TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01 NA NA TCGA-AO-A03T-01 TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01A-21D-A032-05 TCGA-AO-A03T-01 NA TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01 0e6447b4-6e63-4420-bfa8-5b1d711d90fc TCGA-AO-A03T-01 TCGA-AO-A03T-01A-21D-A036-01 NA TCGA-AO-A03T-01A-21R-A034-07 0e6447b4-6e63-4420-bfa8-5b1d711d90fc TCGA-AO-A03T-01A-21D-A036-01 TCGA-AO-A03T-01 |
|
|
366 |
TCGA-AO-A03U-01 Stage IA 31 1 Stage I 1727 1796 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1796 1 Normal Normal-like Negative Basal -5 0 followup T1 T1 DECEASED 1 TCGA-AO-A03U-01 1793 1 days Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AO-A03U 1614 1 days 1793 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 31 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A03U-F20907 TCGA-AO-A03U TCGA-AO-A03U-01B NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -11354 3254 1793 0 NA NA NA 1614 NA NA NA <10% NA Scheduled Follow-up Submission 2012-1-24 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Other, specify NA No NA C50.9 8502/3 C50.9 NA YES NA Core needle biopsy 170 NO Negative Negative NA 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 5 4 NA NA NA Lung New Primary Tumor NA NA YES 0 0 true No M0 N0 (i-) T1c Stage I TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546.pdf A03U TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast B DECEASED 2001 bbca4523-28a7-416c-98a8-02c3350705fc bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01B-11-A13E-20 TCGA-AO-A03U-01B-21D-A10M-09 TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10N-05 93635795-8741-4a0d-b538-48fb08377942 TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10M-09 NA TCGA-AO-A03U-01 NA TCGA-AO-A03U-01B-21D-A10M-09 TCGA-AO-A03U-01 bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10L-01 NA TCGA-AO-A03U-01B-21R-A10J-07 bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01B-21D-A10L-01 TCGA-AO-A03U-01 |
|
|
367 |
TCGA-AO-A03V-01 Stage IA 41 1 Stage I 886 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 886 0 LumA Luminal A Positive NA 0 -3 followup T1 T1 LIVING 0 TCGA-AO-A03V-01 1351 0 days COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 5 TCGA-AO-A03V 1351 0 days 1351 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Inner Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A03V-F20912 TCGA-AO-A03V TCGA-AO-A03V-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA YES NA NA -15284 670 NA 0 1351 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2012-1-24 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 70 NO Negative NA NA 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41.pdf A03V TUMOR FREE NA NA NA NA NA NA NA 80-89% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2008 35a76121-7e58-4e28-a39c-6301a4cc0e2e 35a76121-7e58-4e28-a39c-6301a4cc0e2e NA TCGA-AO-A03V-01A-11D-A10Y-09 TCGA-AO-A03V-01 NA NA TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11D-A10Y-09 TCGA-AO-A03V-01A-11D-A112-05 TCGA-AO-A03V-01 TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11D-A10Y-09 NA 35a76121-7e58-4e28-a39c-6301a4cc0e2e NA TCGA-AO-A03V-01A-11D-A111-01 TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11R-A115-07 35a76121-7e58-4e28-a39c-6301a4cc0e2e TCGA-AO-A03V-01A-11D-A111-01 TCGA-AO-A03V-01 |
|
|
368 |
TCGA-AO-A0J2-01 Stage IA 41 3 Stage I 585 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 585 0 Her2 HER2-enriched Negative Basal -11 -9 followup T1 T1 LIVING 0 TCGA-AO-A0J2-01 997 0 days High C3-BRCA/Luminal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AO-A0J2 997 0 days 997 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Lower Inner Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A0J2-F15481 TCGA-AO-A0J2 TCGA-AO-A0J2-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -15324 668 NA 0 997 NA NA NA NA NA NA <10% 2.4 Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE 30-39% RATIO > 2.2 2+ 40 3.5 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO Equivocal Negative NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf A0J2 TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2008 81689324-2986-49f6-bef6-f5a525ca36c2 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01A-21-A13A-20 TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01 NA c8e29a9a-2a2c-49ad-8101-2f74df959c0c TCGA-AO-A0J2-01 TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01A-11D-A032-05 TCGA-AO-A0J2-01 NA TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01 TCGA-AO-A0J2-01A-11D-A036-01 NA TCGA-AO-A0J2-01A-11R-A034-07 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01A-11D-A036-01 TCGA-AO-A0J2-01 |
|
|
369 |
TCGA-AO-A0J3-01 Stage IIB 67 5 No_Conversion 302 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 302 0 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 LIVING 0 TCGA-AO-A0J3-01 651 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 1 mutation c1uster 9 TCGA-AO-A0J3 651 0 days 651 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-AO-A0J3-F15477 TCGA-AO-A0J3 TCGA-AO-A0J3-01A NA Positive NA 4+ NA NA Positive Modified Radical Mastectomy NA YES NA NA -24519 220 NA 0 651 NA NA NA NA NA NA <10% 2.6 Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ Positive 10-19% Ratio >=2.2 2+ 40 2.4 0.9 NA Other, specify NA No NA C50.9 8523/3 C50.9 4+ YES NA Core needle biopsy 1180 NO Equivocal Negative NA 36 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 1 0 true No M0 N1b T2 Stage IIB TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8.pdf A0J3 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 7455cc98-aceb-4adc-932b-4fddd979c522 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01A-21-A13B-20 TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01 NA 67394de8-86f3-40e0-b897-52e23c163647 TCGA-AO-A0J3-01 TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01A-11D-A032-05 TCGA-AO-A0J3-01 NA TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01 TCGA-AO-A0J3-01A-11D-A036-01 NA TCGA-AO-A0J3-01A-11R-A034-07 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01A-11D-A036-01 TCGA-AO-A0J3-01 |
|
|
370 |
TCGA-AO-A0J4-01 Stage IA 41 1 Stage I 294 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 294 0 Basal Basal-like Negative NA -13 -12 followup T1 T1 LIVING 0 TCGA-AO-A0J4-01 1587 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AO-A0J4 1587 0 days 1587 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A0J4-F15478 TCGA-AO-A0J4 TCGA-AO-A0J4-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -15052 224 NA 0 1587 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO Negative NA NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf A0J4 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 4808bc63-000a-4a49-a25b-4b817ca5ea54 4808bc63-000a-4a49-a25b-4b817ca5ea54 NA TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01 NA NA TCGA-AO-A0J4-01 TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01A-11D-A032-05 TCGA-AO-A0J4-01 NA TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01 4808bc63-000a-4a49-a25b-4b817ca5ea54 TCGA-AO-A0J4-01 TCGA-AO-A0J4-01A-11D-A036-01 NA TCGA-AO-A0J4-01A-11R-A034-07 4808bc63-000a-4a49-a25b-4b817ca5ea54 TCGA-AO-A0J4-01A-11D-A036-01 TCGA-AO-A0J4-01 |
|
|
371 |
TCGA-AO-A0J5-01 Stage IV 48 NA No_Conversion 704 NA Positive FEMALE Negative NA NA NA Positive M1 Positive N1 704 0 LumA NA Negative NA NA NA followup T_Other T4 LIVING 1 TCGA-AO-A0J5-01 792 1 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-AO-A0J5 792 0 days 792 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-AO-A0J5-F19407 TCGA-AO-A0J5 TCGA-AO-A0J5-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -17815 554 792 0 705 735 NA NA NA NA NA 90-99% 64 Scheduled Follow-up Submission 2011-12-12 FEMALE >2.2 Positive 3+ Positive 10-19% NA 2+ 25 71 1.1 NA Other, specify NA Yes NA C50.9 8523/3 C50.9 4+ YES NA Core needle biopsy 500 NO Equivocal Negative NA 2 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung|Bone|Liver NA NA NA NA NA NA NA NA NA NA NO 2 NA true No M1 N1a T4 Stage IV TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22.pdf A0J5 WITH TUMOR NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A DECEASED 2008 5d033f3f-b22f-4d10-b39b-0bae2b4db5be 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01A-21-A13A-20 TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01 NA 42dea565-bb3c-4c5f-badc-b1615a3482e4 TCGA-AO-A0J5-01 TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01A-11D-A032-05 TCGA-AO-A0J5-01 NA TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01 TCGA-AO-A0J5-01A-11D-A036-01 NA TCGA-AO-A0J5-01A-11R-A034-07 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01A-11D-A036-01 TCGA-AO-A0J5-01 |
|
|
372 |
TCGA-AO-A0J6-01 Stage IIA 61 1 Stage IIA 775 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 775 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-AO-A0J6-01 1140 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AO-A0J6 1140 0 days 1140 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A0J6-F15479 TCGA-AO-A0J6 TCGA-AO-A0J6-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -22462 748 NA 0 1140 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 390 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf A0J6 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2008 1fe98b05-6803-4803-83cd-a59e794b956e 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01A-21-A13A-20 TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01 NA 13c00c4c-d6c9-4d3f-b63d-780757d0e5e1 TCGA-AO-A0J6-01 TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01A-11D-A032-05 TCGA-AO-A0J6-01 NA TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01 TCGA-AO-A0J6-01A-11D-A036-01 NA TCGA-AO-A0J6-01A-11R-A034-07 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01A-11D-A036-01 TCGA-AO-A0J6-01 |
|
|
373 |
TCGA-AO-A0J7-01 Stage IIB 71 2 No_Conversion 260 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 260 0 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T2 LIVING 0 TCGA-AO-A0J7-01 618 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AO-A0J7 618 0 days 618 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0J7-F15480 TCGA-AO-A0J7 TCGA-AO-A0J7-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -26281 177 NA 0 618 NA NA NA NA NA NA 90-99% NA NA 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 4+ YES NA Core needle biopsy 300 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 3 0 true No M0 N1 T2 Stage IIB TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE.pdf A0J7 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 542bb107-1b0c-4ace-834d-9e32ed82429c 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01A-21-A13B-20 TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01 NA dd6cd205-238d-4ba8-88db-6f0028931ca7 TCGA-AO-A0J7-01 TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01A-11D-A032-05 TCGA-AO-A0J7-01 NA TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01 TCGA-AO-A0J7-01A-11D-A036-01 NA TCGA-AO-A0J7-01A-11R-A034-07 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01A-11D-A036-01 TCGA-AO-A0J7-01 |
|
|
374 |
TCGA-AO-A0J8-01 Stage IIA 61 2 Stage IIA 277 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 277 0 LumA Luminal A Positive ReacI -12 -3 followup T_Other T2 LIVING 0 TCGA-AO-A0J8-01 680 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0J8 680 0 days 680 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A0J8-F15482 TCGA-AO-A0J8 TCGA-AO-A0J8-01A NA Positive NA 3+ NA NA Positive Lumpectomy NA YES NA NA -22284 241 NA 0 680 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 4+ YES NA Core needle biopsy 670 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 2 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf A0J8 TUMOR FREE NA NA NA NA NA NA NA 70-79% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 70109263-1d2b-4abe-a582-2b28e87cde67 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01A-11-A13A-20 TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01 NA 287094b7-2cf5-415d-81f7-5ef0196d181c TCGA-AO-A0J8-01 TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01A-21D-A032-05 TCGA-AO-A0J8-01 NA TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01 TCGA-AO-A0J8-01A-21D-A036-01 NA TCGA-AO-A0J8-01A-21R-A034-07 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01A-21D-A036-01 TCGA-AO-A0J8-01 |
|
|
375 |
TCGA-AO-A0J9-01 Stage IIIC 61 2 No_Conversion 1255 NA Positive FEMALE Negative 1 4 3 Negative M0 Positive N3 1255 0 LumA Luminal A Positive ReacI -2 -3 followup T_Other T2 LIVING 0 TCGA-AO-A0J9-01 1613 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0J9 1066 1 days 1613 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 61 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0J9-F15483 TCGA-AO-A0J9 TCGA-AO-A0J9-01A Negative Positive NA 4+ NA Mastectomy NOS Positive Lumpectomy NA NO NA 1066 -22642 1207 NA 0 1613 NA NA 1066 NA NA NA 90-99% 127 Scheduled Follow-up Submission 2011-8-22 FEMALE NA NA NA RATIO >EQUAL 2.0 NA 33 149 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 4+ YES NA Core needle biopsy 430 NO NA Negative NA 32 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Positive 90-99% 3+ POSITIVE <10% NA 4 Point Scale 4+ 1+ NA 3 Point Scale 10-19% NA Positive NA NA 4 2 NA NA 4 Point Scale Bone Distant Metastasis NA NA YES 15 0 true No M0 N3 T2 Stage IIIC TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD.pdf A0J9 WITH TUMOR NA NA NA NA NA NA NA 30-39% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2007 2d4b31ad-8790-426a-965b-25b74293156c 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01A-21-A13B-20 TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01 NA 5141cf13-4997-4411-b0d5-9d2ecb048cdb TCGA-AO-A0J9-01 TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01A-11D-A032-05 TCGA-AO-A0J9-01 NA TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01 TCGA-AO-A0J9-01A-11D-A036-01 NA TCGA-AO-A0J9-01A-11R-A034-07 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01A-11D-A036-01 TCGA-AO-A0J9-01 |
|
|
376 |
TCGA-AO-A0JA-01 Stage IIIC 36 2 No_Conversion 346 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 346 0 LumA Luminal A Positive NA -4 -4 followup T_Other T2 LIVING 0 TCGA-AO-A0JA-01 655 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AO-A0JA 143 1 days 655 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 36 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JA-F15484 TCGA-AO-A0JA NA NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA 143 -13307 NA NA 0 655 NA NA 143 NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy NA NA Negative NA NA 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 1+ NA Negative <10% 3+ POSITIVE <10% NA 4 Point Scale NA 2+ NA 3 Point Scale 70-79% NA Positive NA NA 4 1 NA NA 4 Point Scale Bone Distant Metastasis NA NA YES 11 NA NA No M0 N3 T2 Stage IIIC NA A0JA WITH TUMOR NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES AO Breast NA LIVING 2009 d38a839f-06dc-40d2-81e9-3b7822e258c7 d38a839f-06dc-40d2-81e9-3b7822e258c7 NA TCGA-AO-A0JA-01A-11W-A071-09 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11D-A10P-05 NA TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11W-A071-09 NA TCGA-AO-A0JA-01 NA TCGA-AO-A0JA-01A-11W-A071-09 TCGA-AO-A0JA-01 d38a839f-06dc-40d2-81e9-3b7822e258c7 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11D-A059-01 NA TCGA-AO-A0JA-01A-11R-A056-07 d38a839f-06dc-40d2-81e9-3b7822e258c7 TCGA-AO-A0JA-01A-11D-A059-01 TCGA-AO-A0JA-01 |
|
|
377 |
TCGA-AO-A0JB-01 Stage IIIA 50 1 No_Conversion 1150 NA Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 1150 0 NA Normal-like Positive Basal -2 -3 followup T_Other T3 LIVING 0 TCGA-AO-A0JB-01 1542 0 days High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AO-A0JB 1542 0 days 1542 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-AO-A0JB-F15485 TCGA-AO-A0JB NA NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -18561 NA NA 0 1542 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy NA NA Negative NA NA 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 1 0 NA No M0 N1a T3 Stage IIIA NA A0JB TUMOR FREE NA NA NA NA NA NA NA 60-69% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast NA LIVING 2007 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01A-21-A13A-20 TCGA-AO-A0JB-01A-11W-A071-09 TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11D-A10P-05 a9a1fd2e-401f-4469-87fd-a42b3680c32b TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11W-A071-09 NA TCGA-AO-A0JB-01 NA TCGA-AO-A0JB-01A-11W-A071-09 TCGA-AO-A0JB-01 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11D-A059-01 NA TCGA-AO-A0JB-01A-11R-A056-07 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01A-11D-A059-01 TCGA-AO-A0JB-01 |
|
|
378 |
TCGA-AO-A0JC-01 Stage IIA 64 1 Stage IIA 1547 NA Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1547 0 LumA Luminal B Positive LumA -2 -5 followup T_Other T2 LIVING 0 TCGA-AO-A0JC-01 1547 0 days Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0JC 1547 0 days 1547 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JC-F15486 TCGA-AO-A0JC TCGA-AO-A0JC-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA YES NA NA -23404 1522 NA 0 1547 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 550 NO Negative NA NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B.pdf A0JC TUMOR FREE NA NA NA NA NA NA NA 50-59% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2006 0f578102-ede7-46ad-ae1f-3c7351edb491 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01A-21-A13A-20 TCGA-AO-A0JC-01A-11W-A071-09 TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11D-A10P-05 020a471c-8f4c-40c5-b4e2-6181b5499a0a TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11W-A071-09 NA TCGA-AO-A0JC-01 NA TCGA-AO-A0JC-01A-11W-A071-09 TCGA-AO-A0JC-01 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11D-A059-01 NA TCGA-AO-A0JC-01A-11R-A056-07 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01A-11D-A059-01 TCGA-AO-A0JC-01 |
|
|
379 |
TCGA-AO-A0JD-01 Stage IIIA 59 2 No_Conversion 1813 NA Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 1813 0 LumB Luminal B Positive Basal -2 -2 followup T_Other T3 LIVING 0 TCGA-AO-A0JD-01 2190 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 5 mutation cluster 8 TCGA-AO-A0JD 2190 0 days 2190 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JD-F15487 TCGA-AO-A0JD TCGA-AO-A0JD-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -21831 1863 NA 0 2190 NA NA NA NA NA NA 90-99% 49 Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% RATIO > = 2.0 1+ 20 68 1.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 230 NO Negative Negative NA 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 3 0 true No M0 N1a T3 Stage IIIA TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274.pdf A0JD TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2005 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01A-21-A13B-20 TCGA-AO-A0JD-01A-11W-A071-09 TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11D-A10P-05 ac0bdea2-ebe1-454a-8425-960820b9a1ad TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11W-A071-09 NA TCGA-AO-A0JD-01 NA TCGA-AO-A0JD-01A-11W-A071-09 TCGA-AO-A0JD-01 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11D-A059-01 NA TCGA-AO-A0JD-01A-11R-A056-07 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01A-11D-A059-01 TCGA-AO-A0JD-01 |
|
|
380 |
TCGA-AO-A0JE-01 Stage IIIA 53 5 No_Conversion 1965 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N2 1965 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING 0 TCGA-AO-A0JE-01 2335 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 4 mutation cluster 3 TCGA-AO-A0JE 2335 0 days 2335 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JE-F15488 TCGA-AO-A0JE NA NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -19516 NA NA 0 2335 NA NA NA NA NA NA <10% 71 Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE 50-59% RATIO > = 2.0 3+ 33 269 3.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive Positive NA 29 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 8 0 NA No M0 N2a T2 Stage IIIA NA A0JE TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast NA LIVING 2005 d73174ef-182c-48b9-af79-dfb457d5b7be d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01A-21-A13B-20 TCGA-AO-A0JE-01A-11W-A071-09 TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11D-A10P-05 d9cdfaa4-a07d-4172-9ffd-67fb62cc8d9a TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11W-A071-09 NA TCGA-AO-A0JE-01 NA TCGA-AO-A0JE-01A-11W-A071-09 TCGA-AO-A0JE-01 d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11D-A059-01 NA TCGA-AO-A0JE-01A-11R-A056-07 d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01A-11D-A059-01 TCGA-AO-A0JE-01 |
|
|
381 |
TCGA-AO-A0JF-01 Stage IIA 68 2 No_Conversion 354 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 354 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING 0 TCGA-AO-A0JF-01 1980 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 4 TCGA-AO-A0JF 1980 0 days 1980 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JF-F72115 TCGA-AO-A0JF TCGA-AO-A0JF-01A NA Positive NA 2+ NA NA Positive Lumpectomy NA NO NA NA -24923 273 NA 0 1980 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2015-4-15 FEMALE NA 3+ POSITIVE <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 410 NO Negative NA NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T1c Stage IIA TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14.pdf A0JF TUMOR FREE NA NA NA NA NA YES NA 70-79% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 3389d4b9-0190-4a69-a647-a6d53e3c96be 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01A-21-A13B-20 TCGA-AO-A0JF-01A-11W-A071-09 TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11D-A10P-05 c730759a-51df-45f0-94f3-c9054b9f40ff TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11W-A071-09 NA TCGA-AO-A0JF-01 NA TCGA-AO-A0JF-01A-11W-A071-09 TCGA-AO-A0JF-01 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11D-A059-01 NA TCGA-AO-A0JF-01A-11R-A056-07 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01A-11D-A059-01 TCGA-AO-A0JF-01 |
|
|
382 |
TCGA-AO-A0JG-01 Stage IIIA 49 5 No_Conversion 449 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 449 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T2 LIVING 0 TCGA-AO-A0JG-01 798 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AO-A0JG 798 0 days 798 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-AO-A0JG-F15492 TCGA-AO-A0JG TCGA-AO-A0JG-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -18021 395 NA 0 798 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 4+ YES NA Core needle biopsy 410 NO Negative NA NA 19 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 4 0 true No M0 N2a T2 Stage IIIA TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6.pdf A0JG TUMOR FREE NA NA NA NA NA NA NA 10-19% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2009 97b5ef6f-d621-4093-ab77-d60dcf706173 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01A-21-A13C-20 TCGA-AO-A0JG-01A-31D-A099-09 TCGA-AO-A0JG-01 TCGA-AO-A0JG-01A-31D-A10P-05 a9d2c3f6-0a53-4e38-8a3c-93bf0748df8f TCGA-AO-A0JG-01 NA NA TCGA-AO-A0JG-01 NA TCGA-AO-A0JG-01A-31D-A099-09 TCGA-AO-A0JG-01 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01 TCGA-AO-A0JG-01A-31D-A087-01 NA TCGA-AO-A0JG-01A-31R-A084-07 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01A-31D-A087-01 TCGA-AO-A0JG-01 |
|
|
383 |
TCGA-AO-A0JI-01 Stage IIA 56 4 No_Conversion 1172 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 1172 0 LumA Luminal B Negative LumA/B -10 -3 followup T1 T1 LIVING 0 TCGA-AO-A0JI-01 1528 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0JI 1528 0 days 1528 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JI-F19410 TCGA-AO-A0JI NA NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -20694 NA NA 0 1528 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy NA NA Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO 0 1 NA No M0 N1 T1c Stage IIA NA A0JI TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES AO Breast NA LIVING 2007 fb0cd718-5300-4447-9740-a63308f65d92 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01A-11-A13A-20 TCGA-AO-A0JI-01A-21W-A100-09 TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21D-A10P-05 ff238c04-e4ff-43e6-8ee6-38828939ed9f TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21W-A100-09 NA TCGA-AO-A0JI-01 NA TCGA-AO-A0JI-01A-21W-A100-09 TCGA-AO-A0JI-01 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21D-A059-01 NA TCGA-AO-A0JI-01A-21R-A056-07 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01A-21D-A059-01 TCGA-AO-A0JI-01 |
|
|
384 |
TCGA-AO-A0JJ-01 Stage IIB 54 2 No_Conversion 1512 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1512 0 LumA Luminal A Positive LumA/B -5 -7 enrollment T_Other T2 LIVING 0 TCGA-AO-A0JJ-01 1887 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 7 mutation c1uster 9 TCGA-AO-A0JJ 1887 0 days 1887 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JJ-F15493 TCGA-AO-A0JJ NA NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -19758 NA NA 0 1887 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 4+ YES NA Core needle biopsy NA NA Negative NA NA 44 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 2 NA NA No M0 N1a T2 Stage IIB NA A0JJ TUMOR FREE NA NA NA NA NA NA NA 70-79% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast NA LIVING 2006 b5eeba4f-8e46-4084-9054-961ea524cf72 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01A-21-A13A-20 TCGA-AO-A0JJ-01A-11W-A071-09 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11D-A10P-05 c4fcf63c-a35e-451c-bf06-64b36bc30ba0 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11W-A071-09 NA TCGA-AO-A0JJ-01 NA TCGA-AO-A0JJ-01A-11W-A071-09 TCGA-AO-A0JJ-01 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11D-A059-01 NA TCGA-AO-A0JJ-01A-11R-A056-07 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01A-11D-A059-01 TCGA-AO-A0JJ-01 |
|
|
385 |
TCGA-AO-A0JL-01 Stage IIIA 59 3 No_Conversion 1319 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N2 1319 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-AO-A0JL-01 1683 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AO-A0JL 1683 0 days 1683 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-AO-A0JL-F15495 TCGA-AO-A0JL TCGA-AO-A0JL-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21895 1332 NA 0 1683 NA NA NA NA NA NA <10% 50 Scheduled Follow-up Submission 2011-8-22 FEMALE NA 3+ POSITIVE <10% RATIO > = 2.0 1+ 21 131 2.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 380 NO Negative Positive NA 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 7 NA true No M0 N2a T2 Stage IIIA TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722.pdf A0JL TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2006 7953e62d-4871-4928-a2ba-a38c740134e1 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01A-21-A13A-20 TCGA-AO-A0JL-01A-11W-A071-09 TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11D-A10P-05 8299edee-f043-4cf2-8dc5-501df636be7d TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11W-A071-09 NA TCGA-AO-A0JL-01 NA TCGA-AO-A0JL-01A-11W-A071-09 TCGA-AO-A0JL-01 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11D-A059-01 NA TCGA-AO-A0JL-01A-11R-A056-07 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01A-11D-A059-01 TCGA-AO-A0JL-01 |
|
|
386 |
TCGA-AO-A0JM-01 Stage IIB 40 3 No_Conversion 1826 NA Positive FEMALE Positive 4 5 4 Negative M0 Positive N1 1826 0 LumB Luminal B Positive ReacII -2 -5 followup T_Other T2 LIVING 0 TCGA-AO-A0JM-01 2184 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A0JM 2184 0 days 2184 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A0JM-F15496 TCGA-AO-A0JM TCGA-AO-A0JM-01A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -14653 1828 NA 0 2184 NA NA NA NA NA NA 90-99% 74 NA 2011-8-22 FEMALE NA 3+ POSITIVE 70-79% NA 3+ 30 366 5.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 710 NO Positive Positive NA 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05.pdf A0JM TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2005 7b53ba9f-506e-4af7-9752-ae50e4445880 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01A-11-A13A-20 TCGA-AO-A0JM-01A-21W-A071-09 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21D-A10P-05 f53d3976-6b25-4a6d-9969-89f363a1b810 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21W-A071-09 NA TCGA-AO-A0JM-01 NA TCGA-AO-A0JM-01A-21W-A071-09 TCGA-AO-A0JM-01 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21D-A059-01 NA TCGA-AO-A0JM-01A-21R-A056-07 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01A-21D-A059-01 TCGA-AO-A0JM-01 |
|
|
387 |
TCGA-AO-A124-01 Stage IIA 38 3 Stage IIA 3119 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 3119 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-AO-A124-01 3506 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AO-A124 3506 0 days 3506 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A124-F19395 TCGA-AO-A124 TCGA-AO-A124-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -14174 3213 NA 0 3506 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Core needle biopsy 730 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf A124 TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 5th YES NO YES AO Breast A LIVING 2002 5cd42d4a-5971-4a01-8c10-99321105a864 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01A-21-A13E-20 TCGA-AO-A124-01A-11D-A10M-09 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10N-05 184cfad8-a50d-4212-b808-dd5a0275cc32 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10M-09 NA TCGA-AO-A124-01 NA TCGA-AO-A124-01A-11D-A10M-09 TCGA-AO-A124-01 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10L-01 NA TCGA-AO-A124-01A-11R-A10J-07 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01A-11D-A10L-01 TCGA-AO-A124-01 |
|
|
388 |
TCGA-AO-A125-01 Stage IIA 72 2 Stage IIA 3018 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 3018 0 LumA Luminal A Positive NA -12 -3 followup T_Other T2 LIVING 0 TCGA-AO-A125-01 3456 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AO-A125 3456 0 days 3456 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A125-F19398 TCGA-AO-A125 TCGA-AO-A125-01A NA Positive NA 4+ NA NA Positive Simple Mastectomy NA YES NA NA -26466 3193 NA 0 3456 NA NA NA NA NA NA 50-59% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% >=2.0 Positive 0 NA NA 1.0 NA Other, specify NA No NA C50.9 8050/3 C50.9 3+ YES NA Core needle biopsy 90 NO Negative Negative NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf A125 TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NO Primary Tumor 01 NA 5th YES NO YES AO Breast A LIVING 2002 6c8cb6ae-99bb-4878-b6f5-9da28be98588 6c8cb6ae-99bb-4878-b6f5-9da28be98588 NA TCGA-AO-A125-01A-11D-A10M-09 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10N-05 NA TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10M-09 NA TCGA-AO-A125-01 NA TCGA-AO-A125-01A-11D-A10M-09 TCGA-AO-A125-01 6c8cb6ae-99bb-4878-b6f5-9da28be98588 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10L-01 NA TCGA-AO-A125-01A-11R-A10J-07 6c8cb6ae-99bb-4878-b6f5-9da28be98588 TCGA-AO-A125-01A-11D-A10L-01 TCGA-AO-A125-01 |
|
|
389 |
TCGA-AO-A126-01 Stage IIA 39 5 Stage IIA 2850 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 2850 0 LumA Luminal A Positive Her2 0 -3 followup T_Other T2 LIVING 0 TCGA-AO-A126-01 3307 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-AO-A126 267 1 days 3307 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES YES NO 39 Right Upper Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A126-F19402 TCGA-AO-A126 TCGA-AO-A126-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA YES 295 295 -14264 3033 NA 0 3307 NA NA 267 NA NA NA 20-29% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% >=2.0 Positive 0 31 62 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 450 NO Negative Negative NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 0 NA Positive 20-29% NA <10% 1.3 4 Point Scale NA NA Negative NA 60-69% NA Positive NA NA 4 6 NA NA 4 Point Scale NA Locoregional Disease NA NA YES 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0.pdf A126 TUMOR FREE NA NA NA NA NA NA NA 60-69% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2002 690cf196-9b2c-4886-a0e2-ce3a49cb4389 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01A-21-A13E-20 TCGA-AO-A126-01A-11D-A10M-09 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10N-05 da59b9c1-ff1d-4949-ac71-087257291201 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10M-09 NA TCGA-AO-A126-01 NA TCGA-AO-A126-01A-11D-A10M-09 TCGA-AO-A126-01 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10L-01 NA TCGA-AO-A126-01A-11R-A10J-07 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01A-11D-A10L-01 TCGA-AO-A126-01 |
|
|
390 |
TCGA-AO-A128-01 Stage IIA 61 3 Stage IIA 2877 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 2877 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-AO-A128-01 3248 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 6 NA TCGA-AO-A128 3248 0 days 3248 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Lower Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A128-F19405 TCGA-AO-A128 TCGA-AO-A128-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -22340 2960 NA 0 3248 NA NA NA NA NA NA <10% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% >=2.0 Positive 0 30 52 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 590 NO Negative Negative NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf A128 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA NA YES NO YES AO Breast A LIVING 2002 4a93eaee-d821-4640-a441-255008aaf3b4 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01A-21-A13E-20 NA TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10N-05 b629bd13-8d7f-4bff-aa80-08dec4b64d8e TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10M-09 NA TCGA-AO-A128-01 NA NA TCGA-AO-A128-01 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10L-01 NA TCGA-AO-A128-01A-11R-A10J-07 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01A-11D-A10L-01 TCGA-AO-A128-01 |
|
|
391 |
TCGA-AO-A129-01 Stage IIB 29 1 No_Conversion 2923 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 2923 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-AO-A129-01 3286 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 3 mutation cluster 5 TCGA-AO-A129 3286 0 days 3286 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-AO-A129-F19415 TCGA-AO-A129 TCGA-AO-A129-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -10898 2915 NA 0 3286 NA NA NA NA NA NA <10% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% >=2.0 Positive 0 31 52 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 320 NO Negative Negative NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf A129 TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 5th YES NO YES AO Breast A LIVING 2002 15b9736e-eafc-465e-9ddd-b1b498e8b701 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01A-11-A13E-20 TCGA-AO-A129-01A-21D-A10M-09 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10N-05 480c68cf-c569-476a-86eb-cd14d5ba6b54 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10M-09 NA TCGA-AO-A129-01 NA TCGA-AO-A129-01A-21D-A10M-09 TCGA-AO-A129-01 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10L-01 NA TCGA-AO-A129-01A-21R-A10J-07 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01A-21D-A10L-01 TCGA-AO-A129-01 |
|
|
392 |
TCGA-AO-A12A-01 Stage IIA 47 2 Stage IIA 2754 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 2754 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING 0 TCGA-AO-A12A-01 3112 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-AO-A12A 3112 0 days 3112 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A12A-F19418 TCGA-AO-A12A TCGA-AO-A12A-01A NA Positive NA 4+ NA NA Positive Modified Radical Mastectomy NA YES NA NA -17420 2793 NA 0 3112 NA NA NA NA NA NA 90-99% 58 Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% >=2.0 Positive 1+ 30 61 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 220 NO Negative Negative NA 27 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A12A.A54E82A4-D7C2-4A5C-A69C-C66976F0282F.pdf A12A TUMOR FREE NA NA NA NA NA NA NA 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2003 3f4c6d17-a971-4ba0-83ad-3addc24f1298 3f4c6d17-a971-4ba0-83ad-3addc24f1298 TCGA-AO-A12A-01A-11-A13E-20 TCGA-AO-A12A-01A-21D-A10Y-09 TCGA-AO-A12A-01 NA e6f501dd-64cd-404e-92f3-56c0de08d987 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21D-A10Y-09 TCGA-AO-A12A-01A-21D-A112-05 TCGA-AO-A12A-01 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21D-A10Y-09 NA 3f4c6d17-a971-4ba0-83ad-3addc24f1298 NA TCGA-AO-A12A-01A-21D-A111-01 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21R-A115-07 3f4c6d17-a971-4ba0-83ad-3addc24f1298 TCGA-AO-A12A-01A-21D-A111-01 TCGA-AO-A12A-01 |
|
|
393 |
TCGA-AO-A12B-01 Stage IIA 63 3 Stage IIA 2359 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 2359 0 LumA Luminal B Positive LumA/B -12 -3 followup T_Other T2 LIVING 0 TCGA-AO-A12B-01 2989 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-AO-A12B 2989 0 days 2989 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A12B-F43473 TCGA-AO-A12B TCGA-AO-A12B-01A NA Positive NA 4+ NA NA Positive Simple Mastectomy NA YES NA NA -23150 2365 NA 0 2989 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2013-5-22 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 570 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf A12B TUMOR FREE NA NA NA NA NA YES NA 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2004 44225bb7-92c6-4a6d-b136-bc51666ba84a 44225bb7-92c6-4a6d-b136-bc51666ba84a TCGA-AO-A12B-01A-21-A13E-20 TCGA-AO-A12B-01A-11D-A10M-09 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10N-05 1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10M-09 NA TCGA-AO-A12B-01 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10M-09 NA 44225bb7-92c6-4a6d-b136-bc51666ba84a NA TCGA-AO-A12B-01A-11D-A10L-01 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11R-A10J-07 44225bb7-92c6-4a6d-b136-bc51666ba84a TCGA-AO-A12B-01A-11D-A10L-01 TCGA-AO-A12B-01 |
|
|
394 |
TCGA-AO-A12C-01 Stage IIB 42 2 No_Conversion 1993 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 1993 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T2 LIVING 0 TCGA-AO-A12C-01 2372 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 NA TCGA-AO-A12C 2372 0 days 2372 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A12C-F19425 TCGA-AO-A12C TCGA-AO-A12C-01A Negative Positive NA 2+ NA Modified radical mastectomy Positive Lumpectomy NA NO NA NA -15469 2086 NA 0 2372 NA NA NA NA NA NA 90-99% 78 Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive 90-99% >=2.0 Positive 3+ 30 125 1.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 350 NO Positive Negative NA 31 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242.pdf A12C TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2005 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 TCGA-AO-A12C-01A-21-A13E-20 NA TCGA-AO-A12C-01 TCGA-AO-A12C-01A-11D-A10N-05 6b20b15d-4ebc-4169-a36c-e9abab1dd6f0 NA NA NA NA NA NA TCGA-AO-A12C-01 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 TCGA-AO-A12C-01 NA NA TCGA-AO-A12C-01A-11R-A10J-07 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 NA TCGA-AO-A12C-01 |
|
|
395 |
TCGA-AO-A12D-01 Stage IIA 43 3 No_Conversion 1948 NA Negative FEMALE Positive 2 2 1 Negative M0 Positive N1 1948 0 Her2 HER2-enriched Negative Her2 -11 -10 followup T1 T1 LIVING 0 TCGA-AO-A12D-01 2515 0 days High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AO-A12D 2515 0 days 2515 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A12D-F43438 TCGA-AO-A12D TCGA-AO-A12D-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -15774 1948 NA 0 2515 NA NA NA NA NA NA <10% 66 Scheduled Follow-up Submission 2013-5-21 FEMALE NA 3+ Positive 90-99% >=2.0 Positive 3+ 32 441 6.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 750 NO Positive Positive NO 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T1c Stage IIA TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE.pdf A12D TUMOR FREE NA NA NA NA NA YES NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2005 4adf4439-3d60-44ac-a6f0-9f42cc081a93 4adf4439-3d60-44ac-a6f0-9f42cc081a93 TCGA-AO-A12D-01A-21-A13E-20 TCGA-AO-A12D-01A-11D-A10Y-09 TCGA-AO-A12D-01 NA 1dd0fa5e-8122-4008-a89b-025ed17a3dd9 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11D-A10Y-09 TCGA-AO-A12D-01A-11D-A112-05 TCGA-AO-A12D-01 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11D-A10Y-09 NA 4adf4439-3d60-44ac-a6f0-9f42cc081a93 NA TCGA-AO-A12D-01A-11D-A111-01 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11R-A115-07 4adf4439-3d60-44ac-a6f0-9f42cc081a93 TCGA-AO-A12D-01A-11D-A111-01 TCGA-AO-A12D-01 |
|
|
396 |
TCGA-AO-A12E-01 Stage IIB 51 3 Stage IIB 1742 NA Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 1742 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T3 LIVING 0 TCGA-AO-A12E-01 2142 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AO-A12E 2142 0 days 2142 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-AO-A12E-F19431 TCGA-AO-A12E TCGA-AO-A12E-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA YES NA NA -18721 1822 NA 0 2142 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 630 NO Negative NA NA 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2.pdf A12E TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2005 222c7e4d-f6ed-4db0-ba36-1670159cee1b 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01A-21-A13E-20 TCGA-AO-A12E-01A-11D-A10M-09 TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10N-05 b6ec964a-db35-4120-aaaf-f3018a330490 TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10M-09 NA TCGA-AO-A12E-01 NA TCGA-AO-A12E-01A-11D-A10M-09 TCGA-AO-A12E-01 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10L-01 NA TCGA-AO-A12E-01A-11R-A10J-07 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01A-11D-A10L-01 TCGA-AO-A12E-01 |
|
|
397 |
TCGA-AO-A12F-01 Stage IIA 36 1 Stage IIA 1471 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1471 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-AO-A12F-01 1842 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A12F 1842 0 days 1842 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A12F-F19434 TCGA-AO-A12F TCGA-AO-A12F-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -13409 1578 NA 0 1842 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 600 NO Negative NA NA 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf A12F TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2006 05610046-ec77-4592-892a-464a81d55c45 05610046-ec77-4592-892a-464a81d55c45 TCGA-AO-A12F-01A-21-A13D-20 TCGA-AO-A12F-01A-11D-A10Y-09 TCGA-AO-A12F-01 NA 8f64c41b-17ee-40d2-98d6-4c483e5d5384 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11D-A10Y-09 TCGA-AO-A12F-01A-11D-A112-05 TCGA-AO-A12F-01 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11D-A10Y-09 NA 05610046-ec77-4592-892a-464a81d55c45 NA TCGA-AO-A12F-01A-11D-A111-01 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11R-A115-07 05610046-ec77-4592-892a-464a81d55c45 TCGA-AO-A12F-01A-11D-A111-01 TCGA-AO-A12F-01 |
|
|
398 |
TCGA-AO-A12G-01 Stage IIA 75 2 Stage IIA 1265 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1265 0 LumA Luminal A Positive LumA/B -1 0 followup T_Other T2 LIVING 0 TCGA-AO-A12G-01 1639 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 8 TCGA-AO-A12G 1639 0 days 1639 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A12G-F19448 TCGA-AO-A12G TCGA-AO-A12G-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA YES NA NA -27705 1415 NA 0 1639 NA NA NA NA NA NA 90-99% 67 Scheduled Follow-up Submission 2011-6-16 FEMALE NA NA NA >=2.0 Positive 2+ 23 66 1.0 NA Other, specify NA No NA C50.9 8022/3 C50.9 4+ YES NA Core needle biopsy 280 NO Positive Negative NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf A12G TUMOR FREE NA NA NA NA NA NA NA 30-39% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2006 348a0fd6-eb6b-4550-a26a-3896c4963b3a 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01A-21-A13D-20 TCGA-AO-A12G-01A-11D-A10M-09 TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10N-05 e5214399-e1f0-42f1-be38-366c47e438fa TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10M-09 NA TCGA-AO-A12G-01 NA TCGA-AO-A12G-01A-11D-A10M-09 TCGA-AO-A12G-01 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10L-01 NA TCGA-AO-A12G-01A-11R-A10J-07 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01A-11D-A10L-01 TCGA-AO-A12G-01 |
|
|
399 |
TCGA-AO-A12H-01 Stage IIA 69 1 Stage IIA 862 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 862 0 LumA Luminal A Positive LumA/B -12 -3 followup T_Other T2 LIVING 0 TCGA-AO-A12H-01 1234 0 days Quiet C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 2 mutation cluster 4 TCGA-AO-A12H 1234 0 days 1234 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-AO-A12H-F19451 TCGA-AO-A12H TCGA-AO-A12H-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA YES NA NA -25515 1017 NA 0 1234 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA 3+ Positive <10% NA 0 NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 4+ YES NA Core needle biopsy 290 NO Negative NA NA 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B.pdf A12H TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2008 71b58051-3bf8-4dfb-a431-c8aceab7c799 71b58051-3bf8-4dfb-a431-c8aceab7c799 TCGA-AO-A12H-01A-21-A13D-20 TCGA-AO-A12H-01A-11D-A10Y-09 TCGA-AO-A12H-01 NA 6988badd-172f-4880-9ad6-75f7896112bb TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11D-A10Y-09 TCGA-AO-A12H-01A-11D-A112-05 TCGA-AO-A12H-01 TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11D-A10Y-09 NA 71b58051-3bf8-4dfb-a431-c8aceab7c799 NA TCGA-AO-A12H-01A-11D-A111-01 TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11R-A115-07 71b58051-3bf8-4dfb-a431-c8aceab7c799 TCGA-AO-A12H-01A-11D-A111-01 TCGA-AO-A12H-01 |
|
|
400 |
TCGA-AO-A1KO-01 Stage IIB 46 1 Stage IIB 448 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 448 0 Normal NA Positive NA NA NA followup T_Other T3 LIVING 0 TCGA-AO-A1KO-01 622 0 days Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation c1uster 9 TCGA-AO-A1KO 622 0 days 622 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A1KO-F20630 TCGA-AO-A1KO TCGA-AO-A1KO-01A NA Positive 4 Point Scale 4+ 4 Point Scale NA Positive Simple Mastectomy NA YES NA NA -16817 832 NA 0 622 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-20 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 4+ YES NA Excisional Biopsy 580 NO Negative NA NA 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf A1KO TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2008 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 TCGA-AO-A1KO-01A-41-A17I-20 TCGA-AO-A1KO-01A-31D-A188-09 TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A13K-05 a17c27f3-818b-4fbb-aa5d-ab86494f4456 TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A188-09 NA NA TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A188-09 NA 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 NA TCGA-AO-A1KO-01A-31D-A13J-01 TCGA-AO-A1KO-01 NA 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 TCGA-AO-A1KO-01A-31D-A13J-01 |
|
|
401 |
TCGA-AO-A1KP-01 Stage IIA 77 2 Stage IIA 2513 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2513 0 LumB NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-AO-A1KP-01 2953 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-AO-A1KP 2953 0 days 2953 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A1KP-F21774 TCGA-AO-A1KP TCGA-AO-A1KP-01A NA Positive 4 Point Scale 4+ 4 Point Scale NA Positive Simple Mastectomy NA YES NA NA -28247 2604 NA 0 2953 NA NA NA NA NO NA 80-89% NA Scheduled Follow-up Submission 2012-2-20 FEMALE NA NA <10% >=2.0 Positive 1+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 360 NO Negative Negative NA 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 1 true No M0 N1 T1 Stage IIA TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf A1KP TUMOR FREE NA NA NA NA NA NA YES 40-49% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2003 773a2357-99b8-40df-b657-f237d9735db9 773a2357-99b8-40df-b657-f237d9735db9 TCGA-AO-A1KP-01A-21-A17I-20 TCGA-AO-A1KP-01A-11D-A13L-09 TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13K-05 a69b3e33-9fa5-47f1-931d-d100136d9d80 TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13L-09 NA NA TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13L-09 NA 773a2357-99b8-40df-b657-f237d9735db9 NA TCGA-AO-A1KP-01A-11D-A13J-01 TCGA-AO-A1KP-01 NA 773a2357-99b8-40df-b657-f237d9735db9 TCGA-AO-A1KP-01A-11D-A13J-01 |
|
|
402 |
TCGA-AO-A1KQ-01 Stage IIIB 84 4 Stage IIIB 1519 NA Positive MALE Negative NA NA NA Negative M0 Positive N1 1519 0 LumB NA Positive NA NA NA followup T_Other T4 LIVING 0 TCGA-AO-A1KQ-01 1882 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 NA TCGA-AO-A1KQ 1882 0 days 1882 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AO-A1KQ-F21775 TCGA-AO-A1KQ TCGA-AO-A1KQ-01A NA Positive 4 Point Scale 3+ 4 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -30859 1553 NA 0 1882 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-20 MALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 540 NO Negative NA NA 9 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 2 0 true No M0 N1 T4 Stage IIIB TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf A1KQ TUMOR FREE NA NA NA NA NA NA YES 80-89% NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2006 204a78d9-67aa-4e49-b285-bbb25c6ed142 204a78d9-67aa-4e49-b285-bbb25c6ed142 TCGA-AO-A1KQ-01A-21-A17I-20 NA TCGA-AO-A1KQ-01 TCGA-AO-A1KQ-01A-11D-A13K-05 ccdaef5f-d816-426d-8e4f-b1bc561a11c5 TCGA-AO-A1KQ-01 NA NA NA TCGA-AO-A1KQ-01 NA NA 204a78d9-67aa-4e49-b285-bbb25c6ed142 NA TCGA-AO-A1KQ-01A-11D-A13J-01 TCGA-AO-A1KQ-01 NA 204a78d9-67aa-4e49-b285-bbb25c6ed142 TCGA-AO-A1KQ-01A-11D-A13J-01 |
|
|
403 |
TCGA-AO-A1KR-01 NA 51 1 NA 2140 NA Negative FEMALE NA NA NA NA NA NA NA NA 2140 0 Basal NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-AO-A1KR-01 2513 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AO-A1KR 2513 0 days 2513 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-AO-A1KR-F21768 TCGA-AO-A1KR TCGA-AO-A1KR-01A NA Negative 4 Point Scale NA 3 Point Scale NA Negative Simple Mastectomy NA YES NA NA -18900 1932 NA 0 2513 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-5-21 FEMALE NA NA NA NA 1+ NA 1 NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Negative Negative NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf A1KR TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2005 6d22f538-114f-48b6-94ba-fb60151ed567 6d22f538-114f-48b6-94ba-fb60151ed567 TCGA-AO-A1KR-01A-21-A17I-20 TCGA-AO-A1KR-01A-12D-A142-09 TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A145-05 209b9ca9-04fe-441d-915a-b8f4ef9e4b74 TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A142-09 NA NA TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A142-09 NA 6d22f538-114f-48b6-94ba-fb60151ed567 NA TCGA-AO-A1KR-01A-12D-A141-01 TCGA-AO-A1KR-01 NA 6d22f538-114f-48b6-94ba-fb60151ed567 TCGA-AO-A1KR-01A-12D-A141-01 |
|
|
404 |
TCGA-AO-A1KS-01 Stage IIA 69 5 Stage IIA 16 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 16 0 LumB NA Positive NA NA NA followup T_Other T2 LIVING 0 TCGA-AO-A1KS-01 350 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A1KS 350 0 days 350 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A1KS-F21777 TCGA-AO-A1KS TCGA-AO-A1KS-01A NA Positive 4 Point Scale 2+ 4 Point Scale NA Positive Lumpectomy NA YES NA NA -25230 147 NA 0 350 NA NA NA NA NO NA 90-99% 3.2 Scheduled Follow-up Submission 2012-2-20 FEMALE NA NA 10-19% Positive >2.2 2+ 40 3.2 1.0 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 4+ YES NA Core needle biopsy 420 NO Equivocal Negative NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf A1KS TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES AO Breast A LIVING 2010 9eab0553-20cc-41bb-bcdb-9ade0578da82 9eab0553-20cc-41bb-bcdb-9ade0578da82 TCGA-AO-A1KS-01A-21-A17I-20 TCGA-AO-A1KS-01A-11D-A13L-09 TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13K-05 6022e4a0-4bd2-4d51-ac93-56f6b54dfa39 TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13L-09 NA NA TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13L-09 NA 9eab0553-20cc-41bb-bcdb-9ade0578da82 NA TCGA-AO-A1KS-01A-11D-A13J-01 TCGA-AO-A1KS-01 NA 9eab0553-20cc-41bb-bcdb-9ade0578da82 TCGA-AO-A1KS-01A-11D-A13J-01 |
|
|
405 |
TCGA-AO-A1KT-01 Stage IIA 78 2 Stage IIA 541 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 541 0 LumB NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-AO-A1KT-01 541 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AO-A1KT NA NA days 541 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-AO-A1KT-F9905 TCGA-AO-A1KT TCGA-AO-A1KT-01A NA Positive 4 Point Scale 4+ 4 Point Scale NA Positive Lumpectomy NA YES NA NA -28660 617 NA 0 541 NA NA NA NA NO NA 90-99% 1.7 NA 2011-4-1 FEMALE NA NA 10-19% >2.2 Positive 2+ 40 2.4 1.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 200 NO Equivocal Negative NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 1 1 true [Discrepancy] M0 N1 T1 Stage IIA TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf A1KT TUMOR FREE NA NA NA NA NA NA YES 40-49% NA YES Primary Tumor 01 NA 6th YES NO YES AO Breast A LIVING 2009 82140d3a-0787-4e1e-993d-1b222c073cf8 82140d3a-0787-4e1e-993d-1b222c073cf8 TCGA-AO-A1KT-01A-21-A17I-20 TCGA-AO-A1KT-01A-11D-A13L-09 TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13K-05 c440c6d0-6b35-4764-be41-cd4ca2d3c713 TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13L-09 NA NA TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13L-09 NA 82140d3a-0787-4e1e-993d-1b222c073cf8 NA TCGA-AO-A1KT-01A-11D-A13J-01 TCGA-AO-A1KT-01 NA 82140d3a-0787-4e1e-993d-1b222c073cf8 TCGA-AO-A1KT-01A-11D-A13J-01 |
|
|
406 |
TCGA-AQ-A04H-01 Stage IIIA 61 5 No_Conversion 439 NA Positive FEMALE Positive NA NA NA NA NA Positive N2 439 0 LumB Luminal B Positive NA -10 -3 followup T_Other T2 LIVING 0 TCGA-AQ-A04H-01 754 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 5 TCGA-AQ-A04H 754 0 days 754 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-AQ-A04H-F35322 TCGA-AQ-A04H NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22539 NA NA 0 754 NA NA NA NA NA NA 90-99% NA NA 2012-9-24 FEMALE NA NA NA NA 2+ 30 NA 3.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Indeterminate Positive NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 4 NA NA No MX N2a T2 Stage IIIA NA A04H TUMOR FREE NA NA NA >10% >10% YES NA 20-29% NA YES Primary Tumor 01 NA 6th YES NO YES AQ Breast NA LIVING 2009 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d NA TCGA-AQ-A04H-01B-11D-A10M-09 TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10N-05 NA TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10M-09 NA TCGA-AQ-A04H-01 NA TCGA-AQ-A04H-01B-11D-A10M-09 TCGA-AQ-A04H-01 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10L-01 NA TCGA-AQ-A04H-01B-11R-A10J-07 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d TCGA-AQ-A04H-01B-11D-A10L-01 TCGA-AQ-A04H-01 |
|
|
407 |
TCGA-AQ-A04J-01 Stage IIA 45 1 Stage IIA 499 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 499 0 Basal Basal-like Negative NA -13 -12 followup T_Other T2 LIVING 0 TCGA-AQ-A04J-01 819 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AQ-A04J 819 0 days 819 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AQ-A04J-F21740 TCGA-AQ-A04J TCGA-AQ-A04J-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA NO NA NA -16615 118 NA 0 819 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2012-2-20 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 160 NO Negative NA NA 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i+) T2 Stage IIA TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf A04J TUMOR FREE NA NA NA NA NA NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES AQ Breast A LIVING 2009 97168a1f-abf8-414b-af10-b63f5daa7023 97168a1f-abf8-414b-af10-b63f5daa7023 NA TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01 NA NA TCGA-AQ-A04J-01 TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01A-02D-A032-05 TCGA-AQ-A04J-01 NA TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01 97168a1f-abf8-414b-af10-b63f5daa7023 TCGA-AQ-A04J-01 TCGA-AQ-A04J-01A-02D-A036-01 NA TCGA-AQ-A04J-01A-02R-A034-07 97168a1f-abf8-414b-af10-b63f5daa7023 TCGA-AQ-A04J-01A-02D-A036-01 TCGA-AQ-A04J-01 |
|
|
408 |
TCGA-AQ-A04L-01 Stage IIA 48 1 Stage IIA 3344 NA Positive FEMALE Positive 2 2 2 Negative M0 Negative N0 3344 0 LumA Luminal A Negative ReacI -1 -5 followup T_Other T2 LIVING 0 TCGA-AQ-A04L-01 3957 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 13 TCGA-AQ-A04L 3957 0 days 3957 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Sentinel node biopsy alone NA TCGA-AQ-A04L-F35324 TCGA-AQ-A04L TCGA-AQ-A04L-01B NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -17759 3403 NA 0 3957 NA NA NA NA NA NA 60-69% NA NA 2012-9-24 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Fine needle aspiration biopsy 160 NO Positive NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 3 NA NA NA NA NA NA NA NO 0 NA false No MX N0 (i-) T2 Stage IIA TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115.pdf A04L TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA 5th YES NO YES AQ Breast B LIVING 2001 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01B-11-A13D-20 TCGA-AQ-A04L-01B-21D-A10M-09 TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10N-05 16b9cd57-86e9-4409-8ad3-02d5a4540f0f TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10M-09 NA TCGA-AQ-A04L-01 NA TCGA-AQ-A04L-01B-21D-A10M-09 TCGA-AQ-A04L-01 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10L-01 NA TCGA-AQ-A04L-01B-21R-A10J-07 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01B-21D-A10L-01 TCGA-AQ-A04L-01 |
|
|
409 |
TCGA-AQ-A0Y5-01 Stage IIIA 70 3 Stage IIIA NA 161 Positive FEMALE Positive NA NA NA Negative M0 Positive N2 161 1 LumA NA Positive NA NA NA followup T_Other T2 DECEASED 1 TCGA-AQ-A0Y5-01 172 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AQ-A0Y5 NA NA days 172 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AQ-A0Y5-F10119 TCGA-AQ-A0Y5 TCGA-AQ-A0Y5-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -25793 212 172 0 NA NA NA NA NA NO NA 70-79% NA NA 2011-4-7 FEMALE NA NA NA NA 2+ NA NA 3.8 NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 160 NO Positive Positive NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 5 NA false Yes MX N2a T2 Stage IIIA TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf A0Y5 TUMOR FREE NA NA NA NA NA NA YES 40-49% NA NO Primary Tumor 01 NA 7th YES YES NO AQ Breast A DECEASED 2010 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca NA TCGA-AQ-A0Y5-01A-11D-A14K-09 TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14N-05 NA TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14K-09 NA NA TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14K-09 NA 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca NA TCGA-AQ-A0Y5-01A-11D-A14J-01 TCGA-AQ-A0Y5-01 NA 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca TCGA-AQ-A0Y5-01A-11D-A14J-01 |
|
|
410 |
TCGA-AQ-A1H2-01 Stage IIIA 84 5 Stage IIIA 197 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N2 197 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AQ-A1H2-01 475 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AQ-A1H2 475 0 days 475 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AQ-A1H2-F19896 TCGA-AQ-A1H2 TCGA-AQ-A1H2-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -30958 156 NA 0 475 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-1-3 FEMALE NA NA NA NA 2+ NA NA 2.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Indeterminate Positive NA 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 13 NA false No MX N2a T2 Stage IIIA TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf A1H2 TUMOR FREE NA NA NA NA NA NA YES 10-19% NA YES Primary Tumor 01 NA 7th YES YES NO AQ Breast A LIVING 2010 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 TCGA-AQ-A1H2-01A-21-A17I-20 TCGA-AQ-A1H2-01A-11D-A13L-09 TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13K-05 8191dc7a-6508-44aa-beb6-397c035c8052 TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13L-09 NA NA TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13L-09 NA 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 NA TCGA-AQ-A1H2-01A-11D-A13J-01 TCGA-AQ-A1H2-01 NA 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 TCGA-AQ-A1H2-01A-11D-A13J-01 |
|
|
411 |
TCGA-AQ-A1H3-01 Stage IIIC 49 2 Stage IIIC 138 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 138 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AQ-A1H3-01 989 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 cluster 6 mutation c1uster 9 TCGA-AQ-A1H3 989 0 days 989 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AQ-A1H3-F50661 TCGA-AQ-A1H3 TCGA-AQ-A1H3-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -18177 94 NA 0 989 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2013-10-28 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative NA NO 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 14 NA false No MX N3a T2 Stage IIIC TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf A1H3 TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th YES YES NO AQ Breast A LIVING 2010 554df3b0-e305-4dab-a268-47ad7c1dcffc 554df3b0-e305-4dab-a268-47ad7c1dcffc TCGA-AQ-A1H3-01A-41-A17I-20 TCGA-AQ-A1H3-01A-31D-A13L-09 TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13K-05 ba38e345-7c27-4ab0-a8e9-57b727fec06c TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13L-09 NA NA TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13L-09 NA 554df3b0-e305-4dab-a268-47ad7c1dcffc NA TCGA-AQ-A1H3-01A-31D-A13J-01 TCGA-AQ-A1H3-01 NA 554df3b0-e305-4dab-a268-47ad7c1dcffc TCGA-AQ-A1H3-01A-31D-A13J-01 |
|
|
412 |
TCGA-AQ-A54N-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AQ-A54N-01 78 0 days NA NA NA NA NA NA NA NA NA TCGA-AQ-A54N 78 0 days 78 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-AQ-A54N-F55736 TCGA-AQ-A54N TCGA-AQ-A54N-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -18741 639 NA 0 78 NA NA NA NA NA NA NA NA NA 2014-1-14 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO Equivocal Negative YES 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf A54N TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO AQ Breast A LIVING 2011 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 NA NA TCGA-AQ-A54N-01 TCGA-AQ-A54N-01A-11D-A268-05 3b93ce2c-bc79-48ef-910d-9d1e7c070008 TCGA-AQ-A54N-01 TCGA-AQ-A54N-01A-11D-A25Q-09 NA NA TCGA-AQ-A54N-01 NA NA ed3e6c57-a0ec-4441-a1a1-794f3f15e112 NA TCGA-AQ-A54N-01A-11D-A25N-01 TCGA-AQ-A54N-01 NA ed3e6c57-a0ec-4441-a1a1-794f3f15e112 TCGA-AQ-A54N-01A-11D-A25N-01 |
|
|
413 |
TCGA-AQ-A54O-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AQ-A54O-01 1001 0 days NA NA NA NA NA NA NA NA NA TCGA-AQ-A54O 1001 0 days 1001 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AQ-A54O-F55731 TCGA-AQ-A54O TCGA-AQ-A54O-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -18694 617 NA 0 1001 NA NA NA NA NA NA 90-99% NA NA 2014-1-14 MALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 360 NO Negative NA NO 14 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf A54O TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 NA 7th NA YES NO AQ Breast A LIVING 2011 3c1b6647-26bb-4110-aaea-f542024e8bf3 3c1b6647-26bb-4110-aaea-f542024e8bf3 NA NA TCGA-AQ-A54O-01 TCGA-AQ-A54O-01A-11D-A268-05 e546ea71-dcab-49bf-b972-d6b6dbe57b8f TCGA-AQ-A54O-01 TCGA-AQ-A54O-01A-11D-A25Q-09 NA NA TCGA-AQ-A54O-01 NA NA 3c1b6647-26bb-4110-aaea-f542024e8bf3 NA TCGA-AQ-A54O-01A-11D-A25N-01 TCGA-AQ-A54O-01 NA 3c1b6647-26bb-4110-aaea-f542024e8bf3 TCGA-AQ-A54O-01A-11D-A25N-01 |
|
|
414 |
TCGA-AQ-A7U7-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AQ-A7U7-01 584 1 days NA NA NA NA NA NA NA NA NA TCGA-AQ-A7U7 584 0 days 584 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AQ-A7U7-F68763 TCGA-AQ-A7U7 TCGA-AQ-A7U7-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -20239 223 584 0 304 NA NA NA NA NA NA 80-89% NA NA 2014-12-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NO Negative NA NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 4 0 false Yes M0 N2a T2 Stage IIIA TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf A7U7 TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 L Total Mastectomy 7th NA YES NO AQ Breast A DECEASED 2013 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 NA NA TCGA-AQ-A7U7-01 TCGA-AQ-A7U7-01A-22D-A357-05 3956ACBB-F98A-4510-95FF-E9A7FFF1AEF7 TCGA-AQ-A7U7-01 NA NA NA TCGA-AQ-A7U7-01 NA NA 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 NA TCGA-AQ-A7U7-01A-22D-A350-01 TCGA-AQ-A7U7-01 NA 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 TCGA-AQ-A7U7-01A-22D-A350-01 |
|
|
415 |
TCGA-AR-A0TP-01 Stage II 43 1 No_Conversion 2392 NA Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 2392 0 Basal Basal-like Negative Basal -13 -11 enrollment T_Other T2 LIVING 0 TCGA-AR-A0TP-01 4275 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A0TP 4275 0 days 4275 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TP-F71715 TCGA-AR-A0TP NA NA Positive NA NA NA NA Negative Other NA YES NA NA -15812 NA NA 0 4275 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T2 Stage IIA NA A0TP TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast NA LIVING 2003 f9739b94-ac64-40d5-bfdd-041a412976c4 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01A-21-A13C-20 TCGA-AR-A0TP-01A-11D-A099-09 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01A-11D-A10P-05 c8173431-25a0-4853-a0ca-7df5c5cf40e8 TCGA-AR-A0TP-01 NA NA TCGA-AR-A0TP-01 NA TCGA-AR-A0TP-01A-11D-A099-09 TCGA-AR-A0TP-01 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01A-11D-A087-01 NA TCGA-AR-A0TP-01A-11R-A084-07 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01A-11D-A087-01 TCGA-AR-A0TP-01 |
|
|
416 |
TCGA-AR-A0TQ-01 Stage III 27 3 No_Conversion 1500 NA Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 1500 0 LumB Luminal B Negative Her2 -2 -5 enrollment T_Other T3 LIVING 0 TCGA-AR-A0TQ-01 2991 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AR-A0TQ 2991 0 days 2991 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 27 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AR-A0TQ-F71717 TCGA-AR-A0TQ TCGA-AR-A0TQ-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -9873 1512 NA 0 2991 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 750 NO Equivocal Positive NO 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T3 Stage IIIA TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E.pdf A0TQ TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01A-21-A13C-20 TCGA-AR-A0TQ-01A-11D-A099-09 TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01A-11D-A10P-05 e214f5bd-2ee3-4f27-b1e4-2895df122c9f TCGA-AR-A0TQ-01 NA NA TCGA-AR-A0TQ-01 NA TCGA-AR-A0TQ-01A-11D-A099-09 TCGA-AR-A0TQ-01 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01A-11D-A087-01 NA TCGA-AR-A0TQ-01A-11R-A084-07 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01A-11D-A087-01 TCGA-AR-A0TQ-01 |
|
|
417 |
TCGA-AR-A0TR-01 Stage II 68 1 No_Conversion 21 160 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 160 1 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T2 DECEASED 1 TCGA-AR-A0TR-01 160 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 7 mutation cluster 4 TCGA-AR-A0TR 160 0 days 160 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TR-F18771 TCGA-AR-A0TR TCGA-AR-A0TR-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -25190 1535 160 0 NA NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-12-12 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy not specified Other method, specify: 520 NO Equivocal Negative NA 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF.pdf A0TR NA NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES AR Breast A DECEASED 2006 b31bf328-6ead-4ee4-b8c7-4407372dc683 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01A-21-A13C-20 TCGA-AR-A0TR-01A-11D-A099-09 TCGA-AR-A0TR-01 TCGA-AR-A0TR-01A-11D-A10P-05 64d25a8c-e5fc-42f2-8d71-7cf2afb1d9ff TCGA-AR-A0TR-01 NA NA TCGA-AR-A0TR-01 NA TCGA-AR-A0TR-01A-11D-A099-09 TCGA-AR-A0TR-01 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01 TCGA-AR-A0TR-01A-11D-A087-01 NA TCGA-AR-A0TR-01A-11R-A084-07 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01A-11D-A087-01 TCGA-AR-A0TR-01 |
|
|
418 |
TCGA-AR-A0TS-01 Stage II 46 4 No_Conversion 1138 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1138 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A0TS-01 2558 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 5 mutation cluster 5 TCGA-AR-A0TS 2558 0 days 2558 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TS-F71730 TCGA-AR-A0TS TCGA-AR-A0TS-01A NA Negative NA 0 NA NA Negative Lumpectomy NA YES NA NA -17141 1549 NA 0 2558 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO Negative NA NO 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf A0TS TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 3e57b40c-7079-4f05-bf37-f560304966c1 3e57b40c-7079-4f05-bf37-f560304966c1 TCGA-AR-A0TS-01A-21-A13C-20 TCGA-AR-A0TS-01A-11D-A10Y-09 TCGA-AR-A0TS-01 NA 3dd4ebe5-1445-46c9-8815-f9a3dc659585 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11D-A10Y-09 TCGA-AR-A0TS-01A-11D-A112-05 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11D-A10Y-09 NA 3e57b40c-7079-4f05-bf37-f560304966c1 NA TCGA-AR-A0TS-01A-11D-A111-01 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11R-A115-07 3e57b40c-7079-4f05-bf37-f560304966c1 TCGA-AR-A0TS-01A-11D-A111-01 TCGA-AR-A0TS-01 |
|
|
419 |
TCGA-AR-A0TT-01 Stage III 53 3 No_Conversion 1679 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N2 1679 0 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 LIVING 0 TCGA-AR-A0TT-01 3316 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A0TT 3316 0 days 3316 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TT-F71737 TCGA-AR-A0TT TCGA-AR-A0TT-01A NA Positive NA 0 NA NA Negative Other NA NA NA NA -19679 1567 NA 0 3316 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 310 NO Negative NA NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 5 NA true No M0 N2 T2 Stage IIIA TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A.pdf A0TT TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01A-21-A13C-20 TCGA-AR-A0TT-01A-31D-A099-09 TCGA-AR-A0TT-01 TCGA-AR-A0TT-01A-31D-A10P-05 5f13706f-5c4d-421f-9b16-eaeec34f283b TCGA-AR-A0TT-01 NA NA TCGA-AR-A0TT-01 NA TCGA-AR-A0TT-01A-31D-A099-09 TCGA-AR-A0TT-01 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01 TCGA-AR-A0TT-01A-31D-A087-01 NA TCGA-AR-A0TT-01A-31R-A084-07 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01A-31D-A087-01 TCGA-AR-A0TT-01 |
|
|
420 |
TCGA-AR-A0TU-01 Stage II 35 4 No_Conversion 360 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 360 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A0TU-01 709 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation c1uster 9 TCGA-AR-A0TU 709 0 days 709 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TU-F71735 TCGA-AR-A0TU TCGA-AR-A0TU-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -13039 1633 NA 0 709 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 830 NO Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf A0TU TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 2877059f-b560-413b-b8be-40d9fde8fbcf 2877059f-b560-413b-b8be-40d9fde8fbcf TCGA-AR-A0TU-01A-21-A13C-20 TCGA-AR-A0TU-01A-31D-A10G-09 TCGA-AR-A0TU-01 TCGA-AR-A0TU-01A-31D-A10A-05 3c72159d-4ac6-4f06-89f5-4e7bc6a4e134 NA TCGA-AR-A0TU-01A-31D-A10G-09 NA NA NA TCGA-AR-A0TU-01A-31D-A10G-09 NA 2877059f-b560-413b-b8be-40d9fde8fbcf NA NA NA TCGA-AR-A0TU-01A-31R-A109-07 2877059f-b560-413b-b8be-40d9fde8fbcf NA TCGA-AR-A0TU-01 |
|
|
421 |
TCGA-AR-A0TV-01 Stage II 66 1 No_Conversion 904 NA Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 904 0 LumB Luminal B Positive LumA/B -10 -5 enrollment T_Other T2 LIVING 0 TCGA-AR-A0TV-01 2288 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 8 TCGA-AR-A0TV 2288 0 days 2288 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TV-F71734 TCGA-AR-A0TV TCGA-AR-A0TV-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -24279 1716 NA 0 2288 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 550 NO Equivocal Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA.pdf A0TV TUMOR FREE NA NA NA NA NA NO NA NA NA NO Primary Tumor 01 NA 6th NO NO YES AR Breast A LIVING 2005 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01A-11-A13D-20 TCGA-AR-A0TV-01A-21D-A099-09 TCGA-AR-A0TV-01 TCGA-AR-A0TV-01A-21D-A10P-05 457d54a9-a2c9-4747-928c-4c428e187548 TCGA-AR-A0TV-01 NA NA TCGA-AR-A0TV-01 NA TCGA-AR-A0TV-01A-21D-A099-09 TCGA-AR-A0TV-01 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01 TCGA-AR-A0TV-01A-21D-A087-01 NA TCGA-AR-A0TV-01A-21R-A084-07 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01A-21D-A087-01 TCGA-AR-A0TV-01 |
|
|
422 |
TCGA-AR-A0TW-01 Stage III 50 4 No_Conversion 739 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 739 0 LumA Luminal A Positive Basal -2 -5 enrollment T_Other T3 LIVING 0 TCGA-AR-A0TW-01 3009 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-AR-A0TW 3009 0 days 3009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant|Right Lower Outer Quadrant NA NA TCGA-AR-A0TW-F49464 TCGA-AR-A0TW NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -18263 NA NA 0 3009 NA NA 739 NA NA NA NA NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NA 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 3 NA NA No M0 N1 T3 Stage IIIA NA A0TW TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA NA YES NO YES AR Breast NA LIVING 2005 f8fd0762-44b8-41ff-9c1a-ff688497e312 f8fd0762-44b8-41ff-9c1a-ff688497e312 TCGA-AR-A0TW-01A-21-A13D-20 TCGA-AR-A0TW-01A-11D-A099-09 TCGA-AR-A0TW-01 TCGA-AR-A0TW-01A-11D-A10P-05 d09f498e-9952-4926-b6e2-56e774b0bdcf TCGA-AR-A0TW-01 NA NA TCGA-AR-A0TW-01 NA TCGA-AR-A0TW-01A-11D-A099-09 NA f8fd0762-44b8-41ff-9c1a-ff688497e312 NA TCGA-AR-A0TW-01A-11D-A087-01 NA TCGA-AR-A0TW-01A-11R-A084-07 f8fd0762-44b8-41ff-9c1a-ff688497e312 TCGA-AR-A0TW-01A-11D-A087-01 TCGA-AR-A0TW-01 |
|
|
423 |
TCGA-AR-A0TX-01 Stage II 64 1 No_Conversion 15 NA Positive FEMALE Positive 2 2 1 Negative M0 Positive N1 15 0 Her2 HER2-enriched Positive ReacII -11 -5 enrollment T1 T1 LIVING 0 TCGA-AR-A0TX-01 1972 0 days High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-AR-A0TX 1972 0 days 1972 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-AR-A0TX-F63939 TCGA-AR-A0TX TCGA-AR-A0TX-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -23653 1976 NA 0 1972 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2014-8-21 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 470 NO Positive NA NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 1 NA NA NA NA NA NA NA NO 3 NA true No M0 N1 T1 Stage IIA TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf A0TX TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Wide local excision NA NA NO YES AR Breast A LIVING 2005 08d85849-cda7-4709-a934-fdc586418d7f 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01A-21-A13D-20 TCGA-AR-A0TX-01A-11D-A099-09 TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A10P-05 82828084-520c-4384-aa18-0d668bfa5ed6 TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A099-09 NA TCGA-AR-A0TX-01 NA TCGA-AR-A0TX-01A-11D-A099-09 TCGA-AR-A0TX-01 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A087-01 NA TCGA-AR-A0TX-01A-11R-A084-07 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01A-11D-A087-01 TCGA-AR-A0TX-01 |
|
|
424 |
TCGA-AR-A0TY-01 Stage II 54 1 No_Conversion 544 1699 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 1699 1 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 DECEASED 1 TCGA-AR-A0TY-01 1699 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-AR-A0TY 544 1 days 1699 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0TY-F18561 TCGA-AR-A0TY TCGA-AR-A0TY-01A NA Positive NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -19836 2141 1699 0 NA NA NA 544 NA NA NA 10-19% NA Scheduled Follow-up Submission 2011-12-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 410 NO Negative NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA 1+ NA Positive NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 4 4 NA NA NA Bone Distant Metastasis NA NA YES 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf A0TY WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES AR Breast A DECEASED 2004 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 TCGA-AR-A0TY-01A-21-A13D-20 TCGA-AR-A0TY-01A-12W-A12T-09 TCGA-AR-A0TY-01 NA 8a76d3b0-5e1c-48d9-a325-71be8a93a093 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12W-A12T-09 TCGA-AR-A0TY-01A-12D-A112-05 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12W-A12T-09 NA 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 NA TCGA-AR-A0TY-01A-12D-A111-01 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12R-A115-07 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 TCGA-AR-A0TY-01A-12D-A111-01 TCGA-AR-A0TY-01 |
|
|
425 |
TCGA-AR-A0TZ-01 Stage III 43 5 No_Conversion 1313 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N2 1313 0 LumA Luminal B Positive ReacII -10 -3 enrollment T_Other T2 LIVING 1 TCGA-AR-A0TZ-01 3262 1 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A0TZ 1313 1 days 3262 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant NA NA TCGA-AR-A0TZ-F49471 TCGA-AR-A0TZ TCGA-AR-A0TZ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -15720 2239 3262 0 2316 NA NA 1313 NA NA NA NA NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 290 NO Equivocal Negative NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 1+ NA Positive 70-79% NA NA NA NA NA NA NA NA <10% NA Positive Bone NA 3 2 NA NA NA Bone Distant Metastasis NA NA YES 6 NA true No M1 N2 T2 Stage IIIA TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2.pdf A0TZ NA NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA NA YES NO YES AR Breast A DECEASED 2004 1d6480da-a470-4726-8bc4-57fa30799a15 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01A-21-A13D-20 TCGA-AR-A0TZ-01A-12D-A099-09 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01A-12D-A10P-05 5afd9456-59f9-44d4-ac7c-b086ef899105 TCGA-AR-A0TZ-01 NA NA TCGA-AR-A0TZ-01 NA TCGA-AR-A0TZ-01A-12D-A099-09 TCGA-AR-A0TZ-01 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01A-12D-A087-01 NA TCGA-AR-A0TZ-01A-12R-A084-07 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01A-12D-A087-01 TCGA-AR-A0TZ-01 |
|
|
426 |
TCGA-AR-A0U0-01 Stage II 73 1 No_Conversion 8 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 8 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A0U0-01 1988 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation cluster 3 TCGA-AR-A0U0 1988 0 days 1988 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0U0-F65068 TCGA-AR-A0U0 TCGA-AR-A0U0-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA YES NA NA -26993 2289 NA 0 1988 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2014-9-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO NA NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 2 true No M0 N1 T2 Stage IIB TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf A0U0 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA NA NA NO YES AR Breast A LIVING 2004 dea20128-b180-4da1-9da5-0f00bea3b1ab dea20128-b180-4da1-9da5-0f00bea3b1ab TCGA-AR-A0U0-01A-21-A13D-20 TCGA-AR-A0U0-01A-11D-A10G-09 TCGA-AR-A0U0-01 TCGA-AR-A0U0-01A-11D-A10A-05 4c67c3c8-cc93-4bb4-a8c6-76232335c00f TCGA-AR-A0U0-01 TCGA-AR-A0U0-01A-11D-A10G-09 NA TCGA-AR-A0U0-01 NA TCGA-AR-A0U0-01A-11D-A10G-09 NA dea20128-b180-4da1-9da5-0f00bea3b1ab NA TCGA-AR-A0U0-01A-11D-A107-01 NA TCGA-AR-A0U0-01A-11R-A109-07 dea20128-b180-4da1-9da5-0f00bea3b1ab TCGA-AR-A0U0-01A-11D-A107-01 TCGA-AR-A0U0-01 |
|
|
427 |
TCGA-AR-A0U1-01 Stage II 36 1 No_Conversion 185 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 185 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AR-A0U1-01 4052 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 NA miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-AR-A0U1 4052 0 days 4052 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0U1-F71729 TCGA-AR-A0U1 TCGA-AR-A0U1-01A NA Negative NA 0 NA NA Negative Other NA NO NA NA -13467 2301 NA 0 4052 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 300 NO Negative NA NO 31 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA.pdf A0U1 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 wide local excision 6th YES NO YES AR Breast A LIVING 2004 3450eaab-777a-46ab-9d13-8e0783c4a686 3450eaab-777a-46ab-9d13-8e0783c4a686 TCGA-AR-A0U1-01A-21-A13C-20 TCGA-AR-A0U1-01A-11D-A10Y-09 NA NA 9b542860-aebc-49d8-a1a3-3f693c8b119a NA TCGA-AR-A0U1-01A-11D-A10Y-09 TCGA-AR-A0U1-01A-11D-A112-05 NA NA TCGA-AR-A0U1-01A-11D-A10Y-09 NA 3450eaab-777a-46ab-9d13-8e0783c4a686 NA TCGA-AR-A0U1-01A-11D-A111-01 NA TCGA-AR-A0U1-01A-11R-A115-07 3450eaab-777a-46ab-9d13-8e0783c4a686 TCGA-AR-A0U1-01A-11D-A111-01 |
|
|
428 |
TCGA-AR-A0U2-01 Stage III 47 5 No_Conversion 1608 2551 Positive FEMALE Negative NA NA NA Negative M0 Positive N2 2551 1 LumB Luminal B Positive ReacII -10 -5 enrollment T_Other T2 DECEASED 1 TCGA-AR-A0U2-01 2551 1 days High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A0U2 1609 1 days 2551 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-AR-A0U2-F18483 TCGA-AR-A0U2 TCGA-AR-A0U2-01A Negative Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17390 2395 2551 0 NA NA NA 1609 NA NA NA 10-19% NA Scheduled Follow-up Submission 2011-12-15 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 150 NO Negative NA NA 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 2+ NA Positive 70-79% NA NA 2.47 NA NA NA Negative NA NA NA Negative Bone|Liver NA 2 5 NA NA NA Bone Distant Metastasis Liver NA YES 4 0 true No M0 N2 T2 Stage IIIA TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf A0U2 WITH TUMOR NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA NA YES NO YES AR Breast A DECEASED 2004 45f011a1-cc58-47f8-9545-66c313441650 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01A-21-A13D-20 TCGA-AR-A0U2-01A-11D-A10G-09 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A10A-05 bb541d0b-a4ba-482a-b4ff-427185e70239 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A10G-09 NA TCGA-AR-A0U2-01 NA TCGA-AR-A0U2-01A-11D-A10G-09 TCGA-AR-A0U2-01 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A107-01 NA TCGA-AR-A0U2-01A-11R-A109-07 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01A-11D-A107-01 TCGA-AR-A0U2-01 |
|
|
429 |
TCGA-AR-A0U3-01 Stage II 59 4 No_Conversion 2263 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 2263 0 LumA Luminal B Positive LumA/B 0 -3 enrollment T_Other T2 LIVING 0 TCGA-AR-A0U3-01 4080 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 5 TCGA-AR-A0U3 4080 0 days 4080 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0U3-F71712 TCGA-AR-A0U3 NA NA Positive NA NA NA NA Positive Other NA NO NA NA -21755 NA NA 0 4080 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1 T2 Stage IIB NA A0U3 TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast NA LIVING 2004 b36b5a17-972f-442a-84a0-469099a619ec b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01A-21-A13C-20 TCGA-AR-A0U3-01A-11D-A10G-09 TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A10A-05 c5be7166-dd6f-422d-b420-ee73dc2675f4 TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A10G-09 NA TCGA-AR-A0U3-01 NA TCGA-AR-A0U3-01A-11D-A10G-09 TCGA-AR-A0U3-01 b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A107-01 NA TCGA-AR-A0U3-01A-11R-A109-07 b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01A-11D-A107-01 TCGA-AR-A0U3-01 |
|
|
430 |
TCGA-AR-A0U4-01 Stage II 54 1 No_Conversion 1627 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1627 0 Basal Basal-like Negative ReacII -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A0U4-01 3261 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 11 TCGA-AR-A0U4 3261 0 days 3261 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A0U4-F71739 TCGA-AR-A0U4 NA NA Negative NA 0 NA NA Negative Simple Mastectomy NA NO NA NA -19729 NA NA 0 3261 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A0U4 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA 6th YES NO YES AR Breast NA LIVING 2006 ee7156b6-f469-402c-8f63-f4c2f6913db1 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01A-21-A13D-20 TCGA-AR-A0U4-01A-11D-A117-09 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01A-11D-A10A-05 e4120a7f-41ff-4928-a173-0cb5f7fb8674 TCGA-AR-A0U4-01 NA NA TCGA-AR-A0U4-01 NA TCGA-AR-A0U4-01A-11D-A117-09 TCGA-AR-A0U4-01 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01A-11D-A107-01 NA TCGA-AR-A0U4-01A-11R-A109-07 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01A-11D-A107-01 TCGA-AR-A0U4-01 |
|
|
431 |
TCGA-AR-A1AH-01 Stage II 51 1 Stage IIB 2298 NA Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 2298 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AH-01 3807 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A1AH 3807 0 days 3807 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-AR-A1AH-F69267 TCGA-AR-A1AH TCGA-AR-A1AH-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -18991 2368 NA 0 3807 NA NA 1136 NA NA NA 10-19% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA Other, specify New Primary Tumor Renal NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf A1AH TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast A LIVING 2004 ff0d7627-cec2-42e7-891b-cba5f42e3272 ff0d7627-cec2-42e7-891b-cba5f42e3272 TCGA-AR-A1AH-01A-21-A13E-20 TCGA-AR-A1AH-01A-11D-A12B-09 TCGA-AR-A1AH-01 NA 180cde2e-13d3-462d-bba2-ae37bdee0f3f TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11D-A12B-09 TCGA-AR-A1AH-01A-11D-A12E-05 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11D-A12B-09 NA ff0d7627-cec2-42e7-891b-cba5f42e3272 NA TCGA-AR-A1AH-01A-11D-A12A-01 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11R-A12D-07 ff0d7627-cec2-42e7-891b-cba5f42e3272 TCGA-AR-A1AH-01A-11D-A12A-01 TCGA-AR-A1AH-01 |
|
|
432 |
TCGA-AR-A1AI-01 Stage II 47 1 Stage IIA 1881 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1881 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AI-01 3296 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A1AI 3296 0 days 3296 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AI-F69268 TCGA-AR-A1AI TCGA-AR-A1AI-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -17229 1939 NA 0 3296 NA NA 588 NA NA NA NA NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 2+ NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Fine needle aspiration biopsy 1050 NO Equivocal Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA Other, specify New Primary Tumor Contralateral Breast NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf A1AI TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2005 52ff562f-6a13-435a-acab-16a064633b1d 52ff562f-6a13-435a-acab-16a064633b1d TCGA-AR-A1AI-01A-21-A13E-20 TCGA-AR-A1AI-01A-11D-A12Q-09 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12R-05 d872badb-8c24-48fe-b482-6b3c262a4259 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12Q-09 NA TCGA-AR-A1AI-01 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12Q-09 NA 52ff562f-6a13-435a-acab-16a064633b1d NA TCGA-AR-A1AI-01A-11D-A12N-01 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11R-A12P-07 52ff562f-6a13-435a-acab-16a064633b1d TCGA-AR-A1AI-01A-11D-A12N-01 TCGA-AR-A1AI-01 |
|
|
433 |
TCGA-AR-A1AJ-01 Stage I 83 3 Stage I 1604 NA Positive FEMALE Negative 1 2 2 Negative M0 Negative N0 1604 0 Basal Basal-like Negative ReacI -13 -12 enrollment T1 T1 LIVING 0 TCGA-AR-A1AJ-01 3072 0 days High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AR-A1AJ 3072 0 days 3072 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AJ-F69269 TCGA-AR-A1AJ TCGA-AR-A1AJ-01A NA Positive NA NA NA NA Negative Other NA YES NA NA -30489 1828 NA 0 3072 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf A1AJ TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Wide local excision 6th NO NO YES AR Breast A LIVING 2005 98703904-572d-4220-b959-a1293a2e1c33 98703904-572d-4220-b959-a1293a2e1c33 TCGA-AR-A1AJ-01A-31-A13E-20 TCGA-AR-A1AJ-01A-21D-A12Q-09 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12R-05 26cb824a-251d-4b4c-a00c-19de6d7e2562 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12Q-09 NA TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12Q-09 NA 98703904-572d-4220-b959-a1293a2e1c33 NA TCGA-AR-A1AJ-01A-21D-A12N-01 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21R-A12P-07 98703904-572d-4220-b959-a1293a2e1c33 TCGA-AR-A1AJ-01A-21D-A12N-01 TCGA-AR-A1AJ-01 |
|
|
434 |
TCGA-AR-A1AK-01 Stage I 70 3 Stage I 1558 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 1558 0 LumA Luminal A Positive ReacI -5 0 enrollment T1 T1 LIVING 0 TCGA-AR-A1AK-01 3159 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AK 3159 0 days 3159 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AK-F69271 TCGA-AR-A1AK NA NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -25825 NA NA 0 3159 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1 Stage I NA A1AK TUMOR FREE NA NA NA NA NA YES YES 10-19% NA NO Primary Tumor 01 NA 6th YES NO YES AR Breast NA LIVING 2006 a3568fd6-4b6d-4507-9c59-1788834d3a75 a3568fd6-4b6d-4507-9c59-1788834d3a75 TCGA-AR-A1AK-01A-31-A13E-20 TCGA-AR-A1AK-01A-21D-A12Q-09 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12R-05 f0e4daf7-c2e8-40e8-826e-1cb9df14327e TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12Q-09 NA TCGA-AR-A1AK-01 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12Q-09 NA a3568fd6-4b6d-4507-9c59-1788834d3a75 NA TCGA-AR-A1AK-01A-21D-A12N-01 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21R-A12P-07 a3568fd6-4b6d-4507-9c59-1788834d3a75 TCGA-AR-A1AK-01A-21D-A12N-01 TCGA-AR-A1AK-01 |
|
|
435 |
TCGA-AR-A1AL-01 Stage III 60 2 Stage IIIA 1485 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1485 0 LumA Luminal A Positive ReacI -4 0 enrollment T_Other T3 LIVING 0 TCGA-AR-A1AL-01 2971 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 1 TCGA-AR-A1AL 2971 0 days 2971 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AL-F69272 TCGA-AR-A1AL TCGA-AR-A1AL-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -22023 1528 NA 0 2971 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 630 NO Negative NA NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 3 NA true No M0 N1 T3 Stage IIIA TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf A1AL TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 TCGA-AR-A1AL-01A-31-A13E-20 TCGA-AR-A1AL-01A-21D-A12Q-09 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12R-05 12c1530b-8aaf-4eb5-bda4-5d3225242d79 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12Q-09 NA TCGA-AR-A1AL-01 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12Q-09 NA ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 NA TCGA-AR-A1AL-01A-21D-A12N-01 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21R-A12P-07 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 TCGA-AR-A1AL-01A-21D-A12N-01 TCGA-AR-A1AL-01 |
|
|
436 |
TCGA-AR-A1AM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A1AM-01 2991 0 days Iq NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AR-A1AM 2991 0 days 2991 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant NA NA TCGA-AR-A1AM-F71733 TCGA-AR-A1AM NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -19123 NA NA 0 2991 NA NA NA NA NA NA NA NA NA 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No M0 N1 T3 Stage IIIA NA A1AM TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES AR Breast NA LIVING 2006 a58de230-f177-4c58-95ec-55b6edb08452 a58de230-f177-4c58-95ec-55b6edb08452 TCGA-AR-A1AM-01A-31-A24A-20 NA TCGA-AR-A1AM-01 TCGA-AR-A1AM-01A-41D-A22B-05 d30acc0b-b6b7-4134-96f5-4b76004ca893 TCGA-AR-A1AM-01 TCGA-AR-A1AM-01A-41D-A228-09 NA NA TCGA-AR-A1AM-01 NA NA a58de230-f177-4c58-95ec-55b6edb08452 NA TCGA-AR-A1AM-01A-41D-A227-01 TCGA-AR-A1AM-01 NA a58de230-f177-4c58-95ec-55b6edb08452 TCGA-AR-A1AM-01A-41D-A227-01 |
|
|
437 |
TCGA-AR-A1AN-01 Stage II 46 1 Stage IIA 1329 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1329 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AN-01 2920 0 days High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation cluster 5 TCGA-AR-A1AN 2920 0 days 2920 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AN-F69273 TCGA-AR-A1AN TCGA-AR-A1AN-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -16974 1463 NA 0 2920 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Negative NA NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf A1AN TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 Wide Local Excision 6th YES NO YES AR Breast A LIVING 2006 9046caf3-bbfe-4554-b9d2-11b333ad7704 9046caf3-bbfe-4554-b9d2-11b333ad7704 NA TCGA-AR-A1AN-01A-11D-A12Q-09 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12R-05 NA TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12Q-09 NA TCGA-AR-A1AN-01 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12Q-09 NA 9046caf3-bbfe-4554-b9d2-11b333ad7704 NA TCGA-AR-A1AN-01A-11D-A12N-01 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11R-A12P-07 9046caf3-bbfe-4554-b9d2-11b333ad7704 TCGA-AR-A1AN-01A-11D-A12N-01 TCGA-AR-A1AN-01 |
|
|
438 |
TCGA-AR-A1AO-01 Stage II 47 1 Stage IIA 1324 NA Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 1324 0 Normal Normal-like Negative Basal -5 -8 enrollment T1 T1 LIVING 0 TCGA-AR-A1AO-01 2618 0 days Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AO 2618 0 days 2618 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AO-F69274 TCGA-AR-A1AO TCGA-AR-A1AO-01A NA Positive NA NA NA NA Negative Other NA YES NA NA -17332 1471 NA 0 2618 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 39 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T1 Stage IIA TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf A1AO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 56183330-0700-46d7-b45f-6d915ae587fa 56183330-0700-46d7-b45f-6d915ae587fa TCGA-AR-A1AO-01A-21-A13E-20 TCGA-AR-A1AO-01A-11D-A12Q-09 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12R-05 310b6320-7ad9-4977-9c23-e80e0500e94c TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12Q-09 NA TCGA-AR-A1AO-01 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12Q-09 NA 56183330-0700-46d7-b45f-6d915ae587fa NA TCGA-AR-A1AO-01A-11D-A12N-01 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11R-A12P-07 56183330-0700-46d7-b45f-6d915ae587fa TCGA-AR-A1AO-01A-11D-A12N-01 TCGA-AR-A1AO-01 |
|
|
439 |
TCGA-AR-A1AP-01 Stage I 80 2 Stage I 1215 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1215 0 LumA Luminal A Positive LumA/B 0 0 enrollment T1 T1 LIVING 0 TCGA-AR-A1AP-01 2856 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AR-A1AP 2856 0 days 2856 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AP-F69275 TCGA-AR-A1AP TCGA-AR-A1AP-01A Negative Positive NA NA NA Mastectomy NOS Positive Other NA YES NA NA -29406 1450 NA 0 2856 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 310 NO Equivocal Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf A1AP TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 8b0f1897-20d8-492d-9ea9-22f771bbae9d 8b0f1897-20d8-492d-9ea9-22f771bbae9d TCGA-AR-A1AP-01A-21-A13E-20 TCGA-AR-A1AP-01A-11D-A12Q-09 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12R-05 07e57b56-5370-4a69-86e4-cdd0955d371b TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12Q-09 NA TCGA-AR-A1AP-01 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12Q-09 NA 8b0f1897-20d8-492d-9ea9-22f771bbae9d NA TCGA-AR-A1AP-01A-11D-A12N-01 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11R-A12P-07 8b0f1897-20d8-492d-9ea9-22f771bbae9d TCGA-AR-A1AP-01A-11D-A12N-01 TCGA-AR-A1AP-01 |
|
|
440 |
TCGA-AR-A1AQ-01 Stage II 49 1 Stage IIA 1309 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1309 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AQ-01 3021 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A1AQ 3021 0 days 3021 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AQ-F69276 TCGA-AR-A1AQ TCGA-AR-A1AQ-01A NA Negative NA NA NA NA Negative Other NA YES NA NA -18109 1424 NA 0 3021 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2014-12-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 180 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf A1AQ TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 747f56be-2fdd-4eb8-99a7-34afd923d8e1 747f56be-2fdd-4eb8-99a7-34afd923d8e1 TCGA-AR-A1AQ-01A-21-A13E-20 TCGA-AR-A1AQ-01A-11D-A12Q-09 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12R-05 23358473-9909-47ff-b683-d046e292d504 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12Q-09 NA TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12Q-09 NA 747f56be-2fdd-4eb8-99a7-34afd923d8e1 NA TCGA-AR-A1AQ-01A-11D-A12N-01 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11R-A12P-07 747f56be-2fdd-4eb8-99a7-34afd923d8e1 TCGA-AR-A1AQ-01A-11D-A12N-01 TCGA-AR-A1AQ-01 |
|
|
441 |
TCGA-AR-A1AR-01 Stage III 50 1 Stage IIIA NA 523 Negative FEMALE Negative NA NA NA Negative M0 Positive N2 523 1 Basal Basal-like Negative NA -13 0 enrollment T1 T1 DECEASED 1 TCGA-AR-A1AR-01 524 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AR-A1AR 387 1 days 524 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-AR-A1AR-F21825 TCGA-AR-A1AR TCGA-AR-A1AR-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -18482 1416 524 0 NA NA NA 387 NA NA NA NA NA Additional New Tumor Event 2012-2-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO Negative NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA Other, specify New Primary Tumor Breast NA YES 5 NA true Yes M0 N2 T1 Stage IIIA TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf A1AR WITH TUMOR NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A DECEASED 2007 6d066a72-f59f-45a8-ab90-216000b36da4 6d066a72-f59f-45a8-ab90-216000b36da4 NA TCGA-AR-A1AR-01A-31D-A135-09 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A138-05 NA TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A135-09 NA TCGA-AR-A1AR-01 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A135-09 NA 6d066a72-f59f-45a8-ab90-216000b36da4 NA TCGA-AR-A1AR-01A-31D-A134-01 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31R-A137-07 6d066a72-f59f-45a8-ab90-216000b36da4 TCGA-AR-A1AR-01A-31D-A134-01 TCGA-AR-A1AR-01 |
|
|
442 |
TCGA-AR-A1AS-01 Stage II 54 3 Stage IIB 1242 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1242 0 LumA Luminal A Positive LumA -7 -3 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AS-01 1150 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AR-A1AS 1150 0 days 1150 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-AR-A1AS-F49470 TCGA-AR-A1AS TCGA-AR-A1AS-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -20028 1331 NA 0 1150 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative NA NO 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf A1AS TUMOR FREE NA NA NA NA NA NO YES 70-79% NA YES Primary Tumor 01 Wide local excision 6th NO NO YES AR Breast A LIVING 2007 e7b64cc3-9b2b-4938-9896-84b640d1586f e7b64cc3-9b2b-4938-9896-84b640d1586f TCGA-AR-A1AS-01A-21-A13E-20 TCGA-AR-A1AS-01A-11D-A12Q-09 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12R-05 0db7dee4-ca2e-4f47-a9bc-5e55ca0df269 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12Q-09 NA TCGA-AR-A1AS-01 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12Q-09 NA e7b64cc3-9b2b-4938-9896-84b640d1586f NA TCGA-AR-A1AS-01A-11D-A12N-01 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11R-A12P-07 e7b64cc3-9b2b-4938-9896-84b640d1586f TCGA-AR-A1AS-01A-11D-A12N-01 TCGA-AR-A1AS-01 |
|
|
443 |
TCGA-AR-A1AT-01 Stage II 62 NA Stage IIA NA 1272 Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1272 1 NA HER2-enriched Positive Her2 -11 -5 enrollment T_Other T2 DECEASED 1 TCGA-AR-A1AT-01 1272 1 days NA NA cluster 1 BRCA CIMP c7 BRCA basal-like c6 NA miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AT 1272 0 days 1272 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AT-F22148 TCGA-AR-A1AT TCGA-AR-A1AT-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -22942 1339 1272 0 NA NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2012-3-1 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 250 NO Positive NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N0 T2 Stage IIA TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf A1AT NA NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A DECEASED 2007 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 TCGA-AR-A1AT-01A-21-A13E-20 TCGA-AR-A1AT-01A-11D-A12Q-09 TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11D-A12R-05 6605222f-3dc9-4a93-987e-a8720dc38b32 NA TCGA-AR-A1AT-01A-11D-A12Q-09 NA NA TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11D-A12Q-09 NA e70e1882-b4be-4ed6-9c2d-4e8c84fde633 NA NA TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11R-A12P-07 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 NA TCGA-AR-A1AT-01 |
|
|
444 |
TCGA-AR-A1AU-01 Stage III 39 4 Stage IIIA 1409 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 1409 0 LumA Luminal A Positive ReacI -3 -7 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AU-01 2868 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-AR-A1AU 2868 0 days 2868 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AU-F71744 TCGA-AR-A1AU TCGA-AR-A1AU-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -14564 1317 NA 0 2868 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO Equivocal Negative NO 37 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T2 Stage IIIA TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf A1AU TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast A LIVING 2007 bb07b646-1dcc-4cf5-9aae-1df150e84a84 bb07b646-1dcc-4cf5-9aae-1df150e84a84 TCGA-AR-A1AU-01A-21-A13E-20 TCGA-AR-A1AU-01A-11D-A12Q-09 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12R-05 48cc7955-160a-4e19-aafc-4fad203a9082 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12Q-09 NA TCGA-AR-A1AU-01 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12Q-09 NA bb07b646-1dcc-4cf5-9aae-1df150e84a84 NA TCGA-AR-A1AU-01A-11D-A12N-01 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11R-A12P-07 bb07b646-1dcc-4cf5-9aae-1df150e84a84 TCGA-AR-A1AU-01A-11D-A12N-01 TCGA-AR-A1AU-01 |
|
|
445 |
TCGA-AR-A1AV-01 Stage II 68 3 Stage IIB 1295 NA Positive MALE Negative 4 5 4 Negative M0 Positive N1 1295 0 LumA Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AV-01 1864 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A1AV 1864 0 days 1864 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Axillary lymph node dissection alone NA TCGA-AR-A1AV-F49475 TCGA-AR-A1AV TCGA-AR-A1AV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -24875 1233 NA 0 1864 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2013-10-2 MALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO Negative NA NO 25 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf A1AV TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2007 dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a TCGA-AR-A1AV-01A-31-A13E-20 TCGA-AR-A1AV-01A-21D-A12Q-09 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12R-05 9432773f-696b-4104-9232-c6e6a6a379c2 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12Q-09 NA TCGA-AR-A1AV-01 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12Q-09 NA dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a NA TCGA-AR-A1AV-01A-21D-A12N-01 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21R-A12P-07 dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a TCGA-AR-A1AV-01A-21D-A12N-01 TCGA-AR-A1AV-01 |
|
|
446 |
TCGA-AR-A1AW-01 Stage II 65 3 Stage IIA 1072 NA Positive FEMALE Negative 2 2 3 Negative M0 Negative N0 1072 0 LumB Luminal A Positive ReacII -12 -3 enrollment T_Other T2 LIVING 0 TCGA-AR-A1AW-01 2632 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-AR-A1AW 2632 0 days 2632 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AW-F71714 TCGA-AR-A1AW TCGA-AR-A1AW-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -23855 1157 NA 0 2632 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 800 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf A1AW TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2007 cff4a5bc-ba2b-47d6-8d36-6277ae991606 cff4a5bc-ba2b-47d6-8d36-6277ae991606 TCGA-AR-A1AW-01A-11-A13E-20 TCGA-AR-A1AW-01A-21D-A12Q-09 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12R-05 15e9c25c-1736-4fed-9c7f-5a2f86ee7248 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12Q-09 NA TCGA-AR-A1AW-01 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12Q-09 NA cff4a5bc-ba2b-47d6-8d36-6277ae991606 NA TCGA-AR-A1AW-01A-21D-A12N-01 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21R-A12P-07 cff4a5bc-ba2b-47d6-8d36-6277ae991606 TCGA-AR-A1AW-01A-21D-A12N-01 TCGA-AR-A1AW-01 |
|
|
447 |
TCGA-AR-A1AX-01 Stage I 64 4 Stage I 1103 NA Positive FEMALE Positive 3 1 3 Negative M0 Negative N0 1103 0 LumA Luminal A Positive ReacII 0 -5 enrollment T1 T1 LIVING 0 TCGA-AR-A1AX-01 2629 0 days Squamous C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-AR-A1AX 2629 0 days 2629 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AX-F71720 TCGA-AR-A1AX TCGA-AR-A1AX-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -23507 1140 NA 0 2629 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 340 NO Positive NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf A1AX TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 66626142-7c5c-4ed0-8ef0-f4133423f275 66626142-7c5c-4ed0-8ef0-f4133423f275 TCGA-AR-A1AX-01A-21-A13E-20 TCGA-AR-A1AX-01A-11D-A12Q-09 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12R-05 f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12Q-09 NA TCGA-AR-A1AX-01 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12Q-09 NA 66626142-7c5c-4ed0-8ef0-f4133423f275 NA TCGA-AR-A1AX-01A-11D-A12N-01 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11R-A12P-07 66626142-7c5c-4ed0-8ef0-f4133423f275 TCGA-AR-A1AX-01A-11D-A12N-01 TCGA-AR-A1AX-01 |
|
|
448 |
TCGA-AR-A1AY-01 Stage I 65 1 Stage I 614 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 614 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING 0 TCGA-AR-A1AY-01 1026 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A1AY 1026 0 days 1026 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A1AY-F49482 TCGA-AR-A1AY TCGA-AR-A1AY-01A NA Negative NA NA NA NA Negative Other NA YES NA NA -23927 1085 NA 0 1026 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf A1AY TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide Local Excision 6th YES NO YES AR Breast A LIVING 2008 49c4166c-701a-4f53-8968-99aec3347214 49c4166c-701a-4f53-8968-99aec3347214 TCGA-AR-A1AY-01A-11-A13E-20 TCGA-AR-A1AY-01A-21D-A12Q-09 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12R-05 1815b916-4da0-4ada-9774-7231a10c6862 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12Q-09 NA TCGA-AR-A1AY-01 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12Q-09 NA 49c4166c-701a-4f53-8968-99aec3347214 NA TCGA-AR-A1AY-01A-21D-A12N-01 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21R-A12P-07 49c4166c-701a-4f53-8968-99aec3347214 TCGA-AR-A1AY-01A-21D-A12N-01 TCGA-AR-A1AY-01 |
|
|
449 |
TCGA-AR-A24H-01 Stage II 65 2 Stage IIA 3333 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 3333 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24H-01 4894 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 13 NA mutation c1uster 9 TCGA-AR-A24H 4894 0 days 4894 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Lower Inner Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24H-F65797 TCGA-AR-A24H NA NA Positive NA NA NA NA Positive Other NA NA NA NA -24046 NA NA 0 4894 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2014-9-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A24H TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Excision 5th YES NO YES AR Breast NA LIVING 2001 a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c NA TCGA-AR-A24H-01A-11D-A167-09 TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A16A-05 NA TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A167-09 NA NA TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A167-09 NA a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c NA TCGA-AR-A24H-01A-11D-A166-01 TCGA-AR-A24H-01 NA a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c TCGA-AR-A24H-01A-11D-A166-01 |
|
|
450 |
TCGA-AR-A24K-01 Stage II 46 3 Stage IIA 1548 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1548 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24K-01 1548 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 3 TCGA-AR-A24K 1548 0 days 1548 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24K-F49485 TCGA-AR-A24K TCGA-AR-A24K-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -16961 2325 NA 0 1548 NA NA NA NA NA No value Given 10-19% NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Equivocal Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf A24K TUMOR FREE NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2004 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 TCGA-AR-A24K-01A-21-A17I-20 TCGA-AR-A24K-01A-11D-A167-09 TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A16A-05 6308773f-3789-47c1-8254-eaf5f9801868 TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A167-09 NA NA TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A167-09 NA e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 NA TCGA-AR-A24K-01A-11D-A166-01 TCGA-AR-A24K-01 NA e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 TCGA-AR-A24K-01A-11D-A166-01 |
|
|
451 |
TCGA-AR-A24L-01 Stage II 26 5 Stage IIB 2221 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2221 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 1 TCGA-AR-A24L-01 2866 1 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A24L 1414 1 days 2866 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 26 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24L-F49488 TCGA-AR-A24L NA NA Positive NA NA NA NA Positive Other NA NA NA NA -9706 NA 2866 0 2221 NA NA 1414 NA NA NA 10-19% NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA Locoregional Disease NA NA YES 2 NA NA No M0 N1 T2 Stage IIB NA A24L WITH TUMOR NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast NA DECEASED 2005 bfa78a45-16bf-410a-816d-bd369ded91e5 bfa78a45-16bf-410a-816d-bd369ded91e5 TCGA-AR-A24L-01A-21-A17I-20 TCGA-AR-A24L-01A-11D-A167-09 TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A16A-05 e1bd54aa-7e28-47ce-98fb-95593ee07f96 TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A167-09 NA NA TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A167-09 NA bfa78a45-16bf-410a-816d-bd369ded91e5 NA TCGA-AR-A24L-01A-11D-A166-01 TCGA-AR-A24L-01 NA bfa78a45-16bf-410a-816d-bd369ded91e5 TCGA-AR-A24L-01A-11D-A166-01 |
|
|
452 |
TCGA-AR-A24M-01 Stage III 38 3 Stage IIIA 1990 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1990 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24M-01 3660 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A24M 3660 0 days 3660 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24M-F71732 TCGA-AR-A24M TCGA-AR-A24M-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -14119 2245 NA 0 3660 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) Mixed invasive ductal and invasive lobular No NA C50.9 8522/3 C50.9 NA YES NA Core needle biopsy 400 NO Negative NA NO 28 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T2 Stage IIIA TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf A24M TUMOR FREE NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2005 4977200c-765d-475f-8df4-bf8d9a3b0aa9 4977200c-765d-475f-8df4-bf8d9a3b0aa9 TCGA-AR-A24M-01A-21-A17I-20 TCGA-AR-A24M-01A-11D-A167-09 TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A16A-05 8728cab4-4860-4753-aa84-05f91f245005 TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A167-09 NA NA TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A167-09 NA 4977200c-765d-475f-8df4-bf8d9a3b0aa9 NA TCGA-AR-A24M-01A-11D-A166-01 TCGA-AR-A24M-01 NA 4977200c-765d-475f-8df4-bf8d9a3b0aa9 TCGA-AR-A24M-01A-11D-A166-01 |
|
|
453 |
TCGA-AR-A24N-01 Stage I 54 2 Stage I 2074 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2074 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A24N-01 3035 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 3 mutation c1uster 9 TCGA-AR-A24N 3035 0 days 3035 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24N-F71723 TCGA-AR-A24N TCGA-AR-A24N-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19989 2219 NA 0 3035 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 310 NO Equivocal Negative NO 4 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf A24N TUMOR FREE NA NA NA NA NA NO YES 10-19% NA NO Primary Tumor 01 NA 6th NO NO YES AR Breast A LIVING 2005 48bf0fa5-66c2-495d-93ef-943bc7ff31ac 48bf0fa5-66c2-495d-93ef-943bc7ff31ac TCGA-AR-A24N-01A-21-A17I-20 TCGA-AR-A24N-01A-11D-A167-09 TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A16A-05 90813751-60f8-4e79-bfd3-1f363203a029 TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A167-09 NA NA TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A167-09 NA 48bf0fa5-66c2-495d-93ef-943bc7ff31ac NA TCGA-AR-A24N-01A-11D-A166-01 TCGA-AR-A24N-01 NA 48bf0fa5-66c2-495d-93ef-943bc7ff31ac TCGA-AR-A24N-01A-11D-A166-01 |
|
|
454 |
TCGA-AR-A24O-01 Stage III 43 2 Stage IIIA 1997 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1997 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-AR-A24O-01 3607 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A24O 2561 1 days 3607 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left NA NA TCGA-AR-A24O-F71713 TCGA-AR-A24O TCGA-AR-A24O-01A Negative Positive NA NA NA Mastectomy NOS Positive Modified Radical Mastectomy NA NA NA NA -15977 2213 NA 0 3607 NA NA 2561 NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Lobular carcinoma with ductal features No NA C50.9 8522/3 C50.9 NA YES NA Incisional Biopsy 700 NO Negative NA NO 19 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA YES 7 NA true No M0 N2 T3 Stage IIIA TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf A24O WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2005 2cd8167d-d35f-43e8-927f-cd7decebd9cf 2cd8167d-d35f-43e8-927f-cd7decebd9cf TCGA-AR-A24O-01A-21-A17I-20 TCGA-AR-A24O-01A-11D-A167-09 TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A16A-05 c364acc4-6658-4deb-97ff-a367022c6958 TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A167-09 NA NA TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A167-09 NA 2cd8167d-d35f-43e8-927f-cd7decebd9cf NA TCGA-AR-A24O-01A-11D-A166-01 TCGA-AR-A24O-01 NA 2cd8167d-d35f-43e8-927f-cd7decebd9cf TCGA-AR-A24O-01A-11D-A166-01 |
|
|
455 |
TCGA-AR-A24P-01 Stage I 47 2 Stage I 26 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 26 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A24P-01 84 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AR-A24P 84 0 days 84 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24P-F31403 TCGA-AR-A24P TCGA-AR-A24P-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -17490 2161 NA 0 84 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2012-5-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO Equivocal Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf A24P NA NA NA NA NA NA NA YES 10-19% NA NA Primary Tumor 01 Wide local excision 6th NA NO YES AR Breast A LIVING 2005 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b TCGA-AR-A24P-01A-21-A17I-20 TCGA-AR-A24P-01A-11D-A167-09 TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A16A-05 085b7387-61df-4f55-a320-72c165bf8647 TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A167-09 NA NA TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A167-09 NA 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b NA TCGA-AR-A24P-01A-11D-A166-01 TCGA-AR-A24P-01 NA 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b TCGA-AR-A24P-01A-11D-A166-01 |
|
|
456 |
TCGA-AR-A24Q-01 Stage II 49 1 Stage IIB 2008 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2008 0 Basal NA Negative NA NA NA enrollment T_Other T3 LIVING 0 TCGA-AR-A24Q-01 3172 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA c1uster 9 cluster 6 mutation cluster 2 TCGA-AR-A24Q 3172 0 days 3172 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24Q-F65802 TCGA-AR-A24Q TCGA-AR-A24Q-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -18084 1932 NA 0 3172 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2014-9-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 590 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T3 Stage IIB TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf A24Q TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 72c34d2c-f255-492b-9249-e9e9c506ece2 72c34d2c-f255-492b-9249-e9e9c506ece2 TCGA-AR-A24Q-01A-21-A17I-20 TCGA-AR-A24Q-01A-12D-A167-09 TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A16A-05 f39fe8fb-2c5e-403b-aceb-bd9604f1a25e TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A167-09 NA NA TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A167-09 NA 72c34d2c-f255-492b-9249-e9e9c506ece2 NA TCGA-AR-A24Q-01A-12D-A166-01 TCGA-AR-A24Q-01 NA 72c34d2c-f255-492b-9249-e9e9c506ece2 TCGA-AR-A24Q-01A-12D-A166-01 |
|
|
457 |
TCGA-AR-A24R-01 Stage III 45 5 Stage IIIA 1745 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1745 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A24R-01 3430 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AR-A24R 3430 0 days 3430 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24R-F71731 TCGA-AR-A24R TCGA-AR-A24R-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16642 1913 NA 0 3430 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative Negative NO 28 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 6 NA true No M0 N2 T1 Stage IIIA TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf A24R TUMOR FREE NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 401721b2-a1d1-46d3-b73c-ec06df30d61e 401721b2-a1d1-46d3-b73c-ec06df30d61e TCGA-AR-A24R-01A-21-A17I-20 TCGA-AR-A24R-01A-11D-A167-09 TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A16A-05 1734096f-0942-4abe-acb4-cd6e183080c0 TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A167-09 NA NA TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A167-09 NA 401721b2-a1d1-46d3-b73c-ec06df30d61e NA TCGA-AR-A24R-01A-11D-A166-01 TCGA-AR-A24R-01 NA 401721b2-a1d1-46d3-b73c-ec06df30d61e TCGA-AR-A24R-01A-11D-A166-01 |
|
|
458 |
TCGA-AR-A24S-01 Stage I 61 1 Stage I 1888 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1888 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A24S-01 2976 0 days Squamous C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AR-A24S 2976 0 days 2976 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24S-F31496 TCGA-AR-A24S TCGA-AR-A24S-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -22587 1812 NA 0 2976 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2012-5-4 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 520 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf A24S NA NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 TCGA-AR-A24S-01A-21-A17I-20 TCGA-AR-A24S-01A-11D-A167-09 TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A16A-05 9e00e8b9-5977-4a9c-aef4-c9f3e8007475 TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A167-09 NA NA TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A167-09 NA 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 NA TCGA-AR-A24S-01A-11D-A166-01 TCGA-AR-A24S-01 NA 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 TCGA-AR-A24S-01A-11D-A166-01 |
|
|
459 |
TCGA-AR-A24T-01 Stage III 46 2 Stage IIIC 1620 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 1620 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-AR-A24T-01 3202 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A24T 3202 0 days 3202 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24T-F71728 TCGA-AR-A24T TCGA-AR-A24T-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -17135 1786 NA 0 3202 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 490 NO Equivocal Negative NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 15 NA true No M0 N3 T3 Stage IIIC TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf A24T TUMOR FREE NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 TCGA-AR-A24T-01A-21-A17I-20 TCGA-AR-A24T-01A-11D-A167-09 TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A16A-05 7c08cdc2-f620-4ba3-9a66-37bd23d75d3e TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A167-09 NA NA TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A167-09 NA d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 NA TCGA-AR-A24T-01A-11D-A166-01 TCGA-AR-A24T-01 NA d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 TCGA-AR-A24T-01A-11D-A166-01 |
|
|
460 |
TCGA-AR-A24U-01 Stage II 47 4 Stage IIA 1623 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 1623 0 Her2 NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A24U-01 3128 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation c1uster 9 TCGA-AR-A24U 3128 0 days 3128 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24U-F71738 TCGA-AR-A24U TCGA-AR-A24U-01A Negative Negative NA NA NA Mastectomy NOS Negative Simple Mastectomy NA NA NA NA -17523 1763 NA 0 3128 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 320 NO Positive NA NO 25 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T1 Stage IIA TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf A24U TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 296c69de-2b77-4b3a-a228-9552a8a9836e 296c69de-2b77-4b3a-a228-9552a8a9836e TCGA-AR-A24U-01A-21-A17I-20 TCGA-AR-A24U-01A-11D-A167-09 TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A16A-05 c0592373-1465-46d8-984a-2c02e0c53cfc TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A167-09 NA NA TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A167-09 NA 296c69de-2b77-4b3a-a228-9552a8a9836e NA TCGA-AR-A24U-01A-11D-A166-01 TCGA-AR-A24U-01 NA 296c69de-2b77-4b3a-a228-9552a8a9836e TCGA-AR-A24U-01A-11D-A166-01 |
|
|
461 |
TCGA-AR-A24V-01 Stage II 52 5 Stage IIB 1648 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1648 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24V-01 3203 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A24V 3203 0 days 3203 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24V-F71740 TCGA-AR-A24V TCGA-AR-A24V-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -19027 1720 NA 0 3203 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 400 NO Negative NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf A24V TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 29b04717-c5f2-4d4c-b006-e5c5f0aade7a 29b04717-c5f2-4d4c-b006-e5c5f0aade7a TCGA-AR-A24V-01A-11-A17I-20 TCGA-AR-A24V-01A-21D-A167-09 TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A16A-05 38c6af12-c50f-4dbe-8130-0b737b29390a TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A167-09 NA NA TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A167-09 NA 29b04717-c5f2-4d4c-b006-e5c5f0aade7a NA TCGA-AR-A24V-01A-21D-A166-01 TCGA-AR-A24V-01 NA 29b04717-c5f2-4d4c-b006-e5c5f0aade7a TCGA-AR-A24V-01A-21D-A166-01 |
|
|
462 |
TCGA-AR-A24W-01 NA NA 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A24W-01 991 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-AR-A24W 991 0 days 991 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24W-F49476 TCGA-AR-A24W NA NA Positive NA NA NA NA Positive Other NA NA NA NA -20123 NA NA 0 991 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2013-10-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1 T2 Stage IIB NA A24W TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast NA LIVING 2006 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 TCGA-AR-A24W-01A-21-A17I-20 TCGA-AR-A24W-01A-11D-A17G-09 TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A16A-05 bb6402d2-2bc7-461a-8143-4e6939bb6813 TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A17G-09 NA NA TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A17G-09 NA a2f3fd7f-9a5d-44aa-8810-4978abad6e12 NA TCGA-AR-A24W-01A-11D-A166-01 TCGA-AR-A24W-01 NA a2f3fd7f-9a5d-44aa-8810-4978abad6e12 TCGA-AR-A24W-01A-11D-A166-01 |
|
|
463 |
TCGA-AR-A24X-01 Stage II 52 2 Stage IIA 1465 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1465 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24X-01 3004 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A24X 3004 0 days 3004 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24X-F71741 TCGA-AR-A24X TCGA-AR-A24X-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -19030 1717 NA 0 3004 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Mixed Histology (please specify) Mixed invasive ductal and invasive lobular No NA C50.9 8522/3 C50.9 NA YES NA Core needle biopsy 210 NO Equivocal Negative NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf A24X TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES AR Breast A LIVING 2006 42a7e579-365d-4393-8b98-e4516863299e 42a7e579-365d-4393-8b98-e4516863299e TCGA-AR-A24X-01A-21-A17I-20 TCGA-AR-A24X-01A-11D-A167-09 TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A16A-05 44e1a92c-dabb-4fdb-936c-bd1dfb2719ac TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A167-09 NA NA TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A167-09 NA 42a7e579-365d-4393-8b98-e4516863299e NA TCGA-AR-A24X-01A-11D-A166-01 TCGA-AR-A24X-01 NA 42a7e579-365d-4393-8b98-e4516863299e TCGA-AR-A24X-01A-11D-A166-01 |
|
|
464 |
TCGA-AR-A24Z-01 Stage II 57 3 Stage IIA 1574 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1574 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A24Z-01 3001 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation c1uster 9 TCGA-AR-A24Z 3001 0 days 3001 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A24Z-F71743 TCGA-AR-A24Z TCGA-AR-A24Z-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -20900 1673 NA 0 3001 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf A24Z TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total mastectomy 6th YES NO YES AR Breast A LIVING 2006 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 TCGA-AR-A24Z-01A-21-A17I-20 TCGA-AR-A24Z-01A-11D-A167-09 TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A16A-05 93fa3c81-01ce-4073-811d-146d1ef739ac TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A167-09 NA NA TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A167-09 NA 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 NA TCGA-AR-A24Z-01A-11D-A166-01 TCGA-AR-A24Z-01 NA 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 TCGA-AR-A24Z-01A-11D-A166-01 |
|
|
465 |
TCGA-AR-A250-01 Stage II 58 3 Stage IIA 1707 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1707 0 LumB NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A250-01 2707 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A250 2707 0 days 2707 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A250-F65794 TCGA-AR-A250 TCGA-AR-A250-01A Negative Positive NA NA NA Mastectomy NOS Negative Other NA NA NA NA -21309 1629 NA 0 2707 NA NA NA NA NA NA 70-79% NA NA 2014-9-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Equivocal Positive NO 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf A250 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Wide local excision and simple mastectomy 6th YES NO YES AR Breast A LIVING 2006 86373f83-264a-4875-8672-749ea434422f 86373f83-264a-4875-8672-749ea434422f TCGA-AR-A250-01A-41-A17I-20 TCGA-AR-A250-01A-31D-A167-09 TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A16A-05 1c3c4e67-cd5b-42b6-9cd8-5f18356a8e80 TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A167-09 NA NA TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A167-09 NA 86373f83-264a-4875-8672-749ea434422f NA TCGA-AR-A250-01A-31D-A166-01 TCGA-AR-A250-01 NA 86373f83-264a-4875-8672-749ea434422f TCGA-AR-A250-01A-31D-A166-01 |
|
|
466 |
TCGA-AR-A251-01 Stage III 51 1 Stage IIIA 1373 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1373 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A251-01 3030 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 NA mutation c1uster 9 TCGA-AR-A251 3030 0 days 3030 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A251-F71716 TCGA-AR-A251 TCGA-AR-A251-01A Negative Positive NA NA NA Mastectomy NOS Negative Other NA NA NA NA -18771 1611 NA 0 3030 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 450 NO Equivocal Negative NO 7 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T2 Stage IIIA TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf A251 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 06760907-c6ec-4b72-bfd4-87811823b8ba 06760907-c6ec-4b72-bfd4-87811823b8ba TCGA-AR-A251-01A-21-A17I-20 TCGA-AR-A251-01A-12D-A167-09 TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A16A-05 4378eaf7-993d-40b3-ab7f-1a909c768a47 TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A167-09 NA NA TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A167-09 NA 06760907-c6ec-4b72-bfd4-87811823b8ba NA TCGA-AR-A251-01A-12D-A166-01 TCGA-AR-A251-01 NA 06760907-c6ec-4b72-bfd4-87811823b8ba TCGA-AR-A251-01A-12D-A166-01 |
|
|
467 |
TCGA-AR-A252-01 Stage I 50 3 Stage I 1236 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1236 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A252-01 2838 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AR-A252 2838 0 days 2838 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A252-F71727 TCGA-AR-A252 TCGA-AR-A252-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -18611 1405 NA 0 2838 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 480 NO Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 1 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf A252 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 f325c7a8-46b0-4d75-9228-db391c270c71 f325c7a8-46b0-4d75-9228-db391c270c71 TCGA-AR-A252-01A-21-A17I-20 TCGA-AR-A252-01A-11D-A167-09 TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A16A-05 8fd7447f-07c3-4bd3-a877-7bf96db17d03 TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A167-09 NA NA TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A167-09 NA f325c7a8-46b0-4d75-9228-db391c270c71 NA TCGA-AR-A252-01A-11D-A166-01 TCGA-AR-A252-01 NA f325c7a8-46b0-4d75-9228-db391c270c71 TCGA-AR-A252-01A-11D-A166-01 |
|
|
468 |
TCGA-AR-A254-01 Stage III 50 3 Stage IIIA 1212 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N2 1212 0 Her2 NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-AR-A254-01 2605 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 5 TCGA-AR-A254 2605 0 days 2605 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Inner Quadrant|Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A254-F71726 TCGA-AR-A254 TCGA-AR-A254-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -18270 1381 NA 0 2605 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Wide local incision Other method, specify: 990 NO Positive NA NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 9 NA true No M0 N2 T2 Stage IIIA TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf A254 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 5741e1ce-5d4c-40dc-aa01-e71a45341884 5741e1ce-5d4c-40dc-aa01-e71a45341884 TCGA-AR-A254-01A-11-A17I-20 TCGA-AR-A254-01A-21D-A167-09 TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A16A-05 a7ba4821-8817-4411-a013-904b5c771b9e TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A167-09 NA NA TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A167-09 NA 5741e1ce-5d4c-40dc-aa01-e71a45341884 NA TCGA-AR-A254-01A-21D-A166-01 TCGA-AR-A254-01 NA 5741e1ce-5d4c-40dc-aa01-e71a45341884 TCGA-AR-A254-01A-21D-A166-01 |
|
|
469 |
TCGA-AR-A255-01 Stage I 62 5 Stage I 1058 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 1058 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-AR-A255-01 2161 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 4 TCGA-AR-A255 2161 0 days 2161 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A255-F71745 TCGA-AR-A255 TCGA-AR-A255-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -22809 1225 NA 0 2161 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO Positive NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf A255 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 5f714b76-1ed1-4828-8b66-3627c5d78189 5f714b76-1ed1-4828-8b66-3627c5d78189 TCGA-AR-A255-01A-21-A17I-20 TCGA-AR-A255-01A-11D-A167-09 TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A16A-05 1f885532-b89a-406c-af84-bcfc9441ae2a TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A167-09 NA NA TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A167-09 NA 5f714b76-1ed1-4828-8b66-3627c5d78189 NA TCGA-AR-A255-01A-11D-A166-01 TCGA-AR-A255-01 NA 5f714b76-1ed1-4828-8b66-3627c5d78189 TCGA-AR-A255-01A-11D-A166-01 |
|
|
470 |
TCGA-AR-A256-01 Stage II 45 1 Stage IIA 2854 2854 Negative FEMALE Negative NA NA NA Negative M0 Negative N0 2854 1 Basal NA Negative NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-AR-A256-01 2854 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 NA mutation cluster 5 TCGA-AR-A256 1640 1 days 2854 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A256-F31923 TCGA-AR-A256 TCGA-AR-A256-01A NA Negative NA NA NA NA Negative Other NA YES NA NA -16642 3740 2854 0 NA NA NA 1640 NA NA NA NA NA Scheduled Follow-up Submission 2012-5-11 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 210 NO Negative NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA Locoregional Disease NA NA YES 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf A256 NA NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 Mastectomy 5th YES NO YES AR Breast A DECEASED 2001 60534f8f-970a-4308-9844-a3a41dd6c187 60534f8f-970a-4308-9844-a3a41dd6c187 TCGA-AR-A256-01A-21-A17I-20 TCGA-AR-A256-01A-11D-A167-09 TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A16A-05 c98c88ee-f8ed-444b-a51c-67e6d942a8b5 TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A167-09 NA NA TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A167-09 NA 60534f8f-970a-4308-9844-a3a41dd6c187 NA TCGA-AR-A256-01A-11D-A166-01 TCGA-AR-A256-01 NA 60534f8f-970a-4308-9844-a3a41dd6c187 TCGA-AR-A256-01A-11D-A166-01 |
|
|
471 |
TCGA-AR-A2LE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LE-01 5062 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 10 NA NA TCGA-AR-A2LE 5062 0 days 5062 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Sentinel node biopsy alone NA TCGA-AR-A2LE-F35164 TCGA-AR-A2LE TCGA-AR-A2LE-01A NA Positive NA NA NA NA Negative Other NA YES NA NA -25499 3755 NA 0 5062 NA NA 4203 NA NO NA NA NA NA 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 320 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify New Primary Tumor Endometrium NA NO 0 NA true No M0 N0 T1 Stage I TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf A2LE TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Excision 5th NA NO YES AR Breast A LIVING 2001 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 TCGA-AR-A2LE-01A-21-A24A-20 NA TCGA-AR-A2LE-01 TCGA-AR-A2LE-01A-11D-A17Z-05 642d23a8-3c0c-4004-9d50-3787178cb070 TCGA-AR-A2LE-01 TCGA-AR-A2LE-01A-11D-A17W-09 NA NA TCGA-AR-A2LE-01 NA NA 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 NA TCGA-AR-A2LE-01A-11D-A17U-01 TCGA-AR-A2LE-01 NA 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 TCGA-AR-A2LE-01A-11D-A17U-01 |
|
|
472 |
TCGA-AR-A2LH-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 1 TCGA-AR-A2LH-01 616 1 days Quiet C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-AR-A2LH 434 1 days 616 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LH-F35165 TCGA-AR-A2LH TCGA-AR-A2LH-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -20288 1661 616 0 NA NA NA 434 NA YES NA NA NA NA 2012-12-6 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1100 NO Equivocal Negative NO 39 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone|Liver NA NA NA NA NA NA Bone Distant Metastasis NA NA YES 29 NA true No M0 N3 T3 Stage III TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf A2LH NA NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES AR Breast A DECEASED 2007 6aa1a643-013f-43d4-a3e6-a4a946ac3678 6aa1a643-013f-43d4-a3e6-a4a946ac3678 TCGA-AR-A2LH-01A-41-A24A-20 NA TCGA-AR-A2LH-01 TCGA-AR-A2LH-01A-31D-A18O-05 eca21066-45f1-49c3-b6ac-d594ed529c0e TCGA-AR-A2LH-01 TCGA-AR-A2LH-01A-31D-A18P-09 NA NA TCGA-AR-A2LH-01 NA NA 6aa1a643-013f-43d4-a3e6-a4a946ac3678 NA TCGA-AR-A2LH-01A-31D-A18N-01 TCGA-AR-A2LH-01 NA 6aa1a643-013f-43d4-a3e6-a4a946ac3678 TCGA-AR-A2LH-01A-31D-A18N-01 |
|
|
473 |
TCGA-AR-A2LJ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LJ-01 2632 0 days Iq NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-AR-A2LJ 2632 0 days 2632 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LJ-F71721 TCGA-AR-A2LJ TCGA-AR-A2LJ-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -14723 1382 NA 0 2632 NA NA NA NA NO NA 70-79% NA NA 2015-3-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 540 NO Positive Positive NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No MX N1 T3 Stage IIIA TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf A2LJ TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 Total Mastectomy 6th NA NO YES AR Breast A LIVING 2007 52cca577-c5d1-4dff-9e3a-4007beb120db 52cca577-c5d1-4dff-9e3a-4007beb120db TCGA-AR-A2LJ-01A-21-A24B-20 NA TCGA-AR-A2LJ-01 TCGA-AR-A2LJ-01A-12D-A19Z-05 c7155c5f-8110-4eb1-9c42-a959435f5f88 TCGA-AR-A2LJ-01 TCGA-AR-A2LJ-01A-12D-A19Y-09 NA NA TCGA-AR-A2LJ-01 NA NA 52cca577-c5d1-4dff-9e3a-4007beb120db NA TCGA-AR-A2LJ-01A-12D-A19X-01 TCGA-AR-A2LJ-01 NA 52cca577-c5d1-4dff-9e3a-4007beb120db TCGA-AR-A2LJ-01A-12D-A19X-01 |
|
|
474 |
TCGA-AR-A2LK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 1 TCGA-AR-A2LK-01 1649 1 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AR-A2LK 1304 1 days 1649 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LK-F35203 TCGA-AR-A2LK TCGA-AR-A2LK-01A Negative Positive NA NA NA Mastectomy NOS Positive Other NA NA NA NA -22800 1340 1649 0 1304 NA NA 1304 NA NO NA 70-79% NA NA 2012-12-6 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 650 NO Equivocal Negative NO 18 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Positive NA NA NA NA NA NA NA NA NA NA NA Positive NA NA NA NA NA NA NA Bone Distant Metastasis NA NA YES 5 NA true No M0 N2 T3 Stage III TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf A2LK NA NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide local excision 6th NA NO YES AR Breast A DECEASED 2007 047160f7-3727-4915-b02d-61557350d88b 047160f7-3727-4915-b02d-61557350d88b TCGA-AR-A2LK-01A-21-A24A-20 NA TCGA-AR-A2LK-01 TCGA-AR-A2LK-01A-11D-A17Z-05 bcdf5107-7ac1-4f83-8b7e-30173b7d4760 TCGA-AR-A2LK-01 TCGA-AR-A2LK-01A-11D-A17W-09 NA NA TCGA-AR-A2LK-01 NA NA 047160f7-3727-4915-b02d-61557350d88b NA TCGA-AR-A2LK-01A-11D-A17U-01 TCGA-AR-A2LK-01 NA 047160f7-3727-4915-b02d-61557350d88b TCGA-AR-A2LK-01A-11D-A17U-01 |
|
|
475 |
TCGA-AR-A2LL-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LL-01 2012 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA NA TCGA-AR-A2LL 2012 0 days 2012 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LL-F49493 TCGA-AR-A2LL TCGA-AR-A2LL-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -25747 1315 NA 0 2012 NA NA NA NA NO NA 70-79% NA NA 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1300 NO Equivocal Negative NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 T3 Stage IIB TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf A2LL TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 NA 6th NA NO YES AR Breast A LIVING 2007 2c08d3bc-c5f6-4077-86b5-633ed85818ec 2c08d3bc-c5f6-4077-86b5-633ed85818ec TCGA-AR-A2LL-01A-21-A24A-20 NA TCGA-AR-A2LL-01 TCGA-AR-A2LL-01A-11D-A17Z-05 6aee5a1d-a53e-4c02-90f5-fdb8e7765573 TCGA-AR-A2LL-01 TCGA-AR-A2LL-01A-11D-A17W-09 NA NA NA NA NA 2c08d3bc-c5f6-4077-86b5-633ed85818ec NA TCGA-AR-A2LL-01A-11D-A17U-01 NA NA 2c08d3bc-c5f6-4077-86b5-633ed85818ec TCGA-AR-A2LL-01A-11D-A17U-01 |
|
|
476 |
TCGA-AR-A2LM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LM-01 1935 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 NA NA TCGA-AR-A2LM 1935 0 days 1935 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LM-F71746 TCGA-AR-A2LM TCGA-AR-A2LM-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -18053 1339 NA 0 1935 NA NA NA NA NO NA 70-79% NA NA 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 490 NO NA Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T1 Stage II TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf A2LM TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 NA 6th NA NO YES AR Breast A LIVING 2007 461cbf67-a11d-4411-95b5-cf83ecf05d02 461cbf67-a11d-4411-95b5-cf83ecf05d02 TCGA-AR-A2LM-01A-21-A24A-20 NA TCGA-AR-A2LM-01 TCGA-AR-A2LM-01A-11D-A17Z-05 02ae8e2a-6a69-4de2-b23c-f4e6a3b8ef7d TCGA-AR-A2LM-01 TCGA-AR-A2LM-01A-11D-A17W-09 NA NA TCGA-AR-A2LM-01 NA NA 461cbf67-a11d-4411-95b5-cf83ecf05d02 NA TCGA-AR-A2LM-01A-11D-A17U-01 TCGA-AR-A2LM-01 NA 461cbf67-a11d-4411-95b5-cf83ecf05d02 TCGA-AR-A2LM-01A-11D-A17U-01 |
|
|
477 |
TCGA-AR-A2LN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LN-01 1161 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-AR-A2LN 1161 0 days 1161 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LN-F49496 TCGA-AR-A2LN TCGA-AR-A2LN-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23992 513 NA 0 1161 NA NA NA NA NO NA 70-79% NA NA 2013-10-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1460 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf A2LN TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 Mastectomy 7th NA NO YES AR Breast A LIVING 2010 8a23348d-3371-431e-a6c8-b031cde82279 8a23348d-3371-431e-a6c8-b031cde82279 TCGA-AR-A2LN-01A-31-A24A-20 NA TCGA-AR-A2LN-01 TCGA-AR-A2LN-01A-21D-A18O-05 bbf9a555-e910-4604-bffd-d7e76c024c46 TCGA-AR-A2LN-01 TCGA-AR-A2LN-01A-21D-A18P-09 NA NA TCGA-AR-A2LN-01 NA NA 8a23348d-3371-431e-a6c8-b031cde82279 NA TCGA-AR-A2LN-01A-21D-A18N-01 TCGA-AR-A2LN-01 NA 8a23348d-3371-431e-a6c8-b031cde82279 TCGA-AR-A2LN-01A-21D-A18N-01 |
|
|
478 |
TCGA-AR-A2LO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LO-01 1198 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-AR-A2LO 1198 0 days 1198 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LO-F49498 TCGA-AR-A2LO TCGA-AR-A2LO-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -17080 486 NA 0 1198 NA NA NA NA NO NA 70-79% NA NA 2013-10-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1650 NO Equivocal Negative NA 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf A2LO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES AR Breast A LIVING 2010 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 TCGA-AR-A2LO-01A-41-A24A-20 NA TCGA-AR-A2LO-01 TCGA-AR-A2LO-01A-31D-A18O-05 d9a30b5c-ba93-4cee-8ad7-937a95df1679 TCGA-AR-A2LO-01 TCGA-AR-A2LO-01A-31D-A18P-09 NA NA TCGA-AR-A2LO-01 NA NA 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 NA TCGA-AR-A2LO-01A-31D-A19G-01 TCGA-AR-A2LO-01 NA 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 TCGA-AR-A2LO-01A-31D-A19G-01 |
|
|
479 |
TCGA-AR-A2LQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LQ-01 1233 0 days Quiet C3-BRCA/Luminal NA BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-AR-A2LQ 1233 0 days 1233 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LQ-F49500 TCGA-AR-A2LQ TCGA-AR-A2LQ-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -21865 449 NA 0 1233 NA NA NA NA NO NA 70-79% NA NA 2013-10-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 1270 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T3 Stage IIB TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf A2LQ TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA NO YES AR Breast A LIVING 2010 7a72bd47-7504-4a59-ae95-096c32f70965 7a72bd47-7504-4a59-ae95-096c32f70965 TCGA-AR-A2LQ-01A-11-A24A-20 NA TCGA-AR-A2LQ-01 TCGA-AR-A2LQ-01A-22D-A18O-05 a4b9430f-9ede-4e82-8d92-b7483d029609 TCGA-AR-A2LQ-01 TCGA-AR-A2LQ-01A-22D-A18P-09 NA NA TCGA-AR-A2LQ-01 NA NA 7a72bd47-7504-4a59-ae95-096c32f70965 NA TCGA-AR-A2LQ-01A-22D-A18N-01 TCGA-AR-A2LQ-01 NA 7a72bd47-7504-4a59-ae95-096c32f70965 TCGA-AR-A2LQ-01A-22D-A18N-01 |
|
|
480 |
TCGA-AR-A2LR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A2LR-01 1742 0 days High C4-BRCA/Basal NA BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 5 NA NA TCGA-AR-A2LR 1742 0 days 1742 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A2LR-F71747 TCGA-AR-A2LR TCGA-AR-A2LR-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NA NA NA -18214 447 NA 0 1742 NA NA NA NA NO NA NA NA NA 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 800 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 T1 Stage I TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf A2LR TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES AR Breast A LIVING 2010 9f693816-6957-413c-a100-54f7bc0eddf9 9f693816-6957-413c-a100-54f7bc0eddf9 TCGA-AR-A2LR-01A-21-A24A-20 NA TCGA-AR-A2LR-01 TCGA-AR-A2LR-01A-12D-A18O-05 1504ffd3-5ca4-4858-a554-120455f8d456 TCGA-AR-A2LR-01 TCGA-AR-A2LR-01A-12D-A18P-09 NA NA NA NA NA 9f693816-6957-413c-a100-54f7bc0eddf9 NA TCGA-AR-A2LR-01A-12D-A18N-01 NA NA 9f693816-6957-413c-a100-54f7bc0eddf9 TCGA-AR-A2LR-01A-12D-A18N-01 |
|
|
481 |
TCGA-AR-A5QM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A5QM-01 2231 0 days NA NA NA NA NA NA NA NA NA TCGA-AR-A5QM 2231 0 days 2231 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A5QM-F43848 TCGA-AR-A5QM TCGA-AR-A5QM-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -22780 1541 NA 0 2231 NA NA 968 NA NA NA NA NA NA 2014-12-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 350 NO Equivocal NA NO 9 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify New Primary Tumor Malignant melanoma NA NO 0 NA true Yes M0 N0 T2 Stage IIA TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf A5QM TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Wide Excision 6th NA NO YES AR Breast A LIVING 2008 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 NA NA TCGA-AR-A5QM-01 TCGA-AR-A5QM-01A-11D-A27Y-05 049c6f4f-37ba-4507-b37b-0686a3b7bf19 TCGA-AR-A5QM-01 TCGA-AR-A5QM-01A-11D-A27P-09 NA NA TCGA-AR-A5QM-01 NA NA 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 NA TCGA-AR-A5QM-01A-11D-A27O-01 TCGA-AR-A5QM-01 NA 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 TCGA-AR-A5QM-01A-11D-A27O-01 |
|
|
482 |
TCGA-AR-A5QN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A5QN-01 1013 0 days NA NA NA NA NA NA NA NA NA TCGA-AR-A5QN 1013 0 days 1013 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Axillary lymph node dissection alone NA TCGA-AR-A5QN-F69265 TCGA-AR-A5QN TCGA-AR-A5QN-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -25089 328 NA 0 1013 NA NA NA NA NA NA NA NA NA 2014-12-31 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 510 NO Positive NA NO 19 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 10 NA true No M0 N3 T2 Stage IIIC TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf A5QN TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES AR Breast A LIVING 2012 76353751-a05c-432e-a35b-12f2bf62a494 76353751-a05c-432e-a35b-12f2bf62a494 NA NA TCGA-AR-A5QN-01 TCGA-AR-A5QN-01A-12D-A28C-05 29dda56e-2d14-4864-97a2-03bc1a97e7fd TCGA-AR-A5QN-01 TCGA-AR-A5QN-01A-12D-A28B-09 NA NA TCGA-AR-A5QN-01 NA NA 76353751-a05c-432e-a35b-12f2bf62a494 NA TCGA-AR-A5QN-01A-12D-A28A-01 TCGA-AR-A5QN-01 NA 76353751-a05c-432e-a35b-12f2bf62a494 TCGA-AR-A5QN-01A-12D-A28A-01 |
|
|
483 |
TCGA-AR-A5QP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-AR-A5QP-01 1185 0 days NA NA NA NA NA NA NA NA NA TCGA-AR-A5QP 1185 0 days 1185 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-AR-A5QP-F69266 TCGA-AR-A5QP TCGA-AR-A5QP-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -19805 498 NA 0 1185 NA NA NA NA NA NA NA NA NA 2014-12-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 230 NO Equivocal NA NO 40 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf A5QP TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES AR Breast A LIVING 2011 b2d0c724-40ae-44ca-90eb-ce86a9546c05 b2d0c724-40ae-44ca-90eb-ce86a9546c05 NA NA TCGA-AR-A5QP-01 TCGA-AR-A5QP-01A-11D-A28C-05 160070ff-2113-459e-b1ab-ffe2167da75d TCGA-AR-A5QP-01 TCGA-AR-A5QP-01A-11D-A28B-09 NA NA TCGA-AR-A5QP-01 NA NA b2d0c724-40ae-44ca-90eb-ce86a9546c05 NA TCGA-AR-A5QP-01A-11D-A28A-01 TCGA-AR-A5QP-01 NA b2d0c724-40ae-44ca-90eb-ce86a9546c05 TCGA-AR-A5QP-01A-11D-A28A-01 |
|
|
484 |
TCGA-AR-A5QQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-AR-A5QQ-01 322 1 days NA NA NA NA NA NA NA NA NA TCGA-AR-A5QQ 301 1 days 322 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Axillary lymph node dissection alone NA TCGA-AR-A5QQ-F42734 TCGA-AR-A5QQ TCGA-AR-A5QQ-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -24841 576 322 0 NA NA NA 301 NA NA NA NA NA NA 2013-6-10 FEMALE NA NA NA NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 800 NO Negative NA NO 24 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis Liver, bone, chest wall, adrenal glands NA YES 1 NA true No M0 N1 T3 Stage IIIA TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf A5QQ WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES AR Breast A DECEASED 2011 16f90247-c9a5-40d5-a3a1-08bba2d1d266 16f90247-c9a5-40d5-a3a1-08bba2d1d266 NA NA TCGA-AR-A5QQ-01 TCGA-AR-A5QQ-01A-11D-A28C-05 23195a90-ef03-4655-9b11-4668986a94c3 TCGA-AR-A5QQ-01 TCGA-AR-A5QQ-01A-11D-A28B-09 NA NA TCGA-AR-A5QQ-01 NA NA 16f90247-c9a5-40d5-a3a1-08bba2d1d266 NA TCGA-AR-A5QQ-01A-11D-A28A-01 TCGA-AR-A5QQ-01 NA 16f90247-c9a5-40d5-a3a1-08bba2d1d266 TCGA-AR-A5QQ-01A-11D-A28A-01 |
|
|
485 |
TCGA-B6-A0I1-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 1 TCGA-B6-A0I1-01 2361 1 days High NA NA BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 NA NA TCGA-B6-A0I1 1120 1 days 2361 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 73 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-B6-A0I1-F38909 TCGA-B6-A0I1 TCGA-B6-A0I1-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -26902 4248 2361 0 NA NA 1120 1120 NA NA image cytometry NA NA NA 2013-1-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 100 NO NA NA NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA NA NA NA NA NA Lung Distant Metastasis NA YES YES 0 NA true No M0 N0 T2 Stage IIA TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf A0I1 TUMOR FREE image cytometry NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 5th NA NO YES B6 Breast A DECEASED 1998 785856fc-d042-4b7f-a137-95b17c59b876 785856fc-d042-4b7f-a137-95b17c59b876 NA NA TCGA-B6-A0I1-01 TCGA-B6-A0I1-01A-11D-A21R-05 NA TCGA-B6-A0I1-01 TCGA-B6-A0I1-01A-11D-A21Q-09 NA NA TCGA-B6-A0I1-01 NA NA 785856fc-d042-4b7f-a137-95b17c59b876 NA TCGA-B6-A0I1-01A-11D-A21P-01 TCGA-B6-A0I1-01 NA 785856fc-d042-4b7f-a137-95b17c59b876 TCGA-B6-A0I1-01A-11D-A21P-01 |
|
|
486 |
TCGA-B6-A0I2-01 Stage IA 45 3 Stage I 4360 NA NA FEMALE Negative 2 2 2 Negative M0 Negative N0 4360 0 Basal Basal-like NA ReacII -13 -12 followup T1 T1 LIVING 0 TCGA-B6-A0I2-01 4361 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-B6-A0I2 4361 0 days 4361 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0I2-F12630 TCGA-B6-A0I2 TCGA-B6-A0I2-01A NA NA NA NA NA NA NA NA NA NO NA NA -16702 5305 NA 0 4361 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 200 NO NA NA NA 8 NA Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf A0I2 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1995 7175b3eb-5198-4d7f-b205-91ae8df344b4 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01A-21-A13C-20 TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01 NA 3c520911-0d5d-4a69-bef5-f2666b99544c TCGA-B6-A0I2-01 TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01A-11D-A032-05 TCGA-B6-A0I2-01 NA TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01 TCGA-B6-A0I2-01A-11D-A036-01 NA TCGA-B6-A0I2-01A-11R-A034-07 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01A-11D-A036-01 TCGA-B6-A0I2-01 |
|
|
487 |
TCGA-B6-A0I5-01 Stage IIB 49 2 No_Conversion 4549 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 4549 0 LumA Luminal A Positive NA -5 -3 followup T_Other T2 LIVING 0 TCGA-B6-A0I5-01 8556 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 4 TCGA-B6-A0I5 8556 0 days 8556 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-B6-A0I5-F71505 TCGA-B6-A0I5 TCGA-B6-A0I5-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -18038 7820 NA 0 8556 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES biopsy, NOS Other method, specify: 50 NO NA NA NO 13 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 5 NA true No M0 N1b T2 Stage IIB TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf A0I5 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 biopsy 3rd YES NO YES B6 Breast A LIVING 1988 2448118f-9664-4b9e-b67f-c019cf5b8d35 2448118f-9664-4b9e-b67f-c019cf5b8d35 NA TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01 NA NA TCGA-B6-A0I5-01 TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01A-11D-A032-05 TCGA-B6-A0I5-01 NA TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01 2448118f-9664-4b9e-b67f-c019cf5b8d35 TCGA-B6-A0I5-01 TCGA-B6-A0I5-01A-11D-A036-01 NA TCGA-B6-A0I5-01A-11R-A034-07 2448118f-9664-4b9e-b67f-c019cf5b8d35 TCGA-B6-A0I5-01A-11D-A036-01 TCGA-B6-A0I5-01 |
|
|
488 |
TCGA-B6-A0I6-01 Stage IIA 49 NA No_Conversion 991 997 Negative FEMALE NA NA NA NA Negative M0 Positive N1 997 1 Basal Basal-like Negative Basal -13 0 followup T1 T1 DECEASED 1 TCGA-B6-A0I6-01 991 1 days NA C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0I6 859 1 days 991 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 49 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0I6-F12605 TCGA-B6-A0I6 TCGA-B6-A0I6-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18014 7362 991 0 NA NA NA 859 NA NA NA NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 200 NO NA NA NA 32 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA Other, specify Distant Metastasis Skin and bone NA YES 6 NA true No M0 N1 T1c Stage IIA TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf A0I6 WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 3rd YES NO YES B6 Breast A DECEASED 1990 09c248f8-cdd7-4c13-9085-26c56544bcf7 09c248f8-cdd7-4c13-9085-26c56544bcf7 TCGA-B6-A0I6-01A-21-A13B-20 TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01 NA 4b55651d-88f5-411e-9986-702e8173a3d9 NA TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01A-11D-A032-05 NA NA TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01 09c248f8-cdd7-4c13-9085-26c56544bcf7 TCGA-B6-A0I6-01 NA NA TCGA-B6-A0I6-01A-11R-A034-07 09c248f8-cdd7-4c13-9085-26c56544bcf7 NA TCGA-B6-A0I6-01 |
|
|
489 |
TCGA-B6-A0I8-01 NA 46 NA No_Conversion 749 749 NA FEMALE NA NA NA NA Negative M0 Negative N0 749 1 LumA Luminal A NA Her2 0 -3 followup T1 T1 DECEASED 1 TCGA-B6-A0I8-01 749 1 days NA C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0I8 746 1 days 749 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES NA 46 Right Upper Inner Quadrant|Right No axillary staging NA TCGA-B6-A0I8-F12607 TCGA-B6-A0I8 NA NA NA NA NA NA NA NA NA NA NO NA 746 -17073 NA 749 0 NA NA NA 746 NA NA NA NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: NA NA NA NA NA 0 NA Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA Other, specify Locoregional Disease Pectoral muscle NA YES NA NA NA Yes M0 NX T1 Stage X NA A0I8 WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast NA DECEASED 1992 c71ca9f7-248f-460c-b5d3-afb2c648fef2 c71ca9f7-248f-460c-b5d3-afb2c648fef2 TCGA-B6-A0I8-01A-21-A13B-20 TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01 NA b8370b84-548e-42c1-8cf5-435502ae0050 NA TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01A-11D-A032-05 NA NA TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01 c71ca9f7-248f-460c-b5d3-afb2c648fef2 TCGA-B6-A0I8-01 NA NA TCGA-B6-A0I8-01A-11R-A034-07 c71ca9f7-248f-460c-b5d3-afb2c648fef2 NA TCGA-B6-A0I8-01 |
|
|
490 |
TCGA-B6-A0I9-01 Stage IV 62 5 No_Conversion 369 369 Indeterminate FEMALE Positive 1 1 1 Positive M1 Negative N0 369 1 Her2 HER2-enriched Positive Her2 -2 -5 followup T_Other T3 DECEASED 1 TCGA-B6-A0I9-01 362 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0I9 362 0 days 362 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Outer Quadrant|Left No axillary staging NA TCGA-B6-A0I9-F12609 TCGA-B6-A0I9 TCGA-B6-A0I9-01A NA Indeterminate NA NA NA NA Positive NA NA NO NA NA -22798 6687 362 0 NA NA NA NA NA NA IHC NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 180 NO NA NA NA NA NA Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA 4 4 NA NA NA NA NA NA NA NO NA NA true No M1 NX T3 Stage IV TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F.pdf A0I9 WITH TUMOR IHC NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 3rd YES NO YES B6 Breast A DECEASED 1992 1a99c4ba-6948-4054-96cd-62164ff4a6f0 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01A-21-A13B-20 TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01 NA be91388f-7261-4e1a-94a0-29215be9bb4d TCGA-B6-A0I9-01 TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01A-11D-A032-05 TCGA-B6-A0I9-01 NA TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01 TCGA-B6-A0I9-01A-11D-A036-01 NA TCGA-B6-A0I9-01A-11R-A034-07 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01A-11D-A036-01 TCGA-B6-A0I9-01 |
|
|
491 |
TCGA-B6-A0IA-01 Stage IIA 51 4 Stage IIA 6718 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 6718 0 LumA Luminal A Positive NA -12 -3 followup T_Other T2 LIVING 0 TCGA-B6-A0IA-01 8391 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-B6-A0IA 8391 0 days 8391 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Axillary lymph node dissection alone NA TCGA-B6-A0IA-F71513 TCGA-B6-A0IA TCGA-B6-A0IA-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -18748 6664 NA 0 8391 NA NA NA NA NA IHC NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES Biopsy, NOS Other method, specify: 70 NO NA NA NO 15 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf A0IA TUMOR FREE IHC NA NA NA NA YES NA NA NA NO Primary Tumor 01 Excisional biopsy NA YES NO YES B6 Breast A LIVING 1992 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a NA TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01 NA NA TCGA-B6-A0IA-01 TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01A-11D-A032-05 TCGA-B6-A0IA-01 NA TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a TCGA-B6-A0IA-01 TCGA-B6-A0IA-01A-11D-A036-01 NA TCGA-B6-A0IA-01A-11R-A034-07 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a TCGA-B6-A0IA-01A-11D-A036-01 TCGA-B6-A0IA-01 |
|
|
492 |
TCGA-B6-A0IB-01 Stage IV 64 4 No_Conversion 3941 3941 Positive FEMALE Negative 1 3 4 Positive M1 Positive N3 3941 1 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T3 DECEASED 1 TCGA-B6-A0IB-01 3941 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IB 2717 1 days 3941 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 64 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0IB-F12612 TCGA-B6-A0IB TCGA-B6-A0IB-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -23646 6660 3941 0 NA NA NA 2717 NA NA IHC NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 150 NO NA NA NA 15 Negative Indeterminate (neither Pre or Postmenopausal) fmol/mg NA NA image cytometry Positive NA NA NA NA NA NA NA NA NA NA image cytometry Positive Other, specify Skin 4 1 NA NA NA Other, specify Distant Metastasis lung, bone, liver NA YES 8 NA true No M1 N3 T3 Stage IV TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49.pdf A0IB WITH TUMOR IHC NA fmol/mg NA NA NA NA NA NA NO Primary Tumor 01 NA 3rd YES NO YES B6 Breast A DECEASED 1992 9857acef-08eb-43d6-b086-4b513e23753a 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01A-21-A13B-20 TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01 NA 5e4f32df-eccb-4283-b97e-41addb397f4b TCGA-B6-A0IB-01 TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01A-11D-A032-05 TCGA-B6-A0IB-01 NA TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01 TCGA-B6-A0IB-01A-11D-A036-01 NA TCGA-B6-A0IB-01A-11R-A034-07 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01A-11D-A036-01 TCGA-B6-A0IB-01 |
|
|
493 |
TCGA-B6-A0IC-01 NA 90 2 No_Conversion 1542 1542 Positive FEMALE Negative NA NA NA NA NA Negative N0 1542 1 LumA Luminal B Positive NA -12 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0IC-01 1542 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0IC 1542 0 days 1542 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right No axillary staging NA TCGA-B6-A0IC-F12613 TCGA-B6-A0IC TCGA-B6-A0IC-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -32872 6475 1542 0 NA NA NA NA NA NA IHC NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8503/3 C50.9 NA YES NA Fine needle aspiration biopsy 100 NO NA NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO NA NA true No MX NX T2 Stage X TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf A0IC TUMOR FREE IHC NA NA NA NA NA NA NA NA NO Primary Tumor 01 Excisional biopsy 3rd NO NO YES B6 Breast A DECEASED 1992 718599d7-723a-4121-ac07-51120cde9af1 718599d7-723a-4121-ac07-51120cde9af1 NA TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01 NA NA TCGA-B6-A0IC-01 TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01A-11D-A032-05 TCGA-B6-A0IC-01 NA TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01 718599d7-723a-4121-ac07-51120cde9af1 TCGA-B6-A0IC-01 TCGA-B6-A0IC-01A-11D-A036-01 NA TCGA-B6-A0IC-01A-11R-A034-07 718599d7-723a-4121-ac07-51120cde9af1 TCGA-B6-A0IC-01A-11D-A036-01 TCGA-B6-A0IC-01 |
|
|
494 |
TCGA-B6-A0IE-01 NA 38 3 No_Conversion 1998 1998 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 1998 1 LumA Normal-like Negative NA -2 -3 followup NA TX DECEASED 1 TCGA-B6-A0IE-01 1993 1 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-B6-A0IE 834 1 days 1993 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 38 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0IE-F12614 TCGA-B6-A0IE NA Negative Negative NA NA NA NA Negative Other NA NO NA NA -13982 NA 1993 0 NA NA NA 834 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Lobular/Ductal No NA C50.9 8520/3 C50.9 NA YES NA Incisional Biopsy NA NA NA NA NA 24 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA Bone Distant Metastasis NA NA YES 6 NA NA No M0 N1b T3 Stage IIIA NA A0IE WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 Wide re-excisional biopsy 4th YES NO YES B6 Breast NA DECEASED 1995 f40b4aa3-b474-4c2e-a197-0347e46d3309 f40b4aa3-b474-4c2e-a197-0347e46d3309 NA TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01 NA NA TCGA-B6-A0IE-01 TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01A-11D-A032-05 TCGA-B6-A0IE-01 NA TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01 f40b4aa3-b474-4c2e-a197-0347e46d3309 TCGA-B6-A0IE-01 TCGA-B6-A0IE-01A-11D-A036-01 NA TCGA-B6-A0IE-01A-11R-A034-07 f40b4aa3-b474-4c2e-a197-0347e46d3309 TCGA-B6-A0IE-01A-11D-A036-01 TCGA-B6-A0IE-01 |
|
|
495 |
TCGA-B6-A0IG-01 Stage IIB 50 NA No_Conversion 4456 4456 Positive FEMALE NA NA NA NA Negative M0 Positive N1 4456 1 LumA Luminal A Positive Her2 -2 0 followup T_Other T2 DECEASED 1 TCGA-B6-A0IG-01 4456 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 12 TCGA-B6-A0IG NA NA days 4456 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Axillary lymph node dissection alone NA TCGA-B6-A0IG-F12616 TCGA-B6-A0IG TCGA-B6-A0IG-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -18433 5836 4456 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 200 NO NA NA NA 16 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NA 4 NA true No M0 N1b T2 Stage IIB TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5.pdf A0IG WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1994 463d3f12-16bb-456a-8fb1-f200c7996406 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01A-21-A13B-20 TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01 NA 439c88c2-8efe-4981-96b8-015a9360ec6a TCGA-B6-A0IG-01 TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01A-11D-A032-05 TCGA-B6-A0IG-01 NA TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01 TCGA-B6-A0IG-01A-11D-A036-01 NA TCGA-B6-A0IG-01A-11R-A034-07 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01A-11D-A036-01 TCGA-B6-A0IG-01 |
|
|
496 |
TCGA-B6-A0IH-01 Stage IIIA 81 2 Stage IIIA NA 3418 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 3418 1 LumA Luminal A Positive NA -5 -7 followup T_Other T3 DECEASED 1 TCGA-B6-A0IH-01 3418 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-B6-A0IH NA NA days 3418 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0IH-F12617 TCGA-B6-A0IH TCGA-B6-A0IH-01A Negative Positive NA NA NA Modified radical mastectomy Positive Other NA NO NA NA -29907 5388 3418 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 110 NO NA NA NA 27 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NA 25 NA true No M0 N1b T3 Stage IIIA TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf A0IH NA Image Analysis NA NA NA NA NA YES NA NA YES Primary Tumor 01 Excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1995 76fabc98-ad85-4315-8653-4028e24cd2ff 76fabc98-ad85-4315-8653-4028e24cd2ff NA TCGA-B6-A0IH-01A-11D-A10Y-09 TCGA-B6-A0IH-01 NA NA TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11D-A10Y-09 TCGA-B6-A0IH-01A-11D-A112-05 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11D-A10Y-09 NA 76fabc98-ad85-4315-8653-4028e24cd2ff NA TCGA-B6-A0IH-01A-11D-A111-01 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11R-A115-07 76fabc98-ad85-4315-8653-4028e24cd2ff TCGA-B6-A0IH-01A-11D-A111-01 TCGA-B6-A0IH-01 |
|
|
497 |
TCGA-B6-A0IJ-01 Stage IIB 42 3 Stage IIB 5383 NA Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 5383 0 Basal Basal-like Positive Basal -13 -12 followup T_Other T3 LIVING 0 TCGA-B6-A0IJ-01 7106 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-B6-A0IJ 7106 0 days 7106 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0IJ-F71500 TCGA-B6-A0IJ TCGA-B6-A0IJ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15625 5350 NA 0 7106 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 170 NO NA NA NO 27 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf A0IJ TUMOR FREE Image Analysis NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA NA YES NO YES B6 Breast A LIVING 1995 f77e9ef0-0a62-426b-98d9-6813edeb63a5 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01A-21-A13B-20 TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01 NA 25933fc4-60a0-4223-af5f-c8eed92f0f02 TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01A-11D-A032-05 TCGA-B6-A0IJ-01 NA TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01A-11D-A036-01 NA TCGA-B6-A0IJ-01A-11R-A034-07 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01A-11D-A036-01 TCGA-B6-A0IJ-01 |
|
|
498 |
TCGA-B6-A0IK-01 Stage IIIB 63 5 No_Conversion 571 571 Negative FEMALE Negative 1 1 1 Negative M0 Positive N1 571 1 Her2 HER2-enriched Negative ReacII -11 -5 followup T_Other T4 DECEASED 1 TCGA-B6-A0IK-01 571 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-B6-A0IK 489 1 days 571 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES NA 63 Left NA NA TCGA-B6-A0IK-F12621 TCGA-B6-A0IK TCGA-B6-A0IK-01A Negative Negative NA NA NA Modified radical mastectomy Negative Lumpectomy NA NO NA 489 -23150 5724 571 0 NA NA NA 489 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 140 NO NA NA NA 14 Positive Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA Brain Distant Metastasis NA NA YES 1 NA true No M0 N1 T4 Stage IIIB TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf A0IK WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1994 8fb338fe-ffa8-45c2-857b-f713d1935330 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01A-21-A13B-20 TCGA-B6-A0IK-01A-12W-A071-09 TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12D-A10P-05 3d6a2ce9-3d70-4bec-80f1-bd5035ae2b3d TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12W-A071-09 NA TCGA-B6-A0IK-01 NA TCGA-B6-A0IK-01A-12W-A071-09 TCGA-B6-A0IK-01 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12D-A059-01 NA TCGA-B6-A0IK-01A-12R-A056-07 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01A-12D-A059-01 TCGA-B6-A0IK-01 |
|
|
499 |
TCGA-B6-A0IM-01 Stage IIB 75 4 Stage IIB 3836 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 3836 0 LumA Luminal B Positive NA -10 -3 followup T_Other T3 LIVING 1 TCGA-B6-A0IM-01 3873 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0IM 3873 0 days 3873 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0IM-F12623 TCGA-B6-A0IM TCGA-B6-A0IM-01A Negative Positive NA NA NA Modified radical mastectomy Positive Lumpectomy NA NO NA NA -27557 4754 3873 0 3836 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Fine needle aspiration biopsy 110 NO NA NA NA 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf A0IM TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1997 53f4d557-cad7-4367-9546-c10752cc6189 53f4d557-cad7-4367-9546-c10752cc6189 NA TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01 NA NA TCGA-B6-A0IM-01 TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01A-11D-A032-05 TCGA-B6-A0IM-01 NA TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01 53f4d557-cad7-4367-9546-c10752cc6189 TCGA-B6-A0IM-01 TCGA-B6-A0IM-01A-11D-A036-01 NA TCGA-B6-A0IM-01A-11R-A034-07 53f4d557-cad7-4367-9546-c10752cc6189 TCGA-B6-A0IM-01A-11D-A036-01 TCGA-B6-A0IM-01 |
|
|
500 |
TCGA-B6-A0IN-01 NA 45 3 No_Conversion 2573 2573 Positive FEMALE NA NA NA NA NA NA Negative N0 2573 1 LumB Luminal A Negative NA -2 -3 followup T1 T1 DECEASED 1 TCGA-B6-A0IN-01 2573 1 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IN 1412 1 days 2573 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NA NO NA 45 Right Upper Outer Quadrant|Right No axillary staging NA TCGA-B6-A0IN-F12625 TCGA-B6-A0IN TCGA-B6-A0IN-01A Negative Positive NA NA NA Modified radical mastectomy Negative Other NA NO NA NA -16705 5073 2573 0 NA NA NA 1412 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Fine needle aspiration biopsy 20 NO NA NA NA NA Positive Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA Other, specify Distant Metastasis bone, brain NA YES NA NA true No MX NX T1c Stage X TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf A0IN WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 Excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1996 4eaae575-d631-4e2e-8e70-4b4e0a429d74 4eaae575-d631-4e2e-8e70-4b4e0a429d74 NA TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01 NA NA TCGA-B6-A0IN-01 TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01A-11D-A032-05 TCGA-B6-A0IN-01 NA TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01 4eaae575-d631-4e2e-8e70-4b4e0a429d74 TCGA-B6-A0IN-01 TCGA-B6-A0IN-01A-11D-A036-01 NA TCGA-B6-A0IN-01A-11R-A034-07 4eaae575-d631-4e2e-8e70-4b4e0a429d74 TCGA-B6-A0IN-01A-11D-A036-01 TCGA-B6-A0IN-01 |
|
|
501 |
TCGA-B6-A0IO-01 Stage IIA 66 3 Stage IIA 3350 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3350 0 LumA Luminal A Indeterminate X 0 -3 followup T_Other T2 LIVING 0 TCGA-B6-A0IO-01 5042 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IO 5042 0 days 5042 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Axillary lymph node dissection alone NA TCGA-B6-A0IO-F71503 TCGA-B6-A0IO NA NA Positive NA NA NA NA Indeterminate Modified Radical Mastectomy NA NO NA NA -24322 NA NA 0 5042 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA NA NO 17 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A0IO TUMOR FREE Image Analysis NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA NA YES NO YES B6 Breast NA LIVING 2001 e7a1527b-dbaf-48ae-a322-e54efd36985d e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01A-21-A13B-20 TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01 NA f7075f2f-6892-4338-b042-1c48529275bd TCGA-B6-A0IO-01 TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01A-11D-A032-05 TCGA-B6-A0IO-01 NA TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01 e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01 TCGA-B6-A0IO-01A-11D-A036-01 NA TCGA-B6-A0IO-01A-11R-A034-07 e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01A-11D-A036-01 TCGA-B6-A0IO-01 |
|
|
502 |
TCGA-B6-A0IP-01 Stage IA 74 2 Stage I 3374 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 3374 0 LumA Luminal A Positive NA -5 0 followup T1 T1 LIVING 1 TCGA-B6-A0IP-01 3926 1 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0IP 3926 0 days 3926 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-B6-A0IP-F71501 TCGA-B6-A0IP TCGA-B6-A0IP-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -27047 4565 3926 0 3374 NA NA NA NA NA IMAGE ALYSIS NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO NA NA NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf A0IP TUMOR FREE IMAGE ALYSIS NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA NA NO NO YES B6 Breast A DECEASED 1997 9384eb09-5787-49e8-b07e-bd9f71997771 9384eb09-5787-49e8-b07e-bd9f71997771 NA TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01 NA NA TCGA-B6-A0IP-01 TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01A-11D-A032-05 TCGA-B6-A0IP-01 NA TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01 9384eb09-5787-49e8-b07e-bd9f71997771 TCGA-B6-A0IP-01 TCGA-B6-A0IP-01A-11D-A036-01 NA TCGA-B6-A0IP-01A-11R-A034-07 9384eb09-5787-49e8-b07e-bd9f71997771 TCGA-B6-A0IP-01A-11D-A036-01 TCGA-B6-A0IP-01 |
|
|
503 |
TCGA-B6-A0IQ-01 Stage IIIA 40 1 No_Conversion 4284 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 4284 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T3 LIVING 0 TCGA-B6-A0IQ-01 4285 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 5 mutation cluster 5 TCGA-B6-A0IQ 4285 0 days 4285 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0IQ-F12629 TCGA-B6-A0IQ TCGA-B6-A0IQ-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14669 5238 NA 0 4285 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-6-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 210 NO NA NA NA 26 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 1 NA true No M0 N1b T3 Stage IIIA TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf A0IQ TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1996 2e9c893c-1d72-49a7-8755-1ede20b26fcf 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01A-21-A13B-20 TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01 NA 940d8074-3223-49f6-8d86-d50e9ae69c9b TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01A-11D-A032-05 TCGA-B6-A0IQ-01 NA TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01A-11D-A036-01 NA TCGA-B6-A0IQ-01A-11R-A034-07 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01A-11D-A036-01 TCGA-B6-A0IQ-01 |
|
|
504 |
TCGA-B6-A0RE-01 NA 61 1 No_Conversion 6434 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 6434 0 Basal Basal-like Negative NA -13 -12 followup NA TX LIVING 0 TCGA-B6-A0RE-01 7777 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0RE 7777 0 days 7777 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0RE-F71507 TCGA-B6-A0RE NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22449 NA NA 0 7777 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Other method, specify: NA NA NA NA NO 14 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) TX Stage X NA A0RE TUMOR FREE NA NA NA NA NA NO NA NA NA YES Primary Tumor 01 NA NA NO NO YES B6 Breast NA LIVING 1989 ad46ed65-3cc2-4956-9d90-3e1edca24417 ad46ed65-3cc2-4956-9d90-3e1edca24417 NA TCGA-B6-A0RE-01A-11W-A071-09 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11D-A10P-05 NA TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11W-A071-09 NA TCGA-B6-A0RE-01 NA TCGA-B6-A0RE-01A-11W-A071-09 TCGA-B6-A0RE-01 ad46ed65-3cc2-4956-9d90-3e1edca24417 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11D-A059-01 NA TCGA-B6-A0RE-01A-11R-A056-07 ad46ed65-3cc2-4956-9d90-3e1edca24417 TCGA-B6-A0RE-01A-11D-A059-01 TCGA-B6-A0RE-01 |
|
|
505 |
TCGA-B6-A0RG-01 Stage IIB 26 2 Stage IIB 2082 NA Negative FEMALE Negative 3 3 3 Negative M0 Negative N0 2082 0 LumA Luminal A Negative ReacII 0 -3 followup T_Other T3 LIVING 0 TCGA-B6-A0RG-01 2082 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 4 mutation cluster 4 TCGA-B6-A0RG 2082 0 days 2082 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 26 Left Axillary lymph node dissection alone NA TCGA-B6-A0RG-F13793 TCGA-B6-A0RG TCGA-B6-A0RG-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -9840 6869 NA 0 2082 NA NA NA NA NA IHC NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 160 NO NA NA NA 19 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf A0RG TUMOR FREE IHC NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1991 006e88ce-ad31-45bf-8da5-802f0e387b3a 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01A-21-A13C-20 TCGA-B6-A0RG-01A-11W-A071-09 TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11D-A10P-05 5da7a020-3d19-499b-9941-2028de5c5a3e TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11W-A071-09 NA TCGA-B6-A0RG-01 NA TCGA-B6-A0RG-01A-11W-A071-09 TCGA-B6-A0RG-01 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11D-A059-01 NA TCGA-B6-A0RG-01A-11R-A056-07 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01A-11D-A059-01 TCGA-B6-A0RG-01 |
|
|
506 |
TCGA-B6-A0RH-01 Stage IIA 51 2 Stage IIA 5748 NA Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 5748 0 Her2 HER2-enriched Positive ReacII -1 -5 followup T_Other T2 LIVING 1 TCGA-B6-A0RH-01 6456 1 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-B6-A0RH 6456 0 days 6456 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES NA 51 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-B6-A0RH-F71512 TCGA-B6-A0RH TCGA-B6-A0RH-01A Negative Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA 2268 -18759 6821 6456 0 5749 NA NA 2165 NA NA Immunohistochemistry NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 130 NO NA NA NO 23 Positive Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA Other, specify Locoregional Disease Chest Wall NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf A0RH TUMOR FREE Immunohistochemistry NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES B6 Breast A DECEASED 1991 d40f62c9-c134-4477-98d7-11d343b5e867 d40f62c9-c134-4477-98d7-11d343b5e867 TCGA-B6-A0RH-01A-11-A13C-20 TCGA-B6-A0RH-01A-21D-A10Y-09 TCGA-B6-A0RH-01 NA 90975b3f-f130-4032-804a-88f06b0d3147 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21D-A10Y-09 TCGA-B6-A0RH-01A-21D-A112-05 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21D-A10Y-09 NA d40f62c9-c134-4477-98d7-11d343b5e867 NA TCGA-B6-A0RH-01A-21D-A111-01 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21R-A115-07 d40f62c9-c134-4477-98d7-11d343b5e867 TCGA-B6-A0RH-01A-21D-A111-01 TCGA-B6-A0RH-01 |
|
|
507 |
TCGA-B6-A0RI-01 Stage IIIB 44 2 No_Conversion 7125 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 7125 0 LumA Luminal A Positive NA -7 -3 followup T_Other T4 LIVING 0 TCGA-B6-A0RI-01 7126 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0RI 1100 1 days 7126 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES NA 44 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0RI-F13795 TCGA-B6-A0RI TCGA-B6-A0RI-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA 1100 -16138 6755 NA 0 7126 NA NA 1100 NA NA IHC NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 50 NO NA NA NA 15 Negative Indeterminate (neither Pre or Postmenopausal) 105 fmol/mg NA NA image cytometry Positive NA NA NA NA Other Reporting Scale NA NA NA NA NA image cytometry Positive NA NA 2 4 NA NA Other Reporting Scale Other, specify Locoregional Disease Chest Wall NA YES 6 NA true No M0 N1b T4b Stage IIIB TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf A0RI WITH TUMOR IHC NA 133 fmol/mg NA NA NA NA NA NA YES Primary Tumor 01 NA 3rd YES NO YES B6 Breast A LIVING 1992 6f5986b6-28b9-4213-97a9-899190ea36dd 6f5986b6-28b9-4213-97a9-899190ea36dd NA TCGA-B6-A0RI-01A-11W-A071-09 TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11D-A10P-05 NA TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11W-A071-09 NA TCGA-B6-A0RI-01 NA TCGA-B6-A0RI-01A-11W-A071-09 TCGA-B6-A0RI-01 6f5986b6-28b9-4213-97a9-899190ea36dd TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11D-A059-01 NA TCGA-B6-A0RI-01A-11R-A056-07 6f5986b6-28b9-4213-97a9-899190ea36dd TCGA-B6-A0RI-01A-11D-A059-01 TCGA-B6-A0RI-01 |
|
|
508 |
TCGA-B6-A0RL-01 Stage IIA 60 2 Stage IIA 2469 2469 Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 2469 1 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0RL-01 2469 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 10 TCGA-B6-A0RL 2469 0 days 2469 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left Axillary lymph node dissection alone NA TCGA-B6-A0RL-F13796 TCGA-B6-A0RL TCGA-B6-A0RL-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22238 6336 2469 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 170 NO NA NA NA 16 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1.pdf A0RL TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1993 0e704d8f-c0c0-4165-83c4-a1fa93014894 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01A-21-A13C-20 TCGA-B6-A0RL-01A-11D-A099-09 TCGA-B6-A0RL-01 TCGA-B6-A0RL-01A-11D-A10P-05 0ca6a866-1fd5-4144-80a9-01cc7f7caa9c TCGA-B6-A0RL-01 NA NA TCGA-B6-A0RL-01 NA TCGA-B6-A0RL-01A-11D-A099-09 TCGA-B6-A0RL-01 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01 TCGA-B6-A0RL-01A-11D-A087-01 NA TCGA-B6-A0RL-01A-11R-A084-07 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01A-11D-A087-01 TCGA-B6-A0RL-01 |
|
|
509 |
TCGA-B6-A0RM-01 NA 57 4 No_Conversion 2373 2373 Positive FEMALE Negative 3 3 3 NA NA Negative N0 2373 1 LumA Luminal A Positive LumA -10 -3 followup NA TX DECEASED 1 TCGA-B6-A0RM-01 2373 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-B6-A0RM 2373 0 days 2373 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left No axillary staging NA TCGA-B6-A0RM-F13797 TCGA-B6-A0RM TCGA-B6-A0RM-01A NA Positive NA NA NA NA Positive NA NA NO NA NA -21047 6279 2373 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 160 NO NA NA NA 0 NA Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO NA NA true No MX NX TX Stage X TCGA-B6-A0RM.EC8093CD-66E7-4466-99AD-B2A6B93526FD.pdf A0RM TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th NO NO YES B6 Breast A DECEASED 1993 17fdb26d-d808-4b0d-a794-6b664dae8b2b 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01A-21-A13C-20 TCGA-B6-A0RM-01A-11D-A099-09 TCGA-B6-A0RM-01 TCGA-B6-A0RM-01A-11D-A10P-05 10cf7b61-7523-4c17-a786-618537217cff TCGA-B6-A0RM-01 NA NA TCGA-B6-A0RM-01 NA TCGA-B6-A0RM-01A-11D-A099-09 TCGA-B6-A0RM-01 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01 TCGA-B6-A0RM-01A-11D-A087-01 NA TCGA-B6-A0RM-01A-11R-A084-07 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01A-11D-A087-01 TCGA-B6-A0RM-01 |
|
|
510 |
TCGA-B6-A0RN-01 Stage IA 60 2 Stage I 5261 NA Negative FEMALE Negative 1 4 3 Negative M0 Negative N0 5261 0 LumA Luminal A Negative ReacI -5 -3 followup T1 T1 LIVING 0 TCGA-B6-A0RN-01 8008 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0RN 8008 0 days 8008 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0RN-F71514 TCGA-B6-A0RN TCGA-B6-A0RN-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22077 6286 NA 0 8008 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 130 NO NA NA NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf A0RN TUMOR FREE Image Analysis NA NA NA NA YES NA NA NA YES Primary Tumor 01 NA NA YES NO YES B6 Breast A LIVING 1993 c417152a-d278-4aeb-951e-a7b6ae5654c1 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01A-21-A13C-20 TCGA-B6-A0RN-01A-12D-A099-09 TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A10P-05 734fdc04-4666-4ae2-898f-d375c47eb33b TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A099-09 NA TCGA-B6-A0RN-01 NA TCGA-B6-A0RN-01A-12D-A099-09 TCGA-B6-A0RN-01 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A087-01 NA TCGA-B6-A0RN-01A-12R-A084-07 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01A-12D-A087-01 TCGA-B6-A0RN-01 |
|
|
511 |
TCGA-B6-A0RO-01 Stage IIIB 71 3 No_Conversion 4928 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 4928 0 LumA Luminal A Positive ReacI 0 -3 followup T_Other T4 LIVING 0 TCGA-B6-A0RO-01 4929 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-B6-A0RO 4929 0 days 4929 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Axillary lymph node dissection alone NA TCGA-B6-A0RO-F13799 TCGA-B6-A0RO TCGA-B6-A0RO-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -26269 6035 NA 0 4929 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: 140 NO NA NA NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T4 Stage IIIB TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf A0RO TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1993 d99fef01-1eb5-4300-8031-d5a157fd5b28 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01A-11-A13C-20 TCGA-B6-A0RO-01A-22D-A099-09 TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A10P-05 02857059-5b3e-4a7a-a0e0-93ee7f90cfff TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A099-09 NA TCGA-B6-A0RO-01 NA TCGA-B6-A0RO-01A-22D-A099-09 TCGA-B6-A0RO-01 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A087-01 NA TCGA-B6-A0RO-01A-22R-A084-07 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01A-22D-A087-01 TCGA-B6-A0RO-01 |
|
|
512 |
TCGA-B6-A0RP-01 Stage IIIB 73 4 No_Conversion 3126 3126 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 3126 1 LumA Luminal A Positive LumA -12 -4 followup T_Other T2 DECEASED 1 TCGA-B6-A0RP-01 3126 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-B6-A0RP 2787 1 days 3126 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 73 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0RP-F13786 TCGA-B6-A0RP NA Negative Positive NA NA NA Modified radical mastectomy Positive Lumpectomy NA NO NA NA -26941 NA 3126 0 NA NA NA 2787 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) ductal/lobular No NA C50.9 8522/3 C50.9 NA YES Biopsy, NOS Other method, specify: NA NA NA NA NA 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA Bone Distant Metastasis NA NA YES 2 NA NA No M0 N1b T2 [Discrepancy] NA A0RP WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast NA DECEASED 1994 a77173cb-3e81-4957-a76f-18824d5e06dd a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01A-11-A13C-20 TCGA-B6-A0RP-01A-21D-A099-09 TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A10P-05 ac2921f3-13fa-457b-b436-1da8977a163c TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A099-09 NA TCGA-B6-A0RP-01 NA TCGA-B6-A0RP-01A-21D-A099-09 TCGA-B6-A0RP-01 a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A087-01 NA TCGA-B6-A0RP-01A-21R-A084-07 a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01A-21D-A087-01 TCGA-B6-A0RP-01 |
|
|
513 |
TCGA-B6-A0RQ-01 Stage IIB 68 1 Stage IIB NA 4273 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 4273 1 Normal Luminal A Positive ReacI -5 -7 followup T_Other T3 DECEASED 1 TCGA-B6-A0RQ-01 4267 1 days Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-B6-A0RQ 4267 0 days 4267 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0RQ-F13787 TCGA-B6-A0RQ TCGA-B6-A0RQ-01A Negative Positive NA NA NA NA Positive Other NA NO NA NA -25010 5890 4267 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 160 NO NA NA NA 14 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf A0RQ TUMOR FREE Image Analysis NA NA NA NA NA YES NA NA NO Primary Tumor 01 excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1994 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f TCGA-B6-A0RQ-01A-21-A13C-20 TCGA-B6-A0RQ-01A-11D-A10Y-09 TCGA-B6-A0RQ-01 NA 23aabbc3-fe66-44d8-8640-5c153f409754 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11D-A10Y-09 TCGA-B6-A0RQ-01A-11D-A112-05 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11D-A10Y-09 NA 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f NA TCGA-B6-A0RQ-01A-11D-A111-01 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11R-A115-07 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f TCGA-B6-A0RQ-01A-11D-A111-01 TCGA-B6-A0RQ-01 |
|
|
514 |
TCGA-B6-A0RS-01 Stage IIA 38 1 Stage IIA 3062 3062 Negative FEMALE Negative NA NA NA Negative M0 Negative N0 3062 1 Her2 HER2-enriched Negative NA 0 0 followup T_Other T2 DECEASED 1 TCGA-B6-A0RS-01 3063 1 days High C3-BRCA/Luminal cluster 5 Cluster 5 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0RS 2041 1 days 3063 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 38 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0RS-F13788 TCGA-B6-A0RS NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA 2041 -14134 NA 3063 0 NA NA NA 2041 NA NA NA NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Biopsy, NOS Other method, specify: NA NA NA NA NA 15 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 5 4 NA NA NA Other, specify New Primary Tumor Breast NA YES 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A0RS WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 3rd YES NO YES B6 Breast NA DECEASED 1988 be1f09ae-deec-45d7-8504-fea3f6e7feb4 be1f09ae-deec-45d7-8504-fea3f6e7feb4 NA TCGA-B6-A0RS-01A-11D-A099-09 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01A-11D-A10P-05 NA TCGA-B6-A0RS-01 NA NA TCGA-B6-A0RS-01 NA TCGA-B6-A0RS-01A-11D-A099-09 TCGA-B6-A0RS-01 be1f09ae-deec-45d7-8504-fea3f6e7feb4 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01A-11D-A087-01 NA TCGA-B6-A0RS-01A-11R-A084-07 be1f09ae-deec-45d7-8504-fea3f6e7feb4 TCGA-B6-A0RS-01A-11D-A087-01 TCGA-B6-A0RS-01 |
|
|
515 |
TCGA-B6-A0RT-01 Stage IIIA 39 1 No_Conversion 2721 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 2721 0 Basal Basal-like Negative ReacII -13 -12 followup T_Other T3 LIVING 0 TCGA-B6-A0RT-01 2721 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-B6-A0RT 2721 0 days 2721 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0RT-F13789 TCGA-B6-A0RT TCGA-B6-A0RT-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14374 5047 NA 0 2721 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 230 NO NA NA NA 23 Close Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T3 Stage IIIA TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf A0RT TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1996 2b721e04-5452-4b34-b3df-c6cdd04e87b1 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01A-11-A13C-20 TCGA-B6-A0RT-01A-21D-A099-09 TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A10P-05 f4b94eba-e9e8-4f06-812e-7f68eefa407b TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A099-09 NA TCGA-B6-A0RT-01 NA TCGA-B6-A0RT-01A-21D-A099-09 TCGA-B6-A0RT-01 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A087-01 NA TCGA-B6-A0RT-01A-21R-A084-07 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01A-21D-A087-01 TCGA-B6-A0RT-01 |
|
|
516 |
TCGA-B6-A0RU-01 Stage IA 49 1 Stage I 3991 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 3991 0 Basal Basal-like Negative Basal -13 -11 followup T1 T1 LIVING 0 TCGA-B6-A0RU-01 8605 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-B6-A0RU 8605 0 days 8605 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA YES NA 40 Right Axillary lymph node dissection alone NA TCGA-B6-A0RU-F71565 TCGA-B6-A0RU TCGA-B6-A0RU-01A NA Negative NA NA NA NA Negative Other NA NO NA 3076 -14920 7290 NA 0 8605 NA NA 3076 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Tumor resection 170 NO NA NA NO 15 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA Other, specify New Primary Tumor Right Breast NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf A0RU TUMOR FREE Image Analysis NA NA NA NA YES NA NA NA YES Primary Tumor 01 Excisional biopsy 3rd YES NO YES B6 Breast A LIVING 1990 7abad802-817a-4d95-b022-f21cc4b1d9bc 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01A-21-A13C-20 TCGA-B6-A0RU-01A-11D-A099-09 TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A10P-05 608bb166-ceaa-49d5-ae7d-d4060e8c6dc2 TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A099-09 NA TCGA-B6-A0RU-01 NA TCGA-B6-A0RU-01A-11D-A099-09 TCGA-B6-A0RU-01 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A087-01 NA TCGA-B6-A0RU-01A-11R-A084-07 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01A-11D-A087-01 TCGA-B6-A0RU-01 |
|
|
517 |
TCGA-B6-A0RV-01 Stage IIIA 42 4 No_Conversion 4788 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 4788 0 LumA Luminal A Positive ReacII -5 0 followup T_Other T3 LIVING 0 TCGA-B6-A0RV-01 5156 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-B6-A0RV 5156 0 days 5156 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right Axillary lymph node dissection alone NA TCGA-B6-A0RV-F13791 TCGA-B6-A0RV TCGA-B6-A0RV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15507 5165 NA 0 5156 NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-7-12 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Lobular/Ductal No NA C50.9 8522/3 C50.9 NA YES NA Incisional Biopsy 480 NO NA NA NA 10 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 5 NA true No M0 N2 T3 Stage IIIA TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf A0RV TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1996 25068ef3-d87f-45e2-a15f-152b87e9dedb 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01A-21-A13C-20 TCGA-B6-A0RV-01A-11D-A099-09 TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A10P-05 f132d6af-68eb-4b00-8a2d-84322ac5758b TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A099-09 NA TCGA-B6-A0RV-01 NA TCGA-B6-A0RV-01A-11D-A099-09 TCGA-B6-A0RV-01 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A087-01 NA TCGA-B6-A0RV-01A-11R-A084-07 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01A-11D-A087-01 TCGA-B6-A0RV-01 |
|
|
518 |
TCGA-B6-A0WS-01 NA 58 4 Stage I NA 2965 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2965 1 LumA Luminal A Positive NA 0 -4 followup T1 T1 DECEASED 1 TCGA-B6-A0WS-01 2965 1 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-B6-A0WS 2965 0 days 2965 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant|Left No axillary staging NA TCGA-B6-A0WS-F15707 TCGA-B6-A0WS TCGA-B6-A0WS-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21230 5113 2965 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 110 NO NA NA NA NA Positive Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO NA NA true No MX NX T1c Stage X TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf A0WS TUMOR FREE Image Analysis NA NA NA NA NA NO NA NA NO Primary Tumor 01 NA 4th NO NO YES B6 Breast A DECEASED 1996 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b NA TCGA-B6-A0WS-01A-11D-A10Y-09 TCGA-B6-A0WS-01 NA NA TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11D-A10Y-09 TCGA-B6-A0WS-01A-11D-A112-05 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11D-A10Y-09 NA 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b NA TCGA-B6-A0WS-01A-11D-A111-01 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11R-A115-07 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b TCGA-B6-A0WS-01A-11D-A111-01 TCGA-B6-A0WS-01 |
|
|
519 |
TCGA-B6-A0WT-01 Stage IIB 61 3 No_Conversion 5739 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 5739 0 LumA Luminal A Positive NA -2 -4 followup T_Other T2 LIVING 0 TCGA-B6-A0WT-01 5739 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0WT 3862 1 days 5739 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 61 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0WT-F15728 TCGA-B6-A0WT TCGA-B6-A0WT-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA 3862 -22362 5606 NA 0 5739 NA NA 3862 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 90 NO NA NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) fmol/mg Equivocal 2+ image cytometry Positive NA NA NA NA Other Reporting Scale NA NA Negative NA NA image cytometry Positive NA NA 2 4 NA NA Other Reporting Scale Other, specify New Primary Tumor right breast cancer contralateral NA YES 1 NA true No M0 N1 T2 Stage IIB TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf A0WT TUMOR FREE Image Analysis NA fmol/mg NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A LIVING 1995 0507f62d-e776-4efb-bd51-dba9d74090bd 0507f62d-e776-4efb-bd51-dba9d74090bd NA TCGA-B6-A0WT-01A-11D-A10G-09 TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A10A-05 NA TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A10G-09 NA TCGA-B6-A0WT-01 NA TCGA-B6-A0WT-01A-11D-A10G-09 TCGA-B6-A0WT-01 0507f62d-e776-4efb-bd51-dba9d74090bd TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A107-01 NA TCGA-B6-A0WT-01A-11R-A109-07 0507f62d-e776-4efb-bd51-dba9d74090bd TCGA-B6-A0WT-01A-11D-A107-01 TCGA-B6-A0WT-01 |
|
|
520 |
TCGA-B6-A0WV-01 Stage IIB 67 5 No_Conversion 2422 2422 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2422 1 LumB Luminal B Positive NA 0 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0WV-01 2417 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0WV 2417 0 days 2417 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Axillary lymph node dissection alone NA TCGA-B6-A0WV-F15732 TCGA-B6-A0WV TCGA-B6-A0WV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -24803 5531 2417 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 30 NO NA NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 4 NA true No M0 N1b T2 Stage IIB TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf A0WV TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1995 87bdfb78-8690-4569-ba85-592cd2390c24 87bdfb78-8690-4569-ba85-592cd2390c24 NA TCGA-B6-A0WV-01A-11D-A10G-09 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A10A-05 NA TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A10G-09 NA TCGA-B6-A0WV-01 NA TCGA-B6-A0WV-01A-11D-A10G-09 TCGA-B6-A0WV-01 87bdfb78-8690-4569-ba85-592cd2390c24 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A107-01 NA TCGA-B6-A0WV-01A-11R-A109-07 87bdfb78-8690-4569-ba85-592cd2390c24 TCGA-B6-A0WV-01A-11D-A107-01 TCGA-B6-A0WV-01 |
|
|
521 |
TCGA-B6-A0WW-01 NA 58 4 No_Conversion 546 557 Positive FEMALE Negative NA NA NA NA NA Positive N1 557 1 LumB Luminal B Positive NA 0 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0WW-01 558 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0WW 447 1 days 558 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 58 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0WW-F15734 TCGA-B6-A0WW TCGA-B6-A0WW-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -21479 4664 558 0 NA NA NA 447 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 30 NO NA NA NA 18 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA Liver Distant Metastasis NA NA YES 5 NA true No MX N1b T2 Stage X TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf A0WW WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th NO NO YES B6 Breast A DECEASED 1997 3bdcdadf-67da-4a50-b311-81196c0c8362 3bdcdadf-67da-4a50-b311-81196c0c8362 NA TCGA-B6-A0WW-01A-11D-A10G-09 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A10A-05 NA TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A10G-09 NA TCGA-B6-A0WW-01 NA TCGA-B6-A0WW-01A-11D-A10G-09 TCGA-B6-A0WW-01 3bdcdadf-67da-4a50-b311-81196c0c8362 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A107-01 NA TCGA-B6-A0WW-01A-11R-A109-07 3bdcdadf-67da-4a50-b311-81196c0c8362 TCGA-B6-A0WW-01A-11D-A107-01 TCGA-B6-A0WW-01 |
|
|
522 |
TCGA-B6-A0WX-01 Stage IIIA 40 1 No_Conversion 653 653 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 653 1 Basal Basal-like Negative X -13 0 followup T_Other T3 DECEASED 1 TCGA-B6-A0WX-01 639 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0WX 563 1 days 639 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 40 Left Axillary lymph node dissection alone NA TCGA-B6-A0WX-F15729 TCGA-B6-A0WX TCGA-B6-A0WX-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14784 4476 639 0 NA NA NA 563 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8520/3 C50.9 NA YES NA Excisional Biopsy 300 NO NA NA NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA Bone Distant Metastasis NA NA YES 9 NA true No M0 N1b T3 Stage IIIA TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf A0WX WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 5th YES NO YES B6 Breast A DECEASED 1998 8dc04505-fae5-4185-b3f8-53882fbbb4fd 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01A-21-A13D-20 TCGA-B6-A0WX-01A-11D-A10G-09 TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A10A-05 f484ca3b-7c40-42fe-b5aa-a73453b45b0b TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A10G-09 NA TCGA-B6-A0WX-01 NA TCGA-B6-A0WX-01A-11D-A10G-09 TCGA-B6-A0WX-01 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A107-01 NA TCGA-B6-A0WX-01A-11R-A109-07 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01A-11D-A107-01 TCGA-B6-A0WX-01 |
|
|
523 |
TCGA-B6-A0WY-01 Stage IIIA 40 4 No_Conversion 3410 3460 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 3460 1 LumA Luminal A Negative NA -5 -3 followup T_Other T3 DECEASED 1 TCGA-B6-A0WY-01 3461 1 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-B6-A0WY 2011 1 days 3461 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 40 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone NA TCGA-B6-A0WY-F15730 TCGA-B6-A0WY TCGA-B6-A0WY-01A NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -14778 5294 3461 0 NA NA NA 2011 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 30 NO NA NA NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA Negative NA NA NA NA NA NA 1 4 NA NA NA Bone Distant Metastasis NA NA YES 3 NA true No M0 N1b T3 Stage IIIA TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf A0WY WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1996 90a60ebe-ce7e-4b64-af2a-1676f46e6601 90a60ebe-ce7e-4b64-af2a-1676f46e6601 NA TCGA-B6-A0WY-01A-11D-A10G-09 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A10A-05 NA TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A10G-09 NA TCGA-B6-A0WY-01 NA TCGA-B6-A0WY-01A-11D-A10G-09 TCGA-B6-A0WY-01 90a60ebe-ce7e-4b64-af2a-1676f46e6601 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A107-01 NA TCGA-B6-A0WY-01A-11R-A109-07 90a60ebe-ce7e-4b64-af2a-1676f46e6601 TCGA-B6-A0WY-01A-11D-A107-01 TCGA-B6-A0WY-01 |
|
|
524 |
TCGA-B6-A0WZ-01 Stage IIB 50 2 No_Conversion 3941 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 3941 0 LumA Luminal A Positive NA -12 -3 followup T_Other T2 LIVING 0 TCGA-B6-A0WZ-01 6292 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-B6-A0WZ 5117 1 days 6292 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0WZ-F71575 TCGA-B6-A0WZ NA NA Positive NA NA NA NA Positive Other NA NO NA NA -18584 NA NA 0 6292 NA 5117 5117 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA NA NA NO 21 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA Bone New Primary Tumor NA YES YES 11 NA NA No M0 N1b T2 Stage II NA A0WZ TUMOR FREE Image Analysis NA NA NA NA YES NA NA NA YES Primary Tumor 01 Fine Needle aspiration biopsy 4th YES NO YES B6 Breast NA LIVING 1996 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 NA TCGA-B6-A0WZ-01A-11D-A10G-09 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A10A-05 NA TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A10G-09 NA TCGA-B6-A0WZ-01 NA TCGA-B6-A0WZ-01A-11D-A10G-09 TCGA-B6-A0WZ-01 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A107-01 NA TCGA-B6-A0WZ-01A-11R-A109-07 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 TCGA-B6-A0WZ-01A-11D-A107-01 TCGA-B6-A0WZ-01 |
|
|
525 |
TCGA-B6-A0X0-01 Stage IA 54 2 Stage I NA 3945 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3945 1 LumA Luminal A Positive LumA -5 -3 followup T1 T1 DECEASED 1 TCGA-B6-A0X0-01 3945 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 12 TCGA-B6-A0X0 3945 0 days 3945 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-B6-A0X0-F15710 TCGA-B6-A0X0 TCGA-B6-A0X0-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -19802 5243 3945 0 NA NA NA NA NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.919 8201/3 C50.9 NA YES NA Fine needle aspiration biopsy 150 NO NA NA NA 31 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage I TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf A0X0 NA Image Analysis NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1996 222a566c-2bad-4b47-97dc-ca1f60a9a981 222a566c-2bad-4b47-97dc-ca1f60a9a981 TCGA-B6-A0X0-01A-11-A13D-20 TCGA-B6-A0X0-01A-21D-A10Y-09 TCGA-B6-A0X0-01 NA 1831ec43-6958-4950-8b0f-dd822fc81f17 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21D-A10Y-09 TCGA-B6-A0X0-01A-21D-A112-05 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21D-A10Y-09 NA 222a566c-2bad-4b47-97dc-ca1f60a9a981 NA TCGA-B6-A0X0-01A-21D-A111-01 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21R-A115-07 222a566c-2bad-4b47-97dc-ca1f60a9a981 TCGA-B6-A0X0-01A-21D-A111-01 TCGA-B6-A0X0-01 |
|
|
526 |
TCGA-B6-A0X1-01 Stage IV 48 3 No_Conversion 5671 NA Negative FEMALE NA NA NA NA Positive M1 Positive N2 5671 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 1 TCGA-B6-A0X1-01 7455 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation cluster 5 TCGA-B6-A0X1 7455 0 days 7455 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 48 Left Axillary lymph node dissection alone NA TCGA-B6-A0X1-F71498 TCGA-B6-A0X1 TCGA-B6-A0X1-01A NA Negative NA NA NA NA Negative Other NA NO NA NA -17624 6035 7455 0 5677 NA NA 490 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 240 NO NA NA NO 21 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA Brain Distant Metastasis NA NA NO 16 NA true No M1 N1 T2 Stage IIB TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf A0X1 TUMOR FREE Image Analysis NA NA NA NA NO NA NA NA NO Primary Tumor 01 Fine needle aspiration biopsy 4th YES NO YES B6 Breast A DECEASED 1994 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 TCGA-B6-A0X1-01A-21-A13D-20 TCGA-B6-A0X1-01A-11D-A10G-09 TCGA-B6-A0X1-01 TCGA-B6-A0X1-01A-11D-A10A-05 03c36239-f261-44e4-829b-01e679a414ad TCGA-B6-A0X1-01 TCGA-B6-A0X1-01A-11D-A10G-09 NA TCGA-B6-A0X1-01 NA TCGA-B6-A0X1-01A-11D-A10G-09 NA 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 NA TCGA-B6-A0X1-01A-11D-A107-01 NA TCGA-B6-A0X1-01A-11R-A109-07 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 TCGA-B6-A0X1-01A-11D-A107-01 TCGA-B6-A0X1-01 |
|
|
527 |
TCGA-B6-A0X4-01 Stage IIB 62 3 No_Conversion 776 859 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 859 1 LumA Luminal A Positive NA -12 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0X4-01 860 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0X4 716 1 days 860 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 62 Left Axillary lymph node dissection alone NA TCGA-B6-A0X4-F15723 TCGA-B6-A0X4 TCGA-B6-A0X4-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22688 5323 860 0 NA NA NA 716 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 110 NO NA NA NA 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA Bone Distant Metastasis NA NA YES 2 NA true No M0 N1b T2 Stage IIB TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf A0X4 WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast A DECEASED 1996 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 NA TCGA-B6-A0X4-01A-11D-A10G-09 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A10A-05 NA TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A10G-09 NA TCGA-B6-A0X4-01 NA TCGA-B6-A0X4-01A-11D-A10G-09 TCGA-B6-A0X4-01 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A107-01 NA TCGA-B6-A0X4-01A-11R-A109-07 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 TCGA-B6-A0X4-01A-11D-A107-01 TCGA-B6-A0X4-01 |
|
|
528 |
TCGA-B6-A0X5-01 Stage IIB 61 4 No_Conversion 2097 2097 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2097 1 LumB Luminal B Positive NA 0 -3 followup T_Other T2 DECEASED 1 TCGA-B6-A0X5-01 2097 1 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-B6-A0X5 1343 1 days 2097 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 61 Left Axillary lymph node dissection alone NA TCGA-B6-A0X5-F15726 TCGA-B6-A0X5 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22380 NA 2097 0 NA NA NA 1343 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA NA NA NA NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA Other, specify Distant Metastasis Liver and Pleura and Bone NA YES 3 NA NA No M0 N1b T2 Stage IIB NA A0X5 WITH TUMOR Image Analysis NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 4th YES NO YES B6 Breast NA DECEASED 1995 d4d04af8-9c60-4d14-90a2-c2b211e20092 d4d04af8-9c60-4d14-90a2-c2b211e20092 NA TCGA-B6-A0X5-01A-21D-A10G-09 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A10A-05 NA TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A10G-09 NA TCGA-B6-A0X5-01 NA TCGA-B6-A0X5-01A-21D-A10G-09 TCGA-B6-A0X5-01 d4d04af8-9c60-4d14-90a2-c2b211e20092 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A107-01 NA TCGA-B6-A0X5-01A-21R-A109-07 d4d04af8-9c60-4d14-90a2-c2b211e20092 TCGA-B6-A0X5-01A-21D-A107-01 TCGA-B6-A0X5-01 |
|
|
529 |
TCGA-B6-A0X7-01 NA 62 2 No_Conversion 1791 1791 Positive FEMALE Negative NA NA NA NA NA Negative N0 1791 1 LumA Luminal A Positive NA -5 -3 enrollment T1 T1 DECEASED 1 TCGA-B6-A0X7-01 1781 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-B6-A0X7 1104 1 days 1781 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES NA 62 Right No axillary staging NA TCGA-B6-A0X7-F15714 TCGA-B6-A0X7 NA NA Positive NA NA NA NA Positive NA NA NO NA 1104 -22723 NA 1781 0 NA NA NA 1104 NA NA Image Analysis NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Ductal/Lobular No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy NA NA NA NA NA 0 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA Other, specify New Primary Tumor colon NA YES NA NA NA No MX NX T1c Stage X NA A0X7 TUMOR FREE Image Analysis NA NA NA NA NA NA NA NA YES Primary Tumor 01 NA 4th YES NO YES B6 Breast NA DECEASED 1994 b5ec5184-90d6-4b74-b08c-e39af59bc807 b5ec5184-90d6-4b74-b08c-e39af59bc807 NA TCGA-B6-A0X7-01A-11D-A10M-09 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10N-05 NA TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10M-09 NA TCGA-B6-A0X7-01 NA TCGA-B6-A0X7-01A-11D-A10M-09 TCGA-B6-A0X7-01 b5ec5184-90d6-4b74-b08c-e39af59bc807 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10L-01 NA TCGA-B6-A0X7-01A-11R-A10J-07 b5ec5184-90d6-4b74-b08c-e39af59bc807 TCGA-B6-A0X7-01A-11D-A10L-01 TCGA-B6-A0X7-01 |
|
|
530 |
TCGA-B6-A1KC-01 Stage IIA 67 4 Stage IIB 1326 NA Positive FEMALE NA NA NA NA Negative M0 Positive N1 1326 0 LumB NA Negative NA NA NA followup T_Other T2 LIVING 0 TCGA-B6-A1KC-01 1326 0 days BRCA-LUAD+ NA cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA c1uster 9 cluster 5 mutation c1uster 9 TCGA-B6-A1KC 1326 0 days 1326 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-B6-A1KC-F15740 TCGA-B6-A1KC NA NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -24791 NA NA 0 1326 NA NA NA NA NO image cytometry NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1 T2 Stage IIB NA A1KC TUMOR FREE image cytometry NA NA NA 49 fmol/mg protein NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES B6 Breast NA LIVING 2003 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 NA TCGA-B6-A1KC-01B-11D-A159-09 TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A161-05,TCGA-B6-A1KC-01A-11D-A13K-05 NA TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A159-09 NA NA TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A159-09 NA fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 NA TCGA-B6-A1KC-01B-11D-A160-01 TCGA-B6-A1KC-01 NA fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 TCGA-B6-A1KC-01B-11D-A160-01 |
|
|
531 |
TCGA-B6-A1KF-01 Stage IIB 68 1 Stage IIB 3088 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 3088 0 Basal NA Negative NA NA NA followup T_Other T2 LIVING 0 TCGA-B6-A1KF-01 3088 0 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-B6-A1KF 3088 0 days 3088 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-B6-A1KF-F15739 TCGA-B6-A1KF NA NA Negative NA NA NA NA Negative Other NA NO NA NA -24891 NA NA 0 3088 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA 60-69% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Equivocal NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 2 NA NA No M0 N1 T2 Stage IIB NA A1KF TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 Excisional biopsy 5th YES NO YES B6 Breast NA LIVING 1998 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 NA TCGA-B6-A1KF-01A-11D-A13L-09 TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13K-05 NA TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13L-09 NA NA TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13L-09 NA e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 NA TCGA-B6-A1KF-01A-11D-A13J-01 TCGA-B6-A1KF-01 NA e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 TCGA-B6-A1KF-01A-11D-A13J-01 |
|
|
532 |
TCGA-B6-A1KI-01 Stage I 63 2 Stage I 2236 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2236 0 LumA NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-B6-A1KI-01 2236 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A1KI 2236 0 days 2236 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-B6-A1KI-F15737 TCGA-B6-A1KI TCGA-B6-A1KI-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -23031 2634 NA 0 2236 NA NA NA NA NO image cytometry NA 3.1 Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA 90-99% NA 2+ 60 3.8 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 40 NO Equivocal Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf A1KI TUMOR FREE image cytometry NA NA 70 fmol/mg 288 fmol/mg NA YES NA NA YES Primary Tumor 01 Excisional biospy 6th YES NO YES B6 Breast A LIVING 2003 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 NA TCGA-B6-A1KI-01A-11D-A14K-09 TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14N-05 NA TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14K-09 NA NA TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14K-09 NA 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 NA TCGA-B6-A1KI-01A-11D-A14J-01 TCGA-B6-A1KI-01 NA 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 TCGA-B6-A1KI-01A-11D-A14J-01 |
|
|
533 |
TCGA-B6-A1KN-01 Stage IIIB 57 5 Stage IIIC 4233 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 4233 0 LumB NA Negative NA NA NA followup T_Other T4 LIVING 0 TCGA-B6-A1KN-01 4233 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-B6-A1KN 4233 0 days 4233 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-B6-A1KN-F15738 TCGA-B6-A1KN TCGA-B6-A1KN-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21183 4537 NA 0 4233 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-8-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO NA NA NA 30 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NO 24 NA true No M0 N1 T4b Stage IIIB TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf A1KN TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 5th YES NO YES B6 Breast A LIVING 1998 71b773fb-1efb-4d0f-9499-110ba937ade6 71b773fb-1efb-4d0f-9499-110ba937ade6 NA TCGA-B6-A1KN-01A-11D-A13L-09 TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13K-05 NA TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13L-09 NA NA TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13L-09 NA 71b773fb-1efb-4d0f-9499-110ba937ade6 NA TCGA-B6-A1KN-01A-11D-A13J-01 TCGA-B6-A1KN-01 NA 71b773fb-1efb-4d0f-9499-110ba937ade6 TCGA-B6-A1KN-01A-11D-A13J-01 |
|
|
534 |
TCGA-B6-A2IU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A2IU-01 5176 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-B6-A2IU 4224 1 days 5176 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 62 Right Axillary lymph node dissection alone NA TCGA-B6-A2IU-F38907 TCGA-B6-A2IU TCGA-B6-A2IU-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22905 4665 NA 0 5176 NA NA 4224 NA NA image cytometry NA NA NA 2013-1-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 140 NO NA NA NO 28 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify New Primary Tumor Lung NO YES 0 NA true No M0 N0 T2 Stage IIA TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf A2IU WITH TUMOR image cytometry NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 5th NA NO YES B6 Breast A LIVING 1998 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd TCGA-B6-A2IU-01A-21-A24A-20 NA TCGA-B6-A2IU-01 TCGA-B6-A2IU-01A-32D-A18O-05 fe9fb778-16b4-47ef-84a1-e5f74c25ae59 TCGA-B6-A2IU-01 TCGA-B6-A2IU-01A-32D-A19T-09 NA NA TCGA-B6-A2IU-01 NA NA 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd NA TCGA-B6-A2IU-01A-32D-A18N-01 TCGA-B6-A2IU-01 NA 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd TCGA-B6-A2IU-01A-32D-A18N-01 |
|
|
535 |
TCGA-B6-A3ZX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-B6-A3ZX-01 1152 1 days NA NA NA NA NA NA NA NA NA TCGA-B6-A3ZX 994 1 days 1152 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 50 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-B6-A3ZX-F59573 TCGA-B6-A3ZX NA Negative Negative 4 Point Scale 1+ 4 Point Scale Lumpectomy Negative Lumpectomy NA NO NA NA -18434 NA 1152 0 1132 NA 1096 994 NA NA NA <10% NA NA 2014-6-3 FEMALE NA NA <10% NA 1+ NA NA NA NA Mixed Histology (please specify) ductal and lobular No NA C50.9 8522/3 C50.9 1+ YES NA Core needle biopsy NA NA Negative NA NO 7 Close NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA NA NA NA NA NA Bone Distant Metastasis NA YES YES 1 NA NA No M1 N1 T3 Stage IV NA A3ZX WITH TUMOR NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES B6 Breast NA DECEASED 2007 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 NA NA TCGA-B6-A3ZX-01 TCGA-B6-A3ZX-01A-11D-A23D-05 NA TCGA-B6-A3ZX-01 TCGA-B6-A3ZX-01A-11D-A23C-09 NA NA TCGA-B6-A3ZX-01 NA NA e89806d3-1cd5-4bc0-8e8a-edf823d8f110 NA TCGA-B6-A3ZX-01A-11D-A238-01 TCGA-B6-A3ZX-01 NA e89806d3-1cd5-4bc0-8e8a-edf823d8f110 TCGA-B6-A3ZX-01A-11D-A238-01 |
|
|
536 |
TCGA-B6-A400-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A400-01 215 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A400 215 0 days 215 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-B6-A400-F59655 TCGA-B6-A400 TCGA-B6-A400-01A NA Negative 4 Point Scale 1+ 4 Point Scale NA Negative Lumpectomy NA NO NA NA -16022 1610 NA 0 215 NA NA NA NA NA NA <10% NA NA 2014-6-3 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Tumor resection 20 NO Negative NA YES 5 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 4 NA true No M0 N2a T2 Stage IIIA TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf A400 TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES B6 Breast A LIVING 2008 6b70d210-9cbd-44bc-a770-a075fd0d4672 6b70d210-9cbd-44bc-a770-a075fd0d4672 NA NA TCGA-B6-A400-01 TCGA-B6-A400-01A-11D-A23D-05 NA TCGA-B6-A400-01 TCGA-B6-A400-01A-11D-A23C-09 NA NA TCGA-B6-A400-01 NA NA 6b70d210-9cbd-44bc-a770-a075fd0d4672 NA TCGA-B6-A400-01A-11D-A238-01 TCGA-B6-A400-01 NA 6b70d210-9cbd-44bc-a770-a075fd0d4672 TCGA-B6-A400-01A-11D-A238-01 |
|
|
537 |
TCGA-B6-A401-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A401-01 2596 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A401 2596 0 days 2596 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-B6-A401-F59658 TCGA-B6-A401 TCGA-B6-A401-01A NA Positive 4 Point Scale 3+ 4 Point Scale NA Positive Lumpectomy NA NO NA NA -17438 1935 NA 0 2596 NA NA NA NA NA NA 80-89% NA NA 2014-6-3 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 30 NO Negative NA NO 4 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T1c Stage IIA TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf A401 TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 6th NA NO YES B6 Breast A LIVING 2007 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 NA NA TCGA-B6-A401-01 TCGA-B6-A401-01A-11D-A23D-05 NA TCGA-B6-A401-01 TCGA-B6-A401-01A-11D-A23C-09 NA NA TCGA-B6-A401-01 NA NA 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 NA TCGA-B6-A401-01A-11D-A238-01 TCGA-B6-A401-01 NA 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 TCGA-B6-A401-01A-11D-A238-01 |
|
|
538 |
TCGA-B6-A402-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A402-01 2134 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A402 2330 1 days 2134 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 47 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-B6-A402-F60751 TCGA-B6-A402 TCGA-B6-A402-01A NA Negative 4 Point Scale 1+ 4 Point Scale NA Negative Lumpectomy NA YES NA NA -17314 1563 NA 0 2134 NA NA 2330 NA NA NA <10% NA NA 2014-7-8 FEMALE NA NA <10% NA 1+ NA NA NA 4.4 Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 10 NO Negative NA NO 3 Negative NA NA Positive 2+ NA Positive <10% NA <10% 4.1 3 Point Scale 2+ 2+ Negative NA 70-79% NA Negative NA NA NA NA 3.1 NA 3 Point Scale Other, specify Locoregional Recurrence Lymph Node NO YES 0 0 true No M0 N0 (i-) T1c Stage I TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf A402 WITH TUMOR NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES B6 Breast A LIVING 2008 976a1b88-ed7a-493a-8ac9-3d504edfbc76 976a1b88-ed7a-493a-8ac9-3d504edfbc76 NA NA TCGA-B6-A402-01 TCGA-B6-A402-01A-11D-A23D-05 NA TCGA-B6-A402-01 TCGA-B6-A402-01A-11D-A23C-09 NA NA TCGA-B6-A402-01 NA NA 976a1b88-ed7a-493a-8ac9-3d504edfbc76 NA TCGA-B6-A402-01A-11D-A238-01 TCGA-B6-A402-01 NA 976a1b88-ed7a-493a-8ac9-3d504edfbc76 TCGA-B6-A402-01A-11D-A238-01 |
|
|
539 |
TCGA-B6-A408-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A408-01 2072 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A408 2072 0 days 2072 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Axillary lymph node dissection alone NA TCGA-B6-A408-F59666 TCGA-B6-A408 NA NA Positive 4 Point Scale 3+ 4 Point Scale NA Positive Simple Mastectomy NA NO NA NA -20102 NA NA 0 2072 NA NA NA NA NA NA 90-99% 2.6 NA 2014-6-3 FEMALE NA NA 20-29% NA 2+ 60 2.9 1.2 NA Mixed Histology (please specify) ductal and lobular No NA C50.9 8522/3 C50.9 3+ YES NA Tumor resection NA NA Equivocal Negative NO 23 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 10 NA NA No M0 N3a T2 Stage IIIC NA A408 TUMOR FREE NA NA NA NA NA YES YES 60-69% NA YES Primary Tumor 01 NA 6th NA NO YES B6 Breast NA LIVING 2008 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 NA NA TCGA-B6-A408-01 TCGA-B6-A408-01A-12D-A244-05 NA TCGA-B6-A408-01 TCGA-B6-A408-01A-12D-A243-09 NA NA TCGA-B6-A408-01 NA NA bbb7f769-ac55-4e7f-b0bf-acc36294bb05 NA TCGA-B6-A408-01A-12D-A242-01 TCGA-B6-A408-01 NA bbb7f769-ac55-4e7f-b0bf-acc36294bb05 TCGA-B6-A408-01A-12D-A242-01 |
|
|
540 |
TCGA-B6-A409-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-B6-A409-01 573 1 days NA NA NA NA NA NA NA NA NA TCGA-B6-A409 NA NA days 573 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-B6-A409 TCGA-B6-A409-01A NA Negative 4 Point Scale 1+ 4 Point Scale NA Negative Simple Mastectomy NA NO NA NA -16178 1480 573 0 NA NA NA NA NA NA NA <10% 1.8 NA 2012-9-20 FEMALE NA NA 10-19% NA 1+ 60 2 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Fine needle aspiration biopsy 20 NO Equivocal Negative NA 22 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA YES 6 NA true No M0 N2a T1c Stage IIIA TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf A409 WITH TUMOR NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 6th NA NO YES B6 Breast A DECEASED 2008 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 NA NA TCGA-B6-A409-01 TCGA-B6-A409-01A-11D-A244-05 NA TCGA-B6-A409-01 TCGA-B6-A409-01A-11D-A243-09 NA NA TCGA-B6-A409-01 NA NA 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 NA TCGA-B6-A409-01A-11D-A242-01 TCGA-B6-A409-01 NA 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 TCGA-B6-A409-01A-11D-A242-01 |
|
|
541 |
TCGA-B6-A40B-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A40B-01 3152 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A40B 3152 0 days 3152 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-B6-A40B-F59661 TCGA-B6-A40B TCGA-B6-A40B-01A NA Positive 4 Point Scale 3+ 4 Point Scale NA Positive Lumpectomy NA YES NA NA -27811 2467 NA 0 3152 NA NA NA NA NA NA 90-99% NA NA 2014-6-3 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 10 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1b Stage I TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf A40B TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 6th NA NO YES B6 Breast A LIVING 2005 40c7e862-e1f6-4425-af9d-c9d07161a2ed 40c7e862-e1f6-4425-af9d-c9d07161a2ed NA NA TCGA-B6-A40B-01 TCGA-B6-A40B-01A-11D-A23D-05 NA TCGA-B6-A40B-01 TCGA-B6-A40B-01A-11D-A23C-09 NA NA TCGA-B6-A40B-01 NA NA 40c7e862-e1f6-4425-af9d-c9d07161a2ed NA TCGA-B6-A40B-01A-11D-A238-01 TCGA-B6-A40B-01 NA 40c7e862-e1f6-4425-af9d-c9d07161a2ed TCGA-B6-A40B-01A-11D-A238-01 |
|
|
542 |
TCGA-B6-A40C-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-B6-A40C-01 2164 0 days NA NA NA NA NA NA NA NA NA TCGA-B6-A40C 2164 0 days 2164 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-B6-A40C-F59660 TCGA-B6-A40C NA NA Positive 4 Point Scale 3+ 4 Point Scale NA Positive Simple Mastectomy NA YES NA NA -18852 NA NA 0 2164 NA NA NA NA NA NA 50-59% NA NA 2014-6-3 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NO 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T3 Stage IIB NA A40C TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES B6 Breast NA LIVING 2005 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 NA NA TCGA-B6-A40C-01 TCGA-B6-A40C-01A-11D-A23D-05 NA TCGA-B6-A40C-01 TCGA-B6-A40C-01A-11D-A23C-09 NA NA TCGA-B6-A40C-01 NA NA e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 NA TCGA-B6-A40C-01A-11D-A238-01 TCGA-B6-A40C-01 NA e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 TCGA-B6-A40C-01A-11D-A238-01 |
|
|
543 |
TCGA-BH-A0AU-01 Stage IIA 45 1 Stage IIA 746 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 746 0 LumB Luminal B Positive ReacI -3 -3 enrollment T_Other T2 LIVING 0 TCGA-BH-A0AU-01 1914 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0AU 1914 0 days 1914 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Inner Quadrant NA NA TCGA-BH-A0AU-F60769 TCGA-BH-A0AU TCGA-BH-A0AU-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16688 583 NA 0 1914 NA NA NA NA NO NA NA NA NA 2014-6-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Positive Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf A0AU TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 left segmental mastectomy with sentinel node dissection 6th NA NO YES BH Breast A LIVING 2008 d448433c-3c4b-4371-b749-f96af8da2237 d448433c-3c4b-4371-b749-f96af8da2237 TCGA-BH-A0AU-01A-21-A13C-20 TCGA-BH-A0AU-01A-11D-A12Q-09 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12R-05 6b8a5434-3207-46f0-836b-542e427d22d5 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12Q-09 NA TCGA-BH-A0AU-01 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12Q-09 NA d448433c-3c4b-4371-b749-f96af8da2237 NA TCGA-BH-A0AU-01A-11D-A12N-01 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11R-A12P-07 d448433c-3c4b-4371-b749-f96af8da2237 TCGA-BH-A0AU-01A-11D-A12N-01 TCGA-BH-A0AU-01 |
|
|
544 |
TCGA-BH-A0AU-11 NA 45 NA NA 746 NA NA FEMALE NA NA NA NA NA NA NA NA 746 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0AU-11 1914 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0AU 1914 0 days 1914 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Inner Quadrant NA NA TCGA-BH-A0AU-F60769 TCGA-BH-A0AU NA NA Positive NA NA NA NA Positive Other NA NA NA NA -16688 NA NA 0 1914 NA NA NA NA NO NA NA NA NA 2014-6-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A0AU TUMOR FREE NA NA NA NA NA NO YES NA NA YES Solid Tissue Normal 11 left segmental mastectomy with sentinel node dissection 6th NA NO YES BH Breast NA LIVING 2008 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 NA NA NA TCGA-BH-A0AU-11A-11D-A12R-05 NA NA NA NA NA TCGA-BH-A0AU-11 NA NA eb7e6bfc-79ad-4674-9d58-2cbad8c65658 NA NA TCGA-BH-A0AU-11 TCGA-BH-A0AU-11A-11R-A12P-07 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 NA |
|
|
545 |
TCGA-BH-A0AV-01 Stage I 52 1 Stage I 1180 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1180 0 Basal Basal-like Negative ReacII -13 0 enrollment T1 T1 LIVING 0 TCGA-BH-A0AV-01 1820 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0AV 1820 0 days 1820 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Inner Quadrant NA NA TCGA-BH-A0AV-F59174 TCGA-BH-A0AV TCGA-BH-A0AV-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -19314 761 NA 0 1820 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO NA Negative NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf A0AV TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy with left axillary lymph node dissection 6th NA NO YES BH Breast A LIVING 2008 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 TCGA-BH-A0AV-01A-21-A13C-20 TCGA-BH-A0AV-01A-31D-A10Y-09 TCGA-BH-A0AV-01 NA 9a298279-0097-4dfc-bfb0-b119b92d1fd7 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31D-A10Y-09 TCGA-BH-A0AV-01A-31D-A112-05 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31D-A10Y-09 NA afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 NA TCGA-BH-A0AV-01A-31D-A111-01 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31R-A115-07 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 TCGA-BH-A0AV-01A-31D-A111-01 TCGA-BH-A0AV-01 |
|
|
546 |
TCGA-BH-A0AW-01 Stage IIA 56 3 No_Conversion 622 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 622 0 Her2 HER2-enriched Negative NA -11 -5 followup T1 T1 LIVING 0 TCGA-BH-A0AW-01 622 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-BH-A0AW 622 0 days 622 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0AW-F15445 TCGA-BH-A0AW TCGA-BH-A0AW-01A NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -20468 545 NA 0 622 NA NA NA NA NA ER Positive H-Score 95 NA NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 50 NO Positive NA NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 5 NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T1c Stage IIA TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf A0AW TUMOR FREE PR Negative H-Score 0 NA NA H-Score H-Score NA NA NA NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2008 8b615995-6210-4dd5-bf58-cf8a109d7648 8b615995-6210-4dd5-bf58-cf8a109d7648 NA TCGA-BH-A0AW-01A-11W-A071-09 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11D-A10P-05 NA TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11W-A071-09 NA TCGA-BH-A0AW-01 NA TCGA-BH-A0AW-01A-11W-A071-09 TCGA-BH-A0AW-01 8b615995-6210-4dd5-bf58-cf8a109d7648 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11D-A059-01 NA TCGA-BH-A0AW-01A-11R-A056-07 8b615995-6210-4dd5-bf58-cf8a109d7648 TCGA-BH-A0AW-01A-11D-A059-01 TCGA-BH-A0AW-01 |
|
|
547 |
TCGA-BH-A0AY-01 Stage IIA 62 3 Stage IIA 777 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 777 0 LumA Luminal B Positive ReacI -1 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0AY-01 777 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0AY 777 0 days 777 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0AY-F15456 TCGA-BH-A0AY TCGA-BH-A0AY-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -22703 587 NA 0 777 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf A0AY TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2008 80817359-b0f0-4bea-ada4-b48bea37f5d2 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01A-11-A13B-20 TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01 NA 71b12add-c266-433f-b842-86be8893fb06 TCGA-BH-A0AY-01 TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01A-21D-A00Y-05 TCGA-BH-A0AY-01 NA TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01 TCGA-BH-A0AY-01A-21D-A011-01 NA TCGA-BH-A0AY-01A-21R-A00Z-07 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01A-21D-A011-01 TCGA-BH-A0AY-01 |
|
|
548 |
TCGA-BH-A0AY-11 NA 62 NA NA 777 NA NA FEMALE NA NA NA NA NA NA NA NA 777 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0AY-11 777 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0AY 777 0 days 777 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0AY-F15456 TCGA-BH-A0AY TCGA-BH-A0AY-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -22703 587 NA 0 777 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA NA A0AY TUMOR FREE NA NA NA NA NA NA NA NA NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2008 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 NA NA NA TCGA-BH-A0AY-11A-23D-A10Q-05 80042D05-76C1-40BE-90E4-5391A86314E9 NA NA NA NA NA NA TCGA-BH-A0AY-11 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 TCGA-BH-A0AY-11 NA NA TCGA-BH-A0AY-11A-23R-A089-07 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 NA |
|
|
549 |
TCGA-BH-A0AZ-01 Stage IIIA 47 2 Stage IIIA 867 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 867 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 LIVING 0 TCGA-BH-A0AZ-01 1919 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0AZ 1919 0 days 1919 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right NA NA TCGA-BH-A0AZ-F58602 TCGA-BH-A0AZ NA NA Positive NA NA NA NA Positive Other NA NA NA NA -17465 NA NA 0 1919 NA NA NA NA NO NA NA NA NA 2014-4-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 NA NA No cM0 (i+) N1a T3 Stage IIIA NA A0AZ TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 total mastectomy with sentinel lymph node biopsy with tissue reconstruction 6th NA NO YES BH Breast NA LIVING 2008 cb9d4717-15a8-4499-ae3b-e047e5c2926a cb9d4717-15a8-4499-ae3b-e047e5c2926a TCGA-BH-A0AZ-01A-11-A13A-20 TCGA-BH-A0AZ-01A-21D-A12Q-09 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12R-05 e7b4dae9-ba72-4281-a84c-9207120cfd65 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12Q-09 NA TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12Q-09 NA cb9d4717-15a8-4499-ae3b-e047e5c2926a NA TCGA-BH-A0AZ-01A-21D-A12N-01 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21R-A12P-07 cb9d4717-15a8-4499-ae3b-e047e5c2926a TCGA-BH-A0AZ-01A-21D-A12N-01 TCGA-BH-A0AZ-01 |
|
|
550 |
TCGA-BH-A0AZ-11 NA 47 NA NA 867 NA NA FEMALE NA NA NA NA NA NA NA NA 867 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0AZ-11 1919 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0AZ 1919 0 days 1919 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right NA NA TCGA-BH-A0AZ-F58602 TCGA-BH-A0AZ NA NA Positive NA NA NA NA Positive Other NA NA NA NA -17465 NA NA 0 1919 NA NA NA NA NO NA NA NA NA 2014-4-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No cM0 (i+) N1a T3 Stage IIIA NA A0AZ TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 total mastectomy with sentinel lymph node biopsy with tissue reconstruction 6th NA NO YES BH Breast NA LIVING 2008 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 NA NA NA TCGA-BH-A0AZ-11A-22D-A12R-05 NA NA NA NA NA TCGA-BH-A0AZ-11 NA NA ec31d946-74b0-4984-b3d8-cb1bf58e4d20 NA NA TCGA-BH-A0AZ-11 NA ec31d946-74b0-4984-b3d8-cb1bf58e4d20 NA |
|
|
551 |
TCGA-BH-A0B0-01 Stage I 56 2 Stage I 1427 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1427 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0B0-01 2477 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 3 TCGA-BH-A0B0 2477 0 days 2477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant NA NA TCGA-BH-A0B0-F59204 TCGA-BH-A0B0 TCGA-BH-A0B0-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -20776 1223 NA 0 2477 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 320 NO Negative NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf A0B0 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 left segmental mastectomy with axillary sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2006 059c8834-efd5-447c-97c6-49fd68c09c0d 059c8834-efd5-447c-97c6-49fd68c09c0d TCGA-BH-A0B0-01A-11-A13C-20 TCGA-BH-A0B0-01A-21D-A10Y-09 TCGA-BH-A0B0-01 NA 3e408dd6-0e42-4310-909b-95a91fe6cd3c TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21D-A10Y-09 TCGA-BH-A0B0-01A-21D-A112-05 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21D-A10Y-09 NA 059c8834-efd5-447c-97c6-49fd68c09c0d NA TCGA-BH-A0B0-01A-21D-A111-01 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21R-A115-07 059c8834-efd5-447c-97c6-49fd68c09c0d TCGA-BH-A0B0-01A-21D-A111-01 TCGA-BH-A0B0-01 |
|
|
552 |
TCGA-BH-A0B1-01 Stage IIB 66 NA No_Conversion 1148 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1148 0 LumA Luminal A Positive LumA/B -3 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0B1-01 1148 0 days NA NA NA NA BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0B1 1148 0 days 1148 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0B1-F15429 TCGA-BH-A0B1 TCGA-BH-A0B1-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -24315 1071 NA 0 1148 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 740 NO Negative NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T2 Stage IIB TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92.pdf A0B1 TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2007 0042b857-502f-4d8e-baac-845c1a9bb64b 0042b857-502f-4d8e-baac-845c1a9bb64b TCGA-BH-A0B1-01A-21-A13C-20 TCGA-BH-A0B1-01A-12W-A071-09 TCGA-BH-A0B1-01 NA cb0ffa62-bbfe-481a-9eda-099f9381319e NA TCGA-BH-A0B1-01A-12W-A071-09 NA NA NA TCGA-BH-A0B1-01A-12W-A071-09 TCGA-BH-A0B1-01 0042b857-502f-4d8e-baac-845c1a9bb64b TCGA-BH-A0B1-01 NA NA TCGA-BH-A0B1-01A-12R-A056-07 0042b857-502f-4d8e-baac-845c1a9bb64b NA TCGA-BH-A0B1-01 |
|
|
553 |
TCGA-BH-A0B2-01 Stage I 43 NA Stage I 1242 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1242 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING NA TCGA-BH-A0B2-01 NA NA days NA NA NA NA BRCA nonbasal-like c8 NA NA NA NA TCGA-BH-A0B2 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA NA NA NA NA NA NA TCGA-BH-A0B2-01A NA NA NA NA NA NA NA NA NA NA NA NA NA 1031 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 220 NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA true NA NA NA NA NA TCGA-BH-A0B2.81FABA8A-1F6A-43DD-80F2-2466A7E8664E.pdf NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA NA NA NA NA NA NA A NA NA a27c5907-1ad2-4414-a9c9-448f1b484946 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01A-21-A13C-20 NA NA TCGA-BH-A0B2-01A-11D-A10N-05 2cdcaddf-2dd3-492b-a08f-71adc1065fec NA NA NA NA NA NA TCGA-BH-A0B2-01 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01 TCGA-BH-A0B2-01A-11D-A10L-01 NA TCGA-BH-A0B2-01A-11R-A10J-07 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01A-11D-A10L-01 |
|
|
554 |
TCGA-BH-A0B2-11 NA 43 NA NA 1242 NA NA FEMALE NA NA NA NA NA NA NA NA 1242 0 Normal NA NA NA NA NA enrollment NA NA LIVING NA TCGA-BH-A0B2-11 NA NA days NA NA NA NA NA NA NA NA NA TCGA-BH-A0B2 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA NA NA NA NA NA NA TCGA-BH-A0B2-11A NA NA NA NA NA NA NA NA NA NA NA NA NA 1031 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 130 NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA true NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 NA NA NA NA NA NA NA A NA NA 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 NA NA NA TCGA-BH-A0B2-11A-11D-A10N-05 NA NA NA NA NA NA NA NA 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 NA NA NA TCGA-BH-A0B2-11A-11R-A10J-07 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 NA |
|
|
555 |
TCGA-BH-A0B3-01 Stage IIB 53 1 No_Conversion 1203 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1203 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING 0 TCGA-BH-A0B3-01 1203 0 days High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0B3 1203 0 days 1203 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0B3-F15418 TCGA-BH-A0B3 TCGA-BH-A0B3-01A NA Negative NA 0 NA NA Negative Other NA NO NA NA -19479 1030 NA 0 1203 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 280 NO Negative NA NA 29 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf A0B3 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 6d2744ba-4817-482b-ad46-2e4e0897ad88 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01A-21-A13A-20 TCGA-BH-A0B3-01A-11W-A071-09 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11D-A10P-05 971d0c2f-844b-45a2-a541-05189e0278d4 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11W-A071-09 NA TCGA-BH-A0B3-01 NA TCGA-BH-A0B3-01A-11W-A071-09 TCGA-BH-A0B3-01 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11D-A059-01 NA TCGA-BH-A0B3-01A-11R-A056-07 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01A-11D-A059-01 TCGA-BH-A0B3-01 |
|
|
556 |
TCGA-BH-A0B3-11 NA 53 NA NA 1203 NA NA FEMALE NA NA NA NA NA NA NA NA 1203 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0B3-11 1203 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0B3 1203 0 days 1203 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0B3-F15418 TCGA-BH-A0B3 NA NA Negative NA 0 NA NA Negative Other NA NO NA NA -19479 NA NA 0 1203 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy NA NA Negative NA NA 29 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA NA No M0 N1a T2 Stage IIB NA A0B3 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast NA LIVING 2007 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 NA NA NA TCGA-BH-A0B3-11B-21D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0B3-11 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 TCGA-BH-A0B3-11 NA NA TCGA-BH-A0B3-11B-21R-A089-07 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 NA |
|
|
557 |
TCGA-BH-A0B4-01 Stage IIIA 65 5 No_Conversion 1191 NA Positive MALE Positive 1 3 3 Negative M0 Positive N2 1191 0 LumA Luminal A Positive ReacII -3 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0B4-01 1191 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0B4 1191 0 days 1191 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Axillary lymph node dissection alone NA TCGA-BH-A0B4-F15435 TCGA-BH-A0B4 TCGA-BH-A0B4-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -23980 995 NA 0 1191 NA NA NA NA NA NA 80-89% 2.0 Scheduled Follow-up Submission 2010-11-4 MALE NA NA NA NA 2+ 40 5.65 2.83 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 340 NO Equivocal Positive NA 10 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 6 NA true No M0 N2 T2 Stage IIIA TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf A0B4 TUMOR FREE NA NA NA NA NA NA NA 50-59% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2007 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01A-21-A13C-20 TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01 NA 8406b2cf-e6f8-40ac-b0e9-f63535cc3574 TCGA-BH-A0B4-01 TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01A-11D-A00Y-05 TCGA-BH-A0B4-01 NA TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01 TCGA-BH-A0B4-01A-11D-A011-01 NA TCGA-BH-A0B4-01A-11R-A00Z-07 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01A-11D-A011-01 TCGA-BH-A0B4-01 |
|
|
558 |
TCGA-BH-A0B5-01 Stage IIIA 40 2 Stage IIIA 1471 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N2 1471 0 LumA Luminal B Positive ReacII -7 -3 enrollment T_Other T2 LIVING 0 TCGA-BH-A0B5-01 2136 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-BH-A0B5 2136 0 days 2136 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left NA NA TCGA-BH-A0B5-F59182 TCGA-BH-A0B5 TCGA-BH-A0B5-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14920 1008 NA 0 2136 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 700 NO Negative NA NO 24 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T2 Stage IIIA TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf A0B5 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2007 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 TCGA-BH-A0B5-01A-21-A13C-20 TCGA-BH-A0B5-01A-11D-A12Q-09 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12R-05 e6f7c6af-6c88-4305-a8f4-d8ea46f8b302 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12Q-09 NA TCGA-BH-A0B5-01 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12Q-09 NA 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 NA TCGA-BH-A0B5-01A-11D-A12N-01 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11R-A12P-07 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 TCGA-BH-A0B5-01A-11D-A12N-01 TCGA-BH-A0B5-01 |
|
|
559 |
TCGA-BH-A0B5-11 NA 40 NA NA 1471 NA NA FEMALE NA NA NA NA NA NA NA NA 1471 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0B5-11 2136 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 1 TCGA-BH-A0B5 2136 0 days 2136 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left NA NA TCGA-BH-A0B5-F59182 TCGA-BH-A0B5 TCGA-BH-A0B5-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14920 1008 NA 0 2136 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 600 NO Negative NA NO 24 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T2 Stage IIIA NA A0B5 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2007 35429f42-252a-4a9d-8e99-125f26019418 35429f42-252a-4a9d-8e99-125f26019418 NA NA NA NA NA NA NA NA NA NA NA NA 35429f42-252a-4a9d-8e99-125f26019418 NA NA NA TCGA-BH-A0B5-11A-23R-A12P-07 35429f42-252a-4a9d-8e99-125f26019418 NA |
|
|
560 |
TCGA-BH-A0B6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A0B6-01 2483 0 days Squamous NA NA BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 3 NA NA TCGA-BH-A0B6 2483 0 days 2483 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant NA NA TCGA-BH-A0B6-F61943 TCGA-BH-A0B6 NA NA Positive NA NA NA NA Positive Other NA NA NA NA -17346 NA NA 0 2483 NA NA NA NA NO NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Positive NA NO 4 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA Yes M0 N0 T1c Stage I NA A0B6 TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2006 b455387f-a8b4-43b8-b898-89628723d7da b455387f-a8b4-43b8-b898-89628723d7da TCGA-BH-A0B6-01A-21-A24A-20 NA TCGA-BH-A0B6-01 TCGA-BH-A0B6-01A-11D-A19Z-05 e7cb5207-9749-4bfb-9982-58a8efca7a8f TCGA-BH-A0B6-01 TCGA-BH-A0B6-01A-11D-A19Y-09 NA NA NA NA NA b455387f-a8b4-43b8-b898-89628723d7da NA TCGA-BH-A0B6-01A-11D-A19X-01 NA NA b455387f-a8b4-43b8-b898-89628723d7da TCGA-BH-A0B6-01A-11D-A19X-01 |
|
|
561 |
TCGA-BH-A0B7-01 Stage IIB 42 3 Stage IIB 1733 NA Positive FEMALE Positive 2 2 1 Negative M0 Positive N1 1733 0 Her2 HER2-enriched Positive Her2 -11 -8 enrollment T_Other T2 LIVING 0 TCGA-BH-A0B7-01 2559 0 days High C3-BRCA/Luminal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-BH-A0B7 2559 0 days 2559 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right NA NA TCGA-BH-A0B7-F58717 TCGA-BH-A0B7 TCGA-BH-A0B7-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -15593 1391 NA 0 2559 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 320 NO Positive NA NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf A0B7 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP 6th NA NO YES BH Breast A LIVING 2006 2af2adfe-bd7b-4eb1-9971-182b11075159 2af2adfe-bd7b-4eb1-9971-182b11075159 TCGA-BH-A0B7-01A-21-A13B-20 TCGA-BH-A0B7-01A-12D-A10Y-09 TCGA-BH-A0B7-01 NA c759e411-0873-4535-8b6d-ed41dd2e6fba TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12D-A10Y-09 TCGA-BH-A0B7-01A-12D-A112-05 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12D-A10Y-09 NA 2af2adfe-bd7b-4eb1-9971-182b11075159 NA TCGA-BH-A0B7-01A-12D-A111-01 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12R-A115-07 2af2adfe-bd7b-4eb1-9971-182b11075159 TCGA-BH-A0B7-01A-12D-A111-01 TCGA-BH-A0B7-01 |
|
|
562 |
TCGA-BH-A0B7-11 NA 42 NA NA 1733 NA NA FEMALE NA NA NA NA NA NA NA NA 1733 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0B7-11 2559 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0B7 2559 0 days 2559 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right NA NA TCGA-BH-A0B7-F58717 TCGA-BH-A0B7 TCGA-BH-A0B7-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -15593 1391 NA 0 2559 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 930 NO Positive NA NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB NA A0B7 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP 6th NA NO YES BH Breast A LIVING 2006 30cee921-7fb5-4543-aeb6-ab3eaf669f84 30cee921-7fb5-4543-aeb6-ab3eaf669f84 NA NA NA NA A353AE14-6488-43F1-A9D1-BBD0C66D0814 NA NA TCGA-BH-A0B7-11A-34D-A112-05 NA TCGA-BH-A0B7-11 NA NA 30cee921-7fb5-4543-aeb6-ab3eaf669f84 NA NA TCGA-BH-A0B7-11 TCGA-BH-A0B7-11A-34R-A115-07 30cee921-7fb5-4543-aeb6-ab3eaf669f84 NA |
|
|
563 |
TCGA-BH-A0B8-01 Stage IB 64 NA Stage I 1569 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1569 0 LumA Luminal A Positive NA -10 -3 followup T1 T1 LIVING 0 TCGA-BH-A0B8-01 1569 0 days NA NA cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-BH-A0B8 1569 0 days 1569 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0B8-F15442 TCGA-BH-A0B8 NA NA Positive NA 3+ NA NA Positive Lumpectomy NA NO NA NA -23380 NA NA 0 1569 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 2+ NA NA 1.29 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T1b Stage I NA A0B8 TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast NA LIVING 2006 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 NA TCGA-BH-A0B8-01A-21W-A071-09 TCGA-BH-A0B8-01 TCGA-BH-A0B8-01A-21D-A10P-05 NA NA TCGA-BH-A0B8-01A-21W-A071-09 NA NA NA TCGA-BH-A0B8-01A-21W-A071-09 TCGA-BH-A0B8-01 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 TCGA-BH-A0B8-01 NA NA TCGA-BH-A0B8-01A-21R-A056-07 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 NA TCGA-BH-A0B8-01 |
|
|
564 |
TCGA-BH-A0B8-11 NA 64 NA NA 1569 NA NA FEMALE NA NA NA NA NA NA NA NA 1569 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0B8-11 1569 0 days NA NA NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0B8 1569 0 days 1569 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0B8-F15442 TCGA-BH-A0B8 TCGA-BH-A0B8-11A NA Positive NA 3+ NA NA Positive Lumpectomy NA NO NA NA -23380 1401 NA 0 1569 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2010-11-3 FEMALE NA NA NA NA 2+ NA NA 1.29 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 400 NO Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1b Stage I NA A0B8 TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2006 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 NA NA NA TCGA-BH-A0B8-11A-41D-A093-05 NA NA NA NA NA NA NA NA 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 NA NA NA TCGA-BH-A0B8-11A-41R-A089-07 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 NA |
|
|
565 |
TCGA-BH-A0B9-01 Stage IA 44 1 Stage I 1572 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1572 0 NA Basal-like Negative Basal -13 -12 followup T1 T1 LIVING 0 TCGA-BH-A0B9-01 1572 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 NA miRNA cluster 14 cluster 5 mutation cluster 5 TCGA-BH-A0B9 1572 0 days 1572 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0B9-F15438 TCGA-BH-A0B9 TCGA-BH-A0B9-01A NA Negative NA 0 NA NA Negative Other NA NO NA NA -16310 1391 NA 0 1572 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2010-11-4 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 190 NO Negative NA NA 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf A0B9 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2006 d5c39754-79c3-432c-b496-34a394662e17 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01A-21-A13C-20 TCGA-BH-A0B9-01A-11W-A071-09 TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11D-A10P-05 99bf951a-a4c0-424e-bdf5-4308ec20f38d TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11W-A071-09 NA TCGA-BH-A0B9-01 NA TCGA-BH-A0B9-01A-11W-A071-09 TCGA-BH-A0B9-01 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11D-A059-01 NA TCGA-BH-A0B9-01A-11R-A056-07 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01A-11D-A059-01 TCGA-BH-A0B9-01 |
|
|
566 |
TCGA-BH-A0BA-01 Stage IIIC 51 3 No_Conversion 1132 NA Positive FEMALE Negative 1 4 3 Negative M0 Positive N3 1132 0 LumA Luminal A Positive ReacI -5 0 followup T_Other T3 LIVING 0 TCGA-BH-A0BA-01 1132 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0BA 1132 0 days 1132 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BA-F15461 TCGA-BH-A0BA TCGA-BH-A0BA-01A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -18839 1266 NA 0 1132 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2010-11-4 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) Infiltrating ductal & lobular No NA C50.9 8522/3 C50.9 3+ YES NA Core needle biopsy 360 NO Negative NA NA 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 27 NA true No M0 N3a T3 Stage IIIC TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf A0BA TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2006 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01A-21-A13C-20 TCGA-BH-A0BA-01A-11W-A071-09 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11D-A10P-05 348679c1-9edf-44d0-96e2-83602db6c2e7 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11W-A071-09 NA TCGA-BH-A0BA-01 NA TCGA-BH-A0BA-01A-11W-A071-09 TCGA-BH-A0BA-01 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11D-A059-01 NA TCGA-BH-A0BA-01A-11R-A056-07 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01A-11D-A059-01 TCGA-BH-A0BA-01 |
|
|
567 |
TCGA-BH-A0BA-11 NA 51 NA NA 1132 NA NA FEMALE NA NA NA NA NA NA NA NA 1132 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0BA-11 1132 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0BA 1132 0 days 1132 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BA-F15461 TCGA-BH-A0BA TCGA-BH-A0BA-11A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -18839 1266 NA 0 1132 NA NA NA NA NA NA 80-89% NA Scheduled Follow-up Submission 2010-11-4 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) Infiltrating ductal & lobular No NA C50.9 8522/3 C50.9 3+ YES NA Core needle biopsy 220 NO Negative NA NA 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 27 NA true No M0 N3a T3 Stage IIIC NA A0BA TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2006 3bfd1811-bd2a-439d-8dde-237abcf855af 3bfd1811-bd2a-439d-8dde-237abcf855af NA NA NA TCGA-BH-A0BA-11A-22D-A10Q-05 NA NA NA NA NA NA NA NA 3bfd1811-bd2a-439d-8dde-237abcf855af NA NA NA TCGA-BH-A0BA-11A-22R-A089-07 3bfd1811-bd2a-439d-8dde-237abcf855af NA |
|
|
568 |
TCGA-BH-A0BC-01 Stage IIIC 60 2 No_Conversion 974 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N3 974 0 LumA Luminal A Positive ReacI -4 -4 followup T_Other T2 LIVING 0 TCGA-BH-A0BC-01 974 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0BC NA NA days 974 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BC-F4487 TCGA-BH-A0BC TCGA-BH-A0BC-01A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -21949 1098 NA 0 974 NA NA NA NA NA NA 90-99% NA NA 2010-11-4 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 160 NO Negative NA NA 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 12 NA true No M0 N3 T2 Stage IIIC TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf A0BC TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01A-11-A13B-20 TCGA-BH-A0BC-01A-22D-A099-09 TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A10P-05 6b66ea4c-8556-4fc6-8014-f99e59727021 TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A099-09 NA TCGA-BH-A0BC-01 NA TCGA-BH-A0BC-01A-22D-A099-09 TCGA-BH-A0BC-01 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A087-01 NA TCGA-BH-A0BC-01A-22R-A084-07 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01A-22D-A087-01 TCGA-BH-A0BC-01 |
|
|
569 |
TCGA-BH-A0BC-11 NA 60 NA NA 974 NA NA FEMALE NA NA NA NA NA NA NA NA 974 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0BC-11 974 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A0BC NA NA days 974 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BC-F4487 TCGA-BH-A0BC TCGA-BH-A0BC-11A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -21949 1098 NA 0 974 NA NA NA NA NA NA 90-99% NA NA 2010-11-4 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 200 NO Negative NA NA 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 12 NA true No M0 N3 T2 Stage IIIC NA A0BC TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 32336250-dc07-4e96-9a6c-3c7094fd5342 32336250-dc07-4e96-9a6c-3c7094fd5342 NA NA NA TCGA-BH-A0BC-11A-22D-A093-05 NA NA NA NA NA NA NA TCGA-BH-A0BC-11 32336250-dc07-4e96-9a6c-3c7094fd5342 TCGA-BH-A0BC-11 NA NA TCGA-BH-A0BC-11A-22R-A089-07 32336250-dc07-4e96-9a6c-3c7094fd5342 NA |
|
|
570 |
TCGA-BH-A0BD-01 Stage IIA 47 4 No_Conversion 554 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 554 0 LumB Luminal B Positive NA 0 0 followup T1 T1 LIVING 0 TCGA-BH-A0BD-01 554 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0BD 554 0 days 554 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BD-F15423 TCGA-BH-A0BD NA NA Positive NA NA NA NA Positive Other NA NO NA NA -17275 NA NA 0 554 NA NA NA NA NA H-Score-190 NA NA Scheduled Follow-up Submission 2010-11-4 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA NA No M0 N1a T1c Stage IIA NA A0BD TUMOR FREE H-Score-230 NA NA H-Score H-Score NA NA NA NA YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast NA LIVING 2009 bf23a402-18ab-47b7-8bca-a9b01eeaf605 bf23a402-18ab-47b7-8bca-a9b01eeaf605 NA TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01 NA NA TCGA-BH-A0BD-01 TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01A-11D-A032-05 TCGA-BH-A0BD-01 NA TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01 bf23a402-18ab-47b7-8bca-a9b01eeaf605 TCGA-BH-A0BD-01 TCGA-BH-A0BD-01A-11D-A036-01 NA TCGA-BH-A0BD-01A-11R-A034-07 bf23a402-18ab-47b7-8bca-a9b01eeaf605 TCGA-BH-A0BD-01A-11D-A036-01 TCGA-BH-A0BD-01 |
|
|
571 |
TCGA-BH-A0BF-01 Stage IIB 56 2 Stage IIB 781 NA Positive FEMALE Negative 3 1 4 Negative M0 Positive N1 781 0 LumB Luminal B Positive Basal -2 -5 enrollment T_Other T2 LIVING 1 TCGA-BH-A0BF-01 1324 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0BF 1324 0 days 1324 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant NA NA TCGA-BH-A0BF-F59142 TCGA-BH-A0BF TCGA-BH-A0BF-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -20691 413 1324 0 782 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T2 Stage IIB TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf A0BF TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 Total mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A DECEASED 2009 3491d44a-675b-4510-8699-2ee83f960d02 3491d44a-675b-4510-8699-2ee83f960d02 TCGA-BH-A0BF-01A-11-A13C-20 TCGA-BH-A0BF-01A-21D-A12Q-09 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12R-05 3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12Q-09 NA TCGA-BH-A0BF-01 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12Q-09 NA 3491d44a-675b-4510-8699-2ee83f960d02 NA TCGA-BH-A0BF-01A-21D-A12N-01 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21R-A12P-07 3491d44a-675b-4510-8699-2ee83f960d02 TCGA-BH-A0BF-01A-21D-A12N-01 TCGA-BH-A0BF-01 |
|
|
572 |
TCGA-BH-A0BF-11 NA 56 NA NA 781 NA NA FEMALE NA NA NA NA NA NA NA NA 781 0 NA NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-BH-A0BF-11 1324 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A0BF 1324 0 days 1324 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant NA NA TCGA-BH-A0BF-F59142 TCGA-BH-A0BF TCGA-BH-A0BF-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -20691 413 1324 0 782 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T2 Stage IIB NA A0BF TUMOR FREE NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 Total mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A DECEASED 2009 NA NA NA NA NA TCGA-BH-A0BF-11A-31D-A12R-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
573 |
TCGA-BH-A0BG-01 Stage I 73 1 Stage I 756 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 756 0 Basal Basal-like Negative NA -13 -12 enrollment T1 T1 LIVING 0 TCGA-BH-A0BG-01 1871 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA c1uster 9 cluster 4 mutation cluster 5 TCGA-BH-A0BG 1871 0 days 1871 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Lower Outer Quadrant NA NA TCGA-BH-A0BG-F58615 TCGA-BH-A0BG TCGA-BH-A0BG-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -26988 798 NA 0 1871 NA NA NA NA NO NA NA NA NA 2014-4-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 50 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage I TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf A0BG TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel axillary lymph node biopsy 6th NA NO YES BH Breast A LIVING 2008 70b29dd6-1688-4510-94dd-5fcb26a1a908 70b29dd6-1688-4510-94dd-5fcb26a1a908 NA TCGA-BH-A0BG-01A-11D-A10Y-09 TCGA-BH-A0BG-01 NA NA TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11D-A10Y-09 TCGA-BH-A0BG-01A-11D-A112-05 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11D-A10Y-09 NA 70b29dd6-1688-4510-94dd-5fcb26a1a908 NA TCGA-BH-A0BG-01A-11D-A111-01 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11R-A115-07 70b29dd6-1688-4510-94dd-5fcb26a1a908 TCGA-BH-A0BG-01A-11D-A111-01 TCGA-BH-A0BG-01 |
|
|
574 |
TCGA-BH-A0BJ-01 Stage IIB 41 3 No_Conversion 660 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 660 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T2 LIVING 0 TCGA-BH-A0BJ-01 660 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation c1uster 9 TCGA-BH-A0BJ NA NA days 660 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BJ-F4480 TCGA-BH-A0BJ TCGA-BH-A0BJ-01A NA Positive NA 3+ NA NA Positive Other NA NO NA NA -15027 595 NA 0 660 NA NA NA NA NA H-Score 300 90-99% NA NA 2010-11-15 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 110 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NA 2 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf A0BJ TUMOR FREE H-Score 260 NA NA H-Score H Score NA NA 70-79% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 224cbe13-ebf8-41eb-ab1c-1d6792a66774 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01A-21-A13A-20 TCGA-BH-A0BJ-01A-11W-A071-09 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11D-A10P-05 188575e2-83fd-4463-8bd3-aed928b5acf0 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11W-A071-09 NA TCGA-BH-A0BJ-01 NA TCGA-BH-A0BJ-01A-11W-A071-09 TCGA-BH-A0BJ-01 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11D-A059-01 NA TCGA-BH-A0BJ-01A-11R-A056-07 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01A-11D-A059-01 TCGA-BH-A0BJ-01 |
|
|
575 |
TCGA-BH-A0BJ-11 NA 41 NA NA 660 NA NA FEMALE NA NA NA NA NA NA NA NA 660 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0BJ-11 660 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0BJ NA NA days 660 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BJ-F4480 TCGA-BH-A0BJ TCGA-BH-A0BJ-11A NA Positive NA 3+ NA NA Positive Other NA NO NA NA -15027 595 NA 0 660 NA NA NA NA NA H-Score 300 90-99% NA NA 2010-11-15 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 200 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA true No M0 N1a T2 Stage IIB NA A0BJ TUMOR FREE H-Score 260 NA NA H-Score H Score NA NA 70-79% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 4317b197-dc43-44f2-8854-557832570098 4317b197-dc43-44f2-8854-557832570098 NA NA NA TCGA-BH-A0BJ-11A-23D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0BJ-11 4317b197-dc43-44f2-8854-557832570098 TCGA-BH-A0BJ-11 NA NA TCGA-BH-A0BJ-11A-23R-A089-07 4317b197-dc43-44f2-8854-557832570098 NA |
|
|
576 |
TCGA-BH-A0BL-01 Stage I 35 3 Stage I 1339 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 1339 0 Basal Basal-like Negative NA -13 -12 enrollment T1 T1 LIVING 0 TCGA-BH-A0BL-01 2278 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 NA BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0BL 2278 0 days 2278 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Outer Quadrant NA NA TCGA-BH-A0BL-F59189 TCGA-BH-A0BL TCGA-BH-A0BL-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -12841 1135 NA 0 2278 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 60 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf A0BL TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 39ca8590-3733-4b61-9a46-4ec5e6e0501e 39ca8590-3733-4b61-9a46-4ec5e6e0501e NA TCGA-BH-A0BL-01A-11D-A10Y-09 TCGA-BH-A0BL-01 NA NA TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11D-A10Y-09 TCGA-BH-A0BL-01A-11D-A112-05 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11D-A10Y-09 NA 39ca8590-3733-4b61-9a46-4ec5e6e0501e NA TCGA-BH-A0BL-01A-11D-A111-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11R-A115-07 39ca8590-3733-4b61-9a46-4ec5e6e0501e TCGA-BH-A0BL-01A-11D-A111-01 TCGA-BH-A0BL-01 |
|
|
577 |
TCGA-BH-A0BL-11 NA 35 NA NA 1339 NA NA FEMALE NA NA NA NA NA NA NA NA 1339 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BL-11 2278 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0BL 2278 0 days 2278 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Outer Quadrant NA NA TCGA-BH-A0BL-F59189 TCGA-BH-A0BL TCGA-BH-A0BL-11A NA Negative NA NA NA NA Negative Other NA NA NA NA -12841 1135 NA 0 2278 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 50 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I NA A0BL TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 NA NA NA NA NA NA NA NA NA TCGA-BH-A0BL-11A-12D-A112-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
578 |
TCGA-BH-A0BM-01 Stage IIB 54 2 No_Conversion 1117 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1117 0 LumA Luminal A Negative ReacI -5 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A0BM-01 1876 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0BM 1876 0 days 1876 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BM-F34064 TCGA-BH-A0BM TCGA-BH-A0BM-01A NA Positive NA 0 NA NA Negative Lumpectomy NA NO NA NA -20049 1080 NA 0 1876 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 100 NO Negative NA NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf A0BM TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA 6th YES NO YES BH Breast A LIVING 2007 986550fb-92db-4e9f-b79a-6c3023dd63a3 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01A-21-A13B-20 TCGA-BH-A0BM-01A-11W-A071-09 TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11D-A10P-05 f8cccdf6-fdf0-43a1-86f9-4897d845db8c TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11W-A071-09 NA TCGA-BH-A0BM-01 NA TCGA-BH-A0BM-01A-11W-A071-09 TCGA-BH-A0BM-01 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11D-A059-01 NA TCGA-BH-A0BM-01A-11R-A056-07 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01A-11D-A059-01 TCGA-BH-A0BM-01 |
|
|
579 |
TCGA-BH-A0BM-11 NA 54 NA NA 1117 NA NA FEMALE NA NA NA NA NA NA NA NA 1117 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BM-11 1876 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0BM 1876 0 days 1876 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BM-F34064 TCGA-BH-A0BM TCGA-BH-A0BM-11A NA Positive NA 0 NA NA Negative Lumpectomy NA NO NA NA -20049 1080 NA 0 1876 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 100 NO Negative NA NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB NA A0BM TUMOR FREE NA NA NA NA NA NA NA NA NA NO Solid Tissue Normal 11 NA 6th YES NO YES BH Breast A LIVING 2007 fe538d53-c7ce-455f-afe6-cb4fc3a63dbd fe538d53-c7ce-455f-afe6-cb4fc3a63dbd NA NA NA TCGA-BH-A0BM-11A-12D-A093-05 NA NA NA NA NA NA NA NA fe538d53-c7ce-455f-afe6-cb4fc3a63dbd NA NA NA TCGA-BH-A0BM-11A-12R-A089-07 fe538d53-c7ce-455f-afe6-cb4fc3a63dbd NA |
|
|
580 |
TCGA-BH-A0BO-01 Stage I 54 1 Stage I 1085 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1085 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0BO-01 2197 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A0BO 2197 0 days 2197 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant NA NA TCGA-BH-A0BO-F61949 TCGA-BH-A0BO TCGA-BH-A0BO-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -19767 1162 NA 0 2197 NA NA NA NA NO NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 290 NO Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1b Stage I TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf A0BO TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 TCGA-BH-A0BO-01A-11-A13B-20 TCGA-BH-A0BO-01A-23D-A12B-09 TCGA-BH-A0BO-01 NA 6f30f209-57e0-4430-8132-4c36bcc0862c TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23D-A12B-09 TCGA-BH-A0BO-01A-23D-A12E-05 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23D-A12B-09 NA 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 NA TCGA-BH-A0BO-01A-23D-A12A-01 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23R-A12D-07 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 TCGA-BH-A0BO-01A-23D-A12A-01 TCGA-BH-A0BO-01 |
|
|
581 |
TCGA-BH-A0BO-11 NA 54 NA NA 1085 NA NA FEMALE NA NA NA NA NA NA NA NA 1085 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BO-11 2197 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0BO 2197 0 days 2197 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant NA NA TCGA-BH-A0BO-F61949 TCGA-BH-A0BO TCGA-BH-A0BO-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -19767 1162 NA 0 2197 NA NA NA NA NO NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 60 NO Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1b Stage I NA A0BO TUMOR FREE NA NA NA NA NA NO YES NA NA YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 NA NA NA NA NA NA NA NA NA TCGA-BH-A0BO-11A-11D-A12E-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
582 |
TCGA-BH-A0BP-01 Stage I 76 2 Stage I 1481 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 1481 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 1 TCGA-BH-A0BP-01 2296 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0BP 2296 0 days 2296 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant NA NA TCGA-BH-A0BP-F59122 TCGA-BH-A0BP TCGA-BH-A0BP-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -27917 1217 2296 0 1481 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf A0BP TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Segmental mastectomy 6th NA NO YES BH Breast A DECEASED 2006 acbae442-ba6c-4d28-b3bc-58bb4dd93ece acbae442-ba6c-4d28-b3bc-58bb4dd93ece TCGA-BH-A0BP-01A-21-A13C-20 TCGA-BH-A0BP-01A-11D-A10Y-09 TCGA-BH-A0BP-01 NA 4ab91e5f-6fff-4de9-a249-9013a79f6a10 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11D-A10Y-09 TCGA-BH-A0BP-01A-11D-A112-05 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11D-A10Y-09 NA acbae442-ba6c-4d28-b3bc-58bb4dd93ece NA TCGA-BH-A0BP-01A-11D-A111-01 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11R-A115-07 acbae442-ba6c-4d28-b3bc-58bb4dd93ece TCGA-BH-A0BP-01A-11D-A111-01 TCGA-BH-A0BP-01 |
|
|
583 |
TCGA-BH-A0BQ-01 Stage I 39 2 Stage I 826 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 826 0 LumA Luminal A Positive Her2 -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0BQ-01 2255 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0BQ 1709 1 days 2255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left NA NA TCGA-BH-A0BQ-F58695 TCGA-BH-A0BQ TCGA-BH-A0BQ-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -14494 1197 NA 0 2255 NA 1750 1709 NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Positive NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA Other, specify Locoregional Recurrence Dermis and epidermis YES YES 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf A0BQ TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 Total mastectomy with retromammary lymph node excision 6th NA NO YES BH Breast A LIVING 2007 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 TCGA-BH-A0BQ-01A-11-A13C-20 TCGA-BH-A0BQ-01A-21D-A10Y-09 TCGA-BH-A0BQ-01 NA f74f1027-b835-4e74-976c-8a884db74123 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21D-A10Y-09 TCGA-BH-A0BQ-01A-21D-A112-05 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21D-A10Y-09 NA 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 NA TCGA-BH-A0BQ-01A-21D-A111-01 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21R-A115-07 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 TCGA-BH-A0BQ-01A-21D-A111-01 TCGA-BH-A0BQ-01 |
|
|
584 |
TCGA-BH-A0BQ-11 NA 39 NA NA 826 NA NA FEMALE NA NA NA NA NA NA NA NA 826 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BQ-11 2255 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0BQ 1709 1 days 2255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left NA NA TCGA-BH-A0BQ-F58695 TCGA-BH-A0BQ TCGA-BH-A0BQ-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -14494 1197 NA 0 2255 NA 1750 1709 NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 340 NO Positive NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify Locoregional Recurrence Dermis and epidermis YES YES 0 NA true No M0 N0 T1c Stage I NA A0BQ TUMOR FREE NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 Total mastectomy with retromammary lymph node excision 6th NA NO YES BH Breast A LIVING 2007 4096c8a6-5ead-4410-8da1-a20b0f37cce8 4096c8a6-5ead-4410-8da1-a20b0f37cce8 NA NA NA NA NA NA NA TCGA-BH-A0BQ-11A-33D-A112-05 NA TCGA-BH-A0BQ-11 NA NA 4096c8a6-5ead-4410-8da1-a20b0f37cce8 NA NA TCGA-BH-A0BQ-11 TCGA-BH-A0BQ-11A-33R-A115-07 4096c8a6-5ead-4410-8da1-a20b0f37cce8 NA |
|
|
585 |
TCGA-BH-A0BR-01 Stage I 59 1 Stage I 1632 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1632 0 LumA Luminal A Positive ReacI -4 -3 enrollment T1 T1 LIVING 0 TCGA-BH-A0BR-01 2330 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 3 TCGA-BH-A0BR 2330 0 days 2330 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Lower Inner Quadrant NA NA TCGA-BH-A0BR-F61951 TCGA-BH-A0BR TCGA-BH-A0BR-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21622 1170 NA 0 2330 NA NA NA NA NO NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 160 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf A0BR TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 0ef20000-2c8e-47bb-86e5-ffa2814099a7 0ef20000-2c8e-47bb-86e5-ffa2814099a7 TCGA-BH-A0BR-01A-11-A13C-20 TCGA-BH-A0BR-01A-21W-A12T-09 TCGA-BH-A0BR-01 NA 94b57709-97e9-4421-a146-e82570a42258 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21W-A12T-09 TCGA-BH-A0BR-01A-21D-A112-05 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21W-A12T-09 NA 0ef20000-2c8e-47bb-86e5-ffa2814099a7 NA TCGA-BH-A0BR-01A-21D-A111-01 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21R-A115-07 0ef20000-2c8e-47bb-86e5-ffa2814099a7 TCGA-BH-A0BR-01A-21D-A111-01 TCGA-BH-A0BR-01 |
|
|
586 |
TCGA-BH-A0BS-01 Stage IIIA 55 2 Stage IIIA 1640 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1640 0 LumA Luminal A Positive LumA/B 0 -2 enrollment T_Other T3 LIVING 0 TCGA-BH-A0BS-01 2612 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0BS 2612 0 days 2612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left NA NA TCGA-BH-A0BS-F61955 TCGA-BH-A0BS TCGA-BH-A0BS-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -20374 1164 NA 0 2612 NA NA NA NA NO NA NA NA NA 2014-8-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 180 NO NA Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 0 NA true No M0 N1c T3 Stage IIIA TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf A0BS TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2007 354c08e2-61d3-4cfa-9d26-76d74dcfe44f 354c08e2-61d3-4cfa-9d26-76d74dcfe44f TCGA-BH-A0BS-01A-21-A13A-20 TCGA-BH-A0BS-01A-11D-A12Q-09 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12R-05 bc9af2fb-d022-40cc-9fca-685bd206e71b TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12Q-09 NA TCGA-BH-A0BS-01 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12Q-09 NA 354c08e2-61d3-4cfa-9d26-76d74dcfe44f NA TCGA-BH-A0BS-01A-11D-A12N-01 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11R-A12P-07 354c08e2-61d3-4cfa-9d26-76d74dcfe44f TCGA-BH-A0BS-01A-11D-A12N-01 TCGA-BH-A0BS-01 |
|
|
587 |
TCGA-BH-A0BS-11 NA 55 NA NA 1640 NA NA FEMALE NA NA NA NA NA NA NA NA 1640 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BS-11 2612 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0BS 2612 0 days 2612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left NA NA TCGA-BH-A0BS-F61955 TCGA-BH-A0BS TCGA-BH-A0BS-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -20374 1164 NA 0 2612 NA NA NA NA NO NA NA NA NA 2014-8-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO NA Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N1c T3 Stage IIIA NA A0BS TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2007 10d54893-647f-40a9-8aa7-602e04d55faf 10d54893-647f-40a9-8aa7-602e04d55faf NA NA NA TCGA-BH-A0BS-11A-11D-A12R-05 NA NA NA NA NA TCGA-BH-A0BS-11 NA NA 10d54893-647f-40a9-8aa7-602e04d55faf NA NA TCGA-BH-A0BS-11 TCGA-BH-A0BS-11A-11R-A12P-07 10d54893-647f-40a9-8aa7-602e04d55faf NA |
|
|
588 |
TCGA-BH-A0BT-01 Stage IIA 56 4 Stage IIA 1386 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1386 0 LumA Luminal A Positive ReacII -12 -3 enrollment T1 T1 LIVING 0 TCGA-BH-A0BT-01 2365 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation cluster 3 TCGA-BH-A0BT 2365 0 days 2365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Inner Quadrant NA NA TCGA-BH-A0BT-F59143 TCGA-BH-A0BT TCGA-BH-A0BT-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -20625 1167 NA 0 2365 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative NA NO NA Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO NA NA true No M0 N1mi T1c Stage IIA TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf A0BT TUMOR FREE NA NA NA NA NA YES NA NA NA YES Primary Tumor 01 segmental mastectomy with sentinel lymph node excision and biopsy 6th NA NO YES BH Breast A LIVING 2007 fe8764cf-04ee-480d-96ce-09d0d388f4f6 fe8764cf-04ee-480d-96ce-09d0d388f4f6 TCGA-BH-A0BT-01A-21-A13C-20 TCGA-BH-A0BT-01A-11D-A12Q-09 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12R-05 99e5ad3c-e46a-4d06-9feb-33f1b3819e6f TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12Q-09 NA TCGA-BH-A0BT-01 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12Q-09 NA fe8764cf-04ee-480d-96ce-09d0d388f4f6 NA TCGA-BH-A0BT-01A-11D-A12N-01 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11R-A12P-07 fe8764cf-04ee-480d-96ce-09d0d388f4f6 TCGA-BH-A0BT-01A-11D-A12N-01 TCGA-BH-A0BT-01 |
|
|
589 |
TCGA-BH-A0BT-11 NA 56 NA NA 1386 NA NA FEMALE NA NA NA NA NA NA NA NA 1386 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BT-11 2365 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A0BT 2365 0 days 2365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Inner Quadrant NA NA TCGA-BH-A0BT-F59143 TCGA-BH-A0BT TCGA-BH-A0BT-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -20625 1167 NA 0 2365 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO Negative NA NO NA Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No M0 N1mi T1c Stage IIA NA A0BT TUMOR FREE NA NA NA NA NA YES NA NA NA YES Solid Tissue Normal 11 segmental mastectomy with sentinel lymph node excision and biopsy 6th NA NO YES BH Breast A LIVING 2007 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef NA NA NA TCGA-BH-A0BT-11A-21D-A12R-05 NA NA NA NA NA TCGA-BH-A0BT-11 NA NA 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef NA NA TCGA-BH-A0BT-11 NA 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef NA |
|
|
590 |
TCGA-BH-A0BV-01 Stage IIB 78 5 No_Conversion 1519 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 1519 0 LumA Luminal A Positive LumA/B 0 -4 followup T_Other T2 LIVING 0 TCGA-BH-A0BV-01 1519 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 4 TCGA-BH-A0BV NA NA days 1519 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BV-F4513 TCGA-BH-A0BV TCGA-BH-A0BV-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -28699 1328 NA 0 1519 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 450 NO Negative NA NA 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NA 2 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf A0BV TUMOR FREE NA NA NA NA NA NA NA 50-59% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2006 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01A-21-A13B-20 TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01 NA 7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2 TCGA-BH-A0BV-01 TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01A-11D-A00Y-05 TCGA-BH-A0BV-01 NA TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01 TCGA-BH-A0BV-01A-11D-A011-01 NA TCGA-BH-A0BV-01A-11R-A00Z-07 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01A-11D-A011-01 TCGA-BH-A0BV-01 |
|
|
591 |
TCGA-BH-A0BV-11 NA 78 NA NA 1519 NA NA FEMALE NA NA NA NA NA NA NA NA 1519 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0BV-11 1519 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0BV NA NA days 1519 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0BV-F4513 TCGA-BH-A0BV TCGA-BH-A0BV-11A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -28699 1328 NA 0 1519 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 200 NO Negative NA NA 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA true No M0 N1a T2 Stage IIB NA A0BV TUMOR FREE NA NA NA NA NA NA NA 50-59% NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2006 452bf9da-c065-4d95-8272-adce3684a9e9 452bf9da-c065-4d95-8272-adce3684a9e9 NA NA NA TCGA-BH-A0BV-11A-31D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0BV-11 452bf9da-c065-4d95-8272-adce3684a9e9 TCGA-BH-A0BV-11 NA NA TCGA-BH-A0BV-11A-31R-A089-07 452bf9da-c065-4d95-8272-adce3684a9e9 NA |
|
|
592 |
TCGA-BH-A0BW-01 Stage I 71 1 Stage I 355 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 355 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING 0 TCGA-BH-A0BW-01 2371 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A0BW 2371 0 days 2371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Lower Outer Quadrant NA NA TCGA-BH-A0BW-F59127 TCGA-BH-A0BW TCGA-BH-A0BW-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -25974 1344 NA 0 2371 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO NA Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf A0BW TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy 6th NA NO YES BH Breast A LIVING 2006 7e84df9f-1da5-4add-a5e8-a9d9d8af409c 7e84df9f-1da5-4add-a5e8-a9d9d8af409c TCGA-BH-A0BW-01A-21-A13B-20 TCGA-BH-A0BW-01A-11D-A10Y-09 TCGA-BH-A0BW-01 NA a5fc2a17-0d67-4a6f-ae45-373d3cc91129 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11D-A10Y-09 TCGA-BH-A0BW-01A-11D-A112-05 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11D-A10Y-09 NA 7e84df9f-1da5-4add-a5e8-a9d9d8af409c NA TCGA-BH-A0BW-01A-11D-A111-01 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11R-A115-07 7e84df9f-1da5-4add-a5e8-a9d9d8af409c TCGA-BH-A0BW-01A-11D-A111-01 TCGA-BH-A0BW-01 |
|
|
593 |
TCGA-BH-A0BW-11 NA 71 NA NA 355 NA NA FEMALE NA NA NA NA NA NA NA NA 355 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BW-11 2371 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0BW 2371 0 days 2371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Lower Outer Quadrant NA NA TCGA-BH-A0BW-F59127 TCGA-BH-A0BW NA NA Negative NA NA NA NA Negative Other NA NA NA NA -25974 NA NA 0 2371 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A0BW TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 Segmental mastectomy 6th NA NO YES BH Breast NA LIVING 2006 ca5076dc-0fb2-444f-b34f-305c8479cba3 ca5076dc-0fb2-444f-b34f-305c8479cba3 NA NA NA NA NA NA NA TCGA-BH-A0BW-11A-12D-A112-05 NA TCGA-BH-A0BW-11 NA NA ca5076dc-0fb2-444f-b34f-305c8479cba3 NA NA TCGA-BH-A0BW-11 TCGA-BH-A0BW-11A-12R-A115-07 ca5076dc-0fb2-444f-b34f-305c8479cba3 NA |
|
|
594 |
TCGA-BH-A0BZ-01 Stage IIIA 59 4 Stage IIIA 1492 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 1492 0 LumB Luminal B Positive X -2 -5 enrollment T_Other T3 LIVING 0 TCGA-BH-A0BZ-01 2255 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 10 TCGA-BH-A0BZ 2255 0 days 2255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left NA NA TCGA-BH-A0BZ-F58683 TCGA-BH-A0BZ TCGA-BH-A0BZ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -21856 1084 NA 0 2255 NA NA NA NA NO NA NA NA NA 2014-4-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 830 NO Negative NA NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T3 Stage IIIA TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf A0BZ TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2007 317ffb84-f4a8-435b-907b-b05587d6515e 317ffb84-f4a8-435b-907b-b05587d6515e TCGA-BH-A0BZ-01A-21-A13B-20 TCGA-BH-A0BZ-01A-31D-A12Q-09 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12R-05 d2de5993-e58f-4d41-812b-2a355dd855ea TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12Q-09 NA TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12Q-09 NA 317ffb84-f4a8-435b-907b-b05587d6515e NA TCGA-BH-A0BZ-01A-31D-A12N-01 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31R-A12P-07 317ffb84-f4a8-435b-907b-b05587d6515e TCGA-BH-A0BZ-01A-31D-A12N-01 TCGA-BH-A0BZ-01 |
|
|
595 |
TCGA-BH-A0BZ-11 NA 59 NA NA 1492 NA NA FEMALE NA NA NA NA NA NA NA NA 1492 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0BZ-11 2255 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 10 TCGA-BH-A0BZ 2255 0 days 2255 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left NA NA TCGA-BH-A0BZ-F58683 TCGA-BH-A0BZ TCGA-BH-A0BZ-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -21856 1084 NA 0 2255 NA NA NA NA NO NA NA NA NA 2014-4-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 620 NO Negative NA NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T3 Stage IIIA NA A0BZ TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2007 561e0da7-0e2c-430c-8a54-c9a3535a1679 561e0da7-0e2c-430c-8a54-c9a3535a1679 NA NA NA TCGA-BH-A0BZ-11A-61D-A12R-05 C3371B54-7D2D-4868-B8EF-E5C0466B0172 NA NA NA NA TCGA-BH-A0BZ-11 NA NA 561e0da7-0e2c-430c-8a54-c9a3535a1679 NA NA TCGA-BH-A0BZ-11 TCGA-BH-A0BZ-11A-61R-A12P-07 561e0da7-0e2c-430c-8a54-c9a3535a1679 NA |
|
|
596 |
TCGA-BH-A0C0-01 Stage IIA 62 3 No_Conversion 1270 NA Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 1270 0 LumB Luminal B Positive Basal -2 -5 followup T1 T1 LIVING 0 TCGA-BH-A0C0-01 1270 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0C0 NA NA days 1270 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0C0-F4518 TCGA-BH-A0C0 NA NA Positive NA NA NA NA Positive Other NA NO NA NA -23006 NA NA 0 1270 NA NA NA NA NA NA 90-99% 2.65 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 12.45 4.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Equivocal Positive NA 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 1 NA NA No M0 N1a T1c Stage IIA NA A0C0 TUMOR FREE NA NA NA NA NA NA NA 60-69% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast NA LIVING 2007 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01A-11-A13B-20 TCGA-BH-A0C0-01A-21W-A071-09 TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21D-A10P-05 a4009327-f700-4c89-88fa-a560641ab193 TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21W-A071-09 NA TCGA-BH-A0C0-01 NA TCGA-BH-A0C0-01A-21W-A071-09 TCGA-BH-A0C0-01 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21D-A059-01 NA TCGA-BH-A0C0-01A-21R-A056-07 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01A-21D-A059-01 TCGA-BH-A0C0-01 |
|
|
597 |
TCGA-BH-A0C0-11 NA 62 NA NA 1270 NA NA FEMALE NA NA NA NA NA NA NA NA 1270 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0C0-11 1270 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0C0 NA NA days 1270 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0C0-F4518 TCGA-BH-A0C0 TCGA-BH-A0C0-11A NA Positive NA NA NA NA Positive Other NA NO NA NA -23006 1094 NA 0 1270 NA NA NA NA NA NA 90-99% 2.65 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 12.45 4.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 330 NO Equivocal Positive NA 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T1c Stage IIA NA A0C0 TUMOR FREE NA NA NA NA NA NA NA 60-69% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 86c4b2fd-d034-469d-adfa-712055f30dc3 86c4b2fd-d034-469d-adfa-712055f30dc3 NA NA NA TCGA-BH-A0C0-11A-21D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0C0-11 86c4b2fd-d034-469d-adfa-712055f30dc3 TCGA-BH-A0C0-11 NA NA TCGA-BH-A0C0-11A-21R-A089-07 86c4b2fd-d034-469d-adfa-712055f30dc3 NA |
|
|
598 |
TCGA-BH-A0C1-01 Stage IIIA 61 2 Stage IIIA 1338 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 1338 0 LumA Luminal A Positive ReacII -1 -1 enrollment T_Other T3 LIVING 1 TCGA-BH-A0C1-01 1411 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A0C1 1123 1 days 1411 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right NA NA TCGA-BH-A0C1-F63399 TCGA-BH-A0C1 TCGA-BH-A0C1-01B NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -22377 1073 1411 0 1339 NA NA 1123 NA YES NA NA NA NA 2014-8-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 250 NO Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA Bone Distant Metastasis NA NA YES 8 NA true No M0 N2a T3 Stage IIIA TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02.pdf A0C1 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast B DECEASED 2007 73b732bb-f387-4618-a2a3-8c7db1c75fd8 73b732bb-f387-4618-a2a3-8c7db1c75fd8 TCGA-BH-A0C1-01B-21-A13D-20 TCGA-BH-A0C1-01B-11D-A12B-09 TCGA-BH-A0C1-01 NA dc364a19-d15e-4c8e-8d9b-cbd70b27d532 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11D-A12B-09 TCGA-BH-A0C1-01B-11D-A12E-05 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11D-A12B-09 NA 73b732bb-f387-4618-a2a3-8c7db1c75fd8 NA TCGA-BH-A0C1-01B-11D-A12A-01 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11R-A12D-07 73b732bb-f387-4618-a2a3-8c7db1c75fd8 TCGA-BH-A0C1-01B-11D-A12A-01 TCGA-BH-A0C1-01 |
|
|
599 |
TCGA-BH-A0C3-01 Stage I 47 3 Stage I 1464 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1464 0 LumB Luminal B Negative Her2 -4 0 enrollment T1 T1 LIVING 0 TCGA-BH-A0C3-01 2709 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-BH-A0C3 2674 1 days 2709 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left NA NA TCGA-BH-A0C3-F63533 TCGA-BH-A0C3 TCGA-BH-A0C3-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -17221 1335 NA 0 2709 NA NA 2674 NA NO NA NA NA NA 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) with ductal and lobular phenotypes No NA C50.9 8522/3 C50.9 NA YES NA Core needle biopsy 160 NO Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA Bone Distant Metastasis NA NA YES 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf A0C3 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel node biopsy 6th NA NO YES BH Breast A LIVING 2006 52a863fe-b210-456b-9c2d-545277362b65 52a863fe-b210-456b-9c2d-545277362b65 TCGA-BH-A0C3-01A-11-A13C-20 TCGA-BH-A0C3-01A-21D-A12Q-09 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12R-05 42fa3207-2c4f-4499-99b8-fe5275232eed TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12Q-09 NA TCGA-BH-A0C3-01 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12Q-09 NA 52a863fe-b210-456b-9c2d-545277362b65 NA TCGA-BH-A0C3-01A-21D-A12N-01 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21R-A12P-07 52a863fe-b210-456b-9c2d-545277362b65 TCGA-BH-A0C3-01A-21D-A12N-01 TCGA-BH-A0C3-01 |
|
|
600 |
TCGA-BH-A0C3-11 NA 47 NA NA 1464 NA NA FEMALE NA NA NA NA NA NA NA NA 1464 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0C3-11 2709 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0C3 2674 1 days 2709 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left NA NA TCGA-BH-A0C3-F63533 TCGA-BH-A0C3 TCGA-BH-A0C3-11A NA Positive NA NA NA NA Negative Other NA NA NA NA -17221 1335 NA 0 2709 NA NA 2674 NA NO NA NA NA NA 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) with ductal and lobular phenotypes No NA C50.9 8522/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NA YES 0 NA true No M0 N0 T1c Stage I NA A0C3 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 Segmental mastectomy with sentinel node biopsy 6th NA NO YES BH Breast A LIVING 2006 65923c68-2c86-4b4d-abe2-5320c08bb68f 65923c68-2c86-4b4d-abe2-5320c08bb68f NA NA NA TCGA-BH-A0C3-11A-23D-A12R-05 NA NA NA NA NA TCGA-BH-A0C3-11 NA NA 65923c68-2c86-4b4d-abe2-5320c08bb68f NA NA TCGA-BH-A0C3-11 TCGA-BH-A0C3-11A-23R-A12P-07 65923c68-2c86-4b4d-abe2-5320c08bb68f NA |
|
|
601 |
TCGA-BH-A0C7-01 Stage IIB 48 5 Stage IIB 1305 NA Positive FEMALE Positive 1 3 4 Negative M0 Positive N1 1305 0 LumB Luminal B Negative LumA/B 0 -3 enrollment T_Other T2 LIVING 0 TCGA-BH-A0C7-01 2767 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0C7 2767 0 days 2767 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left NA NA TCGA-BH-A0C7-F59178 TCGA-BH-A0C7 TCGA-BH-A0C7-01B NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -17871 1520 NA 0 2767 NA NA NA NA NO NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO NA Positive NO 18 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T2 Stage IIB TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D.pdf A0C7 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES BH Breast B LIVING 2006 e58a6cf4-a4ff-4179-9671-a5661f380a8d e58a6cf4-a4ff-4179-9671-a5661f380a8d TCGA-BH-A0C7-01B-21-A13D-20 TCGA-BH-A0C7-01B-11D-A10Y-09 TCGA-BH-A0C7-01 NA 0846b423-a60b-4c54-9224-b9d129fb3278 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11D-A10Y-09 TCGA-BH-A0C7-01B-11D-A112-05 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11D-A10Y-09 NA e58a6cf4-a4ff-4179-9671-a5661f380a8d NA TCGA-BH-A0C7-01B-11D-A111-01 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11R-A115-07 e58a6cf4-a4ff-4179-9671-a5661f380a8d TCGA-BH-A0C7-01B-11D-A111-01 TCGA-BH-A0C7-01 |
|
|
602 |
TCGA-BH-A0DD-01 Stage IIB 58 3 Stage IIB 1393 NA Positive MALE Positive 1 3 4 Negative M0 Positive N1 1393 0 LumB Luminal B Positive LumA/B -6 -3 enrollment T_Other T2 LIVING 0 TCGA-BH-A0DD-01 2486 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0DD 2486 0 days 2486 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right NA NA TCGA-BH-A0DD-F60386 TCGA-BH-A0DD TCGA-BH-A0DD-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -21386 1248 NA 0 2486 NA NA NA NA NO NA NA NA NA 2014-6-9 MALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 430 NO Positive Positive NO 22 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf A0DD TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2006 e15ff180-38d3-4614-88ee-3645afaab54b e15ff180-38d3-4614-88ee-3645afaab54b TCGA-BH-A0DD-01A-21-A13B-20 TCGA-BH-A0DD-01A-31D-A12Q-09 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12R-05 7ac181c9-6dba-4e27-a5fc-09cf02f735cf TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12Q-09 NA TCGA-BH-A0DD-01 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12Q-09 NA e15ff180-38d3-4614-88ee-3645afaab54b NA TCGA-BH-A0DD-01A-31D-A12N-01 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31R-A12P-07 e15ff180-38d3-4614-88ee-3645afaab54b TCGA-BH-A0DD-01A-31D-A12N-01 TCGA-BH-A0DD-01 |
|
|
603 |
TCGA-BH-A0DD-11 NA 58 NA NA 1393 NA NA MALE NA NA NA NA NA NA NA NA 1393 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DD-11 2486 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DD 2486 0 days 2486 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right NA NA TCGA-BH-A0DD-F60386 TCGA-BH-A0DD TCGA-BH-A0DD-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -21386 1248 NA 0 2486 NA NA NA NA NO NA NA NA NA 2014-6-9 MALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 460 NO Positive Positive NO 22 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N1a T2 Stage IIB NA A0DD TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2006 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 NA NA NA NA NA NA NA NA NA NA NA NA c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 NA NA NA TCGA-BH-A0DD-11A-23R-A12P-07 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 NA |
|
|
604 |
TCGA-BH-A0DE-01 Stage IIA 62 5 Stage IIA 948 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 948 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A0DE-01 2372 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-BH-A0DE 2372 0 days 2372 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant NA NA TCGA-BH-A0DE-F63543 TCGA-BH-A0DE NA NA Positive NA NA NA NA Positive Other NA NA NA NA -22656 NA NA 0 2372 NA NA NA NA NO NA NA NA NA 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A0DE TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2007 b9a1f505-713e-4044-b76e-57134a4802f1 b9a1f505-713e-4044-b76e-57134a4802f1 NA TCGA-BH-A0DE-01A-11D-A10Y-09 TCGA-BH-A0DE-01 NA NA TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11D-A10Y-09 TCGA-BH-A0DE-01A-11D-A112-05 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11D-A10Y-09 NA b9a1f505-713e-4044-b76e-57134a4802f1 NA TCGA-BH-A0DE-01A-11D-A111-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11R-A115-07 b9a1f505-713e-4044-b76e-57134a4802f1 TCGA-BH-A0DE-01A-11D-A111-01 TCGA-BH-A0DE-01 |
|
|
605 |
TCGA-BH-A0DE-11 NA 62 NA NA 948 NA NA FEMALE NA NA NA NA NA NA NA NA 948 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DE-11 2372 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DE 2372 0 days 2372 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant NA NA TCGA-BH-A0DE-F63543 TCGA-BH-A0DE TCGA-BH-A0DE-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -22656 1130 NA 0 2372 NA NA NA NA NO NA NA NA NA 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA NA A0DE TUMOR FREE NA NA NA NA NA NO YES NA NA YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 NA NA NA NA NA NA NA NA NA TCGA-BH-A0DE-11A-23D-A112-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
606 |
TCGA-BH-A0DG-01 Stage IIA 30 3 Stage IIA 713 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 713 0 LumA Luminal A Negative ReacI -4 -4 enrollment T_Other T2 LIVING 0 TCGA-BH-A0DG-01 2041 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0DG 2041 0 days 2041 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 30 Right Upper Outer Quadrant NA NA TCGA-BH-A0DG-F63658 TCGA-BH-A0DG NA NA Positive NA NA NA NA Negative Other NA NA NA NA -11204 NA NA 0 2041 NA NA NA NA NO NA NA NA NA 2014-8-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A0DG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Total mastectomy 6th NA NO YES BH Breast NA LIVING 2007 a6b72c40-c921-4159-abad-b64e20619241 a6b72c40-c921-4159-abad-b64e20619241 TCGA-BH-A0DG-01A-11-A13B-20 TCGA-BH-A0DG-01A-21D-A12Q-09 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12R-05 c74c7143-1584-4072-872f-405fd8e3bf0c TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12Q-09 NA TCGA-BH-A0DG-01 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12Q-09 NA a6b72c40-c921-4159-abad-b64e20619241 NA TCGA-BH-A0DG-01A-21D-A12N-01 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21R-A12P-07 a6b72c40-c921-4159-abad-b64e20619241 TCGA-BH-A0DG-01A-21D-A12N-01 TCGA-BH-A0DG-01 |
|
|
607 |
TCGA-BH-A0DG-11 NA 30 NA NA 713 NA NA FEMALE NA NA NA NA NA NA NA NA 713 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DG-11 2041 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0DG 2041 0 days 2041 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 30 Right Upper Outer Quadrant NA NA TCGA-BH-A0DG-F63658 TCGA-BH-A0DG TCGA-BH-A0DG-11A NA Positive NA NA NA NA Negative Other NA NA NA NA -11204 972 NA 0 2041 NA NA NA NA NO NA NA NA NA 2014-8-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 470 NO Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA NA A0DG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 Total mastectomy 6th NA NO YES BH Breast A LIVING 2007 61c8278b-4c06-4563-b1ac-97cceec76ca4 61c8278b-4c06-4563-b1ac-97cceec76ca4 NA NA NA TCGA-BH-A0DG-11A-43D-A12R-05 NA NA NA NA NA TCGA-BH-A0DG-11 NA NA 61c8278b-4c06-4563-b1ac-97cceec76ca4 NA NA TCGA-BH-A0DG-11 NA 61c8278b-4c06-4563-b1ac-97cceec76ca4 NA |
|
|
608 |
TCGA-BH-A0DH-01 Stage IIB 63 2 No_Conversion 1156 NA Positive FEMALE Negative 5 3 3 Negative M0 Positive N1 1156 0 LumA Luminal A Positive X 0 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0DH-01 1156 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A0DH NA NA days 1156 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0DH-F4529 TCGA-BH-A0DH NA Negative Positive NA 3+ NA Mastectomy NOS Positive Other NA NO NA NA -23366 NA NA 0 1156 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NA 28 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NA 3 NA NA No M0 N1a T2 Stage IIB NA A0DH TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast NA LIVING 2007 c643222a-e138-4b3c-a96d-02be24ccb0d0 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01A-21-A13B-20 TCGA-BH-A0DH-01A-11D-A099-09 TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A10P-05 ce59142d-05cc-4392-92d4-806c8136465b TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A099-09 NA TCGA-BH-A0DH-01 NA TCGA-BH-A0DH-01A-11D-A099-09 TCGA-BH-A0DH-01 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A087-01 NA TCGA-BH-A0DH-01A-11R-A084-07 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01A-11D-A087-01 TCGA-BH-A0DH-01 |
|
|
609 |
TCGA-BH-A0DH-11 NA 63 NA NA 1156 NA NA FEMALE NA NA NA NA NA NA NA NA 1156 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0DH-11 1156 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0DH NA NA days 1156 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0DH-F4529 TCGA-BH-A0DH TCGA-BH-A0DH-11A Negative Positive NA 3+ NA Mastectomy NOS Positive Other NA NO NA NA -23366 968 NA 0 1156 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 280 NO Negative NA NA 28 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA true No M0 N1a T2 Stage IIB NA A0DH TUMOR FREE NA NA NA NA NA NA NA 40-49% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 4a8c96d9-b08d-4812-93ec-c8c9db8139aa 4a8c96d9-b08d-4812-93ec-c8c9db8139aa NA NA NA TCGA-BH-A0DH-11A-31D-A10Q-05 NA NA NA NA NA NA NA NA 4a8c96d9-b08d-4812-93ec-c8c9db8139aa NA NA NA TCGA-BH-A0DH-11A-31R-A089-07 4a8c96d9-b08d-4812-93ec-c8c9db8139aa NA |
|
|
610 |
TCGA-BH-A0DI-01 Stage IIB 63 5 Stage IIB 673 NA Positive FEMALE Negative 1 4 3 Negative M0 Positive N1 673 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A0DI-01 912 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0DI 912 0 days 912 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right NA NA TCGA-BH-A0DI-F58698 TCGA-BH-A0DI TCGA-BH-A0DI-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -23327 267 NA 0 912 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf A0DI TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2009 91285ac6-c627-4101-b551-28f37b947276 91285ac6-c627-4101-b551-28f37b947276 TCGA-BH-A0DI-01A-11-A13B-20 TCGA-BH-A0DI-01A-21D-A12Q-09 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12R-05 12b20a6c-5b0f-4014-85f5-b411c0ad5651 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12Q-09 NA TCGA-BH-A0DI-01 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12Q-09 NA 91285ac6-c627-4101-b551-28f37b947276 NA TCGA-BH-A0DI-01A-21D-A12N-01 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21R-A12P-07 91285ac6-c627-4101-b551-28f37b947276 TCGA-BH-A0DI-01A-21D-A12N-01 TCGA-BH-A0DI-01 |
|
|
611 |
TCGA-BH-A0DI-11 NA 63 NA NA 673 NA NA FEMALE NA NA NA NA NA NA NA NA 673 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DI-11 912 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A0DI 912 0 days 912 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right NA NA TCGA-BH-A0DI-F58698 TCGA-BH-A0DI TCGA-BH-A0DI-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -23327 267 NA 0 912 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 640 NO Negative NA NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB NA A0DI TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2009 NA NA NA NA NA TCGA-BH-A0DI-11A-32D-A12R-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
612 |
TCGA-BH-A0DK-01 Stage IIA 49 2 Stage IIA 423 NA Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 423 0 LumA Luminal A Positive LumA/B -4 -4 followup T_Other T2 LIVING 0 TCGA-BH-A0DK-01 423 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-BH-A0DK NA NA days 423 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0DK-F4532 TCGA-BH-A0DK TCGA-BH-A0DK-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -18237 254 NA 0 423 NA NA NA NA NA H-SCORE 260 NA NA NA 2010-11-16 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 240 NO Negative NA NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf A0DK TUMOR FREE H-SCORE 120 NA NA H-SCORE H-SCORE NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 fef221ff-634b-4188-92cf-5723b9a3c04d fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01A-11-A13B-20 TCGA-BH-A0DK-01A-21W-A071-09 TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21D-A10P-05 1ae8085b-99e9-4a9c-94a7-bcf4f903b95a TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21W-A071-09 NA TCGA-BH-A0DK-01 NA TCGA-BH-A0DK-01A-21W-A071-09 TCGA-BH-A0DK-01 fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21D-A059-01 NA TCGA-BH-A0DK-01A-21R-A056-07 fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01A-21D-A059-01 TCGA-BH-A0DK-01 |
|
|
613 |
TCGA-BH-A0DK-11 NA 49 NA NA 423 NA NA FEMALE NA NA NA NA NA NA NA NA 423 0 LumA NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0DK-11 423 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DK NA NA days 423 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0DK-F4532 TCGA-BH-A0DK TCGA-BH-A0DK-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -18237 254 NA 0 423 NA NA NA NA NA H-SCORE 260 NA NA NA 2010-11-16 FEMALE NA NA NA NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 550 NO Negative NA NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA NA A0DK TUMOR FREE H-SCORE 120 NA NA H-SCORE H-SCORE NA NA NA NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2009 4c1d73ba-31f8-4652-a83d-cc367dde9f43 4c1d73ba-31f8-4652-a83d-cc367dde9f43 NA NA NA TCGA-BH-A0DK-11A-13D-A10Q-05 F17E1810-1E54-4920-A1EA-A5B693205A55 NA NA NA NA NA NA TCGA-BH-A0DK-11 4c1d73ba-31f8-4652-a83d-cc367dde9f43 TCGA-BH-A0DK-11 NA NA TCGA-BH-A0DK-11A-13R-A089-07 4c1d73ba-31f8-4652-a83d-cc367dde9f43 NA |
|
|
614 |
TCGA-BH-A0DL-01 Stage IIA 64 3 Stage IIA 1467 NA Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1467 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING 0 TCGA-BH-A0DL-01 2381 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 11 cluster 4 mutation cluster 3 TCGA-BH-A0DL 2381 0 days 2381 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left NA NA TCGA-BH-A0DL-F60389 TCGA-BH-A0DL TCGA-BH-A0DL-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -23628 1074 NA 0 2381 NA NA NA NA NO NA NA NA NA 2014-6-9 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 350 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf A0DL TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A LIVING 2007 1013446f-5beb-485d-809a-efe81a2138dd 1013446f-5beb-485d-809a-efe81a2138dd TCGA-BH-A0DL-01A-21-A13B-20 TCGA-BH-A0DL-01A-11D-A10Y-09 TCGA-BH-A0DL-01 NA 301ec456-dd25-42ff-9779-a4f7f86ff509 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11D-A10Y-09 TCGA-BH-A0DL-01A-11D-A112-05 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11D-A10Y-09 NA 1013446f-5beb-485d-809a-efe81a2138dd NA TCGA-BH-A0DL-01A-11D-A111-01 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11R-A115-07 1013446f-5beb-485d-809a-efe81a2138dd TCGA-BH-A0DL-01A-11D-A111-01 TCGA-BH-A0DL-01 |
|
|
615 |
TCGA-BH-A0DL-11 NA 64 NA NA 1467 NA NA FEMALE NA NA NA NA NA NA NA NA 1467 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DL-11 2381 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A0DL 2381 0 days 2381 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left NA NA TCGA-BH-A0DL-F60389 TCGA-BH-A0DL NA NA Positive NA NA NA NA Negative Other NA NA NA NA -23628 NA NA 0 2381 NA NA NA NA NO NA NA NA NA 2014-6-9 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A0DL TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2007 f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d NA NA NA NA NA NA NA TCGA-BH-A0DL-11A-13D-A112-05 NA TCGA-BH-A0DL-11 NA NA f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d NA NA TCGA-BH-A0DL-11 TCGA-BH-A0DL-11A-13R-A115-07 f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d NA |
|
|
616 |
TCGA-BH-A0DO-01 Stage I 78 2 Stage I 525 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 525 0 LumA Luminal A Positive NA -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0DO-01 1644 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0DO 1644 0 days 1644 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Inner Quadrant NA NA TCGA-BH-A0DO-F63671 TCGA-BH-A0DO TCGA-BH-A0DO-01B NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -28529 454 NA 0 1644 NA NA NA NA NO NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 T1c Stage I TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA.pdf A0DO TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 6th NA NO YES BH Breast B LIVING 2009 46892fa4-f179-4991-99da-629d8cf936f6 46892fa4-f179-4991-99da-629d8cf936f6 NA TCGA-BH-A0DO-01B-11D-A12B-09 TCGA-BH-A0DO-01 NA NA TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11D-A12B-09 TCGA-BH-A0DO-01B-11D-A12E-05 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11D-A12B-09 NA 46892fa4-f179-4991-99da-629d8cf936f6 NA TCGA-BH-A0DO-01B-11D-A12A-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11R-A12D-07 46892fa4-f179-4991-99da-629d8cf936f6 TCGA-BH-A0DO-01B-11D-A12A-01 TCGA-BH-A0DO-01 |
|
|
617 |
TCGA-BH-A0DO-11 NA 78 NA NA 525 NA NA FEMALE NA NA NA NA NA NA NA NA 525 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DO-11 1644 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DO 1644 0 days 1644 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Inner Quadrant NA NA TCGA-BH-A0DO-F63671 TCGA-BH-A0DO NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -28529 NA NA 0 1644 NA NA NA NA NO NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA Yes M0 N0 T1c Stage I NA A0DO TUMOR FREE NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 NA 6th NA NO YES BH Breast NA LIVING 2009 eb9e415f-0545-4e97-ad35-b56b0f3db79b eb9e415f-0545-4e97-ad35-b56b0f3db79b NA NA NA NA NA NA NA TCGA-BH-A0DO-11A-22D-A12E-05 NA TCGA-BH-A0DO-11 NA NA eb9e415f-0545-4e97-ad35-b56b0f3db79b NA NA TCGA-BH-A0DO-11 TCGA-BH-A0DO-11A-22R-A12D-07 eb9e415f-0545-4e97-ad35-b56b0f3db79b NA |
|
|
618 |
TCGA-BH-A0DP-01 Stage IIB 60 2 Stage IIB 476 NA Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 476 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING 0 TCGA-BH-A0DP-01 476 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation cluster 4 TCGA-BH-A0DP NA NA days 476 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Sentinel node biopsy alone NA TCGA-BH-A0DP-F4538 TCGA-BH-A0DP TCGA-BH-A0DP-01A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA NO NA NA -22199 293 NA 0 476 NA NA NA NA NA H-SCORE 280 80-89% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 510 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf A0DP TUMOR FREE H-SCORE 280 NA NA H-SCORE H-SCORE NA NA 80-89% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 72967b75-a711-425a-819d-dd673c5edc44 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01A-11-A13B-20 TCGA-BH-A0DP-01A-21W-A071-09 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21D-A10P-05 2816036d-ed53-4c0d-b7fa-5a72f37da510 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21W-A071-09 NA TCGA-BH-A0DP-01 NA TCGA-BH-A0DP-01A-21W-A071-09 TCGA-BH-A0DP-01 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21D-A059-01 NA TCGA-BH-A0DP-01A-21R-A056-07 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01A-21D-A059-01 TCGA-BH-A0DP-01 |
|
|
619 |
TCGA-BH-A0DP-11 NA 60 NA NA 476 NA NA FEMALE NA NA NA NA NA NA NA NA 476 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0DP-11 476 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DP NA NA days 476 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Sentinel node biopsy alone NA TCGA-BH-A0DP-F4538 TCGA-BH-A0DP TCGA-BH-A0DP-11A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA NO NA NA -22199 293 NA 0 476 NA NA NA NA NA H-SCORE 280 80-89% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 290 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T3 Stage IIB NA A0DP TUMOR FREE H-SCORE 280 NA NA H-SCORE H-SCORE NA NA 80-89% NA YES Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2009 6ff2976a-2570-409b-afde-b7d2e7f2e4ea 6ff2976a-2570-409b-afde-b7d2e7f2e4ea NA NA NA TCGA-BH-A0DP-11A-12D-A10Q-05 6B935910-61A6-4AC5-87EB-D3557C0777E4 NA NA NA NA NA NA TCGA-BH-A0DP-11 6ff2976a-2570-409b-afde-b7d2e7f2e4ea TCGA-BH-A0DP-11 NA NA TCGA-BH-A0DP-11A-12R-A089-07 6ff2976a-2570-409b-afde-b7d2e7f2e4ea NA |
|
|
620 |
TCGA-BH-A0DQ-01 Stage IIB 42 5 No_Conversion 98 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 98 0 LumA Luminal A Positive NA -5 0 followup T_Other T2 LIVING 0 TCGA-BH-A0DQ-01 98 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0DQ NA NA days 98 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0DQ-F4560 TCGA-BH-A0DQ TCGA-BH-A0DQ-01A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -15533 190 NA 0 98 NA NA NA NA NA H-SCORE 136 60-69% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 110 NO Negative NA NA 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf A0DQ TUMOR FREE H-SCORE 140 NA NA H-SCORE H-SCORE NA NA 70-79% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 6022db68-1e06-4974-b657-cd65aed560c4 6022db68-1e06-4974-b657-cd65aed560c4 NA TCGA-BH-A0DQ-01A-11D-A099-09 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A10P-05 NA TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A099-09 NA TCGA-BH-A0DQ-01 NA TCGA-BH-A0DQ-01A-11D-A099-09 TCGA-BH-A0DQ-01 6022db68-1e06-4974-b657-cd65aed560c4 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A087-01 NA TCGA-BH-A0DQ-01A-11R-A084-07 6022db68-1e06-4974-b657-cd65aed560c4 TCGA-BH-A0DQ-01A-11D-A087-01 TCGA-BH-A0DQ-01 |
|
|
621 |
TCGA-BH-A0DQ-11 NA 42 NA NA 98 NA NA FEMALE NA NA NA NA NA NA NA NA 98 0 LumA NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0DQ-11 98 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0DQ NA NA days 98 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0DQ-F4560 TCGA-BH-A0DQ TCGA-BH-A0DQ-11A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -15533 190 NA 0 98 NA NA NA NA NA H-SCORE 136 60-69% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 100 NO Negative NA NA 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB NA A0DQ TUMOR FREE H-SCORE 140 NA NA H-SCORE H-SCORE NA NA 70-79% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 2b11e565-01a8-4054-a200-03e06765bd5e 2b11e565-01a8-4054-a200-03e06765bd5e NA NA NA TCGA-BH-A0DQ-11A-12D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0DQ-11 2b11e565-01a8-4054-a200-03e06765bd5e TCGA-BH-A0DQ-11 NA NA TCGA-BH-A0DQ-11A-12R-A089-07 2b11e565-01a8-4054-a200-03e06765bd5e NA |
|
|
622 |
TCGA-BH-A0DS-01 Stage IIIA 71 3 No_Conversion 77 NA Positive FEMALE Negative 4 5 3 Negative M0 Positive N2 77 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING 0 TCGA-BH-A0DS-01 78 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-BH-A0DS NA NA days 78 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0DS-F4573 TCGA-BH-A0DS TCGA-BH-A0DS-01A NA Positive NA 2+ NA NA Positive Other NA NO NA NA -25944 79 NA 0 78 NA NA NA NA NA H-SCORE 190 70-79% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 200 NO Negative NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NA 8 NA true No M0 N2a T2 Stage IIIA TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf A0DS TUMOR FREE H-SCORE 162 NA NA H-SCORE H-SCORE NA NA 70-79% NA YES Primary Tumor 01 Segmental mastectomy 7th YES NO YES BH Breast A LIVING 2010 00ee8acd-0841-4c85-a99a-8966a6828dd7 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01A-21-A13B-20 TCGA-BH-A0DS-01A-11W-A071-09 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11D-A10P-05 ad643947-edbf-4a15-a959-76ffd5589907 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11W-A071-09 NA TCGA-BH-A0DS-01 NA TCGA-BH-A0DS-01A-11W-A071-09 TCGA-BH-A0DS-01 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11D-A059-01 NA TCGA-BH-A0DS-01A-11R-A056-07 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01A-11D-A059-01 TCGA-BH-A0DS-01 |
|
|
623 |
TCGA-BH-A0DT-01 Stage IIA 41 2 Stage IIA 1170 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1170 0 LumA Luminal A Positive LumA -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0DT-01 2403 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-BH-A0DT 2403 0 days 2403 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right NA NA TCGA-BH-A0DT-F59149 TCGA-BH-A0DT NA NA Positive NA NA NA NA Positive Other NA NA NA NA -15078 NA NA 0 2403 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1a T1c Stage IIA NA A0DT TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Total mastectomy with sentinel lymoh node biopsy 6th NA NO YES BH Breast NA LIVING 2007 e88bcf68-e904-4511-92f6-01cbd0da62de e88bcf68-e904-4511-92f6-01cbd0da62de TCGA-BH-A0DT-01A-11-A13B-20 TCGA-BH-A0DT-01A-21D-A12B-09 TCGA-BH-A0DT-01 NA b170d872-08a7-4c4a-9e3f-e6525d8d5a88 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21D-A12B-09 TCGA-BH-A0DT-01A-21D-A12E-05 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21D-A12B-09 NA e88bcf68-e904-4511-92f6-01cbd0da62de NA TCGA-BH-A0DT-01A-21D-A12A-01 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21R-A12D-07 e88bcf68-e904-4511-92f6-01cbd0da62de TCGA-BH-A0DT-01A-21D-A12A-01 TCGA-BH-A0DT-01 |
|
|
624 |
TCGA-BH-A0DT-11 NA 41 NA NA 1170 NA NA FEMALE NA NA NA NA NA NA NA NA 1170 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DT-11 2403 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DT 2403 0 days 2403 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right NA NA TCGA-BH-A0DT-F59149 TCGA-BH-A0DT TCGA-BH-A0DT-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -15078 1044 NA 0 2403 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO Negative NA NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T1c Stage IIA NA A0DT TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 Total mastectomy with sentinel lymoh node biopsy 6th NA NO YES BH Breast A LIVING 2007 75ba5803-449e-4770-8105-b675af8e6907 75ba5803-449e-4770-8105-b675af8e6907 NA NA NA NA NA NA NA TCGA-BH-A0DT-11A-12D-A12E-05 NA TCGA-BH-A0DT-11 NA NA 75ba5803-449e-4770-8105-b675af8e6907 NA NA TCGA-BH-A0DT-11 TCGA-BH-A0DT-11A-12R-A12D-07 75ba5803-449e-4770-8105-b675af8e6907 NA |
|
|
625 |
TCGA-BH-A0DV-01 Stage IIIA 54 3 Stage IIIA 1374 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1374 0 LumA NA Positive ReacII NA NA enrollment T_Other T2 LIVING 0 TCGA-BH-A0DV-01 2064 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0DV 2064 0 days 2064 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left NA NA TCGA-BH-A0DV-F63672 TCGA-BH-A0DV TCGA-BH-A0DV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19781 975 NA 0 2064 NA NA NA NA NO NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO Negative NA NO 9 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 9 NA true No M0 N2a T2 Stage IIIA TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf A0DV TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast A LIVING 2007 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 TCGA-BH-A0DV-01A-11-A13B-20 TCGA-BH-A0DV-01A-21D-A12Q-09 TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12R-05 2ddc51b1-8ac4-4b9e-85d3-23c698917d5f TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12Q-09 NA NA TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12Q-09 NA 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 NA TCGA-BH-A0DV-01A-21D-A12N-01 TCGA-BH-A0DV-01 NA 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 TCGA-BH-A0DV-01A-21D-A12N-01 |
|
|
626 |
TCGA-BH-A0DV-11 NA 54 NA NA 1374 NA NA FEMALE NA NA NA NA NA NA NA NA 1374 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0DV-11 2064 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0DV 2064 0 days 2064 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left NA NA TCGA-BH-A0DV-F63672 TCGA-BH-A0DV TCGA-BH-A0DV-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19781 975 NA 0 2064 NA NA NA NA NO NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NO 9 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 9 NA true No M0 N2a T2 Stage IIIA NA A0DV TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A LIVING 2007 09f570eb-a751-41db-9511-300be228f24e 09f570eb-a751-41db-9511-300be228f24e NA NA NA TCGA-BH-A0DV-11A-22D-A12R-05 NA NA NA NA NA TCGA-BH-A0DV-11 NA NA 09f570eb-a751-41db-9511-300be228f24e NA NA TCGA-BH-A0DV-11 TCGA-BH-A0DV-11A-22R-A12P-07 09f570eb-a751-41db-9511-300be228f24e NA |
|
|
627 |
TCGA-BH-A0DX-01 Stage I 62 1 Stage I 1442 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1442 0 LumA Luminal A Positive NA -4 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0DX-01 2156 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-BH-A0DX 2156 0 days 2156 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Inner Quadrant NA NA TCGA-BH-A0DX-F59135 TCGA-BH-A0DX NA NA Positive NA NA NA NA Positive Other NA NA NA NA -22833 NA NA 0 2156 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1b Stage I NA A0DX TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2007 c791026a-9fda-47b4-86fd-9b5933325326 c791026a-9fda-47b4-86fd-9b5933325326 NA TCGA-BH-A0DX-01A-11D-A10Y-09 TCGA-BH-A0DX-01 NA NA TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11D-A10Y-09 TCGA-BH-A0DX-01A-11D-A112-05 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11D-A10Y-09 NA c791026a-9fda-47b4-86fd-9b5933325326 NA TCGA-BH-A0DX-01A-11D-A111-01 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11R-A115-07 c791026a-9fda-47b4-86fd-9b5933325326 TCGA-BH-A0DX-01A-11D-A111-01 TCGA-BH-A0DX-01 |
|
|
628 |
TCGA-BH-A0DZ-01 Stage IIB 43 5 No_Conversion 495 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 495 0 LumA HER2-enriched Positive NA -2 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0DZ-01 495 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-BH-A0DZ NA NA days 495 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0DZ-F4588 TCGA-BH-A0DZ TCGA-BH-A0DZ-01A NA Positive NA 2+ NA NA Positive Simple Mastectomy NA NO NA NA -15980 308 NA 0 495 NA NA NA NA NA H-SCORE 140 50-59% NA NA 2010-11-16 FEMALE NA NA 30-39% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 170 NO Positive NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf A0DZ TUMOR FREE H-SCORE 15 NA NA H-SCORE H-SCORE NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 4543cecd-6333-473b-b5ce-96d33ab47706 4543cecd-6333-473b-b5ce-96d33ab47706 NA TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01 NA NA TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01A-11D-A00Y-05 TCGA-BH-A0DZ-01 NA TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01 4543cecd-6333-473b-b5ce-96d33ab47706 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01A-11D-A011-01 NA TCGA-BH-A0DZ-01A-11R-A00Z-07 4543cecd-6333-473b-b5ce-96d33ab47706 TCGA-BH-A0DZ-01A-11D-A011-01 TCGA-BH-A0DZ-01 |
|
|
629 |
TCGA-BH-A0DZ-11 NA 43 NA NA 495 NA NA FEMALE NA NA NA NA NA NA NA NA 495 0 NA NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0DZ-11 495 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 2 TCGA-BH-A0DZ NA NA days 495 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0DZ-F4588 TCGA-BH-A0DZ NA NA Positive NA 2+ NA NA Positive Simple Mastectomy NA NO NA NA -15980 NA NA 0 495 NA NA NA NA NA H-SCORE 140 50-59% NA NA 2010-11-16 FEMALE NA NA 30-39% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy NA NA Positive NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA No M0 N1a T2 Stage IIB NA A0DZ TUMOR FREE H-SCORE 15 NA NA H-SCORE H-SCORE NA NA <10% NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast NA LIVING 2009 f59f9272-412f-4884-9874-a6ff59ab1740 f59f9272-412f-4884-9874-a6ff59ab1740 NA NA NA TCGA-BH-A0DZ-11A-22D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0DZ-11 f59f9272-412f-4884-9874-a6ff59ab1740 TCGA-BH-A0DZ-11 NA NA TCGA-BH-A0DZ-11A-22R-A089-07 f59f9272-412f-4884-9874-a6ff59ab1740 NA |
|
|
630 |
TCGA-BH-A0E0-01 Stage IIIC 38 1 No_Conversion 133 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N3 133 0 Basal Basal-like Negative Basal -13 0 followup T_Other T3 LIVING 0 TCGA-BH-A0E0-01 134 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-BH-A0E0 NA NA days 134 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0E0-F4603 TCGA-BH-A0E0 TCGA-BH-A0E0-01A NA Negative NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -14175 136 NA 0 134 NA NA NA NA NA H-SCORE 0 NA NA NA 2010-10-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 620 NO Negative NA NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 10 NA true No M0 N3a T3 Stage IIIC TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf A0E0 TUMOR FREE H-SCORE 0 NA NA H-SCORE H-SCORE NA NA NA NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 fac9101c-a974-4415-9eac-d2d433d02b13 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01A-21-A13B-20 TCGA-BH-A0E0-01A-11W-A071-09 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11D-A10P-05 9ccd25d1-e45d-469d-942d-0b514d4cb5a0 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11W-A071-09 NA TCGA-BH-A0E0-01 NA TCGA-BH-A0E0-01A-11W-A071-09 TCGA-BH-A0E0-01 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11D-A059-01 NA TCGA-BH-A0E0-01A-11R-A056-07 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01A-11D-A059-01 TCGA-BH-A0E0-01 |
|
|
631 |
TCGA-BH-A0E0-11 NA 38 NA NA 133 NA NA FEMALE NA NA NA NA NA NA NA NA 133 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0E0-11 134 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0E0 NA NA days 134 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0E0-F4603 TCGA-BH-A0E0 TCGA-BH-A0E0-11A NA Negative NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -14175 136 NA 0 134 NA NA NA NA NA H-SCORE 0 NA NA NA 2010-10-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 140 NO Negative NA NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 10 NA true No M0 N3a T3 Stage IIIC NA A0E0 TUMOR FREE H-SCORE 0 NA NA H-SCORE H-SCORE NA NA NA NA YES Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2009 5cc82d2c-f960-40c3-9b37-59e087563dc1 5cc82d2c-f960-40c3-9b37-59e087563dc1 NA NA NA TCGA-BH-A0E0-11A-13D-A10Q-05 NA NA NA NA NA NA NA NA 5cc82d2c-f960-40c3-9b37-59e087563dc1 NA NA NA TCGA-BH-A0E0-11A-13R-A089-07 5cc82d2c-f960-40c3-9b37-59e087563dc1 NA |
|
|
632 |
TCGA-BH-A0E1-01 Stage IIB 52 2 No_Conversion 477 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 477 0 LumA Luminal A Positive ReacII -12 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0E1-01 477 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation c1uster 10 TCGA-BH-A0E1 NA NA days 477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0E1-F4631 TCGA-BH-A0E1 TCGA-BH-A0E1-01A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA NO NA NA -19192 301 NA 0 477 NA NA NA NA NA H-SCORE 180 70-79% 1.67 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.81 1.69 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 990 NO Equivocal Negative NA 17 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 2 NA true No M0 N1 T2 Stage IIB TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf A0E1 TUMOR FREE H-SCORE 245 NA NA H-SCORE H-SCORE NA NA 50-59% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 9bf836ee-036e-40f2-88fb-cf903a40d9f5 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01A-21-A13B-20 TCGA-BH-A0E1-01A-11W-A071-09 TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11D-A10P-05 e4fbf61f-e3f8-4722-b3fc-b5479c75ddae TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11W-A071-09 NA TCGA-BH-A0E1-01 NA TCGA-BH-A0E1-01A-11W-A071-09 TCGA-BH-A0E1-01 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11D-A059-01 NA TCGA-BH-A0E1-01A-11R-A056-07 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01A-11D-A059-01 TCGA-BH-A0E1-01 |
|
|
633 |
TCGA-BH-A0E1-11 NA 52 NA NA 477 NA NA FEMALE NA NA NA NA NA NA NA NA 477 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0E1-11 477 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 10 TCGA-BH-A0E1 NA NA days 477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0E1-F4631 TCGA-BH-A0E1 TCGA-BH-A0E1-11A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA NO NA NA -19192 301 NA 0 477 NA NA NA NA NA H-SCORE 180 70-79% 1.67 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.81 1.69 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 500 NO Equivocal Negative NA 17 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA true No M0 N1 T2 Stage IIB NA A0E1 TUMOR FREE H-SCORE 245 NA NA H-SCORE H-SCORE NA NA 50-59% NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2009 b6302c6b-2bab-40b1-b835-7f285719fff5 b6302c6b-2bab-40b1-b835-7f285719fff5 NA NA NA TCGA-BH-A0E1-11A-13D-A10Q-05 B5FC6749-9A17-4739-9144-FE17660801C3 NA NA NA NA NA NA TCGA-BH-A0E1-11 b6302c6b-2bab-40b1-b835-7f285719fff5 TCGA-BH-A0E1-11 NA NA TCGA-BH-A0E1-11A-13R-A089-07 b6302c6b-2bab-40b1-b835-7f285719fff5 NA |
|
|
634 |
TCGA-BH-A0E2-01 Stage IIIA 49 2 No_Conversion 435 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 435 0 LumA Luminal A Positive LumA/B -8 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0E2-01 435 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-BH-A0E2 NA NA days 435 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-BH-A0E2-F4639 TCGA-BH-A0E2 TCGA-BH-A0E2-01A NA Positive NA 1+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -18152 210 NA 0 435 NA NA NA NA NA H-SCORE 300 90-99% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 160 NO Negative NA NA 26 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NA 4 NA true No M0 N2a T2 Stage IIIA TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf A0E2 TUMOR FREE H-SCORE 1 NA NA H-SCORE H-SCORE NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 b605d803-523b-46e6-b656-7d9888d306cc b605d803-523b-46e6-b656-7d9888d306cc TCGA-BH-A0E2-01A-21-A13A-20 TCGA-BH-A0E2-01A-11W-A071-09 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11D-A10P-05 98a8d468-efe1-41ff-a02a-615e09da0330 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11W-A071-09 NA TCGA-BH-A0E2-01 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11W-A071-09 NA b605d803-523b-46e6-b656-7d9888d306cc NA TCGA-BH-A0E2-01A-11D-A059-01 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11R-A056-07 b605d803-523b-46e6-b656-7d9888d306cc TCGA-BH-A0E2-01A-11D-A059-01 TCGA-BH-A0E2-01 |
|
|
635 |
TCGA-BH-A0E6-01 Stage IA 69 1 Stage I 292 NA Negative FEMALE Negative 1 4 3 Negative M0 Negative N0 292 0 Basal Basal-like Negative ReacI -13 0 followup T1 T1 LIVING 0 TCGA-BH-A0E6-01 293 0 days High C4-BRCA/Basal cluster 1 BRCA basal-like c8 OV-like c4 BRCA basal-like c8 miRNA cluster 12 cluster 4 mutation cluster 2 TCGA-BH-A0E6 NA NA days 293 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0E6-F4650 TCGA-BH-A0E6 TCGA-BH-A0E6-01A NA Negative NA 0 NA NA Negative Other NA NO NA NA -25408 134 NA 0 293 NA NA NA NA NA H-SCORE 0 NA 2.38 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.83 1.19 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 80 NO Equivocal Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf A0E6 TUMOR FREE H-SCORE 0 NA NA H-SCORE H-SCORE NA NA NA NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 6bf094a5-1f62-406c-9b3a-e686bb4a074e 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01A-21-A13C-20 TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01 NA 1b1bb0d9-e8c0-4efa-bab4-73225525bd9c TCGA-BH-A0E6-01 TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01A-11D-A032-05 TCGA-BH-A0E6-01 NA TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01 TCGA-BH-A0E6-01A-11D-A036-01 NA TCGA-BH-A0E6-01A-11R-A034-07 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01A-11D-A036-01 TCGA-BH-A0E6-01 |
|
|
636 |
TCGA-BH-A0E7-01 Stage IIB 79 4 No_Conversion 1362 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1362 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0E7-01 1363 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0E7 NA NA days 1363 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 79 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0E7-F4656 TCGA-BH-A0E7 TCGA-BH-A0E7-01A NA Positive NA 3+ NA NA Positive Other NA NO NA NA -29115 1259 NA 0 1363 NA NA NA NA NA NA 50-59% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Excisional Biopsy 140 NO Negative NA NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf A0E7 TUMOR FREE NA NA NA NA NA NA NA 60-69% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2006 3850a348-8e53-497d-8e06-680672b19557 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01A-21-A13C-20 TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01 NA 7c513473-0b7a-4cc6-9748-d0eaa83b6744 TCGA-BH-A0E7-01 TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01A-11D-A032-05 TCGA-BH-A0E7-01 NA TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01 TCGA-BH-A0E7-01A-11D-A036-01 NA TCGA-BH-A0E7-01A-11R-A034-07 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01A-11D-A036-01 TCGA-BH-A0E7-01 |
|
|
637 |
TCGA-BH-A0E9-01 Stage IIB 53 3 Stage IIB 1405 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1405 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A0E9-01 2489 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-BH-A0E9 2489 0 days 2489 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right NA NA TCGA-BH-A0E9-F59107 TCGA-BH-A0E9 TCGA-BH-A0E9-01B NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19415 1357 NA 0 2489 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 480 NO Negative NA NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf A0E9 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES BH Breast B LIVING 2006 bfc39e77-7a26-4699-a4a3-217d4ea9425b bfc39e77-7a26-4699-a4a3-217d4ea9425b TCGA-BH-A0E9-01B-21-A13A-20 TCGA-BH-A0E9-01B-11D-A10Y-09 TCGA-BH-A0E9-01 NA 8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11D-A10Y-09 TCGA-BH-A0E9-01B-11D-A112-05 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11D-A10Y-09 NA bfc39e77-7a26-4699-a4a3-217d4ea9425b NA TCGA-BH-A0E9-01B-11D-A111-01 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11R-A115-07 bfc39e77-7a26-4699-a4a3-217d4ea9425b TCGA-BH-A0E9-01B-11D-A111-01 TCGA-BH-A0E9-01 |
|
|
638 |
TCGA-BH-A0EA-01 Stage IIA 72 2 Stage IIA 831 993 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 993 1 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 DECEASED 1 TCGA-BH-A0EA-01 991 1 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-BH-A0EA 991 0 days 991 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left NA NA TCGA-BH-A0EA-F58566 TCGA-BH-A0EA TCGA-BH-A0EA-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26548 567 991 0 NA NA NA NA NA NO NA NA NA NA 2014-4-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 2 NA true Yes M0 N1a T1c Stage IIA TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf A0EA TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast A DECEASED 2008 ca71ca96-cbb7-4eab-9487-251dda34e107 ca71ca96-cbb7-4eab-9487-251dda34e107 TCGA-BH-A0EA-01A-21-A13C-20 TCGA-BH-A0EA-01A-11D-A10Y-09 TCGA-BH-A0EA-01 NA 8629bf5a-cdaf-4f6a-90bb-27dd4a7565c5 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11D-A10Y-09 TCGA-BH-A0EA-01A-11D-A112-05 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11D-A10Y-09 NA ca71ca96-cbb7-4eab-9487-251dda34e107 NA TCGA-BH-A0EA-01A-11D-A111-01 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11R-A115-07 ca71ca96-cbb7-4eab-9487-251dda34e107 TCGA-BH-A0EA-01A-11D-A111-01 TCGA-BH-A0EA-01 |
|
|
639 |
TCGA-BH-A0EB-01 Stage IA 69 2 Stage I 745 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 745 0 LumA Luminal A Positive LumA -12 -4 followup T1 T1 LIVING 0 TCGA-BH-A0EB-01 745 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 4 TCGA-BH-A0EB NA NA days 745 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 69 Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0EB-F4662 TCGA-BH-A0EB NA NA Positive NA 3+ NA NA Positive Other NA NO NA NA -25259 NA NA 0 745 NA NA NA NA NA H-SCORE 300 90-99% 2.13 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.65 1.25 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Equivocal Negative NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 (i-) T1c Stage IA NA A0EB TUMOR FREE H-SCORE 210 NA NA H-SCORE H-SCORE NA NA 40-49% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast NA LIVING 2008 efb01993-cfe4-4f01-b628-ee34fceb4a5e efb01993-cfe4-4f01-b628-ee34fceb4a5e TCGA-BH-A0EB-01A-21-A13C-20 TCGA-BH-A0EB-01A-11W-A050-09 TCGA-BH-A0EB-01 NA ac9f49b6-6bc1-42c6-9722-0cee04e91fdd TCGA-BH-A0EB-01 TCGA-BH-A0EB-01A-11W-A050-09 TCGA-BH-A0EB-01A-11D-A032-05 TCGA-BH-A0EB-01 NA TCGA-BH-A0EB-01A-11W-A050-09 NA efb01993-cfe4-4f01-b628-ee34fceb4a5e NA TCGA-BH-A0EB-01A-11D-A036-01 NA TCGA-BH-A0EB-01A-11R-A034-07 efb01993-cfe4-4f01-b628-ee34fceb4a5e TCGA-BH-A0EB-01A-11D-A036-01 TCGA-BH-A0EB-01 |
|
|
640 |
TCGA-BH-A0EE-01 Stage IIB 68 5 Stage IIB 943 NA Negative FEMALE Positive 2 3 1 Negative M0 Negative N0 943 0 Her2 HER2-enriched Negative Basal -11 -9 followup T_Other T3 LIVING 0 TCGA-BH-A0EE-01 943 0 days High C3-BRCA/Luminal cluster 1 Cluster 6 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0EE NA NA days 943 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 68 Right Upper Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0EE-F4674 TCGA-BH-A0EE TCGA-BH-A0EE-01A NA Negative NA 0 NA NA Negative Simple Mastectomy NA NO NA NA -24850 946 NA 0 943 NA NA NA NA NA NA NA NA NA 2010-11-16 FEMALE NA NA 30-39% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 890 NO Positive NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T3 Stage IIB TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf A0EE TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2007 24c0ef45-670d-4595-b623-87f81aeb92a7 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01A-21-A13C-20 TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01 NA b92e55c0-b921-4817-9984-3f58c13f93b5 TCGA-BH-A0EE-01 TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01A-11D-A032-05 TCGA-BH-A0EE-01 NA TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01 TCGA-BH-A0EE-01A-11D-A036-01 NA TCGA-BH-A0EE-01A-11R-A034-07 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01A-11D-A036-01 TCGA-BH-A0EE-01 |
|
|
641 |
TCGA-BH-A0EI-01 Stage IIA 51 5 Stage IIA 743 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 743 0 LumA Luminal A Positive LumA -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0EI-01 1926 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0EI 1926 0 days 1926 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right NA NA TCGA-BH-A0EI-F59115 TCGA-BH-A0EI NA NA Positive NA NA NA NA Positive Other NA NA NA NA -18741 NA NA 0 1926 NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA NA No M0 N1a T1c Stage IIA NA A0EI TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 segmental mastectomy with right sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2008 c6929312-e22d-4d4e-830d-6f735184d9b2 c6929312-e22d-4d4e-830d-6f735184d9b2 TCGA-BH-A0EI-01A-21-A13B-20 TCGA-BH-A0EI-01A-11D-A10Y-09 TCGA-BH-A0EI-01 NA d2fe1d76-437a-4eec-b376-d17426760c2a TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11D-A10Y-09 TCGA-BH-A0EI-01A-11D-A112-05 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11D-A10Y-09 NA c6929312-e22d-4d4e-830d-6f735184d9b2 NA TCGA-BH-A0EI-01A-11D-A111-01 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11R-A115-07 c6929312-e22d-4d4e-830d-6f735184d9b2 TCGA-BH-A0EI-01A-11D-A111-01 TCGA-BH-A0EI-01 |
|
|
642 |
TCGA-BH-A0GY-01 Stage IIA 67 3 No_Conversion 923 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 923 0 LumA Luminal A Positive ReacI -3 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0GY-01 923 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 3 TCGA-BH-A0GY NA NA days 923 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 67 Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0GY-F4695 TCGA-BH-A0GY TCGA-BH-A0GY-01A NA Positive NA 3+ NA NA Positive Other NA NO NA NA -24493 745 NA 0 923 NA NA NA NA NA H-Score 150 40-49% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 200 NO Negative NA NA 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NA 3 NA true No M0 N1 T2 Stage IIA TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf A0GY TUMOR FREE H-Score 290 NA NA H-Score H-Score NA NA 90-99% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01A-21-A13C-20 TCGA-BH-A0GY-01A-11W-A071-09 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11D-A10P-05 9a0ff086-5678-4a7d-953e-cd6be5d03183 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11W-A071-09 NA TCGA-BH-A0GY-01 NA TCGA-BH-A0GY-01A-11W-A071-09 TCGA-BH-A0GY-01 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11D-A059-01 NA TCGA-BH-A0GY-01A-11R-A056-07 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01A-11D-A059-01 TCGA-BH-A0GY-01 |
|
|
643 |
TCGA-BH-A0GZ-01 Stage IIA 62 3 No_Conversion 328 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 328 0 LumA Luminal A Positive NA 0 -3 followup T1 T1 LIVING 0 TCGA-BH-A0GZ-01 328 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0GZ NA NA days 328 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 62 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0GZ-F4697 TCGA-BH-A0GZ TCGA-BH-A0GZ-01A Negative Positive NA 3+ NA NA Positive Other NA NO NA NA -22714 206 NA 0 328 NA NA NA NA NA H-SCORE 300 90-99% 2.08 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.2 1.05 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 60 NO Equivocal Negative NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T1c Stage IIA TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf A0GZ TUMOR FREE H-SCORE 280 NA NA H-SCORE H-SCORE NA NA 80-89% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 8ffcb765-094c-4623-b172-ea8400965f00 8ffcb765-094c-4623-b172-ea8400965f00 NA TCGA-BH-A0GZ-01A-11W-A071-09 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11D-A10P-05 NA TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11W-A071-09 NA TCGA-BH-A0GZ-01 NA TCGA-BH-A0GZ-01A-11W-A071-09 TCGA-BH-A0GZ-01 8ffcb765-094c-4623-b172-ea8400965f00 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11D-A059-01 NA TCGA-BH-A0GZ-01A-11R-A056-07 8ffcb765-094c-4623-b172-ea8400965f00 TCGA-BH-A0GZ-01A-11D-A059-01 TCGA-BH-A0GZ-01 |
|
|
644 |
TCGA-BH-A0H0-01 Stage IA 69 2 Stage I 461 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 461 0 LumB Luminal B Positive NA -10 -3 followup T1 T1 LIVING 0 TCGA-BH-A0H0-01 461 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-BH-A0H0 NA NA days 461 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0H0-F4704 TCGA-BH-A0H0 TCGA-BH-A0H0-01A NA Positive NA 2+ NA NA Positive Other NA NO NA NA -25223 344 NA 0 461 NA NA NA NA NA H-SCORE 190 50-59% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 70 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf A0H0 TUMOR FREE H-SCORE 7 NA NA H-SCORE H-SCORE NA NA <10% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 38e26122-c473-41c1-afb0-cd3b9096e9f4 38e26122-c473-41c1-afb0-cd3b9096e9f4 NA TCGA-BH-A0H0-01A-11W-A071-09 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11D-A10P-05 NA TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11W-A071-09 NA TCGA-BH-A0H0-01 NA TCGA-BH-A0H0-01A-11W-A071-09 TCGA-BH-A0H0-01 38e26122-c473-41c1-afb0-cd3b9096e9f4 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11D-A059-01 NA TCGA-BH-A0H0-01A-11R-A056-07 38e26122-c473-41c1-afb0-cd3b9096e9f4 TCGA-BH-A0H0-01A-11D-A059-01 TCGA-BH-A0H0-01 |
|
|
645 |
TCGA-BH-A0H3-01 Stage I 46 2 Stage I 1149 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1149 0 LumA Luminal A Positive NA -2 -4 enrollment T1 T1 LIVING 0 TCGA-BH-A0H3-01 1928 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0H3 1928 0 days 1928 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Outer Quadrant NA NA TCGA-BH-A0H3-F58599 TCGA-BH-A0H3 TCGA-BH-A0H3-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -17152 773 NA 0 1928 NA NA NA NA NO NA NA NA NA 2014-4-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO NA Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage I TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf A0H3 TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 Left segmental mastectomy with axillary lymph node dissection 6th NA NO YES BH Breast A LIVING 2008 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d NA TCGA-BH-A0H3-01A-11D-A12Q-09 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12R-05 NA TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12Q-09 NA TCGA-BH-A0H3-01 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12Q-09 NA 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d NA TCGA-BH-A0H3-01A-11D-A12N-01 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11R-A12P-07 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d TCGA-BH-A0H3-01A-11D-A12N-01 TCGA-BH-A0H3-01 |
|
|
646 |
TCGA-BH-A0H5-01 Stage I 45 1 Stage I 1080 NA Positive FEMALE Negative 2 2 1 Negative M0 Negative N0 1080 0 LumA Luminal A Positive Basal -2 -5 enrollment T1 T1 LIVING 0 TCGA-BH-A0H5-01 1620 0 days Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A0H5 1620 0 days 1620 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Outer Quadrant NA NA TCGA-BH-A0H5-F58727 TCGA-BH-A0H5 TCGA-BH-A0H5-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16719 815 NA 0 1620 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 410 NO NA Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage I TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf A0H5 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Right total mastectomy with lymph node left axillary lymph node excision 6th NA NO YES BH Breast A LIVING 2008 e5378cd0-4045-4afe-8157-7187b3d294ef e5378cd0-4045-4afe-8157-7187b3d294ef TCGA-BH-A0H5-01A-11-A13C-20 TCGA-BH-A0H5-01A-21D-A10Y-09 TCGA-BH-A0H5-01 NA 3fd5b19e-218a-400d-85e7-23fb60737f41 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21D-A10Y-09 TCGA-BH-A0H5-01A-21D-A112-05 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21D-A10Y-09 NA e5378cd0-4045-4afe-8157-7187b3d294ef NA TCGA-BH-A0H5-01A-21D-A111-01 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21R-A115-07 e5378cd0-4045-4afe-8157-7187b3d294ef TCGA-BH-A0H5-01A-21D-A111-01 TCGA-BH-A0H5-01 |
|
|
647 |
TCGA-BH-A0H5-11 NA 45 NA NA 1080 NA NA FEMALE NA NA NA NA NA NA NA NA 1080 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0H5-11 1620 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0H5 1620 0 days 1620 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Outer Quadrant NA NA TCGA-BH-A0H5-F58727 TCGA-BH-A0H5 NA NA Positive NA NA NA NA Positive Other NA NA NA NA -16719 NA NA 0 1620 NA NA NA NA NO NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T1c Stage I NA A0H5 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 Right total mastectomy with lymph node left axillary lymph node excision 6th NA NO YES BH Breast NA LIVING 2008 fe1a74fd-c9b4-405b-86a7-61bcb75f825d fe1a74fd-c9b4-405b-86a7-61bcb75f825d NA NA NA NA NA NA NA TCGA-BH-A0H5-11A-62D-A112-05 NA TCGA-BH-A0H5-11 NA NA fe1a74fd-c9b4-405b-86a7-61bcb75f825d NA NA TCGA-BH-A0H5-11 TCGA-BH-A0H5-11A-62R-A115-07 fe1a74fd-c9b4-405b-86a7-61bcb75f825d NA |
|
|
648 |
TCGA-BH-A0H6-01 Stage IA 82 4 No_Conversion 747 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 747 0 LumA Luminal A Positive ReacI -5 -3 followup T1 T1 LIVING 0 TCGA-BH-A0H6-01 747 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0H6 NA NA days 747 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 82 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right No axillary staging NA TCGA-BH-A0H6-F4711 TCGA-BH-A0H6 NA NA Positive NA 3+ NA NA Positive Other NA NO NA NA -30125 NA NA 0 747 NA NA NA NA NA H-SCORE 230 50-59% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy NA NA Negative NA NA 0 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 0 0 NA No M0 NX T1b Stage I NA A0H6 TUMOR FREE H-SCORE 250 NA NA H-SCORE H-SCORE NA NA 60-69% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast NA LIVING 2008 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01A-31-A13C-20 TCGA-BH-A0H6-01A-21W-A071-09 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21D-A10P-05 cc4de94d-e4e4-4e21-823c-005b9a846f19 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21W-A071-09 NA TCGA-BH-A0H6-01 NA TCGA-BH-A0H6-01A-21W-A071-09 TCGA-BH-A0H6-01 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21D-A059-01 NA TCGA-BH-A0H6-01A-21R-A056-07 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01A-21D-A059-01 TCGA-BH-A0H6-01 |
|
|
649 |
TCGA-BH-A0H7-01 Stage IIIA 65 3 No_Conversion 701 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 701 0 LumA Luminal A Positive ReacII -3 -3 followup T1 T1 LIVING 0 TCGA-BH-A0H7-01 702 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-BH-A0H7 NA NA days 702 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-BH-A0H7-F4737 TCGA-BH-A0H7 TCGA-BH-A0H7-01A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -23972 542 NA 0 702 NA NA NA NA NA H-SCORE 255 70-79% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 440 NO Negative NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 6 NA true No M0 N2a T1c Stage IIIA TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf A0H7 TUMOR FREE H-SCORE 150 NA NA H-SCORE H-SCORE NA NA 30-39% NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2008 5969d3bb-19fb-4bda-9483-db4791257b95 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01A-21-A13C-20 TCGA-BH-A0H7-01A-13W-A071-09 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13D-A10P-05 571ca6b7-118d-4261-a194-c0856e62b1d9 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13W-A071-09 NA TCGA-BH-A0H7-01 NA TCGA-BH-A0H7-01A-13W-A071-09 TCGA-BH-A0H7-01 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13D-A059-01 NA TCGA-BH-A0H7-01A-13R-A056-07 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01A-13D-A059-01 TCGA-BH-A0H7-01 |
|
|
650 |
TCGA-BH-A0H7-11 NA 65 NA NA 701 NA NA FEMALE NA NA NA NA NA NA NA NA 701 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0H7-11 702 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A0H7 NA NA days 702 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-BH-A0H7-F4737 TCGA-BH-A0H7 TCGA-BH-A0H7-11A NA Positive NA 2+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -23972 542 NA 0 702 NA NA NA NA NA H-SCORE 255 70-79% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 380 NO Negative NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA true No M0 N2a T1c Stage IIIA NA A0H7 TUMOR FREE H-SCORE 150 NA NA H-SCORE H-SCORE NA NA 30-39% NA YES Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2008 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 NA NA NA TCGA-BH-A0H7-11A-13D-A10Q-05 NA NA NA NA NA NA NA TCGA-BH-A0H7-11 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 TCGA-BH-A0H7-11 NA NA TCGA-BH-A0H7-11A-13R-A089-07 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 NA |
|
|
651 |
TCGA-BH-A0H9-01 Stage IIA 69 1 Stage IIA 1247 NA Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1247 0 LumA Luminal A Positive LumA/B -3 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0H9-01 1247 0 days Iq C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-BH-A0H9 NA NA days 1247 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0H9-F4703 TCGA-BH-A0H9 TCGA-BH-A0H9-01A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -25289 1088 NA 0 1247 NA NA NA NA NA NA 90-99% 2.98 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 3.43 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 120 NO Equivocal Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf A0H9 TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 827431d3-e25a-45b6-9b0f-5732501e2a5b 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01A-21-A13C-20 TCGA-BH-A0H9-01A-11W-A071-09 TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11D-A10P-05 84ff2baf-9961-4324-91b6-e2e9a86128aa TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11W-A071-09 NA TCGA-BH-A0H9-01 NA TCGA-BH-A0H9-01A-11W-A071-09 TCGA-BH-A0H9-01 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11D-A059-01 NA TCGA-BH-A0H9-01A-11R-A056-07 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01A-11D-A059-01 TCGA-BH-A0H9-01 |
|
|
652 |
TCGA-BH-A0H9-11 NA 69 NA NA 1247 NA NA FEMALE NA NA NA NA NA NA NA NA 1247 0 NA NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0H9-11 1247 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 14 TCGA-BH-A0H9 NA NA days 1247 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0H9-F4703 TCGA-BH-A0H9 TCGA-BH-A0H9-11A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -25289 1088 NA 0 1247 NA NA NA NA NA NA 90-99% 2.98 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 3.43 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 220 NO Equivocal Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA NA A0H9 TUMOR FREE NA NA NA NA NA NA NA 30-39% NA YES Solid Tissue Normal 11 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 27d4c881-e906-437f-921d-467eb107798a 27d4c881-e906-437f-921d-467eb107798a NA NA NA TCGA-BH-A0H9-11A-22D-A093-05 NA NA NA NA NA NA NA NA 27d4c881-e906-437f-921d-467eb107798a NA NA NA TCGA-BH-A0H9-11A-22R-A089-07 27d4c881-e906-437f-921d-467eb107798a NA |
|
|
653 |
TCGA-BH-A0HA-01 Stage I 31 1 Stage I 856 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 856 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 0 TCGA-BH-A0HA-01 1611 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0HA 1611 0 days 1611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 31 Right NA NA TCGA-BH-A0HA-F43320 TCGA-BH-A0HA NA NA Positive NA NA NA NA Positive Other NA NA NA NA -11379 NA NA 0 1611 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-5-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T1c Stage I NA A0HA TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 bilateral total mastectomies with right sentinel node biopsy 6th NO NO YES BH Breast NA LIVING 2008 cffc0fe5-533f-46f8-a54a-2e09c392767d cffc0fe5-533f-46f8-a54a-2e09c392767d TCGA-BH-A0HA-01A-21-A13C-20 TCGA-BH-A0HA-01A-11D-A12Q-09 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12R-05 f1a9fcd6-b351-4300-ab8c-e488c8d76cee TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12Q-09 NA TCGA-BH-A0HA-01 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12Q-09 NA cffc0fe5-533f-46f8-a54a-2e09c392767d NA TCGA-BH-A0HA-01A-11D-A12N-01 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11R-A12P-07 cffc0fe5-533f-46f8-a54a-2e09c392767d TCGA-BH-A0HA-01A-11D-A12N-01 TCGA-BH-A0HA-01 |
|
|
654 |
TCGA-BH-A0HA-11 NA 31 NA NA 856 NA NA FEMALE NA NA NA NA NA NA NA NA 856 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A0HA-11 1611 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A0HA 1611 0 days 1611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 31 Right NA NA TCGA-BH-A0HA-F43320 TCGA-BH-A0HA TCGA-BH-A0HA-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -11379 675 NA 0 1611 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-5-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 340 NO NA Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage I NA A0HA TUMOR FREE NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 bilateral total mastectomies with right sentinel node biopsy 6th NO NO YES BH Breast A LIVING 2008 a521a6fa-da2b-48ef-94e8-3307030427b6 a521a6fa-da2b-48ef-94e8-3307030427b6 NA NA NA TCGA-BH-A0HA-11A-31D-A12R-05 4DD09312-C6DE-4532-811D-242BAAE47F9D NA NA NA NA TCGA-BH-A0HA-11 NA NA a521a6fa-da2b-48ef-94e8-3307030427b6 NA NA TCGA-BH-A0HA-11 TCGA-BH-A0HA-11A-31R-A12P-07 a521a6fa-da2b-48ef-94e8-3307030427b6 NA |
|
|
655 |
TCGA-BH-A0HB-01 Stage IA 55 5 Stage I 806 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 806 0 LumA Luminal A Positive NA -8 -3 followup T1 T1 LIVING 0 TCGA-BH-A0HB-01 806 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-BH-A0HB NA NA days 806 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0HB-F4718 TCGA-BH-A0HB TCGA-BH-A0HB-01A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -20448 739 NA 0 806 NA NA NA NA NA H-Score 300 90-99% 2.13 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.58 1.21 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 70 NO Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf A0HB TUMOR FREE H-Score 70 NA NA H-Score H-Score NA NA 30-39% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 67b214bc-ac5f-4993-9907-fe0e0398d4ed 67b214bc-ac5f-4993-9907-fe0e0398d4ed NA TCGA-BH-A0HB-01A-11W-A071-09 TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11D-A10P-05 NA TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11W-A071-09 NA TCGA-BH-A0HB-01 NA TCGA-BH-A0HB-01A-11W-A071-09 TCGA-BH-A0HB-01 67b214bc-ac5f-4993-9907-fe0e0398d4ed TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11D-A059-01 NA TCGA-BH-A0HB-01A-11R-A056-07 67b214bc-ac5f-4993-9907-fe0e0398d4ed TCGA-BH-A0HB-01A-11D-A059-01 TCGA-BH-A0HB-01 |
|
|
656 |
TCGA-BH-A0HF-01 Stage IA 77 NA Stage I 727 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 727 0 LumA Luminal A Positive NA -5 -7 followup T1 T1 LIVING 0 TCGA-BH-A0HF-01 727 0 days NA NA cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 NA TCGA-BH-A0HF NA NA days 727 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0HF-F4734 TCGA-BH-A0HF TCGA-BH-A0HF-01A NA Positive NA 1+ NA NA Positive Other NA NO NA NA -28233 549 NA 0 727 NA NA NA NA NA H-Score 295 90-99% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 40 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf A0HF TUMOR FREE H-Score 15 NA NA H-Score H-Score NA NA <10% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 NA NA TCGA-BH-A0HF-01 TCGA-BH-A0HF-01A-11D-A10P-05 NA NA TCGA-BH-A0HF-01A-11W-A071-09 NA NA NA NA TCGA-BH-A0HF-01 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 TCGA-BH-A0HF-01 NA NA TCGA-BH-A0HF-01A-11R-A056-07 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 NA TCGA-BH-A0HF-01 |
|
|
657 |
TCGA-BH-A0HI-01 Stage IA 78 2 Stage I 619 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 619 0 LumA Luminal A Positive NA -12 -3 followup T1 T1 LIVING 0 TCGA-BH-A0HI-01 620 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0HI NA NA days 620 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0HI-F4756 TCGA-BH-A0HI TCGA-BH-A0HI-01A NA Positive NA 1+ NA NA Positive Other NA YES NA NA -28644 554 NA 0 620 NA NA NA NA NA H-Score 240 50-59% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 20 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NA 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf A0HI TUMOR FREE H-Score 160 NA NA H-Score H-Score NA NA 40-49% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2008 682942cb-589f-4348-abc2-3c7cc76fb34d 682942cb-589f-4348-abc2-3c7cc76fb34d NA TCGA-BH-A0HI-01A-11D-A099-09 TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A10P-05 NA TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A099-09 NA TCGA-BH-A0HI-01 NA TCGA-BH-A0HI-01A-11D-A099-09 TCGA-BH-A0HI-01 682942cb-589f-4348-abc2-3c7cc76fb34d TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A087-01 NA TCGA-BH-A0HI-01A-11R-A084-07 682942cb-589f-4348-abc2-3c7cc76fb34d TCGA-BH-A0HI-01A-11D-A087-01 TCGA-BH-A0HI-01 |
|
|
658 |
TCGA-BH-A0HK-01 Stage IIB 81 2 No_Conversion 178 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 178 0 LumA Luminal A Negative LumA/B 0 0 followup T_Other T2 LIVING 0 TCGA-BH-A0HK-01 178 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-BH-A0HK NA NA days 178 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-BH-A0HK-F4758 TCGA-BH-A0HK TCGA-BH-A0HK-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -29751 35 NA 0 178 NA NA NA NA NA H-SCORE 260 70-79% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 700 NO Negative NA NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NA 2 NA true No M0 N1 T2 Stage IIB TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf A0HK TUMOR FREE H-SCORE 0 NA NA H-SCORE H-SCORE NA NA <10% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2010 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01A-21-A13C-20 TCGA-BH-A0HK-01A-11W-A071-09 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11D-A10P-05 c6d75d78-0a3e-4221-840e-b2c6099b8e72 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11W-A071-09 NA TCGA-BH-A0HK-01 NA TCGA-BH-A0HK-01A-11W-A071-09 TCGA-BH-A0HK-01 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11D-A059-01 NA TCGA-BH-A0HK-01A-11R-A056-07 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01A-11D-A059-01 TCGA-BH-A0HK-01 |
|
|
659 |
TCGA-BH-A0HK-11 NA 81 NA NA 178 NA NA FEMALE NA NA NA NA NA NA NA NA 178 0 Normal NA NA NA NA NA followup NA NA LIVING 0 TCGA-BH-A0HK-11 178 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A0HK NA NA days 178 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone NA TCGA-BH-A0HK-F4758 TCGA-BH-A0HK TCGA-BH-A0HK-11A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -29751 35 NA 0 178 NA NA NA NA NA H-SCORE 260 70-79% NA NA 2010-11-16 FEMALE NA NA <10% NA 0 NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 240 NO Negative NA NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA true No M0 N1 T2 Stage IIB NA A0HK TUMOR FREE H-SCORE 0 NA NA H-SCORE H-SCORE NA NA <10% NA NO Solid Tissue Normal 11 NA NA YES NO YES BH Breast A LIVING 2010 01163f75-8956-40a6-97a5-3c0478d904f8 01163f75-8956-40a6-97a5-3c0478d904f8 NA NA NA TCGA-BH-A0HK-11A-11D-A10Q-05 9959CAD8-B950-41C0-A0C7-3EF86F4DA9EC NA NA NA NA NA NA TCGA-BH-A0HK-11 01163f75-8956-40a6-97a5-3c0478d904f8 TCGA-BH-A0HK-11 NA NA TCGA-BH-A0HK-11A-11R-A089-07 01163f75-8956-40a6-97a5-3c0478d904f8 NA |
|
|
660 |
TCGA-BH-A0HL-01 Stage IIB 56 NA No_Conversion 72 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 72 0 NA Basal-like Positive LumA/B -13 0 followup T_Other T2 LIVING 0 TCGA-BH-A0HL-01 72 0 days NA NA cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 11 cluster 4 mutation c1uster 9 TCGA-BH-A0HL NA NA days 72 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0HL-F4792 TCGA-BH-A0HL TCGA-BH-A0HL-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -20804 352 NA 0 72 NA NA NA NA NA H-SCORE 295 90-99% 2.25 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.23 0.99 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8503/3 C50.9 3+ YES NA Core needle biopsy 250 NO Equivocal Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 2 NA true No M0 N1a T2 Stage IIB TCGA-BH-A0HL.79DAEAE5-A177-40E0-9BFC-54DC9F544764.pdf A0HL TUMOR FREE H-SCORE 200 NA NA H-SCORE H-SCORE NA NA 40-49% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 1ee60bda-48df-4288-90cb-480fbfbc5d50 1ee60bda-48df-4288-90cb-480fbfbc5d50 TCGA-BH-A0HL-01A-21-A13C-20 TCGA-BH-A0HL-01A-11W-A050-09 TCGA-BH-A0HL-01 NA 2167df75-1057-4cb6-acea-3e737541d1ee NA TCGA-BH-A0HL-01A-11W-A050-09 TCGA-BH-A0HL-01A-11D-A032-05 NA TCGA-BH-A0HL-01 TCGA-BH-A0HL-01A-11W-A050-09 NA 1ee60bda-48df-4288-90cb-480fbfbc5d50 NA NA TCGA-BH-A0HL-01 NA 1ee60bda-48df-4288-90cb-480fbfbc5d50 NA |
|
|
661 |
TCGA-BH-A0HN-01 Stage IA 67 NA Stage I 516 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 516 0 NA Basal-like Positive ReacI -13 0 followup T1 T1 LIVING 0 TCGA-BH-A0HN-01 516 0 days NA NA cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 11 cluster 6 mutation cluster 14 TCGA-BH-A0HN NA NA days 516 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0HN-F4811 TCGA-BH-A0HN TCGA-BH-A0HN-01A Negative Positive NA 3+ NA Mastectomy NOS Positive Other NA NO NA NA -24731 359 NA 0 516 NA NA NA NA NA H-SCORE 300 90-99% 1.78 NA 2010-11-16 FEMALE NA NA NA NA 2+ 40 2.0 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 130 NO Equivocal Negative NA 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf A0HN TUMOR FREE H-SCORE 290 NA NA H-SCORE H-SCORE NA NA 90-99% NA NO Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 6f0cf450-76f1-489d-9890-5093816c0680 6f0cf450-76f1-489d-9890-5093816c0680 TCGA-BH-A0HN-01A-21-A13C-20 TCGA-BH-A0HN-01A-11D-A099-09 TCGA-BH-A0HN-01 TCGA-BH-A0HN-01A-11D-A10P-05 b81e2777-d661-4576-b8dc-e95b03351e27 NA TCGA-BH-A0HN-01A-11D-A099-09 NA NA TCGA-BH-A0HN-01 TCGA-BH-A0HN-01A-11D-A099-09 NA 6f0cf450-76f1-489d-9890-5093816c0680 NA NA TCGA-BH-A0HN-01 NA 6f0cf450-76f1-489d-9890-5093816c0680 NA |
|
|
662 |
TCGA-BH-A0HO-01 Stage IIA 48 2 No_Conversion 76 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 76 0 LumA Luminal A Positive NA -12 -3 followup T1 T1 LIVING 0 TCGA-BH-A0HO-01 76 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 2 mutation c1uster 9 TCGA-BH-A0HO NA NA days 76 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0HO-F4771 TCGA-BH-A0HO TCGA-BH-A0HO-01A NA Positive NA 3+ NA NA Positive Other NA YES NA NA -17710 224 NA 0 76 NA NA NA NA NA H-Score 200 90-99% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 110 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf A0HO TUMOR FREE H-Score 290 NA NA H-Score H-Score NA NA 90-99% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 92f53e8e-abd5-4597-a6be-678be549315d 92f53e8e-abd5-4597-a6be-678be549315d NA TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01 NA NA TCGA-BH-A0HO-01 TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01A-11D-A032-05 TCGA-BH-A0HO-01 NA TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01 92f53e8e-abd5-4597-a6be-678be549315d TCGA-BH-A0HO-01 TCGA-BH-A0HO-01A-11D-A036-01 NA TCGA-BH-A0HO-01A-11R-A034-07 92f53e8e-abd5-4597-a6be-678be549315d TCGA-BH-A0HO-01A-11D-A036-01 TCGA-BH-A0HO-01 |
|
|
663 |
TCGA-BH-A0HP-01 Stage IIIA 65 2 No_Conversion 414 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 414 0 LumA Luminal A Negative ReacI -5 -7 followup T_Other T3 LIVING 0 TCGA-BH-A0HP-01 414 0 days Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-BH-A0HP NA NA days 414 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-BH-A0HP-F4784 TCGA-BH-A0HP TCGA-BH-A0HP-01A NA Positive NA 0 NA NA Negative Modified Radical Mastectomy NA NO NA NA -23883 346 NA 0 414 NA NA NA NA NA H-Score 280 80-89% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 720 NO Negative NA NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Positive NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 1 6 NA NA NA NA NA NA NA NA 8 NA true No M0 N2a T3 Stage IIIA TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf A0HP TUMOR FREE H-Score 0 NA NA H-Score H-Score NA NA NA NA YES Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2009 f0c59856-0421-46e3-a2f9-e17f0f267930 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01A-21-A13C-20 TCGA-BH-A0HP-01A-12D-A099-09 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A10P-05 189540a2-042e-4bac-99f0-b7b0feda0a23 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A099-09 NA TCGA-BH-A0HP-01 NA TCGA-BH-A0HP-01A-12D-A099-09 TCGA-BH-A0HP-01 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A087-01 NA TCGA-BH-A0HP-01A-12R-A084-07 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01A-12D-A087-01 TCGA-BH-A0HP-01 |
|
|
664 |
TCGA-BH-A0HQ-01 Stage IIA 56 NA Stage IIA 1121 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1121 0 LumA Luminal A Positive NA -5 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0HQ-01 1121 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0HQ NA NA days 1121 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0HQ-F4795 TCGA-BH-A0HQ TCGA-BH-A0HQ-01A NA Positive NA 3+ NA NA Positive Other NA YES NA NA -20719 962 NA 0 1121 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 110 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i+) T2 Stage IIA TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf A0HQ TUMOR FREE NA NA NA NA NA NA NA 90-99% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2007 856452d1-5480-4921-bf5b-4c6f625a99c0 856452d1-5480-4921-bf5b-4c6f625a99c0 NA TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01 NA NA TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01A-11D-A032-05 TCGA-BH-A0HQ-01 NA TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01 856452d1-5480-4921-bf5b-4c6f625a99c0 TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01A-11D-A036-01 NA TCGA-BH-A0HQ-01A-11R-A034-07 856452d1-5480-4921-bf5b-4c6f625a99c0 TCGA-BH-A0HQ-01A-11D-A036-01 TCGA-BH-A0HQ-01 |
|
|
665 |
TCGA-BH-A0HU-01 Stage IA 52 2 Stage I 392 NA Positive FEMALE Negative 3 1 4 Negative M0 Negative N0 392 0 LumB Luminal B Positive Her2 -2 -3 followup T1 T1 LIVING 0 TCGA-BH-A0HU-01 392 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-BH-A0HU NA NA days 392 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant|Right Sentinel node biopsy alone NA TCGA-BH-A0HU-F4813 TCGA-BH-A0HU TCGA-BH-A0HU-01A NA Positive NA 2+ NA NA Positive Other NA NO NA NA -19216 394 NA 0 392 NA NA NA NA NA H-Score 140 40-49% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 140 NO Negative NA NA 1 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf A0HU TUMOR FREE H-Score 140 NA NA H-Score H-Score NA NA 40-49% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2009 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01A-21-A13A-20 TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01 NA 1b5d1cb8-6b38-485a-aff3-24213e459637 TCGA-BH-A0HU-01 TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01A-11D-A032-05 TCGA-BH-A0HU-01 NA TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01 TCGA-BH-A0HU-01A-11D-A036-01 NA TCGA-BH-A0HU-01A-11R-A034-07 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01A-11D-A036-01 TCGA-BH-A0HU-01 |
|
|
666 |
TCGA-BH-A0HW-01 Stage IA 62 4 Stage I 1560 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1560 0 LumB Luminal B Negative LumA/B -10 -3 followup T1 T1 LIVING 0 TCGA-BH-A0HW-01 1561 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0HW NA NA days 1561 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0HW-F4827 TCGA-BH-A0HW TCGA-BH-A0HW-01A NA Positive NA 0 NA NA Negative Other NA NO NA NA -22962 1591 NA 0 1561 NA NA NA NA NA NA 90-99% NA NA 2010-11-16 FEMALE NA NA NA NA 2+ NA NA 1.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 200 NO Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf A0HW TUMOR FREE NA NA NA NA NA NA NA <10% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2006 0172d30c-287c-4f3e-b70c-5760c6dccb7c 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01A-21-A13B-20 TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01 NA fe1d6a4b-4950-48e6-92fd-7ddc10953a83 TCGA-BH-A0HW-01 TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01A-11D-A032-05 TCGA-BH-A0HW-01 NA TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01 TCGA-BH-A0HW-01A-11D-A036-01 NA TCGA-BH-A0HW-01A-11R-A034-07 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01A-11D-A036-01 TCGA-BH-A0HW-01 |
|
|
667 |
TCGA-BH-A0HX-01 Stage IIB 54 4 No_Conversion 829 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 829 0 LumA Luminal A Positive LumA/B -10 -3 followup T_Other T2 LIVING 0 TCGA-BH-A0HX-01 829 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0HX NA NA days 829 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0HX-F4838 TCGA-BH-A0HX TCGA-BH-A0HX-01A NA Positive NA 3+ NA NA Positive Simple Mastectomy NA YES NA NA -19900 672 NA 0 829 NA NA NA NA NA H-Score 270 80-89% NA NA 2010-11-16 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 190 NO Negative NA NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 2 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf A0HX TUMOR FREE H-Score 190 NA NA H-Score H-Score NA NA 50-59% NA NO Primary Tumor 01 NA NA YES NO YES BH Breast A LIVING 2008 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01A-11-A13B-20 TCGA-BH-A0HX-01A-21W-A071-09 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21D-A10P-05 a58fd02f-a169-42ee-ab9b-761d00d11179 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21W-A071-09 NA TCGA-BH-A0HX-01 NA TCGA-BH-A0HX-01A-21W-A071-09 TCGA-BH-A0HX-01 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21D-A059-01 NA TCGA-BH-A0HX-01A-21R-A056-07 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01A-21D-A059-01 TCGA-BH-A0HX-01 |
|
|
668 |
TCGA-BH-A0HY-01 Stage I 60 NA Stage I 867 NA Positive FEMALE NA NA NA NA Negative M0 Negative N0 867 0 LumB HER2-enriched Negative ReacII -1 -5 enrollment T1 T1 LIVING 0 TCGA-BH-A0HY-01 1545 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0HY 1545 0 days 1545 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left NA NA TCGA-BH-A0HY-F43316 TCGA-BH-A0HY NA NA Positive NA NA NA NA Negative Other NA NA NA NA -22179 NA NA 0 1545 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-5-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A0HY TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Total mastectomy with left sentinel lymph node biospy 6th YES NO YES BH Breast NA LIVING 2009 e074391d-348f-4f95-aad0-7f51c56b9696 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01A-21-A13B-20 TCGA-BH-A0HY-01A-11W-A071-09 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11D-A10P-05 b5cba62d-f66e-40c7-88c8-0040d3d38607 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11W-A071-09 NA TCGA-BH-A0HY-01 NA TCGA-BH-A0HY-01A-11W-A071-09 TCGA-BH-A0HY-01 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11D-A059-01 NA TCGA-BH-A0HY-01A-11R-A056-07 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01A-11D-A059-01 TCGA-BH-A0HY-01 |
|
|
669 |
TCGA-BH-A0RX-01 Stage IIA 59 4 Stage IIA 170 NA Negative FEMALE Negative 3 2 2 Negative M0 Negative N0 170 0 Basal Basal-like Negative ReacII -13 -12 followup T_Other T2 LIVING 0 TCGA-BH-A0RX-01 170 0 days High C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-BH-A0RX NA NA days 170 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA YES NA NA 59 Left Upper Outer Quadrant|Left Sentinel node biopsy alone NA TCGA-BH-A0RX-F4875 TCGA-BH-A0RX TCGA-BH-A0RX-01A NA Negative NA 0 NA NA Negative Other NA NO NA NA -21857 63 NA 0 170 NA NA NA NA NA H-Score 0 <10% NA NA 2010-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 0 YES NA Core needle biopsy 170 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf A0RX TUMOR FREE H-Score 0 NA NA H-Score H-Score NA NA <10% NA YES Primary Tumor 01 Segmental mastectomy NA YES NO YES BH Breast A LIVING 2010 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01A-11-A13C-20 TCGA-BH-A0RX-01A-21D-A099-09 TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A10P-05 c8d587b3-a3d1-4375-bb94-7208c050421a TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A099-09 NA TCGA-BH-A0RX-01 NA TCGA-BH-A0RX-01A-21D-A099-09 TCGA-BH-A0RX-01 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A087-01 NA TCGA-BH-A0RX-01A-21R-A084-07 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01A-21D-A087-01 TCGA-BH-A0RX-01 |
|
|
670 |
TCGA-BH-A0W3-01 Stage IIA 58 2 No_Conversion 180 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 180 0 LumB Luminal B Positive NA -12 -3 enrollment T1 T1 LIVING 0 TCGA-BH-A0W3-01 728 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-BH-A0W3 728 0 days 728 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Inner Quadrant NA NA TCGA-BH-A0W3-F34065 TCGA-BH-A0W3 TCGA-BH-A0W3-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21369 85 NA 0 728 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Equivocal Negative NA 4 NA Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0W3.801A4E2F-E26E-424F-BF42-CD0D9CD62BCE.pdf A0W3 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 Segmental mastectomy 7th NO NO YES BH Breast A LIVING 2010 0def3ef8-7608-483c-b899-4d459f6d2e2d 0def3ef8-7608-483c-b899-4d459f6d2e2d NA TCGA-BH-A0W3-01A-11D-A10G-09 TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A10A-05 NA TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A10G-09 NA TCGA-BH-A0W3-01 NA TCGA-BH-A0W3-01A-11D-A10G-09 TCGA-BH-A0W3-01 0def3ef8-7608-483c-b899-4d459f6d2e2d TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A107-01 NA TCGA-BH-A0W3-01A-11R-A109-07 0def3ef8-7608-483c-b899-4d459f6d2e2d TCGA-BH-A0W3-01A-11D-A107-01 TCGA-BH-A0W3-01 |
|
|
671 |
TCGA-BH-A0W4-01 Stage IIA 46 2 Stage IIA 175 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 175 0 LumA Luminal A Positive LumA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A0W4-01 759 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0W4 759 0 days 759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Outer Quadrant NA NA TCGA-BH-A0W4-F34069 TCGA-BH-A0W4 TCGA-BH-A0W4-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16911 119 NA 0 759 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Negative NA NA 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0W4.0C158269-A420-4E71-9E59-8775FB26084B.pdf A0W4 TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Total mastectomy 7th NO NO YES BH Breast A LIVING 2010 750469b2-05c7-4647-b101-cdd94246d254 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01A-21-A13D-20 TCGA-BH-A0W4-01A-11D-A10G-09 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A10A-05 6a26c8ad-e0f9-44a9-9039-983f6771a989 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A10G-09 NA TCGA-BH-A0W4-01 NA TCGA-BH-A0W4-01A-11D-A10G-09 TCGA-BH-A0W4-01 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A107-01 NA TCGA-BH-A0W4-01A-11R-A109-07 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01A-11D-A107-01 TCGA-BH-A0W4-01 |
|
|
672 |
TCGA-BH-A0W5-01 Stage IIA 77 4 No_Conversion 543 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 543 0 LumA Luminal A Positive LumA -5 -4 enrollment T1 T1 LIVING 0 TCGA-BH-A0W5-01 1288 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-BH-A0W5 1288 0 days 1288 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A0W5-F34070 TCGA-BH-A0W5 TCGA-BH-A0W5-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -28304 906 NA 0 1288 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Equivocal Equivocal NA 11 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf A0W5 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast A LIVING 2008 91e55e6f-b884-4112-8d3f-a9f8974dd63b 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01A-21-A13D-20 TCGA-BH-A0W5-01A-11D-A10G-09 TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A10A-05 ef0f5ff2-5b71-45fa-9036-b5dfc63510aa TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A10G-09 NA TCGA-BH-A0W5-01 NA TCGA-BH-A0W5-01A-11D-A10G-09 TCGA-BH-A0W5-01 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A107-01 NA TCGA-BH-A0W5-01A-11R-A109-07 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01A-11D-A107-01 TCGA-BH-A0W5-01 |
|
|
673 |
TCGA-BH-A0W7-01 Stage IA 49 4 Stage I 558 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 558 0 LumA Luminal A Positive NA -4 -4 enrollment T1 T1 LIVING 0 TCGA-BH-A0W7-01 1363 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0W7 1363 0 days 1363 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A0W7-F34073 TCGA-BH-A0W7 NA NA Positive NA NA NA NA Positive Other NA NA NA NA -17996 NA NA 0 1363 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T1c Stage I NA A0W7 TUMOR FREE NA NA NA NA NA NA NA NA NA YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast NA LIVING 2008 afaeb45f-d795-4fe0-b4ee-5b90816e6427 afaeb45f-d795-4fe0-b4ee-5b90816e6427 NA TCGA-BH-A0W7-01A-11D-A10Y-09 TCGA-BH-A0W7-01 NA NA TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11D-A10Y-09 TCGA-BH-A0W7-01A-11D-A112-05 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11D-A10Y-09 NA afaeb45f-d795-4fe0-b4ee-5b90816e6427 NA TCGA-BH-A0W7-01A-11D-A111-01 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11R-A115-07 afaeb45f-d795-4fe0-b4ee-5b90816e6427 TCGA-BH-A0W7-01A-11D-A111-01 TCGA-BH-A0W7-01 |
|
|
674 |
TCGA-BH-A0WA-01 Stage IA 82 1 Stage I 372 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 372 0 Basal Basal-like Negative NA -13 -12 enrollment T1 T1 LIVING 0 TCGA-BH-A0WA-01 701 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-BH-A0WA 701 0 days 701 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 82 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-BH-A0WA-F34068 TCGA-BH-A0WA TCGA-BH-A0WA-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -30025 724 NA 0 701 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-7-29 FEMALE NA NA NA NA NA NA NA NA NA NA NA No NA C50.9 8575/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO Negative NA NA 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage I TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf A0WA TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 segmental mastectomy 6th NO NO YES BH Breast A LIVING 2008 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 NA TCGA-BH-A0WA-01A-11D-A10G-09 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A10A-05 NA TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A10G-09 NA TCGA-BH-A0WA-01 NA TCGA-BH-A0WA-01A-11D-A10G-09,TCGA-BH-A0WA-01A-11D-A128-09 TCGA-BH-A0WA-01 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A107-01 NA TCGA-BH-A0WA-01A-11R-A109-07 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 TCGA-BH-A0WA-01A-11D-A107-01 TCGA-BH-A0WA-01 |
|
|
675 |
TCGA-BH-A18F-01 Stage IIA 50 2 Stage IIA 268 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 268 0 LumA Luminal B Positive ReacI -4 -7 enrollment T_Other T2 LIVING 0 TCGA-BH-A18F-01 1001 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 4 TCGA-BH-A18F 1001 0 days 1001 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A18F-F59193 TCGA-BH-A18F TCGA-BH-A18F-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA NA NA NA -18594 114 NA 0 1001 NA NA NA NA NA NA 70-79% NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 200 NO Negative NA NO 1 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf A18F TUMOR FREE NA NA NA NA NA YES YES 40-49% NA YES Primary Tumor 01 needle localized segmental mastectomy 7th NA NO YES BH Breast A LIVING 2010 eed6d177-6cec-493a-b811-1779bebae72a eed6d177-6cec-493a-b811-1779bebae72a TCGA-BH-A18F-01A-21-A13F-20 TCGA-BH-A18F-01A-11D-A12B-09 TCGA-BH-A18F-01 NA 90367af6-b44b-46f1-9482-c1ddc1bc42e6 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11D-A12B-09 TCGA-BH-A18F-01A-11D-A12E-05 TCGA-BH-A18F-01 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11D-A12B-09 NA eed6d177-6cec-493a-b811-1779bebae72a NA TCGA-BH-A18F-01A-11D-A12A-01 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11R-A12D-07 eed6d177-6cec-493a-b811-1779bebae72a TCGA-BH-A18F-01A-11D-A12A-01 TCGA-BH-A18F-01 |
|
|
676 |
TCGA-BH-A18F-11 NA 50 NA NA 268 NA NA FEMALE NA NA NA NA NA NA NA NA 268 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A18F-11 1001 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A18F 1001 0 days 1001 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A18F-F59193 TCGA-BH-A18F TCGA-BH-A18F-11A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA NA NA NA -18594 114 NA 0 1001 NA NA NA NA NA NA 70-79% NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 190 NO Negative NA NO 1 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA NA A18F TUMOR FREE NA NA NA NA NA YES YES 40-49% NA YES Solid Tissue Normal 11 needle localized segmental mastectomy 7th NA NO YES BH Breast A LIVING 2010 NA NA NA NA NA NA NA NA NA TCGA-BH-A18F-11A-22D-A12E-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
677 |
TCGA-BH-A18G-01 Stage X 81 3 No_Conversion 61 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 61 0 Basal Basal-like Negative Basal -13 0 enrollment T1 T1 LIVING 0 TCGA-BH-A18G-01 149 0 days Iq C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 NA TCGA-BH-A18G 149 0 days 149 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A18G-F64216 TCGA-BH-A18G TCGA-BH-A18G-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -29820 78 NA 0 149 NA NA NA NA NA NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.5 8500/3 C50.5 NA YES NA Core needle biopsy 100 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage IA TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf A18G TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 right segmental mastectomy NA NA NO YES BH Breast A LIVING 2010 a8a7a335-8e21-4f24-b48b-8764caa21329 a8a7a335-8e21-4f24-b48b-8764caa21329 TCGA-BH-A18G-01A-21-A13F-20 NA TCGA-BH-A18G-01 NA 7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a TCGA-BH-A18G-01 TCGA-BH-A18G-01A-11D-A12B-09 TCGA-BH-A18G-01A-11D-A12E-05 TCGA-BH-A18G-01 TCGA-BH-A18G-01 NA NA a8a7a335-8e21-4f24-b48b-8764caa21329 NA TCGA-BH-A18G-01A-11D-A12A-01 TCGA-BH-A18G-01 TCGA-BH-A18G-01A-11R-A12D-07 a8a7a335-8e21-4f24-b48b-8764caa21329 TCGA-BH-A18G-01A-11D-A12A-01 TCGA-BH-A18G-01 |
|
|
678 |
TCGA-BH-A18H-01 Stage IB 63 3 Stage I 0 NA Positive FEMALE Negative 3 1 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive LumA/B -2 -5 enrollment T1 T1 LIVING 0 TCGA-BH-A18H-01 652 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-BH-A18H 652 0 days 652 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-BH-A18H-F59198 TCGA-BH-A18H TCGA-BH-A18H-01A NA Positive NA NA NA NA Positive Other NA YES NA NA -23065 16 NA 0 652 NA NA NA NA NA NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Positive Equivocal NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 T1b Stage IA TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf A18H TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 segmental mastectomy 7th NA NO YES BH Breast A LIVING 2010 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 TCGA-BH-A18H-01A-21-A13F-20 TCGA-BH-A18H-01A-11D-A12B-09 TCGA-BH-A18H-01 NA d378a15a-1276-482a-b924-87df01d062f2 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11D-A12B-09 TCGA-BH-A18H-01A-11D-A12E-05 TCGA-BH-A18H-01 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11D-A12B-09 NA 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 NA TCGA-BH-A18H-01A-11D-A12A-01 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11R-A12D-07 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 TCGA-BH-A18H-01A-11D-A12A-01 TCGA-BH-A18H-01 |
|
|
679 |
TCGA-BH-A18I-01 Stage IIA 53 4 Stage IIA 220 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 220 0 LumA Luminal A Positive NA -5 -4 enrollment T1 T1 LIVING 0 TCGA-BH-A18I-01 1093 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A18I 1093 0 days 1093 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A18I-F58710 TCGA-BH-A18I TCGA-BH-A18I-01A Negative Positive NA NA NA Modified radical mastectomy Positive Other NA NA NA NA -19489 80 NA 0 1093 NA NA NA NA NA NA NA NA NA 2014-4-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.2 8500/3 C50.2 NA YES NA Core needle biopsy 100 NO Positive NA NO 3 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 1 true No cM0 (i+) N1a T1c Stage IIA TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf A18I TUMOR FREE NA NA NA H score H score YES YES NA NA NO Primary Tumor 01 segmental mastectomy 7th NA NO YES BH Breast A LIVING 2010 844b3442-a740-4cb4-a1fb-b481c552cc88 844b3442-a740-4cb4-a1fb-b481c552cc88 NA TCGA-BH-A18I-01A-11D-A12B-09 TCGA-BH-A18I-01 NA NA TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11D-A12B-09 TCGA-BH-A18I-01A-11D-A12E-05 TCGA-BH-A18I-01 TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11D-A12B-09 NA 844b3442-a740-4cb4-a1fb-b481c552cc88 NA TCGA-BH-A18I-01A-11D-A12A-01 TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11R-A12D-07 844b3442-a740-4cb4-a1fb-b481c552cc88 TCGA-BH-A18I-01A-11D-A12A-01 TCGA-BH-A18I-01 |
|
|
680 |
TCGA-BH-A18J-01 Stage IV 56 2 No_Conversion 611 611 Positive FEMALE Negative 3 3 4 Positive M1 Positive N2 611 1 LumA Luminal B Positive ReacII -1 -3 enrollment T_Other T4 DECEASED 1 TCGA-BH-A18J-01 612 1 days Squamous C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A18J NA NA days 612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right NA NA NA TCGA-BH-A18J TCGA-BH-A18J-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -20678 3948 612 0 NA NA NA NA NA YES NA 40-49% NA NA 2011-6-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 640 NO Negative NA NA NA Negative NA NA Negative NA NA Positive NA NA NA NA NA NA NA Negative NA NA NA Positive Bone NA 1 4 NA NA NA NA NA NA NA NA NA NA true No M1 N2 T4b Stage IV TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2.pdf A18J WITH TUMOR NA NA NA NA NA NA NA 30-39% NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 2000 56d889ba-6484-4940-ae85-1373ce4255b9 56d889ba-6484-4940-ae85-1373ce4255b9 TCGA-BH-A18J-01A-21-A13E-20 TCGA-BH-A18J-01A-11D-A12B-09 TCGA-BH-A18J-01 NA dd4097f7-8330-42c3-aa6f-dd289837f65e TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11D-A12B-09 TCGA-BH-A18J-01A-11D-A12E-05 TCGA-BH-A18J-01 TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11D-A12B-09 NA 56d889ba-6484-4940-ae85-1373ce4255b9 NA TCGA-BH-A18J-01A-11D-A12A-01 TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11R-A12D-07 56d889ba-6484-4940-ae85-1373ce4255b9 TCGA-BH-A18J-01A-11D-A12A-01 TCGA-BH-A18J-01 |
|
|
681 |
TCGA-BH-A18J-11 NA 56 NA NA 611 611 NA FEMALE NA NA NA NA NA NA NA NA 611 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18J-11 612 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A18J NA NA days 612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right NA NA NA TCGA-BH-A18J TCGA-BH-A18J-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -20678 3948 612 0 NA NA NA NA NA YES NA 40-49% NA NA 2011-6-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 230 NO Negative NA NA NA Negative NA NA Negative NA NA Positive NA NA NA NA NA NA NA Negative NA NA NA Positive Bone NA NA NA NA NA NA NA NA NA NA NA NA NA true No M1 N2 T4b Stage IV NA A18J WITH TUMOR NA NA NA NA NA NA NA 30-39% NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 2000 9fa440b0-6e8d-4c48-a425-50abc2682f6e 9fa440b0-6e8d-4c48-a425-50abc2682f6e NA NA NA NA NA NA NA TCGA-BH-A18J-11A-31D-A12E-05 NA TCGA-BH-A18J-11 NA NA 9fa440b0-6e8d-4c48-a425-50abc2682f6e NA NA TCGA-BH-A18J-11 TCGA-BH-A18J-11A-31R-A12D-07 9fa440b0-6e8d-4c48-a425-50abc2682f6e NA |
|
|
682 |
TCGA-BH-A18K-01 Stage I 46 2 Stage I 2547 2762 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2762 1 LumA Basal-like Positive NA -13 -12 enrollment T1 T1 DECEASED 1 TCGA-BH-A18K-01 2763 1 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 4 TCGA-BH-A18K NA NA days 2763 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-BH-A18K TCGA-BH-A18K-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -16824 4011 2763 0 NA NA NA NA NA NO NA NA NA NA 2011-6-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 100 NO Negative NA NA 11 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1 Stage I TCGA-BH-A18K.EEB515A4-4AF3-475B-B6C0-A6134C96480A.pdf A18K WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 segmental mastectomy with axillary dissection 5th NA NO YES BH Breast A DECEASED 1999 78e00469-0dd6-490e-93f1-068b9a386839 78e00469-0dd6-490e-93f1-068b9a386839 NA TCGA-BH-A18K-01A-11D-A12B-09 TCGA-BH-A18K-01 NA NA TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11D-A12B-09 TCGA-BH-A18K-01A-11D-A12E-05 TCGA-BH-A18K-01 TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11D-A12B-09 NA 78e00469-0dd6-490e-93f1-068b9a386839 NA TCGA-BH-A18K-01A-11D-A12A-01 TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11R-A12D-07 78e00469-0dd6-490e-93f1-068b9a386839 TCGA-BH-A18K-01A-11D-A12A-01 TCGA-BH-A18K-01 |
|
|
683 |
TCGA-BH-A18K-11 NA 46 NA NA 2547 2762 NA FEMALE NA NA NA NA NA NA NA NA 2762 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18K-11 2763 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A18K NA NA days 2763 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-BH-A18K NA NA Positive NA NA NA NA Positive Other NA NA NA NA -16824 NA 2763 0 NA NA NA NA NA NO NA NA NA NA 2011-6-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 11 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 T1 Stage I NA A18K WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 segmental mastectomy with axillary dissection 5th NA NO YES BH Breast NA DECEASED 1999 dc55c016-0e33-46b0-ac5e-f854c667a378 dc55c016-0e33-46b0-ac5e-f854c667a378 NA NA NA NA NA NA NA TCGA-BH-A18K-11A-13D-A12E-05 NA TCGA-BH-A18K-11 NA NA dc55c016-0e33-46b0-ac5e-f854c667a378 NA NA TCGA-BH-A18K-11 TCGA-BH-A18K-11A-13R-A12D-07 dc55c016-0e33-46b0-ac5e-f854c667a378 NA |
|
|
684 |
TCGA-BH-A18L-01 Stage IIB 50 5 Stage IIIA 372 811 Positive FEMALE NA 1 1 4 Negative M0 Positive N1 811 1 LumB Luminal B Positive ReacII -10 -5 enrollment T_Other T3 DECEASED 1 TCGA-BH-A18L-01 811 1 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A18L NA NA days 811 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18L NA NA Positive NA NA NA NA Positive Other NA NA NA NA -18519 NA 811 0 NA NA NA NA NA NO NA NA NA NA 2011-6-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NA 1 1 NA No M0 N1mi T3 Stage IIIA NA A18L NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 total mastectomy and sentinel node biopsy 6th NA NO YES BH Breast NA DECEASED 2003 c3604281-d909-4819-a90e-a1081b1e9d7f c3604281-d909-4819-a90e-a1081b1e9d7f TCGA-BH-A18L-01A-21-A13F-20 TCGA-BH-A18L-01A-32D-A12B-09 TCGA-BH-A18L-01 NA ede8d4b2-4cfd-4f4f-a11f-3269c0ba7661 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32D-A12B-09 TCGA-BH-A18L-01A-32D-A12E-05 TCGA-BH-A18L-01 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32D-A12B-09 NA c3604281-d909-4819-a90e-a1081b1e9d7f NA TCGA-BH-A18L-01A-32D-A12A-01 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32R-A12D-07 c3604281-d909-4819-a90e-a1081b1e9d7f TCGA-BH-A18L-01A-32D-A12A-01 TCGA-BH-A18L-01 |
|
|
685 |
TCGA-BH-A18L-11 NA 50 NA NA 372 811 NA FEMALE NA NA NA NA NA NA NA NA 811 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18L-11 811 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A18L NA NA days 811 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18L TCGA-BH-A18L-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -18519 2669 811 0 NA NA NA NA NA NO NA NA NA NA 2011-6-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 530 NO Negative NA NA 3 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 1 true No M0 N1mi T3 Stage IIIA NA A18L NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 total mastectomy and sentinel node biopsy 6th NA NO YES BH Breast A DECEASED 2003 0b937a20-66d4-4d05-bf50-4828cead9c92 0b937a20-66d4-4d05-bf50-4828cead9c92 NA NA NA NA AE6873BA-EA4A-4FE3-9D4F-B32FFC5BBF98 NA NA TCGA-BH-A18L-11A-42D-A12E-05 NA TCGA-BH-A18L-11 NA NA 0b937a20-66d4-4d05-bf50-4828cead9c92 NA NA TCGA-BH-A18L-11 TCGA-BH-A18L-11A-42R-A12D-07 0b937a20-66d4-4d05-bf50-4828cead9c92 NA |
|
|
686 |
TCGA-BH-A18M-01 Stage IIB 39 2 Stage IIIA 2207 2207 Positive FEMALE Positive 3 4 3 Negative M0 Positive N1 2207 1 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 DECEASED 1 TCGA-BH-A18M-01 2207 1 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A18M NA NA days 2207 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Upper Inner Quadrant NA NA NA TCGA-BH-A18M TCGA-BH-A18M-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14532 3629 2207 0 NA NA NA NA NA NO NA NA NA NA 2011-6-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.3 8500/3 C50.3 NA YES NA Core needle biopsy 360 NO Positive Positive NA 6 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 4 4 true No M0 N1 T3 Stage IIIA TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf A18M NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 2001 4dfbdec6-1911-412c-9873-f6782ab8ff66 4dfbdec6-1911-412c-9873-f6782ab8ff66 TCGA-BH-A18M-01A-21-A13E-20 TCGA-BH-A18M-01A-11D-A12B-09 TCGA-BH-A18M-01 NA 1d42bf05-8579-448e-bb82-e07aa1c93c97 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11D-A12B-09 TCGA-BH-A18M-01A-11D-A12E-05 TCGA-BH-A18M-01 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11D-A12B-09 NA 4dfbdec6-1911-412c-9873-f6782ab8ff66 NA TCGA-BH-A18M-01A-11D-A12A-01 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11R-A12D-07 4dfbdec6-1911-412c-9873-f6782ab8ff66 TCGA-BH-A18M-01A-11D-A12A-01 TCGA-BH-A18M-01 |
|
|
687 |
TCGA-BH-A18M-11 NA 39 NA NA 2207 2207 NA FEMALE NA NA NA NA NA NA NA NA 2207 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18M-11 2207 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A18M NA NA days 2207 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Upper Inner Quadrant NA NA NA TCGA-BH-A18M TCGA-BH-A18M-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14532 3629 2207 0 NA NA NA NA NA NO NA NA NA NA 2011-6-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.3 8500/3 C50.3 NA YES NA Core needle biopsy 310 NO Positive Positive NA 6 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 true No M0 N1 T3 Stage IIIA NA A18M NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 2001 2147e537-16f0-4bc3-a87f-572f8dcb9191 2147e537-16f0-4bc3-a87f-572f8dcb9191 NA NA NA NA NA NA NA TCGA-BH-A18M-11A-33D-A12E-05 NA TCGA-BH-A18M-11 NA NA 2147e537-16f0-4bc3-a87f-572f8dcb9191 NA NA TCGA-BH-A18M-11 TCGA-BH-A18M-11A-33R-A12D-07 2147e537-16f0-4bc3-a87f-572f8dcb9191 NA |
|
|
688 |
TCGA-BH-A18N-01 Stage IIA 88 3 No_Conversion 1148 1148 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1148 1 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18N-01 1148 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A18N NA NA days 1148 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Left Axillary lymph node dissection alone NA TCGA-BH-A18N-F59153 TCGA-BH-A18N NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -32404 NA 1148 0 NA NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NO 26 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 2 2 NA No M0 N1b T2 Stage IIA NA A18N NA NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA NA NA NO YES BH Breast NA DECEASED 2001 a8884443-832f-45bb-96a0-dead699cc7e3 a8884443-832f-45bb-96a0-dead699cc7e3 TCGA-BH-A18N-01A-21-A13E-20 TCGA-BH-A18N-01A-11D-A12B-09 TCGA-BH-A18N-01 NA f3320803-e927-4d94-aafa-5bc8cef352f9 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11D-A12B-09 TCGA-BH-A18N-01A-11D-A12E-05 TCGA-BH-A18N-01 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11D-A12B-09 NA a8884443-832f-45bb-96a0-dead699cc7e3 NA TCGA-BH-A18N-01A-11D-A12A-01 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11R-A12D-07 a8884443-832f-45bb-96a0-dead699cc7e3 TCGA-BH-A18N-01A-11D-A12A-01 TCGA-BH-A18N-01 |
|
|
689 |
TCGA-BH-A18N-11 NA 88 NA NA 1148 1148 NA FEMALE NA NA NA NA NA NA NA NA 1148 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18N-11 1148 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A18N NA NA days 1148 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Left Axillary lymph node dissection alone NA TCGA-BH-A18N-F59153 TCGA-BH-A18N TCGA-BH-A18N-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -32404 3374 1148 0 NA NA NA NA NA NO NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 590 NO Negative NA NO 26 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 true No M0 N1b T2 Stage IIA NA A18N NA NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 NA NA NA NO YES BH Breast A DECEASED 2001 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 NA NA NA NA 3A6CFBA6-849B-416F-A652-F3540DEBEB02 NA NA TCGA-BH-A18N-11A-43D-A12E-05 NA TCGA-BH-A18N-11 NA NA d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 NA NA TCGA-BH-A18N-11 TCGA-BH-A18N-11A-43R-A12D-07 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 NA |
|
|
690 |
TCGA-BH-A18P-01 Stage I 60 2 Stage I 921 921 Positive FEMALE Negative 1 3 1 Negative M0 Negative N0 921 1 Her2 HER2-enriched Negative X -1 -1 enrollment T1 T1 DECEASED 1 TCGA-BH-A18P-01 921 1 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-BH-A18P NA NA days 921 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left Lower Inner Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18P TCGA-BH-A18P-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -22222 2639 921 0 NA NA NA NA NA NA NA <10% NA NA 2011-6-22 FEMALE NA NA 10-19% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.3 8500/3 C50.3 1+ YES NA Fine needle aspiration biopsy 230 NO Positive Positive NA 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1 Stage I TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D.pdf A18P WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 6th NA NO YES BH Breast A DECEASED 2003 3b48796b-8591-4d7a-a502-5c4293647156 3b48796b-8591-4d7a-a502-5c4293647156 TCGA-BH-A18P-01A-21-A13F-20 TCGA-BH-A18P-01A-11D-A12B-09 TCGA-BH-A18P-01 NA dc104da8-075e-46cb-b43b-d1c5bda730d3 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11D-A12B-09 TCGA-BH-A18P-01A-11D-A12E-05 TCGA-BH-A18P-01 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11D-A12B-09 NA 3b48796b-8591-4d7a-a502-5c4293647156 NA TCGA-BH-A18P-01A-11D-A12A-01 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11R-A12D-07 3b48796b-8591-4d7a-a502-5c4293647156 TCGA-BH-A18P-01A-11D-A12A-01 TCGA-BH-A18P-01 |
|
|
691 |
TCGA-BH-A18P-11 NA 60 NA NA 921 921 NA FEMALE NA NA NA NA NA NA NA NA 921 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18P-11 921 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A18P NA NA days 921 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left Lower Inner Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18P TCGA-BH-A18P-11A NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -22222 2639 921 0 NA NA NA NA NA NA NA <10% NA NA 2011-6-22 FEMALE NA NA 10-19% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.3 8500/3 C50.3 1+ YES NA Fine needle aspiration biopsy 520 NO Positive Positive NA 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1 Stage I NA A18P WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 6th NA NO YES BH Breast A DECEASED 2003 08236177-a046-4cfe-a11c-a24292a1f777 08236177-a046-4cfe-a11c-a24292a1f777 NA NA NA NA 5C2F7AFD-3F6E-46BB-A17B-F10BE5E243FC NA NA TCGA-BH-A18P-11A-43D-A12E-05 NA TCGA-BH-A18P-11 NA NA 08236177-a046-4cfe-a11c-a24292a1f777 NA NA TCGA-BH-A18P-11 TCGA-BH-A18P-11A-43R-A12D-07 08236177-a046-4cfe-a11c-a24292a1f777 NA |
|
|
692 |
TCGA-BH-A18Q-01 Stage IIB 56 1 No_Conversion 1692 1692 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1692 1 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18Q-01 1692 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 5 mutation cluster 13 TCGA-BH-A18Q NA NA days 1692 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Axillary lymph node dissection alone NA NA TCGA-BH-A18Q TCGA-BH-A18Q-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -20675 3417 1692 0 NA NA NA NA NA NA NA NA NA NA 2011-6-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.8 8500/3 C50.8 NA YES NA Core needle biopsy 130 NO Positive Negative NA 25 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA 2 2 true No M0 N1b T2 Stage IIB TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf A18Q NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA NA NA NO YES BH Breast A DECEASED 2001 2c75afc3-11b5-444d-b6e0-61d76b299f40 2c75afc3-11b5-444d-b6e0-61d76b299f40 TCGA-BH-A18Q-01A-21-A13E-20 TCGA-BH-A18Q-01A-12D-A12B-09 TCGA-BH-A18Q-01 NA 44798c24-89d7-4d25-a4bc-3d2fab66b4e8 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12D-A12B-09 TCGA-BH-A18Q-01A-12D-A12E-05 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12D-A12B-09 NA 2c75afc3-11b5-444d-b6e0-61d76b299f40 NA TCGA-BH-A18Q-01A-12D-A12A-01 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12R-A12D-07 2c75afc3-11b5-444d-b6e0-61d76b299f40 TCGA-BH-A18Q-01A-12D-A12A-01 TCGA-BH-A18Q-01 |
|
|
693 |
TCGA-BH-A18Q-11 NA 56 NA NA 1692 1692 NA FEMALE NA NA NA NA NA NA NA NA 1692 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18Q-11 1692 1 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 13 TCGA-BH-A18Q NA NA days 1692 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Axillary lymph node dissection alone NA NA TCGA-BH-A18Q TCGA-BH-A18Q-11A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -20675 3417 1692 0 NA NA NA NA NA NA NA NA NA NA 2011-6-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.8 8500/3 C50.8 NA YES NA Core needle biopsy 510 NO Positive Negative NA 25 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 true No M0 N1b T2 Stage IIB NA A18Q NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA NA NA NO YES BH Breast A DECEASED 2001 120bc298-f016-4c80-aa5f-a9006444942c 120bc298-f016-4c80-aa5f-a9006444942c NA NA NA NA E36930F3-2442-4C58-B426-DC2C0CDCB79D NA NA TCGA-BH-A18Q-11A-34D-A12E-05 NA TCGA-BH-A18Q-11 NA NA 120bc298-f016-4c80-aa5f-a9006444942c NA NA TCGA-BH-A18Q-11 TCGA-BH-A18Q-11A-34R-A12D-07 120bc298-f016-4c80-aa5f-a9006444942c NA |
|
|
694 |
TCGA-BH-A18R-01 Stage IB 50 3 No_Conversion 1099 1141 Indeterminate FEMALE Positive 1 1 1 Negative M0 Positive N1 1141 1 Her2 HER2-enriched Negative Her2 -2 0 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18R-01 1142 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A18R NA NA days 1142 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant NA NA NA TCGA-BH-A18R NA NA Indeterminate NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -18524 NA 1142 0 NA NA NA NA NA NO NA 20-29% NA NA 2011-7-3 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy NA NA Positive Positive NA 15 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 10 NA NA No M0 N1 T2b Stage IIA NA A18R TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA NA NA NO YES BH Breast NA DECEASED 2001 b05828bc-eb75-4220-9972-6c6d62fa5303 b05828bc-eb75-4220-9972-6c6d62fa5303 TCGA-BH-A18R-01A-21-A13E-20 TCGA-BH-A18R-01A-11D-A12B-09 TCGA-BH-A18R-01 NA ae2a3335-136b-4a32-b247-5b160862fb22 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11D-A12B-09 TCGA-BH-A18R-01A-11D-A12E-05 TCGA-BH-A18R-01 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11D-A12B-09 NA b05828bc-eb75-4220-9972-6c6d62fa5303 NA TCGA-BH-A18R-01A-11D-A12A-01 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11R-A12D-07 b05828bc-eb75-4220-9972-6c6d62fa5303 TCGA-BH-A18R-01A-11D-A12A-01 TCGA-BH-A18R-01 |
|
|
695 |
TCGA-BH-A18R-11 NA 50 NA NA 1099 1141 NA FEMALE NA NA NA NA NA NA NA NA 1141 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18R-11 1142 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A18R NA NA days 1142 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant NA NA NA TCGA-BH-A18R TCGA-BH-A18R-11A NA Indeterminate NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -18524 3571 1142 0 NA NA NA NA NA NO NA 20-29% NA NA 2011-7-3 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 350 NO Positive Positive NA 15 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 10 NA true No M0 N1 T2b Stage IIA NA A18R TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA NA NA NO YES BH Breast A DECEASED 2001 5462aaff-d060-4ba7-9ab5-0e6977accb91 5462aaff-d060-4ba7-9ab5-0e6977accb91 NA NA NA NA 0F909B7E-B7B3-4B79-B3E6-31BAAFFFA9C6 NA NA TCGA-BH-A18R-11A-42D-A12E-05 NA TCGA-BH-A18R-11 NA NA 5462aaff-d060-4ba7-9ab5-0e6977accb91 NA NA TCGA-BH-A18R-11 TCGA-BH-A18R-11A-42R-A12D-07 5462aaff-d060-4ba7-9ab5-0e6977accb91 NA |
|
|
696 |
TCGA-BH-A18S-01 Stage I 79 5 Stage I 2009 2009 Positive FEMALE NA 3 3 3 Negative M0 Negative N0 2009 1 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 DECEASED 1 TCGA-BH-A18S-01 2009 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 12 TCGA-BH-A18S NA NA days 2009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Lower Inner Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18S NA NA Positive NA NA NA NA Positive Other NA NA NA NA -28974 NA 2009 0 NA NA NA NA NA NA NA NA NA NA 2011-7-2 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.3 8523/3 C50.3 NA YES NA Core needle biopsy NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 T1c Stage I NA A18S TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 total mastectomy 6th NA NO YES BH Breast NA DECEASED 2003 cf00b389-d06b-4dd5-9b18-737b06ab9bed cf00b389-d06b-4dd5-9b18-737b06ab9bed TCGA-BH-A18S-01A-21-A13E-20 TCGA-BH-A18S-01A-11D-A12B-09 TCGA-BH-A18S-01 NA cd625353-3b48-44c0-9695-074db13850d9 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11D-A12B-09 TCGA-BH-A18S-01A-11D-A12E-05 TCGA-BH-A18S-01 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11D-A12B-09 NA cf00b389-d06b-4dd5-9b18-737b06ab9bed NA TCGA-BH-A18S-01A-11D-A12A-01 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11R-A12D-07 cf00b389-d06b-4dd5-9b18-737b06ab9bed TCGA-BH-A18S-01A-11D-A12A-01 TCGA-BH-A18S-01 |
|
|
697 |
TCGA-BH-A18S-11 NA 79 NA NA 2009 2009 NA FEMALE NA NA NA NA NA NA NA NA 2009 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18S-11 2009 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 12 TCGA-BH-A18S NA NA days 2009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Lower Inner Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18S NA NA Positive NA NA NA NA Positive Other NA NA NA NA -28974 NA 2009 0 NA NA NA NA NA NA NA NA NA NA 2011-7-2 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.3 8523/3 C50.3 NA YES NA Core needle biopsy NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 T1c Stage I NA A18S TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 total mastectomy 6th NA NO YES BH Breast NA DECEASED 2003 fa7bcdff-10e1-44f1-86ed-90fab26bc61f fa7bcdff-10e1-44f1-86ed-90fab26bc61f NA NA NA NA NA NA NA TCGA-BH-A18S-11A-43D-A12E-05 NA TCGA-BH-A18S-11 NA NA fa7bcdff-10e1-44f1-86ed-90fab26bc61f NA NA TCGA-BH-A18S-11 TCGA-BH-A18S-11A-43R-A12D-07 fa7bcdff-10e1-44f1-86ed-90fab26bc61f NA |
|
|
698 |
TCGA-BH-A18T-01 Stage IIA 70 1 Stage IIA 224 224 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 224 1 Basal Luminal A Negative ReacII 0 -3 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18T-01 224 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-BH-A18T NA NA days 224 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Outer Quadrant Sentinel node biopsy alone NA NA TCGA-BH-A18T TCGA-BH-A18T-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -25674 2737 224 0 NA NA NA NA NA NA NA NA NA NA 2011-7-2 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 210 NO Positive Negative NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NA NA NA true No M0 N0 T2 Stage IIA TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf A18T WITH TUMOR NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 segmental mastectomy 6th NA NO YES BH Breast A DECEASED 2003 733890d7-6557-454e-8697-fe9c619874e3 733890d7-6557-454e-8697-fe9c619874e3 TCGA-BH-A18T-01A-21-A13E-20 TCGA-BH-A18T-01A-11D-A12B-09 TCGA-BH-A18T-01 NA 169f872a-65f6-40ae-8cd9-948822cc3a20 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11D-A12B-09 TCGA-BH-A18T-01A-11D-A12E-05 TCGA-BH-A18T-01 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11D-A12B-09 NA 733890d7-6557-454e-8697-fe9c619874e3 NA TCGA-BH-A18T-01A-11D-A12A-01 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11R-A12D-07 733890d7-6557-454e-8697-fe9c619874e3 TCGA-BH-A18T-01A-11D-A12A-01 TCGA-BH-A18T-01 |
|
|
699 |
TCGA-BH-A18U-01 Stage IIIA 72 3 Stage IIIA 1317 1563 Positive FEMALE Positive 4 5 4 Negative M0 Positive N2 1563 1 LumB Luminal B Positive ReacI -2 -5 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18U-01 1563 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-BH-A18U NA NA days 1563 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-BH-A18U TCGA-BH-A18U-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26426 2697 1563 0 NA NA NA NA NA NA NA NA NA NA 2011-7-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.4 8500/3 C50.4 NA YES NA Core needle biopsy 530 NO Positive NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NA 9 NA true No M0 N2a T2 Stage IIIA TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf A18U TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 total mastectomy 6th NA NO YES BH Breast A DECEASED 2003 f6e76192-c4ed-485f-bb51-1b752bd7f544 f6e76192-c4ed-485f-bb51-1b752bd7f544 TCGA-BH-A18U-01A-31-A13E-20 TCGA-BH-A18U-01A-21D-A12B-09 TCGA-BH-A18U-01 NA 12e8835a-7f82-4402-929a-bdce63fee8ed TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21D-A12B-09 TCGA-BH-A18U-01A-21D-A12E-05 TCGA-BH-A18U-01 TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21D-A12B-09 NA f6e76192-c4ed-485f-bb51-1b752bd7f544 NA TCGA-BH-A18U-01A-21D-A12A-01 TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21R-A12D-07 f6e76192-c4ed-485f-bb51-1b752bd7f544 TCGA-BH-A18U-01A-21D-A12A-01 TCGA-BH-A18U-01 |
|
|
700 |
TCGA-BH-A18U-11 NA 72 NA NA 1317 1563 NA FEMALE NA NA NA NA NA NA NA NA 1563 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18U-11 1563 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 13 TCGA-BH-A18U NA NA days 1563 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-BH-A18U TCGA-BH-A18U-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -26426 2697 1563 0 NA NA NA NA NA NA NA NA NA NA 2011-7-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.4 8500/3 C50.4 NA YES NA Core needle biopsy 230 NO Positive NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 9 NA true No M0 N2a T2 Stage IIIA NA A18U TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 total mastectomy 6th NA NO YES BH Breast A DECEASED 2003 02222fea-f3da-4328-8188-8ef24d1f55e4 02222fea-f3da-4328-8188-8ef24d1f55e4 NA NA NA NA NA NA NA TCGA-BH-A18U-11A-23D-A12E-05 NA TCGA-BH-A18U-11 NA NA 02222fea-f3da-4328-8188-8ef24d1f55e4 NA NA TCGA-BH-A18U-11 TCGA-BH-A18U-11A-23R-A12D-07 02222fea-f3da-4328-8188-8ef24d1f55e4 NA |
|
|
701 |
TCGA-BH-A18V-01 Stage IIB 48 1 No_Conversion 1555 1555 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1555 1 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 DECEASED 1 TCGA-BH-A18V-01 1556 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 2 TCGA-BH-A18V NA NA days 1556 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Axillary lymph node dissection alone NA NA TCGA-BH-A18V TCGA-BH-A18V-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -17682 3621 1556 0 NA NA NA NA NA YES NA NA NA NA 2011-7-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.4 8500/3 C50.4 NA YES NA Core needle biopsy 300 NO Negative NA NA 25 Negative NA NA Negative NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative Other, specify axilaary node negative but intrammary node positive 5 5 NA NA NA NA NA NA NA NA 0 NA true No M0 N1b T2 Stage IIB TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf A18V NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 Modified radical mastectomy with left breast biopsy 5th NA NO YES BH Breast A DECEASED 2001 429b50eb-316f-459c-bc3a-0aca6e6dba46 429b50eb-316f-459c-bc3a-0aca6e6dba46 NA TCGA-BH-A18V-01A-11D-A12B-09 TCGA-BH-A18V-01 NA 7bf9da92-5872-4f29-ba4d-f247ec7984f0 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11D-A12B-09 TCGA-BH-A18V-01A-11D-A12E-05 TCGA-BH-A18V-01 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11D-A12B-09 NA 429b50eb-316f-459c-bc3a-0aca6e6dba46 NA TCGA-BH-A18V-01A-11D-A12A-01 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11R-A12D-07 429b50eb-316f-459c-bc3a-0aca6e6dba46 TCGA-BH-A18V-01A-11D-A12A-01 TCGA-BH-A18V-01 |
|
|
702 |
TCGA-BH-A18V-06 NA 48 NA NA 1555 1555 NA FEMALE NA NA NA NA NA NA NA NA 1555 1 Basal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18V-06 1556 1 days NA C4-BRCA/Basal NA BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 11 NA mutation cluster 2 TCGA-BH-A18V NA NA days 1556 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Axillary lymph node dissection alone NA NA TCGA-BH-A18V NA NA Negative NA NA NA NA Negative Other NA NA NA NA -17682 NA 1556 0 NA NA NA NA NA YES NA NA NA NA 2011-7-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.4 8500/3 C50.4 NA YES NA Core needle biopsy NA NA Negative NA NA 25 Negative NA NA Negative NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative Other, specify axilaary node negative but intrammary node positive NA NA NA NA NA NA NA NA NA NA 0 NA NA No M0 N1b T2 Stage IIB NA A18V NA NA NA NA NA NA NA YES NA NA NA Metastatic 06 Modified radical mastectomy with left breast biopsy 5th NA NO YES BH Breast NA DECEASED 2001 ded1efed-b3b9-4d1a-b4c9-b595543fc461 ded1efed-b3b9-4d1a-b4c9-b595543fc461 TCGA-BH-A18V-06A-21-A24B-20 NA NA TCGA-BH-A18V-06A-11D-A212-05 f03d8a09-8fcf-4f2b-a5b3-ac6ffb2c0681 NA TCGA-BH-A18V-06A-11D-A20S-09 NA NA TCGA-BH-A18V-06 NA NA ded1efed-b3b9-4d1a-b4c9-b595543fc461 NA NA TCGA-BH-A18V-06 NA ded1efed-b3b9-4d1a-b4c9-b595543fc461 NA |
|
|
703 |
TCGA-BH-A18V-11 NA 48 NA NA 1555 1555 NA FEMALE NA NA NA NA NA NA NA NA 1555 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A18V-11 1556 1 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 2 TCGA-BH-A18V NA NA days 1556 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Axillary lymph node dissection alone NA NA TCGA-BH-A18V TCGA-BH-A18V-11A NA Negative NA NA NA NA Negative Other NA NA NA NA -17682 3621 1556 0 NA NA NA NA NA YES NA NA NA NA 2011-7-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.4 8500/3 C50.4 NA YES NA Core needle biopsy 450 NO Negative NA NA 25 Negative NA NA Negative NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative Other, specify axilaary node negative but intrammary node positive NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N1b T2 Stage IIB NA A18V NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 Modified radical mastectomy with left breast biopsy 5th NA NO YES BH Breast A DECEASED 2001 288c81eb-4c43-406b-a5e5-fee452a95afb 288c81eb-4c43-406b-a5e5-fee452a95afb NA NA NA NA 1D76CB85-A291-45F8-88B0-29D72E04FA07 NA NA TCGA-BH-A18V-11A-52D-A12E-05 NA NA NA NA 288c81eb-4c43-406b-a5e5-fee452a95afb NA NA NA TCGA-BH-A18V-11A-52R-A12D-07 288c81eb-4c43-406b-a5e5-fee452a95afb NA |
|
|
704 |
TCGA-BH-A1EN-01 Stage IIA 78 3 Stage IIA NA 2052 Negative FEMALE Positive NA NA NA Negative M0 Negative N0 2052 1 Her2 NA Negative NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1EN-01 2127 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A1EN NA NA days 2127 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right NA NA NA TCGA-BH-A1EN TCGA-BH-A1EN-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -28724 4343 2127 0 NA NA NA NA NA NO NA NA NA NA 2011-9-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 140 NO Positive NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 3 NA NA NA NA NA NA NA NA NA NA true No M0 NX T2 Stage IIA TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf A1EN TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 right segmental mastectomy 5th NA NO YES BH Breast A DECEASED 1999 a6db80e4-b161-412d-932a-fe2898a1722f a6db80e4-b161-412d-932a-fe2898a1722f TCGA-BH-A1EN-01A-21-A17I-20 TCGA-BH-A1EN-01A-11D-A17G-09 TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A13K-05 8de8ac77-d6ea-437d-9ca8-ef6f5480eb1b TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A17G-09 NA NA TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A17G-09 NA a6db80e4-b161-412d-932a-fe2898a1722f NA TCGA-BH-A1EN-01A-11D-A13J-01 TCGA-BH-A1EN-01 NA a6db80e4-b161-412d-932a-fe2898a1722f TCGA-BH-A1EN-01A-11D-A13J-01 |
|
|
705 |
TCGA-BH-A1EN-11 NA 78 NA NA NA 2052 NA FEMALE NA NA NA NA NA NA NA NA 2052 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EN-11 2127 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1EN NA NA days 2127 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right NA NA NA TCGA-BH-A1EN NA NA Negative NA NA NA NA Negative Other NA NA NA NA -28724 NA 2127 0 NA NA NA NA NA NO NA NA NA NA 2011-9-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy NA NA Positive NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA No M0 NX T2 Stage IIA NA A1EN TUMOR FREE NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 right segmental mastectomy 5th NA NO YES BH Breast NA DECEASED 1999 c03683bd-2fe1-4ab2-9a16-796553be5467 c03683bd-2fe1-4ab2-9a16-796553be5467 NA NA NA TCGA-BH-A1EN-11A-23D-A13T-05 NA NA NA NA NA TCGA-BH-A1EN-11 NA NA c03683bd-2fe1-4ab2-9a16-796553be5467 NA NA TCGA-BH-A1EN-11 NA c03683bd-2fe1-4ab2-9a16-796553be5467 NA |
|
|
706 |
TCGA-BH-A1EO-01 Stage IIA 68 3 Stage IIA NA 2798 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2798 1 LumA Luminal A Positive NA -5 -3 enrollment T1 T1 DECEASED 1 TCGA-BH-A1EO-01 2798 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A1EO NA NA days 2798 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right NA NA NA TCGA-BH-A1EO TCGA-BH-A1EO-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25136 4330 2798 0 NA NA NA NA NA NO NA NA NA NA 2011-9-6 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) ductal and lobular features No NA C50.9 8522/3 C50.9 NA YES NA Excisional Biopsy 100 NO Negative NA NA 15 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T1c Stage IIA TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf A1EO TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 right segmental mastectomy witrh axillary node dissection 5th NA NO YES BH Breast A DECEASED 1999 e6f1450a-6731-4593-82c3-28f839ebf148 e6f1450a-6731-4593-82c3-28f839ebf148 TCGA-BH-A1EO-01A-21-A17I-20 TCGA-BH-A1EO-01A-11D-A135-09 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A138-05 819bff28-56b5-455b-b86d-c803b081d75e TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A135-09 NA TCGA-BH-A1EO-01 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A135-09 NA e6f1450a-6731-4593-82c3-28f839ebf148 NA TCGA-BH-A1EO-01A-11D-A134-01 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11R-A137-07 e6f1450a-6731-4593-82c3-28f839ebf148 TCGA-BH-A1EO-01A-11D-A134-01 TCGA-BH-A1EO-01 |
|
|
707 |
TCGA-BH-A1EO-11 NA 68 NA NA NA 2798 NA FEMALE NA NA NA NA NA NA NA NA 2798 1 LumA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EO-11 2798 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1EO NA NA days 2798 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right NA NA NA TCGA-BH-A1EO TCGA-BH-A1EO-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -25136 4330 2798 0 NA NA NA NA NA NO NA NA NA NA 2011-9-6 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) ductal and lobular features No NA C50.9 8522/3 C50.9 NA YES NA Excisional Biopsy 250 NO Negative NA NA 15 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T1c Stage IIA NA A1EO TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 right segmental mastectomy witrh axillary node dissection 5th NA NO YES BH Breast A DECEASED 1999 71cc9cf0-2992-4ac6-8642-6fdb66958fca 71cc9cf0-2992-4ac6-8642-6fdb66958fca NA NA NA TCGA-BH-A1EO-11A-31D-A138-05 NA NA NA NA NA NA NA NA 71cc9cf0-2992-4ac6-8642-6fdb66958fca NA NA NA TCGA-BH-A1EO-11A-31R-A137-07 71cc9cf0-2992-4ac6-8642-6fdb66958fca NA |
|
|
708 |
TCGA-BH-A1ES-01 Stage IIB 35 5 Stage IIB NA 3462 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 3462 1 LumA Luminal A Positive NA -9 -3 enrollment T_Other T2 DECEASED 1 TCGA-BH-A1ES-01 3462 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A1ES NA NA days 3462 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Inner Quadrant NA NA NA TCGA-BH-A1ES NA NA Positive NA NA NA NA Positive Other NA NA NA NA -13138 NA 3462 0 NA NA NA NA NA NO NA NA NA NA 2011-9-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 4 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NA 1 NA NA No M0 N1a T2 Stage IIB NA A1ES WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NA NO YES BH Breast NA DECEASED 1999 cbb45082-6d4e-4457-b023-52f9372ae053 cbb45082-6d4e-4457-b023-52f9372ae053 NA TCGA-BH-A1ES-01A-11D-A135-09 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A138-05 e6c70136-ae35-4294-a16d-5673f0edbea5 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A135-09 NA TCGA-BH-A1ES-01 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A135-09 NA cbb45082-6d4e-4457-b023-52f9372ae053 NA TCGA-BH-A1ES-01A-11D-A134-01 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11R-A137-07 cbb45082-6d4e-4457-b023-52f9372ae053 TCGA-BH-A1ES-01A-11D-A134-01 TCGA-BH-A1ES-01 |
|
|
709 |
TCGA-BH-A1ES-06 NA 35 NA NA NA 3462 NA FEMALE NA NA NA NA NA NA NA NA 3462 1 NA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1ES-06 3462 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1ES NA NA days 3462 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Inner Quadrant NA NA NA TCGA-BH-A1ES TCGA-BH-A1ES-06A NA Positive NA NA NA NA Positive Other NA NA NA NA -13138 4787 3462 0 NA NA NA NA NA NO NA NA NA NA 2011-9-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 400 NO Negative NA NA 4 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB TCGA-BH-A1ES.7222C51A-3A1E-454B-A0E4-B8A0BBA042E4.pdf A1ES WITH TUMOR NA NA NA NA NA NA YES NA NA NA Metastatic 06 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NA NO YES BH Breast A DECEASED 1999 fc895598-73b9-4269-a250-52e4475c6be7 fc895598-73b9-4269-a250-52e4475c6be7 TCGA-BH-A1ES-06A-21-A24B-20 NA NA TCGA-BH-A1ES-06A-12D-A244-05 21ae0b23-d3aa-4b22-a3c7-3eb6d8e98a26 NA TCGA-BH-A1ES-06A-12D-A243-09 NA NA TCGA-BH-A1ES-06 NA NA fc895598-73b9-4269-a250-52e4475c6be7 NA NA TCGA-BH-A1ES-06 NA fc895598-73b9-4269-a250-52e4475c6be7 NA |
|
|
710 |
TCGA-BH-A1ES-11 NA 35 NA NA NA 3462 NA FEMALE NA NA NA NA NA NA NA NA 3462 1 NA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1ES-11 3462 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1ES NA NA days 3462 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Upper Inner Quadrant NA NA NA TCGA-BH-A1ES TCGA-BH-A1ES-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -13138 4242 3462 0 NA NA NA NA NA NO NA NA NA NA 2011-9-6 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 340 NO Negative NA NA 4 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1a T2 Stage IIB NA A1ES WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NA NO YES BH Breast A DECEASED 1999 NA NA NA NA NA TCGA-BH-A1ES-11A-33D-A138-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
711 |
TCGA-BH-A1ET-01 Stage IIA 55 2 Stage I NA 2520 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2520 1 LumA Luminal A Positive NA -12 -7 enrollment T1 T1 DECEASED 1 TCGA-BH-A1ET-01 2520 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A1ET NA NA days 2520 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left NA NA NA TCGA-BH-A1ET NA NA Positive NA NA NA NA Positive Other NA NA NA NA -20425 NA 2520 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 19 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 1 NA NA No M0 N0 T1 Stage I NA A1ET TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 Left segmental mastectomy with left axillary lymph node dissection 5th NA NO YES BH Breast NA DECEASED 1999 b0388c2e-0793-4084-bcc3-454c2ec88931 b0388c2e-0793-4084-bcc3-454c2ec88931 TCGA-BH-A1ET-01A-21-A17I-20 TCGA-BH-A1ET-01A-11D-A135-09 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A138-05 a8e7241b-076a-4fa3-83da-755694823091 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A135-09 NA TCGA-BH-A1ET-01 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A135-09 NA b0388c2e-0793-4084-bcc3-454c2ec88931 NA TCGA-BH-A1ET-01A-11D-A134-01 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11R-A137-07 b0388c2e-0793-4084-bcc3-454c2ec88931 TCGA-BH-A1ET-01A-11D-A134-01 TCGA-BH-A1ET-01 |
|
|
712 |
TCGA-BH-A1ET-11 NA 55 NA NA NA 2520 NA FEMALE NA NA NA NA NA NA NA NA 2520 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1ET-11 2520 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A1ET NA NA days 2520 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left NA NA NA TCGA-BH-A1ET TCGA-BH-A1ET-11B NA Positive NA NA NA NA Positive Other NA NA NA NA -20425 4137 2520 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 380 NO Negative NA NA 19 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA false No M0 N0 T1 Stage I NA A1ET TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 Left segmental mastectomy with left axillary lymph node dissection 5th NA NO YES BH Breast B DECEASED 1999 ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be NA NA NA TCGA-BH-A1ET-11B-23D-A138-05 48D344A0-2C10-412C-A51E-BB830474D9D5 NA NA NA NA TCGA-BH-A1ET-11 NA NA ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be NA NA TCGA-BH-A1ET-11 TCGA-BH-A1ET-11B-23R-A137-07 ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be NA |
|
|
713 |
TCGA-BH-A1EU-01 Stage I 83 1 Stage I NA 1286 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1286 1 LumA Luminal A Positive NA -5 -7 enrollment T1 T1 DECEASED 1 TCGA-BH-A1EU-01 1286 1 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A1EU NA NA days 1286 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Right NA NA NA TCGA-BH-A1EU TCGA-BH-A1EU-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -30339 4106 1286 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 410 NO Negative NA NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA NA NA true No M0 N0 T1 Stage I TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf A1EU TUMOR FREE NA NA NA NA NA NA NO NA NA NA Primary Tumor 01 Right segmental mastectomy 5th NA NO YES BH Breast A DECEASED 1999 bfeed1cc-e0f8-493f-a950-829ecb3acccc bfeed1cc-e0f8-493f-a950-829ecb3acccc TCGA-BH-A1EU-01A-21-A17I-20 TCGA-BH-A1EU-01A-11D-A135-09 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A138-05 73eb0467-0d24-4ef1-b0e6-ca457ad24f09 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A135-09 NA TCGA-BH-A1EU-01 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A135-09 NA bfeed1cc-e0f8-493f-a950-829ecb3acccc NA TCGA-BH-A1EU-01A-11D-A134-01 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11R-A137-07 bfeed1cc-e0f8-493f-a950-829ecb3acccc TCGA-BH-A1EU-01A-11D-A134-01 TCGA-BH-A1EU-01 |
|
|
714 |
TCGA-BH-A1EU-11 NA 83 NA NA NA 1286 NA FEMALE NA NA NA NA NA NA NA NA 1286 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EU-11 1286 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A1EU NA NA days 1286 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 83 Right NA NA NA TCGA-BH-A1EU TCGA-BH-A1EU-11A NA Positive NA NA NA NA Positive NA NA NA NA NA -30339 4106 1286 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 240 NO Negative NA NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA true No M0 N0 T1 Stage I NA A1EU TUMOR FREE NA NA NA NA NA NA NO NA NA NA Solid Tissue Normal 11 Right segmental mastectomy 5th NA NO YES BH Breast A DECEASED 1999 9e12314d-d1f0-44be-93f7-e50a56f86b46 9e12314d-d1f0-44be-93f7-e50a56f86b46 NA NA NA TCGA-BH-A1EU-11A-23D-A138-05 NA NA NA NA NA TCGA-BH-A1EU-11 NA NA 9e12314d-d1f0-44be-93f7-e50a56f86b46 NA NA TCGA-BH-A1EU-11 TCGA-BH-A1EU-11A-23R-A137-07 9e12314d-d1f0-44be-93f7-e50a56f86b46 NA |
|
|
715 |
TCGA-BH-A1EV-01 NA 45 2 NA NA 365 Positive FEMALE NA NA NA NA NA NA NA NA 365 1 Her2 HER2-enriched Positive NA -1 -5 enrollment NA NA DECEASED 1 TCGA-BH-A1EV-01 365 1 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 5 TCGA-BH-A1EV 365 0 days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left NA NA TCGA-BH-A1EV-F59154 TCGA-BH-A1EV TCGA-BH-A1EV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16504 4103 365 0 NA NA NA NA NA NA NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 600 NO Positive NA NO 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 3 NA true No M0 N1b T3 Stage IIIA TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf A1EV WITH TUMOR NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1999 4dac7a33-db46-4815-8c6c-fb326959c741 4dac7a33-db46-4815-8c6c-fb326959c741 TCGA-BH-A1EV-01A-21-A17I-20 TCGA-BH-A1EV-01A-11D-A135-09 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A138-05 59c3ce2b-d84e-4d4a-b6dc-ffdb9e3a34f5 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A135-09 NA TCGA-BH-A1EV-01 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A135-09 NA 4dac7a33-db46-4815-8c6c-fb326959c741 NA TCGA-BH-A1EV-01A-11D-A134-01 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11R-A137-07 4dac7a33-db46-4815-8c6c-fb326959c741 TCGA-BH-A1EV-01A-11D-A134-01 TCGA-BH-A1EV-01 |
|
|
716 |
TCGA-BH-A1EV-11 NA 45 NA NA NA 365 NA FEMALE NA NA NA NA NA NA NA NA 365 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EV-11 365 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1EV 365 0 days 365 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left NA NA TCGA-BH-A1EV-F59154 TCGA-BH-A1EV TCGA-BH-A1EV-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16504 4103 365 0 NA NA NA NA NA NA NA NA NA NA 2014-5-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 580 NO Positive NA NO 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1b T3 Stage IIIA NA A1EV WITH TUMOR NA NA NA NA NA NO YES NA NA YES Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1999 7b234c36-729b-422d-8e2a-ebd42af74bce 7b234c36-729b-422d-8e2a-ebd42af74bce NA NA NA TCGA-BH-A1EV-11A-24D-A138-05 NA NA NA NA NA TCGA-BH-A1EV-11 NA NA 7b234c36-729b-422d-8e2a-ebd42af74bce NA NA TCGA-BH-A1EV-11 NA 7b234c36-729b-422d-8e2a-ebd42af74bce NA |
|
|
717 |
TCGA-BH-A1EW-01 Stage IIA 38 3 No_Conversion NA 1694 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 1694 1 LumA Luminal B Negative NA -3 -3 enrollment T_Other T2 DECEASED 1 TCGA-BH-A1EW-01 1694 1 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A1EW NA NA days 1694 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Upper Outer Quadrant NA NA NA TCGA-BH-A1EW TCGA-BH-A1EW-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -14090 4230 1694 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 550 NO Negative NA NA 16 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 1 NA true No M0 N1b T2 Stage IIA TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf A1EW WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 Left segmental mastectomy with level 1 and level 2 axillary dissection 5th NA NO YES BH Breast A DECEASED 1999 59783c67-6446-44c1-b9b3-505470f54c82 59783c67-6446-44c1-b9b3-505470f54c82 TCGA-BH-A1EW-01A-21-A17I-20 TCGA-BH-A1EW-01A-11D-A135-09 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A138-05 fd676c7e-c137-4699-a8ea-57b72b10ff5b TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A135-09 NA TCGA-BH-A1EW-01 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A135-09 NA 59783c67-6446-44c1-b9b3-505470f54c82 NA TCGA-BH-A1EW-01A-11D-A134-01 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11R-A137-07 59783c67-6446-44c1-b9b3-505470f54c82 TCGA-BH-A1EW-01A-11D-A134-01 TCGA-BH-A1EW-01 |
|
|
718 |
TCGA-BH-A1EW-11 NA 38 NA NA NA 1694 NA FEMALE NA NA NA NA NA NA NA NA 1694 1 LumA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EW-11 1694 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1EW NA NA days 1694 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Upper Outer Quadrant NA NA NA TCGA-BH-A1EW TCGA-BH-A1EW-11B NA Negative NA NA NA NA Negative Other NA NA NA NA -14090 4230 1694 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 1030 NO Negative NA NA 16 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA false No M0 N1b T2 Stage IIA NA A1EW WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 Left segmental mastectomy with level 1 and level 2 axillary dissection 5th NA NO YES BH Breast B DECEASED 1999 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 NA NA NA TCGA-BH-A1EW-11B-33D-A138-05 6AC30F47-7622-4DBF-94E9-4E6D93D8442F NA NA NA NA TCGA-BH-A1EW-11 NA NA cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 NA NA TCGA-BH-A1EW-11 TCGA-BH-A1EW-11B-33R-A137-07 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 NA |
|
|
719 |
TCGA-BH-A1EX-01 Stage IIB 67 3 Stage IIB NA 1508 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1508 1 LumA NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1EX-01 1508 1 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A1EX NA NA days 1508 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Lower Inner Quadrant NA NA NA TCGA-BH-A1EX NA NA Positive NA NA NA NA Positive Other NA NA NA NA -24544 NA 1508 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive Negative NA 24 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NA 2 NA NA No M0 N1b T2 Stage IIB NA A1EX WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy 5th NA NO YES BH Breast NA DECEASED 2000 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 TCGA-BH-A1EX-01A-21-A17I-20 TCGA-BH-A1EX-01A-11D-A13L-09 TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13K-05 e4809caf-a1a9-4d9f-807f-530ae7c2e434 TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13L-09 NA NA TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13L-09 NA b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 NA TCGA-BH-A1EX-01A-11D-A13J-01 TCGA-BH-A1EX-01 NA b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 TCGA-BH-A1EX-01A-11D-A13J-01 |
|
|
720 |
TCGA-BH-A1EY-01 Stage IIA 79 2 Stage IIA NA 538 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 538 1 LumA NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1EY-01 538 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-BH-A1EY 396 1 days 538 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant NA NA TCGA-BH-A1EY-F59173 TCGA-BH-A1EY TCGA-BH-A1EY-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -28940 3840 538 0 NA NA NA 396 NA NA NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 290 NO Negative NA NO 12 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA Lung Distant Metastasis Liver NA YES 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf A1EY WITH TUMOR NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 2000 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce TCGA-BH-A1EY-01A-21-A17I-20 TCGA-BH-A1EY-01A-11D-A13L-09 TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13K-05 7de680e0-63d0-41b4-ace3-82a8e80aaae3 TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13L-09 NA NA TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13L-09 NA 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce NA TCGA-BH-A1EY-01A-11D-A13J-01 TCGA-BH-A1EY-01 NA 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce TCGA-BH-A1EY-01A-11D-A13J-01 |
|
|
721 |
TCGA-BH-A1EY-11 NA 79 NA NA NA 538 NA FEMALE NA NA NA NA NA NA NA NA 538 1 NA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1EY-11 538 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A1EY 396 1 days 538 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant NA NA TCGA-BH-A1EY-F59173 TCGA-BH-A1EY TCGA-BH-A1EY-11B NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -28940 3840 538 0 NA NA NA 396 NA NA NA NA NA NA 2014-5-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 450 NO Negative NA NO 12 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis Liver NA YES 0 NA false No M0 N0 T2 Stage IIA NA A1EY WITH TUMOR NA NA NA NA NA NO YES NA NA NO Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 2000 NA NA NA NA NA TCGA-BH-A1EY-11B-21D-A13T-05 A5047A5B-665D-4C47-ADC8-1DFDF0180130 NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
722 |
TCGA-BH-A1F0-01 Stage IIA 80 1 Stage IIA NA 785 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 785 1 Basal Basal-like Indeterminate NA -13 -12 enrollment T1 T1 DECEASED 1 TCGA-BH-A1F0-01 785 1 days High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 6 mutation cluster 5 TCGA-BH-A1F0 NA NA days 785 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left NA NA NA TCGA-BH-A1F0 NA NA Negative NA NA NA NA Indeterminate Modified Radical Mastectomy NA NA NA NA -29335 NA 785 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 9 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NA 1 NA NA No M0 N1c T1a Stage IIA NA A1F0 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast NA DECEASED 2000 d31b476c-c047-4e5f-a0cb-eff1065f0121 d31b476c-c047-4e5f-a0cb-eff1065f0121 TCGA-BH-A1F0-01A-21-A17I-20 TCGA-BH-A1F0-01A-11D-A135-09 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A138-05 a4bd17eb-0741-4d81-b457-158367d20ae9 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A135-09 NA TCGA-BH-A1F0-01 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A135-09 NA d31b476c-c047-4e5f-a0cb-eff1065f0121 NA TCGA-BH-A1F0-01A-11D-A134-01 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11R-A137-07 d31b476c-c047-4e5f-a0cb-eff1065f0121 TCGA-BH-A1F0-01A-11D-A134-01 TCGA-BH-A1F0-01 |
|
|
723 |
TCGA-BH-A1F0-11 NA 80 NA NA NA 785 NA FEMALE NA NA NA NA NA NA NA NA 785 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F0-11 785 1 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1F0 NA NA days 785 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left NA NA NA TCGA-BH-A1F0 TCGA-BH-A1F0-11B NA Negative NA NA NA NA Indeterminate Modified Radical Mastectomy NA NA NA NA -29335 3879 785 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 180 NO Negative NA NA 9 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA false No M0 N1c T1a Stage IIA NA A1F0 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 2000 889f6f61-9b3a-406c-9af8-ddee74a8a19e 889f6f61-9b3a-406c-9af8-ddee74a8a19e NA NA NA TCGA-BH-A1F0-11B-23D-A138-05 NA NA NA NA NA TCGA-BH-A1F0-11 NA NA 889f6f61-9b3a-406c-9af8-ddee74a8a19e NA NA TCGA-BH-A1F0-11 TCGA-BH-A1F0-11B-23R-A137-07 889f6f61-9b3a-406c-9af8-ddee74a8a19e NA |
|
|
724 |
TCGA-BH-A1F2-01 Stage IIIB 53 5 Stage NA 959 Positive FEMALE Positive NA NA NA Negative M0 Positive N1 959 1 LumB NA Positive NA NA NA enrollment T_Other T4 DECEASED 1 TCGA-BH-A1F2-01 959 1 days High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 14 TCGA-BH-A1F2 NA NA days 959 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left NA NA NA TCGA-BH-A1F2 TCGA-BH-A1F2-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19701 4147 959 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8541/3 C50.9 NA YES NA Core needle biopsy 230 NO Positive NA NA 19 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NA 6 NA true No M0 N1b T4b Stage IIIB TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf A1F2 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1999 dbba4276-4b85-4309-8f98-951313c3a3dc dbba4276-4b85-4309-8f98-951313c3a3dc TCGA-BH-A1F2-01A-21-A17I-20 TCGA-BH-A1F2-01A-31D-A13L-09 TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13K-05 9c29c7e9-78b0-434d-a795-343fa6d8d937 TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13L-09 NA NA TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13L-09 NA dbba4276-4b85-4309-8f98-951313c3a3dc NA TCGA-BH-A1F2-01A-31D-A13J-01 TCGA-BH-A1F2-01 NA dbba4276-4b85-4309-8f98-951313c3a3dc TCGA-BH-A1F2-01A-31D-A13J-01 |
|
|
725 |
TCGA-BH-A1F2-11 NA 53 NA NA NA 959 NA FEMALE NA NA NA NA NA NA NA NA 959 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F2-11 959 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 14 TCGA-BH-A1F2 NA NA days 959 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left NA NA NA TCGA-BH-A1F2 TCGA-BH-A1F2-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19701 4147 959 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8541/3 C50.9 NA YES NA Core needle biopsy 270 NO Positive NA NA 19 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA true No M0 N1b T4b Stage IIIB NA A1F2 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1999 85e9922a-0ede-4fea-8338-ead05addef79 85e9922a-0ede-4fea-8338-ead05addef79 NA NA NA TCGA-BH-A1F2-11A-32D-A13T-05 NA NA NA NA NA TCGA-BH-A1F2-11 NA NA 85e9922a-0ede-4fea-8338-ead05addef79 NA NA TCGA-BH-A1F2-11 NA 85e9922a-0ede-4fea-8338-ead05addef79 NA |
|
|
726 |
TCGA-BH-A1F5-01 NA 62 NA NA NA 2712 Positive FEMALE NA NA NA NA NA NA NA NA 2712 1 LumA NA Positive NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F5-01 2712 1 days Kirc+ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation c1uster 9 TCGA-BH-A1F5 NA NA days 2712 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right NA NA NA TCGA-BH-A1F5 TCGA-BH-A1F5-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -22842 3091 2712 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true Yes M0 N1a T1c Stage IIA TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf A1F5 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 2002 07c52f68-8ece-4702-8573-9b21f32df787 07c52f68-8ece-4702-8573-9b21f32df787 TCGA-BH-A1F5-01A-21-A17I-20 TCGA-BH-A1F5-01A-12D-A13L-09 TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13K-05 07dd3a1f-05f8-488d-9b80-4fe5b94923c4 TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13L-09 NA NA TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13L-09 NA 07c52f68-8ece-4702-8573-9b21f32df787 NA TCGA-BH-A1F5-01A-12D-A13J-01 TCGA-BH-A1F5-01 NA 07c52f68-8ece-4702-8573-9b21f32df787 TCGA-BH-A1F5-01A-12D-A13J-01 |
|
|
727 |
TCGA-BH-A1F5-11 NA 62 NA NA NA 2712 NA FEMALE NA NA NA NA NA NA NA NA 2712 1 NA NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F5-11 2712 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1F5 NA NA days 2712 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right NA NA NA TCGA-BH-A1F5 TCGA-BH-A1F5-11A NA Positive NA NA NA NA Positive NA NA NA NA NA -22842 3091 2712 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO Negative NA NA 4 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true Yes M0 N1a T1c Stage IIA NA A1F5 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 2002 NA NA NA NA NA TCGA-BH-A1F5-11A-43D-A13T-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
728 |
TCGA-BH-A1F6-01 NA 51 NA NA NA 2965 Negative FEMALE NA NA NA NA NA NA NA NA 2965 1 Basal NA Negative NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F6-01 2965 1 days High C4-BRCA/Basal NA BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 NA mutation cluster 5 TCGA-BH-A1F6 NA NA days 2965 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left NA NA NA TCGA-BH-A1F6 TCGA-BH-A1F6-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -18691 5230 2965 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 360 NO Negative NA NA 6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA true No MX N2a T4d NA TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf A1F6 NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA NA NA NO YES BH Breast A DECEASED 1996 5f5a884c-ffbd-401a-8689-baded1bdbe50 5f5a884c-ffbd-401a-8689-baded1bdbe50 TCGA-BH-A1F6-01A-21-A17I-20 TCGA-BH-A1F6-01A-11D-A13L-09 TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13K-05 9e1df13d-422b-46a6-8dd0-0f3d943c301b TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13L-09 NA NA TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13L-09 NA 5f5a884c-ffbd-401a-8689-baded1bdbe50 NA TCGA-BH-A1F6-01A-11D-A13J-01 TCGA-BH-A1F6-01 NA 5f5a884c-ffbd-401a-8689-baded1bdbe50 TCGA-BH-A1F6-01A-11D-A13J-01 |
|
|
729 |
TCGA-BH-A1F6-11 NA 51 NA NA NA 2965 NA FEMALE NA NA NA NA NA NA NA NA 2965 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F6-11 2965 1 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1F6 NA NA days 2965 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left NA NA NA TCGA-BH-A1F6 NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -18691 NA 2965 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NA 6 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA NA No MX N2a T4d NA NA A1F6 NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA NA NA NO YES BH Breast NA DECEASED 1996 a248476b-7c40-42c6-905b-b9c3ba6b2aed a248476b-7c40-42c6-905b-b9c3ba6b2aed NA NA NA TCGA-BH-A1F6-11B-94D-A13T-05 NA NA NA NA NA TCGA-BH-A1F6-11 NA NA a248476b-7c40-42c6-905b-b9c3ba6b2aed NA NA TCGA-BH-A1F6-11 NA a248476b-7c40-42c6-905b-b9c3ba6b2aed NA |
|
|
730 |
TCGA-BH-A1F8-01 Stage IIIB 90 1 Stage IIIC NA 749 Positive FEMALE Negative NA NA NA Negative M0 Positive N2 749 1 LumB NA Positive NA NA NA enrollment T_Other T4 DECEASED 1 TCGA-BH-A1F8-01 763 1 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation cluster 4 TCGA-BH-A1F8 NA NA days 763 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Left NA NA NA TCGA-BH-A1F8 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -32871 NA 763 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive NA NA 13 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 12 NA NA No M0 N2 T4b Stage IIIB NA A1F8 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast NA DECEASED 1999 ca39657a-073d-4b89-a3da-900f7c9f1012 ca39657a-073d-4b89-a3da-900f7c9f1012 TCGA-BH-A1F8-01A-21-A17I-20 TCGA-BH-A1F8-01A-11D-A13L-09 TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13K-05 bcc978dd-e7cd-4cff-be13-d6f0926dfc9d TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13L-09 NA NA TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13L-09 NA ca39657a-073d-4b89-a3da-900f7c9f1012 NA TCGA-BH-A1F8-01A-11D-A13J-01 TCGA-BH-A1F8-01 NA ca39657a-073d-4b89-a3da-900f7c9f1012 TCGA-BH-A1F8-01A-11D-A13J-01 |
|
|
731 |
TCGA-BH-A1F8-11 NA 90 NA NA NA 749 NA FEMALE NA NA NA NA NA NA NA NA 749 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1F8-11 763 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A1F8 NA NA days 763 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Left NA NA NA TCGA-BH-A1F8 TCGA-BH-A1F8-11B NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -32871 4301 763 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 750 NO Positive NA NA 13 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 12 NA false No M0 N2 T4b Stage IIIB NA A1F8 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1999 c6cc7496-98d2-4181-8517-fbd875fd5623 c6cc7496-98d2-4181-8517-fbd875fd5623 NA NA NA TCGA-BH-A1F8-11B-21D-A13T-05 80FD1099-D66E-4A9A-AA9E-CB7D0178D612 NA NA NA NA TCGA-BH-A1F8-11 NA NA c6cc7496-98d2-4181-8517-fbd875fd5623 NA NA TCGA-BH-A1F8-11 NA c6cc7496-98d2-4181-8517-fbd875fd5623 NA |
|
|
732 |
TCGA-BH-A1FB-01 Stage IIB 60 4 Stage IIB NA 3669 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 3669 1 LumA NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FB-01 3669 1 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 NA TCGA-BH-A1FB NA NA days 3669 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right NA NA NA TCGA-BH-A1FB TCGA-BH-A1FB-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -21933 3871 3669 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NA 15 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N1b T2 Stage IIB TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf A1FB WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 segmental mastectomy with sentinel lymph node dissection 5th NA NO YES BH Breast A DECEASED 2000 5b262ec0-72f2-4c54-820e-a39afad67212 5b262ec0-72f2-4c54-820e-a39afad67212 TCGA-BH-A1FB-01A-21-A17I-20 NA TCGA-BH-A1FB-01 TCGA-BH-A1FB-01A-11D-A13K-05 ee88f81e-c7f3-41b4-a115-751d02d07fd0 TCGA-BH-A1FB-01 NA NA NA TCGA-BH-A1FB-01 NA NA 5b262ec0-72f2-4c54-820e-a39afad67212 NA TCGA-BH-A1FB-01A-11D-A13J-01 TCGA-BH-A1FB-01 NA 5b262ec0-72f2-4c54-820e-a39afad67212 TCGA-BH-A1FB-01A-11D-A13J-01 |
|
|
733 |
TCGA-BH-A1FB-11 NA 60 NA NA NA 3669 NA FEMALE NA NA NA NA NA NA NA NA 3669 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FB-11 3669 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA NA TCGA-BH-A1FB NA NA days 3669 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right NA NA NA TCGA-BH-A1FB TCGA-BH-A1FB-11A NA Positive NA NA NA NA Positive NA NA NA NA NA -21933 3871 3669 0 NA NA NA NA NA NA NA NA NA NA 2011-9-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 320 NO Negative NA NA 15 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N1b T2 Stage IIB NA A1FB WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 segmental mastectomy with sentinel lymph node dissection 5th NA NO YES BH Breast A DECEASED 2000 71899388-d223-4774-a1ce-3be260240b2c 71899388-d223-4774-a1ce-3be260240b2c NA NA NA TCGA-BH-A1FB-11A-33D-A13T-05 NA NA NA NA NA TCGA-BH-A1FB-11 NA NA 71899388-d223-4774-a1ce-3be260240b2c NA NA TCGA-BH-A1FB-11 NA 71899388-d223-4774-a1ce-3be260240b2c NA |
|
|
734 |
TCGA-BH-A1FC-01 Stage IIA 78 4 Stage IIA NA 3471 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 3471 1 Basal NA Negative NA NA NA enrollment T1 T1 DECEASED 1 TCGA-BH-A1FC-01 3472 1 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-BH-A1FC NA NA days 3472 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FC TCGA-BH-A1FC-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -28706 4456 3472 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Fine needle aspiration biopsy 90 NO Negative NA NA 23 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NA 1 NA true No M0 N1b T1c Stage IIA TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf A1FC TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 localized segmental mastectomy with axillary node dissection 5th NA NO YES BH Breast A DECEASED 1998 42e2160c-07b5-4be6-a989-1e3474926d2a 42e2160c-07b5-4be6-a989-1e3474926d2a TCGA-BH-A1FC-01A-21-A17I-20 TCGA-BH-A1FC-01A-11D-A13L-09 TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13K-05 9ce04c0d-97f2-4acd-a985-c9b162221210 TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13L-09 NA NA TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13L-09 NA 42e2160c-07b5-4be6-a989-1e3474926d2a NA TCGA-BH-A1FC-01A-11D-A13J-01 TCGA-BH-A1FC-01 NA 42e2160c-07b5-4be6-a989-1e3474926d2a TCGA-BH-A1FC-01A-11D-A13J-01 |
|
|
735 |
TCGA-BH-A1FC-11 NA 78 NA NA NA 3471 NA FEMALE NA NA NA NA NA NA NA NA 3471 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FC-11 3472 1 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1FC NA NA days 3472 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FC TCGA-BH-A1FC-11A NA Negative NA NA NA NA Negative Other NA NA NA NA -28706 4456 3472 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Fine needle aspiration biopsy 260 NO Negative NA NA 23 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1b T1c Stage IIA NA A1FC TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 localized segmental mastectomy with axillary node dissection 5th NA NO YES BH Breast A DECEASED 1998 58e94be5-2da2-4a96-944a-060f20216572 58e94be5-2da2-4a96-944a-060f20216572 NA NA NA TCGA-BH-A1FC-11A-32D-A13T-05 NA NA NA NA NA TCGA-BH-A1FC-11 NA NA 58e94be5-2da2-4a96-944a-060f20216572 NA NA TCGA-BH-A1FC-11 NA 58e94be5-2da2-4a96-944a-060f20216572 NA |
|
|
736 |
TCGA-BH-A1FD-01 Stage I 68 4 Stage I NA 1008 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1008 1 LumB NA Positive NA NA NA enrollment T1 T1 DECEASED 1 TCGA-BH-A1FD-01 1009 1 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 3 TCGA-BH-A1FD NA NA days 1009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left NA NA NA TCGA-BH-A1FD TCGA-BH-A1FD-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -24940 4420 1009 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 19 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1c Stage I TCGA-BH-A1FD.9F838476-4DF1-44D6-989F-33A1D490424B.pdf A1FD WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1998 744ed141-8809-4bc9-90e6-74098383914e 744ed141-8809-4bc9-90e6-74098383914e TCGA-BH-A1FD-01A-21-A17I-20 TCGA-BH-A1FD-01A-11W-A14Q-09 TCGA-BH-A1FD-01 TCGA-BH-A1FD-01A-11D-A13K-05 7c4d6492-831a-4535-b46f-7fdcafd3dcdf TCGA-BH-A1FD-01 TCGA-BH-A1FD-01A-11W-A14Q-09 NA NA NA TCGA-BH-A1FD-01A-11W-A14Q-09 NA 744ed141-8809-4bc9-90e6-74098383914e NA TCGA-BH-A1FD-01A-11D-A13J-01 NA NA 744ed141-8809-4bc9-90e6-74098383914e TCGA-BH-A1FD-01A-11D-A13J-01 |
|
|
737 |
TCGA-BH-A1FD-11 NA 68 NA NA NA 1008 NA FEMALE NA NA NA NA NA NA NA NA 1008 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FD-11 1009 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A1FD NA NA days 1009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left NA NA NA TCGA-BH-A1FD TCGA-BH-A1FD-11B NA Positive NA NA NA NA Positive NA NA NA NA NA -24940 4420 1009 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 440 NO Negative NA NA 19 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA false No M0 N0 T1c Stage I NA A1FD WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1998 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 NA NA NA TCGA-BH-A1FD-11B-21D-A13T-05 81425ECA-DA4A-428C-BAAE-E3B55821C356 NA NA NA NA TCGA-BH-A1FD-11 NA NA e0ed3e93-0ead-4fc0-a82d-79807c7d5162 NA NA TCGA-BH-A1FD-11 NA e0ed3e93-0ead-4fc0-a82d-79807c7d5162 NA |
|
|
738 |
TCGA-BH-A1FE-01 Stage IIB 31 2 Stage IIB NA 2273 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 2273 1 LumA NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FE-01 2273 1 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-BH-A1FE NA NA days 2273 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 31 Left NA NA NA TCGA-BH-A1FE TCGA-BH-A1FE-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -11650 4456 2273 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO NA NA NA 12 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf A1FE WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1998 2cb3a793-6e37-42fd-a544-65aa2d939d50 2cb3a793-6e37-42fd-a544-65aa2d939d50 NA TCGA-BH-A1FE-01A-11D-A13L-09 TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13K-05 8e3a6a91-27f1-497a-84dc-76ab2ee74185 TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13L-09 NA NA TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13L-09 NA 2cb3a793-6e37-42fd-a544-65aa2d939d50 NA TCGA-BH-A1FE-01A-11D-A13J-01 TCGA-BH-A1FE-01 NA 2cb3a793-6e37-42fd-a544-65aa2d939d50 TCGA-BH-A1FE-01A-11D-A13J-01 |
|
|
739 |
TCGA-BH-A1FE-06 NA 31 NA NA NA 2273 NA FEMALE NA NA NA NA NA NA NA NA 2273 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FE-06 2273 1 days NA C3-BRCA/Luminal NA Low purity c2 NA GBM-like c6 miRNA cluster 5 NA mutation cluster 3 TCGA-BH-A1FE NA NA days 2273 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 31 Left NA NA NA TCGA-BH-A1FE NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -11650 NA 2273 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA NA NA 12 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA No M0 N1 T2 Stage IIB NA A1FE WITH TUMOR NA NA NA NA NA NA YES NA NA NA Metastatic 06 NA 5th NA NO YES BH Breast NA DECEASED 1998 aad871a8-1a52-4e96-8b13-444d08289236 aad871a8-1a52-4e96-8b13-444d08289236 TCGA-BH-A1FE-06A-21-A24B-20 NA NA TCGA-BH-A1FE-06A-11D-A212-05 ee4151b6-cf2c-43e9-b3ed-9407e9e83282 NA NA NA NA TCGA-BH-A1FE-06 TCGA-BH-A1FE-06A-11D-A20S-09 NA aad871a8-1a52-4e96-8b13-444d08289236 NA NA TCGA-BH-A1FE-06 NA aad871a8-1a52-4e96-8b13-444d08289236 NA |
|
|
740 |
TCGA-BH-A1FE-11 NA 31 NA NA NA 2273 NA FEMALE NA NA NA NA NA NA NA NA 2273 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FE-11 2273 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-BH-A1FE NA NA days 2273 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 31 Left NA NA NA TCGA-BH-A1FE TCGA-BH-A1FE-11B NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -11650 4456 2273 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 520 NO NA NA NA 12 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB NA A1FE WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1998 64f3f52d-a484-49c6-9048-6eadedd2c2c5 64f3f52d-a484-49c6-9048-6eadedd2c2c5 NA NA NA TCGA-BH-A1FE-11B-14D-A13T-05 160198A9-3024-40DF-9887-E20F9371AC0A NA NA NA NA TCGA-BH-A1FE-11 NA NA 64f3f52d-a484-49c6-9048-6eadedd2c2c5 NA NA TCGA-BH-A1FE-11 NA 64f3f52d-a484-49c6-9048-6eadedd2c2c5 NA |
|
|
741 |
TCGA-BH-A1FG-01 Stage I 88 4 Stage I NA 3738 Positive FEMALE NA NA NA NA Negative M0 Negative N0 3738 1 LumA NA Positive NA NA NA enrollment T1 T1 DECEASED 1 TCGA-BH-A1FG-01 3736 1 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A1FG NA NA days 3736 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Left NA NA NA TCGA-BH-A1FG TCGA-BH-A1FG-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -32295 4460 3736 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 120 NO Negative NA NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NA NA NA true No M0 NX T1c Stage I TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf A1FG NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 segmental mastectomy 5th NA NO YES BH Breast A DECEASED 1998 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 TCGA-BH-A1FG-01A-21-A17I-20 TCGA-BH-A1FG-01A-11D-A13L-09 TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13K-05 590744af-fc53-40ec-957f-ca5ca31d76c5 TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13L-09 NA NA TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13L-09 NA 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 NA TCGA-BH-A1FG-01A-11D-A13J-01 TCGA-BH-A1FG-01 NA 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 TCGA-BH-A1FG-01A-11D-A13J-01 |
|
|
742 |
TCGA-BH-A1FG-11 NA 88 NA NA NA 3738 NA FEMALE NA NA NA NA NA NA NA NA 3738 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FG-11 3736 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1FG NA NA days 3736 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Left NA NA NA TCGA-BH-A1FG NA NA Positive NA NA NA NA Positive Other NA NA NA NA -32295 NA 3736 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy NA NA Negative NA NA NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA No M0 NX T1c Stage I NA A1FG NA NA NA NA NA NA NA NA NA NA NA Solid Tissue Normal 11 segmental mastectomy 5th NA NO YES BH Breast NA DECEASED 1998 ea037776-3759-425c-a7f4-35e8a5571025 ea037776-3759-425c-a7f4-35e8a5571025 NA NA NA TCGA-BH-A1FG-11B-12D-A13T-05 NA NA NA NA NA TCGA-BH-A1FG-11 NA NA ea037776-3759-425c-a7f4-35e8a5571025 NA NA TCGA-BH-A1FG-11 NA ea037776-3759-425c-a7f4-35e8a5571025 NA |
|
|
743 |
TCGA-BH-A1FH-01 Stage IV 47 4 No_Conversion NA 1123 Positive FEMALE Negative NA NA NA Positive M1 Positive N1 1123 1 LumA NA Negative NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FH-01 1034 1 days Kirc+ C3-BRCA/Luminal cluster 1 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A1FH NA NA days 1034 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant NA NA NA TCGA-BH-A1FH TCGA-BH-A1FH-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -17172 4670 1034 0 NA NA NA NA NA YES NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 430 NO NA NA NA 13 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA 1 6 NA NA NA NA NA NA NA NA 8 NA true No M1 N1b T2 Stage IV TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf A1FH WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1998 693a3c69-75bd-435d-874e-f3b90b7ed180 693a3c69-75bd-435d-874e-f3b90b7ed180 TCGA-BH-A1FH-01A-21-A17I-20 TCGA-BH-A1FH-01A-12D-A13L-09 TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13K-05 c2f9d1f7-4fea-4868-a3ec-58f863b4e449 TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13L-09 NA NA TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13L-09 NA 693a3c69-75bd-435d-874e-f3b90b7ed180 NA TCGA-BH-A1FH-01A-12D-A13J-01 TCGA-BH-A1FH-01 NA 693a3c69-75bd-435d-874e-f3b90b7ed180 TCGA-BH-A1FH-01A-12D-A13J-01 |
|
|
744 |
TCGA-BH-A1FH-11 NA 47 NA NA NA 1123 NA FEMALE NA NA NA NA NA NA NA NA 1123 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FH-11 1034 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1FH NA NA days 1034 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant NA NA NA TCGA-BH-A1FH TCGA-BH-A1FH-11B NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -17172 4670 1034 0 NA NA NA NA NA YES NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO NA NA NA 13 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone NA NA NA NA NA NA NA NA NA NA NA 8 NA false No M1 N1b T2 Stage IV NA A1FH WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1998 1b831e2d-c265-4eac-aee0-248493a14218 1b831e2d-c265-4eac-aee0-248493a14218 NA NA NA TCGA-BH-A1FH-11B-42D-A13T-05 NA NA NA NA NA TCGA-BH-A1FH-11 NA NA 1b831e2d-c265-4eac-aee0-248493a14218 NA NA TCGA-BH-A1FH-11 NA 1b831e2d-c265-4eac-aee0-248493a14218 NA |
|
|
745 |
TCGA-BH-A1FJ-01 Stage IIIA 66 3 Stage IIIA NA 1927 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 1927 1 LumB NA Positive NA NA NA enrollment T_Other T3 DECEASED 1 TCGA-BH-A1FJ-01 1927 1 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-BH-A1FJ NA NA days 1927 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FJ TCGA-BH-A1FJ-01A NA Negative NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -24262 4574 1927 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO NA NA NA 35 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NA 6 NA true No M0 N1b T3 Stage IIIA TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf A1FJ NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1998 28bc840d-296e-436e-93b8-9c28c0eaf47a 28bc840d-296e-436e-93b8-9c28c0eaf47a TCGA-BH-A1FJ-01A-21-A17I-20 TCGA-BH-A1FJ-01A-11D-A13L-09 TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13K-05 1efab28c-3820-4638-b688-f34d0daa58d3 TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13L-09 NA NA TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13L-09 NA 28bc840d-296e-436e-93b8-9c28c0eaf47a NA TCGA-BH-A1FJ-01A-11D-A13J-01 TCGA-BH-A1FJ-01 NA 28bc840d-296e-436e-93b8-9c28c0eaf47a TCGA-BH-A1FJ-01A-11D-A13J-01 |
|
|
746 |
TCGA-BH-A1FJ-11 NA 66 NA NA NA 1927 NA FEMALE NA NA NA NA NA NA NA NA 1927 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FJ-11 1927 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1FJ NA NA days 1927 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FJ TCGA-BH-A1FJ-11B NA Negative NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -24262 4574 1927 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 380 NO NA NA NA 35 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 6 NA false No M0 N1b T3 Stage IIIA NA A1FJ NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1998 3078c384-b624-4f5a-ae36-fc896212e616 3078c384-b624-4f5a-ae36-fc896212e616 NA NA NA TCGA-BH-A1FJ-11B-42D-A13T-05 NA NA NA NA NA TCGA-BH-A1FJ-11 NA NA 3078c384-b624-4f5a-ae36-fc896212e616 NA NA TCGA-BH-A1FJ-11 NA 3078c384-b624-4f5a-ae36-fc896212e616 NA |
|
|
747 |
TCGA-BH-A1FL-01 Stage IIB 69 2 Stage IIIA NA 1673 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1673 1 LumA NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FL-01 1673 1 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-BH-A1FL NA NA days 1673 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Outer Quadrant NA NA NA TCGA-BH-A1FL TCGA-BH-A1FL-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -25558 4572 1673 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 100 NO NA NA NA 22 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NA 4 NA true No M0 N1b T2 Stage IIB TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf A1FL WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection 5th NA NO YES BH Breast A DECEASED 1998 0858a026-142c-4428-b05d-fdc22080afd3 0858a026-142c-4428-b05d-fdc22080afd3 TCGA-BH-A1FL-01A-21-A17I-20 TCGA-BH-A1FL-01A-11D-A13L-09 TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13K-05 dcfae1dd-7e5f-49d7-b3b8-171c97913d1a TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13L-09 NA NA TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13L-09 NA 0858a026-142c-4428-b05d-fdc22080afd3 NA TCGA-BH-A1FL-01A-11D-A13J-01 TCGA-BH-A1FL-01 NA 0858a026-142c-4428-b05d-fdc22080afd3 TCGA-BH-A1FL-01A-11D-A13J-01 |
|
|
748 |
TCGA-BH-A1FM-01 Stage IIIA 44 1 Stage IIIA NA 1388 Positive FEMALE Negative NA NA NA Negative M0 Positive N2 1388 1 LumB NA Negative NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FM-01 1388 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A1FM NA NA days 1388 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FM TCGA-BH-A1FM-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -16289 4753 1388 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO NA NA NA 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NA 8 NA true No M0 N2 T2 Stage IIIA TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf A1FM NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1998 99157b66-ae2a-4ba2-8b28-5653803063a9 99157b66-ae2a-4ba2-8b28-5653803063a9 TCGA-BH-A1FM-01A-21-A17I-20 TCGA-BH-A1FM-01A-11D-A13L-09 TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13K-05 25b0f619-ad2b-437a-bf44-e03cce5ff63f TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13L-09 NA NA TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13L-09 NA 99157b66-ae2a-4ba2-8b28-5653803063a9 NA TCGA-BH-A1FM-01A-11D-A13J-01 TCGA-BH-A1FM-01 NA 99157b66-ae2a-4ba2-8b28-5653803063a9 TCGA-BH-A1FM-01A-11D-A13J-01 |
|
|
749 |
TCGA-BH-A1FM-11 NA 44 NA NA NA 1388 NA FEMALE NA NA NA NA NA NA NA NA 1388 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FM-11 1388 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1FM NA NA days 1388 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FM TCGA-BH-A1FM-11B NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -16289 4753 1388 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO NA NA NA 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 8 NA false No M0 N2 T2 Stage IIIA NA A1FM NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast B DECEASED 1998 39ec3623-c15f-4af6-b2df-5413eec21bec 39ec3623-c15f-4af6-b2df-5413eec21bec NA NA NA TCGA-BH-A1FM-11B-23D-A13T-05 NA NA NA NA NA TCGA-BH-A1FM-11 NA NA 39ec3623-c15f-4af6-b2df-5413eec21bec NA NA TCGA-BH-A1FM-11 NA 39ec3623-c15f-4af6-b2df-5413eec21bec NA |
|
|
750 |
TCGA-BH-A1FN-01 Stage IIA 34 1 Stage IIA NA 2192 Positive FEMALE Negative NA NA NA Negative M0 Negative N0 2192 1 LumB NA Positive NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-BH-A1FN-01 2192 1 days High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A1FN NA NA days 2192 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FN TCGA-BH-A1FN-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -12525 4838 2192 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO NA NA NA 29 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf A1FN WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 segmental mastectomy with axillary lymph node dissection 5th NA NO YES BH Breast A DECEASED 1997 c870e04b-c3b7-495c-8465-7ef2a00fadc7 c870e04b-c3b7-495c-8465-7ef2a00fadc7 TCGA-BH-A1FN-01A-21-A17I-20 TCGA-BH-A1FN-01A-11D-A13L-09 TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13K-05 3d0671e6-de93-4023-b91c-66a2e311fed6 TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13L-09 NA NA TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13L-09 NA c870e04b-c3b7-495c-8465-7ef2a00fadc7 NA TCGA-BH-A1FN-01A-11D-A13J-01 TCGA-BH-A1FN-01 NA c870e04b-c3b7-495c-8465-7ef2a00fadc7 TCGA-BH-A1FN-01A-11D-A13J-01 |
|
|
751 |
TCGA-BH-A1FN-11 NA 34 NA NA NA 2192 NA FEMALE NA NA NA NA NA NA NA NA 2192 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FN-11 2192 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1FN NA NA days 2192 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FN TCGA-BH-A1FN-11A NA Positive NA NA NA NA Positive Other NA NA NA NA -12525 4838 2192 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NO NA NA NA 29 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA NA A1FN WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 segmental mastectomy with axillary lymph node dissection 5th NA NO YES BH Breast A DECEASED 1997 48353101-484c-4d47-ae60-239d710ec00a 48353101-484c-4d47-ae60-239d710ec00a NA NA NA TCGA-BH-A1FN-11A-34D-A13T-05 BAC42747-AC16-4A8B-A673-236A4F3F0568 NA NA NA NA TCGA-BH-A1FN-11 NA NA 48353101-484c-4d47-ae60-239d710ec00a NA NA TCGA-BH-A1FN-11 NA 48353101-484c-4d47-ae60-239d710ec00a NA |
|
|
752 |
TCGA-BH-A1FR-01 Stage IIIB 73 1 No_Conversion NA 4398 Positive FEMALE Negative NA NA NA Negative M0 Positive N1 4398 1 LumA NA Positive NA NA NA enrollment T_Other T4 DECEASED 1 TCGA-BH-A1FR-01 1642 1 days Quiet C3-BRCA/Luminal cluster 2 KIRC-like c17 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A1FR NA NA days 1642 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right Upper Inner Quadrant NA NA NA TCGA-BH-A1FR TCGA-BH-A1FR-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -26684 4876 1642 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Core needle biopsy 110 NO NA NA NA 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NA 4 NA true No M0 N1a T4b Stage IIIB TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf A1FR WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 segmental mastectomy with excision of mass on chest wall and axillary node dissection 5th NA NO YES BH Breast A DECEASED 1997 56d5aac4-62b4-43e4-b0e4-f40b19a5893f 56d5aac4-62b4-43e4-b0e4-f40b19a5893f TCGA-BH-A1FR-01A-21-A17I-20 TCGA-BH-A1FR-01A-11D-A13L-09 TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13K-05 a20031de-1d1e-4019-8d09-d8810bea4462 TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13L-09 NA NA TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13L-09 NA 56d5aac4-62b4-43e4-b0e4-f40b19a5893f NA TCGA-BH-A1FR-01A-11D-A13J-01 TCGA-BH-A1FR-01 NA 56d5aac4-62b4-43e4-b0e4-f40b19a5893f TCGA-BH-A1FR-01A-11D-A13J-01 |
|
|
753 |
TCGA-BH-A1FR-11 NA 73 NA NA NA 4398 NA FEMALE NA NA NA NA NA NA NA NA 4398 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FR-11 1642 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-BH-A1FR NA NA days 1642 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right Upper Inner Quadrant NA NA NA TCGA-BH-A1FR NA NA Positive NA NA NA NA Positive Other NA NA NA NA -26684 NA 1642 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Core needle biopsy NA NA NA NA NA 10 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA No M0 N1a T4b Stage IIIB NA A1FR WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 segmental mastectomy with excision of mass on chest wall and axillary node dissection 5th NA NO YES BH Breast NA DECEASED 1997 c2db17b1-c288-4f73-8e22-22929d846678 c2db17b1-c288-4f73-8e22-22929d846678 NA NA NA TCGA-BH-A1FR-11B-42D-A13T-05 NA NA NA NA NA TCGA-BH-A1FR-11 NA NA c2db17b1-c288-4f73-8e22-22929d846678 NA NA TCGA-BH-A1FR-11 NA c2db17b1-c288-4f73-8e22-22929d846678 NA |
|
|
754 |
TCGA-BH-A1FU-01 Stage IA 44 4 Stage I NA 2192 Negative FEMALE Positive NA NA NA Negative M0 Negative N0 2192 1 Normal NA Negative NA NA NA enrollment T1 T1 DECEASED 1 TCGA-BH-A1FU-01 1688 1 days Kirc+ C3-BRCA/Luminal cluster 1 Cluster 5 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-BH-A1FU NA NA days 1688 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FU TCGA-BH-A1FU-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -16174 5041 1688 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 110 NO NA NA NA 5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1c Stage IA TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf A1FU WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1997 05a4f4ff-cdfd-4332-8146-066657a4c3cc 05a4f4ff-cdfd-4332-8146-066657a4c3cc NA TCGA-BH-A1FU-01A-11D-A14G-09 TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14H-05 NA TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14G-09 NA NA TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14G-09 NA 05a4f4ff-cdfd-4332-8146-066657a4c3cc NA TCGA-BH-A1FU-01A-11D-A14F-01 TCGA-BH-A1FU-01 NA 05a4f4ff-cdfd-4332-8146-066657a4c3cc TCGA-BH-A1FU-01A-11D-A14F-01 |
|
|
755 |
TCGA-BH-A1FU-11 NA 44 NA NA NA 2192 NA FEMALE NA NA NA NA NA NA NA NA 2192 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A1FU-11 1688 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-BH-A1FU NA NA days 1688 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant NA NA NA TCGA-BH-A1FU NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -16174 NA 1688 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA NA No M0 N0 T1c Stage IA NA A1FU WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast NA DECEASED 1997 df661ba2-098b-49e0-884c-27cf2ecd87f2 df661ba2-098b-49e0-884c-27cf2ecd87f2 NA NA NA NA NA NA NA NA NA TCGA-BH-A1FU-11 NA NA df661ba2-098b-49e0-884c-27cf2ecd87f2 NA NA TCGA-BH-A1FU-11 NA df661ba2-098b-49e0-884c-27cf2ecd87f2 NA |
|
|
756 |
TCGA-BH-A201-01 NA 64 5 NA 209 NA Positive FEMALE NA NA NA NA NA NA NA NA 209 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A201-01 856 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation c1uster 9 TCGA-BH-A201 856 0 days 856 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left NA NA TCGA-BH-A201-F64222 TCGA-BH-A201 TCGA-BH-A201-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23423 86 NA 0 856 NA NA NA NA NA NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 2 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1 Stage IA TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf A201 TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy and wire localization 7th NA NO YES BH Breast A LIVING 2011 a7050752-eefd-4576-a304-c79dc6fa30e7 a7050752-eefd-4576-a304-c79dc6fa30e7 TCGA-BH-A201-01A-21-A17I-20 TCGA-BH-A201-01A-11D-A14K-09 TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14N-05 27773791-0c8a-421a-9469-3e9b93ce80d2 TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14K-09 NA NA TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14K-09 NA a7050752-eefd-4576-a304-c79dc6fa30e7 NA TCGA-BH-A201-01A-11D-A14J-01 TCGA-BH-A201-01 NA a7050752-eefd-4576-a304-c79dc6fa30e7 TCGA-BH-A201-01A-11D-A14J-01 |
|
|
757 |
TCGA-BH-A202-01 NA 60 2 NA 22 NA Positive FEMALE NA NA NA NA NA NA NA NA 22 0 LumB NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A202-01 795 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-BH-A202 795 0 days 795 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left NA NA TCGA-BH-A202-F64226 TCGA-BH-A202 NA NA Positive NA NA NA NA Positive Other NA NA NA NA -22052 NA NA 0 795 NA NA NA NA NA NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Positive NA NO 4 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage II NA A202 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy 6th NA NO YES BH Breast NA LIVING 2011 d3169d74-dd69-4c6b-8232-6e15ac2920b9 d3169d74-dd69-4c6b-8232-6e15ac2920b9 TCGA-BH-A202-01A-21-A17K-20 TCGA-BH-A202-01A-11D-A14K-09 TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14N-05 c393111f-c4f6-473b-a396-05dd90d531e1 TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14K-09 NA NA TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14K-09 NA d3169d74-dd69-4c6b-8232-6e15ac2920b9 NA TCGA-BH-A202-01A-11D-A14J-01 TCGA-BH-A202-01 NA d3169d74-dd69-4c6b-8232-6e15ac2920b9 TCGA-BH-A202-01A-11D-A14J-01 |
|
|
758 |
TCGA-BH-A203-01 NA 78 3 NA NA 1174 NA FEMALE NA NA NA NA NA NA NA NA 1174 1 Her2 NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A203-01 1174 1 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-BH-A203 NA NA days 1174 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right NA NA NA TCGA-BH-A203 TCGA-BH-A203-01A NA NA NA NA NA NA NA Lumpectomy NA NA NA NA -28609 5418 1174 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 340 NO NA NA NA 39 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NA 35 NA true No M0 N1b T2 Stage IIB TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf A203 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1996 ff6fb75e-aefc-44e3-accd-c4f690a51cca ff6fb75e-aefc-44e3-accd-c4f690a51cca TCGA-BH-A203-01A-21-A17K-20 TCGA-BH-A203-01A-12D-A167-09 TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A16A-05 570d0406-4cbb-471f-bf26-b07dd4f927cf TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A167-09 NA NA TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A167-09 NA ff6fb75e-aefc-44e3-accd-c4f690a51cca NA TCGA-BH-A203-01A-12D-A166-01 TCGA-BH-A203-01 NA ff6fb75e-aefc-44e3-accd-c4f690a51cca TCGA-BH-A203-01A-12D-A166-01 |
|
|
759 |
TCGA-BH-A203-11 NA 78 NA NA NA 1174 NA FEMALE NA NA NA NA NA NA NA NA 1174 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A203-11 1174 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-BH-A203 NA NA days 1174 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right NA NA NA TCGA-BH-A203 TCGA-BH-A203-11A NA NA NA NA NA NA NA Lumpectomy NA NA NA NA -28609 5418 1174 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA NA 480 NO NA NA NA 39 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 35 NA false No M0 N1b T2 Stage IIB NA A203 WITH TUMOR NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1996 6e5015d8-55e8-448a-9663-7b8625f170ae 6e5015d8-55e8-448a-9663-7b8625f170ae NA NA NA TCGA-BH-A203-11A-42D-A16A-05 87EB8632-D2C0-4E37-A707-66410942D9A1 NA NA NA NA TCGA-BH-A203-11 NA NA 6e5015d8-55e8-448a-9663-7b8625f170ae NA NA TCGA-BH-A203-11 NA 6e5015d8-55e8-448a-9663-7b8625f170ae NA |
|
|
760 |
TCGA-BH-A204-01 NA 80 4 NA NA 2534 NA FEMALE NA NA NA NA NA NA NA NA 2534 1 LumB NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A204-01 2534 1 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation cluster 14 TCGA-BH-A204 NA NA days 2534 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left NA NA NA TCGA-BH-A204 TCGA-BH-A204-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NA NA NA -29529 5538 2534 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 420 NO NA NA NA 16 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NA 2 NA true No M0 N1b T2 Stage IIB TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf A204 NA NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1996 19c3c4c7-d34c-47d5-b09f-c5671f49b858 19c3c4c7-d34c-47d5-b09f-c5671f49b858 TCGA-BH-A204-01A-21-A17K-20 TCGA-BH-A204-01A-11D-A159-09 TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A161-05 6bf2c85b-1783-4017-9305-e1f18c0e7645 TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A159-09 NA NA TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A159-09 NA 19c3c4c7-d34c-47d5-b09f-c5671f49b858 NA TCGA-BH-A204-01A-11D-A160-01 TCGA-BH-A204-01 NA 19c3c4c7-d34c-47d5-b09f-c5671f49b858 TCGA-BH-A204-01A-11D-A160-01 |
|
|
761 |
TCGA-BH-A204-11 NA 80 NA NA NA 2534 NA FEMALE NA NA NA NA NA NA NA NA 2534 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A204-11 2534 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 14 TCGA-BH-A204 NA NA days 2534 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left NA NA NA TCGA-BH-A204 TCGA-BH-A204-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NA NA NA -29529 5538 2534 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 450 NO NA NA NA 16 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA false No M0 N1b T2 Stage IIB NA A204 NA NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1996 6b52803e-274b-4a1b-910f-2d307932bbb2 6b52803e-274b-4a1b-910f-2d307932bbb2 NA NA NA TCGA-BH-A204-11A-53D-A161-05 NA NA NA NA NA TCGA-BH-A204-11 NA NA 6b52803e-274b-4a1b-910f-2d307932bbb2 NA NA TCGA-BH-A204-11 NA 6b52803e-274b-4a1b-910f-2d307932bbb2 NA |
|
|
762 |
TCGA-BH-A208-01 NA 48 3 NA NA 1759 NA FEMALE NA NA NA NA NA NA NA NA 1759 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A208-01 1759 1 days High C3-BRCA/Luminal cluster 5 OV-like c1 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 11 NA mutation cluster 8 TCGA-BH-A208 NA NA days 1759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left NA NA NA TCGA-BH-A208 TCGA-BH-A208-01A NA NA NA NA NA NA NA Lumpectomy NA NA NA NA -17715 5893 1759 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 620 NO NA NA NA 15 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NA 3 NA true No M0 N1b T2 Stage IIB TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf A208 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1995 7a276d04-8f45-4c07-9c24-8b1f50a1202d 7a276d04-8f45-4c07-9c24-8b1f50a1202d TCGA-BH-A208-01A-21-A17K-20 TCGA-BH-A208-01A-11D-A159-09 TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A161-05 20175b85-f502-4712-aa9d-f3a96c5921f8 TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A159-09 NA NA TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A159-09 NA 7a276d04-8f45-4c07-9c24-8b1f50a1202d NA TCGA-BH-A208-01A-11D-A160-01 TCGA-BH-A208-01 NA 7a276d04-8f45-4c07-9c24-8b1f50a1202d TCGA-BH-A208-01A-11D-A160-01 |
|
|
763 |
TCGA-BH-A208-11 NA 48 NA NA NA 1759 NA FEMALE NA NA NA NA NA NA NA NA 1759 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A208-11 1759 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 8 TCGA-BH-A208 NA NA days 1759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left NA NA NA TCGA-BH-A208 TCGA-BH-A208-11A NA NA NA NA NA NA NA Lumpectomy NA NA NA NA -17715 5893 1759 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 920 NO NA NA NA 15 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA false No M0 N1b T2 Stage IIB NA A208 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1995 a0ac3d9f-7700-4319-929a-fb51d85c9d49 a0ac3d9f-7700-4319-929a-fb51d85c9d49 NA NA NA TCGA-BH-A208-11A-51D-A161-05 CE2C9C0F-7CD7-4C05-AF2F-85D4552F8183 NA NA NA NA TCGA-BH-A208-11 NA NA a0ac3d9f-7700-4319-929a-fb51d85c9d49 NA NA TCGA-BH-A208-11 NA a0ac3d9f-7700-4319-929a-fb51d85c9d49 NA |
|
|
764 |
TCGA-BH-A209-01 NA 77 4 NA NA 3959 Positive FEMALE NA NA NA NA NA NA NA NA 3959 1 LumB NA Positive NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A209-01 3959 1 days High C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 NA mutation cluster 14 TCGA-BH-A209 NA NA days 3959 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Upper Outer Quadrant NA NA NA TCGA-BH-A209 TCGA-BH-A209-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -28403 5392 3959 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Fine needle aspiration biopsy 390 NO NA NA NA 12 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T1c Stage I TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf A209 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 NA 5th NA NO YES BH Breast A DECEASED 1996 9073fc5c-a281-4ed2-a66e-5235a5a55098 9073fc5c-a281-4ed2-a66e-5235a5a55098 TCGA-BH-A209-01A-21-A17K-20 TCGA-BH-A209-01A-11D-A17G-09 TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A161-05 f89486f5-6292-40bd-a4af-ff27eae691aa TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A17G-09 NA NA TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A17G-09 NA 9073fc5c-a281-4ed2-a66e-5235a5a55098 NA TCGA-BH-A209-01A-11D-A160-01 TCGA-BH-A209-01 NA 9073fc5c-a281-4ed2-a66e-5235a5a55098 TCGA-BH-A209-01A-11D-A160-01 |
|
|
765 |
TCGA-BH-A209-11 NA 77 NA NA NA 3959 NA FEMALE NA NA NA NA NA NA NA NA 3959 1 Normal NA NA NA NA NA enrollment NA NA DECEASED 1 TCGA-BH-A209-11 3959 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 14 TCGA-BH-A209 NA NA days 3959 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Upper Outer Quadrant NA NA NA TCGA-BH-A209 TCGA-BH-A209-11A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -28403 5392 3959 0 NA NA NA NA NA NA NA NA NA NA 2011-9-8 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Fine needle aspiration biopsy 400 NO NA NA NA 12 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 NA false No M0 N0 T1c Stage I NA A209 TUMOR FREE NA NA NA NA NA NA YES NA NA NA Solid Tissue Normal 11 NA 5th NA NO YES BH Breast A DECEASED 1996 7a4e994d-ed10-45e7-9107-51dc02068963 7a4e994d-ed10-45e7-9107-51dc02068963 NA NA NA TCGA-BH-A209-11A-42D-A161-05 NA NA NA NA NA TCGA-BH-A209-11 NA NA 7a4e994d-ed10-45e7-9107-51dc02068963 NA NA TCGA-BH-A209-11 NA 7a4e994d-ed10-45e7-9107-51dc02068963 NA |
|
|
766 |
TCGA-BH-A28O-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A28O-01 1120 0 days Quiet NA NA Low purity c2 NA NA miRNA cluster 4 NA NA TCGA-BH-A28O 1120 0 days 1120 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A28O-F64237 TCGA-BH-A28O TCGA-BH-A28O-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -18501 163 NA 0 1120 NA NA NA NA NO NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO Negative NA NO 14 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 14 NA true No M0 N3 T3a Stage IIIC TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf A28O TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Segmental mastectomy 7th NA YES NO BH Breast A LIVING 2010 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b NA NA TCGA-BH-A28O-01 TCGA-BH-A28O-01A-11D-A22B-05 NA TCGA-BH-A28O-01 TCGA-BH-A28O-01A-11D-A228-09 NA NA TCGA-BH-A28O-01 NA NA 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b NA TCGA-BH-A28O-01A-11D-A227-01 TCGA-BH-A28O-01 NA 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b TCGA-BH-A28O-01A-11D-A227-01 |
|
|
767 |
TCGA-BH-A28Q-01 NA 46 2 NA 196 NA Positive FEMALE NA NA NA NA NA NA NA NA 196 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-BH-A28Q-01 1119 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 NA mutation c1uster 9 TCGA-BH-A28Q 1119 0 days 1119 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right NA NA TCGA-BH-A28Q-F64272 TCGA-BH-A28Q TCGA-BH-A28Q-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16882 223 NA 0 1119 NA NA NA NA NA NA NA NA NA 2014-8-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 400 NO Negative Indeterminate NO 18 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf A28Q TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA NO YES BH Breast A LIVING 2010 5427eb83-38f3-4258-b241-25efae8fa70a 5427eb83-38f3-4258-b241-25efae8fa70a TCGA-BH-A28Q-01A-21-A17K-20 TCGA-BH-A28Q-01A-11D-A16D-09 TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16G-05 45d40b9a-e057-4d32-b7f5-46d9d4e89d89 TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16D-09 NA NA TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16D-09 NA 5427eb83-38f3-4258-b241-25efae8fa70a NA TCGA-BH-A28Q-01A-11D-A16C-01 TCGA-BH-A28Q-01 NA 5427eb83-38f3-4258-b241-25efae8fa70a TCGA-BH-A28Q-01A-11D-A16C-01 |
|
|
768 |
TCGA-BH-A2L8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A2L8-01 612 0 days Kirc+ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-BH-A2L8 612 0 days 612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A2L8-F39616 TCGA-BH-A2L8 TCGA-BH-A2L8-01A NA Positive NA NA NA NA Positive Other NA NO NA NA -16658 86 NA 0 612 NA NA NA NA NO NA 70-79% NA NA 2013-1-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf A2L8 TUMOR FREE NA NA NA Oncotype Dx test Oncotype Dx test YES YES 80-89% NA NO Primary Tumor 01 TOTAL MASTECTOMY 7th NA YES NO BH Breast A LIVING 2011 c55bb0b8-3417-4142-97f8-c43f1ec56496 c55bb0b8-3417-4142-97f8-c43f1ec56496 TCGA-BH-A2L8-01A-21-A24A-20 NA TCGA-BH-A2L8-01 TCGA-BH-A2L8-01A-11D-A18O-05 0c505acf-0d07-4d38-a4cb-ad0311c255b3 TCGA-BH-A2L8-01 TCGA-BH-A2L8-01A-11D-A18P-09 NA NA TCGA-BH-A2L8-01 NA NA c55bb0b8-3417-4142-97f8-c43f1ec56496 NA TCGA-BH-A2L8-01A-11D-A18N-01 TCGA-BH-A2L8-01 NA c55bb0b8-3417-4142-97f8-c43f1ec56496 TCGA-BH-A2L8-01A-11D-A18N-01 |
|
|
769 |
TCGA-BH-A42T-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-BH-A42T-01 320 1 days NA NA NA NA NA NA NA NA NA TCGA-BH-A42T 320 0 days 320 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Sentinel node biopsy alone NA TCGA-BH-A42T-F61922 TCGA-BH-A42T TCGA-BH-A42T-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -27731 80 320 0 30 NA NA NA NA NA NA NA NA NA 2014-7-10 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 130 NO Positive Equivocal NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 1 true No M0 N0 (i+) T2 Stage IIA TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf A42T TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast A DECEASED 2012 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 NA NA TCGA-BH-A42T-01 TCGA-BH-A42T-01A-11D-A244-05 be2031ff-59ba-4ee0-aa0e-9831692a949f TCGA-BH-A42T-01 TCGA-BH-A42T-01A-11D-A243-09 NA NA TCGA-BH-A42T-01 NA NA 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 NA TCGA-BH-A42T-01A-11D-A242-01 TCGA-BH-A42T-01 NA 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 TCGA-BH-A42T-01A-11D-A242-01 |
|
|
770 |
TCGA-BH-A42U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A42U-01 3364 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A42U 3364 0 days 3364 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right NA NA TCGA-BH-A42U-F61923 TCGA-BH-A42U TCGA-BH-A42U-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NA NA NA -29330 3080 NA 0 3364 NA NA NA NA NA NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 290 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf A42U TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 6th NA YES NO BH Breast A LIVING 2004 b3ce7ee4-fc5e-445c-b1ca-5f324b33678a b3ce7ee4-fc5e-445c-b1ca-5f324b33678a NA NA TCGA-BH-A42U-01 TCGA-BH-A42U-01A-12D-A244-05 6bab8423-84c9-41ec-88f7-5efcfcc1ab30 TCGA-BH-A42U-01 TCGA-BH-A42U-01A-12D-A243-09 NA NA TCGA-BH-A42U-01 NA NA b3ce7ee4-fc5e-445c-b1ca-5f324b33678a NA TCGA-BH-A42U-01A-12D-A242-01 TCGA-BH-A42U-01 NA b3ce7ee4-fc5e-445c-b1ca-5f324b33678a TCGA-BH-A42U-01A-12D-A242-01 |
|
|
771 |
TCGA-BH-A42V-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A42V-01 635 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A42V 635 0 days 635 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-BH-A42V-F61941 TCGA-BH-A42V TCGA-BH-A42V-01A Negative Positive NA NA NA Other Positive Modified Radical Mastectomy Reexcision of segmental mastectomy NA NA NA -15158 197 NA 0 635 NA NA NA NA NA NA NA NA NA 2014-7-10 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 60 NO Negative NA NO 3 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T1c Stage IB TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf A42V TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 2fa59be9-ecde-49b2-b109-7000d5180847 2fa59be9-ecde-49b2-b109-7000d5180847 NA NA TCGA-BH-A42V-01 TCGA-BH-A42V-01A-11D-A244-05 719aaf42-d96b-466f-b6ac-40439aec2138 TCGA-BH-A42V-01 TCGA-BH-A42V-01A-11D-A243-09 NA NA TCGA-BH-A42V-01 NA NA 2fa59be9-ecde-49b2-b109-7000d5180847 NA TCGA-BH-A42V-01A-11D-A242-01 TCGA-BH-A42V-01 NA 2fa59be9-ecde-49b2-b109-7000d5180847 TCGA-BH-A42V-01A-11D-A242-01 |
|
|
772 |
TCGA-BH-A5IZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A5IZ-01 567 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A5IZ 567 0 days 567 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left NA NA TCGA-BH-A5IZ-F63663 TCGA-BH-A5IZ TCGA-BH-A5IZ-01A NA Positive NA NA NA NA Negative Lumpectomy NA NA NA NA -18927 140 NA 0 567 NA NA NA NA NA NA NA NA NA 2014-8-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Negative Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No cM0 (i+) N1a T2 Stage IIB TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf A5IZ TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 39033a17-79c9-4723-9fa7-fa82f67f5344 39033a17-79c9-4723-9fa7-fa82f67f5344 NA NA TCGA-BH-A5IZ-01 TCGA-BH-A5IZ-01A-11D-A27Y-05 NA TCGA-BH-A5IZ-01 TCGA-BH-A5IZ-01A-11D-A27P-09 NA NA TCGA-BH-A5IZ-01 NA NA 39033a17-79c9-4723-9fa7-fa82f67f5344 NA TCGA-BH-A5IZ-01A-11D-A27O-01 TCGA-BH-A5IZ-01 NA 39033a17-79c9-4723-9fa7-fa82f67f5344 TCGA-BH-A5IZ-01A-11D-A27O-01 |
|
|
773 |
TCGA-BH-A5J0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A5J0-01 715 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A5J0 715 0 days 715 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left NA NA TCGA-BH-A5J0-F63664 TCGA-BH-A5J0 NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -23072 NA NA 0 715 NA NA NA NA NA NA NA NA NA 2014-8-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage IA NA A5J0 TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast NA LIVING 2012 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 NA NA TCGA-BH-A5J0-01 TCGA-BH-A5J0-01A-11D-A27Y-05 NA TCGA-BH-A5J0-01 TCGA-BH-A5J0-01A-11D-A27P-09 NA NA TCGA-BH-A5J0-01 NA NA a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 NA TCGA-BH-A5J0-01A-11D-A27O-01 TCGA-BH-A5J0-01 NA a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 TCGA-BH-A5J0-01A-11D-A27O-01 |
|
|
774 |
TCGA-BH-A6R8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A6R8-01 293 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A6R8 293 0 days 293 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left NA NA TCGA-BH-A6R8-F63677 TCGA-BH-A6R8 TCGA-BH-A6R8-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -16829 260 NA 0 293 NA NA NA NA NA NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO NA Negative NO 4 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf A6R8 TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 2bea5d05-bcad-4a2e-8954-462b589a8aa4 2bea5d05-bcad-4a2e-8954-462b589a8aa4 NA NA TCGA-BH-A6R8-01 TCGA-BH-A6R8-01A-21D-A33F-05 C23EA212-403F-44F3-B3BC-8F07229D7006 TCGA-BH-A6R8-01 NA NA NA TCGA-BH-A6R8-01 NA NA 2bea5d05-bcad-4a2e-8954-462b589a8aa4 NA TCGA-BH-A6R8-01A-21D-A33D-01 TCGA-BH-A6R8-01 NA 2bea5d05-bcad-4a2e-8954-462b589a8aa4 TCGA-BH-A6R8-01A-21D-A33D-01 |
|
|
775 |
TCGA-BH-A6R9-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A6R9-01 160 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A6R9 160 0 days 160 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left NA NA TCGA-BH-A6R9-F63678 TCGA-BH-A6R9 TCGA-BH-A6R9-01A NA Negative NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -22325 237 NA 0 160 NA NA NA NA NA NA NA NA NA 2014-8-15 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf A6R9 TUMOR FREE NA NA NA NA NA NO NA NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 NA NA TCGA-BH-A6R9-01 TCGA-BH-A6R9-01A-21D-A32T-05 8C499FE0-D3D8-41FD-9E45-679C3403942C TCGA-BH-A6R9-01 NA NA NA TCGA-BH-A6R9-01 NA NA 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 NA TCGA-BH-A6R9-01A-21D-A32H-01 TCGA-BH-A6R9-01 NA 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 TCGA-BH-A6R9-01A-21D-A32H-01 |
|
|
776 |
TCGA-BH-A8FY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-BH-A8FY-01 295 1 days NA NA NA NA NA NA NA NA NA TCGA-BH-A8FY 295 0 days 295 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 87 Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant NA NA NA TCGA-BH-A8FY TCGA-BH-A8FY-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -31932 477 295 0 NA NA NA NA NA NA NA NA NA NA 2014-3-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 200 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 (i+) T1c Stage IA TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf A8FY TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast A DECEASED 2012 f037b9d3-819b-429d-8e2d-fa8b27008e70 f037b9d3-819b-429d-8e2d-fa8b27008e70 NA NA TCGA-BH-A8FY-01 TCGA-BH-A8FY-01A-11D-A36K-05 12726541-C142-46CD-8AE1-763DAC0943B7 TCGA-BH-A8FY-01 NA NA NA TCGA-BH-A8FY-01 NA NA f037b9d3-819b-429d-8e2d-fa8b27008e70 NA TCGA-BH-A8FY-01A-11D-A36I-01 TCGA-BH-A8FY-01 NA f037b9d3-819b-429d-8e2d-fa8b27008e70 TCGA-BH-A8FY-01A-11D-A36I-01 |
|
|
777 |
TCGA-BH-A8FZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A8FZ-01 574 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A8FZ 574 0 days 574 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left NA NA TCGA-BH-A8FZ-F63679 TCGA-BH-A8FZ TCGA-BH-A8FZ-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -21343 468 NA 0 574 NA NA NA NA NA NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 190 NO Equivocal NA NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1b Stage IA TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf A8FZ TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 2281c64c-9394-44f6-a4e7-87c7cce08c13 2281c64c-9394-44f6-a4e7-87c7cce08c13 NA NA TCGA-BH-A8FZ-01 TCGA-BH-A8FZ-01A-11D-A357-05 2B0ED842-B3E6-42E2-9A1E-7D4F96EF2E9D TCGA-BH-A8FZ-01 NA NA NA TCGA-BH-A8FZ-01 NA NA 2281c64c-9394-44f6-a4e7-87c7cce08c13 NA TCGA-BH-A8FZ-01A-11D-A350-01 TCGA-BH-A8FZ-01 NA 2281c64c-9394-44f6-a4e7-87c7cce08c13 TCGA-BH-A8FZ-01A-11D-A350-01 |
|
|
778 |
TCGA-BH-A8G0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-A8G0-01 662 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-A8G0 662 0 days 662 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left NA NA TCGA-BH-A8G0-F64200 TCGA-BH-A8G0 TCGA-BH-A8G0-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -19975 436 NA 0 662 NA NA NA NA NA NA NA NA NA 2014-8-27 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative NA NO 3 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T2 Stage IIB TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf A8G0 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2012 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde NA NA TCGA-BH-A8G0-01 TCGA-BH-A8G0-01A-11D-A357-05 A05330AE-C933-4E90-941C-2063295F9A7A TCGA-BH-A8G0-01 NA NA NA TCGA-BH-A8G0-01 NA NA 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde NA TCGA-BH-A8G0-01A-11D-A350-01 TCGA-BH-A8G0-01 NA 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde TCGA-BH-A8G0-01A-11D-A350-01 |
|
|
779 |
TCGA-BH-AB28-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-BH-AB28-01 287 0 days NA NA NA NA NA NA NA NA NA TCGA-BH-AB28 287 0 days 287 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left NA NA TCGA-BH-AB28-F64209 TCGA-BH-AB28 TCGA-BH-AB28-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -19570 105 NA 0 287 NA NA NA NA NA NA NA NA NA 2015-2-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 440 NO Negative Indeterminate NO 20 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1a T3 Stage IIIA TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf AB28 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO BH Breast A LIVING 2013 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d NA NA TCGA-BH-AB28-01 TCGA-BH-AB28-01A-31D-A41Q-05 NA TCGA-BH-AB28-01 NA NA NA TCGA-BH-AB28-01 NA NA 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d NA TCGA-BH-AB28-01A-31D-A41E-01 TCGA-BH-AB28-01 NA 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d TCGA-BH-AB28-01A-31D-A41E-01 |
|
|
780 |
TCGA-C8-A12K-01 Stage IIB 80 1 No_Conversion 0 NA NA FEMALE Negative 2 2 2 Negative M0 Positive N1 0 0 Basal Basal-like NA Basal -13 -12 enrollment T_Other T2 LIVING NA TCGA-C8-A12K-01 NA NA days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 3 mutation cluster 8 TCGA-C8-A12K NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Upper Inner Quadrant Other (specify) Pateys surgery NA TCGA-C8-A12K TCGA-C8-A12K-01A NA NA NA NA NA NA NA Other NA NO NA NA -29463 57 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-4-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 970 NO NA NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NA 1 NA true No M0 N1 T2 Stage IIB TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf A12K TUMOR FREE NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 Pateys surgery 6th NA YES NO C8 Breast A LIVING 2010 0ef00203-8a0a-4d04-aa1e-c1164958d8ec 0ef00203-8a0a-4d04-aa1e-c1164958d8ec TCGA-C8-A12K-01A-11-A13D-20 TCGA-C8-A12K-01A-21D-A10Y-09 TCGA-C8-A12K-01 NA 5daae9b4-734a-479f-a414-50e0629a8598 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21D-A10Y-09 TCGA-C8-A12K-01A-21D-A112-05 TCGA-C8-A12K-01 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21D-A10Y-09 NA 0ef00203-8a0a-4d04-aa1e-c1164958d8ec NA TCGA-C8-A12K-01A-21D-A111-01 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21R-A115-07 0ef00203-8a0a-4d04-aa1e-c1164958d8ec TCGA-C8-A12K-01A-21D-A111-01 TCGA-C8-A12K-01 |
|
|
781 |
TCGA-C8-A12L-01 Stage IIA 67 1 Stage IIA 0 NA Negative FEMALE Positive 1 1 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Negative Her2 -11 -9 enrollment T_Other T2 LIVING 0 TCGA-C8-A12L-01 363 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A12L 363 0 days 363 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Axillary lymph node dissection alone NA TCGA-C8-A12L-F20258 TCGA-C8-A12L TCGA-C8-A12L-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -24710 62 NA 0 363 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Suregery Other method, specify: 460 NO Equivocal NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf A12L TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 0a5a7511-4e7b-4fe4-b323-c354acffab57 0a5a7511-4e7b-4fe4-b323-c354acffab57 TCGA-C8-A12L-01A-21-A13D-20 TCGA-C8-A12L-01A-11D-A10Y-09 TCGA-C8-A12L-01 NA f9312b49-d0bf-45d8-b6b1-96b3752475e7 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11D-A10Y-09 TCGA-C8-A12L-01A-11D-A112-05 TCGA-C8-A12L-01 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11D-A10Y-09 NA 0a5a7511-4e7b-4fe4-b323-c354acffab57 NA TCGA-C8-A12L-01A-11D-A111-01 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11R-A115-07 0a5a7511-4e7b-4fe4-b323-c354acffab57 TCGA-C8-A12L-01A-11D-A111-01 TCGA-C8-A12L-01 |
|
|
782 |
TCGA-C8-A12M-01 Stage IIA 70 5 Stage IIA 0 NA Positive FEMALE NA 4 1 4 Negative M0 Negative N0 0 0 LumB Luminal B Negative LumA/B -10 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A12M-01 358 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-C8-A12M 358 0 days 358 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Axillary lymph node dissection alone NA TCGA-C8-A12M-F19093 TCGA-C8-A12M TCGA-C8-A12M-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -25811 57 NA 0 358 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 510 NO Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO NA NA true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf A12M TUMOR FREE NA NA NA NA Allred Score 8 NA NA NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 8f007e7a-6260-4ecc-baff-f68665b760cb 8f007e7a-6260-4ecc-baff-f68665b760cb TCGA-C8-A12M-01A-21-A13D-20 TCGA-C8-A12M-01A-11D-A135-09 TCGA-C8-A12M-01 NA abdef80c-32bb-4620-95d2-16d985cd20f0 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11D-A135-09 TCGA-C8-A12M-01A-11D-A112-05 TCGA-C8-A12M-01 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11D-A135-09 NA 8f007e7a-6260-4ecc-baff-f68665b760cb NA TCGA-C8-A12M-01A-11D-A111-01 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11R-A115-07 8f007e7a-6260-4ecc-baff-f68665b760cb TCGA-C8-A12M-01A-11D-A111-01 TCGA-C8-A12M-01 |
|
|
783 |
TCGA-C8-A12N-01 Stage IIA 58 4 Stage IIA 0 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive ReacI -12 -3 enrollment T_Other T2 LIVING 0 TCGA-C8-A12N-01 358 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-C8-A12N 358 0 days 358 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Axillary lymph node dissection alone NA TCGA-C8-A12N-F20264 TCGA-C8-A12N TCGA-C8-A12N-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -21428 57 NA 0 358 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 290 NO Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO NA NA true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf A12N TUMOR FREE NA NA NA Allread Score 8 Allred Score 8 NA NA NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb TCGA-C8-A12N-01A-21-A13D-20 TCGA-C8-A12N-01A-11D-A10Y-09 TCGA-C8-A12N-01 NA 8e2ac007-601d-45c4-a94c-3cefb96b8f99 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11D-A10Y-09 TCGA-C8-A12N-01A-11D-A112-05 TCGA-C8-A12N-01 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11D-A10Y-09 NA 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb NA TCGA-C8-A12N-01A-11D-A111-01 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11R-A115-07 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb TCGA-C8-A12N-01A-11D-A111-01 TCGA-C8-A12N-01 |
|
|
784 |
TCGA-C8-A12O-01 Stage IIA 50 NA Stage IIA 0 NA Positive FEMALE NA NA NA NA Negative M0 Negative N0 0 0 LumA Luminal A Positive Her2 -2 0 enrollment T_Other T2 LIVING 0 TCGA-C8-A12O-01 385 0 days NA C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-C8-A12O 385 0 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Axillary lymph node dissection alone NA TCGA-C8-A12O-F20261 TCGA-C8-A12O TCGA-C8-A12O-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -18506 57 NA 0 385 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 650 NO Negative NA NA 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO NA NA true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf A12O TUMOR FREE NA NA NA Allred Score 7 Allred Score 7 NA NA NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 5efabaa8-f296-4c9c-9632-559ef7f6dd44 5efabaa8-f296-4c9c-9632-559ef7f6dd44 TCGA-C8-A12O-01A-21-A13D-20 TCGA-C8-A12O-01A-11D-A10Y-09 TCGA-C8-A12O-01 NA 834cc759-8dcd-4d51-9570-aef1622b90e1 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11D-A10Y-09 TCGA-C8-A12O-01A-11D-A112-05 TCGA-C8-A12O-01 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11D-A10Y-09 NA 5efabaa8-f296-4c9c-9632-559ef7f6dd44 NA TCGA-C8-A12O-01A-11D-A111-01 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11R-A115-07 5efabaa8-f296-4c9c-9632-559ef7f6dd44 TCGA-C8-A12O-01A-11D-A111-01 TCGA-C8-A12O-01 |
|
|
785 |
TCGA-C8-A12P-01 Stage IIB 55 3 No_Conversion 0 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -10 enrollment T_Other T2 LIVING 0 TCGA-C8-A12P-01 358 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12P 358 0 days 358 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left NA NA TCGA-C8-A12P-F20267 TCGA-C8-A12P TCGA-C8-A12P-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -20332 57 NA 0 358 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 380 NO Positive NA NA 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf A12P TUMOR FREE NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 9e30b9ee-391d-40d9-8eba-de47656f3629 9e30b9ee-391d-40d9-8eba-de47656f3629 TCGA-C8-A12P-01A-21-A13D-20 TCGA-C8-A12P-01A-11D-A10Y-09 TCGA-C8-A12P-01 NA a3b71b2e-5bb6-4585-95e7-6a2ddbf99659 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11D-A10Y-09 TCGA-C8-A12P-01A-11D-A112-05 TCGA-C8-A12P-01 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11D-A10Y-09 NA 9e30b9ee-391d-40d9-8eba-de47656f3629 NA TCGA-C8-A12P-01A-11D-A111-01 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11R-A115-07 9e30b9ee-391d-40d9-8eba-de47656f3629 TCGA-C8-A12P-01A-11D-A111-01 TCGA-C8-A12P-01 |
|
|
786 |
TCGA-C8-A12Q-01 Stage IIIA 78 5 No_Conversion 0 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N2 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T1 T1 LIVING 1 TCGA-C8-A12Q-01 385 1 days High C3-BRCA/Luminal cluster 2 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12Q NA NA days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 78 Left Axillary lymph node dissection alone NA TCGA-C8-A12Q-F20253 TCGA-C8-A12Q TCGA-C8-A12Q-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -28733 57 385 0 2 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 810 NO Positive NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA Liver Distant Metastasis NA NA YES NA NA true No M0 N2 T1 Stage IIIA TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf A12Q WITH TUMOR NA NA NA NA NA NA NA NA NA NO Primary Tumor 01 Pateys Surgery NA NO YES NO C8 Breast A DECEASED 2010 e042ea6d-3204-41a7-9811-25f4ac0c3558 e042ea6d-3204-41a7-9811-25f4ac0c3558 TCGA-C8-A12Q-01A-21-A13D-20 TCGA-C8-A12Q-01A-11D-A10Y-09 TCGA-C8-A12Q-01 NA 588f723a-3e25-4cdc-91f6-36d00bb179e5 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11D-A10Y-09 TCGA-C8-A12Q-01A-11D-A112-05 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11D-A10Y-09 NA e042ea6d-3204-41a7-9811-25f4ac0c3558 NA TCGA-C8-A12Q-01A-11D-A111-01 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11R-A115-07 e042ea6d-3204-41a7-9811-25f4ac0c3558 TCGA-C8-A12Q-01A-11D-A111-01 TCGA-C8-A12Q-01 |
|
|
787 |
TCGA-C8-A12T-01 Stage IIA 43 4 Stage IIA 0 NA Positive FEMALE Positive 1 1 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Positive ReacII -2 -1 enrollment T_Other T2 LIVING NA TCGA-C8-A12T-01 NA NA days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-C8-A12T NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Axillary lymph node dissection alone NA NA TCGA-C8-A12T TCGA-C8-A12T-01A NA Positive NA NA NA NA Positive Other NA NO NA NA NA 51 NA 0 0 NA NA NA NA NO NA NA NA NA 2011-4-11 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 540 NO Positive NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NA 0 NA true No M0 N0 T2 Stage IIA TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf A12T TUMOR FREE NA NA NA Allred Score 8 Allred Score 6 NA YES NA NA NA Primary Tumor 01 Pateys Surgery 6th NA YES NO C8 Breast A LIVING 2010 c13962b2-674a-4edc-a7c8-c077ab86d198 c13962b2-674a-4edc-a7c8-c077ab86d198 TCGA-C8-A12T-01A-21-A13D-20 TCGA-C8-A12T-01A-11D-A10Y-09 TCGA-C8-A12T-01 NA 08bd259e-9a37-4dd1-b97c-c67f288f833e TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11D-A10Y-09 TCGA-C8-A12T-01A-11D-A112-05 TCGA-C8-A12T-01 TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11D-A10Y-09 NA c13962b2-674a-4edc-a7c8-c077ab86d198 NA TCGA-C8-A12T-01A-11D-A111-01 TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11R-A115-07 c13962b2-674a-4edc-a7c8-c077ab86d198 TCGA-C8-A12T-01A-11D-A111-01 TCGA-C8-A12T-01 |
|
|
788 |
TCGA-C8-A12U-01 Stage IB 46 5 Stage IIB 0 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 0 0 LumB Luminal B Positive Basal -2 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A12U-01 385 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 4 TCGA-C8-A12U 385 0 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Axillary lymph node dissection alone NA TCGA-C8-A12U-F20249 TCGA-C8-A12U TCGA-C8-A12U-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -17045 57 NA 0 385 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 580 NO Negative NA NA 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf A12U TUMOR FREE NA NA NA Allred Score 3 Allred Score 5 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 803bb42f-e0f2-44b6-aebb-8f956646ecc7 803bb42f-e0f2-44b6-aebb-8f956646ecc7 TCGA-C8-A12U-01A-21-A13D-20 TCGA-C8-A12U-01A-11D-A10Y-09 TCGA-C8-A12U-01 NA 671835d4-23bb-4945-a62a-26d5f9094325 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11D-A10Y-09 TCGA-C8-A12U-01A-11D-A112-05 TCGA-C8-A12U-01 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11D-A10Y-09 NA 803bb42f-e0f2-44b6-aebb-8f956646ecc7 NA TCGA-C8-A12U-01A-11D-A111-01 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11R-A115-07 803bb42f-e0f2-44b6-aebb-8f956646ecc7 TCGA-C8-A12U-01A-11D-A111-01 TCGA-C8-A12U-01 |
|
|
789 |
TCGA-C8-A12V-01 Stage IIA 55 1 Stage IIA 0 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 0 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-C8-A12V-01 385 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-C8-A12V 385 0 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Axillary lymph node dissection alone NA TCGA-C8-A12V-F19095 TCGA-C8-A12V TCGA-C8-A12V-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -20346 57 NA 0 385 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 540 NO Negative NA NA 5 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf A12V TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 b12c9095-55c7-4add-9e22-3d65eeef2040 b12c9095-55c7-4add-9e22-3d65eeef2040 TCGA-C8-A12V-01A-21-A13D-20 TCGA-C8-A12V-01A-11D-A10Y-09 TCGA-C8-A12V-01 NA 46c61ec3-e651-474c-8ce2-0cbced7cbca5 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11D-A10Y-09 TCGA-C8-A12V-01A-11D-A112-05 TCGA-C8-A12V-01 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11D-A10Y-09 NA b12c9095-55c7-4add-9e22-3d65eeef2040 NA TCGA-C8-A12V-01A-11D-A111-01 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11R-A115-07 b12c9095-55c7-4add-9e22-3d65eeef2040 TCGA-C8-A12V-01A-11D-A111-01 TCGA-C8-A12V-01 |
|
|
790 |
TCGA-C8-A12W-01 Stage IIIB 49 3 Stage IIIB 0 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 0 0 LumB Luminal B Positive ReacII -2 -5 enrollment T_Other T4 LIVING 0 TCGA-C8-A12W-01 385 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12W 385 0 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Axillary lymph node dissection alone NA TCGA-C8-A12W-F20244 TCGA-C8-A12W TCGA-C8-A12W-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -18140 57 NA 0 385 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 890 NO Negative NA NA 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T4 Stage IIIB TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf A12W TUMOR FREE NA NA NA Allred Score 6 Allred Score 7 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 TCGA-C8-A12W-01A-21-A13D-20 TCGA-C8-A12W-01A-11D-A10Y-09 TCGA-C8-A12W-01 NA ee4be56e-b6c6-421f-ae10-fd129c8028df TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11D-A10Y-09 TCGA-C8-A12W-01A-11D-A112-05 TCGA-C8-A12W-01 TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11D-A10Y-09 NA 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 NA TCGA-C8-A12W-01A-11D-A111-01 TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11R-A115-07 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 TCGA-C8-A12W-01A-11D-A111-01 TCGA-C8-A12W-01 |
|
|
791 |
TCGA-C8-A12X-01 Stage IIB 62 4 Stage IIB 0 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 0 0 LumA Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-C8-A12X-01 385 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-C8-A12X 385 0 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Axillary lymph node dissection alone NA TCGA-C8-A12X-F19102 TCGA-C8-A12X TCGA-C8-A12X-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -22889 57 NA 0 385 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA 1+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES Pateys Surgery Other method, specify: 410 NO Negative NA NA 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf A12X TUMOR FREE NA NA NA Allred Score 7 Allred Score 8 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 TCGA-C8-A12X-01A-21-A13D-20 TCGA-C8-A12X-01A-11D-A10Y-09 TCGA-C8-A12X-01 NA b91a61e2-4b2e-4a9c-b79d-07570ae50cc3 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11D-A10Y-09 TCGA-C8-A12X-01A-11D-A112-05 TCGA-C8-A12X-01 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11D-A10Y-09 NA 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 NA TCGA-C8-A12X-01A-11D-A111-01 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11R-A115-07 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 TCGA-C8-A12X-01A-11D-A111-01 TCGA-C8-A12X-01 |
|
|
792 |
TCGA-C8-A12Y-01 Stage IIB 44 2 Stage IIB 0 NA NA FEMALE Negative 3 3 3 Negative M0 Positive N1 0 0 LumA Luminal A NA LumA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-C8-A12Y-01 1476 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-C8-A12Y 1476 0 days 1476 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Axillary lymph node dissection alone NA TCGA-C8-A12Y-F70839 TCGA-C8-A12Y TCGA-C8-A12Y-01A NA NA NA NA NA NA NA Other NA NA NA NA NA 57 NA 0 1476 NA NA NA NA NO NA NA NA NA 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 380 NO NA NA NO 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf A12Y TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Pateys Surgery 6th NA YES NO C8 Breast A LIVING 2010 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 TCGA-C8-A12Y-01A-21-A13D-20 TCGA-C8-A12Y-01A-11D-A12B-09 TCGA-C8-A12Y-01 NA 1e9b9f3a-3fb5-4404-94e5-d22d4702391e TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11D-A12B-09 TCGA-C8-A12Y-01A-11D-A12E-05 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11D-A12B-09 NA ef42155a-112e-48fe-b52a-a99ebcd5f7f5 NA TCGA-C8-A12Y-01A-11D-A12A-01 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11R-A12D-07 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 TCGA-C8-A12Y-01A-11D-A12A-01 TCGA-C8-A12Y-01 |
|
|
793 |
TCGA-C8-A12Z-01 Stage II 45 2 Stage IIB 0 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A12Z-01 382 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A12Z 382 0 days 382 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Axillary lymph node dissection alone NA TCGA-C8-A12Z-F70810 TCGA-C8-A12Z TCGA-C8-A12Z-01A Negative Negative NA NA NA NA Negative Other NA NA NA NA -16508 69 NA 0 382 NA NA NA NA NO NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 490 NO Positive NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf A12Z TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Pateys Surgery 6th NA YES NO C8 Breast A LIVING 2010 4018d26c-0ce0-4c5a-9ce4-200bb4273349 4018d26c-0ce0-4c5a-9ce4-200bb4273349 TCGA-C8-A12Z-01A-21-A13D-20 TCGA-C8-A12Z-01A-11D-A10Y-09 TCGA-C8-A12Z-01 NA 76306f2d-c820-4442-966f-b79872d69025 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11D-A10Y-09 TCGA-C8-A12Z-01A-11D-A112-05 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11D-A10Y-09 NA 4018d26c-0ce0-4c5a-9ce4-200bb4273349 NA TCGA-C8-A12Z-01A-11D-A111-01 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11R-A115-07 4018d26c-0ce0-4c5a-9ce4-200bb4273349 TCGA-C8-A12Z-01A-11D-A111-01 TCGA-C8-A12Z-01 |
|
|
794 |
TCGA-C8-A130-01 Stage IIIA 52 1 Stage IIIA 0 NA Positive FEMALE Equivocal 1 1 1 Negative M0 Positive N2 0 0 LumB HER2-enriched Positive Her2 -2 0 enrollment T_Other T3 LIVING 0 TCGA-C8-A130-01 370 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A130 370 0 days 370 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Axillary lymph node dissection alone NA TCGA-C8-A130-F70814 TCGA-C8-A130 TCGA-C8-A130-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -19117 89 NA 0 370 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 550 NO Equivocal NA NO 8 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA true No M0 N2 T3 Stage IIIA TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf A130 TUMOR FREE NA NA NA Allred Score 7 Allred Score 7 [Discrepancy] YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 TCGA-C8-A130-01A-21-A13D-20 TCGA-C8-A130-01A-31D-A10Y-09 TCGA-C8-A130-01 NA 62caa696-e8a5-46f6-b4c1-1baf5ae62bd4 TCGA-C8-A130-01 TCGA-C8-A130-01A-31D-A10Y-09 TCGA-C8-A130-01A-31D-A112-05 TCGA-C8-A130-01 TCGA-C8-A130-01 TCGA-C8-A130-01A-31D-A10Y-09 NA 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 NA TCGA-C8-A130-01A-31D-A111-01 TCGA-C8-A130-01 TCGA-C8-A130-01A-31R-A115-07 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 TCGA-C8-A130-01A-31D-A111-01 TCGA-C8-A130-01 |
|
|
795 |
TCGA-C8-A131-01 Stage III 82 1 Stage IIIA 0 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N2 0 0 Basal Basal-like Negative ReacII -13 0 enrollment T_Other T2 LIVING 0 TCGA-C8-A131-01 411 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 OV-like c4 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 2 TCGA-C8-A131 411 0 days 411 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 82 Left Axillary lymph node dissection alone NA TCGA-C8-A131-F70827 TCGA-C8-A131 TCGA-C8-A131-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -29966 163 NA 0 411 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 460 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 5 NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T2 Stage IIIA TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf A131 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 5162ef6d-6978-4ff7-b385-a59325cefe17 5162ef6d-6978-4ff7-b385-a59325cefe17 TCGA-C8-A131-01A-21-A13D-20 TCGA-C8-A131-01A-11D-A10Y-09 TCGA-C8-A131-01 NA 4a1fa1ef-67ab-4ea7-a650-5276030b04ee TCGA-C8-A131-01 TCGA-C8-A131-01A-11D-A10Y-09 TCGA-C8-A131-01A-11D-A112-05 TCGA-C8-A131-01 TCGA-C8-A131-01 TCGA-C8-A131-01A-11D-A10Y-09 NA 5162ef6d-6978-4ff7-b385-a59325cefe17 NA TCGA-C8-A131-01A-11D-A111-01 TCGA-C8-A131-01 TCGA-C8-A131-01A-11R-A115-07 5162ef6d-6978-4ff7-b385-a59325cefe17 TCGA-C8-A131-01A-11D-A111-01 TCGA-C8-A131-01 |
|
|
796 |
TCGA-C8-A132-01 Stage II 56 5 Stage IIB 0 NA Positive FEMALE Positive 2 3 3 Negative M0 Positive N1 0 0 LumA Luminal A Positive Her2 -2 -4 enrollment T_Other T2 LIVING 0 TCGA-C8-A132-01 383 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 5 mutation c1uster 9 TCGA-C8-A132 383 0 days 383 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Axillary lymph node dissection alone NA TCGA-C8-A132-F70826 TCGA-C8-A132 TCGA-C8-A132-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -20471 162 NA 0 383 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO NA NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 5 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf A132 TUMOR FREE NA NA NA Allred Score 7 Allred Score 8 [Discrepancy] YES NA NA NO Primary Tumor 01 Modified Radical Masectomy 6th YES YES NO C8 Breast A LIVING 2010 143e8620-56cc-4b65-a2aa-d793543f6854 143e8620-56cc-4b65-a2aa-d793543f6854 TCGA-C8-A132-01A-41-A13D-20 TCGA-C8-A132-01A-31D-A10Y-09 TCGA-C8-A132-01 NA 4b907222-06fc-47d4-b425-b116df8162aa TCGA-C8-A132-01 TCGA-C8-A132-01A-31D-A10Y-09 TCGA-C8-A132-01A-31D-A112-05 TCGA-C8-A132-01 TCGA-C8-A132-01 TCGA-C8-A132-01A-31D-A10Y-09 NA 143e8620-56cc-4b65-a2aa-d793543f6854 NA TCGA-C8-A132-01A-31D-A111-01 TCGA-C8-A132-01 TCGA-C8-A132-01A-31R-A115-07 143e8620-56cc-4b65-a2aa-d793543f6854 TCGA-C8-A132-01A-31D-A111-01 TCGA-C8-A132-01 |
|
|
797 |
TCGA-C8-A133-01 Stage IIIA 65 1 Stage IIIA 0 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 0 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T3 LIVING NA TCGA-C8-A133-01 NA NA days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-C8-A133 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Axillary lymph node dissection alone NA NA TCGA-C8-A133 TCGA-C8-A133-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -23922 119 NA 0 0 NA NA NA NA NA NA NA NA NA 2011-4-15 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES Modified Radical Masectomy Other method, specify: 480 NO NA NA NA 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NA NA NA true No M0 N1 T3 Stage IIIA TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf A133 TUMOR FREE NA NA NA Allred Score 8 Allred Score 8 NA YES NA NA NA Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 3028d15d-698a-4a23-8a09-a79221e28a62 3028d15d-698a-4a23-8a09-a79221e28a62 TCGA-C8-A133-01A-21-A13D-20 TCGA-C8-A133-01A-32D-A12B-09 TCGA-C8-A133-01 NA a4236581-7665-4520-84c9-16fb6fa8fd22 TCGA-C8-A133-01 TCGA-C8-A133-01A-32D-A12B-09 TCGA-C8-A133-01A-32D-A12E-05 TCGA-C8-A133-01 TCGA-C8-A133-01 TCGA-C8-A133-01A-32D-A12B-09 NA 3028d15d-698a-4a23-8a09-a79221e28a62 NA TCGA-C8-A133-01A-32D-A12A-01 TCGA-C8-A133-01 TCGA-C8-A133-01A-32R-A12D-07 3028d15d-698a-4a23-8a09-a79221e28a62 TCGA-C8-A133-01A-32D-A12A-01 TCGA-C8-A133-01 |
|
|
798 |
TCGA-C8-A134-01 Stage IIA 52 1 No_Conversion 0 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 0 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-C8-A134-01 383 0 days BRCA-LUAD+ C8-BLCA cluster 4 Cluster 6 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 cluster 6 mutation cluster 5 TCGA-C8-A134 383 0 days 383 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Axillary lymph node dissection alone NA TCGA-C8-A134-F70822 TCGA-C8-A134 NA NA Negative NA NA NA NA Negative Other NA NA NA NA -19010 NA NA 0 383 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal NA NO 7 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T2 Stage IIA NA A134 TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 Modified Radical Masectomy 6th YES YES NO C8 Breast NA LIVING 2010 d96863aa-33a8-43bf-a9b5-589de1e9cf44 d96863aa-33a8-43bf-a9b5-589de1e9cf44 TCGA-C8-A134-01A-21-A13D-20 TCGA-C8-A134-01A-11D-A10Y-09 TCGA-C8-A134-01 NA ec21c134-e0b1-44e4-be21-ff70c20ee979 TCGA-C8-A134-01 TCGA-C8-A134-01A-11D-A10Y-09 TCGA-C8-A134-01A-11D-A112-05 TCGA-C8-A134-01 TCGA-C8-A134-01 TCGA-C8-A134-01A-11D-A10Y-09 NA d96863aa-33a8-43bf-a9b5-589de1e9cf44 NA TCGA-C8-A134-01A-11D-A111-01 TCGA-C8-A134-01 TCGA-C8-A134-01A-11R-A115-07 d96863aa-33a8-43bf-a9b5-589de1e9cf44 TCGA-C8-A134-01A-11D-A111-01 TCGA-C8-A134-01 |
|
|
799 |
TCGA-C8-A135-01 Stage II 64 1 Stage IIB 0 NA Negative FEMALE Positive 2 2 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A135-01 393 0 days High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 3 TCGA-C8-A135 393 0 days 393 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Axillary lymph node dissection alone NA TCGA-C8-A135-F70817 TCGA-C8-A135 TCGA-C8-A135-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -23667 162 NA 0 393 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 760 NO Positive NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf A135 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NO YES NO C8 Breast A LIVING 2010 306818e8-2e51-4dee-b27c-53ee9cea8d03 306818e8-2e51-4dee-b27c-53ee9cea8d03 TCGA-C8-A135-01A-21-A13D-20 TCGA-C8-A135-01A-11D-A10Y-09 TCGA-C8-A135-01 NA bded0f4f-068a-4577-a130-66b59f0bce47 TCGA-C8-A135-01 TCGA-C8-A135-01A-11D-A10Y-09 TCGA-C8-A135-01A-11D-A112-05 TCGA-C8-A135-01 TCGA-C8-A135-01 TCGA-C8-A135-01A-11D-A10Y-09 NA 306818e8-2e51-4dee-b27c-53ee9cea8d03 NA TCGA-C8-A135-01A-11D-A111-01 TCGA-C8-A135-01 TCGA-C8-A135-01A-11R-A115-07 306818e8-2e51-4dee-b27c-53ee9cea8d03 TCGA-C8-A135-01A-11D-A111-01 TCGA-C8-A135-01 |
|
|
800 |
TCGA-C8-A137-01 Stage II 34 5 Stage IIB 3 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 3 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A137-01 379 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 NA NA mutation c1uster 9 TCGA-C8-A137 136 1 days 379 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 34 Left Axillary lymph node dissection alone NA TCGA-C8-A137-F70815 TCGA-C8-A137 TCGA-C8-A137-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -12729 102 NA 0 379 NA NA 136 NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 610 NO Positive NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA Locoregional Recurrence NA NO YES NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf A137 WITH TUMOR NA NA NA NA NA [Discrepancy] YES NA NA NO Primary Tumor 01 NA 6th YES YES NO C8 Breast A LIVING 2010 2c829af4-a6a7-48b1-9e48-a88be0564752 2c829af4-a6a7-48b1-9e48-a88be0564752 TCGA-C8-A137-01A-21-A13D-20 TCGA-C8-A137-01A-11D-A10Y-09 TCGA-C8-A137-01 NA b7d481d8-71b8-473b-802b-0457592d7054 TCGA-C8-A137-01 TCGA-C8-A137-01A-11D-A10Y-09 TCGA-C8-A137-01A-11D-A112-05 TCGA-C8-A137-01 TCGA-C8-A137-01 TCGA-C8-A137-01A-11D-A10Y-09 NA 2c829af4-a6a7-48b1-9e48-a88be0564752 NA TCGA-C8-A137-01A-11D-A111-01 TCGA-C8-A137-01 TCGA-C8-A137-01A-11R-A115-07 2c829af4-a6a7-48b1-9e48-a88be0564752 TCGA-C8-A137-01A-11D-A111-01 TCGA-C8-A137-01 |
|
|
801 |
TCGA-C8-A138-01 Stage III 54 2 Stage IIIA 7 NA Positive FEMALE Positive 3 2 1 Negative M0 Positive N2 7 0 Her2 HER2-enriched Negative Basal -2 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A138-01 380 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-C8-A138 380 0 days 380 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Axillary lymph node dissection alone NA TCGA-C8-A138-F71893 TCGA-C8-A138 TCGA-C8-A138-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -20053 93 NA 0 380 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 230 NO Equivocal NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO NA NA true No M0 N2 T2 Stage IIIA TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf A138 TUMOR FREE NA NA NA NA Allred Score 5 YES YES NA NA NO Primary Tumor 01 NA 6th NO YES NO C8 Breast A LIVING 2010 f543c792-d997-420a-8bf1-c45456b62a8b f543c792-d997-420a-8bf1-c45456b62a8b TCGA-C8-A138-01A-21-A13D-20 TCGA-C8-A138-01A-11D-A10Y-09 TCGA-C8-A138-01 NA 5fa600b0-7ba1-45bf-be7d-8d60925dce68 TCGA-C8-A138-01 TCGA-C8-A138-01A-11D-A10Y-09 TCGA-C8-A138-01A-11D-A112-05 TCGA-C8-A138-01 TCGA-C8-A138-01 TCGA-C8-A138-01A-11D-A10Y-09 NA f543c792-d997-420a-8bf1-c45456b62a8b NA TCGA-C8-A138-01A-11D-A111-01 TCGA-C8-A138-01 TCGA-C8-A138-01A-11R-A115-07 f543c792-d997-420a-8bf1-c45456b62a8b TCGA-C8-A138-01A-11D-A111-01 TCGA-C8-A138-01 |
|
|
802 |
TCGA-C8-A1HE-01 Stage IIA 59 2 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A1HE-01 375 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-C8-A1HE 375 0 days 375 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Axillary lymph node dissection alone NA TCGA-C8-A1HE-F20269 TCGA-C8-A1HE NA NA Positive NA NA NA NA Positive Other NA NO NA NA NA NA NA 0 375 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: NA NA Equivocal NA NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T2 Stage IIA NA A1HE TUMOR FREE NA NA NA Allred Score 4 Allred Score 7 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast NA LIVING 2010 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 TCGA-C8-A1HE-01A-21-A17J-20 TCGA-C8-A1HE-01A-11D-A188-09 TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A13K-05 f1bdea64-1ae0-442f-83cd-00ae1531f9fb TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A188-09 NA NA TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A188-09 NA b5f56bfb-6fc1-448f-8c2b-4753084aaa00 NA TCGA-C8-A1HE-01A-11D-A13J-01 TCGA-C8-A1HE-01 NA b5f56bfb-6fc1-448f-8c2b-4753084aaa00 TCGA-C8-A1HE-01A-11D-A13J-01 |
|
|
803 |
TCGA-C8-A1HF-01 Stage IIA 48 2 Stage IIA 0 NA Negative FEMALE Positive NA NA NA Negative M0 Negative N0 0 0 Her2 HER2-enriched Positive NA -11 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A1HF-01 332 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-C8-A1HF 332 0 days 332 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Axillary lymph node dissection alone NA TCGA-C8-A1HF-F19092 TCGA-C8-A1HF TCGA-C8-A1HF-01A NA Negative NA NA NA NA Positive Other NA NO NA NA NA 109 NA 0 332 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 460 NO Positive NA NA 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf A1HF TUMOR FREE NA NA NA Allred Score 3 NA NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 62b06301-531d-4fc1-bb00-ede8e507e8f4 62b06301-531d-4fc1-bb00-ede8e507e8f4 TCGA-C8-A1HF-01A-21-A17J-20 TCGA-C8-A1HF-01A-11D-A135-09 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A138-05 c95c9a7c-4192-4100-9452-5def84184e9c TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A135-09 NA TCGA-C8-A1HF-01 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A135-09 NA 62b06301-531d-4fc1-bb00-ede8e507e8f4 NA TCGA-C8-A1HF-01A-11D-A134-01 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11R-A137-07 62b06301-531d-4fc1-bb00-ede8e507e8f4 TCGA-C8-A1HF-01A-11D-A134-01 TCGA-C8-A1HF-01 |
|
|
804 |
TCGA-C8-A1HG-01 Stage IIA 50 4 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB Luminal B Positive NA -2 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A1HG-01 345 0 days High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 8 TCGA-C8-A1HG 345 0 days 345 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Axillary lymph node dissection alone NA TCGA-C8-A1HG-F19096 TCGA-C8-A1HG TCGA-C8-A1HG-01A NA Positive NA NA NA NA Positive Other NA NO NA NA NA 122 NA 0 345 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 300 NO Negative NA NA NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf A1HG TUMOR FREE NA NA NA Allred Score 7 Allred Score 8 NA NO NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 094076d0-97e4-460d-b48c-7ee2371db99d 094076d0-97e4-460d-b48c-7ee2371db99d TCGA-C8-A1HG-01A-21-A17J-20 TCGA-C8-A1HG-01A-11D-A135-09 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A138-05 3ba46266-c84a-482f-abc7-8756831856e6 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A135-09 NA TCGA-C8-A1HG-01 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A135-09 NA 094076d0-97e4-460d-b48c-7ee2371db99d NA TCGA-C8-A1HG-01A-11D-A134-01 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11R-A137-07 094076d0-97e4-460d-b48c-7ee2371db99d TCGA-C8-A1HG-01A-11D-A134-01 TCGA-C8-A1HG-01 |
|
|
805 |
TCGA-C8-A1HI-01 Stage IIIA 40 2 Stage IIIA 2 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 2 0 LumA Luminal A Positive NA -5 0 enrollment T_Other T2 LIVING 0 TCGA-C8-A1HI-01 343 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-C8-A1HI 343 0 days 343 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Axillary lymph node dissection alone NA TCGA-C8-A1HI-F19099 TCGA-C8-A1HI TCGA-C8-A1HI-01A NA Positive NA NA NA NA Positive Other NA NA NA NA NA 120 NA 0 343 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 490 NO Negative NA NA 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO NA NA true No M0 N2 T2 Stage IIIA TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf A1HI TUMOR FREE NA NA NA Allred Score 6 Allred Score 8 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 994c96ec-ea0a-4741-8fef-53cdbfe28cfa 994c96ec-ea0a-4741-8fef-53cdbfe28cfa TCGA-C8-A1HI-01A-21-A17J-20 TCGA-C8-A1HI-01A-11D-A135-09 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A138-05 8e8a6562-23a5-48a7-a06e-efc30fab8f15 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A135-09 NA TCGA-C8-A1HI-01 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A135-09 NA 994c96ec-ea0a-4741-8fef-53cdbfe28cfa NA TCGA-C8-A1HI-01A-11D-A134-01 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11R-A137-07 994c96ec-ea0a-4741-8fef-53cdbfe28cfa TCGA-C8-A1HI-01A-11D-A134-01 TCGA-C8-A1HI-01 |
|
|
806 |
TCGA-C8-A1HJ-01 Stage II 53 1 Stage IIA 5 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 5 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A1HJ-01 5 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-C8-A1HJ NA NA days 5 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Axillary lymph node dissection alone NA NA TCGA-C8-A1HJ TCGA-C8-A1HJ-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -19629 121 NA 0 5 NA NA NA NA NO NA NA NA NA 2011-6-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 1070 NO Negative NA NA 10 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NA NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf A1HJ TUMOR FREE NA NA NA NA NA NA YES NA NA NA Primary Tumor 01 Pateys Surgery 6th NA YES NO C8 Breast A LIVING 2010 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 TCGA-C8-A1HJ-01A-21-A17J-20 TCGA-C8-A1HJ-01A-11D-A13L-09 TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13K-05 6528f6b1-d0f5-413c-a304-0fa218a132ac TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13L-09 NA NA TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13L-09 NA c0dd6c33-008d-44e8-b20c-8089bc3e29a3 NA TCGA-C8-A1HJ-01A-11D-A13J-01 TCGA-C8-A1HJ-01 NA c0dd6c33-008d-44e8-b20c-8089bc3e29a3 TCGA-C8-A1HJ-01A-11D-A13J-01 |
|
|
807 |
TCGA-C8-A1HK-01 Stage IIB 53 5 Stage IIB 7 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 7 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A1HK-01 366 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-C8-A1HK 366 0 days 366 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Axillary lymph node dissection alone NA TCGA-C8-A1HK-F19100 TCGA-C8-A1HK TCGA-C8-A1HK-01A NA Negative NA NA NA NA Negative Other NA NA NA NA NA 116 NA 0 366 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-2 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 460 NO Positive NA NA 8 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf A1HK TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c TCGA-C8-A1HK-01A-11-A17J-20 TCGA-C8-A1HK-01A-21D-A13L-09 TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13K-05 5f7c521f-28b4-46ba-9d1e-a6bf55885d28 TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13L-09 NA NA TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13L-09 NA 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c NA TCGA-C8-A1HK-01A-21D-A13J-01 TCGA-C8-A1HK-01 NA 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c TCGA-C8-A1HK-01A-21D-A13J-01 |
|
|
808 |
TCGA-C8-A1HL-01 Stage IIIA 38 5 Stage IIIA 2 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 2 0 LumB Luminal B Negative NA -2 -3 enrollment T_Other T3 LIVING 0 TCGA-C8-A1HL-01 317 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-C8-A1HL 317 0 days 317 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Left Axillary lymph node dissection alone NA TCGA-C8-A1HL-F20266 TCGA-C8-A1HL TCGA-C8-A1HL-01A NA Positive NA NA NA NA Negative Other NA NA NA NA NA 94 NA 0 317 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 2+ NA NA NA NA Other, specify NA No NA C50.9 8480/3 C50.9 NA YES Pateys Surgery Other method, specify: 980 NO Equivocal NA NA 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO NA NA true Yes M0 N1 T3 Stage IIIA TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf A1HL TUMOR FREE NA NA NA NA Allred Score 8 NA YES NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 9d80ba46-b65f-4338-99bc-370f8eaefe4e 9d80ba46-b65f-4338-99bc-370f8eaefe4e TCGA-C8-A1HL-01A-21-A17J-20 TCGA-C8-A1HL-01A-11D-A135-09 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A138-05 d026ab37-87a8-4486-a09d-0aabeba2dd89 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A135-09 NA TCGA-C8-A1HL-01 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A135-09 NA 9d80ba46-b65f-4338-99bc-370f8eaefe4e NA TCGA-C8-A1HL-01A-11D-A134-01 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11R-A137-07 9d80ba46-b65f-4338-99bc-370f8eaefe4e TCGA-C8-A1HL-01A-11D-A134-01 TCGA-C8-A1HL-01 |
|
|
809 |
TCGA-C8-A1HM-01 Stage II 74 3 Stage IIA 6 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 6 0 LumB Luminal B Positive NA -2 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A1HM-01 375 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-C8-A1HM 375 0 days 375 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Axillary lymph node dissection alone NA TCGA-C8-A1HM-F70806 TCGA-C8-A1HM NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -27063 NA NA 0 375 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T2 Stage IIA NA A1HM TUMOR FREE NA NA NA Allred Score 5 Allred Score 8 YES NO NA NA NO Primary Tumor 01 NA 6th YES YES NO C8 Breast NA LIVING 2010 eb908a6f-d6f2-40ef-90da-97438cd2281e eb908a6f-d6f2-40ef-90da-97438cd2281e TCGA-C8-A1HM-01A-21-A17J-20 TCGA-C8-A1HM-01A-12D-A135-09 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A138-05 e15bb106-69e3-4af4-bd2f-9c9098aa34e3 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A135-09 NA TCGA-C8-A1HM-01 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A135-09 NA eb908a6f-d6f2-40ef-90da-97438cd2281e NA TCGA-C8-A1HM-01A-12D-A134-01 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12R-A137-07 eb908a6f-d6f2-40ef-90da-97438cd2281e TCGA-C8-A1HM-01A-12D-A134-01 TCGA-C8-A1HM-01 |
|
|
810 |
TCGA-C8-A1HN-01 Stage II 56 NA Stage IIA 2 NA Positive FEMALE Equivocal NA NA NA Negative M0 Negative N0 2 0 LumB Luminal B Positive NA -10 -5 enrollment T_Other T2 LIVING 0 TCGA-C8-A1HN-01 394 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-C8-A1HN 394 0 days 394 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Axillary lymph node dissection alone NA TCGA-C8-A1HN-F71885 TCGA-C8-A1HN TCGA-C8-A1HN-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -20712 88 NA 0 394 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-31 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Equivocal NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf A1HN TUMOR FREE NA NA NA Allred Score 3 Allred Score 8 YES NO NA NA NO Primary Tumor 01 NA 6th YES YES NO C8 Breast A LIVING 2010 4795628e-50d8-41e0-b3c6-00fe4600dc5d 4795628e-50d8-41e0-b3c6-00fe4600dc5d TCGA-C8-A1HN-01A-21-A17J-20 TCGA-C8-A1HN-01A-11D-A135-09 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A138-05 4090fc73-565b-4fa8-96c9-958fcb8eda09 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A135-09 NA TCGA-C8-A1HN-01 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A135-09 NA 4795628e-50d8-41e0-b3c6-00fe4600dc5d NA TCGA-C8-A1HN-01A-11D-A134-01 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11R-A137-07 4795628e-50d8-41e0-b3c6-00fe4600dc5d TCGA-C8-A1HN-01A-11D-A134-01 TCGA-C8-A1HN-01 |
|
|
811 |
TCGA-C8-A1HO-01 Stage III 34 5 Stage IIIC 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 0 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-C8-A1HO-01 375 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-C8-A1HO 375 0 days 375 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Left Upper Inner Quadrant NA NA TCGA-C8-A1HO-F70802 TCGA-C8-A1HO TCGA-C8-A1HO-01A NA Positive NA NA NA NA Positive [Discrepancy] NA NA NA NA -12715 52 NA 0 375 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 380 NO Negative NA NO NA Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO NA NA true No M0 N3 T3 Stage IIIC TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf A1HO TUMOR FREE NA NA NA Allred Score 5 Allred Score 7 YES NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 1d8ecbae-6996-4d9d-bff8-ac761a8309ea 1d8ecbae-6996-4d9d-bff8-ac761a8309ea TCGA-C8-A1HO-01A-21-A17J-20 TCGA-C8-A1HO-01A-11D-A13L-09 TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13K-05 654028c2-038a-4cfb-95c6-13ad5000346d TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13L-09 NA NA TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13L-09 NA 1d8ecbae-6996-4d9d-bff8-ac761a8309ea NA TCGA-C8-A1HO-01A-11D-A13J-01 TCGA-C8-A1HO-01 NA 1d8ecbae-6996-4d9d-bff8-ac761a8309ea TCGA-C8-A1HO-01A-11D-A13J-01 |
|
|
812 |
TCGA-C8-A26V-01 Stage III 47 1 Stage IIIA 9 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 9 0 LumB NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-C8-A26V-01 616 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 NA mutation cluster 8 TCGA-C8-A26V 616 0 days 616 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right NA NA TCGA-C8-A26V-F70799 TCGA-C8-A26V TCGA-C8-A26V-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -17468 143 NA 0 616 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Modified Radical Masectomy Other method, specify: 310 NO Negative NA NO NA Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA true No M0 N2 T3 Stage IIIA TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf A26V TUMOR FREE NA NA NA Allred Score 8 Allred Score 8 YES NO NA NA YES Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 67a58c72-fa64-4c63-b568-bec834626edf 67a58c72-fa64-4c63-b568-bec834626edf TCGA-C8-A26V-01A-21-A17K-20 TCGA-C8-A26V-01A-11D-A16D-09 TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16G-05 a8d7929f-263f-4277-be5e-f01eadc08bc3 TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16D-09 NA NA TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16D-09 NA 67a58c72-fa64-4c63-b568-bec834626edf NA TCGA-C8-A26V-01A-11D-A16C-01 TCGA-C8-A26V-01 NA 67a58c72-fa64-4c63-b568-bec834626edf TCGA-C8-A26V-01A-11D-A16C-01 |
|
|
813 |
TCGA-C8-A26W-01 Stage II 58 1 Stage IIB 7 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 7 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A26W-01 381 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 NA mutation cluster 8 TCGA-C8-A26W 381 0 days 381 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant NA NA TCGA-C8-A26W-F70796 TCGA-C8-A26W TCGA-C8-A26W-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -21391 142 NA 0 381 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 300 NO Equivocal NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf A26W TUMOR FREE NA NA NA Allred Score 8 Allred Score 8 YES NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 bd304a35-2d0c-4b11-bd62-3db480c1e730 bd304a35-2d0c-4b11-bd62-3db480c1e730 TCGA-C8-A26W-01A-21-A17K-20 TCGA-C8-A26W-01A-11D-A16D-09 TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16G-05 4c5440c5-3eb7-4bfc-a5e7-51e1a55aa219 TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16D-09 NA NA TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16D-09 NA bd304a35-2d0c-4b11-bd62-3db480c1e730 NA TCGA-C8-A26W-01A-11D-A16C-01 TCGA-C8-A26W-01 NA bd304a35-2d0c-4b11-bd62-3db480c1e730 TCGA-C8-A26W-01A-11D-A16C-01 |
|
|
814 |
TCGA-C8-A26X-01 Stage II 58 4 Stage IIA 11 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 11 0 Her2 NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-C8-A26X-01 376 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 NA mutation cluster 3 TCGA-C8-A26X 376 0 days 376 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant NA NA TCGA-C8-A26X-F70792 TCGA-C8-A26X TCGA-C8-A26X-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -21463 136 NA 0 376 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA true No M0 N1 T1 Stage IIA TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf A26X TUMOR FREE NA NA NA NA NA YES NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 5213da80-35ac-4172-b2e8-de686e73a498 5213da80-35ac-4172-b2e8-de686e73a498 TCGA-C8-A26X-01A-41-A17K-20 TCGA-C8-A26X-01A-31D-A16D-09 TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16G-05 6a344715-e7bd-49b5-9ca7-0e1060a19710 TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16D-09 NA NA TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16D-09 NA 5213da80-35ac-4172-b2e8-de686e73a498 NA TCGA-C8-A26X-01A-31D-A16C-01 TCGA-C8-A26X-01 NA 5213da80-35ac-4172-b2e8-de686e73a498 TCGA-C8-A26X-01A-31D-A16C-01 |
|
|
815 |
TCGA-C8-A26Y-01 Stage II 90 2 Stage IIA 13 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 13 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A26Y-01 394 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-C8-A26Y 394 0 days 394 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Left Upper Outer Quadrant NA NA TCGA-C8-A26Y-F70791 TCGA-C8-A26Y TCGA-C8-A26Y-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -32872 134 NA 0 394 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 140 NO Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf A26Y TUMOR FREE NA NA NA NA NA NO NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 afad9647-befe-4493-8386-475d0097c716 afad9647-befe-4493-8386-475d0097c716 TCGA-C8-A26Y-01A-21-A17K-20 NA TCGA-C8-A26Y-01 TCGA-C8-A26Y-01A-11D-A16G-05 4cf610ef-12f6-4149-ab0b-d0211e9642a6 TCGA-C8-A26Y-01 TCGA-C8-A26Y-01A-11D-A16D-09 NA NA TCGA-C8-A26Y-01 NA NA afad9647-befe-4493-8386-475d0097c716 NA TCGA-C8-A26Y-01A-11D-A16C-01 TCGA-C8-A26Y-01 NA afad9647-befe-4493-8386-475d0097c716 TCGA-C8-A26Y-01A-11D-A16C-01 |
|
|
816 |
TCGA-C8-A26Z-01 Stage IIA 59 3 Stage IIA 4 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 4 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A26Z-01 470 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation c1uster 9 TCGA-C8-A26Z 470 0 days 470 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Inner Quadrant NA NA TCGA-C8-A26Z-F70835 TCGA-C8-A26Z TCGA-C8-A26Z-01A NA Positive NA NA NA NA Positive Other NA NA NA NA NA 125 NA 0 470 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 470 NO Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf A26Z TUMOR FREE NA NA NA Allred Score 4 Allred Score 8 YES NO NA NA NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 8213eb8c-db23-4f92-b3d3-07b45eeec76a 8213eb8c-db23-4f92-b3d3-07b45eeec76a TCGA-C8-A26Z-01A-21-A17K-20 TCGA-C8-A26Z-01A-11D-A16D-09 TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16G-05 fb0eeacf-e38d-42f7-85b5-215ceed54e69 TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16D-09 NA NA TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16D-09 NA 8213eb8c-db23-4f92-b3d3-07b45eeec76a NA TCGA-C8-A26Z-01A-11D-A16C-01 TCGA-C8-A26Z-01 NA 8213eb8c-db23-4f92-b3d3-07b45eeec76a TCGA-C8-A26Z-01A-11D-A16C-01 |
|
|
817 |
TCGA-C8-A273-01 Stage IIB 29 3 Stage IIB 6 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 6 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A273-01 513 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation c1uster 9 TCGA-C8-A273 513 0 days 513 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-C8-A273-F70833 TCGA-C8-A273 TCGA-C8-A273-01A NA Positive NA NA NA NA Positive Other NA NA NA NA NA 168 NA 0 513 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 590 NO Negative NA NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf A273 TUMOR FREE NA NA NA Allred Score 5 Allred Score 8 YES YES NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa TCGA-C8-A273-01A-21-A17K-20 TCGA-C8-A273-01A-11D-A16D-09 TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16G-05 67662a35-222b-4c66-a105-86e9332fc019 TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16D-09 NA NA TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16D-09 NA c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa NA TCGA-C8-A273-01A-11D-A16C-01 TCGA-C8-A273-01 NA c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa TCGA-C8-A273-01A-11D-A16C-01 |
|
|
818 |
TCGA-C8-A274-01 Stage IIA 63 2 Stage IIA 1 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 1 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A274-01 508 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 1 TCGA-C8-A274 508 0 days 508 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right NA NA TCGA-C8-A274-F70831 TCGA-C8-A274 TCGA-C8-A274-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -23337 163 NA 0 508 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 470 NO Negative NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T2 Stage IIA TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf A274 TUMOR FREE NA NA NA Allred Score 7 Allred Score 8 YES NO NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 f9521be2-aaaf-414c-a906-3ba53a060614 f9521be2-aaaf-414c-a906-3ba53a060614 TCGA-C8-A274-01A-21-A17K-20 TCGA-C8-A274-01A-11D-A16D-09 TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16G-05 99762a09-75aa-4d91-8911-2f259e4f4f40 TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16D-09 NA NA TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16D-09 NA f9521be2-aaaf-414c-a906-3ba53a060614 NA TCGA-C8-A274-01A-11D-A16C-01 TCGA-C8-A274-01 NA f9521be2-aaaf-414c-a906-3ba53a060614 TCGA-C8-A274-01A-11D-A16C-01 |
|
|
819 |
TCGA-C8-A275-01 Stage IIA 56 3 Stage IIA 1 NA NA FEMALE Positive NA NA NA Negative M0 Positive N1 1 0 Her2 NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-C8-A275-01 1 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 5 TCGA-C8-A275 NA NA days 1 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant NA NA NA TCGA-C8-A275 TCGA-C8-A275-01A NA NA NA NA NA NA NA Other NA NA NA NA -20774 169 NA 0 1 NA NA NA NA NA NA NA NA NA 2011-7-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 300 NO NA NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NA NA NA true No M0 N1 T1 Stage IIA TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf A275 TUMOR FREE NA NA NA NA NA NA NO NA NA NA Primary Tumor 01 Pateys Surgery 6th NA YES NO C8 Breast A LIVING 2010 59c6ed76-762c-4caa-98c1-0886b6d9651c 59c6ed76-762c-4caa-98c1-0886b6d9651c TCGA-C8-A275-01A-11-A17K-20 TCGA-C8-A275-01A-21D-A16D-09 TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16G-05 46fbe024-54ed-49b2-9492-98b4f59c8f51 TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16D-09 NA NA TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16D-09 NA 59c6ed76-762c-4caa-98c1-0886b6d9651c NA TCGA-C8-A275-01A-21D-A16C-01 TCGA-C8-A275-01 NA 59c6ed76-762c-4caa-98c1-0886b6d9651c TCGA-C8-A275-01A-21D-A16C-01 |
|
|
820 |
TCGA-C8-A278-01 Stage IIIA 61 4 Stage IIIA 1 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N2 1 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A278-01 297 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 NA mutation cluster 3 TCGA-C8-A278 297 0 days 297 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left NA NA TCGA-C8-A278-F20278 TCGA-C8-A278 TCGA-C8-A278-01A NA Negative NA NA NA NA Negative Other NA NA NA NA -22598 163 NA 0 297 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Pateys Surgery Other method, specify: 630 NO Positive NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO NA NA true No M0 N2 T2 Stage IIIA TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf A278 TUMOR FREE NA NA NA NA NA NA NO NA NA NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 TCGA-C8-A278-01A-21-A17K-20 TCGA-C8-A278-01A-11D-A167-09 TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A16A-05 0b7b4dce-2a48-489f-aa4d-68af0d749a17 TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A167-09 NA NA TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A167-09 NA 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 NA TCGA-C8-A278-01A-11D-A166-01 TCGA-C8-A278-01 NA 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 TCGA-C8-A278-01A-11D-A166-01 |
|
|
821 |
TCGA-C8-A27A-01 Stage IIB 48 4 Stage IIB 371 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 371 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-C8-A27A-01 747 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-C8-A27A 747 0 days 747 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant NA NA TCGA-C8-A27A-F70786 TCGA-C8-A27A TCGA-C8-A27A-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -17779 435 NA 0 747 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 230 NO Negative NA NO NA Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO NA NA true No M0 N1 T2 Stage IIB TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf A27A TUMOR FREE NA NA NA NA Allred Score 7 YES NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2010 520a6569-bf3a-495f-9460-7f65e4f59687 520a6569-bf3a-495f-9460-7f65e4f59687 TCGA-C8-A27A-01A-21-A17K-20 TCGA-C8-A27A-01A-11D-A167-09 TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A16A-05 6e6b5e9d-fbb0-480b-9300-d9ecdbbde2b7 TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A167-09 NA NA TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A167-09 NA 520a6569-bf3a-495f-9460-7f65e4f59687 NA TCGA-C8-A27A-01A-11D-A166-01 TCGA-C8-A27A-01 NA 520a6569-bf3a-495f-9460-7f65e4f59687 TCGA-C8-A27A-01A-11D-A166-01 |
|
|
822 |
TCGA-C8-A27B-01 Stage IIB 48 1 Stage IIB 30 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 30 0 Basal NA Negative NA NA NA enrollment T_Other T3 LIVING 0 TCGA-C8-A27B-01 439 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 13 TCGA-C8-A27B 439 0 days 439 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left NA NA TCGA-C8-A27B-F70781 TCGA-C8-A27B TCGA-C8-A27B-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -17763 93 NA 0 439 NA NA NA NA NA NA NA NA NA 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 240 NO Negative NA NO NA Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO NA NA true No M0 N0 T3 Stage IIB TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf A27B TUMOR FREE NA NA NA NA NA YES NO NA NA NO Primary Tumor 01 NA 6th NA YES NO C8 Breast A LIVING 2011 fb03a31f-6611-4343-816d-37a332147eac fb03a31f-6611-4343-816d-37a332147eac TCGA-C8-A27B-01A-21-A17K-20 TCGA-C8-A27B-01A-11D-A167-09 TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A16A-05 14732205-f21b-44fc-9e31-7d8f9dde67df TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A167-09 NA NA TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A167-09 NA fb03a31f-6611-4343-816d-37a332147eac NA TCGA-C8-A27B-01A-11D-A166-01 TCGA-C8-A27B-01 NA fb03a31f-6611-4343-816d-37a332147eac TCGA-C8-A27B-01A-11D-A166-01 |
|
|
823 |
TCGA-C8-A3M7-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 1 TCGA-C8-A3M7-01 1034 1 days Iq C3-BRCA/Luminal NA BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-C8-A3M7 1034 1 days 1034 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 60 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-C8-A3M7-F70838 TCGA-C8-A3M7 NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22096 NA 1034 0 1 NA NA 1034 NA NO NA NA NA NA 2015-3-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Locoregional Recurrence NA NO YES 0 NA NA No M0 N0 T4b Stage IIIB NA A3M7 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO C8 Breast NA DECEASED 2010 b55b6630-7cf5-4bca-b76f-e135271018e4 b55b6630-7cf5-4bca-b76f-e135271018e4 TCGA-C8-A3M7-01A-21-A24A-20 NA TCGA-C8-A3M7-01 TCGA-C8-A3M7-01A-12D-A21R-05 c07c21cd-c286-4fd3-b98a-886e161a6ead TCGA-C8-A3M7-01 TCGA-C8-A3M7-01A-12D-A21Q-09 NA NA TCGA-C8-A3M7-01 NA NA b55b6630-7cf5-4bca-b76f-e135271018e4 NA TCGA-C8-A3M7-01A-12D-A21P-01 TCGA-C8-A3M7-01 NA b55b6630-7cf5-4bca-b76f-e135271018e4 TCGA-C8-A3M7-01A-12D-A21P-01 |
|
|
824 |
TCGA-C8-A3M8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-C8-A3M8-01 394 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-C8-A3M8 394 0 days 394 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-C8-A3M8-F70779 TCGA-C8-A3M8 TCGA-C8-A3M8-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -24877 264 NA 0 394 NA NA NA NA NO NA NA NA NA 2015-3-9 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 280 NO Positive NA NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No M0 N0 T1c Stage IA TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf A3M8 TUMOR FREE NA Dako NA Allred Allred YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO C8 Breast A LIVING 2011 a04ad65d-6d83-4e84-8bd8-3cab2a195642 a04ad65d-6d83-4e84-8bd8-3cab2a195642 TCGA-C8-A3M8-01A-21-A24A-20 NA TCGA-C8-A3M8-01 TCGA-C8-A3M8-01A-11D-A212-05 45db31fd-5919-4580-8641-31aec5565486 TCGA-C8-A3M8-01 TCGA-C8-A3M8-01A-11D-A20S-09 NA NA TCGA-C8-A3M8-01 NA NA a04ad65d-6d83-4e84-8bd8-3cab2a195642 NA TCGA-C8-A3M8-01A-11D-A20R-01 TCGA-C8-A3M8-01 NA a04ad65d-6d83-4e84-8bd8-3cab2a195642 TCGA-C8-A3M8-01A-11D-A20R-01 |
|
|
825 |
TCGA-C8-A8HP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-C8-A8HP-01 396 0 days NA NA NA NA NA NA NA NA NA TCGA-C8-A8HP 396 0 days 396 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-C8-A8HP-F69610 TCGA-C8-A8HP TCGA-C8-A8HP-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -21613 231 NA 0 396 NA NA NA NA NA NA NA NA NA 2015-1-15 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Core needle biopsy 240 NO Positive NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 6 NA true No M0 N2 T2 Stage IIIA TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf A8HP TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO C8 Breast A LIVING 2013 02cf1db9-55c0-4ece-b230-966b30cd0b94 02cf1db9-55c0-4ece-b230-966b30cd0b94 NA NA TCGA-C8-A8HP-01 TCGA-C8-A8HP-01A-11D-A36K-05 0D8764CE-08F0-4612-886E-07065119924F TCGA-C8-A8HP-01 NA NA NA TCGA-C8-A8HP-01 NA NA 02cf1db9-55c0-4ece-b230-966b30cd0b94 NA TCGA-C8-A8HP-01A-11D-A36I-01 TCGA-C8-A8HP-01 NA 02cf1db9-55c0-4ece-b230-966b30cd0b94 TCGA-C8-A8HP-01A-11D-A36I-01 |
|
|
826 |
TCGA-C8-A8HQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-C8-A8HQ-01 380 0 days NA NA NA NA NA NA NA NA NA TCGA-C8-A8HQ 380 0 days 380 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Axillary lymph node dissection alone NA TCGA-C8-A8HQ-F69879 TCGA-C8-A8HQ TCGA-C8-A8HQ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -19432 185 NA 0 380 NA NA NA NA NA NA NA NA NA 2015-1-22 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative NA NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 4 true No M0 N1 T2 Stage IIB TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf A8HQ TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO C8 Breast A LIVING 2013 7f8c9d62-0803-44d6-9375-b4e71612a0b1 7f8c9d62-0803-44d6-9375-b4e71612a0b1 NA NA TCGA-C8-A8HQ-01 TCGA-C8-A8HQ-01A-11D-A36K-05 39E9AC4D-F0C1-4629-9C69-09C72747A2E8 TCGA-C8-A8HQ-01 NA NA NA TCGA-C8-A8HQ-01 NA NA 7f8c9d62-0803-44d6-9375-b4e71612a0b1 NA TCGA-C8-A8HQ-01A-11D-A36I-01 TCGA-C8-A8HQ-01 NA 7f8c9d62-0803-44d6-9375-b4e71612a0b1 TCGA-C8-A8HQ-01A-11D-A36I-01 |
|
|
827 |
TCGA-C8-A8HR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-C8-A8HR-01 408 0 days NA NA NA NA NA NA NA NA NA TCGA-C8-A8HR 408 0 days 408 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Axillary lymph node dissection alone NA TCGA-C8-A8HR-F69796 TCGA-C8-A8HR TCGA-C8-A8HR-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -17921 162 NA 0 408 NA NA NA NA NA NA NA NA NA 2015-1-20 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 420 NO NA NA NO 8 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA true No M0 N2 T3 Stage IIIA TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf A8HR TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO C8 Breast A LIVING 2013 d817dcee-1322-4949-a6e9-138447e6fc56 d817dcee-1322-4949-a6e9-138447e6fc56 NA NA TCGA-C8-A8HR-01 TCGA-C8-A8HR-01A-11D-A36K-05 D888CD95-8F1F-48DE-8DDC-70C9AD64579F TCGA-C8-A8HR-01 NA NA NA TCGA-C8-A8HR-01 NA NA d817dcee-1322-4949-a6e9-138447e6fc56 NA TCGA-C8-A8HR-01A-11D-A36I-01 TCGA-C8-A8HR-01 NA d817dcee-1322-4949-a6e9-138447e6fc56 TCGA-C8-A8HR-01A-11D-A36I-01 |
|
|
828 |
TCGA-C8-A9FZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-C8-A9FZ-01 592 0 days NA NA NA NA NA NA NA NA NA TCGA-C8-A9FZ 592 0 days 592 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Axillary lymph node dissection alone NA TCGA-C8-A9FZ-F69966 TCGA-C8-A9FZ TCGA-C8-A9FZ-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -18038 191 NA 0 592 NA NA NA NA NA NA NA NA NA 2015-1-23 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating Tubulo-Lobular Carcinoma No NA C50.9 8524/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1 T2 Stage IIB TCGA-C8-A9FZ.23B3BAED-E281-4A1D-AB78-51D8D62466FF.pdf A9FZ TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO C8 Breast A LIVING 2013 NA NA NA NA NA TCGA-C8-A9FZ-01A-11D-A41Q-05 7E0EFE5A-8C0A-4B7F-950D-9F0CFFB57F01 NA NA NA NA TCGA-C8-A9FZ-01 NA NA NA NA TCGA-C8-A9FZ-01A-11D-A41E-01 TCGA-C8-A9FZ-01 NA NA TCGA-C8-A9FZ-01A-11D-A41E-01 |
|
|
829 |
TCGA-D8-A13Y-01 Stage IA 52 5 No_Conversion 362 NA Positive FEMALE Negative 3 2 4 Negative M0 Negative N0 362 0 LumB Luminal B Positive Basal -2 -6 followup T1 T1 LIVING 0 TCGA-D8-A13Y-01 1728 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 GBM-like c6 miRNA cluster 6 cluster 1 mutation cluster 2 TCGA-D8-A13Y 1728 0 days 1728 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A13Y-F72210 TCGA-D8-A13Y TCGA-D8-A13Y-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -19028 184 NA 0 1728 NA NA NA NA NA manual counting 70-79% NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA Hecep Test TM DAKO NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 430 NO Negative NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf A13Y TUMOR FREE manual counting NA NA 10-75% 10-75% YES NA 70-79% NA NO Primary Tumor 01 NA NA YES YES NO D8 Breast A LIVING 2010 9a92e20a-2a43-4917-981d-c93179770050 9a92e20a-2a43-4917-981d-c93179770050 TCGA-D8-A13Y-01A-21-A13D-20 TCGA-D8-A13Y-01A-11D-A10Y-09 TCGA-D8-A13Y-01 NA 664694fa-7bea-4f87-b6ff-4df52540d15b TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11D-A10Y-09 TCGA-D8-A13Y-01A-11D-A112-05 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11D-A10Y-09 NA 9a92e20a-2a43-4917-981d-c93179770050 NA TCGA-D8-A13Y-01A-11D-A111-01 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11R-A115-07 9a92e20a-2a43-4917-981d-c93179770050 TCGA-D8-A13Y-01A-11D-A111-01 TCGA-D8-A13Y-01 |
|
|
830 |
TCGA-D8-A13Z-01 Stage X 51 1 Stage IIIA 210 NA Negative FEMALE Negative 2 2 1 Negative M0 Positive N2 210 0 Her2 HER2-enriched Negative Basal -13 -10 enrollment T_Other T2 LIVING 0 TCGA-D8-A13Z-01 635 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-D8-A13Z 635 0 days 635 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A13Z-F20731 TCGA-D8-A13Z TCGA-D8-A13Z-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -18942 214 NA 0 635 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 470 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 9 NA false No M0 N2a T2 NA TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf A13Z TUMOR FREE NA Hercep Test TM Dako NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 TCGA-D8-A13Z-01A-21-A13D-20 TCGA-D8-A13Z-01A-11D-A10Y-09 TCGA-D8-A13Z-01 NA ecffe473-31aa-41e3-a964-ca96147a8023 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11D-A10Y-09 TCGA-D8-A13Z-01A-11D-A112-05 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11D-A10Y-09 NA 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 NA TCGA-D8-A13Z-01A-11D-A111-01 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11R-A115-07 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 TCGA-D8-A13Z-01A-11D-A111-01 TCGA-D8-A13Z-01 |
|
|
831 |
TCGA-D8-A140-01 Stage IIB 62 NA Stage IIB 403 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 403 0 LumA Luminal B Positive LumA/B -10 -5 followup T_Other T2 LIVING 0 TCGA-D8-A140-01 403 0 days NA C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-D8-A140 403 0 days 403 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-D8-A140-F13808 TCGA-D8-A140 TCGA-D8-A140-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22900 204 NA 0 403 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2011-6-20 FEMALE NA Hercep Test TM DAKO NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 400 NO Positive NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T2 Stage IIB TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf A140 TUMOR FREE manual counting NA NA <10% >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 TCGA-D8-A140-01A-21-A13D-20 TCGA-D8-A140-01A-11D-A10Y-09 TCGA-D8-A140-01 NA ce3b8c9f-acd7-4ba7-8042-3a3de6225cde TCGA-D8-A140-01 TCGA-D8-A140-01A-11D-A10Y-09 TCGA-D8-A140-01A-11D-A112-05 TCGA-D8-A140-01 TCGA-D8-A140-01 TCGA-D8-A140-01A-11D-A10Y-09 NA 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 NA TCGA-D8-A140-01A-11D-A111-01 TCGA-D8-A140-01 TCGA-D8-A140-01A-11R-A115-07 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 TCGA-D8-A140-01A-11D-A111-01 TCGA-D8-A140-01 |
|
|
832 |
TCGA-D8-A141-01 Stage X 40 2 Stage IIA 113 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 113 0 LumA Luminal A Positive NA -5 -4 enrollment T1 T1 LIVING 0 TCGA-D8-A141-01 626 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A141 626 0 days 626 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Axillary lymph node dissection alone NA TCGA-D8-A141-F20734 TCGA-D8-A141 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14626 NA NA 0 626 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-14 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 15 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1 T1c NA NA A141 TUMOR FREE manual counting Hercep Test TM Dako NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 NA TCGA-D8-A141-01A-11D-A10Y-09 TCGA-D8-A141-01 NA NA TCGA-D8-A141-01 TCGA-D8-A141-01A-11D-A10Y-09 TCGA-D8-A141-01A-11D-A112-05 TCGA-D8-A141-01 TCGA-D8-A141-01 TCGA-D8-A141-01A-11D-A10Y-09 NA cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 NA TCGA-D8-A141-01A-11D-A111-01 TCGA-D8-A141-01 TCGA-D8-A141-01A-11R-A115-07 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 TCGA-D8-A141-01A-11D-A111-01 TCGA-D8-A141-01 |
|
|
833 |
TCGA-D8-A142-01 Stage IIB 74 1 Stage IIB 425 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 425 0 Basal Basal-like Negative X -13 0 followup T_Other T3 LIVING 0 TCGA-D8-A142-01 425 0 days High C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 3 mutation cluster 5 TCGA-D8-A142 425 0 days 425 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Lower Outer Quadrant|Left Axillary lymph node dissection alone NA TCGA-D8-A142-F13813 TCGA-D8-A142 TCGA-D8-A142-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -27313 212 NA 0 425 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-6-20 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 490 NO Equivocal Negative NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T3 Stage IIB TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf A142 TUMOR FREE NA FISH NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 9f440cd6-d55f-4cb6-a433-637ef1f9d38f 9f440cd6-d55f-4cb6-a433-637ef1f9d38f TCGA-D8-A142-01A-21-A13D-20 TCGA-D8-A142-01A-11D-A10Y-09 TCGA-D8-A142-01 NA d434b104-6d07-417e-9a84-c729c071cf14 TCGA-D8-A142-01 TCGA-D8-A142-01A-11D-A10Y-09 TCGA-D8-A142-01A-11D-A112-05 TCGA-D8-A142-01 TCGA-D8-A142-01 TCGA-D8-A142-01A-11D-A10Y-09 NA 9f440cd6-d55f-4cb6-a433-637ef1f9d38f NA TCGA-D8-A142-01A-11D-A111-01 TCGA-D8-A142-01 TCGA-D8-A142-01A-11R-A115-07 9f440cd6-d55f-4cb6-a433-637ef1f9d38f TCGA-D8-A142-01A-11D-A111-01 TCGA-D8-A142-01 |
|
|
834 |
TCGA-D8-A143-01 Stage IIA 51 3 Stage IIA 431 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 431 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING 0 TCGA-D8-A143-01 431 0 days High C3-BRCA/Luminal cluster 5 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 NA NA mutation cluster 3 TCGA-D8-A143 431 0 days 431 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A143-F13817 TCGA-D8-A143 TCGA-D8-A143-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18984 211 NA 0 431 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-7-4 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf A143 TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 TCGA-D8-A143-01A-21-A13D-20 TCGA-D8-A143-01A-11D-A10Y-09 TCGA-D8-A143-01 NA e9cd47fb-4a8f-44c9-af6a-f931387d14a7 TCGA-D8-A143-01 TCGA-D8-A143-01A-11D-A10Y-09 TCGA-D8-A143-01A-11D-A112-05 TCGA-D8-A143-01 TCGA-D8-A143-01 TCGA-D8-A143-01A-11D-A10Y-09 NA 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 NA TCGA-D8-A143-01A-11D-A111-01 TCGA-D8-A143-01 TCGA-D8-A143-01A-11R-A115-07 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 TCGA-D8-A143-01A-11D-A111-01 TCGA-D8-A143-01 |
|
|
835 |
TCGA-D8-A145-01 Stage IIA 80 1 Stage IIA 410 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 410 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING 0 TCGA-D8-A145-01 410 0 days COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-D8-A145 410 0 days 410 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-D8-A145-F13811 TCGA-D8-A145 TCGA-D8-A145-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -29280 191 NA 0 410 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2011-7-4 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Equivocal Negative NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf A145 TUMOR FREE manual counting NA NA NA >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 6223244a-ed38-46b5-8e65-cc8e4926c809 6223244a-ed38-46b5-8e65-cc8e4926c809 TCGA-D8-A145-01A-21-A13D-20 TCGA-D8-A145-01A-11D-A10Y-09 TCGA-D8-A145-01 NA c734c71e-bd11-4c7c-862a-1d578d1951b1 TCGA-D8-A145-01 TCGA-D8-A145-01A-11D-A10Y-09 TCGA-D8-A145-01A-11D-A112-05 TCGA-D8-A145-01 TCGA-D8-A145-01 TCGA-D8-A145-01A-11D-A10Y-09 NA 6223244a-ed38-46b5-8e65-cc8e4926c809 NA TCGA-D8-A145-01A-11D-A111-01 TCGA-D8-A145-01 TCGA-D8-A145-01A-11R-A115-07 6223244a-ed38-46b5-8e65-cc8e4926c809 TCGA-D8-A145-01A-11D-A111-01 TCGA-D8-A145-01 |
|
|
836 |
TCGA-D8-A146-01 Stage IIA 57 NA Stage IIA 344 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 344 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A146-01 643 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-D8-A146 643 0 days 643 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone NA TCGA-D8-A146-F20750 TCGA-D8-A146 TCGA-D8-A146-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20861 221 NA 0 643 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-1-15 FEMALE NA DAKO Hercep Test TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 230 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false Yes MX N0 T2 Stage IIA TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf A146 TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 69f535c7-8f70-4efc-98bc-7f99924d7db1 69f535c7-8f70-4efc-98bc-7f99924d7db1 TCGA-D8-A146-01A-21-A13D-20 TCGA-D8-A146-01A-31D-A10Y-09 TCGA-D8-A146-01 NA 9953ddb6-cba3-4fd0-9917-42071efaabdb TCGA-D8-A146-01 TCGA-D8-A146-01A-31D-A10Y-09 TCGA-D8-A146-01A-31D-A112-05 TCGA-D8-A146-01 NA TCGA-D8-A146-01A-31D-A10Y-09 NA 69f535c7-8f70-4efc-98bc-7f99924d7db1 NA TCGA-D8-A146-01A-31D-A111-01 NA TCGA-D8-A146-01A-31R-A115-07 69f535c7-8f70-4efc-98bc-7f99924d7db1 TCGA-D8-A146-01A-31D-A111-01 TCGA-D8-A146-01 |
|
|
837 |
TCGA-D8-A147-01 Stage X 45 1 Stage IIA 2 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 2 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-D8-A147-01 584 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 13 TCGA-D8-A147 584 0 days 584 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A147-F20737 TCGA-D8-A147 TCGA-D8-A147-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -16736 163 NA 0 584 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-14 FEMALE NA Hercep Test TM Dako NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Negative NA NA 1 Negative Indeterminate (neither Pre or Postmenopausal) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 NA TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf A147 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 4d28bcbc-dbdd-46f8-9329-49f359480a97 4d28bcbc-dbdd-46f8-9329-49f359480a97 TCGA-D8-A147-01A-21-A13D-20 TCGA-D8-A147-01A-11D-A10Y-09 TCGA-D8-A147-01 NA a8d9009e-ecf1-420f-a3b7-faab805210de TCGA-D8-A147-01 TCGA-D8-A147-01A-11D-A10Y-09 TCGA-D8-A147-01A-11D-A112-05 TCGA-D8-A147-01 TCGA-D8-A147-01 TCGA-D8-A147-01A-11D-A10Y-09 NA 4d28bcbc-dbdd-46f8-9329-49f359480a97 NA TCGA-D8-A147-01A-11D-A111-01 TCGA-D8-A147-01 TCGA-D8-A147-01A-11R-A115-07 4d28bcbc-dbdd-46f8-9329-49f359480a97 TCGA-D8-A147-01A-11D-A111-01 TCGA-D8-A147-01 |
|
|
838 |
TCGA-D8-A1J8-01 Stage IIB 77 2 Stage IIB 256 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 256 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1J8-01 431 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 NA TCGA-D8-A1J8 431 0 days 431 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1J8-F14040 TCGA-D8-A1J8 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -28444 NA NA 0 431 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T2 Stage IIB NA A1J8 TUMOR FREE NA NA NA NA NA NA NA 70-79% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef TCGA-D8-A1J8-01A-21-A17J-20 NA TCGA-D8-A1J8-01 TCGA-D8-A1J8-01A-11D-A13K-05 f1a4f40a-6d0d-49a8-ab70-d275856a8996 TCGA-D8-A1J8-01 TCGA-D8-A1J8-01A-11D-A13L-09 NA NA TCGA-D8-A1J8-01 NA NA ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef NA TCGA-D8-A1J8-01A-11D-A13J-01 TCGA-D8-A1J8-01 NA ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef TCGA-D8-A1J8-01A-11D-A13J-01 |
|
|
839 |
TCGA-D8-A1J9-01 Stage IA 48 2 Stage I 248 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 248 0 LumB NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1J9-01 532 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-D8-A1J9 532 0 days 532 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1J9-F20944 TCGA-D8-A1J9 TCGA-D8-A1J9-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -17879 211 NA 0 532 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA Hecep Test TM DAKO NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 230 NO Positive NA NA 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf A1J9 TUMOR FREE manual counting NA NA 0% 10-75% NA NA NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 ff7159e7-e9f2-4cc8-ab89-f4167d19672c ff7159e7-e9f2-4cc8-ab89-f4167d19672c TCGA-D8-A1J9-01A-21-A17J-20 TCGA-D8-A1J9-01A-11D-A13L-09 TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13K-05 07d51184-85a3-4ba7-9cc2-badcb3ccfa23 TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13L-09 NA NA TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13L-09 NA ff7159e7-e9f2-4cc8-ab89-f4167d19672c NA TCGA-D8-A1J9-01A-11D-A13J-01 TCGA-D8-A1J9-01 NA ff7159e7-e9f2-4cc8-ab89-f4167d19672c TCGA-D8-A1J9-01A-11D-A13J-01 |
|
|
840 |
TCGA-D8-A1JA-01 Stage X 60 1 Stage IIIB 18 NA Negative FEMALE Positive NA NA NA Negative M0 Negative N0 18 0 Her2 NA Negative NA NA NA enrollment T_Other T4 LIVING 0 TCGA-D8-A1JA-01 502 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 NA TCGA-D8-A1JA 431 1 days 502 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NO NA 60 Left Upper Outer Quadrant No axillary staging NA TCGA-D8-A1JA-F20941 TCGA-D8-A1JA TCGA-D8-A1JA-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21918 194 NA 0 502 NA NA 431 NA NA manual counting <10% NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA Hecep Test TM DAKO NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 310 NO Positive NA NA NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA Locoregional Disease NA NA YES NA NA false No M0 NX T4b NA TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf A1JA WITH TUMOR manual counting NA NA 0% NA NA NO NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 ae81378c-ada3-43cb-9855-941467fd856c ae81378c-ada3-43cb-9855-941467fd856c TCGA-D8-A1JA-01A-21-A17J-20 NA TCGA-D8-A1JA-01 TCGA-D8-A1JA-01A-11D-A13K-05 62f05450-0574-4a36-aaae-6a2d2078950e TCGA-D8-A1JA-01 TCGA-D8-A1JA-01A-11D-A13L-09 NA NA TCGA-D8-A1JA-01 NA NA ae81378c-ada3-43cb-9855-941467fd856c NA TCGA-D8-A1JA-01A-11D-A13J-01 TCGA-D8-A1JA-01 NA ae81378c-ada3-43cb-9855-941467fd856c TCGA-D8-A1JA-01A-11D-A13J-01 |
|
|
841 |
TCGA-D8-A1JB-01 Stage IIB 54 3 Stage IIB 0 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JB-01 1688 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-D8-A1JB 1688 0 days 1688 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JB-F72209 TCGA-D8-A1JB TCGA-D8-A1JB-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -19822 232 NA 0 1688 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA Hecep Test TM DAKO NA Path Vysion HER2 D Probe Kit 2+ NA not amplified NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 350 NO Equivocal Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T2 Stage IIB TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf A1JB TUMOR FREE manual counting NA NA 10-75% >75% YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 TCGA-D8-A1JB-01A-21-A17J-20 TCGA-D8-A1JB-01A-11D-A13L-09 TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13K-05 6c49abf3-08bb-47a4-be2c-6957bf1de2eb TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13L-09 NA NA TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13L-09 NA 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 NA TCGA-D8-A1JB-01A-11D-A13J-01 TCGA-D8-A1JB-01 NA 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 TCGA-D8-A1JB-01A-11D-A13J-01 |
|
|
842 |
TCGA-D8-A1JC-01 Stage IIIA 59 5 Stage IIIA 178 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 178 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JC-01 480 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-D8-A1JC 480 0 days 480 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JC-F20847 TCGA-D8-A1JC TCGA-D8-A1JC-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -21898 201 NA 0 480 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 180 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 4 NA false No M0 N2a T2 Stage IIIA TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf A1JC TUMOR FREE NA NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 TCGA-D8-A1JC-01A-21-A17J-20 TCGA-D8-A1JC-01A-11D-A13L-09 TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13K-05 57323434-3660-45b6-90fd-6183e75a5b54 TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13L-09 NA NA TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13L-09 NA d69c60ae-d21b-4e6e-89c5-ef0750a31c71 NA TCGA-D8-A1JC-01A-11D-A13J-01 TCGA-D8-A1JC-01 NA d69c60ae-d21b-4e6e-89c5-ef0750a31c71 TCGA-D8-A1JC-01A-11D-A13J-01 |
|
|
843 |
TCGA-D8-A1JD-01 Stage IIB 41 5 Stage IIB 273 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 273 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JD-01 552 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1JD 552 0 days 552 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JD-F20844 TCGA-D8-A1JD TCGA-D8-A1JD-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -15166 230 NA 0 552 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA Hecep Test TM DAKO NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 400 NO Negative NA NA 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 3 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf A1JD TUMOR FREE manual counting NA NA 10-75% >75% NA NA NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 f2ee7101-b51e-4f75-95fa-555b5b79af74 f2ee7101-b51e-4f75-95fa-555b5b79af74 TCGA-D8-A1JD-01A-21-A17J-20 TCGA-D8-A1JD-01A-11D-A13L-09 TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13K-05 7788922c-5c28-46e3-9ee9-6fb8aab752d4 TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13L-09 NA NA TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13L-09 NA f2ee7101-b51e-4f75-95fa-555b5b79af74 NA TCGA-D8-A1JD-01A-11D-A13J-01 TCGA-D8-A1JD-01 NA f2ee7101-b51e-4f75-95fa-555b5b79af74 TCGA-D8-A1JD-01A-11D-A13J-01 |
|
|
844 |
TCGA-D8-A1JE-01 Stage IIA 62 2 Stage IIA 57 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 57 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1JE-01 575 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1JE 575 0 days 575 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JE-F20759 TCGA-D8-A1JE NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22683 NA NA 0 575 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-8 FEMALE NA Hecep Test TM DAKO NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T1c Stage IIA NA A1JE TUMOR FREE manual counting NA NA 10-75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 c7139402-146f-4c49-bcd0-f2a6a378911e c7139402-146f-4c49-bcd0-f2a6a378911e TCGA-D8-A1JE-01A-21-A17J-20 TCGA-D8-A1JE-01A-11D-A13L-09 TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13K-05 ad15f06b-4988-4132-9b8c-1c04e14fa98e TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13L-09 NA NA TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13L-09 NA c7139402-146f-4c49-bcd0-f2a6a378911e NA TCGA-D8-A1JE-01A-11D-A13J-01 TCGA-D8-A1JE-01 NA c7139402-146f-4c49-bcd0-f2a6a378911e TCGA-D8-A1JE-01A-11D-A13J-01 |
|
|
845 |
TCGA-D8-A1JF-01 Stage IIIA 79 3 Stage IIIA 96 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N2 96 0 Her2 NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1JF-01 366 0 days COAD-READ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 8 TCGA-D8-A1JF 366 0 days 366 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JF-F14058 TCGA-D8-A1JF NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -29199 NA NA 0 366 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: NA NA Negative NA NA 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NO 8 NA NA No M0 N2a T1c Stage IIIA NA A1JF TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 a74b20ca-06f9-47ec-8888-cb01e0ba3257 a74b20ca-06f9-47ec-8888-cb01e0ba3257 TCGA-D8-A1JF-01A-21-A17J-20 TCGA-D8-A1JF-01A-11D-A13L-09 TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13K-05 c9bf8bae-3cf7-4b3f-8fb4-51e9bd4e83a8 TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13L-09 NA NA TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13L-09 NA a74b20ca-06f9-47ec-8888-cb01e0ba3257 NA TCGA-D8-A1JF-01A-11D-A13J-01 TCGA-D8-A1JF-01 NA a74b20ca-06f9-47ec-8888-cb01e0ba3257 TCGA-D8-A1JF-01A-11D-A13J-01 |
|
|
846 |
TCGA-D8-A1JG-01 Stage IIA 62 1 Stage IIA 187 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 187 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JG-01 1612 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-D8-A1JG 1612 0 days 1612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A1JG-F72208 TCGA-D8-A1JG NA NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -22878 NA NA 0 1612 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA NA NA NA 2+ NA not amplified NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: NA NA Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A1JG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 ee8b563d-11bb-4d84-ac53-e2acc8d0275d ee8b563d-11bb-4d84-ac53-e2acc8d0275d TCGA-D8-A1JG-01B-21-A17J-20 TCGA-D8-A1JG-01B-11D-A13L-09 TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13K-05 dc251841-a624-484b-b4ce-b149651d3b57 TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13L-09 NA NA TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13L-09 NA ee8b563d-11bb-4d84-ac53-e2acc8d0275d NA TCGA-D8-A1JG-01B-11D-A13J-01 TCGA-D8-A1JG-01 NA ee8b563d-11bb-4d84-ac53-e2acc8d0275d TCGA-D8-A1JG-01B-11D-A13J-01 |
|
|
847 |
TCGA-D8-A1JH-01 Stage IA 56 1 Stage I 426 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 426 0 LumA NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-D8-A1JH-01 426 0 days Quiet C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-D8-A1JH 426 0 days 426 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JH-F14055 TCGA-D8-A1JH TCGA-D8-A1JH-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -20497 263 NA 0 426 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA Hecep Test TM DAKO NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 140 NO Negative NA NA 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO NA NA false No M0 N0 T1c Stage IA TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf A1JH TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 TCGA-D8-A1JH-01A-21-A17J-20 TCGA-D8-A1JH-01A-11D-A188-09 TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A13K-05 16c99b80-d0de-4a1e-b8f8-d119431fc8db TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A188-09 NA NA TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A188-09 NA 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 NA TCGA-D8-A1JH-01A-11D-A13J-01 TCGA-D8-A1JH-01 NA 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 TCGA-D8-A1JH-01A-11D-A13J-01 |
|
|
848 |
TCGA-D8-A1JI-01 Stage IIA 54 2 Stage IIA 21 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 21 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1JI-01 577 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-D8-A1JI 577 0 days 577 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JI-F20757 TCGA-D8-A1JI TCGA-D8-A1JI-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20072 226 NA 0 577 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA DAKOHercepTest TM NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 190 NO Negative NA NA 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 2 NA false No MX N1a T1c Stage IIA TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf A1JI TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 27706c21-96cb-48e9-88ec-1c52769bfe45 27706c21-96cb-48e9-88ec-1c52769bfe45 TCGA-D8-A1JI-01A-21-A17J-20 TCGA-D8-A1JI-01A-11D-A13L-09 TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13K-05 621f10de-1603-49a6-ab27-8cfc9c4fd621 TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13L-09 NA NA TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13L-09 NA 27706c21-96cb-48e9-88ec-1c52769bfe45 NA TCGA-D8-A1JI-01A-11D-A13J-01 TCGA-D8-A1JI-01 NA 27706c21-96cb-48e9-88ec-1c52769bfe45 TCGA-D8-A1JI-01A-11D-A13J-01 |
|
|
849 |
TCGA-D8-A1JJ-01 Stage IIA 54 1 Stage IIA 274 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 274 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JJ-01 611 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 3 TCGA-D8-A1JJ 611 0 days 611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A1JJ-F20754 TCGA-D8-A1JJ TCGA-D8-A1JJ-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -19966 260 NA 0 611 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA DAKOHercepTest TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf A1JJ TUMOR FREE manual counting 10-75% NA 10-75% >75% NA YES NA NA YES Primary Tumor 01 breast conserving therapy 7th YES YES NO D8 Breast A LIVING 2010 091cb252-dd08-4e9c-939c-749f595713f6 091cb252-dd08-4e9c-939c-749f595713f6 TCGA-D8-A1JJ-01A-11-A17J-20 TCGA-D8-A1JJ-01A-31D-A14K-09 TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14N-05 f1275b85-f44d-447b-8def-00e4f4c9b2c0 TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14K-09 NA NA TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14K-09 NA 091cb252-dd08-4e9c-939c-749f595713f6 NA TCGA-D8-A1JJ-01A-31D-A14J-01 TCGA-D8-A1JJ-01 NA 091cb252-dd08-4e9c-939c-749f595713f6 TCGA-D8-A1JJ-01A-31D-A14J-01 |
|
|
850 |
TCGA-D8-A1JK-01 Stage IIA 90 1 Stage IIA 109 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 109 0 Basal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JK-01 612 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 4 mutation cluster 3 TCGA-D8-A1JK 612 0 days 612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JK-F20751 TCGA-D8-A1JK TCGA-D8-A1JK-01A NA Negative NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -32872 261 NA 0 612 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-19 FEMALE NA DAKOHercepTest TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 270 NO Negative NA NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf A1JK TUMOR FREE manual counting NA NA NA 0% NA YES <10% NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 TCGA-D8-A1JK-01A-21-A17J-20 TCGA-D8-A1JK-01A-11D-A13L-09 TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13K-05 0f3becf1-2a76-4401-950b-6809dfd90276 TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13L-09 NA NA TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13L-09 NA f7dd2e6b-a87e-467b-890a-3c422ae3dea7 NA TCGA-D8-A1JK-01A-11D-A13J-01 TCGA-D8-A1JK-01 NA f7dd2e6b-a87e-467b-890a-3c422ae3dea7 TCGA-D8-A1JK-01A-11D-A13J-01 |
|
|
851 |
TCGA-D8-A1JL-01 Stage IIA 72 3 Stage IIA 265 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 265 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JL-01 611 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-D8-A1JL 611 0 days 611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JL-F20747 TCGA-D8-A1JL NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -26484 NA NA 0 611 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-15 FEMALE NA DAKOHercepTest TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A1JL TUMOR FREE manual counting NA NA 0% 0% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 b4673313-fa18-43e8-a01b-5cdb3cf5425e b4673313-fa18-43e8-a01b-5cdb3cf5425e TCGA-D8-A1JL-01A-21-A17J-20 TCGA-D8-A1JL-01A-11D-A13L-09 TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13K-05 c5c33030-617d-46a1-89a5-fa6ddd7d06fc TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13L-09 NA NA TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13L-09 NA b4673313-fa18-43e8-a01b-5cdb3cf5425e NA TCGA-D8-A1JL-01A-11D-A13J-01 TCGA-D8-A1JL-01 NA b4673313-fa18-43e8-a01b-5cdb3cf5425e TCGA-D8-A1JL-01A-11D-A13J-01 |
|
|
852 |
TCGA-D8-A1JM-01 Stage IIB 59 1 Stage IIB 238 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 238 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1JM-01 590 0 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation c1uster 9 TCGA-D8-A1JM 590 0 days 590 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JM-F20742 TCGA-D8-A1JM TCGA-D8-A1JM-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -21602 243 NA 0 590 NA NA NA NA NA manual counting <10% NA Scheduled Follow-up Submission 2012-1-15 FEMALE NA DAKOHercepTest TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 350 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 3 NA false No M0 N1a T2 Stage IIB TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf A1JM TUMOR FREE manual counting NA NA 0% NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 TCGA-D8-A1JM-01A-21-A17J-20 TCGA-D8-A1JM-01A-11D-A13L-09 TCGA-D8-A1JM-01 TCGA-D8-A1JM-01A-11D-A13K-05 8d31dc1e-928f-4d15-9ebc-cdab6a5e3527 TCGA-D8-A1JM-01 TCGA-D8-A1JM-01A-11D-A13L-09 NA NA NA TCGA-D8-A1JM-01A-11D-A13L-09 NA ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 NA TCGA-D8-A1JM-01A-11D-A13J-01 NA NA ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 TCGA-D8-A1JM-01A-11D-A13J-01 |
|
|
853 |
TCGA-D8-A1JN-01 Stage IIIC 80 2 Stage IIIC 217 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 217 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-D8-A1JN-01 620 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-D8-A1JN 620 0 days 620 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Axillary lymph node dissection alone NA TCGA-D8-A1JN-F20745 TCGA-D8-A1JN TCGA-D8-A1JN-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -29331 273 NA 0 620 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-15 FEMALE HER2 amplification - negative DAKOHercepTest TM NA PathVision HER2 D Probe Kit NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Incisional Biopsy 180 NO Indeterminate Negative NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 3 NA NA NA NA NA NA NA NO 11 NA false No MX N3a T3 Stage IIIC TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf A1JN TUMOR FREE manual counting NA NA NA >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 874de789-c1c4-4fd3-b45c-e885f62aaeab 874de789-c1c4-4fd3-b45c-e885f62aaeab TCGA-D8-A1JN-01A-21-A17J-20 TCGA-D8-A1JN-01A-11D-A13L-09 TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13K-05 42e89a13-3aee-4749-861a-947fc66091bc TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13L-09 NA NA TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13L-09 NA 874de789-c1c4-4fd3-b45c-e885f62aaeab NA TCGA-D8-A1JN-01A-11D-A13J-01 TCGA-D8-A1JN-01 NA 874de789-c1c4-4fd3-b45c-e885f62aaeab TCGA-D8-A1JN-01A-11D-A13J-01 |
|
|
854 |
TCGA-D8-A1JP-01 Stage IA 73 1 Stage I 167 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 167 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1JP-01 639 0 days High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1JP 639 0 days 639 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A1JP-F20740 TCGA-D8-A1JP NA Negative Positive NA NA NA Mastectomy NOS Positive Lumpectomy NA NA NA NA -26862 NA NA 0 639 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2012-1-15 FEMALE NA DAKOHercepTest TM NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO NA NA NA No M0 N0 T1c Stage IA NA A1JP TUMOR FREE manual counting NA NA NA >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 f7461164-08b5-4a5c-ae74-cb4332f5ff7a f7461164-08b5-4a5c-ae74-cb4332f5ff7a TCGA-D8-A1JP-01A-21-A17J-20 TCGA-D8-A1JP-01A-11D-A13L-09 TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13K-05 f51d8572-21b5-4b6f-99dd-00ca06c53b6f TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13L-09 NA NA TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13L-09 NA f7461164-08b5-4a5c-ae74-cb4332f5ff7a NA TCGA-D8-A1JP-01A-11D-A13J-01 TCGA-D8-A1JP-01 NA f7461164-08b5-4a5c-ae74-cb4332f5ff7a TCGA-D8-A1JP-01A-11D-A13J-01 |
|
|
855 |
TCGA-D8-A1JS-01 Stage IA 77 2 Stage I 371 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 371 0 LumA NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-D8-A1JS-01 371 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-D8-A1JS 371 0 days 371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JS-F14051 TCGA-D8-A1JS TCGA-D8-A1JS-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -28178 212 NA 0 371 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA Hecep Test TM DAKO NA NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8503/3 C50.9 NA YES intraoperative examination Other method, specify: 190 NO Negative NA NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf A1JS TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 TCGA-D8-A1JS-01A-21-A17J-20 TCGA-D8-A1JS-01A-11D-A13L-09 TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13K-05 7ec4164a-68b4-4bbd-a560-b754876e5d33 TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13L-09 NA NA TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13L-09 NA b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 NA TCGA-D8-A1JS-01A-11D-A13J-01 TCGA-D8-A1JS-01 NA b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 TCGA-D8-A1JS-01A-11D-A13J-01 |
|
|
856 |
TCGA-D8-A1JT-01 Stage IIA 70 4 Stage IIA 405 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 405 0 LumB NA Positive NA NA NA followup T_Other T2 LIVING 0 TCGA-D8-A1JT-01 405 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-D8-A1JT 405 0 days 405 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1JT-F14048 TCGA-D8-A1JT TCGA-D8-A1JT-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -25677 250 NA 0 405 NA NA NA NA NA NA 70-79% NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA NA 2+ NA not amplified NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Fine needle aspiration biopsy 250 NO Equivocal Negative NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf A1JT TUMOR FREE NA NA NA NA NA NA YES 70-79% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 33600bf2-ec43-49d2-93dd-4985feb500aa 33600bf2-ec43-49d2-93dd-4985feb500aa TCGA-D8-A1JT-01A-41-A17J-20 TCGA-D8-A1JT-01A-31D-A13L-09 TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13K-05 fd766efd-b1bc-4000-97bf-a8f88aea66a7 TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13L-09 NA NA TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13L-09 NA 33600bf2-ec43-49d2-93dd-4985feb500aa NA TCGA-D8-A1JT-01A-31D-A13J-01 TCGA-D8-A1JT-01 NA 33600bf2-ec43-49d2-93dd-4985feb500aa TCGA-D8-A1JT-01A-31D-A13J-01 |
|
|
857 |
TCGA-D8-A1JU-01 Stage IA 51 2 Stage I 447 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 447 0 LumA NA Positive NA NA NA followup T1 T1 LIVING 0 TCGA-D8-A1JU-01 447 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1JU 447 0 days 447 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A1JU-F14045 TCGA-D8-A1JU TCGA-D8-A1JU-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -18733 295 NA 0 447 NA NA NA NA NA manual counting NA NA Scheduled Follow-up Submission 2011-7-18 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 450 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf A1JU TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 8e10b30e-5789-4ad4-a70b-c7a86927ac6b 8e10b30e-5789-4ad4-a70b-c7a86927ac6b TCGA-D8-A1JU-01A-21-A17J-20 TCGA-D8-A1JU-01A-11D-A13L-09 TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13K-05 226a87df-e0cb-4c94-80ab-9d1bed969e0f TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13L-09 NA NA TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13L-09 NA 8e10b30e-5789-4ad4-a70b-c7a86927ac6b NA TCGA-D8-A1JU-01A-11D-A13J-01 TCGA-D8-A1JU-01 NA 8e10b30e-5789-4ad4-a70b-c7a86927ac6b TCGA-D8-A1JU-01A-11D-A13J-01 |
|
|
858 |
TCGA-D8-A1X5-01 Stage IIIC 81 5 Stage IIIC 171 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N3 171 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1X5-01 565 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-D8-A1X5 565 0 days 565 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1X5-F29934 TCGA-D8-A1X5 TCGA-D8-A1X5-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -29734 197 NA 0 565 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-30 FEMALE NA Hercep Test TM Dako NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 240 NO Positive NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 14 NA false No MX N3a T2 Stage IIIC TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf A1X5 TUMOR FREE manual counting NA NA 10-75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 95a12af8-5704-4745-b0a0-960f67af8cec 95a12af8-5704-4745-b0a0-960f67af8cec TCGA-D8-A1X5-01A-21-A17K-20 TCGA-D8-A1X5-01A-11D-A14G-09 TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14H-05 8e7e66c1-ecb2-47e7-a590-56fd4b0cb3b5 TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14G-09 NA NA TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14G-09 NA 95a12af8-5704-4745-b0a0-960f67af8cec NA TCGA-D8-A1X5-01A-11D-A14F-01 TCGA-D8-A1X5-01 NA 95a12af8-5704-4745-b0a0-960f67af8cec TCGA-D8-A1X5-01A-11D-A14F-01 |
|
|
859 |
TCGA-D8-A1X6-01 Stage IIIA 80 4 Stage IIIA 236 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 236 0 LumB NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-D8-A1X6-01 541 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-D8-A1X6 541 0 days 541 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1X6-F29980 TCGA-D8-A1X6 TCGA-D8-A1X6-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -29256 173 NA 0 541 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-31 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 550 NO Negative NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 5 NA false No MX N2a T3 Stage IIIA TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf A1X6 TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 ac361cbe-2302-4115-8c0f-40845c0ccec9 ac361cbe-2302-4115-8c0f-40845c0ccec9 TCGA-D8-A1X6-01A-21-A17K-20 TCGA-D8-A1X6-01A-11D-A14K-09 TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14N-05 45aa8d7f-2fd6-4413-8191-52872f8d31d7 TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14K-09 NA NA TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14K-09 NA ac361cbe-2302-4115-8c0f-40845c0ccec9 NA TCGA-D8-A1X6-01A-11D-A14J-01 TCGA-D8-A1X6-01 NA ac361cbe-2302-4115-8c0f-40845c0ccec9 TCGA-D8-A1X6-01A-11D-A14J-01 |
|
|
860 |
TCGA-D8-A1X7-01 Stage IIA 40 3 Stage IIA 85 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 85 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1X7-01 509 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-D8-A1X7 509 0 days 509 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1X7-F29985 TCGA-D8-A1X7 TCGA-D8-A1X7-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -14858 141 NA 0 509 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-31 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8503/3 C50.9 NA YES NA Fine needle aspiration biopsy 170 NO Negative NA NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA false No MX N0 T2 Stage IIA TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf A1X7 TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 6b2497ef-abe8-4f6f-9225-1d700f55ad1c 6b2497ef-abe8-4f6f-9225-1d700f55ad1c TCGA-D8-A1X7-01A-21-A17K-20 TCGA-D8-A1X7-01A-11D-A14K-09 TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14N-05 436728e0-24a5-4033-86d5-2d24f669ea72 TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14K-09 NA NA TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14K-09 NA 6b2497ef-abe8-4f6f-9225-1d700f55ad1c NA TCGA-D8-A1X7-01A-11D-A14J-01 TCGA-D8-A1X7-01 NA 6b2497ef-abe8-4f6f-9225-1d700f55ad1c TCGA-D8-A1X7-01A-11D-A14J-01 |
|
|
861 |
TCGA-D8-A1X8-01 Stage IIA 62 2 Stage IIIA 272 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 272 0 LumA NA Indeterminate NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1X8-01 783 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-D8-A1X8 783 0 days 783 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1X8-F29428 TCGA-D8-A1X8 TCGA-D8-A1X8-01A NA Positive NA 2+ 4 Point Scale NA Indeterminate Modified Radical Mastectomy NA NO NA NA -22995 225 NA 0 783 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-10-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 360 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 1 NA NA NA NA NA NA NA NO 9 0 false No M0 N2a T1c Stage IIIA TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf A1X8 TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 TCGA-D8-A1X8-01A-21-A17K-20 TCGA-D8-A1X8-01A-11D-A14K-09 TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14N-05 9bd7faf1-8b85-4e46-b968-35a1a5cc2cb5 TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14K-09 NA NA TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14K-09 NA cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 NA TCGA-D8-A1X8-01A-11D-A14J-01 TCGA-D8-A1X8-01 NA cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 TCGA-D8-A1X8-01A-11D-A14J-01 |
|
|
862 |
TCGA-D8-A1X9-01 Stage IIA 66 5 Stage IIB 380 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 380 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1X9-01 727 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 14 TCGA-D8-A1X9 727 0 days 727 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1X9-F29431 TCGA-D8-A1X9 TCGA-D8-A1X9-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -24417 399 NA 0 727 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA NA NA not amplified NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Indeterminate Negative NA 23 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 3 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf A1X9 TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 TCGA-D8-A1X9-01A-21-A17K-20 TCGA-D8-A1X9-01A-12D-A159-09 TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A161-05 4672d6c4-b826-4143-887c-464ab4020a6d TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A159-09 NA NA TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A159-09 NA 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 NA TCGA-D8-A1X9-01A-12D-A160-01 TCGA-D8-A1X9-01 NA 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 TCGA-D8-A1X9-01A-12D-A160-01 |
|
|
863 |
TCGA-D8-A1XA-01 Stage IA 64 1 Stage I 274 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 274 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XA-01 839 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-D8-A1XA 839 0 days 839 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A1XA-F29434 TCGA-D8-A1XA TCGA-D8-A1XA-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -23387 218 NA 0 839 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-12-3 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 140 NO Equivocal NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf A1XA TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 79d0e02e-b518-4dce-8c20-00073d04e399 79d0e02e-b518-4dce-8c20-00073d04e399 TCGA-D8-A1XA-01A-21-A17K-20 TCGA-D8-A1XA-01A-11D-A14G-09 TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14H-05 b480ba7d-ad4f-41f6-87a4-ad062ced62ae TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14G-09 NA NA TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14G-09 NA 79d0e02e-b518-4dce-8c20-00073d04e399 NA TCGA-D8-A1XA-01A-11D-A14F-01 TCGA-D8-A1XA-01 NA 79d0e02e-b518-4dce-8c20-00073d04e399 TCGA-D8-A1XA-01A-11D-A14F-01 |
|
|
864 |
TCGA-D8-A1XB-01 Stage IIB 62 4 Stage IIB 201 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 201 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XB-01 552 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XB 552 0 days 552 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XB-F29436 TCGA-D8-A1XB TCGA-D8-A1XB-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -22976 251 NA 0 552 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 1 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf A1XB TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 8a2adff0-2527-43fa-ad17-a3081e22f846 8a2adff0-2527-43fa-ad17-a3081e22f846 TCGA-D8-A1XB-01A-21-A17K-20 TCGA-D8-A1XB-01A-11D-A14G-09 TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14H-05 7badd356-a8c5-4c61-a520-27a25695f71e TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14G-09 NA NA TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14G-09 NA 8a2adff0-2527-43fa-ad17-a3081e22f846 NA TCGA-D8-A1XB-01A-11D-A14F-01 TCGA-D8-A1XB-01 NA 8a2adff0-2527-43fa-ad17-a3081e22f846 TCGA-D8-A1XB-01A-11D-A14F-01 |
|
|
865 |
TCGA-D8-A1XC-01 Stage IIIB 85 3 Stage IIIB 81 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 81 0 LumA NA Positive NA NA NA enrollment T_Other T4 LIVING 1 TCGA-D8-A1XC-01 377 1 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-D8-A1XC NA NA days 377 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 85 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XC-F29439 TCGA-D8-A1XC TCGA-D8-A1XC-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -31220 215 377 0 81 NA NA [Discrepancy] NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA 1+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES intraoperative examination Other method, specify: 260 NO Negative NA NA 20 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA Bone Distant Metastasis NA NA YES 1 0 false No M0 N1a T4b Stage IIIB TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf A1XC WITH TUMOR %IHC NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A DECEASED 2010 4328ae51-6063-4296-b266-a70bc5dda94f 4328ae51-6063-4296-b266-a70bc5dda94f TCGA-D8-A1XC-01A-21-A17K-20 TCGA-D8-A1XC-01A-11D-A14G-09 TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14H-05 d91c5cb0-55c9-4cf9-814c-d26df5d0a971 TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14G-09 NA NA TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14G-09 NA 4328ae51-6063-4296-b266-a70bc5dda94f NA TCGA-D8-A1XC-01A-11D-A14F-01 TCGA-D8-A1XC-01 NA 4328ae51-6063-4296-b266-a70bc5dda94f TCGA-D8-A1XC-01A-11D-A14F-01 |
|
|
866 |
TCGA-D8-A1XD-01 Stage IIIA 36 4 Stage IIIA 155 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 155 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XD-01 522 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 NA TCGA-D8-A1XD 522 0 days 522 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XD-F29440 TCGA-D8-A1XD TCGA-D8-A1XD-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -13510 188 NA 0 522 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA [Discrepancy] 210 NO Negative NA NA 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 6 NA false No M0 N2a T1c Stage IIIA TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf A1XD TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 af520d74-dc8a-4d36-bd2c-80bc23e6d029 af520d74-dc8a-4d36-bd2c-80bc23e6d029 TCGA-D8-A1XD-01A-21-A17K-20 NA TCGA-D8-A1XD-01 TCGA-D8-A1XD-01A-11D-A14H-05 71a3ddcc-c443-445f-b3c6-e0d36183ac53 TCGA-D8-A1XD-01 NA NA NA TCGA-D8-A1XD-01 NA NA af520d74-dc8a-4d36-bd2c-80bc23e6d029 NA TCGA-D8-A1XD-01A-11D-A14F-01 TCGA-D8-A1XD-01 NA af520d74-dc8a-4d36-bd2c-80bc23e6d029 TCGA-D8-A1XD-01A-11D-A14F-01 |
|
|
867 |
TCGA-D8-A1XF-01 Stage IIA 45 3 Stage IIA 197 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 197 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XF-01 463 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-D8-A1XF 463 0 days 463 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XF-F29442 TCGA-D8-A1XF TCGA-D8-A1XF-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -16787 170 NA 0 463 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 180 NO Negative NA NA 8 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf A1XF TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 80562b20-3e3e-4f77-8ca2-958f8636d720 80562b20-3e3e-4f77-8ca2-958f8636d720 TCGA-D8-A1XF-01A-21-A17K-20 TCGA-D8-A1XF-01A-11D-A14G-09 TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14H-05 83d58431-912e-4861-90cb-1dffc7d4a8b0 TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14G-09 NA NA TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14G-09 NA 80562b20-3e3e-4f77-8ca2-958f8636d720 NA TCGA-D8-A1XF-01A-11D-A14F-01 TCGA-D8-A1XF-01 NA 80562b20-3e3e-4f77-8ca2-958f8636d720 TCGA-D8-A1XF-01A-11D-A14F-01 |
|
|
868 |
TCGA-D8-A1XG-01 Stage IIIB 86 3 Stage IIIB 196 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 196 0 LumA NA Negative NA NA NA enrollment T_Other T4 LIVING 0 TCGA-D8-A1XG-01 448 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-D8-A1XG 448 0 days 448 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 86 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XG-F29444 TCGA-D8-A1XG TCGA-D8-A1XG-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -31748 169 NA 0 448 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 590 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 2 0 false No M0 N1a T4b Stage IIIB TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf A1XG TUMOR FREE NA NA NA NA 10-75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 56bc2076-bafe-47aa-8255-9f03d438cb00 56bc2076-bafe-47aa-8255-9f03d438cb00 TCGA-D8-A1XG-01A-21-A17K-20 TCGA-D8-A1XG-01A-11D-A14G-09 TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14H-05 c51c59e6-0a2c-4597-88df-59166bf2c096 TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14G-09 NA NA TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14G-09 NA 56bc2076-bafe-47aa-8255-9f03d438cb00 NA TCGA-D8-A1XG-01A-11D-A14F-01 TCGA-D8-A1XG-01 NA 56bc2076-bafe-47aa-8255-9f03d438cb00 TCGA-D8-A1XG-01A-11D-A14F-01 |
|
|
869 |
TCGA-D8-A1XJ-01 Stage IIIA 76 1 Stage IIIA 352 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 352 0 Her2 NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-D8-A1XJ-01 663 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 5 TCGA-D8-A1XJ 663 0 days 663 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant|Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XJ-F30111 TCGA-D8-A1XJ TCGA-D8-A1XJ-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -27967 295 NA 0 663 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Hercep Test TM Dako NA NA 3+ NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Fine needle aspiration biopsy 440 NO Positive NA NA 43 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 2 NA false No MX N1a T3 Stage IIIA TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf A1XJ TUMOR FREE manual counting NA NA 10-75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 ef91ee42-e50f-44f7-967a-48698e920d12 ef91ee42-e50f-44f7-967a-48698e920d12 TCGA-D8-A1XJ-01A-21-A17K-20 TCGA-D8-A1XJ-01A-11D-A14K-09 TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14N-05 9dcb0e51-ac2f-4954-ac24-a1c9e20e7c8a TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14K-09 NA NA TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14K-09 NA ef91ee42-e50f-44f7-967a-48698e920d12 NA TCGA-D8-A1XJ-01A-11D-A14J-01 TCGA-D8-A1XJ-01 NA ef91ee42-e50f-44f7-967a-48698e920d12 TCGA-D8-A1XJ-01A-11D-A14J-01 |
|
|
870 |
TCGA-D8-A1XK-01 Stage IB 55 1 Stage IIB 326 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 326 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XK-01 441 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 14 cluster 5 NA TCGA-D8-A1XK 441 0 days 441 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XK-F30074 TCGA-D8-A1XK TCGA-D8-A1XK-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -20092 275 NA 0 441 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-2-4 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 260 NO Negative NA NA 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 3 NA false No MX N1a T2 Stage IIB TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf A1XK TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 e4edbc10-8939-4bbf-befa-ee44229e4394 e4edbc10-8939-4bbf-befa-ee44229e4394 TCGA-D8-A1XK-01A-11-A17K-20 NA TCGA-D8-A1XK-01 TCGA-D8-A1XK-01A-21D-A14N-05 567f0c52-eb40-43cc-a34c-a7e1714b420a TCGA-D8-A1XK-01 TCGA-D8-A1XK-01A-21D-A14K-09 NA NA TCGA-D8-A1XK-01 NA NA e4edbc10-8939-4bbf-befa-ee44229e4394 NA TCGA-D8-A1XK-01A-21D-A14J-01 TCGA-D8-A1XK-01 NA e4edbc10-8939-4bbf-befa-ee44229e4394 TCGA-D8-A1XK-01A-21D-A14J-01 |
|
|
871 |
TCGA-D8-A1XL-01 Stage IIB 34 1 Stage IIB 319 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 319 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XL-01 606 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 3 TCGA-D8-A1XL 606 0 days 606 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XL-F29990 TCGA-D8-A1XL TCGA-D8-A1XL-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -12668 282 NA 0 606 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-31 FEMALE NA HercepTest TM Dako NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 260 NO Equivocal Negative NA 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 2 NA false No MX N1a T2 Stage IIB TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf A1XL TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 26f5aec2-a2d8-4151-b975-33d7518e36d0 26f5aec2-a2d8-4151-b975-33d7518e36d0 TCGA-D8-A1XL-01A-21-A17K-20 TCGA-D8-A1XL-01A-11D-A14K-09 TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14N-05 2505f3cc-34a7-448a-9935-97126fec7c57 TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14K-09 NA NA TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14K-09 NA 26f5aec2-a2d8-4151-b975-33d7518e36d0 NA TCGA-D8-A1XL-01A-11D-A14J-01 TCGA-D8-A1XL-01 NA 26f5aec2-a2d8-4151-b975-33d7518e36d0 TCGA-D8-A1XL-01A-11D-A14J-01 |
|
|
872 |
TCGA-D8-A1XM-01 Stage IA 57 3 Stage I 218 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 218 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XM-01 538 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XM 538 0 days 538 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A1XM-F29445 TCGA-D8-A1XM TCGA-D8-A1XM-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21056 189 NA 0 538 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 200 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf A1XM TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 3049e9ab-8e65-4264-865a-b7a14e27aae1 3049e9ab-8e65-4264-865a-b7a14e27aae1 TCGA-D8-A1XM-01A-11-A17K-20 TCGA-D8-A1XM-01A-21D-A14K-09 TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14N-05 6885966b-8453-46b3-8f90-6dfc1117e87b TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14K-09 NA NA TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14K-09 NA 3049e9ab-8e65-4264-865a-b7a14e27aae1 NA TCGA-D8-A1XM-01A-21D-A14J-01 TCGA-D8-A1XM-01 NA 3049e9ab-8e65-4264-865a-b7a14e27aae1 TCGA-D8-A1XM-01A-21D-A14J-01 |
|
|
873 |
TCGA-D8-A1XO-01 Stage IIB 56 2 Stage IIB 242 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 242 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XO-01 1682 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 7 mutation cluster 4 TCGA-D8-A1XO 1682 0 days 1682 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XO-F72206 TCGA-D8-A1XO NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20606 NA NA 0 1682 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 1 0 NA No M0 N1a T2 Stage IIB NA A1XO TUMOR FREE %IHC NA NA >75% >75% YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2010 eddd285e-a946-4e4e-a21d-6e84ed397594 eddd285e-a946-4e4e-a21d-6e84ed397594 TCGA-D8-A1XO-01A-21-A17K-20 TCGA-D8-A1XO-01A-11D-A14K-09 TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14N-05 f75c4694-aa3e-4855-8b51-bfb5de5373fc TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14K-09 NA NA TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14K-09 NA eddd285e-a946-4e4e-a21d-6e84ed397594 NA TCGA-D8-A1XO-01A-11D-A14J-01 TCGA-D8-A1XO-01 NA eddd285e-a946-4e4e-a21d-6e84ed397594 TCGA-D8-A1XO-01A-11D-A14J-01 |
|
|
874 |
TCGA-D8-A1XQ-01 Stage IIA 69 1 Stage IIA 177 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 177 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XQ-01 499 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 NA TCGA-D8-A1XQ 499 0 days 499 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XQ-F29449 TCGA-D8-A1XQ TCGA-D8-A1XQ-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -25345 158 NA 0 499 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 100 NO Negative NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf A1XQ TUMOR FREE NA NA NA NA 0% NA YES <10% NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 0c7fc003-950b-4138-8390-036c072b640e 0c7fc003-950b-4138-8390-036c072b640e TCGA-D8-A1XQ-01A-21-A17K-20 NA TCGA-D8-A1XQ-01 TCGA-D8-A1XQ-01A-11D-A14N-05 43fa736b-5235-4357-8ae7-2b0029efecfc TCGA-D8-A1XQ-01 TCGA-D8-A1XQ-01A-11D-A14K-09 NA NA TCGA-D8-A1XQ-01 NA NA 0c7fc003-950b-4138-8390-036c072b640e NA TCGA-D8-A1XQ-01A-11D-A14J-01 TCGA-D8-A1XQ-01 NA 0c7fc003-950b-4138-8390-036c072b640e TCGA-D8-A1XQ-01A-11D-A14J-01 |
|
|
875 |
TCGA-D8-A1XR-01 Stage IIB 56 2 Stage IIB 168 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 168 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XR-01 482 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-D8-A1XR 482 0 days 482 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XR-F29451 TCGA-D8-A1XR TCGA-D8-A1XR-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20488 162 NA 0 482 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-6 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Negative NA NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA NA NA NA NA NO 2 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf A1XR TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 9c55164e-fb87-46b5-87ce-cc277ba378f5 9c55164e-fb87-46b5-87ce-cc277ba378f5 TCGA-D8-A1XR-01A-21-A17K-20 TCGA-D8-A1XR-01A-11D-A14K-09 TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14N-05 f97f91f5-8d8b-494d-847c-848251489758 TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14K-09 NA NA TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14K-09 NA 9c55164e-fb87-46b5-87ce-cc277ba378f5 NA TCGA-D8-A1XR-01A-11D-A14J-01 TCGA-D8-A1XR-01 NA 9c55164e-fb87-46b5-87ce-cc277ba378f5 TCGA-D8-A1XR-01A-11D-A14J-01 |
|
|
876 |
TCGA-D8-A1XS-01 Stage IIIC 48 3 Stage IIIC 18 NA Positive MALE Positive NA NA NA Negative M0 Positive N3 18 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XS-01 496 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XS 496 0 days 496 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XS-F12133 TCGA-D8-A1XS TCGA-D8-A1XS-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17708 164 NA 0 496 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 MALE NA NA NA NA 3+ NA NA NA NA Other, specify NA No NA C50.9 8507/3 C50.9 NA YES NA Core needle biopsy 340 NO Positive NA NA 28 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 25 0 false No M0 N3a T2 Stage IIIC TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf A1XS TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 11b43261-66e4-4c28-8d24-6e38b4295f34 11b43261-66e4-4c28-8d24-6e38b4295f34 TCGA-D8-A1XS-01A-21-A17K-20 TCGA-D8-A1XS-01A-11D-A14K-09 TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14N-05 22edabb4-30a0-4d5d-95f2-3ee9c3883fd1 TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14K-09 NA NA TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14K-09 NA 11b43261-66e4-4c28-8d24-6e38b4295f34 NA TCGA-D8-A1XS-01A-11D-A14J-01 TCGA-D8-A1XS-01 NA 11b43261-66e4-4c28-8d24-6e38b4295f34 TCGA-D8-A1XS-01A-11D-A14J-01 |
|
|
877 |
TCGA-D8-A1XT-01 Stage IIA 61 1 Stage IIA 193 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 193 0 Her2 NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XT-01 506 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-D8-A1XT 506 0 days 506 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XT-F29454 TCGA-D8-A1XT TCGA-D8-A1XT-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -22448 144 NA 0 506 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 230 NO Positive NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 3 0 false No M0 N1a T1c Stage IIA TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf A1XT TUMOR FREE %IHC NA NA 0% 0% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 47901dff-8acf-4afa-9e42-851d98777085 47901dff-8acf-4afa-9e42-851d98777085 TCGA-D8-A1XT-01A-21-A17K-20 TCGA-D8-A1XT-01A-11D-A14K-09 TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14N-05 0321074c-bcf8-42f7-9212-b2673201860d TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14K-09 NA NA TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14K-09 NA 47901dff-8acf-4afa-9e42-851d98777085 NA TCGA-D8-A1XT-01A-11D-A14J-01 TCGA-D8-A1XT-01 NA 47901dff-8acf-4afa-9e42-851d98777085 TCGA-D8-A1XT-01A-11D-A14J-01 |
|
|
878 |
TCGA-D8-A1XU-01 Stage IA 56 NA Stage I 149 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 149 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XU-01 395 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1XU 395 0 days 395 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A1XU-F29456 TCGA-D8-A1XU TCGA-D8-A1XU-01A Negative Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20715 102 NA 0 395 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf A1XU TUMOR FREE %IHC NA NA 10-75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 0718af55-25eb-45b7-9e76-5d663a00dca5 0718af55-25eb-45b7-9e76-5d663a00dca5 TCGA-D8-A1XU-01A-21-A17K-20 TCGA-D8-A1XU-01A-11D-A14K-09 TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14N-05 d4978f30-9304-47e3-a4a7-1c5b32f6ddde TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14K-09 NA NA TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14K-09 NA 0718af55-25eb-45b7-9e76-5d663a00dca5 NA TCGA-D8-A1XU-01A-11D-A14J-01 TCGA-D8-A1XU-01 NA 0718af55-25eb-45b7-9e76-5d663a00dca5 TCGA-D8-A1XU-01A-11D-A14J-01 |
|
|
879 |
TCGA-D8-A1XV-01 Stage IIA 84 3 Stage IIA 146 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 146 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XV-01 461 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 7 mutation c1uster 9 TCGA-D8-A1XV 461 0 days 461 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A1XV-F29457 TCGA-D8-A1XV TCGA-D8-A1XV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -30830 103 NA 0 461 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2012-3-19 FEMALE NA NA NA NA 2+ NA not amplified NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Fine needle aspiration biopsy 420 NO Equivocal Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 7 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf A1XV TUMOR FREE %IHC NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 TCGA-D8-A1XV-01A-21-A17K-20 TCGA-D8-A1XV-01A-11D-A14K-09 TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14N-05 fc4169c4-863c-42b2-9b67-2682355d343d TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14K-09 NA NA TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14K-09 NA 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 NA TCGA-D8-A1XV-01A-11D-A14J-01 TCGA-D8-A1XV-01 NA 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 TCGA-D8-A1XV-01A-11D-A14J-01 |
|
|
880 |
TCGA-D8-A1XW-01 Stage IIA 53 3 Stage IIA 117 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 117 0 Normal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XW-01 1309 0 days High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-D8-A1XW 1309 0 days 1309 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-D8-A1XW-F72205 TCGA-D8-A1XW TCGA-D8-A1XW-01A NA Negative NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -19478 76 NA 0 1309 NA NA NA NA NO % IHC NA NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 310 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf A1XW TUMOR FREE NA NA NA NA 0% YES YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 8e24b2f8-459c-4861-9d31-d171e8d1a08b 8e24b2f8-459c-4861-9d31-d171e8d1a08b TCGA-D8-A1XW-01A-21-A17K-20 TCGA-D8-A1XW-01A-11D-A14K-09 TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14N-05 645dc9bf-f601-46eb-84e0-cb5df8d9981b TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14K-09 NA NA TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14K-09 NA 8e24b2f8-459c-4861-9d31-d171e8d1a08b NA TCGA-D8-A1XW-01A-11D-A14J-01 TCGA-D8-A1XW-01 NA 8e24b2f8-459c-4861-9d31-d171e8d1a08b TCGA-D8-A1XW-01A-11D-A14J-01 |
|
|
881 |
TCGA-D8-A1XY-01 Stage IIA 74 NA Stage IIA 81 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 81 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1XY-01 503 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XY 503 0 days 503 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XY-F29994 TCGA-D8-A1XY TCGA-D8-A1XY-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -27106 135 NA 0 503 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-31 FEMALE NA HerceptTest TM Dako NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 190 NO Positive NA NA 3 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 NA false No MX N0 T2 Stage IIA TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf A1XY TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 5b233291-8984-4925-8be4-3911f541a15f 5b233291-8984-4925-8be4-3911f541a15f TCGA-D8-A1XY-01A-21-A17K-20 TCGA-D8-A1XY-01A-11D-A14K-09 TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14N-05 68b05ccb-ae51-4690-9b4d-e18bc9b4e9ea TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14K-09 NA NA TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14K-09 NA 5b233291-8984-4925-8be4-3911f541a15f NA TCGA-D8-A1XY-01A-11D-A14J-01 TCGA-D8-A1XY-01 NA 5b233291-8984-4925-8be4-3911f541a15f TCGA-D8-A1XY-01A-11D-A14J-01 |
|
|
882 |
TCGA-D8-A1XZ-01 Stage IIIA 81 1 Stage IIIA 120 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 120 0 LumB NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1XZ-01 466 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 5 mutation cluster 13 TCGA-D8-A1XZ 466 0 days 466 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 81 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1XZ-F30077 TCGA-D8-A1XZ TCGA-D8-A1XZ-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -29916 98 NA 0 466 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 130 NO Negative NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 6 NA false No MX N2a T1c Stage IIIA TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf A1XZ TUMOR FREE NA NA NA NA >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 8b592b3b-47b5-45fa-98eb-01bf75096605 8b592b3b-47b5-45fa-98eb-01bf75096605 TCGA-D8-A1XZ-01A-21-A17K-20 TCGA-D8-A1XZ-01A-11D-A14K-09 TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14N-05 6de7dbf5-0fdb-4871-a5ba-5909cd85f6e1 TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14K-09 NA NA TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14K-09 NA 8b592b3b-47b5-45fa-98eb-01bf75096605 NA TCGA-D8-A1XZ-01A-11D-A14J-01 TCGA-D8-A1XZ-01 NA 8b592b3b-47b5-45fa-98eb-01bf75096605 TCGA-D8-A1XZ-01A-11D-A14J-01 |
|
|
883 |
TCGA-D8-A1Y0-01 Stage IIIA 65 5 Stage IIIA 166 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 166 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A1Y0-01 472 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-D8-A1Y0 472 0 days 472 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Axillary lymph node dissection alone NA TCGA-D8-A1Y0-F30080 TCGA-D8-A1Y0 TCGA-D8-A1Y0-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -24083 104 NA 0 472 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Incisional Biopsy 190 NO Negative NA NA 15 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 9 NA false No MX N2a T1c Stage IIIA TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf A1Y0 TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 8dd30d68-86d0-456f-814c-ae59a5c0a071 8dd30d68-86d0-456f-814c-ae59a5c0a071 TCGA-D8-A1Y0-01A-21-A17K-20 TCGA-D8-A1Y0-01A-11D-A14K-09 TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14N-05 afa6d295-e75a-41fa-a678-2b0d4d82cbc2 TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14K-09 NA NA TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14K-09 NA 8dd30d68-86d0-456f-814c-ae59a5c0a071 NA TCGA-D8-A1Y0-01A-11D-A14J-01 TCGA-D8-A1Y0-01 NA 8dd30d68-86d0-456f-814c-ae59a5c0a071 TCGA-D8-A1Y0-01A-11D-A14J-01 |
|
|
884 |
TCGA-D8-A1Y1-01 Stage IIIA 80 2 Stage IIIA 115 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 115 0 LumB NA Positive NA NA NA enrollment T_Other T3 LIVING 1 TCGA-D8-A1Y1-01 302 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-D8-A1Y1 302 0 days 302 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1Y1-F30084 TCGA-D8-A1Y1 TCGA-D8-A1Y1-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -29474 93 302 0 116 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 200 NO Negative NA NA 22 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 1 NA false No MX N1a T3 Stage IIIA TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf A1Y1 WITH TUMOR manual counting NA NA >75% 10-75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A DECEASED 2010 2d49cea0-0d08-4203-afa0-a1252cbf739a 2d49cea0-0d08-4203-afa0-a1252cbf739a TCGA-D8-A1Y1-01A-11-A17K-20 TCGA-D8-A1Y1-01A-21D-A14K-09 TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14N-05 2a4e381f-db2d-4b2e-828c-9264d218439c TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14K-09 NA NA TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14K-09 NA 2d49cea0-0d08-4203-afa0-a1252cbf739a NA TCGA-D8-A1Y1-01A-21D-A14J-01 TCGA-D8-A1Y1-01 NA 2d49cea0-0d08-4203-afa0-a1252cbf739a TCGA-D8-A1Y1-01A-21D-A14J-01 |
|
|
885 |
TCGA-D8-A1Y2-01 Stage IIA 71 4 Stage IIA 72 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 72 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1Y2-01 433 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 NA mutation cluster 4 TCGA-D8-A1Y2 433 0 days 433 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1Y2-F30086 TCGA-D8-A1Y2 TCGA-D8-A1Y2-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -26021 65 NA 0 433 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Venten NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 470 NO Indeterminate Negative NA 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T2 Stage IIA TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf A1Y2 TUMOR FREE manual counting NA NA NA >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 4d184421-3a3d-499a-bdb5-230f45e6d16f 4d184421-3a3d-499a-bdb5-230f45e6d16f TCGA-D8-A1Y2-01A-21-A17K-20 TCGA-D8-A1Y2-01A-11D-A159-09 TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A161-05 4a0da6ed-16e6-4f14-8f18-0df68e63d002 TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A159-09 NA NA TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A159-09 NA 4d184421-3a3d-499a-bdb5-230f45e6d16f NA TCGA-D8-A1Y2-01A-11D-A160-01 TCGA-D8-A1Y2-01 NA 4d184421-3a3d-499a-bdb5-230f45e6d16f TCGA-D8-A1Y2-01A-11D-A160-01 |
|
|
886 |
TCGA-D8-A1Y3-01 Stage IIIA 61 4 Stage IIIA 124 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 124 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A1Y3-01 430 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 NA mutation cluster 5 TCGA-D8-A1Y3 430 0 days 430 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A1Y3-F30088 TCGA-D8-A1Y3 TCGA-D8-A1Y3-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -22317 62 NA 0 430 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Venten NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 300 NO Indeterminate Negative NA 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 5 NA false No MX N2a T2 Stage IIIA TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf A1Y3 TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 TCGA-D8-A1Y3-01A-21-A17K-20 TCGA-D8-A1Y3-01A-11D-A159-09 TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A161-05 98a25723-ede5-43a7-988d-5a753c500649 TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A159-09 NA NA TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A159-09 NA e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 NA TCGA-D8-A1Y3-01A-11D-A160-01 TCGA-D8-A1Y3-01 NA e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 TCGA-D8-A1Y3-01A-11D-A160-01 |
|
|
887 |
TCGA-D8-A27E-01 Stage IA 66 NA Stage I 182 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 182 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A27E-01 530 0 days Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation c1uster 9 TCGA-D8-A27E 530 0 days 530 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A27E-F30112 TCGA-D8-A27E TCGA-D8-A27E-01A NA Positive NA NA NA NA Positive [Discrepancy] NA NO NA NA -24315 204 NA 0 530 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Hercep Test TM Dako NA NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 NA YES NA Fine needle aspiration biopsy 110 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf A27E TUMOR FREE NA NA NA NA >75% NA YES <10% NA YES Primary Tumor 01 quadrantectomy 7th YES YES NO D8 Breast A LIVING 2010 5e32f7e7-6022-4ce2-aa79-4c6671493406 5e32f7e7-6022-4ce2-aa79-4c6671493406 TCGA-D8-A27E-01A-21-A17K-20 TCGA-D8-A27E-01A-11D-A16D-09 TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16G-05 bac504b5-18a0-4fdb-aea0-4b6e76e8eeb9 TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16D-09 NA NA TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16D-09 NA 5e32f7e7-6022-4ce2-aa79-4c6671493406 NA TCGA-D8-A27E-01A-11D-A16C-01 TCGA-D8-A27E-01 NA 5e32f7e7-6022-4ce2-aa79-4c6671493406 TCGA-D8-A27E-01A-11D-A16C-01 |
|
|
888 |
TCGA-D8-A27F-01 Stage IIA 40 1 Stage IIA 227 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 227 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27F-01 488 0 days BRCA-LUAD+ C1-LUAD-enriched cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 NA mutation cluster 12 TCGA-D8-A27F 488 0 days 488 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27F-F29515 TCGA-D8-A27F TCGA-D8-A27F-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14731 166 NA 0 488 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-3-21 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 320 NO Negative NA NA 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf A27F TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 0a69935d-9552-4792-9b2e-1a630114691e 0a69935d-9552-4792-9b2e-1a630114691e TCGA-D8-A27F-01A-21-A17K-20 TCGA-D8-A27F-01A-11D-A16D-09 TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16G-05 7ce10802-b13b-47af-abe3-b8deaf2c64f4 TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16D-09 NA NA TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16D-09 NA 0a69935d-9552-4792-9b2e-1a630114691e NA TCGA-D8-A27F-01A-11D-A16C-01 TCGA-D8-A27F-01 NA 0a69935d-9552-4792-9b2e-1a630114691e TCGA-D8-A27F-01A-11D-A16C-01 |
|
|
889 |
TCGA-D8-A27G-01 Stage IIA 75 2 Stage IIA 209 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 209 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27G-01 409 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-D8-A27G 409 0 days 409 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27G-F29519 TCGA-D8-A27G TCGA-D8-A27G-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -27521 156 NA 0 409 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-21 FEMALE NA NA NA NA 2+ NA not amplified NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 170 NO Equivocal Negative NA 31 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf A27G TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2010 2ba9072c-39b9-438d-9a2c-0726dc3dc659 2ba9072c-39b9-438d-9a2c-0726dc3dc659 TCGA-D8-A27G-01A-21-A17K-20 NA TCGA-D8-A27G-01 TCGA-D8-A27G-01A-11D-A16G-05 10a00b30-4059-4d67-90a5-6fc691cb676e TCGA-D8-A27G-01 TCGA-D8-A27G-01A-11D-A16D-09 NA NA TCGA-D8-A27G-01 NA NA 2ba9072c-39b9-438d-9a2c-0726dc3dc659 NA TCGA-D8-A27G-01A-11D-A16C-01 TCGA-D8-A27G-01 NA 2ba9072c-39b9-438d-9a2c-0726dc3dc659 TCGA-D8-A27G-01A-11D-A16C-01 |
|
|
890 |
TCGA-D8-A27H-01 Stage IIA 72 1 Stage IIA 140 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 140 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27H-01 397 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 3 NA mutation cluster 2 TCGA-D8-A27H 397 0 days 397 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Right Upper Outer Quadrant No axillary staging NA TCGA-D8-A27H-F29536 TCGA-D8-A27H TCGA-D8-A27H-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -26588 84 NA 0 397 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-3-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 170 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf A27H TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 123725b8-4f66-4b97-9726-e0c70300d38e 123725b8-4f66-4b97-9726-e0c70300d38e TCGA-D8-A27H-01A-21-A17K-20 TCGA-D8-A27H-01A-11D-A16D-09 TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16G-05 54304e23-2f82-43d6-9ace-f054d7a0f410 TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16D-09 NA NA TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16D-09 NA 123725b8-4f66-4b97-9726-e0c70300d38e NA TCGA-D8-A27H-01A-11D-A16C-01 TCGA-D8-A27H-01 NA 123725b8-4f66-4b97-9726-e0c70300d38e TCGA-D8-A27H-01A-11D-A16C-01 |
|
|
891 |
TCGA-D8-A27I-01 Stage IIIA 58 3 Stage IIIA 185 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 185 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A27I-01 439 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation c1uster 9 TCGA-D8-A27I 439 0 days 439 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27I-F29521 TCGA-D8-A27I TCGA-D8-A27I-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -21327 132 NA 0 439 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-21 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 900 NO Negative NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 4 0 false No M0 N2a T1c Stage IIIA TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf A27I TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2010 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 TCGA-D8-A27I-01A-21-A17L-20 TCGA-D8-A27I-01A-11D-A16D-09 TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16G-05 19440cd1-daa0-4103-9be8-b878a9c59988 TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16D-09 NA NA TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16D-09 NA 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 NA TCGA-D8-A27I-01A-11D-A16C-01 TCGA-D8-A27I-01 NA 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 TCGA-D8-A27I-01A-11D-A16C-01 |
|
|
892 |
TCGA-D8-A27K-01 Stage IIB 47 2 Stage IIB 118 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 118 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27K-01 1461 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 NA mutation cluster 4 TCGA-D8-A27K 1461 0 days 1461 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27K-F72201 TCGA-D8-A27K NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17426 NA NA 0 1461 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2015-4-29 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NO 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 2 NA NA No M0 N1a T2 Stage IIB NA A27K TUMOR FREE manual counting NA NA >75% >75% YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2011 c0ecd31a-9cce-45d2-9d04-89c465f9b55d c0ecd31a-9cce-45d2-9d04-89c465f9b55d TCGA-D8-A27K-01A-21-A17L-20 TCGA-D8-A27K-01A-11D-A16D-09 TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16G-05 d8b985f8-cbad-42bb-995c-42d7f8221ea4 TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16D-09 NA NA TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16D-09 NA c0ecd31a-9cce-45d2-9d04-89c465f9b55d NA TCGA-D8-A27K-01A-11D-A16C-01 TCGA-D8-A27K-01 NA c0ecd31a-9cce-45d2-9d04-89c465f9b55d TCGA-D8-A27K-01A-11D-A16C-01 |
|
|
893 |
TCGA-D8-A27L-01 Stage IIB 49 4 Stage IIIA 125 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 125 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A27L-01 499 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation cluster 14 TCGA-D8-A27L 499 0 days 499 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-D8-A27L-F29590 TCGA-D8-A27L TCGA-D8-A27L-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -18025 84 NA 0 499 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-6-26 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Negative NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 2 NA false No M0 N2a T1c Stage IIIA TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf A27L TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 de27ab29-90b0-4d13-8102-1c2bebc4c29a de27ab29-90b0-4d13-8102-1c2bebc4c29a TCGA-D8-A27L-01A-21-A17L-20 TCGA-D8-A27L-01A-11D-A16D-09 TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16G-05 5f8e2312-38bd-45f9-b2e3-4b51674613c6 TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16D-09 NA NA TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16D-09 NA de27ab29-90b0-4d13-8102-1c2bebc4c29a NA TCGA-D8-A27L-01A-11D-A16C-01 TCGA-D8-A27L-01 NA de27ab29-90b0-4d13-8102-1c2bebc4c29a TCGA-D8-A27L-01A-11D-A16C-01 |
|
|
894 |
TCGA-D8-A27M-01 Stage IIA 59 1 Stage I 144 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 144 0 Basal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A27M-01 410 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 NA mutation cluster 5 TCGA-D8-A27M 410 0 days 410 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A27M-F29592 TCGA-D8-A27M TCGA-D8-A27M-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21910 83 NA 0 410 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 140 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T1c Stage IA TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf A27M TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 20486352-7d5f-4065-ab10-7a3f792ec1e1 20486352-7d5f-4065-ab10-7a3f792ec1e1 TCGA-D8-A27M-01A-21-A17L-20 TCGA-D8-A27M-01A-11D-A16D-09 TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16G-05 1d3de8e5-df7a-4e6c-a929-e03f23ddf78b TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16D-09 NA NA TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16D-09 NA 20486352-7d5f-4065-ab10-7a3f792ec1e1 NA TCGA-D8-A27M-01A-11D-A16C-01 TCGA-D8-A27M-01 NA 20486352-7d5f-4065-ab10-7a3f792ec1e1 TCGA-D8-A27M-01A-11D-A16C-01 |
|
|
895 |
TCGA-D8-A27N-01 Stage IIIA 36 5 Stage IIIA 145 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N2 145 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27N-01 519 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 5 TCGA-D8-A27N 519 0 days 519 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27N-F29594 TCGA-D8-A27N TCGA-D8-A27N-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -13243 75 NA 0 519 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Positive NA NA 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 4 0 false No M0 N2a T2 Stage IIIA TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf A27N TUMOR FREE manual counting NA NA 10-75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 50808f98-d10b-4190-aff7-428f56abb0f9 50808f98-d10b-4190-aff7-428f56abb0f9 TCGA-D8-A27N-01A-21-A17L-20 TCGA-D8-A27N-01A-11D-A16D-09 TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16G-05 40a0ee09-0c09-4320-8895-74c68841c341 TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16D-09 NA NA TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16D-09 NA 50808f98-d10b-4190-aff7-428f56abb0f9 NA TCGA-D8-A27N-01A-11D-A16C-01 TCGA-D8-A27N-01 NA 50808f98-d10b-4190-aff7-428f56abb0f9 TCGA-D8-A27N-01A-11D-A16C-01 |
|
|
896 |
TCGA-D8-A27P-01 Stage IIA 64 2 Stage I 22 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 22 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-D8-A27P-01 49 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 NA mutation cluster 4 TCGA-D8-A27P 49 0 days 49 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-D8-A27P-F29596 TCGA-D8-A27P TCGA-D8-A27P-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -23576 37 NA 0 49 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-10-26 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES intraoperative examination Other method, specify: 100 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf A27P TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NO Primary Tumor 01 NA 7th NO YES NO D8 Breast A LIVING 2011 189c7b41-4d4e-422e-85a2-1f575b5c8b5c 189c7b41-4d4e-422e-85a2-1f575b5c8b5c TCGA-D8-A27P-01A-21-A17L-20 TCGA-D8-A27P-01A-11D-A16D-09 TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16G-05 ead322fe-b46f-4cc6-a367-5e7681a6f494 TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16D-09 NA NA TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16D-09 NA 189c7b41-4d4e-422e-85a2-1f575b5c8b5c NA TCGA-D8-A27P-01A-11D-A16C-01 TCGA-D8-A27P-01 NA 189c7b41-4d4e-422e-85a2-1f575b5c8b5c TCGA-D8-A27P-01A-11D-A16C-01 |
|
|
897 |
TCGA-D8-A27R-01 Stage IIIC 41 5 Stage IIIC 90 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 90 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27R-01 29 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation c1uster 9 TCGA-D8-A27R NA NA days 29 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A27R-F29701 TCGA-D8-A27R TCGA-D8-A27R-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15122 50 NA 0 29 NA NA NA NA NO manual counting NA polisomy Scheduled Follow-up Submission 2012-4-28 FEMALE NA NA NA NA 2+ NA not amplified NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 440 NO Equivocal Negative NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NA 11 NA false No M0 N3a T2 Stage IIIC TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf A27R TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA NA Primary Tumor 01 NA 7th NA YES NO D8 Breast A LIVING 2011 70546486-80a3-452c-8722-1bd7b14d5ac4 70546486-80a3-452c-8722-1bd7b14d5ac4 TCGA-D8-A27R-01A-21-A17L-20 TCGA-D8-A27R-01A-11D-A16D-09 TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16G-05 a5eef620-ca1e-4125-9143-286bada198cf TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16D-09 NA NA TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16D-09 NA 70546486-80a3-452c-8722-1bd7b14d5ac4 NA TCGA-D8-A27R-01A-11D-A16C-01 TCGA-D8-A27R-01 NA 70546486-80a3-452c-8722-1bd7b14d5ac4 TCGA-D8-A27R-01A-11D-A16C-01 |
|
|
898 |
TCGA-D8-A27T-01 Stage IIIC 53 2 Stage IIIC 135 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 135 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27T-01 398 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 NA mutation cluster 4 TCGA-D8-A27T 398 0 days 398 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-D8-A27T-F30096 TCGA-D8-A27T TCGA-D8-A27T-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -19591 68 NA 0 398 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Venten NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 170 NO Negative NA NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 12 NA false No M0 N3a T2 Stage IIIC TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf A27T TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 090d6483-72df-4a55-84ef-5e196d1982cf 090d6483-72df-4a55-84ef-5e196d1982cf TCGA-D8-A27T-01A-21-A17L-20 TCGA-D8-A27T-01A-11D-A16D-09 TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16G-05 bc97c384-d3a4-400b-b9f7-cbca9e5356d8 TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16D-09 NA NA TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16D-09 NA 090d6483-72df-4a55-84ef-5e196d1982cf NA TCGA-D8-A27T-01A-11D-A16C-01 TCGA-D8-A27T-01 NA 090d6483-72df-4a55-84ef-5e196d1982cf TCGA-D8-A27T-01A-11D-A16C-01 |
|
|
899 |
TCGA-D8-A27V-01 Stage IIA 62 2 Stage IIA 73 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 73 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-D8-A27V-01 381 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 NA NA TCGA-D8-A27V 381 0 days 381 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A27V-F30105 TCGA-D8-A27V NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -22958 NA NA 0 381 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-3-29 FEMALE NA Venten NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A27V TUMOR FREE NA NA NA NA >75% NA YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO D8 Breast NA LIVING 2011 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 TCGA-D8-A27V-01A-21-A24A-20 NA TCGA-D8-A27V-01 TCGA-D8-A27V-01A-12D-A17F-05 afa1063a-d82c-4277-a7af-552dd7df54b5 TCGA-D8-A27V-01 TCGA-D8-A27V-01A-12D-A17D-09 NA NA TCGA-D8-A27V-01 NA NA a4c963fd-c8a6-4dcb-8b6e-159591e61d49 NA TCGA-D8-A27V-01A-12D-A17C-01 TCGA-D8-A27V-01 NA a4c963fd-c8a6-4dcb-8b6e-159591e61d49 TCGA-D8-A27V-01A-12D-A17C-01 |
|
|
900 |
TCGA-D8-A27W-01 Stage IIIB 55 3 Stage IIIB 15 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 15 0 LumB NA Positive NA NA NA enrollment T_Other T4 LIVING 0 TCGA-D8-A27W-01 373 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation c1uster 9 TCGA-D8-A27W 373 0 days 373 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Axillary lymph node dissection alone NA TCGA-D8-A27W-F30107 TCGA-D8-A27W TCGA-D8-A27W-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20173 43 NA 0 373 NA NA NA NA NO manual counting NA NA Scheduled Follow-up Submission 2012-4-2 FEMALE NA Venten NA Path Vysion HER2 D Probe Kit 2+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Fine needle aspiration biopsy 390 NO Equivocal Positive NA 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T4b Stage IIIB TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf A27W TUMOR FREE manual counting NA NA >75% >75% NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO D8 Breast A LIVING 2011 65843fe1-4da2-4165-8926-a0d6f878a7f8 65843fe1-4da2-4165-8926-a0d6f878a7f8 TCGA-D8-A27W-01A-21-A17L-20 TCGA-D8-A27W-01A-11D-A16D-09 TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16G-05 14737f59-b01c-4ed7-a08b-3a05926f8d87 TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16D-09 NA NA TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16D-09 NA 65843fe1-4da2-4165-8926-a0d6f878a7f8 NA TCGA-D8-A27W-01A-11D-A16C-01 TCGA-D8-A27W-01 NA 65843fe1-4da2-4165-8926-a0d6f878a7f8 TCGA-D8-A27W-01A-11D-A16C-01 |
|
|
901 |
TCGA-D8-A3Z5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-D8-A3Z5-01 1015 0 days NA NA NA NA NA NA NA NA NA TCGA-D8-A3Z5 1015 0 days 1015 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Other (specify) mastectomy with TLND TCGA-D8-A3Z5-F57869 TCGA-D8-A3Z5 TCGA-D8-A3Z5-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -19846 418 NA 0 1015 NA NA NA NA NO NA NA NA NA 2014-3-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 320 NO Negative NA NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 19 NA false No M0 N3a T2 Stage IIIC TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf A3Z5 TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO D8 Breast A LIVING 2011 f47007db-f16a-4721-aac4-c7fb6e9ca868 f47007db-f16a-4721-aac4-c7fb6e9ca868 NA NA TCGA-D8-A3Z5-01 TCGA-D8-A3Z5-01A-41D-A244-05 4d39d2a1-a65b-4845-8938-cf37bb0ac0ea TCGA-D8-A3Z5-01 TCGA-D8-A3Z5-01A-41D-A243-09 NA NA TCGA-D8-A3Z5-01 NA NA f47007db-f16a-4721-aac4-c7fb6e9ca868 NA TCGA-D8-A3Z5-01A-41D-A242-01 TCGA-D8-A3Z5-01 NA f47007db-f16a-4721-aac4-c7fb6e9ca868 TCGA-D8-A3Z5-01A-41D-A242-01 |
|
|
902 |
TCGA-D8-A3Z6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-D8-A3Z6-01 563 0 days NA NA NA NA NA NA NA NA NA TCGA-D8-A3Z6 563 0 days 563 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Other (specify) mastectomy with TLND TCGA-D8-A3Z6-F51367 TCGA-D8-A3Z6 TCGA-D8-A3Z6-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -20629 160 NA 0 563 NA NA NA NA NO NA NA NA NA 2013-11-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 60 NO Negative NA NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 19 NA false No M0 N3a T3 Stage IIIC TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf A3Z6 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO D8 Breast A LIVING 2011 0593faf5-8fcc-4aba-a926-c06c70cef7a8 0593faf5-8fcc-4aba-a926-c06c70cef7a8 NA NA TCGA-D8-A3Z6-01 TCGA-D8-A3Z6-01A-11D-A23D-05 NA TCGA-D8-A3Z6-01 TCGA-D8-A3Z6-01A-11D-A23C-09 NA NA TCGA-D8-A3Z6-01 NA NA 0593faf5-8fcc-4aba-a926-c06c70cef7a8 NA TCGA-D8-A3Z6-01A-11D-A238-01 TCGA-D8-A3Z6-01 NA 0593faf5-8fcc-4aba-a926-c06c70cef7a8 TCGA-D8-A3Z6-01A-11D-A238-01 |
|
|
903 |
TCGA-D8-A4Z1-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-D8-A4Z1-01 659 0 days NA NA NA NA NA NA NA NA NA TCGA-D8-A4Z1 659 0 days 659 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Right|Right Upper Inner Quadrant No axillary staging NA TCGA-D8-A4Z1-F58485 TCGA-D8-A4Z1 NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -25097 NA NA 0 659 NA NA NA NA NA NA 70-79% NA NA 2014-4-11 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage IA NA A4Z1 TUMOR FREE NA NA NA NA NA YES YES 10-19% NA NO Primary Tumor 01 NA 7th NA YES NO D8 Breast NA LIVING 2012 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 NA NA TCGA-D8-A4Z1-01 TCGA-D8-A4Z1-01A-21D-A268-05 NA TCGA-D8-A4Z1-01 TCGA-D8-A4Z1-01A-21D-A25Q-09 NA NA TCGA-D8-A4Z1-01 NA NA e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 NA TCGA-D8-A4Z1-01A-21D-A25N-01 TCGA-D8-A4Z1-01 NA e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 TCGA-D8-A4Z1-01A-21D-A25N-01 |
|
|
904 |
TCGA-D8-A73U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-D8-A73U-01 492 0 days NA NA NA NA NA NA NA NA NA TCGA-D8-A73U 492 0 days 492 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 88 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-D8-A73U-F57871 TCGA-D8-A73U TCGA-D8-A73U-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -32208 285 NA 0 492 NA NA NA NA NA NA 70-79% NA NA 2014-3-28 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 90 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf A73U WITH TUMOR NA NA NA NA NA YES NO 70-79% NA NO Primary Tumor 01 NA 7th NA YES NO D8 Breast A LIVING 2012 57728a07-cb68-45d9-ac86-eba57e674e1d 57728a07-cb68-45d9-ac86-eba57e674e1d NA NA TCGA-D8-A73U-01 TCGA-D8-A73U-01A-11D-A33F-05 B493DB95-AFD7-42BC-A00E-B703F9FB9D1F TCGA-D8-A73U-01 NA NA NA TCGA-D8-A73U-01 NA NA 57728a07-cb68-45d9-ac86-eba57e674e1d NA TCGA-D8-A73U-01A-11D-A33D-01 TCGA-D8-A73U-01 NA 57728a07-cb68-45d9-ac86-eba57e674e1d TCGA-D8-A73U-01A-11D-A33D-01 |
|
|
905 |
TCGA-D8-A73W-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-D8-A73W-01 385 1 days NA NA NA NA NA NA NA NA NA TCGA-D8-A73W 21 1 days 385 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 79 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-D8-A73W-F72197 TCGA-D8-A73W TCGA-D8-A73W-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -29125 191 385 0 244 NA NA 21 NA NA NA 70-79% NA NA 2015-4-29 FEMALE NA NA NA NA 1+ NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Tumor resection 230 NO Negative NA NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung|Bone NA NA NA NA NA NA Lung Distant Metastasis NA NO YES 1 NA false No MX N1a T3 Stage IIIA TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf A73W WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO D8 Breast A DECEASED 2013 ae442e30-9756-46a8-825b-3e5b7ad394d5 ae442e30-9756-46a8-825b-3e5b7ad394d5 NA NA TCGA-D8-A73W-01 TCGA-D8-A73W-01A-22D-A357-05 411140F2-9383-4269-B52B-D48CC374DBDE TCGA-D8-A73W-01 NA NA NA TCGA-D8-A73W-01 NA NA ae442e30-9756-46a8-825b-3e5b7ad394d5 NA TCGA-D8-A73W-01A-22D-A350-01 TCGA-D8-A73W-01 NA ae442e30-9756-46a8-825b-3e5b7ad394d5 TCGA-D8-A73W-01A-22D-A350-01 |
|
|
906 |
TCGA-D8-A73X-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-D8-A73X-01 767 0 days NA NA NA NA NA NA NA NA NA TCGA-D8-A73X 767 0 days 767 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-D8-A73X-F72193 TCGA-D8-A73X TCGA-D8-A73X-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -19607 140 NA 0 767 NA NA NA NA NA NA 70-79% NA NA 2015-4-29 FEMALE NA NA NA NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8211/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T2 Stage IIA TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf A73X TUMOR FREE NA NA NA NA NA YES NO 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO D8 Breast A LIVING 2013 a982e795-5256-439a-ae7b-9c250eefea53 a982e795-5256-439a-ae7b-9c250eefea53 NA NA TCGA-D8-A73X-01 TCGA-D8-A73X-01A-11D-A32T-05 062D46A5-FB34-4EF7-86A8-C56A88FC5119 TCGA-D8-A73X-01 NA NA NA TCGA-D8-A73X-01 NA NA a982e795-5256-439a-ae7b-9c250eefea53 NA TCGA-D8-A73X-01A-11D-A32H-01 TCGA-D8-A73X-01 NA a982e795-5256-439a-ae7b-9c250eefea53 TCGA-D8-A73X-01A-11D-A32H-01 |
|
|
907 |
TCGA-E2-A105-01 Stage IIA 79 5 Stage IIA 1163 NA Positive FEMALE Equivocal NA NA NA Negative M0 Negative N0 1163 0 LumA Luminal A Positive NA -10 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A105-01 1308 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-E2-A105 1308 0 days 1308 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A105-F17431 TCGA-E2-A105 NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -28855 NA NA 0 1308 NA NA NA NA NA Allred score 3 + 2 = 5 NA NA Scheduled Follow-up Submission 2011-9-9 FEMALE NA NA 70-79% NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A105 TUMOR FREE Allred score 3 + 2 = 5 NA NA Allred score 5 Allred score 5 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2007 b9bb3fb2-5692-4e7b-9353-45db1d58843f b9bb3fb2-5692-4e7b-9353-45db1d58843f NA TCGA-E2-A105-01A-11D-A10M-09 TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10N-05 NA TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10M-09 NA TCGA-E2-A105-01 NA TCGA-E2-A105-01A-11D-A10M-09 TCGA-E2-A105-01 b9bb3fb2-5692-4e7b-9353-45db1d58843f TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10L-01 NA TCGA-E2-A105-01A-11R-A10J-07 b9bb3fb2-5692-4e7b-9353-45db1d58843f TCGA-E2-A105-01A-11D-A10L-01 TCGA-E2-A105-01 |
|
|
908 |
TCGA-E2-A106-01 Stage IB 34 4 No_Conversion 1807 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1807 0 LumA Luminal A Positive NA 0 -3 followup T1 T1 LIVING 0 TCGA-E2-A106-01 2541 0 days Kirc+ NA cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 NA TCGA-E2-A106 2541 0 days 2541 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A106-F70397 TCGA-E2-A106 NA Negative Positive NA NA NA Other Positive Simple Mastectomy inner-upper margin re-excision NO NA NA -12528 NA NA 0 2541 NA NA NA NA NA NA 90-99% NA Scheduled Follow-up Submission 2015-3-17 FEMALE NA NA 10-19% NA 2+ NA NA 1.05 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 16 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1mi T1c Stage IB NA A106 TUMOR FREE NA NA NA NA NA YES NA 80-89% NA NO Primary Tumor 01 NA NA YES NO YES E2 Breast NA LIVING 2006 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 NA NA TCGA-E2-A106-01 TCGA-E2-A106-01A-11D-A10N-05 NA NA NA NA NA NA NA TCGA-E2-A106-01 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 TCGA-E2-A106-01 NA NA TCGA-E2-A106-01A-11R-A10J-07 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 NA TCGA-E2-A106-01 |
|
|
909 |
TCGA-E2-A107-01 Stage IIIA 54 2 No_Conversion 1046 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N2 1046 0 NA Luminal B Negative LumA/B 0 -3 followup T_Other T3 LIVING 0 TCGA-E2-A107-01 1047 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A107 1047 0 days 1047 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A107-F17173 TCGA-E2-A107 TCGA-E2-A107-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -20065 715 NA 0 1047 NA NA NA NA NA Allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-9-28 FEMALE NA NA NA NA 2+ NA NA 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 170 NO Equivocal Negative NA 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 4 NA false No M0 N2a T3 Stage IIIA TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf A107 TUMOR FREE Allred score 0+0=0 NA NA Allred score 0 Allred score 8 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 254c611f-7808-4745-9155-f2d578b29df2 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01A-21-A13D-20 TCGA-E2-A107-01A-11D-A10M-09 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10N-05 ea9612ed-23f6-44e6-92f4-7cc7d3cef266 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10M-09 NA TCGA-E2-A107-01 NA TCGA-E2-A107-01A-11D-A10M-09 TCGA-E2-A107-01 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10L-01 NA TCGA-E2-A107-01A-11R-A10J-07 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01A-11D-A10L-01 TCGA-E2-A107-01 |
|
|
910 |
TCGA-E2-A108-01 Stage IIIA 64 4 No_Conversion 837 NA Positive FEMALE Negative 1 4 3 Negative M0 Positive N2 837 0 Normal Normal-like Positive ReacI -5 -8 followup T_Other T2 LIVING 0 TCGA-E2-A108-01 837 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A108 837 0 days 837 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant NA NA TCGA-E2-A108-F17423 TCGA-E2-A108 TCGA-E2-A108-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -23530 596 NA 0 837 NA NA NA NA NA Allred score 7 (outside facility) NA NA Scheduled Follow-up Submission 2011-9-28 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NA 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 4 NA false No M0 N2a T2 Stage IIIA TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf A108 WITH TUMOR Allred score 7 per outside facility report NA NA Allred score 7 per outside facility report Allred score 7 (per outside facility) NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 48188b57-1f05-43dc-b8d4-a422c4f443a9 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01A-21-A13D-20 TCGA-E2-A108-01A-13D-A10M-09 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10N-05 0e4168e1-0fd3-4a3b-b878-d4c88ced0311 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10M-09 NA TCGA-E2-A108-01 NA TCGA-E2-A108-01A-13D-A10M-09 TCGA-E2-A108-01 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10L-01 NA TCGA-E2-A108-01A-13R-A10J-07 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01A-13D-A10L-01 TCGA-E2-A108-01 |
|
|
911 |
TCGA-E2-A109-01 Stage IIA 64 5 Stage IIA 1417 NA Positive FEMALE Negative 4 1 4 Negative M0 Negative N0 1417 0 LumB Luminal B Negative LumA/B -10 -5 followup T_Other T2 LIVING 0 TCGA-E2-A109-01 1417 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 6 mutation cluster 5 TCGA-E2-A109 1417 0 days 1417 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A109-F17418 TCGA-E2-A109 NA NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -23521 NA NA 0 1417 NA NA NA NA NA Allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-9-9 FEMALE NA NA 50-59% NA 2+ NA NA 1.46 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NA 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A109 TUMOR FREE Allred score 0+0=0 NA NA Allred score 0 Allred score 8 NA NA NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2007 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01A-21-A13D-20 TCGA-E2-A109-01A-11D-A10M-09 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10N-05 a2cbc0c2-b14e-460f-bc12-5aa350950e00 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10M-09 NA TCGA-E2-A109-01 NA TCGA-E2-A109-01A-11D-A10M-09 TCGA-E2-A109-01 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10L-01 NA TCGA-E2-A109-01A-11R-A10J-07 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01A-11D-A10L-01 TCGA-E2-A109-01 |
|
|
912 |
TCGA-E2-A10A-01 Stage IIB 41 2 Stage IIB 1229 NA Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1229 0 LumA Luminal B Positive LumA/B 0 -3 followup T_Other T3 LIVING 0 TCGA-E2-A10A-01 1229 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E2-A10A 92 1 days 1229 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NA 41 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A10A-F17522 TCGA-E2-A10A TCGA-E2-A10A-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -15085 1096 NA 0 1229 NA NA 92 NA NA Allred score 4+3=7 NA NA Scheduled Follow-up Submission 2011-10-12 FEMALE NA NA 40-49% NA 2+ NA NA 1.21 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO Positive Negative NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA Brain Distant Metastasis NA NA YES 0 0 false No M0 N0 (i-) T3 Stage IIB TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf A10A WITH TUMOR Allred score 5+3=8 NA NA Allred score 8 Allred score 7 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 104213ad-3ec6-4a24-9760-72333b6c2c22 104213ad-3ec6-4a24-9760-72333b6c2c22 TCGA-E2-A10A-01A-11-A13D-20 TCGA-E2-A10A-01A-21D-A10Y-09 TCGA-E2-A10A-01 NA 18a5dc5d-47d6-495a-a3d5-e19cd79678f4 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21D-A10Y-09 TCGA-E2-A10A-01A-21D-A112-05 TCGA-E2-A10A-01 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21D-A10Y-09 NA 104213ad-3ec6-4a24-9760-72333b6c2c22 NA TCGA-E2-A10A-01A-21D-A111-01 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21R-A115-07 104213ad-3ec6-4a24-9760-72333b6c2c22 TCGA-E2-A10A-01A-21D-A111-01 TCGA-E2-A10A-01 |
|
|
913 |
TCGA-E2-A10B-01 Stage IIB 67 3 No_Conversion 1141 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 1141 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T2 LIVING 0 TCGA-E2-A10B-01 1141 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A10B 195 1 days 1141 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES NA 67 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A10B-F17370 TCGA-E2-A10B TCGA-E2-A10B-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA 195 -24577 1065 NA 0 1141 NA NA 195 NA NA Allred score 5+3= 8 NA NA Scheduled Follow-up Submission 2011-9-19 FEMALE NA NA 10-19% NA 2+ NA NA 1.11 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Equivocal Negative NA 28 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 4 4 NA NA NA Lung New Primary Tumor NA NA YES 2 0 false No M0 N1a T2 Stage IIB TCGA-E2-A10B.5DAC95DD-5DA6-475B-AC14-5C79FC2F30A6.pdf A10B TUMOR FREE Allred score 5+3= 8 NA NA Allred score 8 Allred score 8 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 3b72a173-8ce4-444e-aeeb-39be3f3eb558 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01A-21-A13D-20 TCGA-E2-A10B-01A-11D-A10M-09 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10N-05 f0d6030f-5893-4ff7-8072-b4ecafb7a860 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10M-09 NA TCGA-E2-A10B-01 NA TCGA-E2-A10B-01A-11D-A10M-09 TCGA-E2-A10B-01 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10L-01 NA TCGA-E2-A10B-01A-11R-A10J-07 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01A-11D-A10L-01 TCGA-E2-A10B-01 |
|
|
914 |
TCGA-E2-A10C-01 Stage IIB 54 3 No_Conversion 1219 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 1219 0 LumB Luminal B Positive ReacI -2 -5 followup T_Other T2 LIVING 0 TCGA-E2-A10C-01 1220 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 3 TCGA-E2-A10C 1220 0 days 1220 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A10C-F17357 TCGA-E2-A10C TCGA-E2-A10C-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -19849 995 NA 0 1220 NA NA NA NA NA Allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-9-26 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 150 NO Negative NA NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T2 Stage IIB TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf A10C TUMOR FREE Allred score 3+3=6 NA NA Allred score 6 Allred score 8 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01A-11-A13D-20 TCGA-E2-A10C-01A-21D-A10M-09 TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10N-05 a000b0bf-7241-4898-8bc9-1d130065cc5d TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10M-09 NA TCGA-E2-A10C-01 NA TCGA-E2-A10C-01A-21D-A10M-09 TCGA-E2-A10C-01 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10L-01 NA TCGA-E2-A10C-01A-21R-A10J-07 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01A-21D-A10L-01 TCGA-E2-A10C-01 |
|
|
915 |
TCGA-E2-A10E-01 Stage IIA 64 2 No_Conversion 865 NA Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 865 0 LumA Luminal A Positive LumA/B -12 -3 followup T1 T1 LIVING 0 TCGA-E2-A10E-01 865 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A10E 865 0 days 865 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A10E-F17248 TCGA-E2-A10E TCGA-E2-A10E-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23684 869 NA 0 865 NA NA NA NA NA Allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-9-26 FEMALE NA NA 40-49% NA 2+ NA NA 1.07 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO Equivocal Negative NA 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T1c Stage IIA TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf A10E TUMOR FREE Allred score 3+2=5 NA NA Allred score 5 Allred score 8 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 0e932148-a592-42e2-b1df-4fd599db21e9 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01A-11-A13D-20 TCGA-E2-A10E-01A-21D-A10M-09 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10N-05 3511ab99-23f6-45bb-b2f9-28e547200841 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10M-09 NA TCGA-E2-A10E-01 NA TCGA-E2-A10E-01A-21D-A10M-09 TCGA-E2-A10E-01 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10L-01 NA TCGA-E2-A10E-01A-21R-A10J-07 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01A-21D-A10L-01 TCGA-E2-A10E-01 |
|
|
916 |
TCGA-E2-A10F-01 Stage IIA 47 2 Stage IIA 878 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 878 0 LumA Luminal A Positive NA -5 -4 followup T_Other T2 LIVING 0 TCGA-E2-A10F-01 878 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A10F 878 0 days 878 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A10F-F17187 TCGA-E2-A10F TCGA-E2-A10F-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -17257 801 NA 0 878 NA NA NA NA NA Allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-9-27 FEMALE NA NA 20-29% NA 2+ NA NA 1.05 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO Equivocal Negative NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 (i-) T2 Stage IIA TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf A10F TUMOR FREE Allred score 5+3=8 NA NA Allred score 8 Allred score 8 NA NA NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 05918561-a713-464b-9b5c-4f7c9258a827 05918561-a713-464b-9b5c-4f7c9258a827 NA TCGA-E2-A10F-01A-11D-A10M-09 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10N-05 NA TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10M-09 NA TCGA-E2-A10F-01 NA TCGA-E2-A10F-01A-11D-A10M-09 TCGA-E2-A10F-01 05918561-a713-464b-9b5c-4f7c9258a827 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10L-01 NA TCGA-E2-A10F-01A-11R-A10J-07 05918561-a713-464b-9b5c-4f7c9258a827 TCGA-E2-A10F-01A-11D-A10L-01 TCGA-E2-A10F-01 |
|
|
917 |
TCGA-E2-A14N-01 Stage IIB 37 4 Stage IIB 1350 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 1350 0 Basal Basal-like Negative NA -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A14N-01 1434 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 cluster 6 mutation cluster 5 TCGA-E2-A14N 1434 0 days 1434 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14N-F19154 TCGA-E2-A14N TCGA-E2-A14N-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -13743 1240 NA 0 1434 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-11-17 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 440 NO Negative NA NA 38 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1 T2 Stage IIB TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf A14N TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 6e45dd01-225d-4871-9a3a-f591808ad234 6e45dd01-225d-4871-9a3a-f591808ad234 TCGA-E2-A14N-01A-21-A17I-20 TCGA-E2-A14N-01A-31D-A135-09 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A138-05 df24b18e-26f0-494d-a7bc-4672b1a0314b TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A135-09 NA TCGA-E2-A14N-01 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A135-09 NA 6e45dd01-225d-4871-9a3a-f591808ad234 NA TCGA-E2-A14N-01A-31D-A134-01 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31R-A137-07 6e45dd01-225d-4871-9a3a-f591808ad234 TCGA-E2-A14N-01A-31D-A134-01 TCGA-E2-A14N-01 |
|
|
918 |
TCGA-E2-A14O-01 Stage IIIA 76 2 Stage IIIA 1172 NA Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 1172 0 LumB Luminal B Positive LumA/B 0 -3 enrollment T_Other T3 LIVING 0 TCGA-E2-A14O-01 1359 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A14O 1359 0 days 1359 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14O-F18521 TCGA-E2-A14O TCGA-E2-A14O-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -27837 1064 NA 0 1359 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-10-19 FEMALE NA NA 50-59% NA 2+ NA NA 1.65 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Equivocal Negative NA 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T3 Stage IIIA TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf A14O TUMOR FREE Allred score 5+2 = 7 NA NA Allred score = 7 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 2791089c-f659-41e8-8e18-57fc6a079e6b 2791089c-f659-41e8-8e18-57fc6a079e6b TCGA-E2-A14O-01A-21-A13E-20 TCGA-E2-A14O-01A-31D-A10Y-09 TCGA-E2-A14O-01 NA 1b57149c-21de-43c8-8f92-f6adbd5623c3 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31D-A10Y-09 TCGA-E2-A14O-01A-31D-A112-05 TCGA-E2-A14O-01 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31D-A10Y-09 NA 2791089c-f659-41e8-8e18-57fc6a079e6b NA TCGA-E2-A14O-01A-31D-A111-01 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31R-A115-07 2791089c-f659-41e8-8e18-57fc6a079e6b TCGA-E2-A14O-01A-31D-A111-01 TCGA-E2-A14O-01 |
|
|
919 |
TCGA-E2-A14P-01 Stage IIIC 79 3 Stage IIIC 487 NA Negative FEMALE Positive 1 1 1 Negative M0 Positive N3 487 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING 0 TCGA-E2-A14P-01 1246 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A14P 1246 0 days 1246 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A14P-F18846 TCGA-E2-A14P TCGA-E2-A14P-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -28923 965 NA 0 1246 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-10-20 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 290 NO Positive NA NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 10 NA false No M0 N3 T2 Stage IIIC TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf A14P TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th NO NO YES E2 Breast A LIVING 2008 a4cb04f5-91b3-40ba-8005-b1df46d6b555 a4cb04f5-91b3-40ba-8005-b1df46d6b555 TCGA-E2-A14P-01A-21-A13E-20 TCGA-E2-A14P-01A-31D-A12B-09 TCGA-E2-A14P-01 NA 3a9dace0-ee3c-42bc-8c9a-30998aae35f0 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31D-A12B-09 TCGA-E2-A14P-01A-31D-A12E-05 TCGA-E2-A14P-01 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31D-A12B-09 NA a4cb04f5-91b3-40ba-8005-b1df46d6b555 NA TCGA-E2-A14P-01A-31D-A12A-01 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31R-A12D-07 a4cb04f5-91b3-40ba-8005-b1df46d6b555 TCGA-E2-A14P-01A-31D-A12A-01 TCGA-E2-A14P-01 |
|
|
920 |
TCGA-E2-A14Q-01 Stage IIA 50 2 Stage IIB 974 NA Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 974 0 LumA Luminal A Positive LumA 0 -7 enrollment T_Other T2 LIVING 0 TCGA-E2-A14Q-01 1163 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A14Q 1163 0 days 1163 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14Q-F18800 TCGA-E2-A14Q TCGA-E2-A14Q-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -18507 960 NA 0 1163 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-10-20 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Negative NA NA 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T2 Stage IIB TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf A14Q TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 48d70a9a-b6ae-4ed6-80da-999a919f8da9 48d70a9a-b6ae-4ed6-80da-999a919f8da9 TCGA-E2-A14Q-01A-21-A13E-20 TCGA-E2-A14Q-01A-11D-A12B-09 TCGA-E2-A14Q-01 NA 9ebd7a3c-5f75-479b-a6a3-b4f00221955f TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11D-A12B-09 TCGA-E2-A14Q-01A-11D-A12E-05 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11D-A12B-09 NA 48d70a9a-b6ae-4ed6-80da-999a919f8da9 NA TCGA-E2-A14Q-01A-11D-A12A-01 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11R-A12D-07 48d70a9a-b6ae-4ed6-80da-999a919f8da9 TCGA-E2-A14Q-01A-11D-A12A-01 TCGA-E2-A14Q-01 |
|
|
921 |
TCGA-E2-A14R-01 Stage IIA 62 1 Stage IIA 845 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 845 0 Basal Basal-like Negative NA -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A14R-01 1174 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A14R 971 1 days 1174 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES YES NA 62 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14R-F18838 TCGA-E2-A14R TCGA-E2-A14R-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA 971 -22686 910 NA 0 1174 NA NA 971 NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-10-24 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Negative NA NA 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA Other, specify New Primary Tumor Endometrial NA YES 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf A14R TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 76a625e9-22b3-42b8-8813-27c133d0b248 76a625e9-22b3-42b8-8813-27c133d0b248 NA TCGA-E2-A14R-01A-11D-A10Y-09 TCGA-E2-A14R-01 NA NA TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11D-A10Y-09 TCGA-E2-A14R-01A-11D-A112-05 TCGA-E2-A14R-01 TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11D-A10Y-09 NA 76a625e9-22b3-42b8-8813-27c133d0b248 NA TCGA-E2-A14R-01A-11D-A111-01 TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11R-A115-07 76a625e9-22b3-42b8-8813-27c133d0b248 TCGA-E2-A14R-01A-11D-A111-01 TCGA-E2-A14R-01 |
|
|
922 |
TCGA-E2-A14S-01 Stage I 65 4 Stage I 834 NA Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 834 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A14S-01 1009 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A14S 1009 0 days 1009 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A14S-F18831 TCGA-E2-A14S TCGA-E2-A14S-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -23878 827 NA 0 1009 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-3 FEMALE NA NA NA NA 2+ NA NA 1.04 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 120 NO Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf A14S TUMOR FREE Allred score 4+3 = 7 NA NA Allred score = 7 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 5aaf8edc-5d66-4099-824b-f4e06827ad12 5aaf8edc-5d66-4099-824b-f4e06827ad12 TCGA-E2-A14S-01A-21-A13E-20 TCGA-E2-A14S-01A-11D-A12B-09 TCGA-E2-A14S-01 NA 010a31fc-4218-4110-b2d0-4791ca77d417 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11D-A12B-09 TCGA-E2-A14S-01A-11D-A12E-05 TCGA-E2-A14S-01 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11D-A12B-09 NA 5aaf8edc-5d66-4099-824b-f4e06827ad12 NA TCGA-E2-A14S-01A-11D-A12A-01 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11R-A12D-07 5aaf8edc-5d66-4099-824b-f4e06827ad12 TCGA-E2-A14S-01A-11D-A12A-01 TCGA-E2-A14S-01 |
|
|
923 |
TCGA-E2-A14T-01 Stage IIA 52 NA Stage IIA 890 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 890 0 LumA Luminal A Positive LumA/B 0 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A14T-01 2311 0 days NA C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E2-A14T 2311 0 days 2311 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A14T-F70396 TCGA-E2-A14T TCGA-E2-A14T-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -19237 792 NA 0 2311 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2015-3-17 FEMALE NA NA NA NA 1+ NA NA 1.29 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Negative Negative NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 1 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf A14T TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 7aa46530-2311-41ed-a452-9ca06f38c0c1 7aa46530-2311-41ed-a452-9ca06f38c0c1 TCGA-E2-A14T-01A-21-A13E-20 TCGA-E2-A14T-01A-11D-A10Y-09 TCGA-E2-A14T-01 NA 356382a7-c34b-4e96-aaf2-9901ccc6d72c TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11D-A10Y-09 TCGA-E2-A14T-01A-11D-A112-05 TCGA-E2-A14T-01 TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11D-A10Y-09 NA 7aa46530-2311-41ed-a452-9ca06f38c0c1 NA TCGA-E2-A14T-01A-11D-A111-01 TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11R-A115-07 7aa46530-2311-41ed-a452-9ca06f38c0c1 TCGA-E2-A14T-01A-11D-A111-01 TCGA-E2-A14T-01 |
|
|
924 |
TCGA-E2-A14U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A14U-01 1318 0 days Quiet NA NA BRCA non-CIMP c9 NA NA miRNA cluster 5 NA NA TCGA-E2-A14U 1318 0 days 1318 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Right Upper Outer Quadrant Other (specify) Sentinel lymph node dissection TCGA-E2-A14U-F33622 TCGA-E2-A14U TCGA-E2-A14U-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27389 796 NA 0 1318 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2012-7-11 FEMALE NA NA 40-49% NA 2+ NA NA 1.04 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 70 NO Equivocal Negative NA 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf A14U TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 20d25e27-b509-45eb-a734-9b8d6a40c632 20d25e27-b509-45eb-a734-9b8d6a40c632 NA NA TCGA-E2-A14U-01 TCGA-E2-A14U-01A-11D-A22B-05 NA TCGA-E2-A14U-01 TCGA-E2-A14U-01A-11D-A228-09 NA NA TCGA-E2-A14U-01 NA NA 20d25e27-b509-45eb-a734-9b8d6a40c632 NA TCGA-E2-A14U-01A-11D-A227-01 TCGA-E2-A14U-01 NA 20d25e27-b509-45eb-a734-9b8d6a40c632 TCGA-E2-A14U-01A-11D-A227-01 |
|
|
925 |
TCGA-E2-A14V-01 Stage IIB 53 5 Stage IIB 748 NA Positive FEMALE Positive 1 1 1 Negative M0 Positive N1 748 0 Her2 HER2-enriched Positive Her2 -1 -5 enrollment T_Other T2 LIVING 0 TCGA-E2-A14V-01 1042 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A14V 1042 0 days 1042 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14V-F18870 TCGA-E2-A14V TCGA-E2-A14V-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -19643 722 NA 0 1042 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-4 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 160 NO Positive NA NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 3 NA false No M0 N1 T2 Stage IIB TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf A14V TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf TCGA-E2-A14V-01A-21-A13E-20 TCGA-E2-A14V-01A-11D-A12B-09 TCGA-E2-A14V-01 NA 40a19899-83c4-44c1-8e91-c4b4339d7ea8 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11D-A12B-09 TCGA-E2-A14V-01A-11D-A12E-05 TCGA-E2-A14V-01 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11D-A12B-09 NA d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf NA TCGA-E2-A14V-01A-11D-A12A-01 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11R-A12D-07 d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf TCGA-E2-A14V-01A-11D-A12A-01 TCGA-E2-A14V-01 |
|
|
926 |
TCGA-E2-A14W-01 Stage IIA 78 5 Stage IIA 833 NA Positive FEMALE Positive 3 3 4 Negative M0 Negative N0 833 0 LumB Luminal B Positive Her2 0 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A14W-01 974 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 12 TCGA-E2-A14W 974 0 days 974 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A14W-F18803 TCGA-E2-A14W NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -28664 NA NA 0 974 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-4 MALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA NA Positive NA 5 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A14W TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2008 f898f44d-a728-41cf-b1ac-20b1995a86b9 f898f44d-a728-41cf-b1ac-20b1995a86b9 TCGA-E2-A14W-01A-21-A13E-20 TCGA-E2-A14W-01A-11D-A12B-09 TCGA-E2-A14W-01 NA de3f269f-cfa8-4ff2-bd60-14ffe2a45d83 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11D-A12B-09 TCGA-E2-A14W-01A-11D-A12E-05 TCGA-E2-A14W-01 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11D-A12B-09 NA f898f44d-a728-41cf-b1ac-20b1995a86b9 NA TCGA-E2-A14W-01A-11D-A12A-01 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11R-A12D-07 f898f44d-a728-41cf-b1ac-20b1995a86b9 TCGA-E2-A14W-01A-11D-A12A-01 TCGA-E2-A14W-01 |
|
|
927 |
TCGA-E2-A14X-01 Stage IIIA 55 4 Stage IIIA 692 NA Negative FEMALE Negative 3 2 2 Negative M0 Positive N2 692 0 Basal Basal-like Negative ReacII -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A14X-01 972 0 days BRCA-LUAD+ C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A14X 972 0 days 972 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A14X-F18857 TCGA-E2-A14X TCGA-E2-A14X-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -20105 652 NA 0 972 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-11-4 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Negative NA NA 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 5 NA false No M0 N2 T2 Stage IIIA TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf A14X TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 d9f827bb-2498-49b0-aa85-71cb554eb926 d9f827bb-2498-49b0-aa85-71cb554eb926 TCGA-E2-A14X-01A-21-A13E-20 TCGA-E2-A14X-01A-11D-A10Y-09 TCGA-E2-A14X-01 NA 29a42295-97db-4c28-885f-801d655b5b0f TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11D-A10Y-09 TCGA-E2-A14X-01A-11D-A112-05 TCGA-E2-A14X-01 TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11D-A10Y-09 NA d9f827bb-2498-49b0-aa85-71cb554eb926 NA TCGA-E2-A14X-01A-11D-A111-01 TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11R-A115-07 d9f827bb-2498-49b0-aa85-71cb554eb926 TCGA-E2-A14X-01A-11D-A111-01 TCGA-E2-A14X-01 |
|
|
928 |
TCGA-E2-A14Y-01 Stage IIA 35 2 Stage IIA 688 NA Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 688 0 Basal Basal-like Positive ReacII -13 0 enrollment T_Other T2 LIVING 0 TCGA-E2-A14Y-01 2109 0 days Iq C4-BRCA/Basal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 3 TCGA-E2-A14Y 2109 0 days 2109 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Sentinel node biopsy alone NA TCGA-E2-A14Y-F70401 TCGA-E2-A14Y TCGA-E2-A14Y-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -13004 597 NA 0 2109 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-17 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Equivocal Positive NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf A14Y TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 3ea70053-af2a-4fec-9416-d18b6156f516 3ea70053-af2a-4fec-9416-d18b6156f516 TCGA-E2-A14Y-01A-11-A13E-20 TCGA-E2-A14Y-01A-21D-A12B-09 TCGA-E2-A14Y-01 NA 173f9cd2-092c-479a-b9f2-f58ebd0ffa69 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21D-A12B-09 TCGA-E2-A14Y-01A-21D-A12E-05 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21D-A12B-09 NA 3ea70053-af2a-4fec-9416-d18b6156f516 NA TCGA-E2-A14Y-01A-21D-A12A-01 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21R-A12D-07 3ea70053-af2a-4fec-9416-d18b6156f516 TCGA-E2-A14Y-01A-21D-A12A-01 TCGA-E2-A14Y-01 |
|
|
929 |
TCGA-E2-A14Y-11 NA 35 NA NA 688 NA NA FEMALE NA NA NA NA NA NA NA NA 688 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A14Y-11 2109 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 3 TCGA-E2-A14Y 2109 0 days 2109 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Right Sentinel node biopsy alone NA TCGA-E2-A14Y-F70401 TCGA-E2-A14Y TCGA-E2-A14Y-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -13004 597 NA 0 2109 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-17 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 290 NO Equivocal Positive NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA NA A14Y TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2009 NA NA NA NA NA NA NA NA NA TCGA-E2-A14Y-11A-33D-A12E-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
930 |
TCGA-E2-A14Z-01 Stage I 64 1 Stage I 518 NA Positive FEMALE Negative 3 2 3 Negative M0 Negative N0 518 0 LumA Luminal A Positive LumA 0 -2 enrollment T1 T1 LIVING 1 TCGA-E2-A14Z-01 563 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-E2-A14Z 188 1 days 563 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 64 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A14Z-F18792 TCGA-E2-A14Z TCGA-E2-A14Z-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -23682 519 563 0 518 NA NA 188 NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-28 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 120 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA Liver Distant Metastasis NA NA YES 0 NA false No M0 N0 T1c Stage I TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf A14Z WITH TUMOR Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A DECEASED 2009 bcf768ee-138c-42a4-a3bf-b8d509c644d9 bcf768ee-138c-42a4-a3bf-b8d509c644d9 TCGA-E2-A14Z-01A-21-A13E-20 TCGA-E2-A14Z-01A-11D-A10Y-09 TCGA-E2-A14Z-01 NA 5a68a63e-17ae-4bd8-ab5d-0451e8ae8cc1 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11D-A10Y-09 TCGA-E2-A14Z-01A-11D-A112-05 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11D-A10Y-09 NA bcf768ee-138c-42a4-a3bf-b8d509c644d9 NA TCGA-E2-A14Z-01A-11D-A111-01 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11R-A115-07 bcf768ee-138c-42a4-a3bf-b8d509c644d9 TCGA-E2-A14Z-01A-11D-A111-01 TCGA-E2-A14Z-01 |
|
|
931 |
TCGA-E2-A150-01 Stage IIA 48 1 Stage IIA 591 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 591 0 Basal Basal-like Negative X -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A150-01 1935 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A150 1935 0 days 1935 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A150-F71066 TCGA-E2-A150 TCGA-E2-A150-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -17580 506 NA 0 1935 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-3-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 180 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf A150 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 46262a6c-8a11-4bb9-8851-8b6e44c95288 46262a6c-8a11-4bb9-8851-8b6e44c95288 TCGA-E2-A150-01A-21-A13E-20 TCGA-E2-A150-01A-11D-A12B-09 TCGA-E2-A150-01 NA c44ec1a9-cea5-46a0-b2c5-1686127fd1eb TCGA-E2-A150-01 TCGA-E2-A150-01A-11D-A12B-09 TCGA-E2-A150-01A-11D-A12E-05 TCGA-E2-A150-01 TCGA-E2-A150-01 TCGA-E2-A150-01A-11D-A12B-09 NA 46262a6c-8a11-4bb9-8851-8b6e44c95288 NA TCGA-E2-A150-01A-11D-A12A-01 TCGA-E2-A150-01 TCGA-E2-A150-01A-11R-A12D-07 46262a6c-8a11-4bb9-8851-8b6e44c95288 TCGA-E2-A150-01A-11D-A12A-01 TCGA-E2-A150-01 |
|
|
932 |
TCGA-E2-A152-01 Stage I 56 1 Stage I 588 NA Positive FEMALE Positive 2 2 1 Negative M0 Negative N0 588 0 Her2 HER2-enriched Negative Her2 -1 -5 enrollment T1 T1 LIVING 0 TCGA-E2-A152-01 2128 0 days High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 8 TCGA-E2-A152 966 1 days 2128 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 56 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A152-F72471 TCGA-E2-A152 NA NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -20705 NA NA 0 2128 NA 1044 966 NA NO NA NA NA Scheduled Follow-up Submission 2015-6-23 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Positive NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Positive 3+ NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 1 5 NA NA NA Other, specify Locoregional Recurrence Breast YES YES 0 NA NA No M0 N0 T1c Stage I NA A152 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2009 be8c1926-064b-4a2f-9345-e34f0dc78bff be8c1926-064b-4a2f-9345-e34f0dc78bff TCGA-E2-A152-01A-21-A13E-20 TCGA-E2-A152-01A-11D-A12B-09 TCGA-E2-A152-01 NA f726d427-03ec-4234-b1e1-fec426bb46ac TCGA-E2-A152-01 TCGA-E2-A152-01A-11D-A12B-09 TCGA-E2-A152-01A-11D-A12E-05 TCGA-E2-A152-01 TCGA-E2-A152-01 TCGA-E2-A152-01A-11D-A12B-09 NA be8c1926-064b-4a2f-9345-e34f0dc78bff NA TCGA-E2-A152-01A-11D-A12A-01 TCGA-E2-A152-01 TCGA-E2-A152-01A-11R-A12D-07 be8c1926-064b-4a2f-9345-e34f0dc78bff TCGA-E2-A152-01A-11D-A12A-01 TCGA-E2-A152-01 |
|
|
933 |
TCGA-E2-A153-01 Stage IIB 51 2 Stage IIA 586 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 586 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A153-01 707 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A153 707 0 days 707 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A153-F18945 TCGA-E2-A153 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -18875 NA NA 0 707 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T2 Stage IIB NA A153 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2009 be4b0243-555a-4e4b-94fb-af6ba60058d0 be4b0243-555a-4e4b-94fb-af6ba60058d0 TCGA-E2-A153-01A-21-A13E-20 TCGA-E2-A153-01A-12D-A12B-09 TCGA-E2-A153-01 NA e93fc765-47be-401c-bbbb-8b3e16ae7c65 TCGA-E2-A153-01 TCGA-E2-A153-01A-12D-A12B-09 TCGA-E2-A153-01A-12D-A12E-05 TCGA-E2-A153-01 TCGA-E2-A153-01 TCGA-E2-A153-01A-12D-A12B-09 NA be4b0243-555a-4e4b-94fb-af6ba60058d0 NA TCGA-E2-A153-01A-12D-A12A-01 TCGA-E2-A153-01 TCGA-E2-A153-01A-12R-A12D-07 be4b0243-555a-4e4b-94fb-af6ba60058d0 TCGA-E2-A153-01A-12D-A12A-01 TCGA-E2-A153-01 |
|
|
934 |
TCGA-E2-A153-11 NA 51 NA NA 586 NA NA FEMALE NA NA NA NA NA NA NA NA 586 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A153-11 707 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E2-A153 707 0 days 707 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A153-F18945 TCGA-E2-A153 NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -18875 NA NA 0 707 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA NA No M0 N1a T2 Stage IIB NA A153 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast NA LIVING 2009 b5ab3b76-36f6-45a7-acad-77288da0d13c b5ab3b76-36f6-45a7-acad-77288da0d13c NA NA NA NA NA NA NA TCGA-E2-A153-11A-31D-A12E-05 NA TCGA-E2-A153-11 NA NA b5ab3b76-36f6-45a7-acad-77288da0d13c NA NA TCGA-E2-A153-11 TCGA-E2-A153-11A-31R-A12D-07 b5ab3b76-36f6-45a7-acad-77288da0d13c NA |
|
|
935 |
TCGA-E2-A154-01 Stage I 68 2 Stage I 325 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 325 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A154-01 591 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-E2-A154 591 0 days 591 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A154-F18940 TCGA-E2-A154 TCGA-E2-A154-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -24999 461 NA 0 591 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 400 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf A154 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 81589acc-5dae-4cad-9f97-88b81fa53f92 81589acc-5dae-4cad-9f97-88b81fa53f92 TCGA-E2-A154-01A-21-A13E-20 TCGA-E2-A154-01A-11D-A10Y-09 TCGA-E2-A154-01 NA 9f67c05d-d95e-4932-bace-78ee0cfbf304 TCGA-E2-A154-01 TCGA-E2-A154-01A-11D-A10Y-09 TCGA-E2-A154-01A-11D-A112-05 TCGA-E2-A154-01 TCGA-E2-A154-01 TCGA-E2-A154-01A-11D-A10Y-09 NA 81589acc-5dae-4cad-9f97-88b81fa53f92 NA TCGA-E2-A154-01A-11D-A111-01 TCGA-E2-A154-01 TCGA-E2-A154-01A-11R-A115-07 81589acc-5dae-4cad-9f97-88b81fa53f92 TCGA-E2-A154-01A-11D-A111-01 TCGA-E2-A154-01 |
|
|
936 |
TCGA-E2-A155-01 Stage IIB 58 1 Stage IIB 553 NA Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 553 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A155-01 640 0 days Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-E2-A155 640 0 days 640 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Inner Quadrant|Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E2-A155-F18942 TCGA-E2-A155 TCGA-E2-A155-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -21348 457 NA 0 640 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 280 NO Negative NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T2 Stage IIB TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf A155 TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 6a345a9e-8173-4c9e-972d-df0b154c97b0 6a345a9e-8173-4c9e-972d-df0b154c97b0 TCGA-E2-A155-01A-21-A13E-20 TCGA-E2-A155-01A-11D-A12B-09 TCGA-E2-A155-01 NA 89f9e8d3-6526-4680-a393-c6b3b997599d TCGA-E2-A155-01 TCGA-E2-A155-01A-11D-A12B-09 TCGA-E2-A155-01A-11D-A12E-05 TCGA-E2-A155-01 TCGA-E2-A155-01 TCGA-E2-A155-01A-11D-A12B-09 NA 6a345a9e-8173-4c9e-972d-df0b154c97b0 NA TCGA-E2-A155-01A-11D-A12A-01 TCGA-E2-A155-01 TCGA-E2-A155-01A-11R-A12D-07 6a345a9e-8173-4c9e-972d-df0b154c97b0 TCGA-E2-A155-01A-11D-A12A-01 TCGA-E2-A155-01 |
|
|
937 |
TCGA-E2-A156-01 Stage I 61 2 Stage I 481 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 481 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A156-01 726 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A156 726 0 days 726 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Sentinel node biopsy alone NA TCGA-E2-A156-F18786 TCGA-E2-A156 NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22422 NA NA 0 726 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A156 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2009 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 TCGA-E2-A156-01A-21-A13E-20 TCGA-E2-A156-01A-11D-A12B-09 TCGA-E2-A156-01 NA eafe692c-6651-466b-a92c-1ed965eba047 TCGA-E2-A156-01 TCGA-E2-A156-01A-11D-A12B-09 TCGA-E2-A156-01A-11D-A12E-05 TCGA-E2-A156-01 TCGA-E2-A156-01 TCGA-E2-A156-01A-11D-A12B-09 NA b6ed3dfa-4d81-4e5c-9c1a-166894f92752 NA TCGA-E2-A156-01A-11D-A12A-01 TCGA-E2-A156-01 TCGA-E2-A156-01A-11R-A12D-07 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 TCGA-E2-A156-01A-11D-A12A-01 TCGA-E2-A156-01 |
|
|
938 |
TCGA-E2-A158-01 Stage IIA 43 1 Stage IIA 450 NA Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 450 0 Basal Basal-like Negative Basal -13 0 enrollment T1 T1 LIVING 0 TCGA-E2-A158-01 450 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A158 450 0 days 450 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A158-F18956 TCGA-E2-A158 TCGA-E2-A158-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -15903 436 NA 0 450 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 200 NO Negative NA NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 1 NA false Yes M0 N1mi T1c Stage IIA TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf A158 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 43326f71-c61c-410b-af4b-c71a054e27c9 43326f71-c61c-410b-af4b-c71a054e27c9 TCGA-E2-A158-01A-21-A13E-20 TCGA-E2-A158-01A-11D-A12B-09 TCGA-E2-A158-01 NA cc34e050-b748-413b-a5ec-064c216e98c3 TCGA-E2-A158-01 TCGA-E2-A158-01A-11D-A12B-09 TCGA-E2-A158-01A-11D-A12E-05 TCGA-E2-A158-01 TCGA-E2-A158-01 TCGA-E2-A158-01A-11D-A12B-09 NA 43326f71-c61c-410b-af4b-c71a054e27c9 NA TCGA-E2-A158-01A-11D-A12A-01 TCGA-E2-A158-01 TCGA-E2-A158-01A-11R-A12D-07 43326f71-c61c-410b-af4b-c71a054e27c9 TCGA-E2-A158-01A-11D-A12A-01 TCGA-E2-A158-01 |
|
|
939 |
TCGA-E2-A158-11 NA 43 NA NA 450 NA NA FEMALE NA NA NA NA NA NA NA NA 450 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A158-11 450 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-E2-A158 450 0 days 450 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A158-F18956 TCGA-E2-A158 TCGA-E2-A158-11A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -15903 436 NA 0 450 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 170 NO Negative NA NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false Yes M0 N1mi T1c Stage IIA NA A158 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA NO Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2009 5ba99650-56d2-4951-aa24-3d2fea3d1921 5ba99650-56d2-4951-aa24-3d2fea3d1921 NA NA NA NA NA NA NA TCGA-E2-A158-11A-22D-A12E-05 NA NA NA NA 5ba99650-56d2-4951-aa24-3d2fea3d1921 NA NA NA TCGA-E2-A158-11A-22R-A12D-07 5ba99650-56d2-4951-aa24-3d2fea3d1921 NA |
|
|
940 |
TCGA-E2-A159-01 Stage IIA 50 1 Stage IIA 515 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 515 0 Basal Basal-like Negative Basal -13 -10 enrollment T_Other T2 LIVING 0 TCGA-E2-A159-01 762 0 days High C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A159 762 0 days 762 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A159-F19115 TCGA-E2-A159 TCGA-E2-A159-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -18621 434 NA 0 762 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-11-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 240 NO NA Negative NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf A159 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 95c7abfa-a417-4d81-96c2-a952a081d997 95c7abfa-a417-4d81-96c2-a952a081d997 TCGA-E2-A159-01A-21-A13E-20 TCGA-E2-A159-01A-11D-A10Y-09 TCGA-E2-A159-01 NA c9662a04-c4e9-42c3-989f-cade253340dc TCGA-E2-A159-01 TCGA-E2-A159-01A-11D-A10Y-09 TCGA-E2-A159-01A-11D-A112-05 TCGA-E2-A159-01 TCGA-E2-A159-01 TCGA-E2-A159-01A-11D-A10Y-09 NA 95c7abfa-a417-4d81-96c2-a952a081d997 NA TCGA-E2-A159-01A-11D-A111-01 TCGA-E2-A159-01 TCGA-E2-A159-01A-11R-A115-07 95c7abfa-a417-4d81-96c2-a952a081d997 TCGA-E2-A159-01A-11D-A111-01 TCGA-E2-A159-01 |
|
|
941 |
TCGA-E2-A15A-01 Stage IIIC 45 4 Stage IIIC 502 NA Positive FEMALE Negative 1 1 4 Negative M0 Positive N3 502 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING 0 TCGA-E2-A15A-01 710 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15A 710 0 days 710 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A15A-F18926 TCGA-E2-A15A NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -16750 NA NA 0 710 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-10 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 13 NA NA No M0 N3a T2 Stage IIIC NA A15A TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2009 a4754430-f713-4aeb-998c-0f470a5549d1 a4754430-f713-4aeb-998c-0f470a5549d1 NA TCGA-E2-A15A-01A-11D-A12B-09 TCGA-E2-A15A-01 NA eee0fe49-2254-4347-b328-49a69bea7619 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11D-A12B-09 TCGA-E2-A15A-01A-11D-A12E-05 TCGA-E2-A15A-01 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11D-A12B-09 NA a4754430-f713-4aeb-998c-0f470a5549d1 NA TCGA-E2-A15A-01A-11D-A12A-01 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11R-A12D-07 a4754430-f713-4aeb-998c-0f470a5549d1 TCGA-E2-A15A-01A-11D-A12A-01 TCGA-E2-A15A-01 |
|
|
942 |
TCGA-E2-A15A-06 NA 45 NA NA 502 NA NA FEMALE NA NA NA NA NA NA NA NA 502 0 LumB NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15A-06 710 0 days NA C3-BRCA/Luminal cluster 4 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15A 710 0 days 710 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A15A-F18926 TCGA-E2-A15A TCGA-E2-A15A-06A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -16750 426 NA 0 710 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-10 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 120 NO Negative NA NA 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 13 NA false No M0 N3a T2 Stage IIIC TCGA-E2-A15A.3687AF42-4BB3-46E2-8091-E0C5C84F15E6.pdf A15A TUMOR FREE NA NA NA NA NA NA YES NA NA YES Metastatic 06 NA 6th YES NO YES E2 Breast A LIVING 2009 e55bc0c9-ee0f-4efb-8024-3baed3c24080 e55bc0c9-ee0f-4efb-8024-3baed3c24080 TCGA-E2-A15A-06A-21-A24B-20 NA NA NA 234a8293-3dd6-4625-9f76-fa9e144aee3e NA TCGA-E2-A15A-06A-11D-A12B-09 TCGA-E2-A15A-06A-11D-A12E-05 NA TCGA-E2-A15A-06 TCGA-E2-A15A-06A-11D-A12B-09 NA e55bc0c9-ee0f-4efb-8024-3baed3c24080 NA NA TCGA-E2-A15A-06 TCGA-E2-A15A-06A-11R-A12D-07 e55bc0c9-ee0f-4efb-8024-3baed3c24080 NA |
|
|
943 |
TCGA-E2-A15C-01 Stage I 61 4 Stage I 496 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 496 0 LumA Luminal A Positive ReacI -5 -4 enrollment T1 T1 LIVING 0 TCGA-E2-A15C-01 694 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A15C 694 0 days 694 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15C-F18935 TCGA-E2-A15C TCGA-E2-A15C-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22583 393 NA 0 694 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-9 FEMALE NA NA 20-29% NA 2+ NA NA 1.02 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 200 NO Equivocal Negative NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf A15C TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 1a77082d-f130-436b-9028-23c8dd9dc565 1a77082d-f130-436b-9028-23c8dd9dc565 TCGA-E2-A15C-01A-21-A13E-20 TCGA-E2-A15C-01A-31D-A12B-09 TCGA-E2-A15C-01 NA b003e078-2c0b-42bc-ad2e-adb171765c57 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31D-A12B-09 TCGA-E2-A15C-01A-31D-A12E-05 TCGA-E2-A15C-01 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31D-A12B-09 NA 1a77082d-f130-436b-9028-23c8dd9dc565 NA TCGA-E2-A15C-01A-31D-A12A-01 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31R-A12D-07 1a77082d-f130-436b-9028-23c8dd9dc565 TCGA-E2-A15C-01A-31D-A12A-01 TCGA-E2-A15C-01 |
|
|
944 |
TCGA-E2-A15D-01 Stage IIA 47 NA Stage IIA 315 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 315 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15D-01 526 0 days NA C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15D 526 0 days 526 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Sentinel node biopsy alone NA TCGA-E2-A15D-F18783 TCGA-E2-A15D TCGA-E2-A15D-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -17224 393 NA 0 526 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-9 FEMALE NA NA NA NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 330 NO Equivocal Negative NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf A15D TUMOR FREE NA NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 b58514d7-7785-497d-ba94-165ee0a1b941 b58514d7-7785-497d-ba94-165ee0a1b941 TCGA-E2-A15D-01A-21-A13E-20 TCGA-E2-A15D-01A-11D-A10Y-09 TCGA-E2-A15D-01 NA 0a257700-c228-4e46-9b2d-af39db001515 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11D-A10Y-09 TCGA-E2-A15D-01A-11D-A112-05 TCGA-E2-A15D-01 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11D-A10Y-09 NA b58514d7-7785-497d-ba94-165ee0a1b941 NA TCGA-E2-A15D-01A-11D-A111-01 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11R-A115-07 b58514d7-7785-497d-ba94-165ee0a1b941 TCGA-E2-A15D-01A-11D-A111-01 TCGA-E2-A15D-01 |
|
|
945 |
TCGA-E2-A15E-01 Stage IIA 40 4 Stage IIA 517 NA Positive FEMALE Positive 3 4 3 Negative M0 Positive N1 517 0 LumA Luminal A Positive Her2 -5 -7 enrollment T1 T1 LIVING 0 TCGA-E2-A15E-01 630 0 days Squamous C3-BRCA/Luminal cluster 2 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-E2-A15E 630 0 days 630 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A15E-F18919 TCGA-E2-A15E TCGA-E2-A15E-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -14894 387 NA 0 630 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 520 NO NA Positive NA 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-E2-A15E.514D4C2E-8215-4770-9FC1-25F988232A85.pdf A15E TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 TCGA-E2-A15E-01A-21-A13E-20 TCGA-E2-A15E-01A-11D-A12B-09 TCGA-E2-A15E-01 NA d0c1fe33-e7c4-4705-9a97-1520151d4ffb TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11D-A12B-09 TCGA-E2-A15E-01A-11D-A12E-05 TCGA-E2-A15E-01 TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11D-A12B-09 NA 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 NA TCGA-E2-A15E-01A-11D-A12A-01 TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11R-A12D-07 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 TCGA-E2-A15E-01A-11D-A12A-01 TCGA-E2-A15E-01 |
|
|
946 |
TCGA-E2-A15E-06 NA 40 NA NA 517 NA NA FEMALE NA NA NA NA NA NA NA NA 517 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15E-06 630 0 days NA C3-BRCA/Luminal cluster 2 Low purity c2 NA BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-E2-A15E 630 0 days 630 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A15E-F18919 TCGA-E2-A15E TCGA-E2-A15E-06A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -14894 387 NA 0 630 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 60 NO NA Positive NA 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-E2-A15E.57341F00-74F5-4015-B6D4-7BDED33F35A7.pdf A15E TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Metastatic 06 NA 6th YES NO YES E2 Breast A LIVING 2009 8131b824-c3db-4c83-99b9-aa0c60747c5d 8131b824-c3db-4c83-99b9-aa0c60747c5d NA NA NA NA NA NA TCGA-E2-A15E-06A-11D-A12B-09 TCGA-E2-A15E-06A-11D-A12E-05 NA TCGA-E2-A15E-06 TCGA-E2-A15E-06A-11D-A12B-09 NA 8131b824-c3db-4c83-99b9-aa0c60747c5d NA NA TCGA-E2-A15E-06 TCGA-E2-A15E-06A-11R-A12D-07 8131b824-c3db-4c83-99b9-aa0c60747c5d NA |
|
|
947 |
TCGA-E2-A15F-01 Stage I 64 NA Stage IIA 468 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 468 0 NA Luminal A Positive ReacI -3 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15F-01 658 0 days NA NA cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15F 658 0 days 658 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15F-F18906 TCGA-E2-A15F TCGA-E2-A15F-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA NO NA NA -23660 360 NA 0 658 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2011-11-10 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 190 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf A15F TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 2e41bc6a-bece-4b6d-a646-be9b98707bba 2e41bc6a-bece-4b6d-a646-be9b98707bba TCGA-E2-A15F-01A-21-A13E-20 TCGA-E2-A15F-01A-11D-A10Y-09 TCGA-E2-A15F-01 NA 3d2f1976-cf0a-4cab-817a-92301b6d9275 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11D-A10Y-09 TCGA-E2-A15F-01A-11D-A112-05 TCGA-E2-A15F-01 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11D-A10Y-09 NA 2e41bc6a-bece-4b6d-a646-be9b98707bba NA TCGA-E2-A15F-01A-11D-A111-01 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11R-A115-07 2e41bc6a-bece-4b6d-a646-be9b98707bba TCGA-E2-A15F-01A-11D-A111-01 TCGA-E2-A15F-01 |
|
|
948 |
TCGA-E2-A15G-01 Stage IIA 76 2 Stage IIA 315 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 315 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15G-01 554 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-E2-A15G 554 0 days 554 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 76 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15G-F18901 TCGA-E2-A15G TCGA-E2-A15G-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -28013 358 NA 0 554 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-14 FEMALE NA NA NA NA 1+ NA NA NA NA Mixed Histology (please specify) Invasive ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 110 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 1 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf A15G TUMOR FREE NA NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 a88e6892-93fe-451f-9b7e-f6fe260ba9af a88e6892-93fe-451f-9b7e-f6fe260ba9af TCGA-E2-A15G-01A-21-A13E-20 TCGA-E2-A15G-01A-11D-A12B-09 TCGA-E2-A15G-01 NA 1af0a946-026d-4dbb-b52d-db12449e4c31 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11D-A12B-09 TCGA-E2-A15G-01A-11D-A12E-05 TCGA-E2-A15G-01 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11D-A12B-09 NA a88e6892-93fe-451f-9b7e-f6fe260ba9af NA TCGA-E2-A15G-01A-11D-A12A-01 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11R-A12D-07 a88e6892-93fe-451f-9b7e-f6fe260ba9af TCGA-E2-A15G-01A-11D-A12A-01 TCGA-E2-A15G-01 |
|
|
949 |
TCGA-E2-A15H-01 Stage IIA 38 2 Stage IIA 42 NA Positive FEMALE Positive 3 1 3 Negative M0 Positive N1 42 0 LumA Luminal A Positive Her2 0 0 enrollment T1 T1 LIVING 0 TCGA-E2-A15H-01 393 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15H 393 0 days 393 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15H-F18916 TCGA-E2-A15H TCGA-E2-A15H-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -13985 357 NA 0 393 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-14 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 90 NO Equivocal Positive NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T1c Stage IIA TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf A15H TUMOR FREE NA NA NA Allred score = 8 Allred Score = 7 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 75b2227e-0279-4dfb-a1a1-e64c53b48d7a 75b2227e-0279-4dfb-a1a1-e64c53b48d7a TCGA-E2-A15H-01A-21-A13E-20 TCGA-E2-A15H-01A-11D-A12B-09 TCGA-E2-A15H-01 NA f381f799-7861-47be-b54f-26a1e5236887 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11D-A12B-09 TCGA-E2-A15H-01A-11D-A12E-05 TCGA-E2-A15H-01 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11D-A12B-09 NA 75b2227e-0279-4dfb-a1a1-e64c53b48d7a NA TCGA-E2-A15H-01A-11D-A12A-01 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11R-A12D-07 75b2227e-0279-4dfb-a1a1-e64c53b48d7a TCGA-E2-A15H-01A-11D-A12A-01 TCGA-E2-A15H-01 |
|
|
950 |
TCGA-E2-A15I-01 Stage IIA 44 2 Stage IIA 411 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 411 0 LumA Luminal A Positive NA -5 -7 enrollment T_Other T2 LIVING 0 TCGA-E2-A15I-01 1692 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-E2-A15I 1692 0 days 1692 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15I-F70023 TCGA-E2-A15I TCGA-E2-A15I-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -16163 344 NA 0 1692 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 2+ NA NA 1.04 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 100 NO Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf A15I TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c TCGA-E2-A15I-01A-11-A17I-20 TCGA-E2-A15I-01A-21D-A135-09 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A138-05 6be5e02d-4e5b-4b24-b603-4512dff0f17c TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A135-09 NA TCGA-E2-A15I-01 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A135-09 NA 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c NA TCGA-E2-A15I-01A-21D-A134-01 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21R-A137-07 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c TCGA-E2-A15I-01A-21D-A134-01 TCGA-E2-A15I-01 |
|
|
951 |
TCGA-E2-A15I-11 NA 44 NA NA 411 NA NA FEMALE NA NA NA NA NA NA NA NA 411 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15I-11 1692 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E2-A15I 1692 0 days 1692 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15I-F70023 TCGA-E2-A15I NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -16163 NA NA 0 1692 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 2+ NA NA 1.04 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A15I TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast NA LIVING 2009 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 NA NA NA TCGA-E2-A15I-11A-32D-A138-05 NA NA NA NA NA TCGA-E2-A15I-11 NA NA f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 NA NA TCGA-E2-A15I-11 TCGA-E2-A15I-11A-32R-A137-07 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 NA |
|
|
952 |
TCGA-E2-A15J-01 Stage I 51 2 Stage I 463 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 463 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A15J-01 1640 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15J 1640 0 days 1640 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15J-F70020 TCGA-E2-A15J TCGA-E2-A15J-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -18771 344 NA 0 1640 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Equivocal Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf A15J TUMOR FREE NA NA NA Allred score = 8 Allred score = 7 YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 376c13fa-ba3e-4f2e-a8bc-87fb70541239 376c13fa-ba3e-4f2e-a8bc-87fb70541239 TCGA-E2-A15J-01A-21-A13E-20 TCGA-E2-A15J-01A-11D-A12Q-09 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12R-05 ffe06b3a-f290-463c-bb0e-994c0679f8be TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12Q-09 NA TCGA-E2-A15J-01 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12Q-09 NA 376c13fa-ba3e-4f2e-a8bc-87fb70541239 NA TCGA-E2-A15J-01A-11D-A12N-01 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11R-A12P-07 376c13fa-ba3e-4f2e-a8bc-87fb70541239 TCGA-E2-A15J-01A-11D-A12N-01 TCGA-E2-A15J-01 |
|
|
953 |
TCGA-E2-A15K-01 Stage IIA 58 2 Stage IIB 34 NA Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 34 0 LumB Luminal B Positive LumA -12 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15K-01 275 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A15K 275 0 days 275 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21514 309 NA 0 275 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA 10-19% NA 2+ NA NA 0.9 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 170 NO Equivocal Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T2 Stage IIB TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf A15K TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 141e15ac-1537-4182-9db5-ba2115cd93d6 141e15ac-1537-4182-9db5-ba2115cd93d6 NA TCGA-E2-A15K-01A-11D-A12Q-09 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12R-05 1afef343-eb28-46d1-ba40-2475188b33c5 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12Q-09 NA TCGA-E2-A15K-01 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12Q-09 NA 141e15ac-1537-4182-9db5-ba2115cd93d6 NA TCGA-E2-A15K-01A-11D-A12N-01 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11R-A12P-07 141e15ac-1537-4182-9db5-ba2115cd93d6 TCGA-E2-A15K-01A-11D-A12N-01 TCGA-E2-A15K-01 |
|
|
954 |
TCGA-E2-A15K-06 NA 58 NA NA 34 NA NA FEMALE NA NA NA NA NA NA NA NA 34 0 LumB NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15K-06 275 0 days NA C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-E2-A15K 275 0 days 275 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-06A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21514 309 NA 0 275 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA 10-19% NA 2+ NA NA 0.9 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 280 NO Equivocal Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T2 Stage IIB TCGA-E2-A15K.72FE0659-6B7E-4129-B61D-C376C59C428F.pdf A15K TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 NA YES NA NA YES Metastatic 06 NA 7th YES NO YES E2 Breast A LIVING 2010 69f0bc59-c026-40e2-a3b6-88fcde091a82 69f0bc59-c026-40e2-a3b6-88fcde091a82 TCGA-E2-A15K-06A-21-A24B-20 NA NA TCGA-E2-A15K-06A-11D-A12R-05 7e1db33b-2235-49f6-8f01-5d8ab274ce14 NA TCGA-E2-A15K-06A-11D-A12Q-09 NA NA TCGA-E2-A15K-06 TCGA-E2-A15K-06A-11D-A12Q-09 NA 69f0bc59-c026-40e2-a3b6-88fcde091a82 NA NA TCGA-E2-A15K-06 TCGA-E2-A15K-06A-11R-A12P-07 69f0bc59-c026-40e2-a3b6-88fcde091a82 NA |
|
|
955 |
TCGA-E2-A15K-11 NA 58 NA NA 34 NA NA FEMALE NA NA NA NA NA NA NA NA 34 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15K-11 275 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E2-A15K 275 0 days 275 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-11A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21514 309 NA 0 275 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA 10-19% NA 2+ NA NA 0.9 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 120 NO Equivocal Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false No M0 N1a T2 Stage IIB NA A15K TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 NA YES NA NA YES Solid Tissue Normal 11 NA 7th YES NO YES E2 Breast A LIVING 2010 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 NA NA NA TCGA-E2-A15K-11A-13D-A12R-05 NA NA NA NA NA TCGA-E2-A15K-11 NA NA 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 NA NA TCGA-E2-A15K-11 NA 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 NA |
|
|
956 |
TCGA-E2-A15L-01 Stage IIA 65 2 Stage IIA 331 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 331 0 LumA Luminal B Positive ReacI -12 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15L-01 626 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 4 TCGA-E2-A15L 626 0 days 626 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Sentinel node biopsy alone NA TCGA-E2-A15L-F18885 TCGA-E2-A15L TCGA-E2-A15L-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23845 289 NA 0 626 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA 30-39% NA 2+ NA NA 0.9 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 240 NO Equivocal Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf A15L TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 68a4bd03-2b97-4387-926f-c9d25fac8d29 68a4bd03-2b97-4387-926f-c9d25fac8d29 TCGA-E2-A15L-01A-21-A13E-20 TCGA-E2-A15L-01A-11D-A12B-09 TCGA-E2-A15L-01 NA bf925eb7-7a5b-44b2-9ace-627782f168c3 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11D-A12B-09 TCGA-E2-A15L-01A-11D-A12E-05 TCGA-E2-A15L-01 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11D-A12B-09 NA 68a4bd03-2b97-4387-926f-c9d25fac8d29 NA TCGA-E2-A15L-01A-11D-A12A-01 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11R-A12D-07 68a4bd03-2b97-4387-926f-c9d25fac8d29 TCGA-E2-A15L-01A-11D-A12A-01 TCGA-E2-A15L-01 |
|
|
957 |
TCGA-E2-A15L-11 NA 65 NA NA 331 NA NA FEMALE NA NA NA NA NA NA NA NA 331 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A15L-11 626 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E2-A15L 626 0 days 626 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Sentinel node biopsy alone NA TCGA-E2-A15L-F18885 TCGA-E2-A15L TCGA-E2-A15L-11A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -23845 289 NA 0 626 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA 30-39% NA 2+ NA NA 0.9 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 210 NO Equivocal Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA NA A15L TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA NO Solid Tissue Normal 11 NA 7th YES NO YES E2 Breast A LIVING 2010 NA NA NA NA NA NA NA NA NA TCGA-E2-A15L-11A-31D-A12E-05 NA NA NA NA NA NA NA NA NA NA NA |
|
|
958 |
TCGA-E2-A15M-01 Stage IIA 66 3 Stage IIA 234 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 234 0 LumA Luminal B Positive ReacI -4 -4 enrollment T_Other T2 LIVING 1 TCGA-E2-A15M-01 336 1 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-E2-A15M 336 0 days 336 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15M-F18852 TCGA-E2-A15M TCGA-E2-A15M-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -24266 287 336 0 235 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 270 NO Negative NA NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf A15M TUMOR FREE NA NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A DECEASED 2010 e596b149-e807-4d29-b0fa-685f07efb9d6 e596b149-e807-4d29-b0fa-685f07efb9d6 TCGA-E2-A15M-01A-21-A13E-20 TCGA-E2-A15M-01A-11D-A12B-09 TCGA-E2-A15M-01 NA 52e4ab39-3d51-4623-a65a-09a99017e96b TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11D-A12B-09 TCGA-E2-A15M-01A-11D-A12E-05 TCGA-E2-A15M-01 TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11D-A12B-09 NA e596b149-e807-4d29-b0fa-685f07efb9d6 NA TCGA-E2-A15M-01A-11D-A12A-01 TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11R-A12D-07 e596b149-e807-4d29-b0fa-685f07efb9d6 TCGA-E2-A15M-01A-11D-A12A-01 TCGA-E2-A15M-01 |
|
|
959 |
TCGA-E2-A15M-11 NA 66 NA NA 234 NA NA FEMALE NA NA NA NA NA NA NA NA 234 0 Normal NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-E2-A15M-11 336 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-E2-A15M 336 0 days 336 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15M-F18852 TCGA-E2-A15M NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -24266 NA 336 0 235 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A15M TUMOR FREE NA NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Solid Tissue Normal 11 NA 7th YES NO YES E2 Breast NA DECEASED 2010 f75e5efb-056f-40bf-afed-33d971478ca4 f75e5efb-056f-40bf-afed-33d971478ca4 NA NA NA NA NA NA NA TCGA-E2-A15M-11A-22D-A12E-05 NA TCGA-E2-A15M-11 NA NA f75e5efb-056f-40bf-afed-33d971478ca4 NA NA TCGA-E2-A15M-11 TCGA-E2-A15M-11A-22R-A12D-07 f75e5efb-056f-40bf-afed-33d971478ca4 NA |
|
|
960 |
TCGA-E2-A15O-01 Stage I 89 4 Stage IIA 395 NA Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 395 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15O-01 1545 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E2-A15O 1210 1 days 1545 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 89 Left Upper Inner Quadrant No axillary staging NA TCGA-E2-A15O-F70024 TCGA-E2-A15O TCGA-E2-A15O-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -32583 273 NA 0 1545 NA 1230 1210 NA NO Allred score 5+2 = 7 NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA 10-19% NA 2+ NA NA 0.9 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Equivocal Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Positive NA NA NA NA 3 Point Scale 3+ 3+ NA NA NA NA Positive NA NA 4 2 NA NA 3 Point Scale NA Locoregional Recurrence NA YES YES NA NA false Yes M0 NX T1c Stage I TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf A15O TUMOR FREE Allred score 4+3 = 7 NA NA Allred score = 7 Allred score = 7 YES NO NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 4a28ecf3-c70e-42d0-918b-866d11804c13 4a28ecf3-c70e-42d0-918b-866d11804c13 TCGA-E2-A15O-01A-21-A13E-20 TCGA-E2-A15O-01A-11D-A10Y-09 TCGA-E2-A15O-01 NA 538d33c5-6bc8-4cda-950b-93c16e500d48 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11D-A10Y-09 TCGA-E2-A15O-01A-11D-A112-05 TCGA-E2-A15O-01 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11D-A10Y-09 NA 4a28ecf3-c70e-42d0-918b-866d11804c13 NA TCGA-E2-A15O-01A-11D-A111-01 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11R-A115-07 4a28ecf3-c70e-42d0-918b-866d11804c13 TCGA-E2-A15O-01A-11D-A111-01 TCGA-E2-A15O-01 |
|
|
961 |
TCGA-E2-A15P-01 Stage IA 61 2 Stage I 315 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 315 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 0 TCGA-E2-A15P-01 595 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A15P 595 0 days 595 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15P-F19144 TCGA-E2-A15P TCGA-E2-A15P-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22524 269 NA 0 595 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-11-16 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf A15P TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 61c279ee-777a-4c05-bc38-e1a9183faaff 61c279ee-777a-4c05-bc38-e1a9183faaff TCGA-E2-A15P-01A-21-A13E-20 TCGA-E2-A15P-01A-11D-A10Y-09 TCGA-E2-A15P-01 NA 776d3800-9f60-4eb4-930c-8bb036607730 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11D-A10Y-09 TCGA-E2-A15P-01A-11D-A112-05 TCGA-E2-A15P-01 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11D-A10Y-09 NA 61c279ee-777a-4c05-bc38-e1a9183faaff NA TCGA-E2-A15P-01A-11D-A111-01 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11R-A115-07 61c279ee-777a-4c05-bc38-e1a9183faaff TCGA-E2-A15P-01A-11D-A111-01 TCGA-E2-A15P-01 |
|
|
962 |
TCGA-E2-A15R-01 Stage IIIA 64 4 Stage IIA 330 NA Positive FEMALE Negative 4 3 3 Negative M0 Positive N1 330 0 LumA Luminal A Positive LumA/B -10 -3 enrollment T1 T1 LIVING 0 TCGA-E2-A15R-01 1732 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-E2-A15R 1732 0 days 1732 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15R-F70011 TCGA-E2-A15R TCGA-E2-A15R-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -23570 247 NA 0 1732 NA NA NA NA NO Allred score 5+3 = 8 NA 1.9 Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 2+ NA 2.4 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 140 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 5 NA NA NA NA NA NA NA NO 3 NA false No M0 N1a T1c Stage IIA TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf A15R TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 YES YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 8f90121d-5f9a-4702-a2ae-2a9b34a99171 8f90121d-5f9a-4702-a2ae-2a9b34a99171 TCGA-E2-A15R-01A-21-A13E-20 TCGA-E2-A15R-01A-11D-A10Y-09 TCGA-E2-A15R-01 NA 7bec7525-d926-443f-a521-09334b963a89 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11D-A10Y-09 TCGA-E2-A15R-01A-11D-A112-05 TCGA-E2-A15R-01 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11D-A10Y-09 NA 8f90121d-5f9a-4702-a2ae-2a9b34a99171 NA TCGA-E2-A15R-01A-11D-A111-01 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11R-A115-07 8f90121d-5f9a-4702-a2ae-2a9b34a99171 TCGA-E2-A15R-01A-11D-A111-01 TCGA-E2-A15R-01 |
|
|
963 |
TCGA-E2-A15S-01 Stage IIB 34 NA Stage IIB 274 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 274 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15S-01 428 0 days NA C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 6 mutation c1uster 9 TCGA-E2-A15S 428 0 days 428 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A15S-F19135 TCGA-E2-A15S TCGA-E2-A15S-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA NO NA NA -12671 247 NA 0 428 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-11-16 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 560 NO Equivocal Negative NA 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1 T2 Stage IIB TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf A15S TUMOR FREE NA NA NA Allred score = 2 Allred score = 7 NA YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 754fd66b-f39a-4308-a57c-05de251f9014 754fd66b-f39a-4308-a57c-05de251f9014 TCGA-E2-A15S-01A-21-A13E-20 TCGA-E2-A15S-01A-11D-A10Y-09 TCGA-E2-A15S-01 NA 19e14655-2099-4ebc-91eb-d95db082bbc7 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11D-A10Y-09 TCGA-E2-A15S-01A-11D-A112-05 TCGA-E2-A15S-01 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11D-A10Y-09 NA 754fd66b-f39a-4308-a57c-05de251f9014 NA TCGA-E2-A15S-01A-11D-A111-01 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11R-A115-07 754fd66b-f39a-4308-a57c-05de251f9014 TCGA-E2-A15S-01A-11D-A111-01 TCGA-E2-A15S-01 |
|
|
964 |
TCGA-E2-A15T-01 Stage IIA 65 NA Stage IIA 267 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 267 0 NA Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A15T-01 1563 0 days NA NA cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E2-A15T 1563 0 days 1563 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A15T-F70019 TCGA-E2-A15T TCGA-E2-A15T-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -24054 162 NA 0 1563 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 2+ NA NA 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 360 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf A15T TUMOR FREE Allred score 2+3 = 5 NA NA Allred score = 5 Allred score = 8 YES YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 5db1c37a-2329-4bd3-baf2-89d26a8959fa 5db1c37a-2329-4bd3-baf2-89d26a8959fa TCGA-E2-A15T-01A-21-A13E-20 TCGA-E2-A15T-01A-11D-A10Y-09 TCGA-E2-A15T-01 NA e8fe1a3f-ec8a-49a8-a932-01341de67004 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11D-A10Y-09 TCGA-E2-A15T-01A-11D-A112-05 TCGA-E2-A15T-01 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11D-A10Y-09 NA 5db1c37a-2329-4bd3-baf2-89d26a8959fa NA TCGA-E2-A15T-01A-11D-A111-01 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11R-A115-07 5db1c37a-2329-4bd3-baf2-89d26a8959fa TCGA-E2-A15T-01A-11D-A111-01 TCGA-E2-A15T-01 |
|
|
965 |
TCGA-E2-A1AZ-01 Stage IIB 63 4 Stage IIB 1964 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 1964 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A1AZ-01 2329 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA mutation c1uster 9 TCGA-E2-A1AZ 2329 0 days 2329 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A1AZ-F19462 TCGA-E2-A1AZ TCGA-E2-A1AZ-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -23230 2527 NA 0 2329 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-6 FEMALE NA NA NA NA NA NA NA 0.42 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 250 NO Indeterminate Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf A1AZ TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2004 fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c TCGA-E2-A1AZ-01A-21-A13E-20 TCGA-E2-A1AZ-01A-11D-A12Q-09 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12R-05 187a4af6-1941-419e-a58d-d3fb18510b65 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12Q-09 NA TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12Q-09 NA fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c NA TCGA-E2-A1AZ-01A-11D-A12N-01 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11R-A12P-07 fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c TCGA-E2-A1AZ-01A-11D-A12N-01 TCGA-E2-A1AZ-01 |
|
|
966 |
TCGA-E2-A1B0-01 Stage IIIA 50 3 Stage IIIA 1271 NA Negative FEMALE Positive 1 2 2 Negative M0 Positive N2 1271 0 Her2 HER2-enriched Negative ReacI -13 -10 enrollment T_Other T2 LIVING 0 TCGA-E2-A1B0-01 1631 0 days High C3-BRCA/Luminal cluster 5 Cluster 5 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A1B0 1631 0 days 1631 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A1B0-F19460 TCGA-E2-A1B0 TCGA-E2-A1B0-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18346 1315 NA 0 1631 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-12-7 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Positive NA NA 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 6 NA true No M0 N2 T2 Stage IIIA TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf A1B0 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 8bb3543b-5c83-41c6-b81c-b20935c38d72 8bb3543b-5c83-41c6-b81c-b20935c38d72 TCGA-E2-A1B0-01A-21-A13E-20 TCGA-E2-A1B0-01A-11D-A12Q-09 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12R-05 2eae7190-37af-4257-9a9e-29a8c937a513 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12Q-09 NA TCGA-E2-A1B0-01 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12Q-09 NA 8bb3543b-5c83-41c6-b81c-b20935c38d72 NA TCGA-E2-A1B0-01A-11D-A12N-01 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11R-A12P-07 8bb3543b-5c83-41c6-b81c-b20935c38d72 TCGA-E2-A1B0-01A-11D-A12N-01 TCGA-E2-A1B0-01 |
|
|
967 |
TCGA-E2-A1B1-01 Stage IIB 45 3 Stage IIB 1361 NA Positive FEMALE Positive 1 2 3 Negative M0 Positive N1 1361 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING 0 TCGA-E2-A1B1-01 2653 0 days Kirc+ C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A1B1 2653 0 days 2653 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1B1-F70009 TCGA-E2-A1B1 TCGA-E2-A1B1-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -16603 1268 NA 0 2653 NA NA NA NA NO Allred score 3+2 = 5 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA 70-79% NA 2+ NA NA 15.12 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 300 NO Equivocal Positive NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 4 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf A1B1 TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 5 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 2aa34033-a6f5-45a8-833b-b433352e58ba 2aa34033-a6f5-45a8-833b-b433352e58ba TCGA-E2-A1B1-01A-11-A13E-20 TCGA-E2-A1B1-01A-21D-A12Q-09 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12R-05 c476545a-0d56-4d49-9180-bb707d02a1c9 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12Q-09 NA TCGA-E2-A1B1-01 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12Q-09 NA 2aa34033-a6f5-45a8-833b-b433352e58ba NA TCGA-E2-A1B1-01A-21D-A12N-01 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21R-A12P-07 2aa34033-a6f5-45a8-833b-b433352e58ba TCGA-E2-A1B1-01A-21D-A12N-01 TCGA-E2-A1B1-01 |
|
|
968 |
TCGA-E2-A1B4-01 Stage IIIA 74 2 Stage IIIA 911 NA Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 911 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 LIVING 1 TCGA-E2-A1B4-01 1004 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-E2-A1B4 1004 0 days 1004 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A1B4-F19443 TCGA-E2-A1B4 TCGA-E2-A1B4-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27241 798 1004 0 911 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA 10-19% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 3 NA true No M0 N2a T1c Stage IIIA TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf A1B4 TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A DECEASED 2008 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 TCGA-E2-A1B4-01A-21-A13E-20 TCGA-E2-A1B4-01A-11D-A12Q-09 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12R-05 4b198843-12fe-41e0-af18-0638dd948c6a TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12Q-09 NA TCGA-E2-A1B4-01 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12Q-09 NA 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 NA TCGA-E2-A1B4-01A-11D-A12N-01 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11R-A12P-07 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 TCGA-E2-A1B4-01A-11D-A12N-01 TCGA-E2-A1B4-01 |
|
|
969 |
TCGA-E2-A1B5-01 Stage IIA 46 3 Stage IIA 774 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 774 0 LumA Basal-like Positive ReacI -13 -12 enrollment T_Other T2 LIVING 0 TCGA-E2-A1B5-01 984 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-E2-A1B5 984 0 days 984 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Sentinel node biopsy alone NA TCGA-E2-A1B5-F19393 TCGA-E2-A1B5 TCGA-E2-A1B5-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -17039 783 NA 0 984 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 260 NO Negative NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf A1B5 TUMOR FREE Allred score 2+3 = 5 NA NA Allred score = 5 Allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 a2c80f8e-f08d-4574-90a0-f0651c0a9b1b a2c80f8e-f08d-4574-90a0-f0651c0a9b1b TCGA-E2-A1B5-01A-31-A13E-20 TCGA-E2-A1B5-01A-21D-A12Q-09 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12R-05 96c90192-0896-42a2-bc87-ae6bf8bb5c9f TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12Q-09 NA TCGA-E2-A1B5-01 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12Q-09 NA a2c80f8e-f08d-4574-90a0-f0651c0a9b1b NA TCGA-E2-A1B5-01A-21D-A12N-01 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21R-A12P-07 a2c80f8e-f08d-4574-90a0-f0651c0a9b1b TCGA-E2-A1B5-01A-21D-A12N-01 TCGA-E2-A1B5-01 |
|
|
970 |
TCGA-E2-A1B5-11 NA 46 NA NA 774 NA NA FEMALE NA NA NA NA NA NA NA NA 774 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1B5-11 984 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E2-A1B5 984 0 days 984 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Sentinel node biopsy alone NA TCGA-E2-A1B5-F19393 TCGA-E2-A1B5 TCGA-E2-A1B5-11A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -17039 783 NA 0 984 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 260 NO Negative NA NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA NA A1B5 TUMOR FREE Allred score 2+3 = 5 NA NA Allred score = 5 Allred score = 8 NA YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2008 NA NA NA NA NA TCGA-E2-A1B5-11A-23D-A12R-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
971 |
TCGA-E2-A1B6-01 Stage IIA 44 1 Stage IIA 338 NA Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 338 0 NA Luminal A Negative Basal -5 -7 enrollment T_Other T2 LIVING 0 TCGA-E2-A1B6-01 867 0 days Quiet C13-AML cluster 5 Low purity c2 BRCA basal-like c6 NA miRNA cluster 15 cluster 6 mutation cluster 5 TCGA-E2-A1B6 867 0 days 867 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Sentinel node biopsy alone NA TCGA-E2-A1B6-F19389 TCGA-E2-A1B6 NA NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -16370 NA NA 0 867 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA 10-19% NA 2+ NA NA 1.03 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Equivocal Negative NA 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A1B6 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2008 eb398b00-8669-4c22-8285-03cdf76436f3 eb398b00-8669-4c22-8285-03cdf76436f3 TCGA-E2-A1B6-01A-21-A13E-20 TCGA-E2-A1B6-01A-31D-A12Q-09 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12R-05 dc503863-7967-469b-b966-69dcea2dfb86 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12Q-09 NA TCGA-E2-A1B6-01 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12Q-09 NA eb398b00-8669-4c22-8285-03cdf76436f3 NA TCGA-E2-A1B6-01A-31D-A12N-01 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31R-A12P-07 eb398b00-8669-4c22-8285-03cdf76436f3 TCGA-E2-A1B6-01A-31D-A12N-01 TCGA-E2-A1B6-01 |
|
|
972 |
TCGA-E2-A1BC-01 Stage IA 63 2 Stage I 297 NA Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 297 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING 0 TCGA-E2-A1BC-01 501 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1BC 501 0 days 501 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel node biopsy alone NA TCGA-E2-A1BC-F19427 TCGA-E2-A1BC TCGA-E2-A1BC-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -23168 275 NA 0 501 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8524/3 C50.9 NA YES NA Tumor resection 100 NO Negative NA NA 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 NA true Yes M0 N0 T1c Stage IA TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf A1BC TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 a2cf164c-5b26-43eb-9de9-d1d457a5de06 a2cf164c-5b26-43eb-9de9-d1d457a5de06 TCGA-E2-A1BC-01A-21-A13E-20 TCGA-E2-A1BC-01A-11D-A14G-09 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A12R-05 8d3961ff-444a-4808-a697-c21898446648 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A14G-09 NA TCGA-E2-A1BC-01 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A14G-09 NA a2cf164c-5b26-43eb-9de9-d1d457a5de06 NA TCGA-E2-A1BC-01A-11D-A12N-01 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11R-A12P-07 a2cf164c-5b26-43eb-9de9-d1d457a5de06 TCGA-E2-A1BC-01A-11D-A12N-01 TCGA-E2-A1BC-01 |
|
|
973 |
TCGA-E2-A1BC-11 NA 63 NA NA 297 NA NA FEMALE NA NA NA NA NA NA NA NA 297 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1BC-11 501 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E2-A1BC 501 0 days 501 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel node biopsy alone NA TCGA-E2-A1BC-F19427 TCGA-E2-A1BC NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -23168 NA NA 0 501 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2011-12-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8524/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA Yes M0 N0 T1c Stage IA NA A1BC TUMOR FREE NA NA NA NA NA NA YES NA NA NO Solid Tissue Normal 11 NA 7th YES NO YES E2 Breast NA LIVING 2010 afe373b9-f1c1-412d-9506-091749d47534 afe373b9-f1c1-412d-9506-091749d47534 NA NA NA TCGA-E2-A1BC-11A-32D-A12R-05 NA NA NA NA NA TCGA-E2-A1BC-11 NA NA afe373b9-f1c1-412d-9506-091749d47534 NA NA TCGA-E2-A1BC-11 TCGA-E2-A1BC-11A-32R-A12P-07 afe373b9-f1c1-412d-9506-091749d47534 NA |
|
|
974 |
TCGA-E2-A1BD-01 Stage IIA 53 2 Stage IIA 317 NA Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 317 0 LumA Luminal A Positive LumA -7 -3 enrollment T_Other T2 LIVING 0 TCGA-E2-A1BD-01 1133 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1BD 1133 0 days 1133 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1BD-F70021 TCGA-E2-A1BD TCGA-E2-A1BD-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -19627 260 NA 0 1133 NA NA NA NA NO Allred score 5+3 = 8 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA 10-19% NA 2+ NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 100 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf A1BD TUMOR FREE Allred score 5+3 = 8 NA NA Allred score = 8 Allred score = 8 YES YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 fa1917b0-c3e1-412d-b063-e74b5cafb8dc fa1917b0-c3e1-412d-b063-e74b5cafb8dc TCGA-E2-A1BD-01A-21-A13E-20 TCGA-E2-A1BD-01A-11D-A12Q-09 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12R-05 139a9795-35ff-4c82-9530-fb103ea5ca8c TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12Q-09 NA TCGA-E2-A1BD-01 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12Q-09 NA fa1917b0-c3e1-412d-b063-e74b5cafb8dc NA TCGA-E2-A1BD-01A-11D-A12N-01 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11R-A12P-07 fa1917b0-c3e1-412d-b063-e74b5cafb8dc TCGA-E2-A1BD-01A-11D-A12N-01 TCGA-E2-A1BD-01 |
|
|
975 |
TCGA-E2-A1IE-01 Stage IIB 61 5 Stage IIB 983 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 983 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1IE-01 2362 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-E2-A1IE 1810 1 days 2362 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 61 Right Sentinel node biopsy alone NA TCGA-E2-A1IE-F70297 TCGA-E2-A1IE NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22510 NA NA 0 2362 NA NA 1810 NA NO allred score 5 + 3 = 8 NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA 20-29% NA 2+ NA NA 1.05 2.1 Infiltrating Ductal Carcinoma NA No 200 C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Equivocal Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Positive NA NA NA 1.0 3 Point Scale 3+ 3+ Negative NA NA NA Positive NA NA 3 6 2.2 NA 3 Point Scale Liver Distant Metastasis NA NO YES 1 NA NA No M0 N1 T2 Stage IIB NA A1IE WITH TUMOR allred score 3 + 3 = 6 NA NA allred score = 6 allred score = 8 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2008 ec6f69db-ff0b-491c-8b70-d53d0e7ad65f ec6f69db-ff0b-491c-8b70-d53d0e7ad65f NA TCGA-E2-A1IE-01A-11D-A188-09 TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A13K-05 NA TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A188-09 NA NA TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A188-09 NA ec6f69db-ff0b-491c-8b70-d53d0e7ad65f NA TCGA-E2-A1IE-01A-11D-A13J-01 TCGA-E2-A1IE-01 NA ec6f69db-ff0b-491c-8b70-d53d0e7ad65f TCGA-E2-A1IE-01A-11D-A13J-01 |
|
|
976 |
TCGA-E2-A1IF-01 Stage I 74 2 Stage I 956 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 956 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IF-01 1138 0 days Iq C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 1 TCGA-E2-A1IF 1138 0 days 1138 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IF-F19962 TCGA-E2-A1IF TCGA-E2-A1IF-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27341 932 NA 0 1138 NA NA NA NA NO allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 70 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 6 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf A1IF TUMOR FREE allred score 4+2=6 NA NA allred score = 6 allred scrore = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 34a8b02b-01a2-4f2d-8e8e-c3358d43665a 34a8b02b-01a2-4f2d-8e8e-c3358d43665a NA TCGA-E2-A1IF-01A-11D-A142-09 TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A145-05 NA TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A142-09 NA NA TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A142-09 NA 34a8b02b-01a2-4f2d-8e8e-c3358d43665a NA TCGA-E2-A1IF-01A-11D-A141-01 TCGA-E2-A1IF-01 NA 34a8b02b-01a2-4f2d-8e8e-c3358d43665a TCGA-E2-A1IF-01A-11D-A141-01 |
|
|
977 |
TCGA-E2-A1IF-11 NA 74 NA NA 956 NA NA FEMALE NA NA NA NA NA NA NA NA 956 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1IF-11 1138 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 1 TCGA-E2-A1IF 1138 0 days 1138 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IF-F19962 TCGA-E2-A1IF TCGA-E2-A1IF-11A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27341 932 NA 0 1138 NA NA NA NA NO allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 140 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I NA A1IF TUMOR FREE allred score 4+2=6 NA NA allred score = 6 allred scrore = 8 NA YES NA NA NO Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2008 NA NA NA NA NA TCGA-E2-A1IF-11A-22D-A145-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
978 |
TCGA-E2-A1IG-01 Stage IIB 45 5 Stage IIB 755 NA Positive FEMALE NA NA NA NA Negative M0 Positive N1 755 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1IG-01 2140 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-E2-A1IG 2140 0 days 2140 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IG-F70394 TCGA-E2-A1IG NA NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -16757 NA NA 0 2140 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 1 NA NA No M0 N1mi T2 Stage IIB NA A1IG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2009 d0705a73-e6d0-4282-82b1-76d44bda242f d0705a73-e6d0-4282-82b1-76d44bda242f TCGA-E2-A1IG-01A-21-A17J-20 TCGA-E2-A1IG-01A-11D-A142-09 TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A145-05 e1a96343-ccc9-4e16-a96d-749528da4dfb TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A142-09 NA NA TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A142-09 NA d0705a73-e6d0-4282-82b1-76d44bda242f NA TCGA-E2-A1IG-01A-11D-A141-01 TCGA-E2-A1IG-01 NA d0705a73-e6d0-4282-82b1-76d44bda242f TCGA-E2-A1IG-01A-11D-A141-01 |
|
|
979 |
TCGA-E2-A1IG-11 NA 45 NA NA 755 NA NA FEMALE NA NA NA NA NA NA NA NA 755 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1IG-11 2140 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E2-A1IG 2140 0 days 2140 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IG-F70394 TCGA-E2-A1IG TCGA-E2-A1IG-11A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -16757 679 NA 0 2140 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 210 NO Negative NA NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T2 Stage IIB NA A1IG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2009 1e55cf08-da43-471d-813c-9d37c7abc730 1e55cf08-da43-471d-813c-9d37c7abc730 NA NA NA NA NA NA NA NA NA TCGA-E2-A1IG-11 NA NA 1e55cf08-da43-471d-813c-9d37c7abc730 NA NA TCGA-E2-A1IG-11 NA 1e55cf08-da43-471d-813c-9d37c7abc730 NA |
|
|
980 |
TCGA-E2-A1IH-01 Stage I 80 2 Stage I 658 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 658 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IH-01 1026 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 10 TCGA-E2-A1IH 1026 0 days 1026 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IH-F19960 TCGA-E2-A1IH TCGA-E2-A1IH-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -29444 883 NA 0 1026 NA NA NA NA NO allred score 5+3=8 NA NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA 20-29% NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 80 NO Equivocal NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf A1IH TUMOR FREE allred score 5+3+8 NA NA allred score = 8 allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 2d06908f-3332-4b77-b88c-145dc5c4828f 2d06908f-3332-4b77-b88c-145dc5c4828f NA TCGA-E2-A1IH-01A-11D-A188-09 TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A13K-05 NA TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A188-09 NA NA TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A188-09 NA 2d06908f-3332-4b77-b88c-145dc5c4828f NA TCGA-E2-A1IH-01A-11D-A13J-01 TCGA-E2-A1IH-01 NA 2d06908f-3332-4b77-b88c-145dc5c4828f TCGA-E2-A1IH-01A-11D-A13J-01 |
|
|
981 |
TCGA-E2-A1II-01 Stage I 51 2 Stage I 850 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 850 0 Basal NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1II-01 1025 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A1II 1025 0 days 1025 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Sentinel node biopsy alone NA TCGA-E2-A1II-F19954 TCGA-E2-A1II NA NA Negative NA NA NA NA Positive Lumpectomy NA NO NA NA -18788 NA NA 0 1025 NA NA NA NA NO allred score 0 + 0 = 0 NA NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A1II TUMOR FREE allred score 2+2 = 4 NA NA allred score = 4 allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2008 f7a5cfcb-623c-4858-ba32-e6ca63c75d2a f7a5cfcb-623c-4858-ba32-e6ca63c75d2a NA TCGA-E2-A1II-01A-11D-A142-09 TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A145-05 NA TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A142-09 NA NA TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A142-09 NA f7a5cfcb-623c-4858-ba32-e6ca63c75d2a NA TCGA-E2-A1II-01A-11D-A141-01 TCGA-E2-A1II-01 NA f7a5cfcb-623c-4858-ba32-e6ca63c75d2a TCGA-E2-A1II-01A-11D-A141-01 |
|
|
982 |
TCGA-E2-A1II-11 NA 51 NA NA 850 NA NA FEMALE NA NA NA NA NA NA NA NA 850 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1II-11 1025 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-E2-A1II 1025 0 days 1025 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Sentinel node biopsy alone NA TCGA-E2-A1II-F19954 TCGA-E2-A1II TCGA-E2-A1II-11A NA Negative NA NA NA NA Positive Lumpectomy NA NO NA NA -18788 854 NA 0 1025 NA NA NA NA NO allred score 0 + 0 = 0 NA NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 170 NO Negative NA NA 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I NA A1II TUMOR FREE allred score 2+2 = 4 NA NA allred score = 4 allred score = 0 NA YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2008 NA NA NA NA NA TCGA-E2-A1II-11A-21D-A145-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
983 |
TCGA-E2-A1IJ-01 Stage I 57 3 Stage I 725 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 725 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IJ-01 865 0 days Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A1IJ 865 0 days 865 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IJ-F19950 TCGA-E2-A1IJ TCGA-E2-A1IJ-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -20956 707 NA 0 865 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2011-12-21 FEMALE NA NA NA NA 2+ NA NA 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 70 NO Equivocal Negative NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf A1IJ TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 NA TCGA-E2-A1IJ-01A-11D-A142-09 TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A145-05 NA TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A142-09 NA NA TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A142-09 NA 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 NA TCGA-E2-A1IJ-01A-11D-A141-01 TCGA-E2-A1IJ-01 NA 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 TCGA-E2-A1IJ-01A-11D-A141-01 |
|
|
984 |
TCGA-E2-A1IK-01 Stage IIA 71 1 Stage IIA 518 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 518 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IK-01 1800 0 days Quiet C5-KIRC cluster 1 Low purity c2 NA BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-E2-A1IK 1800 0 days 1800 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Sentinel node biopsy alone NA TCGA-E2-A1IK-F70395 TCGA-E2-A1IK TCGA-E2-A1IK-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -26052 423 NA 0 1800 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 70 NO Negative NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T1c Stage IIA TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf A1IK TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 96a11934-f6cd-4892-a808-672433f84429 96a11934-f6cd-4892-a808-672433f84429 NA TCGA-E2-A1IK-01A-11D-A17G-09 TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A145-05 NA TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A17G-09 NA NA TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A17G-09 NA 96a11934-f6cd-4892-a808-672433f84429 NA TCGA-E2-A1IK-01A-11D-A141-01 TCGA-E2-A1IK-01 NA 96a11934-f6cd-4892-a808-672433f84429 TCGA-E2-A1IK-01A-11D-A141-01 |
|
|
985 |
TCGA-E2-A1IL-01 Stage IIA 78 2 Stage IIA 14 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 14 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IL-01 118 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-E2-A1IL 118 0 days 118 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IL-F20276 TCGA-E2-A1IL TCGA-E2-A1IL-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -28495 417 NA 0 118 NA NA NA NA NO allred score 5+3=8 NA NA Scheduled Follow-up Submission 2012-1-3 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 120 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf A1IL TUMOR FREE allred score 4 + 3 = 7 NA NA allred score = 7 allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d TCGA-E2-A1IL-01A-21-A17J-20 TCGA-E2-A1IL-01A-11D-A14G-09 TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14H-05 dbdb0a12-88ea-4a7b-a215-e7e83adc666f TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14G-09 NA NA TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14G-09 NA 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d NA TCGA-E2-A1IL-01A-11D-A14F-01 TCGA-E2-A1IL-01 NA 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d TCGA-E2-A1IL-01A-11D-A14F-01 |
|
|
986 |
TCGA-E2-A1IN-01 Stage I 60 4 Stage I 392 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 392 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IN-01 675 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-E2-A1IN 675 0 days 675 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Sentinel node biopsy alone NA TCGA-E2-A1IN-F20323 TCGA-E2-A1IN NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -22199 NA NA 0 675 NA NA NA NA NO allred score 5+3=8 NA NA Scheduled Follow-up Submission 2012-1-4 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A1IN TUMOR FREE allred score 5+3+8 NA NA allred score = 8 allred score = 8 NA YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast NA LIVING 2010 dde1d3ab-ad71-4526-bc98-058b6049edcf dde1d3ab-ad71-4526-bc98-058b6049edcf NA TCGA-E2-A1IN-01A-11D-A13L-09 TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13K-05 NA TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13L-09 NA NA TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13L-09 NA dde1d3ab-ad71-4526-bc98-058b6049edcf NA TCGA-E2-A1IN-01A-11D-A13J-01 TCGA-E2-A1IN-01 NA dde1d3ab-ad71-4526-bc98-058b6049edcf TCGA-E2-A1IN-01A-11D-A13J-01 |
|
|
987 |
TCGA-E2-A1IO-01 Stage I 37 1 Stage I 448 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 448 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IO-01 1855 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-E2-A1IO 1855 0 days 1855 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Sentinel node biopsy alone NA TCGA-E2-A1IO-F70391 TCGA-E2-A1IO TCGA-E2-A1IO-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -13671 416 NA 0 1855 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA 30-39% NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf A1IO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 72611671-51cc-4662-b992-6701eb1df987 72611671-51cc-4662-b992-6701eb1df987 NA TCGA-E2-A1IO-01A-11D-A142-09 TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A145-05 NA TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A142-09 NA NA TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A142-09 NA 72611671-51cc-4662-b992-6701eb1df987 NA TCGA-E2-A1IO-01A-11D-A141-01 TCGA-E2-A1IO-01 NA 72611671-51cc-4662-b992-6701eb1df987 TCGA-E2-A1IO-01A-11D-A141-01 |
|
|
988 |
TCGA-E2-A1IO-11 NA 37 NA NA 448 NA NA FEMALE NA NA NA NA NA NA NA NA 448 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1IO-11 1855 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-E2-A1IO 1855 0 days 1855 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Sentinel node biopsy alone NA TCGA-E2-A1IO-F70391 TCGA-E2-A1IO TCGA-E2-A1IO-11A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -13671 416 NA 0 1855 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA 30-39% NA 2+ NA NA 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I NA A1IO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2009 NA NA NA NA NA TCGA-E2-A1IO-11A-21D-A145-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
989 |
TCGA-E2-A1IP-01 Stage IIB 42 NA Stage IIB 427 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 427 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING NA TCGA-E2-A1IP-01 NA NA days NA NA NA NA NA NA NA NA NA TCGA-E2-A1IP NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA NA NA NA NA NA NA TCGA-E2-A1IP-01A NA NA NA NA NA NA NA NA NA NA NA NA NA 359 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 80 NO NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA false NA NA NA NA NA TCGA-E2-A1IP.021D6868-16EA-4D55-9784-46A0F85C50C8.pdf NA NA NA NA NA NA NA NA NA NA NA NA Primary Tumor 01 NA NA NA NA NA NA NA A NA NA dfd81aa5-5be4-4cf3-877f-0f52e01beb60 dfd81aa5-5be4-4cf3-877f-0f52e01beb60 NA NA NA TCGA-E2-A1IP-01A-11D-A14H-05 NA NA NA NA NA NA NA NA dfd81aa5-5be4-4cf3-877f-0f52e01beb60 NA NA NA NA dfd81aa5-5be4-4cf3-877f-0f52e01beb60 NA |
|
|
990 |
TCGA-E2-A1IU-01 Stage IA 60 2 Stage I 127 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 127 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1IU-01 337 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 2 mutation cluster 4 TCGA-E2-A1IU 337 0 days 337 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1IU-F19974 TCGA-E2-A1IU TCGA-E2-A1IU-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -22279 136 NA 0 337 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-4 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 270 NO Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 2 NA NA NA NA NA NA NA NO 0 NA false No M0 N0 (mol+) T1c Stage IA TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf A1IU TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 53c8bbbd-16cd-4790-a99b-f45b0f958157 53c8bbbd-16cd-4790-a99b-f45b0f958157 TCGA-E2-A1IU-01A-21-A17J-20 TCGA-E2-A1IU-01A-11D-A14G-09 TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14H-05 19429156-19ad-44f5-a671-1fef7a6e693c TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14G-09 NA NA TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14G-09 NA 53c8bbbd-16cd-4790-a99b-f45b0f958157 NA TCGA-E2-A1IU-01A-11D-A14F-01 TCGA-E2-A1IU-01 NA 53c8bbbd-16cd-4790-a99b-f45b0f958157 TCGA-E2-A1IU-01A-11D-A14F-01 |
|
|
991 |
TCGA-E2-A1L6-01 Stage IIA 44 2 Stage IIA 1312 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1312 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1L6-01 1648 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 4 TCGA-E2-A1L6 1648 0 days 1648 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A1L6-F20570 TCGA-E2-A1L6 TCGA-E2-A1L6-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -16403 1325 NA 0 1648 NA NA NA NA NO allred score 5 + 3 = 8 NA NA Scheduled Follow-up Submission 2012-1-10 FEMALE NA NA 40-49% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 110 NO Negative NA NA 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T1c Stage IIA TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf A1L6 TUMOR FREE allred score 5 + 3 = 8 NA NA allred score = 8 allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2007 4142c779-86ab-44f5-9371-539bbaa363d2 4142c779-86ab-44f5-9371-539bbaa363d2 TCGA-E2-A1L6-01A-21-A17J-20 TCGA-E2-A1L6-01A-11D-A13L-09 TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13K-05 bca87047-7257-4983-9e8c-e6811b33a10e TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13L-09 NA NA TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13L-09 NA 4142c779-86ab-44f5-9371-539bbaa363d2 NA TCGA-E2-A1L6-01A-11D-A13J-01 TCGA-E2-A1L6-01 NA 4142c779-86ab-44f5-9371-539bbaa363d2 TCGA-E2-A1L6-01A-11D-A13J-01 |
|
|
992 |
TCGA-E2-A1L7-01 Stage IIIA 40 1 Stage IIIA 633 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N2 633 0 LumB NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1L7-01 1836 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-E2-A1L7 1619 1 days 1836 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 40 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1L7-F70298 TCGA-E2-A1L7 TCGA-E2-A1L7-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14854 548 NA 0 1836 NA 1662 1619 NA NO Allred score 1+1 = 2 NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 150 NO Negative NA NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 2 5 NA NA NA Other, specify New Primary Tumor left breast YES YES 7 NA false No M0 N2 T2 Stage IIIA TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf A1L7 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 2 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 ec38c31b-def8-41cc-8656-57ce98f3faa7 ec38c31b-def8-41cc-8656-57ce98f3faa7 TCGA-E2-A1L7-01A-21-A17J-20 TCGA-E2-A1L7-01A-11D-A142-09 TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A145-05 9a9baaf4-427c-48cd-ae41-25fd84ae612f TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A142-09 NA NA TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A142-09 NA ec38c31b-def8-41cc-8656-57ce98f3faa7 NA TCGA-E2-A1L7-01A-11D-A141-01 TCGA-E2-A1L7-01 NA ec38c31b-def8-41cc-8656-57ce98f3faa7 TCGA-E2-A1L7-01A-11D-A141-01 |
|
|
993 |
TCGA-E2-A1L7-11 NA 40 NA NA 633 NA NA FEMALE NA NA NA NA NA NA NA NA 633 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1L7-11 1836 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-E2-A1L7 1619 1 days 1836 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NA NA 40 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1L7-F70298 TCGA-E2-A1L7 TCGA-E2-A1L7-11A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -14854 548 NA 0 1836 NA 1662 1619 NA NO Allred score 1+1 = 2 NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 280 NO Negative NA NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA NA NA NA NA NA Other, specify New Primary Tumor left breast YES YES 7 NA false No M0 N2 T2 Stage IIIA NA A1L7 TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 2 YES YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2009 53e9749e-5554-443b-b41e-5efade6fce7a 53e9749e-5554-443b-b41e-5efade6fce7a NA NA NA TCGA-E2-A1L7-11A-33D-A145-05 NA NA NA NA NA TCGA-E2-A1L7-11 NA NA 53e9749e-5554-443b-b41e-5efade6fce7a NA NA TCGA-E2-A1L7-11 NA 53e9749e-5554-443b-b41e-5efade6fce7a NA |
|
|
994 |
TCGA-E2-A1L8-01 Stage IIA 52 2 Stage IIB 1015 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1015 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1L8-01 2240 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-E2-A1L8 2240 0 days 2240 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A1L8-F70018 TCGA-E2-A1L8 TCGA-E2-A1L8-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -19187 912 NA 0 2240 NA NA NA NA NO allred score 5 + 3 = 8 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA 40-49% NA 2+ NA NA 1.10 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 180 NO Equivocal Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 2 NA false Yes M0 N1a T2 Stage IIB TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf A1L8 TUMOR FREE allred score 4 + 3 = 7 NA NA allred score = 7 allred score = 8 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 TCGA-E2-A1L8-01A-21-A17J-20 TCGA-E2-A1L8-01A-11D-A13L-09 TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13K-05 da720181-484f-4eff-8f96-b7e4298c751b TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13L-09 NA NA TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13L-09 NA 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 NA TCGA-E2-A1L8-01A-11D-A13J-01 TCGA-E2-A1L8-01 NA 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 TCGA-E2-A1L8-01A-11D-A13J-01 |
|
|
995 |
TCGA-E2-A1L9-01 Stage IIB 40 3 Stage IIA 388 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 388 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1L9-01 598 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1L9 598 0 days 598 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Sentinel node biopsy alone NA TCGA-E2-A1L9-F20597 TCGA-E2-A1L9 TCGA-E2-A1L9-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -14868 465 NA 0 598 NA NA NA NA NO NA 80-89% NA Scheduled Follow-up Submission 2012-1-11 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 40 NO Negative NA NA 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 1 NA false No M0 N1mi T1c Stage IIA TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf A1L9 TUMOR FREE NA NA NA allred score = 7 allred score = 7 NA YES 80-89% NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 05329e4e-6623-4044-9abf-46f3ed4ccfd8 05329e4e-6623-4044-9abf-46f3ed4ccfd8 NA TCGA-E2-A1L9-01A-11D-A13L-09 TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13K-05 NA TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13L-09 NA NA TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13L-09 NA 05329e4e-6623-4044-9abf-46f3ed4ccfd8 NA TCGA-E2-A1L9-01A-11D-A13J-01 TCGA-E2-A1L9-01 NA 05329e4e-6623-4044-9abf-46f3ed4ccfd8 TCGA-E2-A1L9-01A-11D-A13J-01 |
|
|
996 |
TCGA-E2-A1LA-01 Stage IIA 59 5 Stage IIA 463 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 463 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1LA-01 748 0 days High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 12 TCGA-E2-A1LA 748 0 days 748 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A1LA-F20586 TCGA-E2-A1LA TCGA-E2-A1LA-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -21773 581 NA 0 748 NA NA NA NA NO allred score 5 + 3 = 8 NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA 2+ NA NA 1.15 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 40 NO Equivocal Negative NA 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T1c Stage IIA TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf A1LA TUMOR FREE allred score 5 +3 = 8 NA NA allred score = 8 allred score = 8 NA YES NA NA NO Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2009 9a56eb8b-99fa-4671-99dc-29776dca4cd6 9a56eb8b-99fa-4671-99dc-29776dca4cd6 NA TCGA-E2-A1LA-01A-11D-A142-09 TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A145-05 NA TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A142-09 NA NA TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A142-09 NA 9a56eb8b-99fa-4671-99dc-29776dca4cd6 NA TCGA-E2-A1LA-01A-11D-A141-01 TCGA-E2-A1LA-01 NA 9a56eb8b-99fa-4671-99dc-29776dca4cd6 TCGA-E2-A1LA-01A-11D-A141-01 |
|
|
997 |
TCGA-E2-A1LB-01 Stage IIB 41 1 Stage IIB 972 NA Negative FEMALE Positive NA NA NA Negative M0 Positive N1 972 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1LB-01 2306 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-E2-A1LB 2306 0 days 2306 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1LB-F70015 TCGA-E2-A1LB TCGA-E2-A1LB-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -15283 909 NA 0 2306 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Positive NA NO 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 2 NA false No M0 N1 T2 Stage IIB TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf A1LB TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 acf1ec71-46a5-4e7b-84b1-55203bca29d8 acf1ec71-46a5-4e7b-84b1-55203bca29d8 TCGA-E2-A1LB-01A-21-A17J-20 TCGA-E2-A1LB-01A-11D-A142-09 TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A145-05 82c21aa1-4547-4da6-aaf4-ca207c327ea1 TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A142-09 NA NA TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A142-09 NA acf1ec71-46a5-4e7b-84b1-55203bca29d8 NA TCGA-E2-A1LB-01A-11D-A141-01 TCGA-E2-A1LB-01 NA acf1ec71-46a5-4e7b-84b1-55203bca29d8 TCGA-E2-A1LB-01A-11D-A141-01 |
|
|
998 |
TCGA-E2-A1LB-11 NA 41 NA NA 972 NA NA FEMALE NA NA NA NA NA NA NA NA 972 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1LB-11 2306 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E2-A1LB 2306 0 days 2306 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1LB-F70015 TCGA-E2-A1LB NA NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -15283 NA NA 0 2306 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Positive NA NO 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA NA No M0 N1 T2 Stage IIB NA A1LB TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast NA LIVING 2008 b34ad5ac-c581-4747-88db-e2d52fa7e463 b34ad5ac-c581-4747-88db-e2d52fa7e463 NA NA NA TCGA-E2-A1LB-11A-22D-A145-05 NA NA NA NA NA TCGA-E2-A1LB-11 NA NA b34ad5ac-c581-4747-88db-e2d52fa7e463 NA NA TCGA-E2-A1LB-11 NA b34ad5ac-c581-4747-88db-e2d52fa7e463 NA |
|
|
999 |
TCGA-E2-A1LE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-E2-A1LE-01 879 1 days Squamous NA NA BRCA CIMP c7 BRCA basal-like c6 NA miRNA cluster 7 NA NA TCGA-E2-A1LE 361 1 days 879 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 71 Right Upper Inner Quadrant|Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A1LE-F20657 TCGA-E2-A1LE TCGA-E2-A1LE-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -26239 986 879 0 NA NA NA 361 NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2012-1-18 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 600 NO Positive NA NA 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis NA NA YES 27 NA false No M0 N3a T2 Stage IIIC TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf A1LE WITH TUMOR Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A DECEASED 2008 776c18b3-4e53-41d6-8838-70a6029c07dd 776c18b3-4e53-41d6-8838-70a6029c07dd TCGA-E2-A1LE-01A-21-A24A-20 NA TCGA-E2-A1LE-01 TCGA-E2-A1LE-01A-12D-A19Z-05 fc80abcf-e8e0-4354-8646-d9ea84d87f7d TCGA-E2-A1LE-01 TCGA-E2-A1LE-01A-12D-A19Y-09 NA NA TCGA-E2-A1LE-01 NA NA 776c18b3-4e53-41d6-8838-70a6029c07dd NA TCGA-E2-A1LE-01A-12D-A19X-01 TCGA-E2-A1LE-01 NA 776c18b3-4e53-41d6-8838-70a6029c07dd TCGA-E2-A1LE-01A-12D-A19X-01 |
|
|
1000 |
TCGA-E2-A1LG-01 Stage IIA 50 2 Stage IIA 350 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 350 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1LG-01 1523 0 days Squamous C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-E2-A1LG 1523 0 days 1523 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1LG-F70390 TCGA-E2-A1LG TCGA-E2-A1LG-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -18492 252 NA 0 1523 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-3-16 FEMALE NA NA 60-69% NA 2+ NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 310 NO Equivocal Negative NO 19 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 NA false Yes M0 N0 T2 Stage IIA TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf A1LG TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e TCGA-E2-A1LG-01A-41-A17J-20 TCGA-E2-A1LG-01A-21D-A14K-09 TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14N-05 ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075 TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14K-09 NA NA TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14K-09 NA 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e NA TCGA-E2-A1LG-01A-21D-A14J-01 TCGA-E2-A1LG-01 NA 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e TCGA-E2-A1LG-01A-21D-A14J-01 |
|
|
1001 |
TCGA-E2-A1LH-01 Stage I 59 3 Stage I 2875 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 2875 0 Basal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1LH-01 3247 0 days High C4-BRCA/Basal cluster 5 Low purity c2 NA BRCA basal-like c8 NA NA mutation cluster 2 TCGA-E2-A1LH 3247 0 days 3247 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Sentinel node biopsy alone NA TCGA-E2-A1LH-F20649 TCGA-E2-A1LH TCGA-E2-A1LH-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21628 2998 NA 0 3247 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 130 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage I TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf A1LH TUMOR FREE NA ACIS NA NA NA NA YES NA NA YES Primary Tumor 01 NA 5th YES NO YES E2 Breast A LIVING 2002 66f3892f-f4ec-412c-9c56-a9e9b56a15ee 66f3892f-f4ec-412c-9c56-a9e9b56a15ee NA TCGA-E2-A1LH-01A-11D-A14G-09 TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14H-05 NA TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14G-09 NA NA TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14G-09 NA 66f3892f-f4ec-412c-9c56-a9e9b56a15ee NA TCGA-E2-A1LH-01A-11D-A14F-01 TCGA-E2-A1LH-01 NA 66f3892f-f4ec-412c-9c56-a9e9b56a15ee TCGA-E2-A1LH-01A-11D-A14F-01 |
|
|
1002 |
TCGA-E2-A1LH-11 NA 59 NA NA 2875 NA NA FEMALE NA NA NA NA NA NA NA NA 2875 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1LH-11 3247 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 2 TCGA-E2-A1LH 3247 0 days 3247 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Sentinel node biopsy alone NA TCGA-E2-A1LH-F20649 TCGA-E2-A1LH NA NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21628 NA NA 0 3247 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage I NA A1LH TUMOR FREE NA ACIS NA NA NA NA YES NA NA YES Solid Tissue Normal 11 NA 5th YES NO YES E2 Breast NA LIVING 2002 c0c2059a-2931-4834-84a7-bfacf137c182 c0c2059a-2931-4834-84a7-bfacf137c182 NA NA NA NA NA NA NA NA NA TCGA-E2-A1LH-11 NA NA c0c2059a-2931-4834-84a7-bfacf137c182 NA NA TCGA-E2-A1LH-11 NA c0c2059a-2931-4834-84a7-bfacf137c182 NA |
|
|
1003 |
TCGA-E2-A1LI-01 Stage IIB 57 3 Stage IIB 2750 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 2750 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E2-A1LI-01 3121 0 days High C4-BRCA/Basal cluster 4 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 7 NA mutation c1uster 9 TCGA-E2-A1LI 3121 0 days 3121 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1LI-F20623 TCGA-E2-A1LI NA NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21064 NA NA 0 3121 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA NA NA NA 1.21 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Equivocal Negative NA 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N1 T2 Stage IIB NA A1LI TUMOR FREE NA ACIS NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast NA LIVING 2003 fa643dcc-4f4c-44d0-9f4d-199de04f8d2b fa643dcc-4f4c-44d0-9f4d-199de04f8d2b NA TCGA-E2-A1LI-01A-12D-A159-09 TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A161-05 NA TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A159-09 NA NA TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A159-09 NA fa643dcc-4f4c-44d0-9f4d-199de04f8d2b NA TCGA-E2-A1LI-01A-12D-A160-01 TCGA-E2-A1LI-01 NA fa643dcc-4f4c-44d0-9f4d-199de04f8d2b TCGA-E2-A1LI-01A-12D-A160-01 |
|
|
1004 |
TCGA-E2-A1LI-11 NA 57 NA NA 2750 NA NA FEMALE NA NA NA NA NA NA NA NA 2750 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1LI-11 3121 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation c1uster 9 TCGA-E2-A1LI 3121 0 days 3121 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1LI-F20623 TCGA-E2-A1LI TCGA-E2-A1LI-11A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21064 2815 NA 0 3121 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA NA NA NA NA NA 1.21 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 190 NO Equivocal Negative NA 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N1 T2 Stage IIB NA A1LI TUMOR FREE NA ACIS NA NA NA NA YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES E2 Breast A LIVING 2003 NA NA NA NA NA TCGA-E2-A1LI-11A-23D-A161-05 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
1005 |
TCGA-E2-A1LK-01 Stage IIIC 84 4 Stage IIIA NA 266 Negative FEMALE Negative NA NA NA Negative M0 Positive N1 266 1 Basal NA Negative NA NA NA enrollment T_Other T3 DECEASED 1 TCGA-E2-A1LK-01 266 1 days Squamous C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-E2-A1LK 155 1 days 266 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES NA 84 Left Upper Outer Quadrant|Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1LK-F20620 TCGA-E2-A1LK NA NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA 200 -30757 NA 266 0 NA NA NA 155 NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2012-1-12 FEMALE NA NA 80-89% NA 2+ NA NA 1.41 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA Equivocal Negative NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Allred Score = 0 Equivocal 2+ Allred score 0+0 = 0 Negative NA NA 30-39% 0.95 NA NA NA Negative NA NA Allred score 0+0 = 0 Negative NA NA 3 5 NA NA NA Other, specify Locoregional Disease Left axilla NA YES 11 NA NA No M0 N3a T4b Stage IIIC NA A1LK WITH TUMOR Allred score 0+0 = 0 NA Allred score = 0 Allred score = 0 Allred score = 0 NA YES NA NA NO Primary Tumor 01 NA 6th NO NO YES E2 Breast NA DECEASED 2008 d6301614-9ba7-4632-bdca-ac1b11e8e811 d6301614-9ba7-4632-bdca-ac1b11e8e811 TCGA-E2-A1LK-01A-11-A17K-20 TCGA-E2-A1LK-01A-21D-A14G-09 TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14H-05 f5fd203d-214a-42f1-aaf9-c9ee9b12c4fc TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14G-09 NA NA TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14G-09 NA d6301614-9ba7-4632-bdca-ac1b11e8e811 NA TCGA-E2-A1LK-01A-21D-A14F-01 TCGA-E2-A1LK-01 NA d6301614-9ba7-4632-bdca-ac1b11e8e811 TCGA-E2-A1LK-01A-21D-A14F-01 |
|
|
1006 |
TCGA-E2-A1LL-01 Stage IIIA 73 1 Stage IIIA 1014 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N2 1014 0 Basal NA Negative NA NA NA enrollment T_Other T3 LIVING 0 TCGA-E2-A1LL-01 1309 0 days Squamous C2-Squamous-like cluster 1 BRCA CIMP c7 KIRC-like c1 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A1LL 1303 1 days 1309 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NA 73 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A1LL-F20616 TCGA-E2-A1LL TCGA-E2-A1LL-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -27028 988 NA 0 1309 NA NA 1303 NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2012-1-17 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 290 NO Negative NA NA 44 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA Liver Distant Metastasis NA NA YES 5 NA false No MX N2a T3 Stage IIIA TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf A1LL WITH TUMOR Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES E2 Breast A LIVING 2008 526c9170-0f25-4374-9287-1fc40acb6555 526c9170-0f25-4374-9287-1fc40acb6555 TCGA-E2-A1LL-01A-21-A17J-20 TCGA-E2-A1LL-01A-11D-A142-09 TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A145-05 fdf3231f-d485-4a5e-b10b-43d9ab536a66 TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A142-09 NA NA TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A142-09 NA 526c9170-0f25-4374-9287-1fc40acb6555 NA TCGA-E2-A1LL-01A-11D-A141-01 TCGA-E2-A1LL-01 NA 526c9170-0f25-4374-9287-1fc40acb6555 TCGA-E2-A1LL-01A-11D-A141-01 |
|
|
1007 |
TCGA-E2-A1LS-01 Stage IA 46 NA Stage I 239 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 239 0 Basal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-E2-A1LS-01 1604 0 days NA C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 NA mutation cluster 5 TCGA-E2-A1LS 1604 0 days 1604 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1LS-F70016 TCGA-E2-A1LS TCGA-E2-A1LS-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -16887 176 NA 0 1604 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 100 NO Negative NA NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf A1LS TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast A LIVING 2010 81239059-614b-46b7-a21e-224ec62e2939 81239059-614b-46b7-a21e-224ec62e2939 TCGA-E2-A1LS-01A-21-A17J-20 TCGA-E2-A1LS-01A-12D-A159-09 TCGA-E2-A1LS-01 TCGA-E2-A1LS-01A-12D-A161-05 9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65 NA TCGA-E2-A1LS-01A-12D-A159-09 NA NA TCGA-E2-A1LS-01 TCGA-E2-A1LS-01A-12D-A159-09 NA 81239059-614b-46b7-a21e-224ec62e2939 NA NA TCGA-E2-A1LS-01 NA 81239059-614b-46b7-a21e-224ec62e2939 NA |
|
|
1008 |
TCGA-E2-A1LS-11 NA 46 NA NA 239 NA NA FEMALE NA NA NA NA NA NA NA NA 239 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E2-A1LS-11 1604 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-E2-A1LS 1604 0 days 1604 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A1LS-F70016 TCGA-E2-A1LS TCGA-E2-A1LS-11A NA Negative NA NA NA NA Negative Simple Mastectomy NA NO NA NA -16887 176 NA 0 1604 NA NA NA NA NO Allred score 0+0 = 0 NA NA Scheduled Follow-up Submission 2015-2-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 280 NO Negative NA NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T1c Stage IA NA A1LS TUMOR FREE Allred score 0+0 = 0 NA NA Allred score = 0 Allred score = 0 YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES NO YES E2 Breast A LIVING 2010 a2c2973d-0af5-4065-a5b0-1dd73abdc581 a2c2973d-0af5-4065-a5b0-1dd73abdc581 NA NA NA TCGA-E2-A1LS-11A-32D-A161-05 NA NA NA NA NA NA NA NA a2c2973d-0af5-4065-a5b0-1dd73abdc581 NA NA NA NA a2c2973d-0af5-4065-a5b0-1dd73abdc581 NA |
|
|
1009 |
TCGA-E2-A2P5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-E2-A2P5-01 821 1 days High NA NA BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 5 NA NA TCGA-E2-A2P5 597 1 days 821 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 78 Left Axillary lymph node dissection alone NA TCGA-E2-A2P5-F68575 TCGA-E2-A2P5 TCGA-E2-A2P5-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -28621 219 821 0 515 NA NA 597 NA NO Allred score = 8 NA NA Scheduled Follow-up Submission 2014-11-26 FEMALE NA NA NA NA NA NA NA 1.0 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 260 NO NA Negative NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 21 NA true Yes M0 N3 T2 Stage IIIC TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf A2P5 WITH TUMOR Allred score = 8 NA NA Allred score = 8 Allred score = 8 YES YES NA NA YES Primary Tumor 01 NA 7th YES NO YES E2 Breast A DECEASED 2011 90d04601-4a15-44fc-bf1b-e0859310e644 90d04601-4a15-44fc-bf1b-e0859310e644 TCGA-E2-A2P5-01A-21-A24A-20 NA TCGA-E2-A2P5-01 TCGA-E2-A2P5-01A-11D-A19Z-05 b4da5ffb-397d-4760-8e01-a67791dd37fc TCGA-E2-A2P5-01 TCGA-E2-A2P5-01A-11D-A19Y-09 NA NA TCGA-E2-A2P5-01 NA NA 90d04601-4a15-44fc-bf1b-e0859310e644 NA TCGA-E2-A2P5-01A-11D-A19X-01 TCGA-E2-A2P5-01 NA 90d04601-4a15-44fc-bf1b-e0859310e644 TCGA-E2-A2P5-01A-11D-A19X-01 |
|
|
1010 |
TCGA-E2-A2P6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A2P6-01 1051 0 days Iq NA NA BRCA CIMP c7 NA NA miRNA cluster 14 NA NA TCGA-E2-A2P6 1051 0 days 1051 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A2P6-F68574 TCGA-E2-A2P6 NA Negative Positive NA NA NA Modified radical mastectomy Positive Lumpectomy NA NO NA NA -28411 NA NA 0 1051 NA NA NA NA NO Allread score 5+3 = 8 NA NA Scheduled Follow-up Submission 2014-11-26 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 5 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No M0 N1 T2 Stage IIB NA A2P6 TUMOR FREE Allred score 2+2 = 4 NA NA Allred score = 4 Allred score = 8 YES YES NA NA NO Primary Tumor 01 NA 7th YES NO YES E2 Breast NA LIVING 2011 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 NA NA TCGA-E2-A2P6-01 TCGA-E2-A2P6-01A-11D-A19Z-05 NA TCGA-E2-A2P6-01 TCGA-E2-A2P6-01A-11D-A19Y-09 NA NA TCGA-E2-A2P6-01 NA NA bc94874b-f73a-44c8-bc6f-9ec50972c9b2 NA TCGA-E2-A2P6-01A-11D-A19X-01 TCGA-E2-A2P6-01 NA bc94874b-f73a-44c8-bc6f-9ec50972c9b2 TCGA-E2-A2P6-01A-11D-A19X-01 |
|
|
1011 |
TCGA-E2-A3DX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A3DX-01 1325 0 days Quiet C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-E2-A3DX 1325 0 days 1325 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Axillary lymph node dissection alone NA TCGA-E2-A3DX-F70017 TCGA-E2-A3DX TCGA-E2-A3DX-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15969 142 NA 0 1325 NA NA NA NA NO NA NA NA NA 2015-2-9 FEMALE NA NA NA NA NA NA NA 7.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 180 NO NA Positive NO 36 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 25 NA false No M0 N3 T2 Stage IIIC TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf A3DX TUMOR FREE NA NA NA Allred score = 8 Allred score = 7 YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2011 2424c058-78c6-41dd-86e9-efcd61b72add 2424c058-78c6-41dd-86e9-efcd61b72add TCGA-E2-A3DX-01A-11-A24A-20 NA TCGA-E2-A3DX-01 TCGA-E2-A3DX-01A-21D-A212-05 8439f41b-dd33-46a5-bf4a-f10a23d65b36 TCGA-E2-A3DX-01 TCGA-E2-A3DX-01A-21D-A20S-09 NA NA TCGA-E2-A3DX-01 NA NA 2424c058-78c6-41dd-86e9-efcd61b72add NA TCGA-E2-A3DX-01A-21D-A20R-01 TCGA-E2-A3DX-01 NA 2424c058-78c6-41dd-86e9-efcd61b72add TCGA-E2-A3DX-01A-21D-A20R-01 |
|
|
1012 |
TCGA-E2-A56Z-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A56Z-01 252 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A56Z 252 0 days 252 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-E2-A56Z-F67584 TCGA-E2-A56Z TCGA-E2-A56Z-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -25282 254 NA 0 252 NA NA NA NA NA Allred 8 = 5+3 10-19% 2.2 NA 2014-11-6 FEMALE NA NA 10-19% NA 2+ 200 3.2 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 150 NO Equivocal Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf A56Z TUMOR FREE Allred 5 = 2+3 NA NA Allred Score Allred Score YES YES <10% NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2012 96af7552-6f51-4abe-8394-b9e966a70228 96af7552-6f51-4abe-8394-b9e966a70228 NA NA TCGA-E2-A56Z-01 TCGA-E2-A56Z-01A-12D-A29O-05 dc92e37a-e9dd-4055-acaf-bb63ec1d901b TCGA-E2-A56Z-01 TCGA-E2-A56Z-01A-12D-A29N-09 NA NA TCGA-E2-A56Z-01 NA NA 96af7552-6f51-4abe-8394-b9e966a70228 NA TCGA-E2-A56Z-01A-12D-A29M-01 TCGA-E2-A56Z-01 NA 96af7552-6f51-4abe-8394-b9e966a70228 TCGA-E2-A56Z-01A-12D-A29M-01 |
|
|
1013 |
TCGA-E2-A570-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A570-01 931 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A570 931 0 days 931 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-E2-A570-F61335 TCGA-E2-A570 TCGA-E2-A570-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -17456 416 NA 0 931 NA NA NA NA NA Allred 7 = 5+2 NA 2.0 NA 2014-6-27 FEMALE NA NA 10-19% NA 2+ 200 2.2 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Equivocal Negative NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1mi T1c Stage IB TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf A570 TUMOR FREE Allred 8 = 5+3 NA NA Allred Score Allred Score YES YES NA NA NO Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2011 635a7c2c-7731-48c1-948d-4d7ecf05c472 635a7c2c-7731-48c1-948d-4d7ecf05c472 NA NA TCGA-E2-A570-01 TCGA-E2-A570-01A-11D-A29O-05 NA TCGA-E2-A570-01 TCGA-E2-A570-01A-11D-A29N-09 NA NA TCGA-E2-A570-01 NA NA 635a7c2c-7731-48c1-948d-4d7ecf05c472 NA TCGA-E2-A570-01A-11D-A29M-01 TCGA-E2-A570-01 NA 635a7c2c-7731-48c1-948d-4d7ecf05c472 TCGA-E2-A570-01A-11D-A29M-01 |
|
|
1014 |
TCGA-E2-A572-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A572-01 1208 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A572 1208 0 days 1208 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Axillary lymph node dissection alone NA TCGA-E2-A572-F65007 TCGA-E2-A572 TCGA-E2-A572-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -26399 560 NA 0 1208 NA NA NA NA NA NA NA NA NA 2014-9-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 140 NO Equivocal Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 8 true Yes M0 N2 T2 Stage IIIA TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf A572 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2011 43a88718-f528-4d0b-88e6-f2ade6854c53 43a88718-f528-4d0b-88e6-f2ade6854c53 NA NA TCGA-E2-A572-01 TCGA-E2-A572-01A-13D-A31V-05 7b3b60fa-cd2e-4340-98f8-085f61b2148d NA NA NA NA TCGA-E2-A572-01 NA NA 43a88718-f528-4d0b-88e6-f2ade6854c53 NA NA TCGA-E2-A572-01 NA 43a88718-f528-4d0b-88e6-f2ade6854c53 NA |
|
|
1015 |
TCGA-E2-A573-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A573-01 1062 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A573 1062 0 days 1062 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A573-F61338 TCGA-E2-A573 NA NA Negative NA NA NA NA Negative Other NA NO NA NA -17689 NA NA 0 1062 NA NA NA NA NA Allred 0 = 0+0 NA 1.8 NA 2014-6-27 FEMALE NA NA 10-19% NA 2+ 200 2.3 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 4 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage IA NA A573 TUMOR FREE Allred 0 = 0+0 NA NA Allred Score Allred Score YES YES NA NA YES Primary Tumor 01 Partial Mastectomy 7th NA NO YES E2 Breast NA LIVING 2011 be17bc7b-550a-461b-9f7b-2a5845cc12b2 be17bc7b-550a-461b-9f7b-2a5845cc12b2 NA NA TCGA-E2-A573-01 TCGA-E2-A573-01A-11D-A29O-05 NA TCGA-E2-A573-01 TCGA-E2-A573-01A-11D-A29N-09 NA NA TCGA-E2-A573-01 NA NA be17bc7b-550a-461b-9f7b-2a5845cc12b2 NA TCGA-E2-A573-01A-11D-A29M-01 TCGA-E2-A573-01 NA be17bc7b-550a-461b-9f7b-2a5845cc12b2 TCGA-E2-A573-01A-11D-A29M-01 |
|
|
1016 |
TCGA-E2-A574-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A574-01 1179 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A574 1179 0 days 1179 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Sentinel node biopsy alone NA TCGA-E2-A574-F70296 TCGA-E2-A574 TCGA-E2-A574-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -16195 429 NA 0 1179 NA NA NA NA NA Allred 0 = 0+0 NA 2.8 NA 2015-2-9 FEMALE NA NA 10-19% NA 2+ 200 2.8 1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf A574 TUMOR FREE Allred 0 = 0+0 NA NA Allred Score Allred Score YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2011 fec9b75b-9a91-4979-9056-ecdd852429d8 fec9b75b-9a91-4979-9056-ecdd852429d8 NA NA TCGA-E2-A574-01 TCGA-E2-A574-01A-11D-A29O-05 19a7926b-5288-4e60-b0a3-ebdb0ff58b1a TCGA-E2-A574-01 TCGA-E2-A574-01A-11D-A29N-09 NA NA TCGA-E2-A574-01 NA NA fec9b75b-9a91-4979-9056-ecdd852429d8 NA TCGA-E2-A574-01A-11D-A29M-01 TCGA-E2-A574-01 NA fec9b75b-9a91-4979-9056-ecdd852429d8 TCGA-E2-A574-01A-11D-A29M-01 |
|
|
1017 |
TCGA-E2-A576-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A576-01 1043 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A576 1043 0 days 1043 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-E2-A576-F67575 TCGA-E2-A576 TCGA-E2-A576-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -25350 343 NA 0 1043 NA NA NA NA NA NA NA NA NA 2014-11-6 FEMALE NA NA NA NA 2+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO Equivocal Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No MX N0 T1c Stage IA TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf A576 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2011 1323e58e-5e3f-459a-99ff-e7a6748d3d77 1323e58e-5e3f-459a-99ff-e7a6748d3d77 NA NA TCGA-E2-A576-01 TCGA-E2-A576-01A-11D-A31V-05 NA TCGA-E2-A576-01 NA NA NA TCGA-E2-A576-01 NA NA 1323e58e-5e3f-459a-99ff-e7a6748d3d77 NA TCGA-E2-A576-01A-11D-A31T-01 TCGA-E2-A576-01 NA 1323e58e-5e3f-459a-99ff-e7a6748d3d77 TCGA-E2-A576-01A-11D-A31T-01 |
|
|
1018 |
TCGA-E2-A9RU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E2-A9RU-01 538 0 days NA NA NA NA NA NA NA NA NA TCGA-E2-A9RU 538 0 days 538 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E2-A9RU-F70313 TCGA-E2-A9RU TCGA-E2-A9RU-01A NA Positive NA NA NA NA Negative Lumpectomy NA YES NA NA -32873 188 NA 0 538 NA NA NA NA NA NA 70-79% NA NA 2015-2-9 FEMALE NA NA NA NA 2+ NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 220 NO Equivocal Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 12 NA true No MX N3a T2 Stage IIIC TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf A9RU TUMOR FREE NA NA NA NA Allred Score 6 YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES E2 Breast A LIVING 2013 12037b1a-ef64-4ea7-99c8-703132eb2d1e 12037b1a-ef64-4ea7-99c8-703132eb2d1e NA NA TCGA-E2-A9RU-01 TCGA-E2-A9RU-01A-11D-A41Q-05 5492E47A-045A-4CB8-A83D-D30F7E68CCF0 TCGA-E2-A9RU-01 NA NA NA TCGA-E2-A9RU-01 NA NA 12037b1a-ef64-4ea7-99c8-703132eb2d1e NA TCGA-E2-A9RU-01A-11D-A41E-01 TCGA-E2-A9RU-01 NA 12037b1a-ef64-4ea7-99c8-703132eb2d1e TCGA-E2-A9RU-01A-11D-A41E-01 |
|
|
1019 |
TCGA-E9-A1N3-01 Stage IIIA 70 1 Stage IIIA 0 NA NA FEMALE Negative NA NA NA Negative M0 Positive N2 0 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1N3-01 1059 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 NA mutation c1uster 9 TCGA-E9-A1N3 1059 0 days 1059 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N3-F62627 TCGA-E9-A1N3 TCGA-E9-A1N3-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -25714 65 NA 0 1059 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-22 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 230 NO NA NA NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 7 NA true No M0 N2 T1c Stage IIIA TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf A1N3 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 aaddb80d-7710-4aab-8efc-e84da79f9c68 aaddb80d-7710-4aab-8efc-e84da79f9c68 TCGA-E9-A1N3-01A-21-A17J-20 TCGA-E9-A1N3-01A-12D-A159-09 TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A161-05 167bccdb-afaa-49f7-b3af-6d5bd49e7422 TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A159-09 NA NA TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A159-09 NA aaddb80d-7710-4aab-8efc-e84da79f9c68 NA TCGA-E9-A1N3-01A-12D-A160-01 TCGA-E9-A1N3-01 NA aaddb80d-7710-4aab-8efc-e84da79f9c68 TCGA-E9-A1N3-01A-12D-A160-01 |
|
|
1020 |
TCGA-E9-A1N4-01 Stage IIIA 41 2 Stage IIIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1N4-01 1000 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-E9-A1N4 1000 0 days 1000 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N4-F39767 TCGA-E9-A1N4 TCGA-E9-A1N4-01A NA Positive NA NA NA NA Positive NA NA NO NA NA -15055 65 NA 0 1000 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 310 NO Positive NA NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 7 NA NA NA NA NA NA NA NO 4 0 true No M0 N2 T2 Stage IIIA TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf A1N4 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a TCGA-E9-A1N4-01A-21-A17K-20 TCGA-E9-A1N4-01A-11D-A14K-09 TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14N-05 e593a9f8-484a-4693-9d6c-75ddc09dea59 TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14K-09 NA NA TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14K-09 NA 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a NA TCGA-E9-A1N4-01A-11D-A14J-01 TCGA-E9-A1N4-01 NA 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a TCGA-E9-A1N4-01A-11D-A14J-01 |
|
|
1021 |
TCGA-E9-A1N4-11 NA 41 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1N4-11 1000 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E9-A1N4 1000 0 days 1000 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N4-F39767 TCGA-E9-A1N4 TCGA-E9-A1N4-11A NA Positive NA NA NA NA Positive NA NA NO NA NA -15055 65 NA 0 1000 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 340 NO Positive NA NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 4 0 true No M0 N2 T2 Stage IIIA NA A1N4 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2010 922b7051-1447-4e8d-9343-c5521ee45346 922b7051-1447-4e8d-9343-c5521ee45346 NA NA NA TCGA-E9-A1N4-11A-33D-A14N-05 NA NA NA NA NA TCGA-E9-A1N4-11 NA NA 922b7051-1447-4e8d-9343-c5521ee45346 NA NA TCGA-E9-A1N4-11 NA 922b7051-1447-4e8d-9343-c5521ee45346 NA |
|
|
1022 |
TCGA-E9-A1N5-01 Stage IIB 45 5 Stage IIB 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1N5-01 1120 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-E9-A1N5 1120 0 days 1120 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N5-F39765 TCGA-E9-A1N5 TCGA-E9-A1N5-01A NA Positive NA NA NA NA Positive NA NA NO NA NA -16736 63 NA 0 1120 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 190 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 2 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf A1N5 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 1adf0e70-b1fb-4862-8a01-6454b09636f4 1adf0e70-b1fb-4862-8a01-6454b09636f4 TCGA-E9-A1N5-01A-21-A17J-20 TCGA-E9-A1N5-01A-11D-A14G-09 TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14H-05 1efeb02c-7e68-449e-9f4f-8b8f985ab01e TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14G-09 NA NA TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14G-09 NA 1adf0e70-b1fb-4862-8a01-6454b09636f4 NA TCGA-E9-A1N5-01A-11D-A14F-01 TCGA-E9-A1N5-01 NA 1adf0e70-b1fb-4862-8a01-6454b09636f4 TCGA-E9-A1N5-01A-11D-A14F-01 |
|
|
1023 |
TCGA-E9-A1N5-11 NA 45 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1N5-11 1120 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 3 TCGA-E9-A1N5 1120 0 days 1120 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N5-F39765 TCGA-E9-A1N5 TCGA-E9-A1N5-11A NA Positive NA NA NA NA Positive NA NA NO NA NA -16736 63 NA 0 1120 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection NA NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1 T2 Stage IIB NA A1N5 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2010 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 NA NA NA TCGA-E9-A1N5-11A-41D-A14H-05 0D7A5303-6F45-4910-8BC5-F08E8FC11463 NA NA NA NA TCGA-E9-A1N5-11 NA NA 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 NA NA TCGA-E9-A1N5-11 NA 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 NA |
|
|
1024 |
TCGA-E9-A1N6-01 Stage IIB 52 5 Stage IIB 0 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 1 TCGA-E9-A1N6-01 678 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 NA TCGA-E9-A1N6 443 1 days 678 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 52 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N6-F63536 TCGA-E9-A1N6 TCGA-E9-A1N6-01A NA Positive NA NA NA NA Positive NA NA NO NA NA -19327 63 678 0 410 NA NA 443 NA NO NA NA NA Scheduled Follow-up Submission 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 220 NO Positive NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA Bone Distant Metastasis NA NO YES 2 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf A1N6 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2010 05b5084f-5e4f-43a3-9819-456a4f24ad82 05b5084f-5e4f-43a3-9819-456a4f24ad82 TCGA-E9-A1N6-01A-21-A17K-20 NA TCGA-E9-A1N6-01 TCGA-E9-A1N6-01A-11D-A145-05 4a7c1f26-54e8-40e4-a966-b01498c98782 TCGA-E9-A1N6-01 NA NA NA TCGA-E9-A1N6-01 NA NA 05b5084f-5e4f-43a3-9819-456a4f24ad82 NA TCGA-E9-A1N6-01A-11D-A141-01 TCGA-E9-A1N6-01 NA 05b5084f-5e4f-43a3-9819-456a4f24ad82 TCGA-E9-A1N6-01A-11D-A141-01 |
|
|
1025 |
TCGA-E9-A1N6-11 NA 52 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-E9-A1N6-11 678 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA NA TCGA-E9-A1N6 443 1 days 678 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 52 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N6-F63536 TCGA-E9-A1N6 TCGA-E9-A1N6-11A NA Positive NA NA NA NA Positive NA NA NO NA NA -19327 63 678 0 410 NA NA 443 NA NO NA NA NA Scheduled Follow-up Submission 2014-8-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 670 NO Positive NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 2 0 true No M0 N1 T2 Stage IIB NA A1N6 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A DECEASED 2010 0f263a65-a664-4e23-bd9c-91e955f3bf21 0f263a65-a664-4e23-bd9c-91e955f3bf21 NA NA NA TCGA-E9-A1N6-11A-32D-A145-05 F251633F-A6B6-4238-93A8-6C32EFCA1607 NA NA NA NA TCGA-E9-A1N6-11 NA NA 0f263a65-a664-4e23-bd9c-91e955f3bf21 NA NA TCGA-E9-A1N6-11 NA 0f263a65-a664-4e23-bd9c-91e955f3bf21 NA |
|
|
1026 |
TCGA-E9-A1N8-01 Stage IIA 48 1 Stage IIA 0 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 Basal NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1N8-01 1039 0 days Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E9-A1N8 1039 0 days 1039 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N8-F53518 TCGA-E9-A1N8 TCGA-E9-A1N8-01A NA Negative NA NA NA NA NA NA NA NO NA NA -17652 66 NA 0 1039 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-12-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 680 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf A1N8 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 7d6b6a17-5f1e-4586-9316-195c0e96925c 7d6b6a17-5f1e-4586-9316-195c0e96925c TCGA-E9-A1N8-01A-21-A17K-20 TCGA-E9-A1N8-01A-11D-A142-09 TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A145-05 8ea109e3-1e03-468c-b117-43cbd5c7571d TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A142-09 NA NA TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A142-09 NA 7d6b6a17-5f1e-4586-9316-195c0e96925c NA TCGA-E9-A1N8-01A-11D-A141-01 TCGA-E9-A1N8-01 NA 7d6b6a17-5f1e-4586-9316-195c0e96925c TCGA-E9-A1N8-01A-11D-A141-01 |
|
|
1027 |
TCGA-E9-A1N8-11 NA 48 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1N8-11 1039 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 5 TCGA-E9-A1N8 1039 0 days 1039 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N8-F53518 TCGA-E9-A1N8 TCGA-E9-A1N8-11A NA Negative NA NA NA NA NA NA NA NO NA NA -17652 66 NA 0 1039 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-12-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 510 NO Negative NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA NA A1N8 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2010 NA NA NA NA NA TCGA-E9-A1N8-11A-42D-A145-05 EFBC87A0-993F-4C1E-9D9A-32C76BCCC13A NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
1028 |
TCGA-E9-A1N9-01 Stage IIA 58 4 Stage IIA 0 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 Basal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1N9-01 1101 0 days High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E9-A1N9 1101 0 days 1101 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N9-F58373 TCGA-E9-A1N9 NA NA Negative NA NA NA NA Positive NA NA YES NA NA -21228 NA NA 0 1101 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-4-8 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection NA NA Positive NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 5 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T2 Stage IIA NA A1N9 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 cdada0b1-f90d-40bc-9257-6377987b7baa cdada0b1-f90d-40bc-9257-6377987b7baa TCGA-E9-A1N9-01A-21-A17K-20 TCGA-E9-A1N9-01A-11D-A14G-09 TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14H-05 f211c550-de9f-47f6-a1c2-546f560ac335 TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14G-09 NA NA TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14G-09 NA cdada0b1-f90d-40bc-9257-6377987b7baa NA TCGA-E9-A1N9-01A-11D-A14F-01 TCGA-E9-A1N9-01 NA cdada0b1-f90d-40bc-9257-6377987b7baa TCGA-E9-A1N9-01A-11D-A14F-01 |
|
|
1029 |
TCGA-E9-A1N9-11 NA 58 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1N9-11 1101 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-E9-A1N9 1101 0 days 1101 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1N9-F58373 TCGA-E9-A1N9 TCGA-E9-A1N9-11A NA Negative NA NA NA NA Positive NA NA YES NA NA -21228 44 NA 0 1101 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-4-8 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 1190 NO Positive NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA NA A1N9 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 NA NA NA NA 39636744-785B-4D93-8EE5-40D075AEAB71 NA NA NA NA TCGA-E9-A1N9-11 NA NA f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 NA NA TCGA-E9-A1N9-11 NA f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 NA |
|
|
1030 |
TCGA-E9-A1NA-01 Stage IIA 58 5 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1NA-01 1112 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E9-A1NA 1112 0 days 1112 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1-F39782 TCGA-E9-A1 TCGA-E9-A1-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -21397 42 NA 0 1112 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 110 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf A1 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 7edc6614-6c8b-43ec-87dd-7720961bd174 7edc6614-6c8b-43ec-87dd-7720961bd174 TCGA-E9-A1NA-01A-21-A17K-20 TCGA-E9-A1NA-01A-11D-A142-09 TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A145-05 693f43fc-0cb7-44e8-90c4-7c1bc12d7da6 TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A142-09 NA NA TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A142-09 NA 7edc6614-6c8b-43ec-87dd-7720961bd174 NA TCGA-E9-A1NA-01A-11D-A141-01 TCGA-E9-A1NA-01 NA 7edc6614-6c8b-43ec-87dd-7720961bd174 TCGA-E9-A1NA-01A-11D-A141-01 |
|
|
1031 |
TCGA-E9-A1NA-11 NA 58 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1NA-11 1112 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E9-A1NA 1112 0 days 1112 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1-F39782 TCGA-E9-A1 TCGA-E9-A1-11A NA Positive NA NA NA NA Positive NA NA YES NA NA -21397 42 NA 0 1112 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 330 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA NA A1 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 7b9569bc-f513-4b64-9a7c-7bb53b9be79b 7b9569bc-f513-4b64-9a7c-7bb53b9be79b NA NA NA TCGA-E9-A1NA-11A-33D-A145-05 NA NA NA NA NA TCGA-E9-A1NA-11 NA NA 7b9569bc-f513-4b64-9a7c-7bb53b9be79b NA NA TCGA-E9-A1NA-11 NA 7b9569bc-f513-4b64-9a7c-7bb53b9be79b NA |
|
|
1032 |
TCGA-E9-A1NC-01 Stage IIB 61 1 Stage IIB 0 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 NA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1NC-01 1203 0 days Squamous NA cluster 5 Low purity c2 NA NA miRNA cluster 13 NA mutation c1uster 9 TCGA-E9-A1NC 1203 0 days 1203 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NC-F40639 TCGA-E9-A1NC TCGA-E9-A1NC-01A NA Negative NA NA NA NA Positive NA NA YES NA NA -22355 38 NA 0 1203 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-26 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 200 NO Positive NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf A1NC TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 NA TCGA-E9-A1NC-01A-12W-A16L-09 TCGA-E9-A1NC-01 TCGA-E9-A1NC-01A-12D-A161-05 NA TCGA-E9-A1NC-01 TCGA-E9-A1NC-01A-12W-A16L-09 NA NA NA TCGA-E9-A1NC-01A-12W-A16L-09 NA 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 NA TCGA-E9-A1NC-01A-12D-A160-01 NA NA 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 TCGA-E9-A1NC-01A-12D-A160-01 |
|
|
1033 |
TCGA-E9-A1ND-01 Stage IIB 75 1 Stage IIB 0 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1ND-01 1266 0 days Squamous C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 2 TCGA-E9-A1ND 1266 0 days 1266 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1ND-F62586 TCGA-E9-A1ND TCGA-E9-A1ND-01A NA Negative NA NA NA NA Negative NA NA YES NA NA -27400 37 NA 0 1266 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 420 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf A1ND TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 526da11e-9125-4fcd-98d7-02994c9783d1 526da11e-9125-4fcd-98d7-02994c9783d1 TCGA-E9-A1ND-01A-21-A17J-20 TCGA-E9-A1ND-01A-11D-A142-09 TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A145-05 c323e6ab-8ba2-4347-a5d0-931a5d9754a1 TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A142-09 NA NA TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A142-09 NA 526da11e-9125-4fcd-98d7-02994c9783d1 NA TCGA-E9-A1ND-01A-11D-A141-01 TCGA-E9-A1ND-01 NA 526da11e-9125-4fcd-98d7-02994c9783d1 TCGA-E9-A1ND-01A-11D-A141-01 |
|
|
1034 |
TCGA-E9-A1ND-11 NA 75 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1ND-11 1266 0 days NA C4-BRCA/Basal NA NA NA NA NA NA mutation cluster 2 TCGA-E9-A1ND 1266 0 days 1266 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1ND-F62586 TCGA-E9-A1ND TCGA-E9-A1ND-11A NA Negative NA NA NA NA Negative NA NA YES NA NA -27400 37 NA 0 1266 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 1070 NO Positive NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB NA A1ND TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 ef84a69f-37bc-46fa-98ac-b3976212e11d ef84a69f-37bc-46fa-98ac-b3976212e11d NA NA NA TCGA-E9-A1ND-11A-43D-A145-05 1DFA3ABA-51BC-48FA-B854-39ED4F94E701 NA NA NA NA TCGA-E9-A1ND-11 NA NA ef84a69f-37bc-46fa-98ac-b3976212e11d NA NA TCGA-E9-A1ND-11 NA ef84a69f-37bc-46fa-98ac-b3976212e11d NA |
|
|
1035 |
TCGA-E9-A1NE-01 Stage IIB 28 1 Stage IIB 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1NE-01 1088 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-E9-A1NE 1088 0 days 1088 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 28 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NE-F39781 TCGA-E9-A1NE TCGA-E9-A1NE-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -10564 31 NA 0 1088 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 280 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 6 NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf A1NE TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 92691eb7-5df9-4da9-8bd0-c4f4de528bdc 92691eb7-5df9-4da9-8bd0-c4f4de528bdc TCGA-E9-A1NE-01A-11-A17K-20 TCGA-E9-A1NE-01A-21D-A14K-09 TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14N-05 8eb2885b-f9c7-4fcc-a9fe-a7673af9a3ec TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14K-09 NA NA TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14K-09 NA 92691eb7-5df9-4da9-8bd0-c4f4de528bdc NA TCGA-E9-A1NE-01A-21D-A14J-01 TCGA-E9-A1NE-01 NA 92691eb7-5df9-4da9-8bd0-c4f4de528bdc TCGA-E9-A1NE-01A-21D-A14J-01 |
|
|
1036 |
TCGA-E9-A1NE-11 NA 28 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1NE-11 1088 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E9-A1NE 1088 0 days 1088 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 28 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NE-F39781 TCGA-E9-A1NE TCGA-E9-A1NE-11A NA Positive NA NA NA NA Positive NA NA YES NA NA -10564 31 NA 0 1088 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 830 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB NA A1NE TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 NA NA NA NA NA TCGA-E9-A1NE-11A-43D-A14N-05 233FE7AC-4003-4A6C-80A1-101B561B6842 NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
1037 |
TCGA-E9-A1NF-01 Stage IIA 60 5 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 1 TCGA-E9-A1NF-01 1072 1 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-E9-A1NF 1072 0 days 1072 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NA NO NA 60 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NF-F39778 TCGA-E9-A1NF TCGA-E9-A1NF-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -21981 31 1072 0 610 NA NA 90 NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 240 NO Negative NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA Lung Distant Metastasis NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf A1NF WITH TUMOR NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 69e0026c-c87c-4987-8e46-f94d21f6bfb6 69e0026c-c87c-4987-8e46-f94d21f6bfb6 TCGA-E9-A1NF-01A-21-A17K-20 TCGA-E9-A1NF-01A-11D-A14G-09 TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14H-05 710e4246-7a43-4a0a-b6e2-0dddc3420c59 TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14G-09 NA NA TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14G-09 NA 69e0026c-c87c-4987-8e46-f94d21f6bfb6 NA TCGA-E9-A1NF-01A-11D-A14F-01 TCGA-E9-A1NF-01 NA 69e0026c-c87c-4987-8e46-f94d21f6bfb6 TCGA-E9-A1NF-01A-11D-A14F-01 |
|
|
1038 |
TCGA-E9-A1NF-11 NA 60 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 LumA NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-E9-A1NF-11 1072 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 13 TCGA-E9-A1NF 1072 0 days 1072 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NA NO NA 60 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NF-F39778 TCGA-E9-A1NF TCGA-E9-A1NF-11A NA Positive NA NA NA NA Positive NA NA YES NA NA -21981 31 1072 0 610 NA NA 90 NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 1520 NO Negative NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung Distant Metastasis NA NA NO 0 0 true No M0 N0 T2 Stage IIA NA A1NF WITH TUMOR NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A DECEASED 2011 39f6a4d4-650f-4caf-a778-4a24af4f11ba 39f6a4d4-650f-4caf-a778-4a24af4f11ba NA NA NA TCGA-E9-A1NF-11A-73D-A14H-05 DF5927EA-DE81-492A-B1AD-03A0E533A338 NA NA NA NA NA NA NA 39f6a4d4-650f-4caf-a778-4a24af4f11ba NA NA NA NA 39f6a4d4-650f-4caf-a778-4a24af4f11ba NA |
|
|
1039 |
TCGA-E9-A1NG-01 Stage IIA 62 1 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 1 TCGA-E9-A1NG-01 786 1 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 1 TCGA-E9-A1NG 786 0 days 786 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NG-F39774 TCGA-E9-A1NG TCGA-E9-A1NG-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -22896 30 786 0 656 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 380 NO Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf A1NG TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 TCGA-E9-A1NG-01A-11-A17K-20 TCGA-E9-A1NG-01A-21D-A14K-09 TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14N-05 38b632fe-cdcb-4b5d-9687-86977604c842 TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14K-09 NA NA TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14K-09 NA 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 NA TCGA-E9-A1NG-01A-21D-A14J-01 TCGA-E9-A1NG-01 NA 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 TCGA-E9-A1NG-01A-21D-A14J-01 |
|
|
1040 |
TCGA-E9-A1NG-11 NA 62 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 Normal NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-E9-A1NG-11 786 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 1 TCGA-E9-A1NG 786 0 days 786 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NG-F39774 TCGA-E9-A1NG TCGA-E9-A1NG-11A NA Positive NA NA NA NA Positive NA NA YES NA NA -22896 30 786 0 656 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 740 NO Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA NA A1NG TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A DECEASED 2011 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 NA NA NA TCGA-E9-A1NG-11A-52D-A14N-05 89FE3D24-088B-4F16-82A2-534DB14FF98D NA NA NA NA TCGA-E9-A1NG-11 NA NA a4172e12-2a82-436e-8cb9-a532dc0e9ec4 NA NA TCGA-E9-A1NG-11 NA a4172e12-2a82-436e-8cb9-a532dc0e9ec4 NA |
|
|
1041 |
TCGA-E9-A1NH-01 Stage IIB 71 2 Stage IIB 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1NH-01 576 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-E9-A1NH 576 0 days 576 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NH-F35049 TCGA-E9-A1NH TCGA-E9-A1NH-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -26221 30 NA 0 576 NA NA NA NA NO NA NA NA NA 2012-9-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 140 NO Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 3 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf A1NH TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2011 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 TCGA-E9-A1NH-01A-21-A17K-20 TCGA-E9-A1NH-01A-11D-A14G-09 TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14H-05 14a33bcb-ec41-48da-9c49-cfbcc3fab7de TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14G-09 NA NA TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14G-09 NA 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 NA TCGA-E9-A1NH-01A-11D-A14F-01 TCGA-E9-A1NH-01 NA 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 TCGA-E9-A1NH-01A-11D-A14F-01 |
|
|
1042 |
TCGA-E9-A1NH-11 NA 71 NA NA 0 NA NA FEMALE NA NA NA NA NA NA NA NA 0 0 NA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1NH-11 576 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E9-A1NH 576 0 days 576 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NH-F35049 TCGA-E9-A1NH TCGA-E9-A1NH-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -26221 30 NA 0 576 NA NA NA NA NO NA NA NA NA 2012-9-14 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 730 NO Negative NA NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 true No M0 N1 T2 Stage IIB NA A1NH TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th NA YES NO E9 Breast A LIVING 2011 NA NA NA NA NA NA A6417AA5-7E20-4D27-AFCC-306B837B095F NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
1043 |
TCGA-E9-A1NI-01 Stage IIA 51 2 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1NI-01 300 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1NI 300 0 days 300 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1NI-F52056 TCGA-E9-A1NI TCGA-E9-A1NI-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -18985 21 NA 0 300 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-11-27 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection 280 NO Negative NA YES 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf A1NI TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 07ac0536-240f-46be-9909-a8af1a22e2b8 07ac0536-240f-46be-9909-a8af1a22e2b8 TCGA-E9-A1NI-01A-21-A17K-20 TCGA-E9-A1NI-01A-11W-A16H-09 TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11D-A14H-05 e1eda531-b715-4139-9c80-c91ffc100fc2 TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11W-A16H-09 NA NA TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11W-A16H-09 NA 07ac0536-240f-46be-9909-a8af1a22e2b8 NA TCGA-E9-A1NI-01A-11D-A14F-01 TCGA-E9-A1NI-01 NA 07ac0536-240f-46be-9909-a8af1a22e2b8 TCGA-E9-A1NI-01A-11D-A14F-01 |
|
|
1044 |
TCGA-E9-A1QZ-01 Stage IIA 61 3 Stage IIA 0 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1QZ-01 755 0 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation c1uster 9 TCGA-E9-A1QZ 755 0 days 755 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1QZ-F66270 TCGA-E9-A1QZ TCGA-E9-A1QZ-01A NA NA NA NA NA NA NA NA NA NA NA NA -22397 58 NA 0 755 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-10-7 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 590 NO NA NA NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf A1QZ TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NO YES NO E9 Breast A LIVING 2011 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 TCGA-E9-A1QZ-01A-41-A17J-20 TCGA-E9-A1QZ-01A-21D-A167-09 TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A16A-05 0794c219-5e82-4c62-9e40-091a0c71c6b4 TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A167-09 NA NA TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A167-09 NA 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 NA TCGA-E9-A1QZ-01A-21D-A166-01 TCGA-E9-A1QZ-01 NA 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 TCGA-E9-A1QZ-01A-21D-A166-01 |
|
|
1045 |
TCGA-E9-A1R0-01 Stage IIA 58 2 Stage IIA 0 NA NA FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1R0-01 860 0 days Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 NA mutation cluster 4 TCGA-E9-A1R0 860 0 days 860 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R0-F41214 TCGA-E9-A1R0 TCGA-E9-A1R0-01A NA NA NA NA NA NA NA NA NA NA NA NA -21394 44 NA 0 860 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-3-13 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 400 NO NA NA NO 12 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T1c Stage IIA TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf A1R0 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 TCGA-E9-A1R0-01A-11-A17J-20 TCGA-E9-A1R0-01A-22D-A16D-09 TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16G-05 79bdc020-426c-41df-8b45-be0425815405 TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16D-09 NA NA TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16D-09 NA 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 NA TCGA-E9-A1R0-01A-22D-A16C-01 TCGA-E9-A1R0-01 NA 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 TCGA-E9-A1R0-01A-22D-A16C-01 |
|
|
1046 |
TCGA-E9-A1R2-01 Stage IIIC 51 5 Stage IIIC 19 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N3 19 0 LumA NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1R2-01 1063 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-E9-A1R2 1063 0 days 1063 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R2-F57941 TCGA-E9-A1R2 NA NA Positive NA NA NA NA Negative Lumpectomy NA NO NA NA -18936 NA NA 0 1063 NA NA NA NA NO NA 90-99% 74 Scheduled Follow-up Submission 2014-3-31 FEMALE NA NA 90-99% NA NA NA 114 NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy NA NA Equivocal Negative YES 19 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 17 NA NA No MX N3 T2 Stage IIIC NA A1R2 TUMOR FREE NA NA NA Two-tier Two-tier NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 e24bfd9d-87b2-44a7-bddc-7b7f60461252 e24bfd9d-87b2-44a7-bddc-7b7f60461252 TCGA-E9-A1R2-01A-21-A17J-20 TCGA-E9-A1R2-01A-11D-A14G-09 TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14H-05 e2a04b43-75e6-4ede-8536-d3cfe5eb9113 TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14G-09 NA NA TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14G-09 NA e24bfd9d-87b2-44a7-bddc-7b7f60461252 NA TCGA-E9-A1R2-01A-11D-A14F-01 TCGA-E9-A1R2-01 NA e24bfd9d-87b2-44a7-bddc-7b7f60461252 TCGA-E9-A1R2-01A-11D-A14F-01 |
|
|
1047 |
TCGA-E9-A1R3-01 Stage IIIC 70 2 Stage IIIC 64 NA NA FEMALE Negative NA NA NA Negative M0 Positive N3 64 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1R3-01 78 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1R3 78 0 days 78 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R3-F48697 TCGA-E9-A1R3 TCGA-E9-A1R3-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -25693 80 NA 0 78 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 420 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 10 NA true No M0 N3 T2 Stage IIIC TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf A1R3 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 678ba111-3b01-49b7-83d9-165ef0288a34 678ba111-3b01-49b7-83d9-165ef0288a34 TCGA-E9-A1R3-01A-41-A17J-20 TCGA-E9-A1R3-01A-31D-A14K-09 TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14N-05 fa7047e6-5a4e-4979-a1ee-ecac9434f163 TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14K-09 NA NA TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14K-09 NA 678ba111-3b01-49b7-83d9-165ef0288a34 NA TCGA-E9-A1R3-01A-31D-A14J-01 TCGA-E9-A1R3-01 NA 678ba111-3b01-49b7-83d9-165ef0288a34 TCGA-E9-A1R3-01A-31D-A14J-01 |
|
|
1048 |
TCGA-E9-A1R4-01 Stage IA 66 1 Stage I 29 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 29 0 LumB NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1R4-01 186 0 days Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 4 TCGA-E9-A1R4 186 0 days 186 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R4-F48699 TCGA-E9-A1R4 TCGA-E9-A1R4-01A NA NA NA NA NA NA NA NA NA NO NA NA -24181 45 NA 0 186 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Lumpectomy Other method, specify: 430 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage IA TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf A1R4 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 11353ea3-2ff0-4658-b528-6aa922dbb665 11353ea3-2ff0-4658-b528-6aa922dbb665 TCGA-E9-A1R4-01A-11-A17J-20 TCGA-E9-A1R4-01A-21D-A14G-09 TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14H-05 146230f2-2e64-46d7-84da-719567028426 TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14G-09 NA NA TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14G-09 NA 11353ea3-2ff0-4658-b528-6aa922dbb665 NA TCGA-E9-A1R4-01A-21D-A14F-01 TCGA-E9-A1R4-01 NA 11353ea3-2ff0-4658-b528-6aa922dbb665 TCGA-E9-A1R4-01A-21D-A14F-01 |
|
|
1049 |
TCGA-E9-A1R5-01 Stage IA 63 2 Stage I 42 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 42 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1R5-01 92 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1R5 92 0 days 92 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R5-F48700 TCGA-E9-A1R5 TCGA-E9-A1R5-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23116 58 NA 0 92 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 370 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage IA TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf A1R5 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 7b06a333-ba77-41dd-bfd1-4824fe43d06f 7b06a333-ba77-41dd-bfd1-4824fe43d06f TCGA-E9-A1R5-01A-21-A17J-20 TCGA-E9-A1R5-01A-11D-A14K-09 TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14N-05 95daa854-64b7-48d2-a82b-bacbfea25944 TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14K-09 NA NA TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14K-09 NA 7b06a333-ba77-41dd-bfd1-4824fe43d06f NA TCGA-E9-A1R5-01A-11D-A14J-01 TCGA-E9-A1R5-01 NA 7b06a333-ba77-41dd-bfd1-4824fe43d06f TCGA-E9-A1R5-01A-11D-A14J-01 |
|
|
1050 |
TCGA-E9-A1R6-01 Stage IIA 63 4 Stage IIA 84 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 84 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1R6-01 339 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E9-A1R6 339 0 days 339 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R6-F39520 TCGA-E9-A1R6 TCGA-E9-A1R6-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23347 100 NA 0 339 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 730 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 2 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf A1R6 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2010 2b022043-a976-40a7-929e-664b9549c411 2b022043-a976-40a7-929e-664b9549c411 TCGA-E9-A1R6-01A-21-A17J-20 TCGA-E9-A1R6-01A-11D-A14G-09 TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14H-05 e3b3d877-30e8-48f5-bc12-87618c1dbb34 TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14G-09 NA NA TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14G-09 NA 2b022043-a976-40a7-929e-664b9549c411 NA TCGA-E9-A1R6-01A-11D-A14F-01 TCGA-E9-A1R6-01 NA 2b022043-a976-40a7-929e-664b9549c411 TCGA-E9-A1R6-01A-11D-A14F-01 |
|
|
1051 |
TCGA-E9-A1R7-01 Stage IIA 64 5 Stage IIA 34 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 34 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1R7-01 1467 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E9-A1R7 1467 0 days 1467 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R7-F71424 TCGA-E9-A1R7 TCGA-E9-A1R7-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23397 51 NA 0 1467 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 400 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf A1R7 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 5ac273e2-3a3f-48a6-8782-956587bab667 5ac273e2-3a3f-48a6-8782-956587bab667 TCGA-E9-A1R7-01A-21-A17J-20 TCGA-E9-A1R7-01A-11D-A14K-09 TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14N-05 95f3d6af-2e61-4df8-b5bd-ce495b3b8b69 TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14K-09 NA NA TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14K-09 NA 5ac273e2-3a3f-48a6-8782-956587bab667 NA TCGA-E9-A1R7-01A-11D-A14J-01 TCGA-E9-A1R7-01 NA 5ac273e2-3a3f-48a6-8782-956587bab667 TCGA-E9-A1R7-01A-11D-A14J-01 |
|
|
1052 |
TCGA-E9-A1R7-11 NA 64 NA NA 34 NA NA FEMALE NA NA NA NA NA NA NA NA 34 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1R7-11 1467 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E9-A1R7 1467 0 days 1467 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1R7-F71424 TCGA-E9-A1R7 TCGA-E9-A1R7-11A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23397 51 NA 0 1467 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-3-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 440 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA NA A1R7 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 1457ae2c-4b9b-448a-b455-432a7121beb4 1457ae2c-4b9b-448a-b455-432a7121beb4 NA NA NA TCGA-E9-A1R7-11A-42D-A14N-05 NA NA NA NA NA TCGA-E9-A1R7-11 NA NA 1457ae2c-4b9b-448a-b455-432a7121beb4 NA NA TCGA-E9-A1R7-11 NA 1457ae2c-4b9b-448a-b455-432a7121beb4 NA |
|
|
1053 |
TCGA-E9-A1RA-01 Stage IA 48 3 Stage I 29 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 29 0 NA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1RA-01 1369 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 NA miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E9-A1RA 1369 0 days 1369 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RA-F68493 TCGA-E9-A1RA NA NA NA NA NA NA NA NA NA NA NO NA NA -17699 NA NA 0 1369 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-11-20 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Lumpectomy Other method, specify: NA NA NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T1c Stage IA NA A1RA TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 TCGA-E9-A1RA-01A-21-A17J-20 TCGA-E9-A1RA-01A-11D-A14G-09 TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14H-05 e20d43c8-401d-4975-ac2a-b355dd5bd528 TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14G-09 NA NA TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14G-09 NA da9bcd8c-7f5b-41f4-bff8-7129a88caf22 NA TCGA-E9-A1RA-01A-11D-A14F-01 TCGA-E9-A1RA-01 NA da9bcd8c-7f5b-41f4-bff8-7129a88caf22 TCGA-E9-A1RA-01A-11D-A14F-01 |
|
|
1054 |
TCGA-E9-A1RB-01 Stage IIA 40 4 Stage IIA 21 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 21 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 1 TCGA-E9-A1RB-01 976 1 days High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 5 TCGA-E9-A1RB 976 0 days 976 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RB-F39530 TCGA-E9-A1RB TCGA-E9-A1RB-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -14755 39 976 0 633 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 490 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf A1RB TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 7e2a8676-10a4-4abf-b153-2255e06bcb40 7e2a8676-10a4-4abf-b153-2255e06bcb40 TCGA-E9-A1RB-01A-21-A17J-20 TCGA-E9-A1RB-01A-11D-A17G-09 TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A161-05 d0e45995-93b2-4247-85b7-bc7071578e1f TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A17G-09 NA NA TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A17G-09 NA 7e2a8676-10a4-4abf-b153-2255e06bcb40 NA TCGA-E9-A1RB-01A-11D-A160-01 TCGA-E9-A1RB-01 NA 7e2a8676-10a4-4abf-b153-2255e06bcb40 TCGA-E9-A1RB-01A-11D-A160-01 |
|
|
1055 |
TCGA-E9-A1RB-11 NA 40 NA NA 21 NA NA FEMALE NA NA NA NA NA NA NA NA 21 0 Normal NA NA NA NA NA enrollment NA NA LIVING 1 TCGA-E9-A1RB-11 976 1 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 5 TCGA-E9-A1RB 976 0 days 976 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RB-F39530 TCGA-E9-A1RB TCGA-E9-A1RB-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -14755 39 976 0 633 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 640 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA NA A1RB TUMOR FREE NA NA NA NA NA YES YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A DECEASED 2011 b8499b28-1746-4ffd-a183-a765e6d290e3 b8499b28-1746-4ffd-a183-a765e6d290e3 NA NA NA TCGA-E9-A1RB-11A-33D-A161-05 0EFB66E0-3439-4FAE-9B6A-C5D085876AAF NA NA NA NA TCGA-E9-A1RB-11 NA NA b8499b28-1746-4ffd-a183-a765e6d290e3 NA NA TCGA-E9-A1RB-11 NA b8499b28-1746-4ffd-a183-a765e6d290e3 NA |
|
|
1056 |
TCGA-E9-A1RC-01 Stage IIIC 56 3 Stage IIIC 1228 NA NA FEMALE Negative NA NA NA Negative M0 Positive N3 1228 0 LumA NA NA NA NA NA enrollment T_Other T4 LIVING 0 TCGA-E9-A1RC-01 1224 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation cluster 4 TCGA-E9-A1RC 1224 0 days 1224 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RC-F48701 TCGA-E9-A1RC TCGA-E9-A1RC-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -20795 1246 NA 0 1224 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 620 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 10 0 true No M0 N3 T4b Stage IIIC TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf A1RC TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2007 00168e86-d23a-48ae-8c60-36d970051907 00168e86-d23a-48ae-8c60-36d970051907 TCGA-E9-A1RC-01A-21-A17J-20 TCGA-E9-A1RC-01A-11D-A159-09 TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A161-05 9243e0b1-b98d-4d50-817a-b2fed305e841 TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A159-09 NA NA TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A159-09 NA 00168e86-d23a-48ae-8c60-36d970051907 NA TCGA-E9-A1RC-01A-11D-A160-01 TCGA-E9-A1RC-01 NA 00168e86-d23a-48ae-8c60-36d970051907 TCGA-E9-A1RC-01A-11D-A160-01 |
|
|
1057 |
TCGA-E9-A1RC-11 NA 56 NA NA 1228 NA NA FEMALE NA NA NA NA NA NA NA NA 1228 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1RC-11 1224 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E9-A1RC 1224 0 days 1224 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RC-F48701 TCGA-E9-A1RC TCGA-E9-A1RC-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -20795 1246 NA 0 1224 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 1040 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 10 0 false No M0 N3 T4b Stage IIIC NA A1RC TUMOR FREE NA NA NA NA NA NA YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2007 81769714-1765-4b76-8a3a-18f79e314852 81769714-1765-4b76-8a3a-18f79e314852 NA NA NA TCGA-E9-A1RC-11A-33D-A161-05 68A3D687-0B01-4BDD-B650-D8D204E65559 NA NA NA NA NA NA NA 81769714-1765-4b76-8a3a-18f79e314852 NA NA NA NA 81769714-1765-4b76-8a3a-18f79e314852 NA |
|
|
1058 |
TCGA-E9-A1RD-01 Stage IIA 67 2 Stage IIA 20 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 20 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1RD-01 34 0 days Iq C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 NA mutation cluster 4 TCGA-E9-A1RD 34 0 days 34 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RD-F48702 TCGA-E9-A1RD NA NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -24719 NA NA 0 34 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 T2 Stage IIA NA A1RD TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 TCGA-E9-A1RD-01A-21-A17J-20 TCGA-E9-A1RD-01A-11D-A159-09 TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A161-05 ef7d073e-90b6-4d14-bcad-a6d9759122dc TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A159-09 NA NA TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A159-09 NA eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 NA TCGA-E9-A1RD-01A-11D-A160-01 TCGA-E9-A1RD-01 NA eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 TCGA-E9-A1RD-01A-11D-A160-01 |
|
|
1059 |
TCGA-E9-A1RD-11 NA 67 NA NA 20 NA NA FEMALE NA NA NA NA NA NA NA NA 20 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1RD-11 34 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E9-A1RD 34 0 days 34 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RD-F48702 TCGA-E9-A1RD TCGA-E9-A1RD-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -24719 38 NA 0 34 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 640 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA NA A1RD TUMOR FREE NA NA NA NA NA NA YES NA NA NO Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 000d877f-8d03-44bc-8607-27b5ba84b5fe 000d877f-8d03-44bc-8607-27b5ba84b5fe NA NA NA TCGA-E9-A1RD-11A-33D-A161-05 738328DA-0CBE-4801-A523-667D56E6A73E NA NA NA NA TCGA-E9-A1RD-11 NA NA 000d877f-8d03-44bc-8607-27b5ba84b5fe NA NA TCGA-E9-A1RD-11 NA 000d877f-8d03-44bc-8607-27b5ba84b5fe NA |
|
|
1060 |
TCGA-E9-A1RE-01 Stage IIIA 74 4 Stage IIIA 47 NA NA FEMALE Negative NA NA NA Negative M0 Positive N2 47 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1RE-01 1419 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 NA mutation cluster 4 TCGA-E9-A1RE 1419 0 days 1419 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RE-F68732 TCGA-E9-A1RE TCGA-E9-A1RE-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -27392 65 NA 0 1419 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-12-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 730 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 9 NA true No M0 N2 T2 Stage IIIA TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf A1RE TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 dce9e705-2d4f-4786-ad68-fb47615c7f3f dce9e705-2d4f-4786-ad68-fb47615c7f3f TCGA-E9-A1RE-01A-21-A17J-20 TCGA-E9-A1RE-01A-11D-A159-09 TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A161-05 347208e2-3e3d-4b02-8fc0-1092a95f9bcf TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A159-09 NA NA TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A159-09 NA dce9e705-2d4f-4786-ad68-fb47615c7f3f NA TCGA-E9-A1RE-01A-11D-A160-01 TCGA-E9-A1RE-01 NA dce9e705-2d4f-4786-ad68-fb47615c7f3f TCGA-E9-A1RE-01A-11D-A160-01 |
|
|
1061 |
TCGA-E9-A1RF-01 Stage IIIA 68 5 Stage IIIA 38 NA NA FEMALE Negative NA NA NA Negative M0 Positive N2 38 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1RF-01 200 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation c1uster 9 TCGA-E9-A1RF 200 0 days 200 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RF-F48703 TCGA-E9-A1RF TCGA-E9-A1RF-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -25119 56 NA 0 200 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 330 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 5 NA true No M0 N2 T2 Stage IIIA TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf A1RF TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 502939cc-3381-4bc2-9ae6-332846cf836b 502939cc-3381-4bc2-9ae6-332846cf836b TCGA-E9-A1RF-01A-21-A17J-20 TCGA-E9-A1RF-01A-11D-A159-09 TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A161-05 97534d53-162f-4e78-bf68-a227f1c2ae36 TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A159-09 NA NA TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A159-09 NA 502939cc-3381-4bc2-9ae6-332846cf836b NA TCGA-E9-A1RF-01A-11D-A160-01 TCGA-E9-A1RF-01 NA 502939cc-3381-4bc2-9ae6-332846cf836b TCGA-E9-A1RF-01A-11D-A160-01 |
|
|
1062 |
TCGA-E9-A1RF-11 NA 68 NA NA 38 NA NA FEMALE NA NA NA NA NA NA NA NA 38 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1RF-11 200 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-E9-A1RF 200 0 days 200 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RF-F48703 TCGA-E9-A1RF TCGA-E9-A1RF-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -25119 56 NA 0 200 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 1050 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA false No M0 N2 T2 Stage IIIA NA A1RF TUMOR FREE NA NA NA NA NA NA YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 da13db3f-cde6-4e25-9596-009147aa3fa9 da13db3f-cde6-4e25-9596-009147aa3fa9 NA NA NA TCGA-E9-A1RF-11A-32D-A161-05 97627951-60EF-4283-940A-9550114962F1 NA NA NA NA NA NA NA da13db3f-cde6-4e25-9596-009147aa3fa9 NA NA NA NA da13db3f-cde6-4e25-9596-009147aa3fa9 NA |
|
|
1063 |
TCGA-E9-A1RG-01 Stage IIIA 62 2 Stage IIIA 35 NA NA FEMALE Negative NA NA NA Negative M0 Positive N2 35 0 NA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1RG-01 647 0 days High C1-LUAD-enriched cluster 2 Cluster 5 BRCA nonbasal-like c8 NA miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-E9-A1RG 647 0 days 647 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RG-F39534 TCGA-E9-A1RG TCGA-E9-A1RG-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -22788 53 NA 0 647 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 540 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 4 NA true No M0 N2 T1c Stage IIIA TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf A1RG TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 dbf09347-4e3e-490e-977f-97d826143634 dbf09347-4e3e-490e-977f-97d826143634 TCGA-E9-A1RG-01A-21-A17J-20 TCGA-E9-A1RG-01A-11D-A14G-09 TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14H-05 4c16616e-47cf-474c-b8c3-f681f390493f TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14G-09 NA NA TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14G-09 NA dbf09347-4e3e-490e-977f-97d826143634 NA TCGA-E9-A1RG-01A-11D-A14F-01 TCGA-E9-A1RG-01 NA dbf09347-4e3e-490e-977f-97d826143634 TCGA-E9-A1RG-01A-11D-A14F-01 |
|
|
1064 |
TCGA-E9-A1RH-01 Stage IIA 63 4 Stage IIA 14 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 14 0 Her2 NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A1RH-01 1417 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1RH 1417 0 days 1417 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RH-F70141 TCGA-E9-A1RH TCGA-E9-A1RH-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23224 32 NA 0 1417 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-1-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 410 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf A1RH TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 422a4277-12f1-42ae-9f94-88d37517b9b0 422a4277-12f1-42ae-9f94-88d37517b9b0 TCGA-E9-A1RH-01A-11-A17J-20 TCGA-E9-A1RH-01A-21D-A167-09 TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A16A-05 7daa20aa-d253-4dc4-a90b-c68c6535d837 TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A167-09 NA NA TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A167-09 NA 422a4277-12f1-42ae-9f94-88d37517b9b0 NA TCGA-E9-A1RH-01A-21D-A166-01 TCGA-E9-A1RH-01 NA 422a4277-12f1-42ae-9f94-88d37517b9b0 TCGA-E9-A1RH-01A-21D-A166-01 |
|
|
1065 |
TCGA-E9-A1RH-11 NA 63 NA NA 14 NA NA FEMALE NA NA NA NA NA NA NA NA 14 0 Normal NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1RH-11 1417 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E9-A1RH 1417 0 days 1417 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RH-F70141 TCGA-E9-A1RH TCGA-E9-A1RH-11A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23224 32 NA 0 1417 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-1-28 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 720 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No M0 N0 T2 Stage IIA NA A1RH TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 6574e15e-7e1f-4dca-899e-56e911f27848 6574e15e-7e1f-4dca-899e-56e911f27848 NA NA NA TCGA-E9-A1RH-11A-34D-A16A-05 ABDD9B9C-278F-4077-BB4F-5B890D7E58C7 NA NA NA NA TCGA-E9-A1RH-11 NA NA 6574e15e-7e1f-4dca-899e-56e911f27848 NA NA TCGA-E9-A1RH-11 NA 6574e15e-7e1f-4dca-899e-56e911f27848 NA |
|
|
1066 |
TCGA-E9-A1RI-01 Stage IIIA 43 2 Stage IIIA 48 NA NA FEMALE NA NA NA NA Negative M0 Positive N2 48 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A1RI-01 1449 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1RI 1449 0 days 1449 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RI-F70144 TCGA-E9-A1RI TCGA-E9-A1RI-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -15942 64 NA 0 1449 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-1-28 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 290 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 5 NA true No M0 N2 T1c Stage IIIA TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf A1RI TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 1c77a00e-8cea-48ae-b9b5-193cdecf3604 1c77a00e-8cea-48ae-b9b5-193cdecf3604 TCGA-E9-A1RI-01A-21-A17J-20 TCGA-E9-A1RI-01A-11D-A167-09 TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A16A-05 fde109be-d1bb-48df-af59-0bee2ca9ed1e TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A167-09 NA NA TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A167-09 NA 1c77a00e-8cea-48ae-b9b5-193cdecf3604 NA TCGA-E9-A1RI-01A-11D-A166-01 TCGA-E9-A1RI-01 NA 1c77a00e-8cea-48ae-b9b5-193cdecf3604 TCGA-E9-A1RI-01A-11D-A166-01 |
|
|
1067 |
TCGA-E9-A1RI-11 NA 43 NA NA 48 NA NA FEMALE NA NA NA NA NA NA NA NA 48 0 LumA NA NA NA NA NA enrollment NA NA LIVING 0 TCGA-E9-A1RI-11 1449 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation cluster 4 TCGA-E9-A1RI 1449 0 days 1449 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A1RI-F70144 TCGA-E9-A1RI TCGA-E9-A1RI-11A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -15942 64 NA 0 1449 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2015-1-28 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 800 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA false No M0 N2 T1c Stage IIIA NA A1RI TUMOR FREE NA NA NA NA NA YES YES NA NA YES Solid Tissue Normal 11 NA 7th YES YES NO E9 Breast A LIVING 2011 7391b882-0be5-45b0-aa01-43c3381a476d 7391b882-0be5-45b0-aa01-43c3381a476d NA NA NA TCGA-E9-A1RI-11A-41D-A16A-05 21E8CC9D-962D-4FA5-9814-8134FFA59C51 NA NA NA NA NA NA NA 7391b882-0be5-45b0-aa01-43c3381a476d NA NA NA NA 7391b882-0be5-45b0-aa01-43c3381a476d NA |
|
|
1068 |
TCGA-E9-A226-01 Stage IIIA 45 2 Stage IIIA 16 NA NA FEMALE Negative NA NA NA Negative M0 Positive N2 16 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 1 TCGA-E9-A226-01 1048 1 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 3 TCGA-E9-A226 1048 0 days 1048 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 45 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A226-F39536 TCGA-E9-A226 TCGA-E9-A226-01A NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -16511 48 1048 0 628 NA NA 790 NA NO NA NA NA Scheduled Follow-up Submission 2015-3-2 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 510 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA Bone Distant Metastasis NA NO NO 6 NA true No M0 N2 T2 Stage IIIA TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf A226 WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 2f11f003-9c39-46ba-990f-10d326953f1b 2f11f003-9c39-46ba-990f-10d326953f1b TCGA-E9-A226-01A-11-A17K-20 TCGA-E9-A226-01A-21D-A159-09 TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A161-05 67837600-8189-44bd-af2f-1cb30522bc65 TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A159-09 NA NA TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A159-09 NA 2f11f003-9c39-46ba-990f-10d326953f1b NA TCGA-E9-A226-01A-21D-A160-01 TCGA-E9-A226-01 NA 2f11f003-9c39-46ba-990f-10d326953f1b TCGA-E9-A226-01A-21D-A160-01 |
|
|
1069 |
TCGA-E9-A227-01 Stage IIB 42 2 Stage IIB 24 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 24 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A227-01 975 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation cluster 1 TCGA-E9-A227 975 0 days 975 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-E9-A227-F58571 TCGA-E9-A227 TCGA-E9-A227-01A Negative Positive NA 4+ NA Other Positive Lumpectomy Re-excision of original lumpectomy site NO NA NA -15602 66 NA 0 975 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2014-4-29 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 4+ YES NA Core needle biopsy 180 NO Negative NA YES 17 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T2 Stage IIB TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf A227 TUMOR FREE NA NA NA Two-tier Two-tier NA YES 80-89% NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 2f315234-dee1-4f36-b7dc-72280c219a1c 2f315234-dee1-4f36-b7dc-72280c219a1c TCGA-E9-A227-01A-21-A17K-20 TCGA-E9-A227-01A-11D-A159-09 TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A161-05 ad8672fa-20e1-4624-ac65-10e1d4f057ed TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A159-09 NA NA TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A159-09 NA 2f315234-dee1-4f36-b7dc-72280c219a1c NA TCGA-E9-A227-01A-11D-A160-01 TCGA-E9-A227-01 NA 2f315234-dee1-4f36-b7dc-72280c219a1c TCGA-E9-A227-01A-11D-A160-01 |
|
|
1070 |
TCGA-E9-A228-01 Stage IIB 58 5 Stage IIB 0 NA NA FEMALE Positive NA NA NA Negative M0 Positive N1 0 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A228-01 1285 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 NA mutation c1uster 9 TCGA-E9-A228 1285 0 days 1285 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A228-F65804 TCGA-E9-A228 TCGA-E9-A228-01A NA NA NA NA NA NA NA NA NA NA NA NA -21294 42 NA 0 1285 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-9-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 740 NO NA NA NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf A228 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 5903d969-2fd6-4952-b475-a79e6c241efd 5903d969-2fd6-4952-b475-a79e6c241efd TCGA-E9-A228-01A-41-A17K-20 TCGA-E9-A228-01A-31D-A159-09 TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A161-05 edcb326a-16d2-4ac1-a8da-de4ffcaca34a TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A159-09 NA NA TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A159-09 NA 5903d969-2fd6-4952-b475-a79e6c241efd NA TCGA-E9-A228-01A-31D-A160-01 TCGA-E9-A228-01 NA 5903d969-2fd6-4952-b475-a79e6c241efd TCGA-E9-A228-01A-31D-A160-01 |
|
|
1071 |
TCGA-E9-A229-01 Stage IA 37 5 Stage I 0 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A229-01 1148 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation cluster 4 TCGA-E9-A229 1148 0 days 1148 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 37 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A229-F65803 TCGA-E9-A229 TCGA-E9-A229-01A NA NA NA NA NA NA NA NA NA NA NA NA -13817 56 NA 0 1148 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-9-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 160 NO NA NA NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage IA TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf A229 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 b956a823-b7d5-4a9e-a9d1-c66f0faf544a b956a823-b7d5-4a9e-a9d1-c66f0faf544a TCGA-E9-A229-01A-21-A17K-20 TCGA-E9-A229-01A-31D-A17G-09 TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A161-05 9ff7a9ee-7e6e-4f4d-95f8-d2f6e1e88cc3 TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A17G-09 NA NA TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A17G-09 NA b956a823-b7d5-4a9e-a9d1-c66f0faf544a NA TCGA-E9-A229-01A-31D-A160-01 TCGA-E9-A229-01 NA b956a823-b7d5-4a9e-a9d1-c66f0faf544a TCGA-E9-A229-01A-31D-A160-01 |
|
|
1072 |
TCGA-E9-A22A-01 Stage IIA 74 1 Stage IIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumB NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A22A-01 1189 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 NA mutation c1uster 9 TCGA-E9-A22A 1189 0 days 1189 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22A-F39785 TCGA-E9-A22A TCGA-E9-A22A-01A NA Positive NA NA NA NA Negative NA NA YES NA NA -27288 59 NA 0 1189 NA NA NA NA NO NA 10-19% NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 340 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf A22A TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 TCGA-E9-A22A-01A-21-A17K-20 TCGA-E9-A22A-01A-11D-A159-09 TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A161-05 31514349-7cce-4d67-8dd4-4fb5f7fea530 TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A159-09 NA NA TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A159-09 NA 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 NA TCGA-E9-A22A-01A-11D-A160-01 TCGA-E9-A22A-01 NA 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 TCGA-E9-A22A-01A-11D-A160-01 |
|
|
1073 |
TCGA-E9-A22B-01 Stage IA 71 5 Stage I 0 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 LumA NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A22B-01 1167 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 NA mutation c1uster 9 TCGA-E9-A22B 1167 0 days 1167 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22B-F64425 TCGA-E9-A22B NA NA Positive NA NA NA NA Negative NA NA YES NA NA -26278 NA NA 0 1167 NA NA NA NA NO NA 10-19% NA Scheduled Follow-up Submission 2014-9-2 FEMALE NA NA NA NA NA NA NA NA NA Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No NA C50.9 8522/3 C50.9 NA YES NA Tumor resection NA NA Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T1c Stage IA NA A22B TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 f563bc24-00d1-4637-a073-87744ed7311a f563bc24-00d1-4637-a073-87744ed7311a TCGA-E9-A22B-01A-21-A17K-20 TCGA-E9-A22B-01A-11D-A159-09 TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A161-05 be719b89-4746-465d-9b38-1f32c86a2914 TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A159-09 NA NA TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A159-09 NA f563bc24-00d1-4637-a073-87744ed7311a NA TCGA-E9-A22B-01A-11D-A160-01 TCGA-E9-A22B-01 NA f563bc24-00d1-4637-a073-87744ed7311a TCGA-E9-A22B-01A-11D-A160-01 |
|
|
1074 |
TCGA-E9-A22D-01 Stage IIA 38 5 Stage IIA 0 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A22D-01 1248 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation c1uster 9 TCGA-E9-A22D 1248 0 days 1248 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22D-F39787 TCGA-E9-A22D TCGA-E9-A22D-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -14115 52 NA 0 1248 NA NA NA NA NA NA 10-19% NA Scheduled Follow-up Submission 2013-2-1 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 620 NO Positive NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf A22D TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 1fdac226-ed6b-41a8-9575-67117b4cf035 1fdac226-ed6b-41a8-9575-67117b4cf035 TCGA-E9-A22D-01A-21-A17K-20 TCGA-E9-A22D-01A-11D-A159-09 TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A161-05 4691c2b1-8da2-48b4-9510-badea3a8353f TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A159-09 NA NA TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A159-09 NA 1fdac226-ed6b-41a8-9575-67117b4cf035 NA TCGA-E9-A22D-01A-11D-A160-01 TCGA-E9-A22D-01 NA 1fdac226-ed6b-41a8-9575-67117b4cf035 TCGA-E9-A22D-01A-11D-A160-01 |
|
|
1075 |
TCGA-E9-A22E-01 Stage IIIA 56 1 Stage IIIA 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A22E-01 1269 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 NA mutation c1uster 9 TCGA-E9-A22E 1269 0 days 1269 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22E-F63565 TCGA-E9-A22E TCGA-E9-A22E-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -20574 52 NA 0 1269 NA NA NA NA NO NA 10-19% NA Scheduled Follow-up Submission 2014-8-13 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 620 NO Positive NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 4 0 true No M0 N2 T2 Stage IIIA TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf A22E TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b TCGA-E9-A22E-01A-21-A17K-20 TCGA-E9-A22E-01A-11D-A159-09 TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A161-05 30d1b1ed-e4da-4758-b523-271f2bc19e6c TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A159-09 NA NA TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A159-09 NA e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b NA TCGA-E9-A22E-01A-11D-A160-01 TCGA-E9-A22E-01 NA e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b TCGA-E9-A22E-01A-11D-A160-01 |
|
|
1076 |
TCGA-E9-A22G-01 Stage IIIA 47 1 Stage IIA 0 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 0 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A22G-01 1239 0 days Squamous C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 1 NA mutation cluster 5 TCGA-E9-A22G 1239 0 days 1239 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22G-F62594 TCGA-E9-A22G TCGA-E9-A22G-01A NA Negative NA NA NA NA Negative NA NA YES NA NA -17300 45 NA 0 1239 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-21 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 650 NO Positive NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf A22G TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 88d93dca-ffae-4d57-9a60-346aec436543 88d93dca-ffae-4d57-9a60-346aec436543 TCGA-E9-A22G-01A-21-A17K-20 TCGA-E9-A22G-01A-11D-A159-09 TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A161-05 62d5983b-ccc1-4700-9cb9-e97ff4bb1277 TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A159-09 NA NA TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A159-09 NA 88d93dca-ffae-4d57-9a60-346aec436543 NA TCGA-E9-A22G-01A-11D-A160-01 TCGA-E9-A22G-01 NA 88d93dca-ffae-4d57-9a60-346aec436543 TCGA-E9-A22G-01A-11D-A160-01 |
|
|
1077 |
TCGA-E9-A22H-01 Stage IIB 42 2 Stage IIB 0 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 0 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A22H-01 1232 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation cluster 4 TCGA-E9-A22H 1232 0 days 1232 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 42 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A22H-F63224 TCGA-E9-A22H TCGA-E9-A22H-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -15504 38 NA 0 1232 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2014-8-4 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection 500 NO Positive NA NO 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 NA NA NA NA NA NA NA NA NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf A22H TUMOR FREE NA NA NA NA NA YES YES 10-19% NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 c388d3be-37d9-4377-8c85-f6124b2ad436 c388d3be-37d9-4377-8c85-f6124b2ad436 TCGA-E9-A22H-01A-21-A17K-20 TCGA-E9-A22H-01A-11D-A159-09 TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A161-05 25eba4f9-cda1-4925-8504-5291fd135b5f TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A159-09 NA NA TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A159-09 NA c388d3be-37d9-4377-8c85-f6124b2ad436 NA TCGA-E9-A22H-01A-11D-A160-01 TCGA-E9-A22H-01 NA c388d3be-37d9-4377-8c85-f6124b2ad436 TCGA-E9-A22H-01A-11D-A160-01 |
|
|
1078 |
TCGA-E9-A243-01 Stage IIA 52 3 Stage IIA 43 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 43 0 Basal NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A243-01 612 0 days High C4-BRCA/Basal cluster 5 OV-like c1 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E9-A243 305 1 days 612 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 52 Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A243-F56656 TCGA-E9-A243 TCGA-E9-A243-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA 305 -19035 94 NA 0 612 NA NA 305 NA NO NA NA NA Scheduled Follow-up Submission 2014-2-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 270 NO NA NA YES 10 Negative Peri (6-12 months since last menstrual period) NA Negative NA NA Negative NA NA NA NA NA NA NA NA NA NA NA Negative NA NA 5 3 NA NA NA Bone Distant Metastasis NA NA YES 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf A243 WITH TUMOR NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a TCGA-E9-A243-01A-11-A17K-20 TCGA-E9-A243-01A-21D-A167-09 TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A16A-05 a1b3b8fa-af81-479c-a27b-485bc4557e82 TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A167-09 NA NA TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A167-09 NA 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a NA TCGA-E9-A243-01A-21D-A166-01 TCGA-E9-A243-01 NA 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a TCGA-E9-A243-01A-21D-A166-01 |
|
|
1079 |
TCGA-E9-A244-01 Stage IIA 54 1 Stage IIA 20 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 20 0 Basal NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A244-01 21 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 NA mutation cluster 5 TCGA-E9-A244 21 0 days 21 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A244-F31164 TCGA-E9-A244 TCGA-E9-A244-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -19778 58 NA 0 21 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-4-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 310 NO NA NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf A244 TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 147d6ebb-7359-449a-9e6a-6c8443ebaa2e 147d6ebb-7359-449a-9e6a-6c8443ebaa2e TCGA-E9-A244-01A-21-A17K-20 TCGA-E9-A244-01A-11D-A167-09 TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A16A-05 a6266eec-b341-4642-aed5-9c6cd44f14df TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A167-09 NA NA TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A167-09 NA 147d6ebb-7359-449a-9e6a-6c8443ebaa2e NA TCGA-E9-A244-01A-11D-A166-01 TCGA-E9-A244-01 NA 147d6ebb-7359-449a-9e6a-6c8443ebaa2e TCGA-E9-A244-01A-11D-A166-01 |
|
|
1080 |
TCGA-E9-A245-01 Stage IIB 47 3 Stage IIB 25 NA NA FEMALE Negative NA NA NA Negative M0 Positive N1 25 0 LumA NA NA NA NA NA enrollment T_Other T2 LIVING NA TCGA-E9-A245-01 NA NA days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation c1uster 9 TCGA-E9-A245 NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A245-F31169 TCGA-E9-A245 TCGA-E9-A245-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -17363 62 NA 0 26 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-4-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 490 NO NA NA NA 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO 3 NA true No M0 N1 T2 Stage IIB TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf A245 TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 538ab6dc-6dff-49e2-ae6a-b91ee6619bce 538ab6dc-6dff-49e2-ae6a-b91ee6619bce TCGA-E9-A245-01A-11-A17K-20 TCGA-E9-A245-01A-22D-A16D-09 TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16G-05 7a2a6276-0ac6-40a8-b678-d53877fe07fb TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16D-09 NA NA TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16D-09 NA 538ab6dc-6dff-49e2-ae6a-b91ee6619bce NA TCGA-E9-A245-01A-22D-A16C-01 TCGA-E9-A245-01 NA 538ab6dc-6dff-49e2-ae6a-b91ee6619bce TCGA-E9-A245-01A-22D-A16C-01 |
|
|
1081 |
TCGA-E9-A247-01 Stage IB 59 4 Stage I 12 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 12 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A247-01 1186 0 days High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation c1uster 9 TCGA-E9-A247 1186 0 days 1186 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A247-F61874 TCGA-E9-A247 TCGA-E9-A247-01A NA NA NA NA NA NA NA NA NA NA NA NA -21562 49 NA 0 1186 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-23 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Lumpectomy Other method, specify: 370 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1c Stage IA TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf A247 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 3c38c1fe-9f57-4523-9654-c4bc6b02e84f 3c38c1fe-9f57-4523-9654-c4bc6b02e84f TCGA-E9-A247-01A-21-A17K-20 TCGA-E9-A247-01A-11D-A167-09 TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A16A-05 572eb344-87fb-46f5-9d4b-81756d946892 TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A167-09 NA NA TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A167-09 NA 3c38c1fe-9f57-4523-9654-c4bc6b02e84f NA TCGA-E9-A247-01A-11D-A166-01 TCGA-E9-A247-01 NA 3c38c1fe-9f57-4523-9654-c4bc6b02e84f TCGA-E9-A247-01A-11D-A166-01 |
|
|
1082 |
TCGA-E9-A248-01 Stage IIA 51 4 Stage IIA 21 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 21 0 Her2 NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A248-01 59 0 days Squamous C3-BRCA/Luminal cluster 1 OV-like c1 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-E9-A248 59 0 days 59 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A248-F31211 TCGA-E9-A248 TCGA-E9-A248-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -18684 52 NA 0 59 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-4-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 540 NO NA NA NA 10 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf A248 TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 0a9215ea-d5d2-41ad-a00d-bd7722f41229 0a9215ea-d5d2-41ad-a00d-bd7722f41229 TCGA-E9-A248-01A-21-A17K-20 TCGA-E9-A248-01A-11D-A167-09 TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A16A-05 1b143b9f-74db-42c6-903c-b446834bd9f2 TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A167-09 NA NA TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A167-09 NA 0a9215ea-d5d2-41ad-a00d-bd7722f41229 NA TCGA-E9-A248-01A-11D-A166-01 TCGA-E9-A248-01 NA 0a9215ea-d5d2-41ad-a00d-bd7722f41229 TCGA-E9-A248-01A-11D-A166-01 |
|
|
1083 |
TCGA-E9-A249-01 Stage IIA 45 2 Stage IIA 28 NA NA FEMALE Negative NA NA NA Negative M0 Negative N0 28 0 LumB NA NA NA NA NA enrollment T_Other T2 LIVING 0 TCGA-E9-A249-01 217 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-E9-A249 217 0 days 217 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A249-F49108 TCGA-E9-A249 TCGA-E9-A249-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -16689 59 NA 0 217 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-9-25 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 470 NO NA NA YES 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf A249 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e TCGA-E9-A249-01A-21-A17K-20 TCGA-E9-A249-01A-11D-A167-09 TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A16A-05 8917880a-d278-410b-974b-440741ceb6de TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A167-09 NA NA TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A167-09 NA 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e NA TCGA-E9-A249-01A-11D-A166-01 TCGA-E9-A249-01 NA 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e TCGA-E9-A249-01A-11D-A166-01 |
|
|
1084 |
TCGA-E9-A24A-01 Stage IIA 69 2 Stage IIA 10 NA NA FEMALE Negative NA NA NA Negative M0 Positive N1 10 0 LumA NA NA NA NA NA enrollment T1 T1 LIVING 0 TCGA-E9-A24A-01 747 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E9-A24A 747 0 days 747 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A24A-F39541 TCGA-E9-A24A TCGA-E9-A24A-01A NA NA NA NA NA NA NA NA NA NO NA NA -25370 41 NA 0 747 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2013-1-24 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Lumpectomy Other method, specify: 390 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 1 NA true No M0 N1 T1c Stage IIA TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf A24A TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 a2bec98a-d946-40d2-b4d9-6495d815de9a a2bec98a-d946-40d2-b4d9-6495d815de9a TCGA-E9-A24A-01A-21-A17K-20 TCGA-E9-A24A-01A-11D-A167-09 TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A16A-05 8d96bc5d-6af2-4f5b-82d2-2b8f20848870 TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A167-09 NA NA TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A167-09 NA a2bec98a-d946-40d2-b4d9-6495d815de9a NA TCGA-E9-A24A-01A-11D-A166-01 TCGA-E9-A24A-01 NA a2bec98a-d946-40d2-b4d9-6495d815de9a TCGA-E9-A24A-01A-11D-A166-01 |
|
|
1085 |
TCGA-E9-A295-01 NA NA 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A295-01 375 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA mutation cluster 4 TCGA-E9-A295 375 0 days 375 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A295-F35355 TCGA-E9-A295 TCGA-E9-A295-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -25957 63 NA 0 375 NA NA NA NA NA NA 80-89% NA NA 2012-9-25 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 670 NO Positive NA YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf A295 TUMOR FREE NA NA NA 7 7 YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2011 28ad8481-78a8-4103-b501-5cfd23ae3e81 28ad8481-78a8-4103-b501-5cfd23ae3e81 TCGA-E9-A295-01A-21-A17K-20 TCGA-E9-A295-01A-11D-A16D-09 TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16G-05 21dc7633-3a7e-407d-ae43-88edfef05091 TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16D-09 NA NA TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16D-09 NA 28ad8481-78a8-4103-b501-5cfd23ae3e81 NA TCGA-E9-A295-01A-11D-A16C-01 TCGA-E9-A295-01 NA 28ad8481-78a8-4103-b501-5cfd23ae3e81 TCGA-E9-A295-01A-11D-A16C-01 |
|
|
1086 |
TCGA-E9-A2JS-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 1 TCGA-E9-A2JS-01 904 1 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-E9-A2JS 524 1 days 904 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NA 72 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A2JS-F40293 TCGA-E9-A2JS TCGA-E9-A2JS-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -26407 79 904 0 540 NA NA 524 NA NA NA NA NA Scheduled Follow-up Submission 2013-2-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 420 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis Liver NO YES 1 NA true No M0 N1 T2 Stage IIB TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf A2JS WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A DECEASED 2011 4fe55069-e1b6-4d85-a51a-03a10c6116e2 4fe55069-e1b6-4d85-a51a-03a10c6116e2 TCGA-E9-A2JS-01A-21-A24B-20 NA TCGA-E9-A2JS-01 TCGA-E9-A2JS-01A-11D-A17Z-05 e26e41fb-223b-484b-8463-a20e34844050 TCGA-E9-A2JS-01 TCGA-E9-A2JS-01A-11D-A17W-09 NA NA TCGA-E9-A2JS-01 NA NA 4fe55069-e1b6-4d85-a51a-03a10c6116e2 NA TCGA-E9-A2JS-01A-11D-A17U-01 TCGA-E9-A2JS-01 NA 4fe55069-e1b6-4d85-a51a-03a10c6116e2 TCGA-E9-A2JS-01A-11D-A17U-01 |
|
|
1087 |
TCGA-E9-A2JT-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A2JT-01 288 0 days Kirc+ C3-BRCA/Luminal NA Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-E9-A2JT 288 0 days 288 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A2JT-F40292 TCGA-E9-A2JT TCGA-E9-A2JT-01A NA NA NA NA NA NA NA Lumpectomy NA NO NA NA -23318 94 NA 0 288 NA NA NA NA NA NA NA NA Scheduled Follow-up Submission 2013-2-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 260 NO NA NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf A2JT TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th YES YES NO E9 Breast A LIVING 2011 95b5e301-f942-43bb-8211-d992948e8136 95b5e301-f942-43bb-8211-d992948e8136 TCGA-E9-A2JT-01A-11-A24A-20 NA TCGA-E9-A2JT-01 TCGA-E9-A2JT-01A-22D-A18O-05 013e6c9f-a4fb-4588-9159-562bd6f2721c TCGA-E9-A2JT-01 TCGA-E9-A2JT-01A-22D-A18P-09 NA NA TCGA-E9-A2JT-01 NA NA 95b5e301-f942-43bb-8211-d992948e8136 NA TCGA-E9-A2JT-01A-22D-A18N-01 TCGA-E9-A2JT-01 NA 95b5e301-f942-43bb-8211-d992948e8136 TCGA-E9-A2JT-01A-22D-A18N-01 |
|
|
1088 |
TCGA-E9-A3HO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A3HO-01 1158 0 days Iq C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA NA TCGA-E9-A3HO 1158 0 days 1158 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A3HO-F61875 TCGA-E9-A3HO NA NA NA NA NA NA NA NA Modified Radical Mastectomy NA NO NA NA -18046 NA NA 0 1158 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2014-7-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) NA NA NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No M0 N0 (i-) T2 Stage IIA NA A3HO TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th YES YES NO E9 Breast NA LIVING 2011 d151b46a-1e20-455a-bab3-9c698cee312d d151b46a-1e20-455a-bab3-9c698cee312d TCGA-E9-A3HO-01A-21-A24A-20 NA TCGA-E9-A3HO-01 TCGA-E9-A3HO-01A-11D-A212-05 c6f8e3fb-8702-4064-b325-1f85c2d9815b TCGA-E9-A3HO-01 TCGA-E9-A3HO-01A-11D-A20S-09 NA NA NA NA NA d151b46a-1e20-455a-bab3-9c698cee312d NA TCGA-E9-A3HO-01A-11D-A20R-01 NA NA d151b46a-1e20-455a-bab3-9c698cee312d TCGA-E9-A3HO-01A-11D-A20R-01 |
|
|
1089 |
TCGA-E9-A3Q9-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A3Q9-01 1001 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA NA TCGA-E9-A3Q9 1001 0 days 1001 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 78 Right Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A3Q9-F59741 TCGA-E9-A3Q9 TCGA-E9-A3Q9-01A NA Positive NA NA NA NA Positive NA NA YES NA NA -28715 198 NA 0 1001 NA NA NA NA NO NA 40-49% NA NA 2014-5-20 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 580 NO Indeterminate NA NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 22 0 true No M0 N3 T3 Stage IIIC TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf A3Q9 TUMOR FREE NA NA NA 8 8 YES YES 40-49% NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2011 941748e8-5690-4e98-a5f4-d79b0e033ba1 941748e8-5690-4e98-a5f4-d79b0e033ba1 TCGA-E9-A3Q9-01A-21-A24A-20 NA TCGA-E9-A3Q9-01 TCGA-E9-A3Q9-01A-11D-A21R-05 acbb7029-4851-48e2-8517-9c69b0f9aaf4 TCGA-E9-A3Q9-01 TCGA-E9-A3Q9-01A-11D-A21Q-09 NA NA TCGA-E9-A3Q9-01 NA NA 941748e8-5690-4e98-a5f4-d79b0e033ba1 NA TCGA-E9-A3Q9-01A-11D-A21P-01 TCGA-E9-A3Q9-01 NA 941748e8-5690-4e98-a5f4-d79b0e033ba1 TCGA-E9-A3Q9-01A-11D-A21P-01 |
|
|
1090 |
TCGA-E9-A3QA-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A3QA-01 918 0 days High NA NA Low purity c2 BRCA basal-like c6 NA miRNA cluster 4 NA NA TCGA-E9-A3QA 918 0 days 918 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 33 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-E9-A3QA-F66100 TCGA-E9-A3QA TCGA-E9-A3QA-01A NA NA NA NA NA NA NA NA NA NA NA NA -12142 282 NA 0 918 NA NA NA NA NO NA NA NA NA 2014-10-2 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Tumor resection 750 NO NA NA NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf A3QA TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2011 8a7e272c-39f2-42e6-b1d5-7225cf12fceb 8a7e272c-39f2-42e6-b1d5-7225cf12fceb TCGA-E9-A3QA-01A-71-A24A-20 NA TCGA-E9-A3QA-01 TCGA-E9-A3QA-01A-61D-A22B-05 ed7f6269-7805-4032-870a-0f105960bfbc TCGA-E9-A3QA-01 TCGA-E9-A3QA-01A-61D-A228-09 NA NA TCGA-E9-A3QA-01 NA NA 8a7e272c-39f2-42e6-b1d5-7225cf12fceb NA TCGA-E9-A3QA-01A-61D-A227-01 TCGA-E9-A3QA-01 NA 8a7e272c-39f2-42e6-b1d5-7225cf12fceb TCGA-E9-A3QA-01A-61D-A227-01 |
|
|
1091 |
TCGA-E9-A3X8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A3X8-01 926 0 days NA NA NA NA BRCA nonbasal-like c8 NA NA NA NA TCGA-E9-A3X8 926 0 days 926 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A3X8-F59742 TCGA-E9-A3X8 TCGA-E9-A3X8-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -17588 233 NA 0 926 NA NA NA NA NO NA 20-29% NA NA 2014-5-20 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 260 NO Positive NA NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 4 0 true No M0 N1 T2 Stage IIB TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf A3X8 TUMOR FREE NA NA NA 8 8 YES YES 20-29% NA YES Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2011 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 TCGA-E9-A3X8-01A-21-A24A-20 NA TCGA-E9-A3X8-01 TCGA-E9-A3X8-01A-31D-A230-05 1ba9391b-4d20-4637-8c2a-6765cd37beb4 TCGA-E9-A3X8-01 TCGA-E9-A3X8-01A-31D-A22X-09 NA NA TCGA-E9-A3X8-01 NA NA b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 NA TCGA-E9-A3X8-01A-31D-A22W-01 TCGA-E9-A3X8-01 NA b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 TCGA-E9-A3X8-01A-31D-A22W-01 |
|
|
1092 |
TCGA-E9-A54X-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A54X-01 727 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A54X 727 0 days 727 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 85 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A54X-F66449 TCGA-E9-A54X TCGA-E9-A54X-01A NA Positive NA 3+ NA NA Positive Lumpectomy NA NO NA NA -31173 78 NA 0 727 NA NA NA NA NA NA 90-99% NA NA 2014-10-15 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 3+ YES NA Core needle biopsy 220 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 (i-) T1b Stage IA TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf A54X TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2012 fc36b662-fabd-4caa-81f7-00fe0a3164a6 fc36b662-fabd-4caa-81f7-00fe0a3164a6 NA NA TCGA-E9-A54X-01 TCGA-E9-A54X-01A-11D-A268-05 4168faaa-8df8-48b5-a9cb-86932b2a0ffe TCGA-E9-A54X-01 TCGA-E9-A54X-01A-11D-A25Q-09 NA NA TCGA-E9-A54X-01 NA NA fc36b662-fabd-4caa-81f7-00fe0a3164a6 NA TCGA-E9-A54X-01A-11D-A25N-01 TCGA-E9-A54X-01 NA fc36b662-fabd-4caa-81f7-00fe0a3164a6 TCGA-E9-A54X-01A-11D-A25N-01 |
|
|
1093 |
TCGA-E9-A54Y-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A54Y-01 725 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A54Y 725 0 days 725 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Axillary lymph node dissection alone NA TCGA-E9-A54Y-F66450 TCGA-E9-A54Y TCGA-E9-A54Y-01A NA Positive NA 3+ NA NA Positive Modified Radical Mastectomy NA NO NA NA -23057 76 NA 0 725 NA NA NA NA NA NA 90-99% NA NA 2014-10-15 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Fine needle aspiration biopsy 370 NO Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 8 NA true No M0 N2 T2 Stage IIIA TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf A54Y TUMOR FREE NA NA NA NA NA NO YES 50-59% NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2012 c11ffcd0-8e82-4815-b30b-2d08945ce0bc c11ffcd0-8e82-4815-b30b-2d08945ce0bc NA NA TCGA-E9-A54Y-01 TCGA-E9-A54Y-01A-11D-A268-05 190643c9-d8a9-4e20-ac54-de58928ddfaf TCGA-E9-A54Y-01 TCGA-E9-A54Y-01A-11D-A25Q-09 NA NA TCGA-E9-A54Y-01 NA NA c11ffcd0-8e82-4815-b30b-2d08945ce0bc NA TCGA-E9-A54Y-01A-11D-A25N-01 TCGA-E9-A54Y-01 NA c11ffcd0-8e82-4815-b30b-2d08945ce0bc TCGA-E9-A54Y-01A-11D-A25N-01 |
|
|
1094 |
TCGA-E9-A5FK-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A5FK-01 812 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A5FK 812 0 days 812 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A5FK-F70209 TCGA-E9-A5FK TCGA-E9-A5FK-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -22199 77 NA 0 812 NA NA NA NA NA NA 80-89% NA NA 2015-1-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Cytology (e.g. Peritoneal or pleural fluid) 490 NO Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 10 NA true No M0 N3 T2 Stage IIIC TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf A5FK TUMOR FREE NA NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2012 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 NA NA TCGA-E9-A5FK-01 TCGA-E9-A5FK-01A-11D-A27Y-05 4dc0a26f-8214-4458-a74d-309dcd10c6a1 TCGA-E9-A5FK-01 TCGA-E9-A5FK-01A-11D-A27P-09 NA NA TCGA-E9-A5FK-01 NA NA 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 NA TCGA-E9-A5FK-01A-11D-A27O-01 TCGA-E9-A5FK-01 NA 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 TCGA-E9-A5FK-01A-11D-A27O-01 |
|
|
1095 |
TCGA-E9-A5FL-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A5FL-01 24 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A5FL 24 0 days 24 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A5FL-F56061 TCGA-E9-A5FL TCGA-E9-A5FL-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA NO NA NA -24053 73 NA 0 24 NA NA NA NA NA NA NA NA NA 2014-1-24 FEMALE NA NA NA NA NA NA NA NA NA Metaplastic Carcinoma NA No NA C50.9 8575/3 C50.9 NA YES NA Cytology (e.g. Peritoneal or pleural fluid) 590 NO Negative NA YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T3 Stage IIB TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf A5FL TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2012 7810122d-fa8b-483d-9398-aa26fc7fedc5 7810122d-fa8b-483d-9398-aa26fc7fedc5 NA NA TCGA-E9-A5FL-01 TCGA-E9-A5FL-01A-11D-A27Y-05 dca0a85a-e2c5-4dcf-bc19-4b0374669de4 TCGA-E9-A5FL-01 TCGA-E9-A5FL-01A-11D-A27P-09 NA NA TCGA-E9-A5FL-01 NA NA 7810122d-fa8b-483d-9398-aa26fc7fedc5 NA TCGA-E9-A5FL-01A-11D-A27O-01 TCGA-E9-A5FL-01 NA 7810122d-fa8b-483d-9398-aa26fc7fedc5 TCGA-E9-A5FL-01A-11D-A27O-01 |
|
|
1096 |
TCGA-E9-A5UO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A5UO-01 785 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A5UO 785 0 days 785 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A5UO-F70210 TCGA-E9-A5UO TCGA-E9-A5UO-01A NA NA NA NA NA NA NA Other NA NO NA NA -15050 98 NA 0 785 NA NA NA NA NA NA NA NA NA 2015-1-30 FEMALE NA NA NA NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Fine needle aspiration biopsy 400 NO NA NA NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf A5UO TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 Partial mastectomy 7th NA YES NO E9 Breast A LIVING 2012 4d601c2f-824f-461e-9270-42db0ab9138e 4d601c2f-824f-461e-9270-42db0ab9138e NA NA TCGA-E9-A5UO-01 TCGA-E9-A5UO-01A-11D-A28C-05 9efb2dc7-5c0d-459f-9819-f1ca46df5bb0 TCGA-E9-A5UO-01 TCGA-E9-A5UO-01A-11D-A28B-09 NA NA TCGA-E9-A5UO-01 NA NA 4d601c2f-824f-461e-9270-42db0ab9138e NA TCGA-E9-A5UO-01A-11D-A28A-01 TCGA-E9-A5UO-01 NA 4d601c2f-824f-461e-9270-42db0ab9138e TCGA-E9-A5UO-01A-11D-A28A-01 |
|
|
1097 |
TCGA-E9-A5UP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A5UP-01 803 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A5UP 803 0 days 803 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-E9-A5UP-F71525 TCGA-E9-A5UP TCGA-E9-A5UP-01A NA NA NA NA NA NA NA NA NA NO NA NA -23371 85 NA 0 803 NA NA NA NA NA NA NA NA NA 2015-3-26 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8503/3 C50.9 NA YES NA Tumor resection 140 NO NA NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf A5UP TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO E9 Breast A LIVING 2012 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 NA NA TCGA-E9-A5UP-01 TCGA-E9-A5UP-01A-11D-A28C-05 7ba6fce9-3ad3-4659-9756-a6642af820e1 TCGA-E9-A5UP-01 TCGA-E9-A5UP-01A-11D-A28B-09 NA NA TCGA-E9-A5UP-01 NA NA 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 NA TCGA-E9-A5UP-01A-11D-A28A-01 TCGA-E9-A5UP-01 NA 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 TCGA-E9-A5UP-01A-11D-A28A-01 |
|
|
1098 |
TCGA-E9-A6HE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-E9-A6HE-01 847 0 days NA NA NA NA NA NA NA NA NA TCGA-E9-A6HE 847 0 days 847 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 45 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-E9-A6HE-F70947 TCGA-E9-A6HE NA NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -16697 NA NA 0 847 NA NA NA NA NA NA 90-99% 1.7 NA 2015-3-10 FEMALE NA NA <10% NA 1+ 30 1.8 1.08 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 12 NA NA No MX N3 T3 Stage IIIC NA A6HE TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO E9 Breast NA LIVING 2012 ce48b228-7e2a-46e9-beca-ab990b5c2b3e ce48b228-7e2a-46e9-beca-ab990b5c2b3e NA NA TCGA-E9-A6HE-01 TCGA-E9-A6HE-01A-11D-A31V-05 a828df39-aa87-48a0-936a-7fd28c031dcf TCGA-E9-A6HE-01 NA NA NA TCGA-E9-A6HE-01 NA NA ce48b228-7e2a-46e9-beca-ab990b5c2b3e NA TCGA-E9-A6HE-01A-11D-A31T-01 TCGA-E9-A6HE-01 NA ce48b228-7e2a-46e9-beca-ab990b5c2b3e TCGA-E9-A6HE-01A-11D-A31T-01 |
|
|
1099 |
TCGA-EW-A1IW-01 Stage IIB 80 2 Stage IIB 252 NA Positive FEMALE Positive NA NA NA Negative M0 Positive N1 252 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1IW-01 371 0 days Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-EW-A1IW 371 0 days 371 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Lower Inner Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1IW-F21380 TCGA-EW-A1IW TCGA-EW-A1IW-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -29529 213 NA 0 371 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA + or - 90-99% NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 90 NO Positive NA NA 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 4 NA NA NA NA NA NA NA NO 2 0 true No MX N1a T2 Stage IIB TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf A1IW TUMOR FREE NA CISH NA NA NA NA YES 90-99% NA NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 NA TCGA-EW-A1IW-01A-11D-A13L-09 TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13K-05 NA TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13L-09 NA NA TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13L-09 NA 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 NA TCGA-EW-A1IW-01A-11D-A13J-01 TCGA-EW-A1IW-01 NA 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 TCGA-EW-A1IW-01A-11D-A13J-01 |
|
|
1100 |
TCGA-EW-A1IX-01 Stage IIA 48 4 Stage IIA 1082 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1082 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1IX-01 1208 0 days Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-EW-A1IX 1208 0 days 1208 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1IX-F21542 TCGA-EW-A1IX TCGA-EW-A1IX-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -17597 1030 NA 0 1208 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA <10% NA NA NA NA NA NA Other, specify NA No NA C50.9 8524/3 C50.9 3+ YES NA Core needle biopsy 130 NO Negative NA NA 27 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 1 1 true No MX N1a T1b Stage IIA TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf A1IX TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 total mastectomy 6th YES NO YES EW Breast A LIVING 2008 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 TCGA-EW-A1IX-01A-21-A17J-20 TCGA-EW-A1IX-01A-12D-A142-09 TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A145-05 9b8d5601-180a-45df-a639-787f257c2e95 TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A142-09 NA NA TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A142-09 NA b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 NA TCGA-EW-A1IX-01A-12D-A141-01 TCGA-EW-A1IX-01 NA b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 TCGA-EW-A1IX-01A-12D-A141-01 |
|
|
1101 |
TCGA-EW-A1IY-01 Stage I 38 2 Stage I 258 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 258 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1IY-01 258 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 4 TCGA-EW-A1IY 258 0 days 258 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Right Upper Inner Quadrant Other (specify) sentinel LN and one non sentinel LN TCGA-EW-A1IY-F29084 TCGA-EW-A1IY TCGA-EW-A1IY-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -14122 590 NA 0 258 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-5 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 50 NO Negative NA NA 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 7 NA NA NA NA NA NA NA NO 0 0 true No MX N0 T1c Stage I TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf A1IY TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 NA TCGA-EW-A1IY-01A-11D-A188-09 TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A13K-05 NA TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A188-09 NA NA TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A188-09 NA 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 NA TCGA-EW-A1IY-01A-11D-A13J-01 TCGA-EW-A1IY-01 NA 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 TCGA-EW-A1IY-01A-11D-A13J-01 |
|
|
1102 |
TCGA-EW-A1IZ-01 Stage IIIA 53 1 Stage IIIA 260 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N2 260 0 NA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1IZ-01 554 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 NA miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-EW-A1IZ 554 0 days 554 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A1IZ-F21543 TCGA-EW-A1IZ TCGA-EW-A1IZ-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -19706 194 NA 0 554 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES stereotactic biopsy Other method, specify: 130 NO Negative NA NA 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 3 NA NA NA NA NA NA NA NO 5 NA true No MX N2a T2 Stage IIIA TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf A1IZ TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 f5c72291-4c3f-456f-97a3-d93878744b54 f5c72291-4c3f-456f-97a3-d93878744b54 TCGA-EW-A1IZ-01A-21-A17J-20 TCGA-EW-A1IZ-01A-11D-A188-09 TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A13K-05 401f0a1d-c38e-463b-8195-8eba9ea21869 TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A188-09 NA NA TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A188-09 NA f5c72291-4c3f-456f-97a3-d93878744b54 NA TCGA-EW-A1IZ-01A-11D-A13J-01 TCGA-EW-A1IZ-01 NA f5c72291-4c3f-456f-97a3-d93878744b54 TCGA-EW-A1IZ-01A-11D-A13J-01 |
|
|
1103 |
TCGA-EW-A1J1-01 Stage IIB 38 2 Stage IIB 282 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 282 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1J1-01 575 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-EW-A1J1 575 0 days 575 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 38 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1J1-F21181 TCGA-EW-A1J1 TCGA-EW-A1J1-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -14122 214 NA 0 575 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-3 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 170 NO Negative NA NA 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 5 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T2 Stage IIB TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf A1J1 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 TCGA-EW-A1J1-01A-21-A17J-20 TCGA-EW-A1J1-01A-11D-A188-09 TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A13K-05 e87551f0-94b3-418c-b313-7cea4e66f70d TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A188-09 NA NA TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A188-09 NA 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 NA TCGA-EW-A1J1-01A-11D-A13J-01 TCGA-EW-A1J1-01 NA 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 TCGA-EW-A1J1-01A-11D-A13J-01 |
|
|
1104 |
TCGA-EW-A1J2-01 Stage IIB 50 2 Stage IIA 139 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 139 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1J2-01 403 0 days Iq C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-EW-A1J2 403 0 days 403 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1J2-F21544 TCGA-EW-A1J2 TCGA-EW-A1J2-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -18558 51 NA 0 403 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 110 NO Negative NA NA 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 6 NA NA NA NA NA NA NA NO 1 1 true No MX N1mi T1c [Discrepancy] TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf A1J2 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 5a6b6013-11d0-498d-a014-3ea8e14c61d5 5a6b6013-11d0-498d-a014-3ea8e14c61d5 TCGA-EW-A1J2-01A-11-A17J-20 TCGA-EW-A1J2-01A-21D-A13L-09 TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13K-05 ff844a9f-6c79-4252-bbb3-b5bbf5c3cf6f TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13L-09 NA NA TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13L-09 NA 5a6b6013-11d0-498d-a014-3ea8e14c61d5 NA TCGA-EW-A1J2-01A-21D-A13J-01 TCGA-EW-A1J2-01 NA 5a6b6013-11d0-498d-a014-3ea8e14c61d5 TCGA-EW-A1J2-01A-21D-A13J-01 |
|
|
1105 |
TCGA-EW-A1J3-01 Stage IA 61 2 Stage I 252 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 252 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1J3-01 504 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1J3 504 0 days 504 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1J3-F21351 TCGA-EW-A1J3 TCGA-EW-A1J3-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -22332 155 NA 0 504 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 80 NO Positive NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T1c Stage IA TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf A1J3 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 TOTAL MASTECTOMY 7th YES NO YES EW Breast A LIVING 2010 6e757a91-de03-4c2d-9088-22235e4b745a 6e757a91-de03-4c2d-9088-22235e4b745a TCGA-EW-A1J3-01A-21-A17J-20 TCGA-EW-A1J3-01A-11D-A13L-09 TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13K-05 01473e37-dbc5-42f9-b5e1-332a9b47c175 TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13L-09 NA NA TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13L-09 NA 6e757a91-de03-4c2d-9088-22235e4b745a NA TCGA-EW-A1J3-01A-11D-A13J-01 TCGA-EW-A1J3-01 NA 6e757a91-de03-4c2d-9088-22235e4b745a TCGA-EW-A1J3-01A-11D-A13J-01 |
|
|
1106 |
TCGA-EW-A1J5-01 Stage IIB 59 5 Stage IIB 227 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 227 0 LumA NA Positive NA NA NA enrollment T_Other T3 LIVING 0 TCGA-EW-A1J5-01 477 0 days Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-EW-A1J5 477 0 days 477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Sentinel node biopsy alone NA TCGA-EW-A1J5-F21353 TCGA-EW-A1J5 TCGA-EW-A1J5-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -21559 123 NA 0 477 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 180 NO Negative NA NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 7 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T3 Stage IIB TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf A1J5 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 b1c4af00-f395-47ac-93c7-b32a293ca060 b1c4af00-f395-47ac-93c7-b32a293ca060 TCGA-EW-A1J5-01A-21-A17J-20 TCGA-EW-A1J5-01A-11D-A13L-09 TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13K-05 7470a7db-5af2-4e9e-92f6-d9f8ca74e15d TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13L-09 NA NA TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13L-09 NA b1c4af00-f395-47ac-93c7-b32a293ca060 NA TCGA-EW-A1J5-01A-11D-A13J-01 TCGA-EW-A1J5-01 NA b1c4af00-f395-47ac-93c7-b32a293ca060 TCGA-EW-A1J5-01A-11D-A13J-01 |
|
|
1107 |
TCGA-EW-A1J6-01 Stage I 70 4 Stage I 595 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 595 0 LumB NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1J6-01 875 0 days High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1J6 875 0 days 875 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-EW-A1J6-F21347 TCGA-EW-A1J6 TCGA-EW-A1J6-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -25830 528 NA 0 875 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-2-6 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 80 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf A1J6 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 7051836f-e1d4-49dd-8118-4541c0bdde57 7051836f-e1d4-49dd-8118-4541c0bdde57 NA TCGA-EW-A1J6-01A-11D-A188-09 TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A13K-05 NA TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A188-09 NA NA TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A188-09 NA 7051836f-e1d4-49dd-8118-4541c0bdde57 NA TCGA-EW-A1J6-01A-11D-A13J-01 TCGA-EW-A1J6-01 NA 7051836f-e1d4-49dd-8118-4541c0bdde57 TCGA-EW-A1J6-01A-11D-A13J-01 |
|
|
1108 |
TCGA-EW-A1OV-01 Stage IIB 56 1 Stage IIB 522 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 522 0 Her2 NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1OV-01 789 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-EW-A1OV 789 0 days 789 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1OV-F29119 TCGA-EW-A1OV NA Negative Negative 3 Point Scale NA 3 Point Scale Modified radical mastectomy Negative Lumpectomy NA YES NA NA -20764 NA NA 0 789 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA 1.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Negative NA 6 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 5 NA NA NA NA NA NA NA NO 0 1 NA No MX N1mi T2 Stage IIB NA A1OV TUMOR FREE NA NA NA NA NA NA YES <10% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast NA LIVING 2009 b21367b5-91a3-4546-ba89-e33c462cb75b b21367b5-91a3-4546-ba89-e33c462cb75b TCGA-EW-A1OV-01A-21-A17J-20 TCGA-EW-A1OV-01A-11D-A142-09 TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A145-05 c9e8a21c-2cd8-404b-a8dc-7958940df71a TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A142-09 NA NA TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A142-09 NA b21367b5-91a3-4546-ba89-e33c462cb75b NA TCGA-EW-A1OV-01A-11D-A141-01 TCGA-EW-A1OV-01 NA b21367b5-91a3-4546-ba89-e33c462cb75b TCGA-EW-A1OV-01A-11D-A141-01 |
|
|
1109 |
TCGA-EW-A1OW-01 Stage IIA 58 1 Stage IIA 463 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 463 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1OW-01 694 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 NA NA NA TCGA-EW-A1OW 694 0 days 694 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1OW-F29117 TCGA-EW-A1OW TCGA-EW-A1OW-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA NA -21465 444 NA 0 694 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8090/3 C50.9 NA YES NA Core needle biopsy 100 NO Negative NA NA 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 NA NA NA NA NA NA NA NA NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf A1OW TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 21cc5775-0987-4088-b19c-86bf43f09bb2 21cc5775-0987-4088-b19c-86bf43f09bb2 TCGA-EW-A1OW-01A-11-A17J-20 NA TCGA-EW-A1OW-01 TCGA-EW-A1OW-01A-21D-A145-05 a4d72446-5d9b-4b8d-af59-9add055da84e TCGA-EW-A1OW-01 NA NA NA TCGA-EW-A1OW-01 NA NA 21cc5775-0987-4088-b19c-86bf43f09bb2 NA TCGA-EW-A1OW-01A-21D-A141-01 TCGA-EW-A1OW-01 NA 21cc5775-0987-4088-b19c-86bf43f09bb2 TCGA-EW-A1OW-01A-21D-A141-01 |
|
|
1110 |
TCGA-EW-A1OX-01 Stage IIA 43 3 Stage IIA 562 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 562 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1OX-01 911 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-EW-A1OX 911 0 days 911 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Upper Inner Quadrant Other (specify) sentinel + non sentinel TCGA-EW-A1OX-F29099 TCGA-EW-A1OX TCGA-EW-A1OX-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -15837 550 NA 0 911 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Mucinous Carcinoma NA No NA C50.9 8523/3 C50.9 3+ YES NA Core needle biopsy 140 NO Negative NA NA 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 1 NA NA NA NA NA NA NA NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf A1OX TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 9b5d680e-5662-442c-a8ab-5fd16551b23e 9b5d680e-5662-442c-a8ab-5fd16551b23e TCGA-EW-A1OX-01A-21-A17J-20 TCGA-EW-A1OX-01A-11D-A142-09 TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A145-05 7cf0f94c-e8fc-4237-8cbf-164c073c26b0 TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A142-09 NA NA TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A142-09 NA 9b5d680e-5662-442c-a8ab-5fd16551b23e NA TCGA-EW-A1OX-01A-11D-A141-01 TCGA-EW-A1OX-01 NA 9b5d680e-5662-442c-a8ab-5fd16551b23e TCGA-EW-A1OX-01A-11D-A141-01 |
|
|
1111 |
TCGA-EW-A1OY-01 Stage IIA 63 5 Stage IIA 593 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 593 0 LumB NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1OY-01 908 0 days Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-EW-A1OY 908 0 days 908 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Sentinel node biopsy alone NA TCGA-EW-A1OY-F30950 TCGA-EW-A1OY TCGA-EW-A1OY-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -23266 526 NA 0 908 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-23 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 100 NO Negative Negative NA 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf A1OY TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 0c3f0857-32d7-4ef6-b303-6e452ee04516 0c3f0857-32d7-4ef6-b303-6e452ee04516 TCGA-EW-A1OY-01A-21-A17J-20 TCGA-EW-A1OY-01A-11D-A142-09 TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A145-05 5355fa5f-6aba-4f01-9799-7f1a83eadc2a TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A142-09 NA NA TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A142-09 NA 0c3f0857-32d7-4ef6-b303-6e452ee04516 NA TCGA-EW-A1OY-01A-11D-A141-01 TCGA-EW-A1OY-01 NA 0c3f0857-32d7-4ef6-b303-6e452ee04516 TCGA-EW-A1OY-01A-11D-A141-01 |
|
|
1112 |
TCGA-EW-A1OZ-01 Stage IIA 56 5 Stage IIA 941 NA Positive FEMALE Positive NA NA NA Negative M0 Negative N0 941 0 LumB NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1OZ-01 1229 0 days High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-EW-A1OZ 1229 0 days 1229 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1OZ-F29098 TCGA-EW-A1OZ TCGA-EW-A1OZ-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Other NA YES NA NA -20664 928 NA 0 1229 NA NA NA NA NO NA 90-99% 2 Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA 20-29% NA 2+ 40 NA 2.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 210 NO Equivocal Positive NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 4 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf A1OZ TUMOR FREE NA NA NA NA NA NA YES <10% NA NO Primary Tumor 01 total mastectomy 6th YES NO YES EW Breast A LIVING 2008 73f6a579-eab4-4fbf-bb17-41f1a6614ace 73f6a579-eab4-4fbf-bb17-41f1a6614ace TCGA-EW-A1OZ-01A-21-A17J-20 TCGA-EW-A1OZ-01A-11D-A142-09 TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A145-05 ec87ecc1-dbdd-478f-aea6-a982f92222e8 TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A142-09 NA NA TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A142-09 NA 73f6a579-eab4-4fbf-bb17-41f1a6614ace NA TCGA-EW-A1OZ-01A-11D-A141-01 TCGA-EW-A1OZ-01 NA 73f6a579-eab4-4fbf-bb17-41f1a6614ace TCGA-EW-A1OZ-01A-11D-A141-01 |
|
|
1113 |
TCGA-EW-A1P0-01 Stage IIB 55 4 Stage IIB 1121 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 1121 0 LumB NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P0-01 1251 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-EW-A1P0 1094 1 days 1251 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 55 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A1P0-F29105 TCGA-EW-A1P0 TCGA-EW-A1P0-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Modified Radical Mastectomy NA NO NA 1105 -20107 1142 NA 0 1251 NA NA 1094 NA YES NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Other, specify NA No NA C50.9 8523/3 C50.9 3+ YES NA Core needle biopsy 190 NO Negative NA NA 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative 1+ NA Positive 90-99% NA <10% NA NA 3+ 1+ NA NA <10% NA Negative NA NA 5 7 NA NA NA Other, specify Distant Metastasis mediastinal lymph node NA YES 1 NA true No MX N1b T2 Stage IIB TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf A1P0 TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2008 16fcbaec-f629-4d04-ab61-3f9b782e710d 16fcbaec-f629-4d04-ab61-3f9b782e710d TCGA-EW-A1P0-01A-21-A17J-20 TCGA-EW-A1P0-01A-11D-A142-09 TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A145-05 d39ecd5c-5a18-46dc-b6e6-356c239d7ec3 TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A142-09 NA NA TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A142-09 NA 16fcbaec-f629-4d04-ab61-3f9b782e710d NA TCGA-EW-A1P0-01A-11D-A141-01 TCGA-EW-A1P0-01 NA 16fcbaec-f629-4d04-ab61-3f9b782e710d TCGA-EW-A1P0-01A-11D-A141-01 |
|
|
1114 |
TCGA-EW-A1P1-01 Stage IIIC 68 1 Stage IIIC 919 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N3 919 0 NA NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P1-01 1210 0 days Kirc+ C5-KIRC cluster 1 Low purity c2 KIRC-like c1 NA miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-EW-A1P1 1014 1 days 1210 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES NA 68 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1P1-F29115 TCGA-EW-A1P1 TCGA-EW-A1P1-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA 1200 -24923 850 NA 0 1210 NA NA 1014 NA YES NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA 2+ NA NA 1.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Equivocal Negative NA 32 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Equivocal 1+ NA Negative <10% NA <10% NA NA NA NA NA NA <10% NA Negative Lung NA 1 6 NA NA NA Lung Distant Metastasis NA NA YES 11 NA true No MX N3b T2 Stage IIIC TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf A1P1 TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2008 8a430d45-6511-4900-954e-fd01106d0f22 8a430d45-6511-4900-954e-fd01106d0f22 TCGA-EW-A1P1-01A-21-A17J-20 TCGA-EW-A1P1-01A-31D-A14G-09 TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14H-05 3d649ce7-95df-442d-a4bb-88e71c4f5b10 TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14G-09 NA NA TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14G-09 NA 8a430d45-6511-4900-954e-fd01106d0f22 NA TCGA-EW-A1P1-01A-31D-A14F-01 TCGA-EW-A1P1-01 NA 8a430d45-6511-4900-954e-fd01106d0f22 TCGA-EW-A1P1-01A-31D-A14F-01 |
|
|
1115 |
TCGA-EW-A1P3-01 Stage IIA 48 2 Stage IIA 987 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 987 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P3-01 1611 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-EW-A1P3 1611 0 days 1611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Lower Outer Quadrant Other (specify) SN+1 non sentinel node TCGA-EW-A1P3-F41142 TCGA-EW-A1P3 TCGA-EW-A1P3-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -17637 919 NA 0 1611 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2013-3-12 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 150 NO Negative NA NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 true Yes MX N0 T2 Stage IIA TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf A1P3 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2008 43c8eaea-f686-4e28-ba9c-360fea61b3ca 43c8eaea-f686-4e28-ba9c-360fea61b3ca TCGA-EW-A1P3-01A-21-A17J-20 TCGA-EW-A1P3-01A-11D-A142-09 TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A145-05 d1b203a1-19d6-4504-a925-2cf22b888095 TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A142-09 NA NA TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A142-09 NA 43c8eaea-f686-4e28-ba9c-360fea61b3ca NA TCGA-EW-A1P3-01A-11D-A141-01 TCGA-EW-A1P3-01 NA 43c8eaea-f686-4e28-ba9c-360fea61b3ca TCGA-EW-A1P3-01A-11D-A141-01 |
|
|
1116 |
TCGA-EW-A1P4-01 Stage IIA 43 1 Stage IIA 501 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 501 0 Basal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P4-01 907 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-EW-A1P4 907 0 days 907 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1P4-F29684 TCGA-EW-A1P4 TCGA-EW-A1P4-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Simple Mastectomy NA YES NA NA -15989 525 NA 0 907 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA <10% NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Core needle biopsy 290 NO Negative NA NA 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf A1P4 TUMOR FREE NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2009 91a5b906-6a04-4f0d-8710-172311e84789 91a5b906-6a04-4f0d-8710-172311e84789 TCGA-EW-A1P4-01A-11-A17J-20 TCGA-EW-A1P4-01A-21D-A142-09 TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A145-05 b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A142-09 NA NA TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A142-09 NA 91a5b906-6a04-4f0d-8710-172311e84789 NA TCGA-EW-A1P4-01A-21D-A141-01 TCGA-EW-A1P4-01 NA 91a5b906-6a04-4f0d-8710-172311e84789 TCGA-EW-A1P4-01A-21D-A141-01 |
|
|
1117 |
TCGA-EW-A1P5-01 Stage IIB 77 3 Stage IIB 365 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 365 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P5-01 703 0 days High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 3 mutation cluster 4 TCGA-EW-A1P5 703 0 days 703 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1P5-F32249 TCGA-EW-A1P5 NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -28177 NA NA 0 703 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-5-15 FEMALE NA NA <10% NA NA NA NA 1.12 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative Negative NA 40 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 3 NA NA NA NA NA NA NA NO 3 0 NA No M0 N1a T2 Stage IIB NA A1P5 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast NA LIVING 2010 e9d4f9c8-7355-44c4-9b18-923db7bae832 e9d4f9c8-7355-44c4-9b18-923db7bae832 TCGA-EW-A1P5-01A-21-A17J-20 TCGA-EW-A1P5-01A-11D-A142-09 TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A145-05 ef44d5ee-0e6f-4ec3-8db0-b0c426708430 TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A142-09 NA NA TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A142-09 NA e9d4f9c8-7355-44c4-9b18-923db7bae832 NA TCGA-EW-A1P5-01A-11D-A141-01 TCGA-EW-A1P5-01 NA e9d4f9c8-7355-44c4-9b18-923db7bae832 TCGA-EW-A1P5-01A-11D-A141-01 |
|
|
1118 |
TCGA-EW-A1P6-01 Stage IIB 64 4 Stage IIB 312 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 312 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P6-01 562 0 days Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1P6 562 0 days 562 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1P6-F29114 TCGA-EW-A1P6 TCGA-EW-A1P6-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -23485 249 NA 0 562 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 50 NO Negative NA NA 25 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 2 NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf A1P6 TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 9dddaf60-64ed-4d41-a546-79e86db1101e 9dddaf60-64ed-4d41-a546-79e86db1101e NA TCGA-EW-A1P6-01A-11D-A142-09 TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A145-05 NA TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A142-09 NA NA TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A142-09 NA 9dddaf60-64ed-4d41-a546-79e86db1101e NA TCGA-EW-A1P6-01A-11D-A141-01 TCGA-EW-A1P6-01 NA 9dddaf60-64ed-4d41-a546-79e86db1101e TCGA-EW-A1P6-01A-11D-A141-01 |
|
|
1119 |
TCGA-EW-A1P7-01 Stage IIA 59 1 Stage IIA 635 NA Negative FEMALE Negative NA NA NA Negative M0 Negative N0 635 0 Normal NA Negative NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1P7-01 915 0 days Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 NA BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-EW-A1P7 729 1 days 915 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES NA 59 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A1P7-F29118 TCGA-EW-A1P7 NA NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA 793 -21750 NA NA 0 915 NA NA 729 NA NO NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA 10-19% NA 2+ NA NA 1.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 3 NA NA NA Other, specify Distant Metastasis mediastinal lymph nodes NA YES 0 0 NA No M0 N0 (i-) T2 Stage IIA NA A1P7 WITH TUMOR NA NA NA NA NA NA YES <10% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast NA LIVING 2009 e11a1fd3-d409-4e09-a8ab-5d0afb455263 e11a1fd3-d409-4e09-a8ab-5d0afb455263 NA TCGA-EW-A1P7-01A-21D-A142-09 TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A145-05 NA TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A142-09 NA NA TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A142-09 NA e11a1fd3-d409-4e09-a8ab-5d0afb455263 NA TCGA-EW-A1P7-01A-21D-A141-01 TCGA-EW-A1P7-01 NA e11a1fd3-d409-4e09-a8ab-5d0afb455263 TCGA-EW-A1P7-01A-21D-A141-01 |
|
|
1120 |
TCGA-EW-A1P8-01 Stage IIIC 58 3 Stage IIIC 239 239 Negative FEMALE Negative NA NA NA Negative M0 Positive N3 239 1 Basal NA Negative NA NA NA enrollment T_Other T2 DECEASED 1 TCGA-EW-A1P8-01 239 1 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 12 TCGA-EW-A1P8 207 1 days 239 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NO NA 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1P8-F29121 TCGA-EW-A1P8 TCGA-EW-A1P8-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21501 224 239 0 NA NA NA 207 NA YES NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 160 NO Negative NA NA 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Negative NA NA Negative <10% NA <10% NA NA NA NA NA NA <10% NA Negative Lung|Bone|Liver|Other, specify skin 5 5 NA NA NA Lung Distant Metastasis NA NA YES 14 NA true No M0 N3b T2 Stage IIIC TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf A1P8 WITH TUMOR NA NA NA NA NA NA YES <10% NA NO Primary Tumor 01 NA 7th YES NO YES EW Breast A DECEASED 2010 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 TCGA-EW-A1P8-01A-21-A17J-20 TCGA-EW-A1P8-01A-11D-A142-09 TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A145-05 9729bae9-2494-4ef3-9382-a564fa2a1363 TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A142-09 NA NA TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A142-09 NA d763ccd4-4a11-4e84-b0a6-1b42da020ce4 NA TCGA-EW-A1P8-01A-11D-A141-01 TCGA-EW-A1P8-01 NA d763ccd4-4a11-4e84-b0a6-1b42da020ce4 TCGA-EW-A1P8-01A-11D-A141-01 |
|
|
1121 |
TCGA-EW-A1PA-01 Stage IIB 59 1 Stage IIB 267 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 267 0 LumA NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1PA-01 575 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 NA NA mutation cluster 5 TCGA-EW-A1PA 575 0 days 575 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A1PA-F30937 TCGA-EW-A1PA TCGA-EW-A1PA-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA NO NA NA -21837 220 NA 0 575 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 60 NO Negative NA NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T2 Stage IIB TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf A1PA TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 8c0b7027-f371-4a72-9152-2d00fc54e086 8c0b7027-f371-4a72-9152-2d00fc54e086 TCGA-EW-A1PA-01A-21-A17K-20 TCGA-EW-A1PA-01A-11D-A142-09 TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A145-05 281ecf6a-bcfa-485e-bec7-694899bf33ba TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A142-09 NA NA TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A142-09 NA 8c0b7027-f371-4a72-9152-2d00fc54e086 NA TCGA-EW-A1PA-01A-11D-A141-01 TCGA-EW-A1PA-01 NA 8c0b7027-f371-4a72-9152-2d00fc54e086 TCGA-EW-A1PA-01A-11D-A141-01 |
|
|
1122 |
TCGA-EW-A1PB-01 Stage IIIA 70 3 Stage IIIA 608 NA Negative FEMALE Negative NA NA NA Negative M0 Positive N1 608 0 Basal NA Negative NA NA NA enrollment T_Other T3 LIVING 0 TCGA-EW-A1PB-01 608 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-EW-A1PB 608 0 days 608 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A1PB-F29107 TCGA-EW-A1PB TCGA-EW-A1PB-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Simple Mastectomy NA NO NA NA -25770 569 NA 0 608 NA NA NA NA NA NA <10% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 320 NO Negative NA NA 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 2 NA NA NA NA NA NA NA NO 2 NA true No MX N1a T3 Stage IIIA TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf A1PB TUMOR FREE NA NA NA NA NA NA YES <10% NA NO Primary Tumor 01 NA 6th NO NO YES EW Breast A LIVING 2009 50674dde-30c1-4530-a164-381d5326e29c 50674dde-30c1-4530-a164-381d5326e29c TCGA-EW-A1PB-01A-21-A17J-20 TCGA-EW-A1PB-01A-11D-A142-09 TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A145-05 0bdf178b-3488-411a-bda6-2b7ee3beb0fd TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A142-09 NA NA TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A142-09 NA 50674dde-30c1-4530-a164-381d5326e29c NA TCGA-EW-A1PB-01A-11D-A141-01 TCGA-EW-A1PB-01 NA 50674dde-30c1-4530-a164-381d5326e29c TCGA-EW-A1PB-01A-11D-A141-01 |
|
|
1123 |
TCGA-EW-A1PC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumB NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A1PC-01 187 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-EW-A1PC 187 0 days 187 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left Sentinel node biopsy alone NA TCGA-EW-A1PC-F29681 TCGA-EW-A1PC TCGA-EW-A1PC-01B NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -24434 146 NA 0 187 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-26 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 150 NO Negative NA NA 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No MX N0 (i-) T3 Stage IIB TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf A1PC TUMOR FREE NA NA NA NA NA NA YES 50-59% NA NO Primary Tumor 01 NA 7th YES NO YES EW Breast B LIVING 2011 3960601b-c341-45fb-8a8c-ec244ee719ac 3960601b-c341-45fb-8a8c-ec244ee719ac TCGA-EW-A1PC-01B-21-A24A-20 NA TCGA-EW-A1PC-01 TCGA-EW-A1PC-01B-11D-A21R-05 ea4d6b89-3adf-4eb2-a91c-88e799d79af3 TCGA-EW-A1PC-01 TCGA-EW-A1PC-01B-11D-A21Q-09 NA NA TCGA-EW-A1PC-01 NA NA 3960601b-c341-45fb-8a8c-ec244ee719ac NA TCGA-EW-A1PC-01B-11D-A21P-01 TCGA-EW-A1PC-01 NA 3960601b-c341-45fb-8a8c-ec244ee719ac TCGA-EW-A1PC-01B-11D-A21P-01 |
|
|
1124 |
TCGA-EW-A1PD-01 Stage IIA 61 5 Stage IIA 174 NA Positive MALE Positive NA NA NA Negative M0 Positive N1 174 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1PD-01 424 0 days High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation c1uster 9 TCGA-EW-A1PD 424 0 days 424 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1PD-F29106 TCGA-EW-A1PD TCGA-EW-A1PD-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -22536 112 NA 0 424 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 MALE NA NA 20-29% NA 2+ NA >6.0 2.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 120 NO Equivocal Positive NA 7 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 4 NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T1c Stage IIA TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf A1PD TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 69971d5c-5be4-4886-bf7c-753de9593a1e 69971d5c-5be4-4886-bf7c-753de9593a1e TCGA-EW-A1PD-01A-21-A17J-20 TCGA-EW-A1PD-01A-11D-A142-09 TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A145-05 1dab2beb-b0c7-4eee-bc45-71997f6077e9 TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A142-09 NA NA TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A142-09 NA 69971d5c-5be4-4886-bf7c-753de9593a1e NA TCGA-EW-A1PD-01A-11D-A141-01 TCGA-EW-A1PD-01 NA 69971d5c-5be4-4886-bf7c-753de9593a1e TCGA-EW-A1PD-01A-11D-A141-01 |
|
|
1125 |
TCGA-EW-A1PE-01 Stage IIA 56 2 Stage IIA 139 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 139 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1PE-01 320 0 days Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-EW-A1PE 320 0 days 320 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A1PE-F29108 TCGA-EW-A1PE TCGA-EW-A1PE-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA NO NA NA -20694 44 NA 0 320 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8507/3 C50.9 3+ YES NA [Discrepancy] 150 NO Negative NA NA 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 3 NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T1c Stage IIA TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf A1PE TUMOR FREE NA NA NA NA NA NA YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2011 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 TCGA-EW-A1PE-01A-21-A17J-20 TCGA-EW-A1PE-01A-11D-A142-09 TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A145-05 f5581422-7c21-4ccb-8006-b976b1b49459 TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A142-09 NA NA TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A142-09 NA 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 NA TCGA-EW-A1PE-01A-11D-A141-01 TCGA-EW-A1PE-01 NA 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 TCGA-EW-A1PE-01A-11D-A141-01 |
|
|
1126 |
TCGA-EW-A1PF-01 Stage IA 50 5 Stage I 139 NA Positive FEMALE Negative NA NA NA Negative M0 Negative N0 139 0 LumA NA Positive NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1PF-01 439 0 days Kirc+ NA cluster 1 BRCA CIMP c7 NA BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 NA TCGA-EW-A1PF 439 0 days 439 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right Upper Outer Quadrant Other (specify) sentinel + 2 non-sentinel LN TCGA-EW-A1PF-F29109 TCGA-EW-A1PF NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -18384 NA NA 0 439 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NA 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 4 NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 T1c Stage IA NA A1PF TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast NA LIVING 2010 faa3383f-6f9f-43d8-b61d-4a1522a71444 faa3383f-6f9f-43d8-b61d-4a1522a71444 NA NA TCGA-EW-A1PF-01 TCGA-EW-A1PF-01A-11D-A145-05 NA TCGA-EW-A1PF-01 NA NA NA TCGA-EW-A1PF-01 NA NA faa3383f-6f9f-43d8-b61d-4a1522a71444 NA TCGA-EW-A1PF-01A-11D-A141-01 TCGA-EW-A1PF-01 NA faa3383f-6f9f-43d8-b61d-4a1522a71444 TCGA-EW-A1PF-01A-11D-A141-01 |
|
|
1127 |
TCGA-EW-A1PG-01 Stage IIB 53 1 Stage IIB 875 NA Positive FEMALE Negative NA NA NA Negative M0 Positive N1 875 0 Normal NA Positive NA NA NA enrollment T_Other T2 LIVING 0 TCGA-EW-A1PG-01 1051 0 days Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-EW-A1PG 1051 0 days 1051 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1PG-F29103 TCGA-EW-A1PG TCGA-EW-A1PG-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -19464 829 NA 0 1051 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-3-8 FEMALE NA NA 10-19% NA 2+ NA <4.0 1.8 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 210 NO Equivocal Negative NA 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 6 NA NA NA NA NA NA NA NO 1 1 true No MX N1a T2 Stage IIB TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf A1PG TUMOR FREE NA NA NA NA NA NA YES 90-99% NA NO Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2008 1205dc3c-e766-4a25-b485-c66e301e3b6d 1205dc3c-e766-4a25-b485-c66e301e3b6d TCGA-EW-A1PG-01A-21-A17J-20 TCGA-EW-A1PG-01A-11D-A142-09 TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A145-05 6621baf4-3dc5-4905-99b2-f40d75886fa0 TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A142-09 NA NA TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A142-09 NA 1205dc3c-e766-4a25-b485-c66e301e3b6d NA TCGA-EW-A1PG-01A-11D-A141-01 TCGA-EW-A1PG-01 NA 1205dc3c-e766-4a25-b485-c66e301e3b6d TCGA-EW-A1PG-01A-11D-A141-01 |
|
|
1128 |
TCGA-EW-A1PH-01 Stage IIA 52 1 Stage IIA 139 NA Negative FEMALE NA NA NA NA Negative M0 Positive N1 139 0 Basal NA Negative NA NA NA enrollment T1 T1 LIVING 0 TCGA-EW-A1PH-01 607 0 days High C4-BRCA/Basal cluster 5 BRCA basal-like c8 NA BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-EW-A1PH 607 0 days 607 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A1PH-F41145 TCGA-EW-A1PH TCGA-EW-A1PH-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA NA -19073 77 NA 0 607 NA NA NA NA NO NA <10% NA Scheduled Follow-up Submission 2013-3-12 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 70 NO Negative NA NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 5 5 NA NA NA NA NA NA NA NO 1 0 true No M0 N1a T1c Stage IIA TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf A1PH TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2010 39413018-090f-46ca-b6df-244124f098c3 39413018-090f-46ca-b6df-244124f098c3 NA TCGA-EW-A1PH-01A-11D-A14K-09 TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14N-05 NA TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14K-09 NA NA TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14K-09 NA 39413018-090f-46ca-b6df-244124f098c3 NA TCGA-EW-A1PH-01A-11D-A14J-01 TCGA-EW-A1PH-01 NA 39413018-090f-46ca-b6df-244124f098c3 TCGA-EW-A1PH-01A-11D-A14J-01 |
|
|
1129 |
TCGA-EW-A2FR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Her2 NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A2FR-01 1673 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-EW-A2FR 1673 0 days 1673 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-EW-A2FR-F42056 TCGA-EW-A2FR TCGA-EW-A2FR-01A NA Negative 3 Point Scale 1+ 3 Point Scale NA Negative Lumpectomy NA NO NA NA -21628 1015 NA 0 1673 NA NA NA NA NO NA <10% 2 Scheduled Follow-up Submission 2013-4-10 FEMALE NA NA 10-19% ratio > 2.2 is positive 2+ 40 >6 3.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 100 NO Equivocal Positive NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 19 NA true No MX N3a T1b Stage IIIC TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf A2FR TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast A LIVING 2008 2bd1673c-b5c0-425b-9e62-c501bf29616b 2bd1673c-b5c0-425b-9e62-c501bf29616b TCGA-EW-A2FR-01A-21-A24A-20 NA TCGA-EW-A2FR-01 TCGA-EW-A2FR-01A-11D-A21R-05 977e315e-d1c6-4ef2-a078-178b88ff0ee5 TCGA-EW-A2FR-01 TCGA-EW-A2FR-01A-11D-A21Q-09 NA NA TCGA-EW-A2FR-01 NA NA 2bd1673c-b5c0-425b-9e62-c501bf29616b NA TCGA-EW-A2FR-01A-11D-A21P-01 TCGA-EW-A2FR-01 NA 2bd1673c-b5c0-425b-9e62-c501bf29616b TCGA-EW-A2FR-01A-11D-A21P-01 |
|
|
1130 |
TCGA-EW-A2FS-01 NA 41 5 NA 1173 NA Positive FEMALE NA NA NA NA NA NA NA NA 1173 0 LumA NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-EW-A2FS-01 1604 0 days Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-EW-A2FS 1604 0 days 1604 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A2FS-F42061 TCGA-EW-A2FS NA NA Positive 3 Point Scale 1+ 3 Point Scale NA Negative Lumpectomy NA YES NA NA -15302 NA NA 0 1604 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2013-4-10 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NO 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 1 NA NA No MX N1mi T2 Stage IIB NA A2FS TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES EW Breast NA LIVING 2008 c0f29396-d239-4f0d-a95a-0838770eb24a c0f29396-d239-4f0d-a95a-0838770eb24a TCGA-EW-A2FS-01A-21-A24A-20 NA TCGA-EW-A2FS-01 TCGA-EW-A2FS-01A-11D-A17F-05 f5d09917-197f-4ba1-b19d-437841854522 TCGA-EW-A2FS-01 TCGA-EW-A2FS-01A-11D-A17D-09 NA NA TCGA-EW-A2FS-01 NA NA c0f29396-d239-4f0d-a95a-0838770eb24a NA TCGA-EW-A2FS-01A-11D-A17C-01 TCGA-EW-A2FS-01 NA c0f29396-d239-4f0d-a95a-0838770eb24a TCGA-EW-A2FS-01A-11D-A17C-01 |
|
|
1131 |
TCGA-EW-A2FV-01 NA 39 3 NA 238 NA Positive FEMALE NA NA NA NA NA NA NA NA 238 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-EW-A2FV-01 788 0 days BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-EW-A2FV 788 0 days 788 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Left Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-EW-A2FV-F42065 TCGA-EW-A2FV TCGA-EW-A2FV-01A Negative Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -14316 133 NA 0 788 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2013-4-10 FEMALE NA NA <10% NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8507/3 C50.9 3+ YES NA Excisional Biopsy 80 NO Negative NA NO 32 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 4 NA NA NA NA NA NA NA NA NO 29 NA true No MX N3a T3 Stage IIIC TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf A2FV TUMOR FREE NA NA NA NA NA YES NA 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2011 d60bfd82-87f0-4f13-8e90-6766beb84e9a d60bfd82-87f0-4f13-8e90-6766beb84e9a TCGA-EW-A2FV-01A-21-A24A-20 NA TCGA-EW-A2FV-01 TCGA-EW-A2FV-01A-11D-A17F-05 65bf3e8b-5558-49a2-a59e-6066ce8f38b5 TCGA-EW-A2FV-01 TCGA-EW-A2FV-01A-11D-A17D-09 NA NA TCGA-EW-A2FV-01 NA NA d60bfd82-87f0-4f13-8e90-6766beb84e9a NA TCGA-EW-A2FV-01A-11D-A17C-01 TCGA-EW-A2FV-01 NA d60bfd82-87f0-4f13-8e90-6766beb84e9a TCGA-EW-A2FV-01A-11D-A17C-01 |
|
|
1132 |
TCGA-EW-A2FW-01 NA 52 3 NA 190 NA Positive FEMALE NA NA NA NA NA NA NA NA 190 0 LumB NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-EW-A2FW-01 672 0 days Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA NA TCGA-EW-A2FW 672 0 days 672 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A2FW-F42062 TCGA-EW-A2FW TCGA-EW-A2FW-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -19085 99 NA 0 672 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2013-4-10 FEMALE NA NA <10% NA 1+ NA NA NA NA Other, specify NA No NA C50.9 8503/3 C50.9 3+ YES NA Core needle biopsy 150 NO Negative NA NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 2 NA NA NA NA NA NA NA NA NO 0 0 true No MX N0 (i-) T2 Stage IIA TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf A2FW TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th YES NO YES EW Breast A LIVING 2011 743f2962-126c-4b28-92fa-250b1170b825 743f2962-126c-4b28-92fa-250b1170b825 TCGA-EW-A2FW-01A-21-A24A-20 NA TCGA-EW-A2FW-01 TCGA-EW-A2FW-01A-11D-A17F-05 a4c623f3-e037-4a14-9be5-665cfc6a0c65 TCGA-EW-A2FW-01 TCGA-EW-A2FW-01A-11D-A17D-09 NA NA TCGA-EW-A2FW-01 NA NA 743f2962-126c-4b28-92fa-250b1170b825 NA TCGA-EW-A2FW-01A-11D-A17C-01 TCGA-EW-A2FW-01 NA 743f2962-126c-4b28-92fa-250b1170b825 TCGA-EW-A2FW-01A-11D-A17C-01 |
|
|
1133 |
TCGA-EW-A3E8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A3E8-01 1035 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A3E8 1035 0 days 1035 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A3E8-F57617 TCGA-EW-A3E8 TCGA-EW-A3E8-01B NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -21922 505 NA 0 1035 NA NA NA NA NA NA NA NA NA 2014-3-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 50 NO Negative NA NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No MX N0 T3 Stage IIB TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf A3E8 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO EW Breast B LIVING 2011 37cb523b-c33a-4980-9b06-6e91389ce70e 37cb523b-c33a-4980-9b06-6e91389ce70e NA NA TCGA-EW-A3E8-01 TCGA-EW-A3E8-01B-11D-A244-05 NA TCGA-EW-A3E8-01 TCGA-EW-A3E8-01B-11D-A243-09 NA NA TCGA-EW-A3E8-01 NA NA 37cb523b-c33a-4980-9b06-6e91389ce70e NA TCGA-EW-A3E8-01B-11D-A242-01 TCGA-EW-A3E8-01 NA 37cb523b-c33a-4980-9b06-6e91389ce70e TCGA-EW-A3E8-01B-11D-A242-01 |
|
|
1134 |
TCGA-EW-A3U0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A3U0-01 532 0 days High NA NA Low purity c2 BRCA basal-like c6 NA miRNA cluster 4 NA NA TCGA-EW-A3U0 532 0 days 532 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Sentinel lymph node biopsy plus axillary dissection NA TCGA-EW-A3U0-F42032 TCGA-EW-A3U0 TCGA-EW-A3U0-01A NA Negative NA NA NA NA Negative Other NA NO NA NA -22520 182 NA 0 532 NA NA NA NA NO NA NA NA NA 2013-4-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 280 NO Negative NA NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No M0 N1a T3 Stage IIIA TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf A3U0 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 partial left mastectomy 7th NA YES NO EW Breast A LIVING 2011 4763b4dd-1eef-4503-9381-4baa57cc690f 4763b4dd-1eef-4503-9381-4baa57cc690f TCGA-EW-A3U0-01A-21-A24A-20 NA TCGA-EW-A3U0-01 TCGA-EW-A3U0-01A-11D-A22B-05 0c52f4b2-07d9-4591-a6b7-e4700f8d476d TCGA-EW-A3U0-01 TCGA-EW-A3U0-01A-11D-A228-09 NA NA TCGA-EW-A3U0-01 NA NA 4763b4dd-1eef-4503-9381-4baa57cc690f NA TCGA-EW-A3U0-01A-11D-A227-01 TCGA-EW-A3U0-01 NA 4763b4dd-1eef-4503-9381-4baa57cc690f TCGA-EW-A3U0-01A-11D-A227-01 |
|
|
1135 |
TCGA-EW-A423-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A423-01 533 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A423 533 0 days 533 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-EW-A423-F42558 TCGA-EW-A423 TCGA-EW-A423-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -27627 161 NA 0 533 NA NA NA NA NA NA 50-59% NA NA 2014-3-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 80 NO Negative NA YES 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf A423 TUMOR FREE NA NA NA NA NA [Discrepancy] YES <10% NA [Discrepancy] Primary Tumor 01 NA 7th NA YES NO EW Breast A LIVING 2012 994c8287-b6e2-4743-80bb-fe8d0076ae44 994c8287-b6e2-4743-80bb-fe8d0076ae44 NA NA TCGA-EW-A423-01 TCGA-EW-A423-01A-11D-A244-05 9632bb77-ebd1-4a10-86ba-86f090839a31 TCGA-EW-A423-01 TCGA-EW-A423-01A-11D-A243-09 NA NA TCGA-EW-A423-01 NA NA 994c8287-b6e2-4743-80bb-fe8d0076ae44 NA TCGA-EW-A423-01A-11D-A242-01 TCGA-EW-A423-01 NA 994c8287-b6e2-4743-80bb-fe8d0076ae44 TCGA-EW-A423-01A-11D-A242-01 |
|
|
1136 |
TCGA-EW-A424-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A424-01 715 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A424 715 0 days 715 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Sentinel node biopsy alone NA TCGA-EW-A424-F57612 TCGA-EW-A424 TCGA-EW-A424-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -18850 141 NA 0 715 NA NA NA NA NA NA 50-59% NA NA 2014-3-18 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 140 NO Positive NA NO 1 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 true No MX N1 T3 Stage IIIA TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf A424 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO EW Breast A LIVING 2012 1a571942-1f4c-4f93-8ad3-ea84dad7edaa 1a571942-1f4c-4f93-8ad3-ea84dad7edaa NA NA TCGA-EW-A424-01 TCGA-EW-A424-01A-11D-A244-05 f3c98936-9cae-4e6c-8ff3-0af1a45b4a24 TCGA-EW-A424-01 NA NA NA TCGA-EW-A424-01 NA NA 1a571942-1f4c-4f93-8ad3-ea84dad7edaa NA TCGA-EW-A424-01A-11D-A242-01 TCGA-EW-A424-01 NA 1a571942-1f4c-4f93-8ad3-ea84dad7edaa TCGA-EW-A424-01A-11D-A242-01 |
|
|
1137 |
TCGA-EW-A6S9-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A6S9-01 463 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A6S9 463 0 days 463 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 34 Right|Right Upper Outer Quadrant NA NA TCGA-EW-A6S9-F71706 TCGA-EW-A6S9 TCGA-EW-A6S9-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -12755 139 NA 0 463 NA NA NA NA NA NA 50-59% NA NA 2015-3-30 FEMALE NA NA 50-59% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Positive NA NO 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 1 true No M0 N1 T1c Stage IIA TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf A6S9 TUMOR FREE NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA NA NA EW Breast A LIVING 2013 692abecd-9c2a-48ec-8794-7e84a5317c46 692abecd-9c2a-48ec-8794-7e84a5317c46 NA NA TCGA-EW-A6S9-01 TCGA-EW-A6S9-01A-22D-A33F-05 58744A3B-FEB8-4ADD-8B01-36397505D052 TCGA-EW-A6S9-01 NA NA NA TCGA-EW-A6S9-01 NA NA 692abecd-9c2a-48ec-8794-7e84a5317c46 NA TCGA-EW-A6S9-01A-22D-A33D-01 TCGA-EW-A6S9-01 NA 692abecd-9c2a-48ec-8794-7e84a5317c46 TCGA-EW-A6S9-01A-22D-A33D-01 |
|
|
1138 |
TCGA-EW-A6SA-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A6SA-01 510 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A6SA 510 0 days 510 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left|Left Lower Inner Quadrant Sentinel node biopsy alone NA NA TCGA-EW-A6SA TCGA-EW-A6SA-01A NA Positive NA NA NA NA Negative Simple Mastectomy NA YES NA NA -21623 152 NA 0 510 NA NA NA NA NA NA 50-59% NA NA 2015-2-27 MALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 80 NO Negative NA NA 4 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 1 true No MX N0 (i+) T2 Stage II TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf A6SA TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO EW Breast A LIVING 2013 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 NA NA TCGA-EW-A6SA-01 TCGA-EW-A6SA-01A-21D-A32T-05 3C4C4A1F-544E-4CB5-A1E8-50534496B737 TCGA-EW-A6SA-01 NA NA NA TCGA-EW-A6SA-01 NA NA 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 NA TCGA-EW-A6SA-01A-21D-A32H-01 TCGA-EW-A6SA-01 NA 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 TCGA-EW-A6SA-01A-21D-A32H-01 |
|
|
1139 |
TCGA-EW-A6SB-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A6SB-01 760 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A6SB 760 0 days 760 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left|Left Upper Inner Quadrant Sentinel node biopsy alone NA NA TCGA-EW-A6SB TCGA-EW-A6SB-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -22844 244 NA 0 760 NA NA NA NA NA NA NA NA NA 2015-3-12 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 200 NO Negative NA NA 8 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage II TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf A6SB TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NA NA EW Breast A LIVING 2012 5cb6b038-fe0b-48db-af0b-2a25beb8d79b 5cb6b038-fe0b-48db-af0b-2a25beb8d79b NA NA TCGA-EW-A6SB-01 TCGA-EW-A6SB-01A-12D-A32T-05 85666B68-022F-4583-83BB-7CD199387E0F TCGA-EW-A6SB-01 NA NA NA TCGA-EW-A6SB-01 NA NA 5cb6b038-fe0b-48db-af0b-2a25beb8d79b NA TCGA-EW-A6SB-01A-12D-A32H-01 TCGA-EW-A6SB-01 NA 5cb6b038-fe0b-48db-af0b-2a25beb8d79b TCGA-EW-A6SB-01A-12D-A32H-01 |
|
|
1140 |
TCGA-EW-A6SC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A6SC-01 952 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A6SC 952 0 days 952 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 60 Left|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-EW-A6SC-F71017 TCGA-EW-A6SC TCGA-EW-A6SC-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -21918 350 NA 0 952 NA NA NA NA NA NA 50-59% NA NA 2015-3-12 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 160 NO Negative NA NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf A6SC TUMOR FREE NA NA NA NA NA YES YES 40-49% NA YES Primary Tumor 01 NA 7th NA NA NA EW Breast A LIVING 2012 3b7ae466-954f-42aa-8e01-9908ef1c8123 3b7ae466-954f-42aa-8e01-9908ef1c8123 NA NA TCGA-EW-A6SC-01 TCGA-EW-A6SC-01A-12D-A32T-05 79418E7F-949D-489B-B953-B4942BC4C027 TCGA-EW-A6SC-01 NA NA NA TCGA-EW-A6SC-01 NA NA 3b7ae466-954f-42aa-8e01-9908ef1c8123 NA TCGA-EW-A6SC-01A-12D-A32H-01 TCGA-EW-A6SC-01 NA 3b7ae466-954f-42aa-8e01-9908ef1c8123 TCGA-EW-A6SC-01A-12D-A32H-01 |
|
|
1141 |
TCGA-EW-A6SD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-EW-A6SD-01 1010 0 days NA NA NA NA NA NA NA NA NA TCGA-EW-A6SD 1010 0 days 1010 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 32 Left|Left Upper Outer Quadrant NA NA NA TCGA-EW-A6SD TCGA-EW-A6SD-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -12006 441 NA 0 1010 NA NA NA NA NA NA <10% NA NA 2015-3-14 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO NA NA NA 31 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf A6SD TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO EW Breast A LIVING 2012 54d166b6-fb32-4003-b944-8d0f23cfa125 54d166b6-fb32-4003-b944-8d0f23cfa125 NA NA TCGA-EW-A6SD-01 TCGA-EW-A6SD-01A-12D-A33F-05 9085B5BF-0B41-4E31-940F-BE8AF05ED3EC TCGA-EW-A6SD-01 NA NA NA TCGA-EW-A6SD-01 NA NA 54d166b6-fb32-4003-b944-8d0f23cfa125 NA TCGA-EW-A6SD-01A-12D-A33D-01 TCGA-EW-A6SD-01 NA 54d166b6-fb32-4003-b944-8d0f23cfa125 TCGA-EW-A6SD-01A-12D-A33D-01 |
|
|
1142 |
TCGA-GI-A2C8-01 NA NA 3 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-GI-A2C8-01 225 0 days Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA mutation c1uster 9 TCGA-GI-A2C8 225 0 days 225 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel node biopsy alone NA TCGA-GI-A2C8-F21661 TCGA-GI-A2C8 TCGA-GI-A2C8-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -23103 2429 NA 0 225 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-5-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 3+ YES NA NA 100 NO Negative Negative NA 10 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 3 NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T4b Stage IIIB TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf A2C8 NA NA NA NA NA NA NA YES <10% NA YES Primary Tumor 01 NA 6th YES NO YES GI Breast A LIVING 2004 21531069-76ec-4e0f-b915-51c00b2c42f1 21531069-76ec-4e0f-b915-51c00b2c42f1 TCGA-GI-A2C8-01A-21-A17K-20 TCGA-GI-A2C8-01A-11D-A16D-09 TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16G-05 b9f3060c-ac00-4181-acde-92e45a2ae5a8 TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16D-09 NA NA TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16D-09 NA 21531069-76ec-4e0f-b915-51c00b2c42f1 NA TCGA-GI-A2C8-01A-11D-A16C-01 TCGA-GI-A2C8-01 NA 21531069-76ec-4e0f-b915-51c00b2c42f1 TCGA-GI-A2C8-01A-11D-A16C-01 |
|
|
1143 |
TCGA-GI-A2C8-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-GI-A2C8-11 225 0 days NA C3-BRCA/Luminal NA NA NA NA NA NA mutation c1uster 9 TCGA-GI-A2C8 225 0 days 225 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel node biopsy alone NA TCGA-GI-A2C8-F21661 TCGA-GI-A2C8 TCGA-GI-A2C8-11A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -23103 2429 NA 0 225 NA NA NA NA NO NA 90-99% NA Scheduled Follow-up Submission 2012-5-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA Yes NA C50.9 8500/3 C50.9 3+ YES NA NA 100 NO Negative Negative NA 10 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T4b Stage IIIB NA A2C8 NA NA NA NA NA NA NA YES <10% NA YES Solid Tissue Normal 11 NA 6th YES NO YES GI Breast A LIVING 2004 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 NA NA NA NA NA NA NA NA NA NA NA NA 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 NA NA NA NA 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 NA |
|
|
1144 |
TCGA-GI-A2C9-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 0 TCGA-GI-A2C9-01 3342 0 days High C4-BRCA/Basal NA BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 NA NA TCGA-GI-A2C9 3342 0 days 3342 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-GI-A2C9-F21663 TCGA-GI-A2C9 TCGA-GI-A2C9-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -21534 2979 NA 0 3342 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-5-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T3 Stage IIB TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf A2C9 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Primary Tumor 01 NA 6th YES NO YES GI Breast A LIVING 2003 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 TCGA-GI-A2C9-01A-21-A24A-20 NA TCGA-GI-A2C9-01 TCGA-GI-A2C9-01A-11D-A21R-05 179ce5cd-da63-4c2e-bf72-253129faf128 TCGA-GI-A2C9-01 TCGA-GI-A2C9-01A-11D-A21Q-09 NA NA TCGA-GI-A2C9-01 NA NA b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 NA TCGA-GI-A2C9-01A-11D-A21P-01 TCGA-GI-A2C9-01 NA b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 TCGA-GI-A2C9-01A-11D-A21P-01 |
|
|
1145 |
TCGA-GI-A2C9-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Normal NA NA NA NA NA NA NA NA NA 0 TCGA-GI-A2C9-11 3342 0 days NA C4-BRCA/Basal NA NA NA NA NA NA NA TCGA-GI-A2C9 3342 0 days 3342 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-GI-A2C9-F21663 TCGA-GI-A2C9 TCGA-GI-A2C9-11A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -21534 2979 NA 0 3342 NA NA NA NA NO NA NA NA Scheduled Follow-up Submission 2012-5-8 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NA 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T3 Stage IIB NA A2C9 TUMOR FREE NA NA NA NA NA NA YES NA NA YES Solid Tissue Normal 11 NA 6th YES NO YES GI Breast A LIVING 2003 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 NA NA NA NA NA NA NA NA NA TCGA-GI-A2C9-11 NA NA 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 NA NA TCGA-GI-A2C9-11 NA 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 NA |
|
|
1146 |
TCGA-GM-A2D9-01 NA 69 NA NA NA 1812 Positive FEMALE NA NA NA NA NA NA NA NA 1812 1 LumA NA Positive NA NA NA enrollment NA NA DECEASED 1 TCGA-GM-A2D9-01 1812 1 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 NA NA TCGA-GM-A2D9 536 1 days 1812 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 69 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-GM-A2D9-F47033 TCGA-GM-A2D9 TCGA-GM-A2D9-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -25490 1910 1812 0 NA NA 536 536 NA YES NA 90-99% 1.93 NA 2013-8-21 FEMALE NA NA NA NA NA 60 2.23 1.16 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 130 NO NA Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Positive 90-99% NA NA NA NA NA NA NA NA NA NA NA Bone NA NA NA NA NA NA Bone Distant Metastasis NA YES YES 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf A2D9 WITH TUMOR NA NA NA NA NA YES YES 40-49% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A DECEASED 2006 4ffff9ea-3386-47d5-8974-722037f31849 4ffff9ea-3386-47d5-8974-722037f31849 TCGA-GM-A2D9-01A-21-A24A-20 NA TCGA-GM-A2D9-01 TCGA-GM-A2D9-01A-11D-A18O-05 3a04c178-dd57-499e-959e-ba106a878397 TCGA-GM-A2D9-01 TCGA-GM-A2D9-01A-11D-A18P-09 NA NA TCGA-GM-A2D9-01 NA NA 4ffff9ea-3386-47d5-8974-722037f31849 NA TCGA-GM-A2D9-01A-11D-A18N-01 TCGA-GM-A2D9-01 NA 4ffff9ea-3386-47d5-8974-722037f31849 TCGA-GM-A2D9-01A-11D-A18N-01 |
|
|
1147 |
TCGA-GM-A2DA-01 NA 46 NA NA 5909 NA Positive FEMALE NA NA NA NA NA NA NA NA 5909 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 1 TCGA-GM-A2DA-01 6593 1 days Iq NA NA BRCA non-CIMP c9 NA BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DA 3014 1 days 6593 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 46 Right Upper Inner Quadrant|Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-GM-A2DA-F47040 TCGA-GM-A2DA NA NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -16854 NA 6593 0 5909 NA NA 3014 NA YES NA 90-99% 3.70 NA 2013-8-21 FEMALE NA NA 90-99% NA 2+ 60 15 4.05 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy NA NA Equivocal Positive NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 2 0 NA No M0 N1b T2 Stage IIB NA A2DA WITH TUMOR NA NA NA NA NA YES YES 50-59% NA YES Primary Tumor 01 NA 4th NA NO YES GM Breast NA DECEASED 1993 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 NA NA TCGA-GM-A2DA-01 TCGA-GM-A2DA-01A-11D-A18O-05 NA TCGA-GM-A2DA-01 TCGA-GM-A2DA-01A-11D-A18P-09 NA NA TCGA-GM-A2DA-01 NA NA df5061ca-929b-4e23-89fb-6d05c1a9ffa4 NA TCGA-GM-A2DA-01A-11D-A18N-01 TCGA-GM-A2DA-01 NA df5061ca-929b-4e23-89fb-6d05c1a9ffa4 TCGA-GM-A2DA-01A-11D-A18N-01 |
|
|
1148 |
TCGA-GM-A2DB-01 NA 62 NA NA 1615 NA Negative FEMALE NA NA NA NA NA NA NA NA 1615 0 Her2 NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DB-01 2406 0 days Squamous C3-BRCA/Luminal NA BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DB 2406 0 days 2406 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DB-F47156 TCGA-GM-A2DB TCGA-GM-A2DB-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -22883 1644 NA 0 2406 NA NA NA NA NO NA <10% 1.50 NA 2013-8-22 FEMALE NA NA NA NA 1+ 60 1.67 1.11 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Negative Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf A2DB TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2006 e5aeb7a3-1454-4605-a924-d4b1ed082e87 e5aeb7a3-1454-4605-a924-d4b1ed082e87 TCGA-GM-A2DB-01A-21-A24A-20 NA TCGA-GM-A2DB-01 TCGA-GM-A2DB-01A-31D-A18O-05 06141302-8b54-448e-811d-c6b69434ec4a TCGA-GM-A2DB-01 TCGA-GM-A2DB-01A-31D-A19Y-09 NA NA TCGA-GM-A2DB-01 NA NA e5aeb7a3-1454-4605-a924-d4b1ed082e87 NA TCGA-GM-A2DB-01A-31D-A18N-01 TCGA-GM-A2DB-01 NA e5aeb7a3-1454-4605-a924-d4b1ed082e87 TCGA-GM-A2DB-01A-31D-A18N-01 |
|
|
1149 |
TCGA-GM-A2DC-01 NA 57 NA NA 1628 NA Positive FEMALE NA NA NA NA NA NA NA NA 1628 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DC-01 2535 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DC 2535 0 days 2535 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-GM-A2DC-F47061 TCGA-GM-A2DC NA NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -21122 NA NA 0 2535 NA NA NA NA NO NA 90-99% 4.43 NA 2013-8-22 FEMALE NA NA NA NA NA 60 4.70 1.06 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 NA No M0 N1a T1c Stage IIA NA A2DC TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast NA LIVING 2006 beb2f2cc-8893-4db2-a527-50a7a40d6d4f beb2f2cc-8893-4db2-a527-50a7a40d6d4f TCGA-GM-A2DC-01A-21-A24A-20 NA TCGA-GM-A2DC-01 TCGA-GM-A2DC-01A-11D-A18O-05 efd14d4d-750d-43ac-ae08-7e75a25ec143 TCGA-GM-A2DC-01 TCGA-GM-A2DC-01A-11D-A18P-09 NA NA TCGA-GM-A2DC-01 NA NA beb2f2cc-8893-4db2-a527-50a7a40d6d4f NA TCGA-GM-A2DC-01A-11D-A18N-01 TCGA-GM-A2DC-01 NA beb2f2cc-8893-4db2-a527-50a7a40d6d4f TCGA-GM-A2DC-01A-11D-A18N-01 |
|
|
1150 |
TCGA-GM-A2DD-01 NA 53 NA NA 1309 NA Negative FEMALE NA NA NA NA NA NA NA NA 1309 0 Normal NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DD-01 2282 0 days High C3-BRCA/Luminal NA BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DD 2282 0 days 2282 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Right Sentinel node biopsy alone NA TCGA-GM-A2DD-F47070 TCGA-GM-A2DD NA NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -19415 NA NA 0 2282 NA NA NA NA NO NA <10% 1.45 NA 2013-8-22 FEMALE NA NA <10% NA 2+ 60 1.62 1.11 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA Yes M0 N0 (i-) T1c Stage I NA A2DD TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 6th NA NO YES GM Breast NA LIVING 2007 ddc6e148-34b7-4466-b692-3bb227004e2b ddc6e148-34b7-4466-b692-3bb227004e2b TCGA-GM-A2DD-01A-21-A24A-20 NA TCGA-GM-A2DD-01 TCGA-GM-A2DD-01A-11D-A17Z-05 cf5d72b5-6d47-450b-90e3-8ffe9e291e75 TCGA-GM-A2DD-01 TCGA-GM-A2DD-01A-11D-A17W-09 NA NA TCGA-GM-A2DD-01 NA NA ddc6e148-34b7-4466-b692-3bb227004e2b NA TCGA-GM-A2DD-01A-11D-A17U-01 TCGA-GM-A2DD-01 NA ddc6e148-34b7-4466-b692-3bb227004e2b TCGA-GM-A2DD-01A-11D-A17U-01 |
|
|
1151 |
TCGA-GM-A2DF-01 NA 53 NA NA 1299 NA Negative FEMALE NA NA NA NA NA NA NA NA 1299 0 Basal NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DF-01 2155 0 days High C4-BRCA/Basal NA BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 5 NA NA TCGA-GM-A2DF 2155 0 days 2155 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 53 Left Lower Outer Quadrant Axillary lymph node dissection alone NA TCGA-GM-A2DF-F47074 TCGA-GM-A2DF TCGA-GM-A2DF-01A NA Negative NA NA NA NA Negative Lumpectomy NA NO NA NA -19614 1372 NA 0 2155 NA NA NA NA NO NA <10% 1.40 NA 2013-8-22 FEMALE NA NA NA NA 1+ 60 1.57 1.12 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 100 NO Negative Negative NO 32 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 false No M0 N1a T1c Stage IIA TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf A2DF TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2007 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 TCGA-GM-A2DF-01A-21-A24A-20 NA TCGA-GM-A2DF-01 TCGA-GM-A2DF-01A-11D-A17Z-05 1af97bf7-a99d-48f9-9ed1-69612327c1f9 TCGA-GM-A2DF-01 TCGA-GM-A2DF-01A-11D-A17W-09 NA NA TCGA-GM-A2DF-01 NA NA 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 NA TCGA-GM-A2DF-01A-11D-A17U-01 TCGA-GM-A2DF-01 NA 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 TCGA-GM-A2DF-01A-11D-A17U-01 |
|
|
1152 |
TCGA-GM-A2DH-01 NA 58 NA NA 1286 NA Negative FEMALE NA NA NA NA NA NA NA NA 1286 0 Her2 NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DH-01 2193 0 days High C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 10 NA NA TCGA-GM-A2DH 2193 0 days 2193 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DH-F47081 TCGA-GM-A2DH NA NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -21344 NA NA 0 2193 NA NA NA NA NO NA <10% 2.80 NA 2013-8-22 FEMALE NA NA NA NA 1+ 60 2.80 1.00 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA Negative Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 NA No M0 N0 (i+) T1c Stage I NA A2DH TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 6th NA NO YES GM Breast NA LIVING 2007 ec2ac902-f5ca-45a5-a72a-1b266360410a ec2ac902-f5ca-45a5-a72a-1b266360410a TCGA-GM-A2DH-01A-21-A24A-20 NA TCGA-GM-A2DH-01 TCGA-GM-A2DH-01A-11D-A17Z-05 d2a00ef2-dd0f-4bd7-91e5-21e80e8b7e9e TCGA-GM-A2DH-01 TCGA-GM-A2DH-01A-11D-A17W-09 NA NA TCGA-GM-A2DH-01 NA NA ec2ac902-f5ca-45a5-a72a-1b266360410a NA TCGA-GM-A2DH-01A-11D-A17U-01 TCGA-GM-A2DH-01 NA ec2ac902-f5ca-45a5-a72a-1b266360410a TCGA-GM-A2DH-01A-11D-A17U-01 |
|
|
1153 |
TCGA-GM-A2DI-01 NA 52 NA NA 1883 NA Negative FEMALE NA NA NA NA NA NA NA NA 1883 0 LumA NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DI-01 2590 0 days Squamous C3-BRCA/Luminal NA Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 NA NA TCGA-GM-A2DI 2590 0 days 2590 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DI-F47089 TCGA-GM-A2DI TCGA-GM-A2DI-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -19030 2144 NA 0 2590 NA NA NA NA NO NA <10% 3.33 NA 2013-8-22 FEMALE NA NA NA NA NA 60 3.53 1.06 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 150 NO NA Negative NO 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 false No M0 N0 (i+) T1c Stage I TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf A2DI TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2005 c50e1f9f-6059-4609-876d-938efb8a784e c50e1f9f-6059-4609-876d-938efb8a784e TCGA-GM-A2DI-01A-21-A24A-20 NA TCGA-GM-A2DI-01 TCGA-GM-A2DI-01A-31D-A18O-05 88140136-0e0a-44e3-84ac-ae2e2724a95f TCGA-GM-A2DI-01 TCGA-GM-A2DI-01A-31D-A18P-09 NA NA TCGA-GM-A2DI-01 NA NA c50e1f9f-6059-4609-876d-938efb8a784e NA TCGA-GM-A2DI-01A-31D-A18N-01 TCGA-GM-A2DI-01 NA c50e1f9f-6059-4609-876d-938efb8a784e TCGA-GM-A2DI-01A-31D-A18N-01 |
|
|
1154 |
TCGA-GM-A2DK-01 NA 58 NA NA 1896 NA Positive FEMALE NA NA NA NA NA NA NA NA 1896 0 LumA NA Negative NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DK-01 2645 0 days COAD-READ C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DK 2645 0 days 2645 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DK-F47094 TCGA-GM-A2DK TCGA-GM-A2DK-01A NA Positive NA NA NA NA Negative Lumpectomy NA YES NA NA -21198 2109 NA 0 2645 NA NA NA NA NO NA 90-99% NA NA 2013-8-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf A2DK TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2005 52df7d5d-7236-464f-9394-7c20f8726280 52df7d5d-7236-464f-9394-7c20f8726280 TCGA-GM-A2DK-01A-11-A24A-20 NA TCGA-GM-A2DK-01 TCGA-GM-A2DK-01A-21D-A17Z-05 7f74c5f0-6c1f-4b93-a192-ee7d9c492c67 TCGA-GM-A2DK-01 TCGA-GM-A2DK-01A-21D-A17W-09 NA NA TCGA-GM-A2DK-01 NA NA 52df7d5d-7236-464f-9394-7c20f8726280 NA TCGA-GM-A2DK-01A-21D-A17U-01 TCGA-GM-A2DK-01 NA 52df7d5d-7236-464f-9394-7c20f8726280 TCGA-GM-A2DK-01A-21D-A17U-01 |
|
|
1155 |
TCGA-GM-A2DL-01 NA 50 NA NA 2762 NA Positive FEMALE NA NA NA NA NA NA NA NA 2762 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DL-01 3519 0 days BRCA-LUAD+ C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DL 3519 0 days 3519 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DL-F47098 TCGA-GM-A2DL TCGA-GM-A2DL-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -18475 2723 NA 0 3519 NA NA NA NA NO NA 90-99% NA NA 2013-8-22 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 130 NO Negative NA NO 2 Negative Peri (6-12 months since last menstrual period) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf A2DL TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2003 8955404a-c756-4116-9613-dea06077a056 8955404a-c756-4116-9613-dea06077a056 TCGA-GM-A2DL-01A-21-A24A-20 NA TCGA-GM-A2DL-01 TCGA-GM-A2DL-01A-11D-A18O-05 eba15eee-e233-45cc-b24d-fd3d99aa7e00 TCGA-GM-A2DL-01 TCGA-GM-A2DL-01A-11D-A18P-09 NA NA TCGA-GM-A2DL-01 NA NA 8955404a-c756-4116-9613-dea06077a056 NA TCGA-GM-A2DL-01A-11D-A18N-01 TCGA-GM-A2DL-01 NA 8955404a-c756-4116-9613-dea06077a056 TCGA-GM-A2DL-01A-11D-A18N-01 |
|
|
1156 |
TCGA-GM-A2DM-01 NA 57 NA NA 2331 NA Positive FEMALE NA NA NA NA NA NA NA NA 2331 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DM-01 3226 0 days Quiet C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA NA TCGA-GM-A2DM 3226 0 days 3226 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DM-F47104 TCGA-GM-A2DM TCGA-GM-A2DM-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -21160 2464 NA 0 3226 NA NA NA NA NO NA 40-49% NA NA 2013-8-22 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf A2DM TUMOR FREE NA NA NA NA NA YES YES 30-39% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2004 8d8fed5e-4b27-472a-93fa-2dba57098576 8d8fed5e-4b27-472a-93fa-2dba57098576 TCGA-GM-A2DM-01A-21-A24A-20 NA TCGA-GM-A2DM-01 TCGA-GM-A2DM-01A-11D-A17Z-05 0f5e7aba-bcea-43bb-b280-ad49450691dd TCGA-GM-A2DM-01 TCGA-GM-A2DM-01A-11D-A17W-09 NA NA TCGA-GM-A2DM-01 NA NA 8d8fed5e-4b27-472a-93fa-2dba57098576 NA TCGA-GM-A2DM-01A-11D-A17U-01 TCGA-GM-A2DM-01 NA 8d8fed5e-4b27-472a-93fa-2dba57098576 TCGA-GM-A2DM-01A-11D-A17U-01 |
|
|
1157 |
TCGA-GM-A2DN-01 NA 58 NA NA 2352 NA Positive FEMALE NA NA NA NA NA NA NA NA 2352 0 LumA NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DN-01 3091 0 days Iq C3-BRCA/Luminal NA BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 NA NA TCGA-GM-A2DN 3091 0 days 3091 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-GM-A2DN-F47124 TCGA-GM-A2DN TCGA-GM-A2DN-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -21288 2436 NA 0 3091 NA NA NA NA NO NA 90-99% NA NA 2013-8-22 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 210 NO Negative NA NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf A2DN TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2004 0872770d-ed18-47c4-8190-212b7250f7cf 0872770d-ed18-47c4-8190-212b7250f7cf TCGA-GM-A2DN-01A-21-A24A-20 NA TCGA-GM-A2DN-01 TCGA-GM-A2DN-01A-11D-A17Z-05 cbb6932d-84f3-4a8f-9518-d8135db77eb2 TCGA-GM-A2DN-01 TCGA-GM-A2DN-01A-11D-A17W-09 NA NA TCGA-GM-A2DN-01 NA NA 0872770d-ed18-47c4-8190-212b7250f7cf NA TCGA-GM-A2DN-01A-11D-A17U-01 TCGA-GM-A2DN-01 NA 0872770d-ed18-47c4-8190-212b7250f7cf TCGA-GM-A2DN-01A-11D-A17U-01 |
|
|
1158 |
TCGA-GM-A2DO-01 NA 54 NA NA 1622 NA Positive FEMALE NA NA NA NA NA NA NA NA 1622 0 LumB NA Positive NA NA NA enrollment NA NA LIVING 0 TCGA-GM-A2DO-01 2596 0 days Kirc+ C3-BRCA/Luminal NA Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 NA NA TCGA-GM-A2DO 2596 0 days 2596 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A2DO-F47151 TCGA-GM-A2DO TCGA-GM-A2DO-01A NA Positive NA NA NA NA Positive Lumpectomy NA YES NA NA -19842 1932 NA 0 2596 NA NA NA NA NO NA 90-99% NA NA 2013-8-22 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf A2DO TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2006 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 TCGA-GM-A2DO-01A-21-A24A-20 NA TCGA-GM-A2DO-01 TCGA-GM-A2DO-01A-11D-A18O-05 0db11312-24bd-4df2-9bb6-f271db3a0d30 TCGA-GM-A2DO-01 TCGA-GM-A2DO-01A-11D-A19Y-09 NA NA TCGA-GM-A2DO-01 NA NA 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 NA TCGA-GM-A2DO-01A-11D-A18N-01 TCGA-GM-A2DO-01 NA 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 TCGA-GM-A2DO-01A-11D-A18N-01 |
|
|
1159 |
TCGA-GM-A3NW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A3NW-01 3361 0 days BRCA-LUAD+ NA NA BRCA CIMP c7 NA NA miRNA cluster 14 NA NA TCGA-GM-A3NW 3361 0 days 3361 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-GM-A3NW-F40398 TCGA-GM-A3NW NA NA Negative NA NA NA NA Positive Simple Mastectomy NA YES NA NA -23041 NA NA 0 3361 NA NA NA NA NO NA NA 1.57 NA 2013-2-18 FEMALE NA NA 30-39% NA 1+ 60 1.80 1.15 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 NA No M0 N0 (i-) T2 Stage IIA NA A3NW TUMOR FREE NA NA NA NA NA YES YES 20-29% NA NO Primary Tumor 01 NA 6th NA NO YES GM Breast NA LIVING 2003 e996b750-d0d3-43c8-860a-17da2f607b15 e996b750-d0d3-43c8-860a-17da2f607b15 NA NA TCGA-GM-A3NW-01 TCGA-GM-A3NW-01A-21D-A22B-05 NA TCGA-GM-A3NW-01 TCGA-GM-A3NW-01A-21D-A228-09 NA NA TCGA-GM-A3NW-01 NA NA e996b750-d0d3-43c8-860a-17da2f607b15 NA TCGA-GM-A3NW-01A-21D-A227-01 TCGA-GM-A3NW-01 NA e996b750-d0d3-43c8-860a-17da2f607b15 TCGA-GM-A3NW-01A-21D-A227-01 |
|
|
1160 |
TCGA-GM-A3NY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA LumA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A3NY-01 1162 0 days Iq C3-BRCA/Luminal NA BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 NA NA TCGA-GM-A3NY 1162 0 days 1162 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-GM-A3NY-F40403 TCGA-GM-A3NY TCGA-GM-A3NY-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -26642 778 NA 0 1162 NA NA NA NA NO NA 90-99% NA NA 2013-2-19 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 140 NO Negative NA NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 false No M0 N1a T2 Stage IIB TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf A3NY TUMOR FREE NA NA NA NA NA YES YES 20-29% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2009 85c4a097-4567-4bdf-879c-96c9a4f48052 85c4a097-4567-4bdf-879c-96c9a4f48052 TCGA-GM-A3NY-01A-21-A24A-20 NA TCGA-GM-A3NY-01 TCGA-GM-A3NY-01A-11D-A21R-05 b6420819-1738-4d07-9a22-c3a38f0755d4 TCGA-GM-A3NY-01 TCGA-GM-A3NY-01A-11D-A21Q-09 NA NA TCGA-GM-A3NY-01 NA NA 85c4a097-4567-4bdf-879c-96c9a4f48052 NA TCGA-GM-A3NY-01A-11D-A21P-01 TCGA-GM-A3NY-01 NA 85c4a097-4567-4bdf-879c-96c9a4f48052 TCGA-GM-A3NY-01A-11D-A21P-01 |
|
|
1161 |
TCGA-GM-A3XG-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A3XG-01 1330 0 days NA NA NA NA NA NA NA NA NA TCGA-GM-A3XG 1330 0 days 1330 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-GM-A3XG-F46963 TCGA-GM-A3XG TCGA-GM-A3XG-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -16948 899 NA 0 1330 NA NA NA NA NA NA 90-99% 1.67 NA 2013-8-20 FEMALE NA NA NA NA 1+ 60 1.73 1.04 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 270 NO Negative Negative NO 26 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 false No M0 N1a T3 Stage IIIA TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf A3XG TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2009 718c3d2a-517e-4e32-a96b-ef17848d56d8 718c3d2a-517e-4e32-a96b-ef17848d56d8 NA NA TCGA-GM-A3XG-01 TCGA-GM-A3XG-01A-31D-A244-05 fef9a497-d85c-46eb-9ebf-6a9645462a4a TCGA-GM-A3XG-01 TCGA-GM-A3XG-01A-31D-A243-09 NA NA TCGA-GM-A3XG-01 NA NA 718c3d2a-517e-4e32-a96b-ef17848d56d8 NA TCGA-GM-A3XG-01A-31D-A242-01 TCGA-GM-A3XG-01 NA 718c3d2a-517e-4e32-a96b-ef17848d56d8 TCGA-GM-A3XG-01A-31D-A242-01 |
|
|
1162 |
TCGA-GM-A3XL-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A3XL-01 2108 0 days NA NA NA NA BRCA basal-like c6 NA miRNA cluster 4 NA NA TCGA-GM-A3XL 2108 0 days 2108 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right|Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-GM-A3XL-F41970 TCGA-GM-A3XL TCGA-GM-A3XL-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -18171 1779 NA 0 2108 NA NA NA NA NA NA <10% NA NA 2013-4-8 FEMALE NA NA NA NA NA NA NA 0.99 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO NA Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf A3XL TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2007 29c98197-249e-45c9-96dc-34dfb4ac1430 29c98197-249e-45c9-96dc-34dfb4ac1430 TCGA-GM-A3XL-01A-21-A24A-20 NA TCGA-GM-A3XL-01 TCGA-GM-A3XL-01A-11D-A230-05 01083b39-09ef-40dd-86c0-5cb8a2a5a646 TCGA-GM-A3XL-01 TCGA-GM-A3XL-01A-11D-A22X-09 NA NA TCGA-GM-A3XL-01 NA NA 29c98197-249e-45c9-96dc-34dfb4ac1430 NA TCGA-GM-A3XL-01A-11D-A22W-01 TCGA-GM-A3XL-01 NA 29c98197-249e-45c9-96dc-34dfb4ac1430 TCGA-GM-A3XL-01A-11D-A22W-01 |
|
|
1163 |
TCGA-GM-A3XN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A3XN-01 2019 0 days NA NA NA NA BRCA nonbasal-like c8 NA miRNA cluster 4 NA NA TCGA-GM-A3XN 2019 0 days 2019 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-GM-A3XN-F46967 TCGA-GM-A3XN TCGA-GM-A3XN-01A NA Positive NA NA NA NA Positive Lumpectomy NA NO NA NA -16109 1627 NA 0 2019 NA NA NA NA NA NA 80-89% 1.73 NA 2013-8-20 FEMALE NA NA NA NA 1+ 60 1.85 1.07 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Incisional Biopsy 100 NO Negative Negative NO 34 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 0 false No M0 N2a T1c Stage IIIA TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf A3XN TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2007 740c53d0-b037-4475-82b3-044b2f879aac 740c53d0-b037-4475-82b3-044b2f879aac TCGA-GM-A3XN-01A-21-A24A-20 NA TCGA-GM-A3XN-01 TCGA-GM-A3XN-01A-12D-A230-05 dc2ec9a1-7c3d-4265-be91-132bb9456eff TCGA-GM-A3XN-01 TCGA-GM-A3XN-01A-12D-A22X-09 NA NA TCGA-GM-A3XN-01 NA NA 740c53d0-b037-4475-82b3-044b2f879aac NA TCGA-GM-A3XN-01A-12D-A22W-01 TCGA-GM-A3XN-01 NA 740c53d0-b037-4475-82b3-044b2f879aac TCGA-GM-A3XN-01A-12D-A22W-01 |
|
|
1164 |
TCGA-GM-A4E0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A4E0-01 2191 0 days NA NA NA NA NA NA NA NA NA TCGA-GM-A4E0 2191 0 days 2191 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-GM-A4E0-F47030 TCGA-GM-A4E0 TCGA-GM-A4E0-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA YES NA NA -24788 1871 NA 0 2191 NA NA NA NA NA NA 90-99% NA NA 2013-8-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 210 NO NA Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 10 1 false No M0 N3a T3 Stage IIIC TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf A4E0 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES GM Breast A LIVING 2007 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 NA NA TCGA-GM-A4E0-01 TCGA-GM-A4E0-01A-12D-A268-05 016da2b9-36c0-4cde-bf58-e0a46e381af9 TCGA-GM-A4E0-01 TCGA-GM-A4E0-01A-12D-A25Q-09 NA NA TCGA-GM-A4E0-01 NA NA da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 NA TCGA-GM-A4E0-01A-12D-A25N-01 TCGA-GM-A4E0-01 NA da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 TCGA-GM-A4E0-01A-12D-A25N-01 |
|
|
1165 |
TCGA-GM-A5PV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A5PV-01 412 0 days NA NA NA NA NA NA NA NA NA TCGA-GM-A5PV 412 0 days 412 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-GM-A5PV TCGA-GM-A5PV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -23215 499 NA 0 412 NA NA NA NA NA NA 90-99% 2.70 NA 2013-4-12 FEMALE NA NA NA NA NA 40 3.65 1.35 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 190 NO NA Negative NA 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T2 Stage IIB TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf A5PV TUMOR FREE NA NA NA NA NA YES YES 30-39% NA NO Primary Tumor 01 NA 7th NA NO YES GM Breast A LIVING 2011 96c1cfef-0507-46f5-a007-d0f7369cced5 96c1cfef-0507-46f5-a007-d0f7369cced5 NA NA TCGA-GM-A5PV-01 TCGA-GM-A5PV-01A-11D-A28C-05 a099aed3-9597-47e9-afd2-58e19aba2018 TCGA-GM-A5PV-01 TCGA-GM-A5PV-01A-11D-A28B-09 NA NA TCGA-GM-A5PV-01 NA NA 96c1cfef-0507-46f5-a007-d0f7369cced5 NA TCGA-GM-A5PV-01A-11D-A28A-01 TCGA-GM-A5PV-01 NA 96c1cfef-0507-46f5-a007-d0f7369cced5 TCGA-GM-A5PV-01A-11D-A28A-01 |
|
|
1166 |
TCGA-GM-A5PX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-GM-A5PX-01 551 0 days NA NA NA NA NA NA NA NA NA TCGA-GM-A5PX 551 0 days 551 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Left Sentinel lymph node biopsy plus axillary dissection NA NA TCGA-GM-A5PX TCGA-GM-A5PX-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA YES NA NA -23753 616 NA 0 551 NA NA NA NA NA NA 90-99% 1.78 NA 2013-4-12 FEMALE NA NA 30-39% NA 1+ 60 1.98 NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 110 NO Negative Negative NA 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 2 false No M0 N1mi T2 Stage IIB TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf A5PX TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 7th NA NO YES GM Breast A LIVING 2011 76f171dd-1980-4504-8dc2-d8c8264458c9 76f171dd-1980-4504-8dc2-d8c8264458c9 NA NA TCGA-GM-A5PX-01 TCGA-GM-A5PX-01A-12D-A28C-05 e0413f7a-1629-4323-84d0-53d7819eea0e TCGA-GM-A5PX-01 TCGA-GM-A5PX-01A-12D-A28B-09 NA NA TCGA-GM-A5PX-01 NA NA 76f171dd-1980-4504-8dc2-d8c8264458c9 NA TCGA-GM-A5PX-01A-12D-A28A-01 TCGA-GM-A5PX-01 NA 76f171dd-1980-4504-8dc2-d8c8264458c9 TCGA-GM-A5PX-01A-12D-A28A-01 |
|
|
1167 |
TCGA-HN-A2NL-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Basal NA NA NA NA NA NA NA NA NA 0 TCGA-HN-A2NL-01 79 0 days Squamous C4-BRCA/Basal NA BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 1 NA NA TCGA-HN-A2NL 79 0 days 79 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-HN-A2NL-F60149 TCGA-HN-A2NL TCGA-HN-A2NL-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -20483 NA NA 0 79 NA NA NA NA NA NA NA NA NA 2014-5-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Tumor resection 170 NO Negative NA YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf A2NL TUMOR FREE NA NA NA NA NA YES YES NA NA NA Primary Tumor 01 NA 6th NA NO YES HN Breast A LIVING NA 6593576c-a4a8-4284-8591-321f980f2e58 6593576c-a4a8-4284-8591-321f980f2e58 TCGA-HN-A2NL-01A-21-A24A-20 NA TCGA-HN-A2NL-01 TCGA-HN-A2NL-01A-11D-A18O-05 826ef0de-68ba-4771-a305-97f27770407a TCGA-HN-A2NL-01 TCGA-HN-A2NL-01A-11D-A18P-09 NA NA TCGA-HN-A2NL-01 NA NA 6593576c-a4a8-4284-8591-321f980f2e58 NA TCGA-HN-A2NL-01A-11D-A18N-01 TCGA-HN-A2NL-01 NA 6593576c-a4a8-4284-8591-321f980f2e58 TCGA-HN-A2NL-01A-11D-A18N-01 |
|
|
1168 |
TCGA-HN-A2OB-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-HN-A2OB-01 1900 1 days NA NA NA NA NA NA NA NA NA TCGA-HN-A2OB 1552 1 days 1900 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NA NA 45 Right|Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-HN-A2OB-F71891 TCGA-HN-A2OB TCGA-HN-A2OB-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -16672 NA 1900 0 1849 NA NA 1552 NA NA NA NA 1.7 NA 2015-4-1 FEMALE NA NA NA NA NA 60 2.0 1.2 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 320 NO Negative Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA Negative 1+ NA Positive NA NA NA NA 3 Point Scale 3+ 2+ NA NA NA NA Positive NA NA NA NA NA NA 3 Point Scale Bone Distant Metastasis NA NO YES 2 NA false No M0 N1 T2 Stage IIB TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf A2OB WITH TUMOR NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES HN Breast A DECEASED NA f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e NA NA TCGA-HN-A2OB-01 TCGA-HN-A2OB-01A-21D-A27Y-05 27e8a52c-a4b2-4773-afde-1e2dba0e5822 TCGA-HN-A2OB-01 TCGA-HN-A2OB-01A-21D-A27P-09 NA NA TCGA-HN-A2OB-01 NA NA f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e NA TCGA-HN-A2OB-01A-21D-A27O-01 TCGA-HN-A2OB-01 NA f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e TCGA-HN-A2OB-01A-21D-A27O-01 |
|
|
1169 |
TCGA-JL-A3YW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-JL-A3YW-01 360 0 days NA NA NA NA BRCA basal-like c6 NA NA NA NA TCGA-JL-A3YW 360 0 days 360 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Axillary lymph node dissection alone NA NA TCGA-JL-A3YW NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NA NA NA NA NA NA 0 360 NA NA NA NA NA NA 30-39% NA NA 2012-11-8 FEMALE NA NA 30-39% NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Tumor resection NA NA Positive NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 NA No M0 N1 T2 Stage IIB NA A3YW NA NA NA NA NA NA NO YES 30-39% NA NO Primary Tumor 01 NA 7th NA YES NO JL Breast NA LIVING 2011 a550da17-2d06-49ac-96dc-a2204298ddfb a550da17-2d06-49ac-96dc-a2204298ddfb TCGA-JL-A3YW-01A-21-A24B-20 NA TCGA-JL-A3YW-01 TCGA-JL-A3YW-01A-12D-A23D-05 c2d6cdae-b8a7-4d4b-a4ee-b4ff66bd1b38 TCGA-JL-A3YW-01 TCGA-JL-A3YW-01A-12D-A23C-09 NA NA TCGA-JL-A3YW-01 NA NA a550da17-2d06-49ac-96dc-a2204298ddfb NA TCGA-JL-A3YW-01A-12D-A238-01 TCGA-JL-A3YW-01 NA a550da17-2d06-49ac-96dc-a2204298ddfb TCGA-JL-A3YW-01A-12D-A238-01 |
|
|
1170 |
TCGA-JL-A3YX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-JL-A3YX-01 352 0 days NA NA NA NA KIRC-like c1 NA miRNA cluster 4 NA NA TCGA-JL-A3YX 352 0 days 352 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Axillary lymph node dissection alone NA NA TCGA-JL-A3YX TCGA-JL-A3YX-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NA NA NA NA 306 NA 0 352 NA NA NA NA NA NA 30-39% NA NA 2012-11-8 FEMALE NA NA 30-39% NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Tumor resection 900 NO Positive NA NA 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf A3YX NA NA NA NA NA NA NO YES 30-39% NA NO Primary Tumor 01 NA 7th NA YES NO JL Breast A LIVING 2011 b2b92b23-3f2a-4305-8c6c-27c91c67c072 b2b92b23-3f2a-4305-8c6c-27c91c67c072 TCGA-JL-A3YX-01A-21-A24B-20 NA TCGA-JL-A3YX-01 TCGA-JL-A3YX-01A-11D-A230-05 28195fde-9084-494d-9b76-a65c7fe11ba9 TCGA-JL-A3YX-01 TCGA-JL-A3YX-01A-11D-A22X-09 NA NA TCGA-JL-A3YX-01 NA NA b2b92b23-3f2a-4305-8c6c-27c91c67c072 NA TCGA-JL-A3YX-01A-11D-A22W-01 TCGA-JL-A3YX-01 NA b2b92b23-3f2a-4305-8c6c-27c91c67c072 TCGA-JL-A3YX-01A-11D-A22W-01 |
|
|
1171 |
TCGA-LD-A66U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LD-A66U-01 646 0 days NA NA NA NA NA NA NA NA NA TCGA-LD-A66U 646 0 days 646 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-LD-A66U-F63067 TCGA-LD-A66U NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -16101 NA NA 0 646 NA NA NA NA NA NA 90-99% NA NA 2014-7-30 FEMALE NA NA <10% NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Negative NA NO 15 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA NA No MX N1mi T2 Stage IIB NA A66U TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO LD Breast NA LIVING 2012 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 NA NA TCGA-LD-A66U-01 TCGA-LD-A66U-01A-11D-A31V-05 c65aac48-9f36-4802-8509-a1bff8136db3 TCGA-LD-A66U-01 NA NA NA TCGA-LD-A66U-01 NA NA d37ab528-22b6-4b9e-b838-4d90f6d8bc14 NA TCGA-LD-A66U-01A-11D-A31T-01 TCGA-LD-A66U-01 NA d37ab528-22b6-4b9e-b838-4d90f6d8bc14 TCGA-LD-A66U-01A-11D-A31T-01 |
|
|
1172 |
TCGA-LD-A74U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LD-A74U-01 402 0 days NA NA NA NA NA NA NA NA NA TCGA-LD-A74U 402 0 days 402 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 79 Right Axillary lymph node dissection alone NA TCGA-LD-A74U-F69186 TCGA-LD-A74U TCGA-LD-A74U-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA NA NA NA -28981 59 NA 0 402 NA NA NA NA NA NA <10% NA NA 2014-12-30 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 8524/3 C50.9 3+ YES NA Core needle biopsy 210 NO Negative NA NO 12 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 11 NA true Yes M0 N3a T3 Stage IIIC TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf A74U WITH TUMOR NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO LD Breast A LIVING 2013 11782f87-4d58-4897-9a61-7a4605c05eca 11782f87-4d58-4897-9a61-7a4605c05eca NA NA TCGA-LD-A74U-01 TCGA-LD-A74U-01A-13D-A33F-05 F4F6B174-8640-46C3-9913-5F5043856ADA TCGA-LD-A74U-01 NA NA NA TCGA-LD-A74U-01 NA NA 11782f87-4d58-4897-9a61-7a4605c05eca NA TCGA-LD-A74U-01A-13D-A33D-01 TCGA-LD-A74U-01 NA 11782f87-4d58-4897-9a61-7a4605c05eca TCGA-LD-A74U-01A-13D-A33D-01 |
|
|
1173 |
TCGA-LD-A7W5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LD-A7W5-01 216 0 days NA NA NA NA NA NA NA NA NA TCGA-LD-A7W5 216 0 days 216 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-LD-A7W5-F69184 TCGA-LD-A7W5 TCGA-LD-A7W5-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA NO NA NA -19169 83 NA 0 216 NA NA NA NA NA NA 90-99% NA NA 2014-12-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 360 NO Negative NA NO 23 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 23 NA true No M0 N3a T2 Stage IIIC TCGA-LD-A7W5.ADBA741B-AABF-4A33-A61F-C10EE555D175.pdf A7W5 WITH TUMOR NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO LD Breast A LIVING 2013 c83d9436-3f08-4197-9392-ff33fe4c632e c83d9436-3f08-4197-9392-ff33fe4c632e NA NA TCGA-LD-A7W5-01 TCGA-LD-A7W5-01A-22D-A357-05 7DEB3148-9179-4E71-98E3-81DE903CE3E5 TCGA-LD-A7W5-01 NA NA NA TCGA-LD-A7W5-01 NA NA c83d9436-3f08-4197-9392-ff33fe4c632e NA TCGA-LD-A7W5-01A-22D-A350-01 TCGA-LD-A7W5-01 NA c83d9436-3f08-4197-9392-ff33fe4c632e TCGA-LD-A7W5-01A-22D-A350-01 |
|
|
1174 |
TCGA-LD-A7W6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LD-A7W6-01 404 0 days NA NA NA NA NA NA NA NA NA TCGA-LD-A7W6 404 0 days 404 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right|Right Upper Inner Quadrant Axillary lymph node dissection alone NA TCGA-LD-A7W6-F69193 TCGA-LD-A7W6 TCGA-LD-A7W6-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -20077 91 NA 0 404 NA NA NA NA NA NA 90-99% NA NA 2014-12-30 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.2 8524/3 C50.2 3+ YES NA Core needle biopsy 630 NO Negative NA NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA true No M0 N1a T2 Stage IIB TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf A7W6 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO LD Breast A LIVING 2013 da8e08c7-6006-4e66-ae0f-7047177ca02a da8e08c7-6006-4e66-ae0f-7047177ca02a NA NA TCGA-LD-A7W6-01 TCGA-LD-A7W6-01A-81D-A357-05 4F831753-0FF7-4B6E-987C-CCC50799E73D TCGA-LD-A7W6-01 NA NA NA TCGA-LD-A7W6-01 NA NA da8e08c7-6006-4e66-ae0f-7047177ca02a NA TCGA-LD-A7W6-01A-81D-A350-01 TCGA-LD-A7W6-01 NA da8e08c7-6006-4e66-ae0f-7047177ca02a TCGA-LD-A7W6-01A-81D-A350-01 |
|
|
1175 |
TCGA-LD-A9QF-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LD-A9QF-01 323 0 days NA NA NA NA NA NA NA NA NA TCGA-LD-A9QF 323 0 days 323 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Left Sentinel node biopsy alone NA TCGA-LD-A9QF-F69216 TCGA-LD-A9QF TCGA-LD-A9QF-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA YES NA NA -26869 85 NA 0 323 NA NA NA NA NA NA NA NA NA 2014-12-30 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 190 NO Positive NA NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T1c Stage IA TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf A9QF TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO LD Breast A LIVING 2013 c2df60f6-40d5-4fe0-88f8-d168feb0d921 c2df60f6-40d5-4fe0-88f8-d168feb0d921 NA NA TCGA-LD-A9QF-01 TCGA-LD-A9QF-01A-32D-A41Q-05 1D404A66-9E4B-4AA3-9ADA-A5A789ECF185 TCGA-LD-A9QF-01 NA NA NA TCGA-LD-A9QF-01 NA NA c2df60f6-40d5-4fe0-88f8-d168feb0d921 NA TCGA-LD-A9QF-01A-32D-A41E-01 TCGA-LD-A9QF-01 NA c2df60f6-40d5-4fe0-88f8-d168feb0d921 TCGA-LD-A9QF-01A-32D-A41E-01 |
|
|
1176 |
TCGA-LL-A440-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A440-01 759 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A440 759 0 days 759 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-LL-A440-F46387 TCGA-LL-A440 TCGA-LL-A440-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -22497 32 NA 0 759 NA NA NA NA NA NA 90-99% 46 NA 2013-8-7 FEMALE NA NA NA NA 2+ 20 79 1.7 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 200 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes MX N0 (i-) T1c Stage IA TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf A440 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2012 f34965fe-e7d5-48bd-b0a0-575cbd895c5a f34965fe-e7d5-48bd-b0a0-575cbd895c5a NA NA TCGA-LL-A440-01 TCGA-LL-A440-01A-11D-A244-05 4bc983f8-0b5f-456c-88be-f1a7e901255b TCGA-LL-A440-01 TCGA-LL-A440-01A-11D-A243-09 NA NA TCGA-LL-A440-01 NA NA f34965fe-e7d5-48bd-b0a0-575cbd895c5a NA TCGA-LL-A440-01A-11D-A242-01 TCGA-LL-A440-01 NA f34965fe-e7d5-48bd-b0a0-575cbd895c5a TCGA-LL-A440-01A-11D-A242-01 |
|
|
1177 |
TCGA-LL-A441-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A441-01 996 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A441 996 0 days 996 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-LL-A441-F46386 TCGA-LL-A441 TCGA-LL-A441-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA NA -22772 37 NA 0 996 NA NA NA NA NA NA NA NA NA 2013-8-7 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 300 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T1c Stage IA TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf A441 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2012 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 NA NA TCGA-LL-A441-01 TCGA-LL-A441-01A-11D-A244-05 76fc75d8-5131-4ccf-9c99-be1dac58876d TCGA-LL-A441-01 TCGA-LL-A441-01A-11D-A243-09 NA NA TCGA-LL-A441-01 NA NA 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 NA TCGA-LL-A441-01A-11D-A242-01 TCGA-LL-A441-01 NA 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 TCGA-LL-A441-01A-11D-A242-01 |
|
|
1178 |
TCGA-LL-A442-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A442-01 889 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A442 889 0 days 889 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 56 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-LL-A442-F46384 TCGA-LL-A442 TCGA-LL-A442-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -20495 60 NA 0 889 NA NA NA NA NA NA 90-99% 35 NA 2013-8-7 FEMALE NA NA NA NA 2+ 20 60 1.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 140 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes MX N0 (i-) T2 Stage IIA TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf A442 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2012 7c355987-c70f-43f1-94cc-f4d12afe0132 7c355987-c70f-43f1-94cc-f4d12afe0132 NA NA TCGA-LL-A442-01 TCGA-LL-A442-01A-11D-A244-05 068153fa-935a-429c-9719-84aebe91f185 TCGA-LL-A442-01 NA NA NA TCGA-LL-A442-01 NA NA 7c355987-c70f-43f1-94cc-f4d12afe0132 NA TCGA-LL-A442-01A-11D-A242-01 TCGA-LL-A442-01 NA 7c355987-c70f-43f1-94cc-f4d12afe0132 TCGA-LL-A442-01A-11D-A242-01 |
|
|
1179 |
TCGA-LL-A50Y-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A50Y-01 762 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A50Y 762 0 days 762 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 84 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-LL-A50Y-F50406 TCGA-LL-A50Y TCGA-LL-A50Y-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -30934 91 NA 0 762 NA NA NA NA NA NA 90-99% 2.5 NA 2013-10-23 FEMALE NA NA NA NA 2+ 167 2.6 1.0 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 130 NO Equivocal Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes MX N0 T2 Stage IIA TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf A50Y TUMOR FREE NA NA NA NA NA YES YES 90-99% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2012 02a65cb0-158c-478b-b72e-d6bae04429c7 02a65cb0-158c-478b-b72e-d6bae04429c7 NA NA TCGA-LL-A50Y-01 TCGA-LL-A50Y-01A-11D-A268-05 acabe392-7b49-4967-90b5-81ac53cfec8e TCGA-LL-A50Y-01 TCGA-LL-A50Y-01A-11D-A25Q-09 NA NA TCGA-LL-A50Y-01 NA NA 02a65cb0-158c-478b-b72e-d6bae04429c7 NA TCGA-LL-A50Y-01A-11D-A25N-01 TCGA-LL-A50Y-01 NA 02a65cb0-158c-478b-b72e-d6bae04429c7 TCGA-LL-A50Y-01A-11D-A25N-01 |
|
|
1180 |
TCGA-LL-A5YL-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A5YL-01 519 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A5YL 519 0 days 519 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right|Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-LL-A5YL-F59650 TCGA-LL-A5YL TCGA-LL-A5YL-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Simple Mastectomy NA NA NA NA -23395 84 NA 0 519 NA NA NA NA NA NA 90-99% 2.9 NA 2014-5-19 FEMALE NA NA NA NA 3+ 65 2.6 0.9 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 570 NO Positive Negative NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 0 false No MX N1a T2 Stage IIB TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf A5YL NA NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2012 979d9841-337c-47a3-acaf-77d45e276589 979d9841-337c-47a3-acaf-77d45e276589 NA NA TCGA-LL-A5YL-01 TCGA-LL-A5YL-01A-12D-A29O-05 daaf11f9-0595-4ad7-9f96-7a3a0a82513e TCGA-LL-A5YL-01 TCGA-LL-A5YL-01A-12D-A29N-09 NA NA TCGA-LL-A5YL-01 NA NA 979d9841-337c-47a3-acaf-77d45e276589 NA TCGA-LL-A5YL-01A-12D-A29M-01 TCGA-LL-A5YL-01 NA 979d9841-337c-47a3-acaf-77d45e276589 TCGA-LL-A5YL-01A-12D-A29M-01 |
|
|
1181 |
TCGA-LL-A5YM-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A5YM-01 466 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A5YM 258 1 days 466 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 88 Left|Left Upper Inner Quadrant No axillary staging NA TCGA-LL-A5YM-F57541 TCGA-LL-A5YM TCGA-LL-A5YM-01A Negative Positive 3 Point Scale 3+ 3 Point Scale Mastectomy NOS Positive Other NA NA NA NA -32478 131 NA 0 466 NA 258 258 NA NA NA 90-99% 54 NA 2014-3-14 FEMALE NA NA NA NA 2+ 20 172 3.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8541/3 C50.9 3+ YES NA Core needle biopsy 280 NO Equivocal Positive NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify Locoregional Recurrence Skin left chest wall YES YES NA NA false No M0 NX T4b Stage IIIB TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf A5YM WITH TUMOR NA NA NA NA NA NO NO 90-99% NA NO Primary Tumor 01 partial mastectomy 7th NA YES NO LL Breast A LIVING 2012 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 NA NA TCGA-LL-A5YM-01 TCGA-LL-A5YM-01A-11D-A28C-05 38350a57-ff95-4cd4-bf2c-44c934606d80 TCGA-LL-A5YM-01 TCGA-LL-A5YM-01A-11D-A28B-09 NA NA TCGA-LL-A5YM-01 NA NA 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 NA TCGA-LL-A5YM-01A-11D-A28A-01 TCGA-LL-A5YM-01 NA 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 TCGA-LL-A5YM-01A-11D-A28A-01 |
|
|
1182 |
TCGA-LL-A5YN-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A5YN-01 447 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A5YN 447 0 days 447 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right|Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-LL-A5YN-F59362 TCGA-LL-A5YN TCGA-LL-A5YN-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA NO NA NA -16884 41 NA 0 447 NA NA NA NA NA NA 90-99% 54 NA 2014-5-9 FEMALE NA NA NA NA 2+ 20 172 3.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 230 NO Equivocal Positive NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf A5YN TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 844d9d2c-4467-415f-b66d-a4c35c818310 844d9d2c-4467-415f-b66d-a4c35c818310 NA NA TCGA-LL-A5YN-01 TCGA-LL-A5YN-01A-11D-A28C-05 297362a8-ec87-42d7-b56a-25a29b04b91d TCGA-LL-A5YN-01 TCGA-LL-A5YN-01A-11D-A28B-09 NA NA TCGA-LL-A5YN-01 NA NA 844d9d2c-4467-415f-b66d-a4c35c818310 NA TCGA-LL-A5YN-01A-11D-A28A-01 TCGA-LL-A5YN-01 NA 844d9d2c-4467-415f-b66d-a4c35c818310 TCGA-LL-A5YN-01A-11D-A28A-01 |
|
|
1183 |
TCGA-LL-A5YO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A5YO-01 440 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A5YO 440 0 days 440 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-LL-A5YO-F58638 TCGA-LL-A5YO TCGA-LL-A5YO-01A NA Negative NA NA NA NA Negative Lumpectomy NA YES NA NA -18354 47 NA 0 440 NA NA NA NA NA NA NA NA NA 2014-4-17 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO Negative NA NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T1b Stage IA TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf A5YO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 4b5b44ea-8589-4aea-a69f-b5d5041b1acd 4b5b44ea-8589-4aea-a69f-b5d5041b1acd NA NA TCGA-LL-A5YO-01 TCGA-LL-A5YO-01A-21D-A28C-05 62e25802-1209-470d-8fe1-6c17c1c28b71 TCGA-LL-A5YO-01 TCGA-LL-A5YO-01A-21D-A28B-09 NA NA TCGA-LL-A5YO-01 NA NA 4b5b44ea-8589-4aea-a69f-b5d5041b1acd NA TCGA-LL-A5YO-01A-21D-A28A-01 TCGA-LL-A5YO-01 NA 4b5b44ea-8589-4aea-a69f-b5d5041b1acd TCGA-LL-A5YO-01A-21D-A28A-01 |
|
|
1184 |
TCGA-LL-A5YP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A5YP-01 450 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A5YP 450 0 days 450 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right|Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-LL-A5YP-F59323 TCGA-LL-A5YP TCGA-LL-A5YP-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Modified Radical Mastectomy NA NO NA NA -18041 29 NA 0 450 NA NA NA NA NA NA <10% 35 NA 2014-5-8 FEMALE NA NA <10% NA 1+ 20 118 3.4 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 490 NO Negative Positive NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA false Yes M0 N1a T2 Stage IIB TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf A5YP NA NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c NA NA TCGA-LL-A5YP-01 TCGA-LL-A5YP-01A-21D-A28C-05 e0457a11-2e43-40f1-a33b-f7cae98e4073 TCGA-LL-A5YP-01 TCGA-LL-A5YP-01A-21D-A28B-09 NA NA TCGA-LL-A5YP-01 NA NA 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c NA TCGA-LL-A5YP-01A-21D-A28A-01 TCGA-LL-A5YP-01 NA 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c TCGA-LL-A5YP-01A-21D-A28A-01 |
|
|
1185 |
TCGA-LL-A6FP-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A6FP-01 677 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A6FP 677 0 days 677 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 90 Right Upper Outer Quadrant No axillary staging NA TCGA-LL-A6FP-F64050 TCGA-LL-A6FP NA NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -32873 NA NA 0 677 NA NA NA NA NA NA 90-99% 3.1 NA 2014-8-25 FEMALE NA NA NA NA 2+ 549 2.6 0.9 NA Infiltrating Lobular Carcinoma NA Yes NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy NA NA Equivocal Negative NO NA Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA NA No MX NX T2 Stage IIA NA A6FP TUMOR FREE NA NA NA NA NA YES NO 20-29% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast NA LIVING 2012 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 NA NA TCGA-LL-A6FP-01 TCGA-LL-A6FP-01A-11D-A31V-05 abc6d9bf-6269-4601-8200-f1e6758789fb TCGA-LL-A6FP-01 NA NA NA TCGA-LL-A6FP-01 NA NA b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 NA TCGA-LL-A6FP-01A-11D-A31T-01 TCGA-LL-A6FP-01 NA b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 TCGA-LL-A6FP-01A-11D-A31T-01 |
|
|
1186 |
TCGA-LL-A6FQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A6FQ-01 80 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A6FQ NA NA days 80 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-LL-A6FQ-F58204 TCGA-LL-A6FQ TCGA-LL-A6FQ-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -28375 128 NA 0 80 NA NA NA NA NA NA 90-99% NA NA 2014-4-2 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 250 NO Negative NA YES 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 7 0 false No MX N2a T2 Stage IIIA TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf A6FQ NA NA NA NA NA NA NO YES 80-89% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 d490ceb7-e3b2-44ee-8c46-923cbd4374dd d490ceb7-e3b2-44ee-8c46-923cbd4374dd NA NA TCGA-LL-A6FQ-01 TCGA-LL-A6FQ-01A-11D-A31V-05 349f287a-7f9a-4b55-a3ad-0f8527b84b94 TCGA-LL-A6FQ-01 NA NA NA TCGA-LL-A6FQ-01 NA NA d490ceb7-e3b2-44ee-8c46-923cbd4374dd NA TCGA-LL-A6FQ-01A-11D-A31T-01 TCGA-LL-A6FQ-01 NA d490ceb7-e3b2-44ee-8c46-923cbd4374dd TCGA-LL-A6FQ-01A-11D-A31T-01 |
|
|
1187 |
TCGA-LL-A6FR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A6FR-01 489 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A6FR 489 0 days 489 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 50 Right|Right Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-LL-A6FR-F64045 TCGA-LL-A6FR TCGA-LL-A6FR-01A NA Negative NA 1+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -18520 30 NA 0 489 NA NA NA NA NA NA NA NA NA 2014-8-25 FEMALE NA NA NA NA 2+ 20 NA 2.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 250 NO Equivocal Positive NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf A6FR TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 1cefed42-1e09-4bff-b323-55faeaee18e1 1cefed42-1e09-4bff-b323-55faeaee18e1 NA NA TCGA-LL-A6FR-01 TCGA-LL-A6FR-01A-12D-A31V-05 dda737e9-f03b-4125-9b62-3a8fa1e2da16 TCGA-LL-A6FR-01 NA NA NA TCGA-LL-A6FR-01 NA NA 1cefed42-1e09-4bff-b323-55faeaee18e1 NA TCGA-LL-A6FR-01A-12D-A31T-01 TCGA-LL-A6FR-01 NA 1cefed42-1e09-4bff-b323-55faeaee18e1 TCGA-LL-A6FR-01A-12D-A31T-01 |
|
|
1188 |
TCGA-LL-A73Y-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A73Y-01 477 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A73Y 477 0 days 477 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right|Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-LL-A73Y-F67099 TCGA-LL-A73Y TCGA-LL-A73Y-01A NA Negative 3 Point Scale 3+ 3 Point Scale NA Negative Simple Mastectomy NA NO NA NA -24647 55 NA 0 477 NA NA NA NA NA NA NA NA NA 2014-10-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 60 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 T1c Stage IA TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf A73Y TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 535ab8cf-47a9-4541-b3ef-223bba76a13e 535ab8cf-47a9-4541-b3ef-223bba76a13e NA NA TCGA-LL-A73Y-01 TCGA-LL-A73Y-01A-11D-A33F-05 NA TCGA-LL-A73Y-01 NA NA NA TCGA-LL-A73Y-01 NA NA 535ab8cf-47a9-4541-b3ef-223bba76a13e NA TCGA-LL-A73Y-01A-11D-A33D-01 TCGA-LL-A73Y-01 NA 535ab8cf-47a9-4541-b3ef-223bba76a13e TCGA-LL-A73Y-01A-11D-A33D-01 |
|
|
1189 |
TCGA-LL-A73Z-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-LL-A73Z-01 227 1 days NA NA NA NA NA NA NA NA NA TCGA-LL-A73Z 192 1 days 227 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NA NA 55 Left|Left Lower Inner Quadrant No axillary staging NA TCGA-LL-A73Z-F64983 TCGA-LL-A73Z TCGA-LL-A73Z-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Lumpectomy NA NO NA NA -20118 40 227 0 137 NA NA 192 NA NA NA 10-19% 2.2 NA 2014-9-16 FEMALE NA NA NA NA 2+ 243 2.5 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Excisional Biopsy 240 NO Equivocal Negative NO NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Other, specify skin NA NA NA NA NA Brain Distant Metastasis NA NO YES NA NA false No M1 NX T1c Stage IV TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf A73Z WITH TUMOR NA NA NA NA NA YES NO <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A DECEASED 2013 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 NA NA TCGA-LL-A73Z-01 TCGA-LL-A73Z-01A-11D-A32T-05 31B0CE66-3E66-4210-ABBC-82C85BB9902C TCGA-LL-A73Z-01 NA NA NA TCGA-LL-A73Z-01 NA NA 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 NA TCGA-LL-A73Z-01A-11D-A32H-01 TCGA-LL-A73Z-01 NA 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 TCGA-LL-A73Z-01A-11D-A32H-01 |
|
|
1190 |
TCGA-LL-A740-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A740-01 441 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A740 441 0 days 441 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-LL-A740-F65059 TCGA-LL-A740 TCGA-LL-A740-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA NA -22416 37 NA 0 441 NA NA NA NA NA NA NA 2.9 NA 2014-9-18 FEMALE NA NA NA NA 2+ 113 3.3 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 410 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf A740 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 NA NA TCGA-LL-A740-01 TCGA-LL-A740-01A-21D-A32T-05 A13762BD-83CD-4DBC-94FE-1879E3A4B5A4 TCGA-LL-A740-01 NA NA NA TCGA-LL-A740-01 NA NA 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 NA TCGA-LL-A740-01A-21D-A32H-01 TCGA-LL-A740-01 NA 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 TCGA-LL-A740-01A-21D-A32H-01 |
|
|
1191 |
TCGA-LL-A7SZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A7SZ-01 594 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A7SZ 594 0 days 594 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-LL-A7SZ-F66973 TCGA-LL-A7SZ TCGA-LL-A7SZ-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Other NA YES NA NA -18161 63 NA 0 594 NA NA NA NA NA NA 90-99% NA NA 2014-10-29 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 240 NO Negative NA NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 false No MX N1a T2 Stage IIB TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf A7SZ TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 SKIN SPARING RADICAL MASTECTOMY 7th NA YES NO LL Breast A LIVING 2013 e256282c-da2c-4272-a94b-14cf44da6178 e256282c-da2c-4272-a94b-14cf44da6178 NA NA TCGA-LL-A7SZ-01 TCGA-LL-A7SZ-01A-32D-A357-05 C972C687-4BA1-4F38-A073-4A2AB182F8B0 TCGA-LL-A7SZ-01 NA NA NA TCGA-LL-A7SZ-01 NA NA e256282c-da2c-4272-a94b-14cf44da6178 NA TCGA-LL-A7SZ-01A-32D-A350-01 TCGA-LL-A7SZ-01 NA e256282c-da2c-4272-a94b-14cf44da6178 TCGA-LL-A7SZ-01A-32D-A350-01 |
|
|
1192 |
TCGA-LL-A7T0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A7T0-01 376 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A7T0 376 0 days 376 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Lower Inner Quadrant Axillary lymph node dissection alone NA TCGA-LL-A7T0-F64970 TCGA-LL-A7T0 TCGA-LL-A7T0-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -25867 70 NA 0 376 NA NA NA NA NA NA 90-99% NA NA 2014-9-16 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Tumor resection 380 NO Positive NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false No M0 N1a T2 Stage IIB TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf A7T0 TUMOR FREE NA NA NA NA NA NO YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 67e967d6-be17-4fe1-a1fb-197655fad18d 67e967d6-be17-4fe1-a1fb-197655fad18d NA NA TCGA-LL-A7T0-01 TCGA-LL-A7T0-01A-31D-A357-05 NA TCGA-LL-A7T0-01 NA NA NA TCGA-LL-A7T0-01 NA NA 67e967d6-be17-4fe1-a1fb-197655fad18d NA TCGA-LL-A7T0-01A-31D-A350-01 TCGA-LL-A7T0-01 NA 67e967d6-be17-4fe1-a1fb-197655fad18d TCGA-LL-A7T0-01A-31D-A350-01 |
|
|
1193 |
TCGA-LL-A8F5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A8F5-01 596 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A8F5 596 0 days 596 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right|Right Upper Inner Quadrant Sentinel node biopsy alone NA TCGA-LL-A8F5-F66965 TCGA-LL-A8F5 TCGA-LL-A8F5-01A NA Positive 3 Point Scale NA 3 Point Scale NA Negative Lumpectomy NA YES NA NA -22544 78 NA 0 596 NA NA NA NA NA NA 20-29% NA NA 2014-10-29 FEMALE NA NA <10% NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 1+ YES NA Core needle biopsy 230 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf A8F5 TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 3cc7e12e-2bc8-494c-b74a-de071d711410 3cc7e12e-2bc8-494c-b74a-de071d711410 NA NA TCGA-LL-A8F5-01 TCGA-LL-A8F5-01A-11D-A36K-05 FBB89BA4-95C2-4EEE-8248-B344B94C696F TCGA-LL-A8F5-01 NA NA NA TCGA-LL-A8F5-01 NA NA 3cc7e12e-2bc8-494c-b74a-de071d711410 NA TCGA-LL-A8F5-01A-11D-A36I-01 TCGA-LL-A8F5-01 NA 3cc7e12e-2bc8-494c-b74a-de071d711410 TCGA-LL-A8F5-01A-11D-A36I-01 |
|
|
1194 |
TCGA-LL-A9Q3-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LL-A9Q3-01 532 0 days NA NA NA NA NA NA NA NA NA TCGA-LL-A9Q3 532 0 days 532 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 69 Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-LL-A9Q3-F67103 TCGA-LL-A9Q3 TCGA-LL-A9Q3-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -25477 80 NA 0 532 NA NA NA NA NA NA 90-99% NA NA 2014-10-30 FEMALE NA NA NA NA 3+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 610 NO Positive NA NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 28 0 false No MX N3a T3 Stage IIIC TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf A9Q3 TUMOR FREE NA NA NA NA NA YES YES <10% NA YES Primary Tumor 01 NA 7th NA YES NO LL Breast A LIVING 2013 0aad6d2a-1699-4403-8d45-f0b315ec89c7 0aad6d2a-1699-4403-8d45-f0b315ec89c7 NA NA TCGA-LL-A9Q3-01 TCGA-LL-A9Q3-01A-11D-A41Q-05 A26726B7-5B72-4AC3-9EDF-F3F13C2E471F TCGA-LL-A9Q3-01 NA NA NA TCGA-LL-A9Q3-01 NA NA 0aad6d2a-1699-4403-8d45-f0b315ec89c7 NA TCGA-LL-A9Q3-01A-11D-A41E-01 TCGA-LL-A9Q3-01 NA 0aad6d2a-1699-4403-8d45-f0b315ec89c7 TCGA-LL-A9Q3-01A-11D-A41E-01 |
|
|
1195 |
TCGA-LQ-A4E4-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-LQ-A4E4-01 849 0 days NA NA NA NA NA NA NA NA NA TCGA-LQ-A4E4 681 1 days 849 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NA NA 73 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-LQ-A4E4-F52290 TCGA-LQ-A4E4 TCGA-LQ-A4E4-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NO NA NA -26883 414 NA 0 849 NA NA 681 NA NA NA 90-99% 1.1 NA 2013-12-2 FEMALE NA NA NA NA NA 60 1.1 1.05 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 1+ YES NA Core needle biopsy 200 NO NA Negative NO 26 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA Positive NA NA NA NA NA NA NA NA NA NA NA Negative NA NA NA NA NA NA NA Bone Distant Metastasis NA NO YES 3 0 true No MX N1a T3 Stage IIIA TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf A4E4 WITH TUMOR NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA NO YES LQ Breast A LIVING 2011 5965fc49-0ee5-41d8-b673-9ade5c70db71 5965fc49-0ee5-41d8-b673-9ade5c70db71 NA NA TCGA-LQ-A4E4-01 TCGA-LQ-A4E4-01A-11D-A268-05 610e443b-3ef2-4a65-80f9-6d300736ba70 TCGA-LQ-A4E4-01 TCGA-LQ-A4E4-01A-11D-A25Q-09 NA NA TCGA-LQ-A4E4-01 NA NA 5965fc49-0ee5-41d8-b673-9ade5c70db71 NA TCGA-LQ-A4E4-01A-11D-A25N-01 TCGA-LQ-A4E4-01 NA 5965fc49-0ee5-41d8-b673-9ade5c70db71 TCGA-LQ-A4E4-01A-11D-A25N-01 |
|
|
1196 |
TCGA-MS-A51U-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-MS-A51U-01 681 0 days NA NA NA NA NA NA NA NA NA TCGA-MS-A51U 681 0 days 681 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left NA NA TCGA-MS-A51U-F59818 TCGA-MS-A51U TCGA-MS-A51U-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -16213 129 NA 0 681 NA NA NA NA NO NA 90-99% NA NA 2014-6-4 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 190 NO Negative Negative NO 18 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA true No M0 N1 T2 Stage IIB TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf A51U TUMOR FREE NA NA NA NA NA YES YES 20-29% NA YES Primary Tumor 01 NA 7th NA YES NO MS Breast A LIVING 2012 b41dfa6b-a221-4e03-95d7-428781787067 b41dfa6b-a221-4e03-95d7-428781787067 NA NA TCGA-MS-A51U-01 TCGA-MS-A51U-01A-31D-A268-05 8eb29e3b-4e9b-481e-9bb2-564d1ee1a5dc TCGA-MS-A51U-01 TCGA-MS-A51U-01A-31D-A25Q-09 NA NA TCGA-MS-A51U-01 NA NA b41dfa6b-a221-4e03-95d7-428781787067 NA TCGA-MS-A51U-01A-31D-A25N-01 TCGA-MS-A51U-01 NA b41dfa6b-a221-4e03-95d7-428781787067 TCGA-MS-A51U-01A-31D-A25N-01 |
|
|
1197 |
TCGA-OK-A5Q2-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OK-A5Q2-01 64 0 days NA NA NA NA NA NA NA NA NA TCGA-OK-A5Q2 64 0 days 64 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Right Axillary lymph node dissection alone NA NA TCGA-OK-A5Q2 NA NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -21555 NA NA 0 64 NA NA NA NA NA NA 90-99% NA NA 2013-1-22 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA NA NA NA Negative NA NA 13 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 2 NA No MX N1a T2 Stage II NA A5Q2 NA NA NA NA NA NA NA YES 20-29% NA NA Primary Tumor 01 NA 7th NA YES NO OK Breast NA LIVING 2012 b835c127-4f06-4870-a0a4-7f95be0260a4 b835c127-4f06-4870-a0a4-7f95be0260a4 NA NA TCGA-OK-A5Q2-01 TCGA-OK-A5Q2-01A-11D-A27Y-05 NA TCGA-OK-A5Q2-01 TCGA-OK-A5Q2-01A-11D-A27P-09 NA NA TCGA-OK-A5Q2-01 NA NA b835c127-4f06-4870-a0a4-7f95be0260a4 NA TCGA-OK-A5Q2-01A-11D-A27O-01 TCGA-OK-A5Q2-01 NA b835c127-4f06-4870-a0a4-7f95be0260a4 TCGA-OK-A5Q2-01A-11D-A27O-01 |
|
|
1198 |
TCGA-OL-A5D6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-OL-A5D6-01 1104 1 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5D6 1104 0 days 1104 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A5D6-F55437 TCGA-OL-A5D6 TCGA-OL-A5D6-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NA NA NA -26052 1378 1104 0 385 NA NA NA NA NA NA NA NA NA 2014-1-10 FEMALE NA NA NA NA NA NA NA 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 200 NO NA Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 0 true No MX N0 T2 Stage IIA TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf A5D6 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES OL Breast A DECEASED 2009 5657c6b6-ba04-4dd8-8623-2a3834820f7d 5657c6b6-ba04-4dd8-8623-2a3834820f7d NA NA TCGA-OL-A5D6-01 TCGA-OL-A5D6-01A-21D-A27Y-05 NA TCGA-OL-A5D6-01 TCGA-OL-A5D6-01A-21D-A27P-09 NA NA TCGA-OL-A5D6-01 NA NA 5657c6b6-ba04-4dd8-8623-2a3834820f7d NA TCGA-OL-A5D6-01A-21D-A27O-01 TCGA-OL-A5D6-01 NA 5657c6b6-ba04-4dd8-8623-2a3834820f7d TCGA-OL-A5D6-01A-21D-A27O-01 |
|
|
1199 |
TCGA-OL-A5D7-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5D7-01 1780 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5D7 1780 0 days 1780 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 70 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A5D7-F55439 TCGA-OL-A5D7 TCGA-OL-A5D7-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -25643 1415 NA 0 1780 NA NA NA NA NA NA NA NA NA 2014-1-10 FEMALE NA NA NA NA NA NA NA 1.36 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO NA Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 0 true No MX N0 T2 Stage IIA TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf A5D7 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES OL Breast A LIVING 2009 a9f404db-e7fa-49bf-acca-fccd676f2e7c a9f404db-e7fa-49bf-acca-fccd676f2e7c NA NA TCGA-OL-A5D7-01 TCGA-OL-A5D7-01A-11D-A27Y-05 2cdb08fa-d13c-496e-8f53-9852a8a165ef TCGA-OL-A5D7-01 TCGA-OL-A5D7-01A-11D-A27P-09 NA NA TCGA-OL-A5D7-01 NA NA a9f404db-e7fa-49bf-acca-fccd676f2e7c NA TCGA-OL-A5D7-01A-11D-A27O-01 TCGA-OL-A5D7-01 NA a9f404db-e7fa-49bf-acca-fccd676f2e7c TCGA-OL-A5D7-01A-11D-A27O-01 |
|
|
1200 |
TCGA-OL-A5D8-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5D8-01 973 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5D8 973 0 days 973 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Left Lower Outer Quadrant Other (specify) axillary ultrasound TCGA-OL-A5D8-F55438 TCGA-OL-A5D8 TCGA-OL-A5D8-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NO NA NA -14853 1357 NA 0 973 NA NA NA NA NA NA 90-99% 2.25 NA 2014-1-10 FEMALE NA NA NA NA NA 20 2 0.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO NA Negative NO 2 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N0 T3 Stage IIB TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf A5D8 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 6th NA NO YES OL Breast A LIVING 2009 8c435d42-a76a-4078-a593-6a41a2bb6f5e 8c435d42-a76a-4078-a593-6a41a2bb6f5e NA NA TCGA-OL-A5D8-01 TCGA-OL-A5D8-01A-11D-A27Y-05 321a0511-ed95-4937-92b2-5a77c86e1f48 TCGA-OL-A5D8-01 TCGA-OL-A5D8-01A-11D-A27P-09 NA NA TCGA-OL-A5D8-01 NA NA 8c435d42-a76a-4078-a593-6a41a2bb6f5e NA TCGA-OL-A5D8-01A-11D-A27O-01 TCGA-OL-A5D8-01 NA 8c435d42-a76a-4078-a593-6a41a2bb6f5e TCGA-OL-A5D8-01A-11D-A27O-01 |
|
|
1201 |
TCGA-OL-A5DA-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5DA-01 1783 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5DA 1783 0 days 1783 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A5DA-F55440 TCGA-OL-A5DA TCGA-OL-A5DA-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -22411 1407 NA 0 1783 NA NA NA NA NA NA 60-69% NA NA 2014-1-10 FEMALE 1 NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES Ultrasound-guided mammotome biopsy Other method, specify: 240 NO NA Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA 0 true No MX N0 T2 Stage IIA TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf A5DA TUMOR FREE NA NA NA NA NA NO YES 60-69% NA NO Primary Tumor 01 partial mastectomy 6th NA NO YES OL Breast A LIVING 2009 b881706f-5ee8-43da-a691-53c036d94494 b881706f-5ee8-43da-a691-53c036d94494 NA NA TCGA-OL-A5DA-01 TCGA-OL-A5DA-01A-11D-A27Y-05 1e062952-e6da-43a7-ad52-e2eff10461da TCGA-OL-A5DA-01 TCGA-OL-A5DA-01A-11D-A27P-09 NA NA TCGA-OL-A5DA-01 NA NA b881706f-5ee8-43da-a691-53c036d94494 NA TCGA-OL-A5DA-01A-11D-A27O-01 TCGA-OL-A5DA-01 NA b881706f-5ee8-43da-a691-53c036d94494 TCGA-OL-A5DA-01A-11D-A27O-01 |
|
|
1202 |
TCGA-OL-A5RU-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RU-01 1219 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RU 1219 0 days 1219 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A5RU-F56569 TCGA-OL-A5RU TCGA-OL-A5RU-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -23108 826 NA 0 1219 NA NA NA NA NA NA 90-99% NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 1.02 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 430 NO NA Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No MX N1 T1c Stage IIA TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf A5RU TUMOR FREE NA NA NA NA NA YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2010 02873204-1097-45ea-b143-a97f3e047537 02873204-1097-45ea-b143-a97f3e047537 NA NA TCGA-OL-A5RU-01 TCGA-OL-A5RU-01A-11D-A28C-05 63002326-8f58-4457-b841-9d0773e65587 TCGA-OL-A5RU-01 TCGA-OL-A5RU-01A-11D-A28B-09 NA NA TCGA-OL-A5RU-01 NA NA 02873204-1097-45ea-b143-a97f3e047537 NA TCGA-OL-A5RU-01A-11D-A28A-01 TCGA-OL-A5RU-01 NA 02873204-1097-45ea-b143-a97f3e047537 TCGA-OL-A5RU-01A-11D-A28A-01 |
|
|
1203 |
TCGA-OL-A5RV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RV-01 1062 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RV 1062 0 days 1062 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-OL-A5RV-F56564 TCGA-OL-A5RV TCGA-OL-A5RV-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -15820 755 NA 0 1062 NA NA NA NA NA NA 90-99% NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 1.00 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 370 NO NA Negative NO 29 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 20 NA true No MX N3 T2 Stage IIIC TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf A5RV TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2011 2dca31d2-af60-4529-afac-e8838a7ee67c 2dca31d2-af60-4529-afac-e8838a7ee67c NA NA TCGA-OL-A5RV-01 TCGA-OL-A5RV-01A-12D-A28C-05 ec9c3ed3-1246-42ab-9120-6a027f56d494 TCGA-OL-A5RV-01 TCGA-OL-A5RV-01A-12D-A28B-09 NA NA TCGA-OL-A5RV-01 NA NA 2dca31d2-af60-4529-afac-e8838a7ee67c NA TCGA-OL-A5RV-01A-12D-A28A-01 TCGA-OL-A5RV-01 NA 2dca31d2-af60-4529-afac-e8838a7ee67c TCGA-OL-A5RV-01A-12D-A28A-01 |
|
|
1204 |
TCGA-OL-A5RW-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RW-01 1106 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RW 1106 0 days 1106 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 40 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-OL-A5RW-F56568 TCGA-OL-A5RW NA NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -14638 NA NA 0 1106 NA NA NA NA NA NA NA NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 1.91 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy NA NA NA Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA NA No MX N1 T1c Stage IIA NA A5RW TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast NA LIVING 2010 c5a7673a-c45e-4789-a2c8-32889f39c102 c5a7673a-c45e-4789-a2c8-32889f39c102 NA NA TCGA-OL-A5RW-01 TCGA-OL-A5RW-01A-11D-A28C-05 e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75 TCGA-OL-A5RW-01 TCGA-OL-A5RW-01A-11D-A28B-09 NA NA TCGA-OL-A5RW-01 NA NA c5a7673a-c45e-4789-a2c8-32889f39c102 NA TCGA-OL-A5RW-01A-11D-A28A-01 TCGA-OL-A5RW-01 NA c5a7673a-c45e-4789-a2c8-32889f39c102 TCGA-OL-A5RW-01A-11D-A28A-01 |
|
|
1205 |
TCGA-OL-A5RX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RX-01 878 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RX 878 0 days 878 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A5RX-F56570 TCGA-OL-A5RX TCGA-OL-A5RX-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -18942 561 NA 0 878 NA NA NA NA NA NA 90-99% NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 1.0 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO NA Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N0 T1c Stage IA TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf A5RX TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2011 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 NA NA TCGA-OL-A5RX-01 TCGA-OL-A5RX-01A-11D-A28C-05 7f3a5deb-3015-4ca7-aa12-f46870a5da8e TCGA-OL-A5RX-01 TCGA-OL-A5RX-01A-11D-A28B-09 NA NA TCGA-OL-A5RX-01 NA NA 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 NA TCGA-OL-A5RX-01A-11D-A28A-01 TCGA-OL-A5RX-01 NA 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 TCGA-OL-A5RX-01A-11D-A28A-01 |
|
|
1206 |
TCGA-OL-A5RY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RY-01 752 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RY 752 0 days 752 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 52 Right Sentinel node biopsy alone NA TCGA-OL-A5RY-F56565 TCGA-OL-A5RY TCGA-OL-A5RY-01A Negative Positive NA NA NA Mastectomy NOS Negative Lumpectomy NA NA NA NA -19216 421 NA 0 752 NA NA NA NA NA NA 10-19% NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 7.6 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES Ultrasound-guided biopsy Other method, specify: 300 NO NA Positive NO 25 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA true No MX N1 T1c Stage IIA TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf A5RY TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2011 2407816a-86e7-4094-a028-e81c0cda5448 2407816a-86e7-4094-a028-e81c0cda5448 NA NA TCGA-OL-A5RY-01 TCGA-OL-A5RY-01A-21D-A28C-05 7bd9aba2-054f-48ac-ab14-ee53896d353d TCGA-OL-A5RY-01 TCGA-OL-A5RY-01A-21D-A28B-09 NA NA TCGA-OL-A5RY-01 NA NA 2407816a-86e7-4094-a028-e81c0cda5448 NA TCGA-OL-A5RY-01A-21D-A28A-01 TCGA-OL-A5RY-01 NA 2407816a-86e7-4094-a028-e81c0cda5448 TCGA-OL-A5RY-01A-21D-A28A-01 |
|
|
1207 |
TCGA-OL-A5RZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5RZ-01 679 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5RZ 679 0 days 679 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 57 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-OL-A5RZ-F56571 TCGA-OL-A5RZ NA NA Positive NA NA NA NA Negative Simple Mastectomy NA NA NA NA -21038 NA NA 0 679 NA NA NA NA NA NA 30-39% 2.0 NA 2014-2-14 FEMALE NA NA NA NA NA NA 21.0 10.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy NA NA NA Positive NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA NA No MX N0 T1b Stage IA NA A5RZ TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast NA LIVING 2012 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 NA NA TCGA-OL-A5RZ-01 TCGA-OL-A5RZ-01A-11D-A28C-05 aae8eb5d-0797-424c-a2a1-6b8d08c7463e TCGA-OL-A5RZ-01 TCGA-OL-A5RZ-01A-11D-A28B-09 NA NA TCGA-OL-A5RZ-01 NA NA fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 NA TCGA-OL-A5RZ-01A-11D-A28A-01 TCGA-OL-A5RZ-01 NA fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 TCGA-OL-A5RZ-01A-11D-A28A-01 |
|
|
1208 |
TCGA-OL-A5S0-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A5S0-01 620 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A5S0 620 0 days 620 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Right Axillary lymph node dissection alone NA TCGA-OL-A5S0-F56567 TCGA-OL-A5S0 TCGA-OL-A5S0-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -24139 279 NA 0 620 NA NA NA NA NA NA 30-39% NA NA 2014-2-14 FEMALE NA NA NA NA NA NA NA 3.8 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 530 NO NA Positive NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 NA true No MX N1a T2 Stage IIB TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf A5S0 TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2012 f6e02767-7522-4895-bc70-c7de6b1796ab f6e02767-7522-4895-bc70-c7de6b1796ab NA NA TCGA-OL-A5S0-01 TCGA-OL-A5S0-01A-11D-A28C-05 07817555-b5eb-4502-9229-236a38430974 TCGA-OL-A5S0-01 TCGA-OL-A5S0-01A-11D-A28B-09 NA NA TCGA-OL-A5S0-01 NA NA f6e02767-7522-4895-bc70-c7de6b1796ab NA TCGA-OL-A5S0-01A-11D-A28A-01 TCGA-OL-A5S0-01 NA f6e02767-7522-4895-bc70-c7de6b1796ab TCGA-OL-A5S0-01A-11D-A28A-01 |
|
|
1209 |
TCGA-OL-A66H-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66H-01 812 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66H 812 0 days 812 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 74 Right NA NA TCGA-OL-A66H-F58492 TCGA-OL-A66H TCGA-OL-A66H-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -27280 441 NA 0 812 NA NA NA NA NA NA 90-99% 1.7 NA 2014-4-11 FEMALE NA NA NA NA NA NA 1.8 1.03 NA Mucinous Carcinoma NA No NA C50.9 8480/3 C50.9 NA YES NA Fine needle aspiration biopsy 80 NO NA Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N1mi T1c Stage IB TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf A66H TUMOR FREE NA NA NA NA NA NO YES 80-89% NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2012 428ca7a1-6f08-4426-8f2d-28939166df70 428ca7a1-6f08-4426-8f2d-28939166df70 NA NA TCGA-OL-A66H-01 TCGA-OL-A66H-01A-11D-A29O-05 NA TCGA-OL-A66H-01 TCGA-OL-A66H-01A-11D-A29N-09 NA NA TCGA-OL-A66H-01 NA NA 428ca7a1-6f08-4426-8f2d-28939166df70 NA TCGA-OL-A66H-01A-11D-A29M-01 TCGA-OL-A66H-01 NA 428ca7a1-6f08-4426-8f2d-28939166df70 TCGA-OL-A66H-01A-11D-A29M-01 |
|
|
1210 |
TCGA-OL-A66I-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66I-01 714 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66I 714 0 days 714 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 36 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A66I-F58496 TCGA-OL-A66I TCGA-OL-A66I-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -13458 1715 NA 0 714 NA NA NA NA NA NA NA NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.04 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 240 NO NA Negative YES 13 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No MX N1mi T1c Stage IIA TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf A66I TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES OL Breast A LIVING 2008 d92ddf45-68b6-42da-9497-8faabcc50be0 d92ddf45-68b6-42da-9497-8faabcc50be0 NA NA TCGA-OL-A66I-01 TCGA-OL-A66I-01A-21D-A29O-05 3e69923d-a657-4a7f-b605-bd2b9222c94f TCGA-OL-A66I-01 TCGA-OL-A66I-01A-21D-A29N-09 NA NA TCGA-OL-A66I-01 NA NA d92ddf45-68b6-42da-9497-8faabcc50be0 NA TCGA-OL-A66I-01A-21D-A29M-01 TCGA-OL-A66I-01 NA d92ddf45-68b6-42da-9497-8faabcc50be0 TCGA-OL-A66I-01A-21D-A29M-01 |
|
|
1211 |
TCGA-OL-A66J-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66J-01 1996 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66J 1996 0 days 1996 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 80 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A66J-F58495 TCGA-OL-A66J NA NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -29345 NA NA 0 1996 NA NA NA NA NA NA 90-99% NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.50 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy NA NA NA Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA NA No MX N0 T1c Stage I NA A66J TUMOR FREE NA NA NA NA NA NO YES 50-59% NA YES Primary Tumor 01 NA 6th NA NO YES OL Breast NA LIVING 2008 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 NA NA TCGA-OL-A66J-01 TCGA-OL-A66J-01A-11D-A29O-05 cffbe18d-d8c9-4bb3-8916-634e6ad7ab8a TCGA-OL-A66J-01 TCGA-OL-A66J-01A-11D-A29N-09 NA NA TCGA-OL-A66J-01 NA NA fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 NA TCGA-OL-A66J-01A-11D-A29M-01 TCGA-OL-A66J-01 NA fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 TCGA-OL-A66J-01A-11D-A29M-01 |
|
|
1212 |
TCGA-OL-A66K-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-OL-A66K-01 1275 1 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66K 1275 0 days 1275 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A66K-F58498 TCGA-OL-A66K TCGA-OL-A66K-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -26299 981 1275 0 1021 NA NA NA NA NA NA 70-79% NA NA 2014-4-11 FEMALE NA NA NA NA 2+ NA NA 1.23 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 230 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N0 T2 Stage IIA TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf A66K TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A DECEASED 2010 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf NA NA TCGA-OL-A66K-01 TCGA-OL-A66K-01A-11D-A29O-05 97c6fb8d-f158-4f4c-8139-6a886bf38f99 TCGA-OL-A66K-01 TCGA-OL-A66K-01A-11D-A29N-09 NA NA TCGA-OL-A66K-01 NA NA 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf NA TCGA-OL-A66K-01A-11D-A29M-01 TCGA-OL-A66K-01 NA 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf TCGA-OL-A66K-01A-11D-A29M-01 |
|
|
1213 |
TCGA-OL-A66L-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66L-01 1301 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66L 1301 0 days 1301 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Right Lower Inner Quadrant NA NA TCGA-OL-A66L-F58493 TCGA-OL-A66L TCGA-OL-A66L-01A NA Positive NA NA NA NA Positive Lumpectomy NA NA NA NA -26186 952 NA 0 1301 NA NA NA NA NA NA 90-99% NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.10 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 170 NO NA Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N0 T1c Stage IA TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf A66L TUMOR FREE NA NA NA NA NA NO YES 90-99% NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2010 0df01f96-a14b-4bd9-bddb-1dab47491d2d 0df01f96-a14b-4bd9-bddb-1dab47491d2d NA NA TCGA-OL-A66L-01 TCGA-OL-A66L-01A-12D-A31V-05 NA TCGA-OL-A66L-01 NA NA NA TCGA-OL-A66L-01 NA NA 0df01f96-a14b-4bd9-bddb-1dab47491d2d NA TCGA-OL-A66L-01A-12D-A31T-01 TCGA-OL-A66L-01 NA 0df01f96-a14b-4bd9-bddb-1dab47491d2d TCGA-OL-A66L-01A-12D-A31T-01 |
|
|
1214 |
TCGA-OL-A66N-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66N-01 792 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66N 792 0 days 792 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 59 Left Sentinel node biopsy alone NA TCGA-OL-A66N-F58500 TCGA-OL-A66N TCGA-OL-A66N-01A NA Positive NA NA NA NA Negative Modified Radical Mastectomy NA NA NA NA -21608 505 NA 0 792 NA NA NA NA NA NA 80-89% NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.1 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 310 NO NA Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 13 NA true No MX N3 T3 Stage IIIC TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf A66N TUMOR FREE NA NA NA NA NA NO YES NA NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2011 43cde130-82ef-43ca-ba81-8ab14588069c 43cde130-82ef-43ca-ba81-8ab14588069c NA NA TCGA-OL-A66N-01 TCGA-OL-A66N-01A-12D-A31V-05 3acac7e1-22c1-4a61-847d-bda89e3a10c1 TCGA-OL-A66N-01 NA NA NA TCGA-OL-A66N-01 NA NA 43cde130-82ef-43ca-ba81-8ab14588069c NA TCGA-OL-A66N-01A-12D-A31T-01 TCGA-OL-A66N-01 NA 43cde130-82ef-43ca-ba81-8ab14588069c TCGA-OL-A66N-01A-12D-A31T-01 |
|
|
1215 |
TCGA-OL-A66O-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66O-01 528 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66O 528 0 days 528 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 39 Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A66O-F58497 TCGA-OL-A66O TCGA-OL-A66O-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NA NA NA -14272 170 NA 0 528 NA NA NA NA NA NA 90-99% NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.2 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 260 NO NA Negative NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 3 NA true No MX N1a T2 Stage IIB TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf A66O TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2012 c7f57147-b774-4209-8b7f-2666f59543d8 c7f57147-b774-4209-8b7f-2666f59543d8 NA NA TCGA-OL-A66O-01 TCGA-OL-A66O-01A-11D-A31V-05 024e8275-694b-4942-832d-3137b1c5303a TCGA-OL-A66O-01 NA NA NA TCGA-OL-A66O-01 NA NA c7f57147-b774-4209-8b7f-2666f59543d8 NA TCGA-OL-A66O-01A-11D-A31T-01 TCGA-OL-A66O-01 NA c7f57147-b774-4209-8b7f-2666f59543d8 TCGA-OL-A66O-01A-11D-A31T-01 |
|
|
1216 |
TCGA-OL-A66P-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A66P-01 428 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A66P 428 0 days 428 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Sentinel node biopsy alone NA TCGA-OL-A66P-F58494 TCGA-OL-A66P TCGA-OL-A66P-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NA NA NA -27489 98 NA 0 428 NA NA NA NA NA NA NA NA NA 2014-4-11 FEMALE NA NA NA NA NA NA NA 1.13 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 140 NO NA Negative NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA true No MX N0 T2 Stage IIA TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf A66P TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2013 bbd01868-6fc1-42e7-b375-f0ac1a54a43c bbd01868-6fc1-42e7-b375-f0ac1a54a43c NA NA TCGA-OL-A66P-01 TCGA-OL-A66P-01A-11D-A31V-05 737f4dca-ab51-4053-ad90-6654f312ca6d TCGA-OL-A66P-01 NA NA NA TCGA-OL-A66P-01 NA NA bbd01868-6fc1-42e7-b375-f0ac1a54a43c NA TCGA-OL-A66P-01A-11D-A31T-01 TCGA-OL-A66P-01 NA bbd01868-6fc1-42e7-b375-f0ac1a54a43c TCGA-OL-A66P-01A-11D-A31T-01 |
|
|
1217 |
TCGA-OL-A6VO-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A6VO-01 858 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A6VO 858 0 days 858 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 43 Right|Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-OL-A6VO-F59365 TCGA-OL-A6VO TCGA-OL-A6VO-01A NA Negative NA NA NA NA Negative Lumpectomy NA NA NA NA -15780 507 NA 0 858 NA NA NA NA NA NA NA NA NA 2014-5-10 FEMALE NA NA NA NA NA NA NA 1.23 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 120 NO Negative Negative NO 7 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No MX N0 T1c Stage IA TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf A6VO TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2012 5cb12edf-25a1-40f6-831a-5fb1f56676e1 5cb12edf-25a1-40f6-831a-5fb1f56676e1 NA NA TCGA-OL-A6VO-01 TCGA-OL-A6VO-01A-12D-A33F-05 79E2C9D4-0FF5-43E0-B7CE-EF665A49853D TCGA-OL-A6VO-01 NA NA NA TCGA-OL-A6VO-01 NA NA 5cb12edf-25a1-40f6-831a-5fb1f56676e1 NA TCGA-OL-A6VO-01A-12D-A33D-01 TCGA-OL-A6VO-01 NA 5cb12edf-25a1-40f6-831a-5fb1f56676e1 TCGA-OL-A6VO-01A-12D-A33D-01 |
|
|
1218 |
TCGA-OL-A6VQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A6VQ-01 600 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A6VQ 600 0 days 600 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 49 Right NA NA TCGA-OL-A6VQ-F59366 TCGA-OL-A6VQ TCGA-OL-A6VQ-01A Negative Positive NA NA NA Mastectomy NOS Positive Lumpectomy NA NA NA NA -18151 278 NA 0 600 NA NA NA NA NA NA 90-99% NA NA 2014-5-10 FEMALE NA NA NA NA NA NA NA 1.05 NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 110 NO NA Negative NO 1 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No MX N0 T2 Stage IIA TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf A6VQ TUMOR FREE NA NA NA NA NA NO YES 10-19% NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2012 10fbe91f-3570-4cc4-9a86-ea660a86a806 10fbe91f-3570-4cc4-9a86-ea660a86a806 NA NA TCGA-OL-A6VQ-01 TCGA-OL-A6VQ-01A-12D-A41Q-05 EF77266B-ED91-4FDA-AA99-CCCFAA90E687 TCGA-OL-A6VQ-01 NA NA NA TCGA-OL-A6VQ-01 NA NA 10fbe91f-3570-4cc4-9a86-ea660a86a806 NA TCGA-OL-A6VQ-01A-12D-A41E-01 TCGA-OL-A6VQ-01 NA 10fbe91f-3570-4cc4-9a86-ea660a86a806 TCGA-OL-A6VQ-01A-12D-A41E-01 |
|
|
1219 |
TCGA-OL-A6VR-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A6VR-01 1220 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A6VR 1220 0 days 1220 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 48 Right Sentinel lymph node biopsy plus axillary dissection NA TCGA-OL-A6VR-F59367 TCGA-OL-A6VR TCGA-OL-A6VR-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -17702 869 NA 0 1220 NA NA NA NA NA NA 30-39% NA NA 2014-5-10 FEMALE NA NA NA NA NA NA NA 1.23 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 380 NO Negative Negative NO 2 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No MX N0 T1b Stage IA TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf A6VR TUMOR FREE NA NA NA NA NA NO YES 90-99% NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2011 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 NA NA TCGA-OL-A6VR-01 TCGA-OL-A6VR-01A-32D-A33F-05 NA TCGA-OL-A6VR-01 NA NA NA TCGA-OL-A6VR-01 NA NA 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 NA TCGA-OL-A6VR-01A-32D-A33D-01 TCGA-OL-A6VR-01 NA 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 TCGA-OL-A6VR-01A-32D-A33D-01 |
|
|
1220 |
TCGA-OL-A97C-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-OL-A97C-01 271 0 days NA NA NA NA NA NA NA NA NA TCGA-OL-A97C 271 0 days 271 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Left NA NA TCGA-OL-A97C-F66330 TCGA-OL-A97C TCGA-OL-A97C-01A NA Negative NA NA NA NA Negative Simple Mastectomy NA NA NA NA -24735 216 NA 0 271 NA NA NA NA NA NA NA NA NA 2014-10-31 FEMALE NA NA NA NA NA NA NA NA NA Other, specify NA No NA C50.9 9020/3 C50.9 NA YES NA Fine needle aspiration biopsy 410 NO NA Negative NO 6 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T3 Stage IIB TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf A97C TUMOR FREE NA NA NA NA NA NA YES NA NA NO Primary Tumor 01 NA 7th NA NO YES OL Breast A LIVING 2013 590ae2bc-c076-4547-97dc-e2c8a0d396a6 590ae2bc-c076-4547-97dc-e2c8a0d396a6 NA NA TCGA-OL-A97C-01 TCGA-OL-A97C-01A-32D-A41Q-05 NA TCGA-OL-A97C-01 NA NA NA TCGA-OL-A97C-01 NA NA 590ae2bc-c076-4547-97dc-e2c8a0d396a6 NA TCGA-OL-A97C-01A-32D-A41E-01 TCGA-OL-A97C-01 NA 590ae2bc-c076-4547-97dc-e2c8a0d396a6 TCGA-OL-A97C-01A-32D-A41E-01 |
|
|
1221 |
TCGA-PE-A5DC-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-PE-A5DC-01 1430 1 days NA NA NA NA NA NA NA NA NA TCGA-PE-A5DC 1430 0 days 1430 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 72 Right Upper Inner Quadrant NA NA NA TCGA-PE-A5DC TCGA-PE-A5DC-01A NA Positive NA NA NA NA Positive NA NA NA NA NA -26514 2858 1430 0 NA NA NA NA NA NA NA NA NA NA 2013-4-30 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA NA 350 NO Positive NA NA 31 NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA true No M0 N2a T2 Stage IIIA TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf A5DC TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 6th NA NO YES PE Breast A DECEASED 2005 05a8e240-5384-4a03-abeb-7ef3697c946d 05a8e240-5384-4a03-abeb-7ef3697c946d NA NA TCGA-PE-A5DC-01 TCGA-PE-A5DC-01A-12D-A27Y-05 bf2669ec-ff95-4bbd-9d78-451fd90ba389 TCGA-PE-A5DC-01 TCGA-PE-A5DC-01A-12D-A27P-09 NA NA TCGA-PE-A5DC-01 NA NA 05a8e240-5384-4a03-abeb-7ef3697c946d NA TCGA-PE-A5DC-01A-12D-A27O-01 TCGA-PE-A5DC-01 NA 05a8e240-5384-4a03-abeb-7ef3697c946d TCGA-PE-A5DC-01A-12D-A27O-01 |
|
|
1222 |
TCGA-PE-A5DD-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-PE-A5DD-01 1953 0 days NA NA NA NA NA NA NA NA NA TCGA-PE-A5DD 1953 0 days 1953 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right Lower Inner Quadrant NA NA TCGA-PE-A5DD-F66361 TCGA-PE-A5DD TCGA-PE-A5DD-01A NA Positive NA NA NA NA Negative Other NA NA NA NA -23686 2411 NA 0 1953 NA NA NA NA NA NA NA NA NA 2014-10-13 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Incisional Biopsy 270 NO Positive Positive YES 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf A5DD TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Reexc of biopsy site for gross/micro residual disease 6th NA NO YES PE Breast A LIVING 2006 38adc5a4-bf82-4a06-a179-e84dd42593da 38adc5a4-bf82-4a06-a179-e84dd42593da NA NA TCGA-PE-A5DD-01 TCGA-PE-A5DD-01A-12D-A27Y-05 9e583b42-e1d2-4055-bf6d-eb6122474edf TCGA-PE-A5DD-01 TCGA-PE-A5DD-01A-12D-A27P-09 NA NA TCGA-PE-A5DD-01 NA NA 38adc5a4-bf82-4a06-a179-e84dd42593da NA TCGA-PE-A5DD-01A-12D-A27O-01 TCGA-PE-A5DD-01 NA 38adc5a4-bf82-4a06-a179-e84dd42593da TCGA-PE-A5DD-01A-12D-A27O-01 |
|
|
1223 |
TCGA-PE-A5DE-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-PE-A5DE-01 2645 0 days NA NA NA NA NA NA NA NA NA TCGA-PE-A5DE 2645 0 days 2645 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 41 Left NA NA TCGA-PE-A5DE-F66373 TCGA-PE-A5DE TCGA-PE-A5DE-01A NA Positive NA NA NA NA Positive Other NA NA NA NA -15216 2066 NA 0 2645 NA NA NA NA NA NA NA NA NA 2014-10-13 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 190 NO Negative NA NO 1 NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf A5DE TUMOR FREE NA NA NA NA NA YES YES NA NA YES Primary Tumor 01 Partial Mastectomy 6th NA NO YES PE Breast A LIVING 2007 041c71a0-06d5-44a5-8930-7f1dd2a638d1 041c71a0-06d5-44a5-8930-7f1dd2a638d1 NA NA TCGA-PE-A5DE-01 TCGA-PE-A5DE-01A-11D-A27Y-05 9a364ab7-d541-4771-bf12-11b8628cd9f1 TCGA-PE-A5DE-01 TCGA-PE-A5DE-01A-11D-A27P-09 NA NA TCGA-PE-A5DE-01 NA NA 041c71a0-06d5-44a5-8930-7f1dd2a638d1 NA TCGA-PE-A5DE-01A-11D-A27O-01 TCGA-PE-A5DE-01 NA 041c71a0-06d5-44a5-8930-7f1dd2a638d1 TCGA-PE-A5DE-01A-11D-A27O-01 |
|
|
1224 |
TCGA-PL-A8LV-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA TCGA-PL-A8LV-01 NA NA days NA NA NA NA NA NA NA NA NA TCGA-PL-A8LV NA NA days NA days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 54 Right|Right Upper Outer Quadrant No axillary staging NA TCGA-PL-A8LV-F64849 TCGA-PL-A8LV TCGA-PL-A8LV-01A NA NA NA NA NA NA NA NA NA NA NA NA -19746 240 NA 0 -7 NA NA NA NA NA NA NA NA NA 2014-10-17 FEMALE NA NA NA NA NA NA NA NA NA Medullary Carcinoma NA No NA C50.9 8510/3 C50.9 NA YES NA Excisional Biopsy 840 NO NA NA YES NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA false No M0 N0 T4 Stage IIIB TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf A8LV WITH TUMOR NA NA NA NA NA NA NO NA NA NO Primary Tumor 01 NA 7th NA YES NO PL Breast A LIVING 2013 34f3d207-0bfe-4699-b01b-d145942ba488 34f3d207-0bfe-4699-b01b-d145942ba488 NA NA TCGA-PL-A8LV-01 TCGA-PL-A8LV-01A-21D-A41Q-05 E260A9A0-230C-482C-A3E6-9A4DB6ECD90F TCGA-PL-A8LV-01 NA NA NA TCGA-PL-A8LV-01 NA NA 34f3d207-0bfe-4699-b01b-d145942ba488 NA TCGA-PL-A8LV-01A-21D-A41E-01 TCGA-PL-A8LV-01 NA 34f3d207-0bfe-4699-b01b-d145942ba488 TCGA-PL-A8LV-01A-21D-A41E-01 |
|
|
1225 |
TCGA-PL-A8LX-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-PL-A8LX-01 5 0 days NA NA NA NA NA NA NA NA NA TCGA-PL-A8LX NA NA days 5 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 35 Left|Left Upper Outer Quadrant NA NA TCGA-PL-A8LX-F64852 TCGA-PL-A8LX TCGA-PL-A8LX-01A NA NA NA NA NA NA NA NA NA NA NA NA -12840 74 NA 0 5 NA NA NA NA NA NA NA NA NA 2014-10-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 540 NO NA NA YES NA NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone|Liver NA NA NA NA NA NA NA NA NA NA NA NA NA false No M1 N1a T4 Stage IV TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf A8LX WITH TUMOR NA NA NA NA NA NO YES NA NA NO Primary Tumor 01 NA 7th NA YES NO PL Breast A LIVING 2013 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 NA NA TCGA-PL-A8LX-01 TCGA-PL-A8LX-01A-11D-A41Q-05 22B100C7-397E-4940-8A06-94FA7D3F46DC TCGA-PL-A8LX-01 NA NA NA TCGA-PL-A8LX-01 NA NA 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 NA TCGA-PL-A8LX-01A-11D-A41E-01 TCGA-PL-A8LX-01 NA 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 TCGA-PL-A8LX-01A-11D-A41E-01 |
|
|
1226 |
TCGA-PL-A8LY-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-PL-A8LY-01 8 0 days NA NA NA NA NA NA NA NA NA TCGA-PL-A8LY 8 0 days 8 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 30 Right|Right Upper Outer Quadrant NA NA TCGA-PL-A8LY-F64851 TCGA-PL-A8LY TCGA-PL-A8LY-01A NA NA NA NA NA NA NA NA NA NA NA NA -11199 129 NA 0 8 NA NA NA NA NA NA NA NA NA 2014-10-17 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy 350 NO NA NA YES NA NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA false No M0 N0 T3 Stage IIB TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf A8LY WITH TUMOR NA NA NA NA NA NO NO NA NA NO Primary Tumor 01 NA 7th NA YES NO PL Breast A LIVING 2013 2ca5942e-dcbf-46f1-8427-1ea7216dc559 2ca5942e-dcbf-46f1-8427-1ea7216dc559 NA NA TCGA-PL-A8LY-01 TCGA-PL-A8LY-01A-11D-A41Q-05 1133DAAA-33B9-4DA6-B84C-F1C7B576AB64 TCGA-PL-A8LY-01 NA NA NA TCGA-PL-A8LY-01 NA NA 2ca5942e-dcbf-46f1-8427-1ea7216dc559 NA TCGA-PL-A8LY-01A-11D-A41E-01 TCGA-PL-A8LY-01 NA 2ca5942e-dcbf-46f1-8427-1ea7216dc559 TCGA-PL-A8LY-01A-11D-A41E-01 |
|
|
1227 |
TCGA-PL-A8LZ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-PL-A8LZ-01 302 0 days NA NA NA NA NA NA NA NA NA TCGA-PL-A8LZ 302 0 days 302 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Left|Left Upper Outer Quadrant NA NA TCGA-PL-A8LZ-F64850 TCGA-PL-A8LZ NA NA NA NA NA NA NA NA NA NA NA NA NA -10869 NA NA 0 302 NA NA NA NA NA NA NA NA NA 2014-9-15 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Excisional Biopsy NA NA NA NA NO NA NA Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO NA NA NA No M0 N2 T4b Stage IIIB NA A8LZ TUMOR FREE NA NA NA NA NA YES NA NA NA NO Primary Tumor 01 NA 7th NA YES NO PL Breast NA LIVING 2013 de01d9b6-e29d-495e-815a-c7d2a7c15af3 de01d9b6-e29d-495e-815a-c7d2a7c15af3 NA NA TCGA-PL-A8LZ-01 TCGA-PL-A8LZ-01A-31D-A36K-05 NA TCGA-PL-A8LZ-01 NA NA NA TCGA-PL-A8LZ-01 NA NA de01d9b6-e29d-495e-815a-c7d2a7c15af3 NA TCGA-PL-A8LZ-01A-31D-A36I-01 TCGA-PL-A8LZ-01 NA de01d9b6-e29d-495e-815a-c7d2a7c15af3 TCGA-PL-A8LZ-01A-31D-A36I-01 |
|
|
1228 |
TCGA-S3-A6ZF-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-A6ZF-01 572 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-A6ZF 572 0 days 572 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right|Right Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-S3-A6ZF-F67764 TCGA-S3-A6ZF TCGA-S3-A6ZF-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -23650 107 NA 0 572 NA NA NA NA NA CAP scoring guideline 2010 90-99% 39 NA 2014-11-11 FEMALE NA CAP scoring guideline 2010 50-59% NA 2+ 20 60 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 1350 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false No M0 N0 T2 Stage IIA TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf A6ZF TUMOR FREE CAP scoring guideline 2010 NA NA moderate Moderate YES YES 40-49% NA NO Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 4d464cde-4885-4b17-9e02-23be26be0540 4d464cde-4885-4b17-9e02-23be26be0540 NA NA TCGA-S3-A6ZF-01 TCGA-S3-A6ZF-01A-32D-A32T-05 NA TCGA-S3-A6ZF-01 NA NA NA TCGA-S3-A6ZF-01 NA NA 4d464cde-4885-4b17-9e02-23be26be0540 NA TCGA-S3-A6ZF-01A-32D-A32H-01 TCGA-S3-A6ZF-01 NA 4d464cde-4885-4b17-9e02-23be26be0540 TCGA-S3-A6ZF-01A-32D-A32H-01 |
|
|
1229 |
TCGA-S3-A6ZG-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-A6ZG-01 562 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-A6ZG 562 0 days 562 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 71 Left|Left Upper Outer Quadrant Sentinel node biopsy alone NA TCGA-S3-A6ZG-F70438 TCGA-S3-A6ZG TCGA-S3-A6ZG-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Lumpectomy NA YES NA NA -26141 102 NA 0 562 NA NA NA NA NA CAP scoring guideline 2010 90-99% NA NA 2015-2-26 FEMALE NA CAP scoring guidelines 2010 <10% NA NA NA NA NA NA Mixed Histology (please specify) Invasive mixed ductal and lobular carcinoma No NA C50.9 8520/3 C50.9 NA YES NA Excisional Biopsy 980 NO Negative NA NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 0 false No M0 N1 T2 Stage IIB TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf A6ZG TUMOR FREE CAP scoring guideline 2010 NA NA Moderate Moderate YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 0967df37-66ae-4ab3-a1fd-e196d4bc9995 0967df37-66ae-4ab3-a1fd-e196d4bc9995 NA NA TCGA-S3-A6ZG-01 TCGA-S3-A6ZG-01A-22D-A32T-05 CA211F7F-3EF6-4AC7-9C51-321C035AA4AF TCGA-S3-A6ZG-01 NA NA NA TCGA-S3-A6ZG-01 NA NA 0967df37-66ae-4ab3-a1fd-e196d4bc9995 NA TCGA-S3-A6ZG-01A-22D-A32H-01 TCGA-S3-A6ZG-01 NA 0967df37-66ae-4ab3-a1fd-e196d4bc9995 TCGA-S3-A6ZG-01A-22D-A32H-01 |
|
|
1230 |
TCGA-S3-A6ZH-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-A6ZH-01 641 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-A6ZH 641 0 days 641 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 29 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-S3-A6ZH-F68306 TCGA-S3-A6ZH TCGA-S3-A6ZH-01A NA Positive 3 Point Scale NA 3 Point Scale NA Positive Simple Mastectomy NA NO NA NA -10832 158 NA 0 641 NA NA NA NA NA NA 90-99% 69 NA 2014-11-14 FEMALE NA CAP scoring guideline 2010 NA CAP scoring guideline 2010 2+ 20 79 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 580 NO Equivocal Negative NO 21 Negative NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 14 0 false No MX N3a T3 Stage IIIC TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf A6ZH TUMOR FREE CAP scoring guideline 2010 NA NA Strong Strong YES YES 80-89% NA YES Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 4cb51871-a26f-467e-8742-bb7c09b26ed2 4cb51871-a26f-467e-8742-bb7c09b26ed2 NA NA TCGA-S3-A6ZH-01 TCGA-S3-A6ZH-01A-22D-A32T-05 45E0455A-5D80-4D40-ACE5-F70316204288 TCGA-S3-A6ZH-01 NA NA NA TCGA-S3-A6ZH-01 NA NA 4cb51871-a26f-467e-8742-bb7c09b26ed2 NA TCGA-S3-A6ZH-01A-22D-A32H-01 TCGA-S3-A6ZH-01 NA 4cb51871-a26f-467e-8742-bb7c09b26ed2 TCGA-S3-A6ZH-01A-22D-A32H-01 |
|
|
1231 |
TCGA-S3-AA0Z-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA0Z-01 629 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA0Z 629 0 days 629 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-S3-AA0Z-F70168 TCGA-S3-AA0Z TCGA-S3-AA0Z-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Modified Radical Mastectomy NA YES NA NA -23314 204 NA 0 629 NA NA NA NA NA CAP scoring guideline 2010 90-99% 33 NA 2015-2-26 FEMALE NA CAP scoring guideline 2010 10-19% CAP scoring guideline 2010 1+ 20 42 1.3 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 330 NO Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No M0 N1a T2 Stage IIB TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf AA0Z TUMOR FREE CAP scoring guideline 2010 NA NA NA moderate YES YES <10% NA NO Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 cfe44709-9e63-4dd4-9778-80176be7fbd9 cfe44709-9e63-4dd4-9778-80176be7fbd9 NA NA TCGA-S3-AA0Z-01 TCGA-S3-AA0Z-01A-11D-A41Q-05 A46027BA-DFAC-427A-89E3-51088763C0A0 TCGA-S3-AA0Z-01 NA NA NA TCGA-S3-AA0Z-01 NA NA cfe44709-9e63-4dd4-9778-80176be7fbd9 NA TCGA-S3-AA0Z-01A-11D-A41E-01 TCGA-S3-AA0Z-01 NA cfe44709-9e63-4dd4-9778-80176be7fbd9 TCGA-S3-AA0Z-01A-11D-A41E-01 |
|
|
1232 |
TCGA-S3-AA10-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA10-01 586 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA10 586 0 days 586 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 65 Right|Right Upper Outer Quadrant Axillary lymph node dissection alone NA TCGA-S3-AA10-F70441 TCGA-S3-AA10 TCGA-S3-AA10-01A NA Negative 3 Point Scale NA 3 Point Scale NA Negative Simple Mastectomy NA NO NA NA -24075 168 NA 0 586 NA NA NA NA NA CAP scoring guideline 2010 NA NA NA 2015-2-26 FEMALE NA CAP scoring guideline 2010 NA NA 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Fine needle aspiration biopsy 410 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA true No M0 N0 T2 Stage IIA TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf AA10 TUMOR FREE CAP scoring guideline 2010 NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 NA NA TCGA-S3-AA10-01 TCGA-S3-AA10-01A-21D-A41Q-05 F3DF6E4D-CA53-4DEA-B48D-652306B60C77 TCGA-S3-AA10-01 NA NA NA TCGA-S3-AA10-01 NA NA 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 NA TCGA-S3-AA10-01A-21D-A41E-01 TCGA-S3-AA10-01 NA 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 TCGA-S3-AA10-01A-21D-A41E-01 |
|
|
1233 |
TCGA-S3-AA11-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA11-01 421 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA11 421 0 days 421 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 67 Right Sentinel node biopsy alone NA TCGA-S3-AA11-F67563 TCGA-S3-AA11 TCGA-S3-AA11-01A NA Positive 4 Point Scale 2+ 3 Point Scale NA Positive Lumpectomy NA YES NA NA -24813 148 NA 0 421 NA NA NA NA NA CAP scoring guideline 2010 90-99% 40 NA 2014-11-7 FEMALE NA CAP scoring guideline 2010 <10% CAP scoring guideline 2010 2+ 20 59 1.5 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 280 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T2 Stage IIA TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf AA11 TUMOR FREE CAP scoring guideline 2010 NA NA NA NA YES YES 60-69% NA YES Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 NA NA TCGA-S3-AA11-01 TCGA-S3-AA11-01A-31D-A41Q-05 424E9C41-A1FA-4342-AFA8-01DA15FD41E7 TCGA-S3-AA11-01 NA NA NA TCGA-S3-AA11-01 NA NA 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 NA TCGA-S3-AA11-01A-31D-A41E-01 TCGA-S3-AA11-01 NA 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 TCGA-S3-AA11-01A-31D-A41E-01 |
|
|
1234 |
TCGA-S3-AA12-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA12-01 574 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA12 574 0 days 574 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 82 Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-S3-AA12-F70442 TCGA-S3-AA12 TCGA-S3-AA12-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Negative Simple Mastectomy NA NO NA NA -30101 156 NA 0 574 NA NA NA NA NA CAP SCORING GUIDELINE 2010 90-99% NA NA 2015-2-26 FEMALE NA CAP SCORING GUIDELINE 2010 NA CAP SCORING GUIDELINE 2007 1+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 2+ YES NA Core needle biopsy 2190 NO Negative Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Lung|Other, specify left adrenal gland NA NA NA NA NA NA NA NA NA NO 2 0 true Yes MX N1a T3 Stage IIIA TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf AA12 TUMOR FREE CAP SCORING GUIDELINE 2010 NA NA MODERATE MODERATE YES YES NA NA NO Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 a18a4d65-5383-4c29-ac03-959f8b9cb37d a18a4d65-5383-4c29-ac03-959f8b9cb37d NA NA TCGA-S3-AA12-01 TCGA-S3-AA12-01A-11D-A41Q-05 3761BFE6-9A5D-41AB-AA78-DFF11DA7B9B3 TCGA-S3-AA12-01 NA NA NA TCGA-S3-AA12-01 NA NA a18a4d65-5383-4c29-ac03-959f8b9cb37d NA TCGA-S3-AA12-01A-11D-A41E-01 TCGA-S3-AA12-01 NA a18a4d65-5383-4c29-ac03-959f8b9cb37d TCGA-S3-AA12-01A-11D-A41E-01 |
|
|
1235 |
TCGA-S3-AA14-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA14-01 529 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA14 529 0 days 529 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 47 Right Sentinel node biopsy alone NA TCGA-S3-AA14-F70444 TCGA-S3-AA14 TCGA-S3-AA14-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Other NA YES NA NA -17352 127 NA 0 529 NA NA NA NA NA CAP SCORING GUIDELINE 2010 70-79% NA NA 2015-2-26 FEMALE NA CAP SCORING GUIDELINE 2010 70-79% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 290 NO Positive NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 3 true No cM0 (i+) N0 (i+) T1 Stage I TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf AA14 TUMOR FREE CAP SCORING GUIDELINE 2010 NA NA NA NA YES YES 70-79% NA YES Primary Tumor 01 EXCISION WITH NEEDLE WIRE LOCALIZATION 7th NA YES NO S3 Breast A LIVING 2013 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 NA NA TCGA-S3-AA14-01 TCGA-S3-AA14-01A-11D-A41Q-05 0F0662DF-E193-4F71-B2A3-FBE544DA5869 TCGA-S3-AA14-01 NA NA NA TCGA-S3-AA14-01 NA NA eb8b259a-b2b3-4fb1-b9d3-b41480642da7 NA TCGA-S3-AA14-01A-11D-A41E-01 TCGA-S3-AA14-01 NA eb8b259a-b2b3-4fb1-b9d3-b41480642da7 TCGA-S3-AA14-01A-11D-A41E-01 |
|
|
1236 |
TCGA-S3-AA15-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA15-01 525 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA15 525 0 days 525 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 51 Right|Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-S3-AA15-F72098 TCGA-S3-AA15 TCGA-S3-AA15-01A NA Negative NA NA 3 Point Scale NA Negative Simple Mastectomy NA YES NA NA -18659 93 NA 0 525 NA NA NA NA NA CAP SCORING GUIDELINE 2010 NA NA NA 2015-4-10 FEMALE NA CAP SCORING GUIDELINE 2010 NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 990 NO Negative NA NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 2 0 true No cM0 (i+) N1a T2 Stage IIB TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf AA15 TUMOR FREE CAP SCORING GUIDELINE 2010 NA NA NA NA YES YES NA NA YES Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 181e9c9f-7dbd-4f3a-8298-12797c717e1f 181e9c9f-7dbd-4f3a-8298-12797c717e1f NA NA TCGA-S3-AA15-01 TCGA-S3-AA15-01A-11D-A41Q-05 A6D6E30B-1F8A-4B8B-B81C-5E016CBC4561 TCGA-S3-AA15-01 NA NA NA TCGA-S3-AA15-01 NA NA 181e9c9f-7dbd-4f3a-8298-12797c717e1f NA TCGA-S3-AA15-01A-11D-A41E-01 TCGA-S3-AA15-01 NA 181e9c9f-7dbd-4f3a-8298-12797c717e1f TCGA-S3-AA15-01A-11D-A41E-01 |
|
|
1237 |
TCGA-S3-AA17-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-S3-AA17-01 424 0 days NA NA NA NA NA NA NA NA NA TCGA-S3-AA17 424 0 days 424 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 64 Right|Right Lower Outer Quadrant Sentinel node biopsy alone NA TCGA-S3-AA17-F67708 TCGA-S3-AA17 TCGA-S3-AA17-01A NA Positive 3 Point Scale 2+ 3 Point Scale NA Positive Simple Mastectomy NA YES NA NA -23642 92 NA 0 424 NA NA NA NA NA CAP SCORING GUIDELINE 2010 90-99% 35 NA 2014-11-11 FEMALE NA CAP SCORING GUIDELINE 2010 NA CAP SCORING GUIDELINE 2010 2+ 20 61 1.7 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 520 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 1 true Yes cM0 (i+) N1mi T2 Stage IIB TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf AA17 TUMOR FREE CAP SCORING GUIDELINE 2010 NA NA MODERATE STRONG YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA YES NO S3 Breast A LIVING 2013 5e032694-2d7f-4e11-8800-0451ff71e5fe 5e032694-2d7f-4e11-8800-0451ff71e5fe NA NA TCGA-S3-AA17-01 TCGA-S3-AA17-01A-11D-A41Q-05 6D0969F0-27F9-4FF0-B943-F4F4510F917D TCGA-S3-AA17-01 NA NA NA TCGA-S3-AA17-01 NA NA 5e032694-2d7f-4e11-8800-0451ff71e5fe NA TCGA-S3-AA17-01A-11D-A41E-01 TCGA-S3-AA17-01 NA 5e032694-2d7f-4e11-8800-0451ff71e5fe TCGA-S3-AA17-01A-11D-A41E-01 |
|
|
1238 |
TCGA-UL-AAZ6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-UL-AAZ6-01 518 0 days NA NA NA NA NA NA NA NA NA TCGA-UL-AAZ6 518 0 days 518 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 73 Right NA NA TCGA-UL-AAZ6-F69329 TCGA-UL-AAZ6 TCGA-UL-AAZ6-01A NA Positive 3 Point Scale NA NA NA Positive NA NA NA NA NA -26999 187 NA 0 518 NA NA NA NA NA NA 90-99% NA NA 2015-1-5 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA NA 170 NO Positive NA NO NA NA Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA Positive 3+ NA Positive 90-99% NA 50-59% NA 3 Point Scale 3+ 1+ NA NA <10% NA Negative NA NA NA NA NA NA 3 Point Scale NA NA NA NA NO NA NA true No MX N0 T2 Stage IIA TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf AAZ6 TUMOR FREE NA NA NA NA NA YES NA <10% NA NO Primary Tumor 01 NA 7th NA YES NO UL Breast A LIVING 2013 5a6b1292-431d-4057-912f-6c8b8f12aed8 5a6b1292-431d-4057-912f-6c8b8f12aed8 NA NA TCGA-UL-AAZ6-01 TCGA-UL-AAZ6-01A-11D-A41Q-05 2102D1F5-40E4-41EA-A564-27AABF047BF9 TCGA-UL-AAZ6-01 NA NA NA TCGA-UL-AAZ6-01 NA NA 5a6b1292-431d-4057-912f-6c8b8f12aed8 NA TCGA-UL-AAZ6-01A-11D-A41E-01 TCGA-UL-AAZ6-01 NA 5a6b1292-431d-4057-912f-6c8b8f12aed8 TCGA-UL-AAZ6-01A-11D-A41E-01 |
|
|
1239 |
TCGA-UU-A93S-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 1 TCGA-UU-A93S-01 116 1 days NA NA NA NA NA NA NA NA NA TCGA-UU-A93S 116 0 days 116 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 63 Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant No axillary staging NA NA TCGA-UU-A93S TCGA-UU-A93S-01A NA Negative NA NA NA NA Negative Modified Radical Mastectomy NA YES NA NA -23278 22 116 0 NA NA NA NA NA NA NA NA NA NA 2014-11-11 FEMALE NA NA 90-99% NA 3+ NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Core needle biopsy 980 NO Positive NA NA NA Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone|Liver NA NA NA NA NA NA NA NA NA NA NO NA NA true No M1 N3b T4d Stage IV TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf A93S WITH TUMOR NA NA NA NA NA NO NO NA NA NO Primary Tumor 01 NA 7th NA YES NO UU Breast A DECEASED 2013 24ef9702-a1e5-4276-abb2-87088861d471 24ef9702-a1e5-4276-abb2-87088861d471 NA NA TCGA-UU-A93S-01 TCGA-UU-A93S-01A-21D-A41Q-05 49836FDA-BD22-48FC-A520-BC9CA5757C04 TCGA-UU-A93S-01 NA NA NA TCGA-UU-A93S-01 NA NA 24ef9702-a1e5-4276-abb2-87088861d471 NA TCGA-UU-A93S-01A-21D-A41E-01 TCGA-UU-A93S-01 NA 24ef9702-a1e5-4276-abb2-87088861d471 TCGA-UU-A93S-01A-21D-A41E-01 |
|
|
1240 |
TCGA-V7-A7HQ-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-V7-A7HQ-01 2033 0 days NA NA NA NA NA NA NA NA NA TCGA-V7-A7HQ 2033 0 days 2033 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 75 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-V7-A7HQ-F71970 TCGA-V7-A7HQ NA Negative Positive 3 Point Scale 3+ 3 Point Scale Other Positive Modified Radical Mastectomy Additional resection/ margins (taken after first margin positive) NO NA NA -27684 NA NA 0 2033 NA NA NA NA NA NA 60-69% 1.0 NA 2015-3-31 FEMALE NA NA NA NA NA 20 1.1 1.1 NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 NA YES NA Tumor resection NA NA NA Negative NO 18 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 NA NA No M0 N2a T1c Stage IIIA NA A7HQ TUMOR FREE NA NA NA NA Moderate to strong YES YES 80-89% NA YES Primary Tumor 01 NA 6th NA NO YES V7 Breast NA LIVING 2009 d42c079f-31a6-42cd-b02a-ea951b8d15a9 d42c079f-31a6-42cd-b02a-ea951b8d15a9 NA NA TCGA-V7-A7HQ-01 TCGA-V7-A7HQ-01A-11D-A33F-05 NA TCGA-V7-A7HQ-01 NA NA NA TCGA-V7-A7HQ-01 NA NA d42c079f-31a6-42cd-b02a-ea951b8d15a9 NA TCGA-V7-A7HQ-01A-11D-A33D-01 TCGA-V7-A7HQ-01 NA d42c079f-31a6-42cd-b02a-ea951b8d15a9 TCGA-V7-A7HQ-01A-11D-A33D-01 |
|
|
1241 |
TCGA-W8-A86G-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-W8-A86G-01 347 0 days NA NA NA NA NA NA NA NA NA TCGA-W8-A86G 347 0 days 347 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 66 Left|Left Lower Inner Quadrant Sentinel node biopsy alone NA TCGA-W8-A86G-F65574 TCGA-W8-A86G TCGA-W8-A86G-01A Negative Positive 3 Point Scale 1+ 3 Point Scale Other Positive Lumpectomy Mastectomy YES NA NA -24125 126 NA 0 347 NA NA NA NA NA NA 90-99% NA NA 2014-9-25 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 1+ YES NA Core needle biopsy 210 NO Negative NA NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 false Yes MX N0 (i-) T2a Stage IIA TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf A86G TUMOR FREE NA NA NA NA NA YES YES 70-79% NA NO Primary Tumor 01 NA 7th NA YES NO W8 Breast A LIVING 2013 37106eb9-90ee-4468-aded-0709fa4bba47 37106eb9-90ee-4468-aded-0709fa4bba47 NA NA TCGA-W8-A86G-01 TCGA-W8-A86G-01A-21D-A36K-05 3927BD5E-5BB3-45A3-886F-639895BA69F8 TCGA-W8-A86G-01 NA NA NA TCGA-W8-A86G-01 NA NA 37106eb9-90ee-4468-aded-0709fa4bba47 NA TCGA-W8-A86G-01A-21D-A36I-01 TCGA-W8-A86G-01 NA 37106eb9-90ee-4468-aded-0709fa4bba47 TCGA-W8-A86G-01A-21D-A36I-01 |
|
|
1242 |
TCGA-WT-AB41-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-WT-AB41-01 1611 0 days NA NA NA NA NA NA NA NA NA TCGA-WT-AB41 1611 0 days 1611 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 55 Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant No axillary staging NA TCGA-WT-AB41-F66639 TCGA-WT-AB41 TCGA-WT-AB41-01A NA Positive 3 Point Scale 1+ 3 Point Scale NA Positive Modified Radical Mastectomy NA NA NA NA NA 1415 NA 0 1611 NA NA NA NA NA NA 90-99% NA NA 2014-10-21 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Ductal Carcinoma NA No NA C50.9 8500/3 C50.9 3+ YES NA Core needle biopsy 110 NO NA NA NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 1 NA false Yes MX N1mi T2 Stage IIB TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf AB41 TUMOR FREE NA NA NA NA NA YES YES <10% NA NO Primary Tumor 01 NA 7th NA NO YES WT Breast A LIVING 2010 a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa NA NA TCGA-WT-AB41-01 TCGA-WT-AB41-01A-11D-A41Q-05 3A31AEBF-2CC3-4604-8AF6-84DB45550587 TCGA-WT-AB41-01 NA NA NA TCGA-WT-AB41-01 NA NA a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa NA TCGA-WT-AB41-01A-11D-A41E-01 TCGA-WT-AB41-01 NA a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa TCGA-WT-AB41-01A-11D-A41E-01 |
|
|
1243 |
TCGA-WT-AB44-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-WT-AB44-01 883 0 days NA NA NA NA NA NA NA NA NA TCGA-WT-AB44 883 0 days 883 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 77 Left No axillary staging NA TCGA-WT-AB44-F66640 TCGA-WT-AB44 TCGA-WT-AB44-01A NA Positive 3 Point Scale 3+ 3 Point Scale NA Positive Lumpectomy NA NA NA NA NA 656 NA 0 883 NA NA NA NA NA NA 90-99% NA NA 2014-10-21 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 3+ YES NA Core needle biopsy 20 NO Negative NA NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 (i-) T1c Stage IA TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf AB44 TUMOR FREE NA NA NA NA NA YES YES 90-99% NA YES Primary Tumor 01 NA 7th NA NO YES WT Breast A LIVING 2012 77ea5b95-f8df-4fae-b271-182680c4a62a 77ea5b95-f8df-4fae-b271-182680c4a62a NA NA TCGA-WT-AB44-01 TCGA-WT-AB44-01A-11D-A41Q-05 NA TCGA-WT-AB44-01 NA NA NA TCGA-WT-AB44-01 NA NA 77ea5b95-f8df-4fae-b271-182680c4a62a NA TCGA-WT-AB44-01A-11D-A41E-01 TCGA-WT-AB44-01 NA 77ea5b95-f8df-4fae-b271-182680c4a62a TCGA-WT-AB44-01A-11D-A41E-01 |
|
|
1244 |
TCGA-XX-A899-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-XX-A899-01 467 0 days NA NA NA NA NA NA NA NA NA TCGA-XX-A899 467 0 days 467 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-XX-A899-F67626 TCGA-XX-A899 TCGA-XX-A899-01A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17022 181 NA 0 467 NA NA NA NA NA NA 90-99% NA NA 2014-11-11 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 260 NO Negative NA NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 0 false No MX N2a T1c Stage IIIA TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf A899 TUMOR FREE NA NA NA strong strong YES YES 70-79% NA YES Primary Tumor 01 NA 7th NA NO YES XX Breast A LIVING 2013 8e339298-3e3c-4b31-96a9-a842e973e583 8e339298-3e3c-4b31-96a9-a842e973e583 NA NA TCGA-XX-A899-01 TCGA-XX-A899-01A-11D-A36K-05 1D814A7B-DA34-4E53-B6C5-23A22F6B5F10 TCGA-XX-A899-01 NA NA NA TCGA-XX-A899-01 NA NA 8e339298-3e3c-4b31-96a9-a842e973e583 NA TCGA-XX-A899-01A-11D-A36I-01 TCGA-XX-A899-01 NA 8e339298-3e3c-4b31-96a9-a842e973e583 TCGA-XX-A899-01A-11D-A36I-01 |
|
|
1245 |
TCGA-XX-A899-11 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-XX-A899-11 467 0 days NA NA NA NA NA NA NA NA NA TCGA-XX-A899 467 0 days 467 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-XX-A899-F67626 TCGA-XX-A899 TCGA-XX-A899-11A NA Positive NA NA NA NA Positive Modified Radical Mastectomy NA NO NA NA -17022 181 NA 0 467 NA NA NA NA NA NA 90-99% NA NA 2014-11-11 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 510 NO Negative NA NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 5 0 false No MX N2a T1c Stage IIIA NA A899 TUMOR FREE NA NA NA strong strong YES YES 70-79% NA YES Solid Tissue Normal 11 NA 7th NA NO YES XX Breast A LIVING 2013 NA NA NA NA NA NA A8CECAA2-9F67-4079-8D69-3EA987F4BF69 NA NA NA NA NA NA NA NA NA NA NA NA NA NA |
|
|
1246 |
TCGA-XX-A89A-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-XX-A89A-01 488 0 days NA NA NA NA NA NA NA NA NA TCGA-XX-A89A 488 0 days 488 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 68 Left Upper Outer Quadrant NA NA TCGA-XX-A89A-F67425 TCGA-XX-A89A TCGA-XX-A89A-01A NA Positive NA NA NA NA Positive Simple Mastectomy NA NA NA NA -25000 174 NA 0 488 NA NA NA NA NA NA 70-79% NA NA 2014-11-11 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 NA YES NA Core needle biopsy 250 NO Negative NA NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 NA false No MX N0 T3 Stage IIB TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf A89A TUMOR FREE NA NA NA moderately to strongly moderately to strongly NO YES 70-79% NA YES Primary Tumor 01 NA 7th NA NO YES XX Breast A LIVING 2013 501a70d8-3932-49c0-aa13-774756fb89e3 501a70d8-3932-49c0-aa13-774756fb89e3 NA NA TCGA-XX-A89A-01 TCGA-XX-A89A-01A-11D-A36K-05 NA TCGA-XX-A89A-01 NA NA NA TCGA-XX-A89A-01 NA NA 501a70d8-3932-49c0-aa13-774756fb89e3 NA TCGA-XX-A89A-01A-11D-A36I-01 TCGA-XX-A89A-01 NA 501a70d8-3932-49c0-aa13-774756fb89e3 TCGA-XX-A89A-01A-11D-A36I-01 |
|
|
1247 |
TCGA-Z7-A8R5-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-Z7-A8R5-01 3287 0 days NA NA NA NA NA NA NA NA NA TCGA-Z7-A8R5 3287 1 days 3287 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 61 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-Z7-A8R5-F58763 TCGA-Z7-A8R5 TCGA-Z7-A8R5-01A NA Positive 4 Point Scale 1+ 4 Point Scale NA Positive Other NA YES NA NA -22280 2928 NA 0 3287 NA NA 3287 NA NA NA NA NA NA 2014-7-9 FEMALE NA NA NA NA NA NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.9 8520/3 C50.9 2+ YES NA Core needle biopsy 450 NO Negative NA NO 5 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA Bone Locoregional Recurrence NA NA YES 3 3 true Yes MX N1a T3 Stage IIIA TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf A8R5 WITH TUMOR NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 Segmental Mastectomy 6th NA NO YES Z7 Breast A LIVING 2005 43c6d23b-2fcd-499e-82ef-10f15d8ede90 43c6d23b-2fcd-499e-82ef-10f15d8ede90 NA NA TCGA-Z7-A8R5-01 TCGA-Z7-A8R5-01A-42D-A41Q-05 049AE25E-31B6-4E0D-B67F-08B7034BF093 TCGA-Z7-A8R5-01 NA NA NA TCGA-Z7-A8R5-01 NA NA 43c6d23b-2fcd-499e-82ef-10f15d8ede90 NA TCGA-Z7-A8R5-01A-42D-A41E-01 TCGA-Z7-A8R5-01 NA 43c6d23b-2fcd-499e-82ef-10f15d8ede90 TCGA-Z7-A8R5-01A-42D-A41E-01 |
|
|
1248 |
TCGA-Z7-A8R6-01 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 0 TCGA-Z7-A8R6-01 3256 0 days NA NA NA NA NA NA NA NA NA TCGA-Z7-A8R6 3256 0 days 3256 days TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NA NA NA NA 46 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection NA TCGA-Z7-A8R6-F58752 TCGA-Z7-A8R6 TCGA-Z7-A8R6-01A NA Positive 4 Point Scale 2+ 4 Point Scale NA Positive Lumpectomy NA YES NA NA -16955 3020 NA 0 3256 NA NA NA NA NA NA NA NA NA 2014-7-9 FEMALE NA NA NA NA 1+ NA NA NA NA Infiltrating Lobular Carcinoma NA No NA C50.8 8022/3 C50.8 2+ YES NA Tumor resection 520 NO Negative NA NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NO 0 0 true No M0 N0 T1c Stage I TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf A8R6 TUMOR FREE NA NA NA NA NA YES YES NA NA NO Primary Tumor 01 NA 6th NA NO YES Z7 Breast A LIVING 2005 d8a45ca6-8f09-4949-8d55-13259b4826d2 d8a45ca6-8f09-4949-8d55-13259b4826d2 NA NA TCGA-Z7-A8R6-01 TCGA-Z7-A8R6-01A-11D-A41Q-05 DEEEA4DC-9DF5-4D60-92BF-01AEA22171DD TCGA-Z7-A8R6-01 NA NA NA TCGA-Z7-A8R6-01 NA NA d8a45ca6-8f09-4949-8d55-13259b4826d2 NA TCGA-Z7-A8R6-01A-11D-A41E-01 TCGA-Z7-A8R6-01 NA d8a45ca6-8f09-4949-8d55-13259b4826d2 TCGA-Z7-A8R6-01A-11D-A41E-01 |